data_1ojg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ojg _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 46' ' ' ASP . 74.4 p . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.751 0.786 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 47' ' ' MET . 69.5 m-20 -74.75 -65.39 0.87 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.529 1.157 . . . . 0.0 109.967 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 46' ' ' ASP . 26.4 ttt -41.76 -54.76 3.23 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 122.267 1.032 . . . . 0.0 111.146 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 52' ' ' LEU . 13.5 t -58.77 -35.94 73.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.273 1.035 . . . . 0.0 110.158 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 48' ' ' THR . 67.1 ttp85 -39.04 -52.66 1.83 Allowed 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 122.253 1.025 . . . . 0.0 111.855 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -86.06 -55.44 3.94 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -78.2 -45.76 9.81 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.787 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.484 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -56.64 -41.82 77.82 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 120.894 2.347 . . . . 0.0 105.068 176.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.05 -59.39 4.22 Favored 'General case' 0 C--O 1.206 -1.184 0 C-N-CA 117.613 -1.635 . . . . 0.0 107.86 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -74.85 -68.36 0.55 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.457 -1.402 . . . . 0.0 112.457 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 51' ' ' GLY . 25.7 mtpp -47.75 -41.56 23.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 112.703 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' O ' ' HB1' ' A' ' 60' ' ' ALA . . . -86.62 -27.28 23.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 119.103 -2.248 . . . . 0.0 110.246 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.7 tp -62.93 -46.4 87.97 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 120.187 -1.571 . . . . 0.0 107.711 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.02 77.3 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 t -76.44 -30.72 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 119.378 -2.076 . . . . 0.0 107.261 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 56' ' ' ALA . . . -64.44 -28.55 69.75 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 176.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -78.85 -16.89 56.49 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.398 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.0 m -72.29 -43.61 63.97 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 115.499 -2.48 . . . . 0.0 107.149 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 3.8 mm? -85.71 -36.18 20.37 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.313 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 69' ' ' ILE . . . -62.21 -13.66 30.01 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.492 ' N ' ' C ' ' A' ' 63' ' ' LEU . 16.3 t0 -94.52 -11.35 29.77 Favored 'General case' 0 N--CA 1.518 2.975 0 CA-C-N 112.652 -2.067 . . . . 0.0 112.07 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.522 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -66.38 -152.83 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.97 0 O-C-N 120.054 -1.653 . . . . 0.0 109.695 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -104.11 -38.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.478 2.119 . . . . 0.0 113.582 178.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 7.1 pt-20 -48.32 -29.65 4.12 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.763 1.268 . . . . 0.0 108.104 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.824 HG23 ' O ' ' A' ' 64' ' ' ALA . 42.9 mm -56.44 -78.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.028 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' ILE . 45.2 ttt85 -46.19 -31.23 2.32 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -79.16 -14.24 59.22 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.683 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -83.69 -43.82 7.11 Favored Glycine 0 N--CA 1.487 2.085 1 N-CA-C 101.966 -4.454 . . . . 0.0 101.966 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 mp -49.31 -39.9 32.96 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.35 -2.87 4.95 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 72' ' ' GLY . 20.5 tptt -122.73 -158.15 0.77 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.238 -1.539 . . . . 0.0 108.306 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.458 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -133.69 168.78 16.18 Favored Pre-proline 0 CA--C 1.569 1.684 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -38.59 -73.53 0.04 OUTLIER 'Trans proline' 0 N--CA 1.521 3.12 0 C-N-CA 124.927 3.751 . . . . 0.0 117.996 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.492 ' CD ' ' H ' ' A' ' 78' ' ' GLN . 2.2 mp0 -56.08 -14.25 2.52 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -174.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.458 ' OE1' ' NZ ' ' A' ' 76' ' ' LYS . 44.3 tt0 -121.74 2.76 10.07 Favored 'General case' 0 N--CA 1.514 2.757 0 O-C-N 120.61 -1.306 . . . . 0.0 110.78 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.484 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 40.4 t -66.97 -154.78 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.889 -1.132 . . . . 0.0 109.218 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.484 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . -149.58 64.95 0.39 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.405 ' CD1' ' H ' ' A' ' 100' ' ' VAL . 3.7 tp -76.22 7.41 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.737 -0.86 . . . . 0.0 110.455 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -63.48 -26.78 68.88 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 120.329 -1.482 . . . . 0.0 112.837 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.893 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -83.12 -60.63 2.09 Favored 'General case' 0 C--O 1.202 -1.442 0 O-C-N 118.861 -2.399 . . . . 0.0 108.622 -176.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.876 ' O ' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -41.51 -43.88 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.249 0 CA-C-N 123.517 2.871 . . . . 0.0 105.756 172.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.678 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -44.25 -25.07 0.2 Allowed 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 121.498 1.954 . . . . 0.0 108.143 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.893 ' N ' ' O ' ' A' ' 84' ' ' ALA . 53.6 mt-10 -52.21 -33.89 43.1 Favored 'General case' 0 N--CA 1.536 3.849 0 N-CA-C 102.352 -3.203 . . . . 0.0 102.352 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.876 ' N ' ' O ' ' A' ' 85' ' ' ILE . . . -68.82 -29.81 68.22 Favored 'General case' 0 N--CA 1.52 3.028 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.609 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.678 ' N ' ' O ' ' A' ' 86' ' ' ALA . 1.8 t -55.0 -55.8 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 O-C-N 120.525 -1.359 . . . . 0.0 107.656 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -56.22 -59.9 4.27 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.66 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -54.89 -49.98 69.87 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.024 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -57.8 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.949 -1.094 . . . . 0.0 110.475 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -148.33 27.4 0.93 Allowed 'General case' 0 N--CA 1.513 2.676 0 CA-C-N 122.258 2.299 . . . . 0.0 113.029 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.9 t70 70.74 -1.34 2.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.973 -1.079 . . . . 0.0 108.742 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 1.3 pp -146.06 162.36 38.07 Favored 'General case' 0 N--CA 1.519 2.996 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.7 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.501 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER 152.91 170.69 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.361 0 CA-C-O 117.513 -1.232 . . . . 0.0 108.245 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.664 ' CD1' ' CD2' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -119.75 82.8 1.94 Allowed 'General case' 0 C--O 1.215 -0.752 1 N-CA-C 96.318 -5.438 . . . . 0.0 96.318 166.605 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.5 tt -87.94 110.46 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -120.56 137.69 53.51 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.975 0 CA-C-N 112.173 -2.285 . . . . 0.0 113.424 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.405 ' H ' ' CD1' ' A' ' 82' ' ' ILE . 38.9 t -113.98 140.18 35.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 1 N-CA-C 97.953 -4.832 . . . . 0.0 97.953 171.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 102' ' ' ASP . 38.0 p -122.06 145.28 48.3 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 120.767 1.621 . . . . 0.0 111.192 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 104' ' ' GLN . 66.3 t0 -74.18 -168.07 0.59 Allowed 'General case' 0 C--N 1.319 -0.746 1 N-CA-C 99.914 -4.106 . . . . 0.0 99.914 168.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.587 ' SD ' ' O ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -78.64 66.1 4.07 Favored 'General case' 0 C--N 1.274 -2.694 0 C-N-CA 115.207 -2.597 . . . . 0.0 104.985 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 102' ' ' ASP . 5.1 tm0? -170.89 107.93 0.29 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 101.179 -3.638 . . . . 0.0 101.179 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.694 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 29.1 t -61.67 161.17 10.33 Favored 'General case' 0 CA--C 1.462 -2.408 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.693 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.694 ' HB2' ' O ' ' A' ' 105' ' ' SER . 12.1 tp 153.5 142.27 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.475 ' CZ ' ' CE2' ' A' ' 97' ' ' PHE . 99.1 mtt180 -75.68 109.44 9.27 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -70.94 -34.68 71.73 Favored 'General case' 0 C--N 1.262 -3.216 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.493 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 1.1 t -119.84 157.75 28.03 Favored 'General case' 0 C--O 1.196 -1.746 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.657 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.765 ' HD1' ' N ' ' A' ' 112' ' ' GLU . 47.1 t-80 169.86 140.12 0.07 OUTLIER Pre-proline 0 N--CA 1.524 3.228 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.37 -55.86 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 CA-C-N 120.561 1.236 . . . . 0.0 109.136 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.765 ' N ' ' HD1' ' A' ' 110' ' ' HIS . 34.0 mt-10 -79.75 142.48 35.36 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.46 -42.91 24.3 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.548 -0.72 . . . . 0.0 112.638 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -60.87 -35.64 77.13 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.529 ' NH2' ' OE1' ' A' ' 112' ' ' GLU . 3.8 tpp180 -61.96 -31.72 72.08 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 119.39 -2.069 . . . . 0.0 108.151 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.657 ' O ' ' N ' ' A' ' 118' ' ' GLN . 55.6 mt -51.69 -82.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.242 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.428 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -33.96 -11.69 0.0 OUTLIER Glycine 0 N--CA 1.498 2.793 0 CA-C-O 119.156 -0.802 . . . . 0.0 113.97 -175.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 116' ' ' ILE . 6.2 mm-40 -80.79 -70.5 0.16 Allowed Pre-proline 0 N--CA 1.503 2.223 0 CA-C-N 121.383 2.591 . . . . 0.0 113.369 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 17.4 Cg_exo -29.91 117.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 124.196 3.264 . . . . 0.0 114.651 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.626 ' C ' ' H ' ' A' ' 122' ' ' GLY . 85.3 t80 -175.37 149.86 1.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 123' ' ' ASP . 27.3 ttpt 48.95 11.32 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.327 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.626 ' H ' ' C ' ' A' ' 120' ' ' PHE . . . -46.28 -12.54 0.06 OUTLIER Glycine 0 N--CA 1.501 2.967 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 121' ' ' LYS . 4.2 m-20 62.71 -11.88 0.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.585 -0.95 . . . . 0.0 111.232 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 122' ' ' GLY . 49.8 m-20 -75.34 -29.4 59.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.3 pt -78.03 -34.24 19.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.654 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -38.5 -32.62 0.08 Allowed 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.536 -0.727 . . . . 0.0 110.289 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -90.55 -40.23 12.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.157 -0.965 . . . . 0.0 109.571 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -78.74 -48.15 15.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.971 -1.08 . . . . 0.0 109.192 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.599 ' C ' HD21 ' A' ' 130' ' ' ASN . 1.5 mt -36.44 -42.03 0.32 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 123.171 1.463 . . . . 0.0 108.053 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.599 HD21 ' C ' ' A' ' 129' ' ' LEU . 3.8 m120 -102.44 22.04 14.14 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.078 -1.419 . . . . 0.0 113.388 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 132' ' ' GLU . . . 87.16 100.87 0.84 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 131' ' ' GLY . 4.1 tp10 167.75 140.47 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.069 0 CA-C-N 113.551 -1.325 . . . . 0.0 113.394 175.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -81.77 142.29 32.74 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.923 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 4.0 t-20 -162.55 144.9 10.84 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.248 -1.533 . . . . 0.0 110.592 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 147' ' ' ARG . 8.6 p -135.58 151.86 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 O-C-N 119.774 -1.829 . . . . 0.0 108.29 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -159.48 162.7 35.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.82 -1.175 . . . . 0.0 109.372 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.59 141.71 16.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 122.214 1.007 . . . . 0.0 112.49 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -106.9 159.63 16.11 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -147.97 103.04 3.45 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.082 -1.636 . . . . 0.0 110.376 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -143.15 161.52 27.59 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.311 -2.316 . . . . 0.0 107.311 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.596 ' C ' ' H ' ' A' ' 143' ' ' ALA . 84.0 m-85 -44.13 118.77 1.58 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.216 -1.167 . . . . 0.0 109.675 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.466 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 0.3 OUTLIER 62.7 -11.17 0.08 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.423 -0.798 . . . . 0.0 109.024 -179.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.596 ' H ' ' C ' ' A' ' 141' ' ' PHE . . . -81.31 -10.9 59.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.771 -1.206 . . . . 0.0 112.772 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 143' ' ' ALA . 93.0 mt-30 -40.9 114.44 0.48 Allowed 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 167' ' ' LEU . . . -158.85 160.15 35.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.111 -1.618 . . . . 0.0 111.238 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 tp -105.19 160.81 14.79 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.79 -1.194 . . . . 0.0 108.285 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.484 ' O ' ' CG2' ' A' ' 135' ' ' VAL . 12.4 ptt180 -150.01 146.21 26.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.766 -1.209 . . . . 0.0 109.294 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 m -105.53 167.65 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 CA-C-O 122.008 0.908 . . . . 0.0 109.152 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 32.6 m-85 -134.98 138.63 44.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 p -144.48 157.56 55.67 Favored Pre-proline 0 C--N 1.308 -1.238 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -102.33 152.6 0.29 Allowed 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.369 2.713 . . . . 0.0 114.983 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 83.2 mt -113.48 134.94 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.48 ' C ' ' H ' ' A' ' 155' ' ' GLU . 66.6 m-85 -102.04 142.45 33.3 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.455 -0.778 . . . . 0.0 111.884 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 26.7 t70 -58.87 -2.41 0.23 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.586 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 154' ' ' ASP . 56.1 tt0 98.25 21.52 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -140.78 19.13 2.33 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 15.3 t60 69.35 11.47 8.11 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -96.1 116.76 29.47 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.668 ' N ' ' NE2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -65.08 122.58 17.37 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.5 pp -137.62 1.89 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 O-C-N 120.841 -1.162 . . . . 0.0 113.541 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.75 176.08 41.91 Favored Glycine 0 N--CA 1.507 3.4 0 C-N-CA 119.243 -1.456 . . . . 0.0 110.587 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.18 145.92 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 O-C-N 121.175 -1.191 . . . . 0.0 112.939 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.65 116.07 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -113.07 157.51 21.5 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 48.9 mt -146.4 107.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.433 ' HA2' ' CD2' ' A' ' 97' ' ' PHE . . . -108.84 122.64 6.65 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.54 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.518 ' O ' ' CB ' ' A' ' 145' ' ' ALA . 27.1 tp -85.61 108.95 18.23 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 169' ' ' LEU . 10.8 tm-20 -53.94 -36.37 62.72 Favored 'General case' 0 N--CA 1.518 2.93 0 O-C-N 123.786 0.679 . . . . 0.0 110.239 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.48 ' CB ' ' O ' ' A' ' 168' ' ' GLU . 4.4 tp . . . . . 0 N--CA 1.51 2.553 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.794 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' MET . 76.2 m-20 -75.61 -59.02 2.93 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.41 1.1 . . . . 0.0 108.648 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.499 ' C ' ' SD ' ' A' ' 47' ' ' MET . 0.9 OUTLIER -36.97 -62.27 0.5 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 123.066 1.412 . . . . 0.0 109.666 -177.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 52' ' ' LEU . 5.9 t -54.78 -41.37 70.46 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.092 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' THR . 50.7 ttp180 -35.57 -51.22 0.63 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.661 -1.274 . . . . 0.0 112.57 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -91.55 -53.77 4.18 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -71.96 -47.3 32.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -176.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 48' ' ' THR . 0.9 OUTLIER -56.99 -44.06 82.32 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 175.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.09 -55.8 13.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 118.081 -1.447 . . . . 0.0 109.932 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -83.53 -62.92 1.46 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.399 -1.438 . . . . 0.0 112.989 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.542 ' HZ2' ' NH1' ' A' ' 92' ' ' ARG . 5.3 ptmt -52.55 -34.69 51.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.456 -0.778 . . . . 0.0 111.217 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 57' ' ' LEU . . . -84.89 -31.62 23.6 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 119.443 -2.036 . . . . 0.0 109.176 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 56' ' ' ALA . 4.8 tt -47.24 -46.12 24.2 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.35 -1.469 . . . . 0.0 108.165 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 61' ' ' ARG . . . -67.86 -41.3 83.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.685 -1.884 . . . . 0.0 110.208 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.0 t -52.73 -45.89 49.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 O-C-N 120.065 -1.647 . . . . 0.0 107.504 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.77 -24.13 5.53 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -73.59 -37.15 65.56 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 115.799 -2.36 . . . . 0.0 111.647 -178.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 m -57.71 -29.21 64.52 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 119.58 -1.95 . . . . 0.0 107.595 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.752 ' HB3' HD11 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -74.56 -26.13 59.74 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 117.59 -1.644 . . . . 0.0 108.051 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.65 -12.28 59.51 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-O 117.668 -1.158 . . . . 0.0 110.952 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.456 ' OD2' ' NH1' ' A' ' 61' ' ' ARG . 3.9 m-20 -103.96 -24.8 13.21 Favored 'General case' 0 N--CA 1.51 2.555 0 CA-C-N 123.367 2.803 . . . . 0.0 113.853 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.534 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -76.61 -161.1 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 119.793 -1.817 . . . . 0.0 111.91 -175.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.606 ' HD2' ' H ' ' A' ' 68' ' ' GLU . 6.6 Cg_endo -109.92 -38.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 124.049 3.166 . . . . 0.0 114.172 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.606 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 2.5 pt-20 -52.01 -33.16 37.14 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.401 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.631 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.3 mp -58.71 -73.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.909 0.861 . . . . 0.0 111.744 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -48.46 -37.0 16.16 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -75.68 -14.08 60.34 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -82.01 -39.27 11.8 Favored Glycine 0 CA--C 1.486 -1.761 0 N-CA-C 103.324 -3.91 . . . . 0.0 103.324 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.412 ' C ' ' H ' ' A' ' 75' ' ' LYS . 6.3 mp -56.81 -29.62 62.93 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -64.18 -3.78 3.05 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' CG ' ' H ' ' A' ' 76' ' ' LYS . 26.5 tptt -134.97 -150.58 0.39 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 78' ' ' GLN . 2.1 pttt -122.41 157.95 57.41 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 123.943 0.897 . . . . 0.0 109.119 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.669 ' O ' ' CE2' ' A' ' 108' ' ' TYR . 7.3 Cg_exo -29.0 -16.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.516 2.821 1 C-N-CA 125.551 4.167 . . . . 0.0 118.281 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 76' ' ' LYS . 83.0 mt-30 -90.37 1.66 56.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.191 -2.193 . . . . 0.0 108.918 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -132.68 2.3 3.74 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.659 ' N ' ' OH ' ' A' ' 108' ' ' TYR . 2.5 m -68.57 -156.75 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.146 -2.221 . . . . 0.0 108.863 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -150.11 58.11 0.45 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.725 HD13 HD12 ' A' ' 85' ' ' ILE . 2.2 tp -49.55 -7.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 C-N-CA 123.203 0.601 . . . . 0.0 110.766 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.435 ' H ' ' C ' ' A' ' 81' ' ' GLY . 86.6 mt-30 -47.38 -43.67 23.58 Favored 'General case' 0 C--N 1.269 -2.908 0 O-C-N 120.046 -1.659 . . . . 0.0 114.397 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.823 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -87.88 -53.34 4.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 119.365 -2.085 . . . . 0.0 110.122 -173.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.892 ' O ' ' N ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -46.32 -51.64 3.98 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.707 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 172.007 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.785 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -44.41 -21.93 0.06 Allowed 'General case' 0 N--CA 1.507 2.399 0 O-C-N 119.237 -2.164 . . . . 0.0 107.225 174.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.823 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.5 tt0 -48.47 -28.83 3.56 Favored 'General case' 1 N--CA 1.544 4.245 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 171.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.892 ' N ' ' O ' ' A' ' 85' ' ' ILE . . . -71.28 -28.05 63.86 Favored 'General case' 0 N--CA 1.515 2.778 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.698 172.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.785 ' N ' ' O ' ' A' ' 86' ' ' ALA . 33.0 m -65.69 -43.95 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.255 0 C-N-CA 116.241 -2.184 . . . . 0.0 110.346 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.412 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 19.6 mtp-105 -56.19 -52.08 65.71 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -58.19 -30.69 66.64 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.383 -1.327 . . . . 0.0 108.63 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.542 ' NH1' ' HZ2' ' A' ' 55' ' ' LYS . 6.5 mmm180 -76.33 -93.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.193 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.679 ' N ' ' ND2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -144.44 31.12 1.21 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.679 -1.263 . . . . 0.0 111.724 -177.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 60.7 24.07 13.9 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.292 -1.505 . . . . 0.0 109.414 -175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 96' ' ' LEU . 2.7 pp -167.13 160.08 13.55 Favored 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.575 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.418 ' CD2' ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER 164.62 176.77 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.934 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -177.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 109' ' ' SER . 58.5 m-85 -136.75 80.51 1.82 Allowed 'General case' 0 C--O 1.214 -0.774 1 N-CA-C 99.295 -4.335 . . . . 0.0 99.295 170.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.7 tt -100.06 118.36 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.717 ' CG1' ' H ' ' A' ' 164' ' ' ALA . 10.9 p -98.7 131.93 44.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 CA-C-O 124.587 2.137 . . . . 0.0 111.067 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.435 HG22 HD12 ' A' ' 85' ' ' ILE . 97.1 t -132.9 109.95 14.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 1 N-CA-C 98.02 -4.807 . . . . 0.0 98.02 175.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.535 ' OG1' ' N ' ' A' ' 102' ' ' ASP . 1.2 t -130.6 170.69 13.94 Favored 'General case' 0 CA--C 1.461 -2.445 0 CA-C-O 122.386 1.088 . . . . 0.0 108.319 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 104' ' ' GLN . 44.4 t0 -78.9 -174.7 4.12 Favored 'General case' 0 C--N 1.269 -2.906 1 N-CA-C 99.458 -4.275 . . . . 0.0 99.458 169.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.89 72.35 0.09 Allowed 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 113.471 -3.292 . . . . 0.0 104.78 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.684 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.5 tp-100 -140.7 -52.24 0.47 Allowed 'General case' 0 C--N 1.364 1.198 0 O-C-N 119.453 -2.029 . . . . 0.0 111.057 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 104' ' ' GLN . 2.1 t 97.38 137.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.372 1.069 . . . . 0.0 108.794 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER 157.44 95.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 178.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.583 ' NH2' HH11 ' A' ' 147' ' ' ARG . 1.4 mtt180 -39.43 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 112.524 -2.125 . . . . 0.0 110.167 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.669 ' CE2' ' O ' ' A' ' 77' ' ' PRO . 1.1 t80 -57.22 -26.18 60.27 Favored 'General case' 0 C--N 1.284 -2.245 0 O-C-N 121.02 -1.05 . . . . 0.0 108.471 -177.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -113.61 148.44 36.21 Favored 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.429 ' ND1' ' CD1' ' A' ' 116' ' ' ILE 0.256 45.1 p-80 -174.44 149.68 1.39 Allowed Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 118.0 -1.48 . . . . 0.0 113.349 -176.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.527 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 32.9 Cg_endo -91.09 -22.35 0.59 Allowed 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.463 2.109 . . . . 0.0 106.801 171.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 38.8 tt0 -111.44 136.62 50.34 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.02 -42.35 48.18 Favored 'General case' 0 C--N 1.289 -2.054 0 O-C-N 119.965 -1.709 . . . . 0.0 111.985 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 118' ' ' GLN . 87.7 mt-30 -70.36 -24.28 62.94 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 119.768 -1.832 . . . . 0.0 115.871 -176.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -28.13 67.61 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 119.839 -1.788 . . . . 0.0 106.916 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 118' ' ' GLN . 87.9 mt -56.0 -88.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 117.453 -1.699 . . . . 0.0 109.991 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -37.02 -12.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 O-C-N 121.545 -0.722 . . . . 0.0 113.604 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.7 OUTLIER -69.64 -72.42 0.24 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 119.457 -2.202 . . . . 0.0 114.579 -174.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.426 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 19.2 Cg_exo -24.95 120.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 123.923 3.082 . . . . 0.0 113.82 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.649 ' C ' ' H ' ' A' ' 122' ' ' GLY . 0.8 OUTLIER -178.11 138.12 0.19 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 123' ' ' ASP . 85.6 mttt 50.47 4.98 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 CA-C-O 121.456 0.646 . . . . 0.0 109.389 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.649 ' H ' ' C ' ' A' ' 120' ' ' PHE . . . -42.94 -18.75 0.05 OUTLIER Glycine 0 N--CA 1.505 3.239 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 121' ' ' LYS . 11.1 t70 71.04 -17.98 0.29 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.292 -1.122 . . . . 0.0 111.233 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.22 -14.89 61.0 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 129' ' ' LEU . 20.2 mt -89.99 -28.48 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.637 -0.664 . . . . 0.0 111.629 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -40.04 -56.34 1.88 Allowed 'General case' 0 N--CA 1.515 2.802 0 O-C-N 120.842 -1.161 . . . . 0.0 110.137 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -74.11 -37.08 64.22 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.773 -1.205 . . . . 0.0 110.591 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -63.28 -47.31 82.88 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 128' ' ' ALA . 0.3 OUTLIER -28.85 -44.68 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 113.587 -1.642 . . . . 0.0 106.966 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 2.1 m120 -105.0 -99.94 0.32 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -128.63 120.35 3.3 Favored Glycine 0 N--CA 1.507 3.431 0 CA-C-O 122.985 1.325 . . . . 0.0 112.124 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 133' ' ' GLU . 5.9 tp10 178.49 169.47 0.83 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 113.379 -1.41 . . . . 0.0 111.728 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.511 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 22.9 mp0 -124.21 127.45 47.73 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 176.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 133' ' ' GLU . 32.1 m120 -150.71 138.51 19.88 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.245 1.021 . . . . 0.0 111.072 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 147' ' ' ARG . 8.5 p -134.44 126.3 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.473 -0.767 . . . . 0.0 109.011 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.51 169.06 18.3 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 121.724 0.773 . . . . 0.0 111.368 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.6 mt -101.17 141.91 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-O 121.716 0.77 . . . . 0.0 112.826 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -114.07 153.61 29.15 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -147.73 108.11 4.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.494 -1.379 . . . . 0.0 109.901 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 141' ' ' PHE . . . -158.06 106.23 0.29 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.531 ' C ' ' H ' ' A' ' 143' ' ' ALA . 84.1 t80 38.42 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.845 -0.797 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.44 ' C ' ' CD1' ' A' ' 142' ' ' LEU . 0.1 OUTLIER 70.77 -30.15 0.2 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.56 -0.713 . . . . 0.0 110.268 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 141' ' ' PHE . . . -53.49 -2.93 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.105 -1.038 . . . . 0.0 113.035 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 143' ' ' ALA . 5.3 pt20 -45.01 98.88 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 O-C-N 119.949 -1.72 . . . . 0.0 107.842 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 143' ' ' ALA . . . -149.17 163.36 37.82 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.599 -1.313 . . . . 0.0 110.024 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tp -108.45 155.51 20.51 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 120.777 -1.202 . . . . 0.0 110.912 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.583 HH11 ' NH2' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -136.47 155.42 50.01 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.605 -0.684 . . . . 0.0 110.174 178.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.49 151.76 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.298 0 CA-C-O 121.691 0.757 . . . . 0.0 109.924 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.425 ' N ' ' O ' ' A' ' 134' ' ' ASN . 27.7 m-85 -116.8 138.97 51.12 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.751 0.786 . . . . 0.0 110.356 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -152.72 160.33 31.25 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.4 ' CB ' ' O ' ' A' ' 130' ' ' ASN . 0.1 OUTLIER -104.44 162.74 0.2 Allowed 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 123.537 2.825 . . . . 0.0 116.224 -178.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 47.7 mt -123.59 136.9 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 0.0 OUTLIER -117.14 157.05 26.59 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.401 1.096 . . . . 0.0 112.339 -179.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.579 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 9.3 p30 -53.98 -95.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.232 -0.917 . . . . 0.0 110.327 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.579 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 9.6 pt-20 -160.11 28.71 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.522 HD21 ' C ' ' A' ' 155' ' ' GLU . 2.3 m-80 -143.49 23.01 1.82 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.0 m80 67.1 46.83 1.45 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.153 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.77 122.43 30.55 Favored 'General case' 0 N--CA 1.522 3.173 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.692 HE21 ' N ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -58.23 118.35 5.4 Favored 'General case' 0 N--CA 1.518 2.934 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -177.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 154' ' ' ASP . 1.7 pp -141.27 22.32 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 O-C-N 120.349 -1.469 . . . . 0.0 112.124 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.04 169.42 41.75 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.5 t -136.0 138.93 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 CA-C-N 119.614 1.707 . . . . 0.0 112.502 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.502 ' O ' ' OG1' ' A' ' 150' ' ' THR . 1.9 p -119.68 113.83 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.459 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.717 ' H ' ' CG1' ' A' ' 99' ' ' VAL . . . -116.85 165.77 12.93 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 3.3 mt -142.92 107.99 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.03 -1.669 . . . . 0.0 106.919 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.91 114.79 4.87 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.556 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.442 ' O ' ' CB ' ' A' ' 145' ' ' ALA . 5.1 tt -88.47 110.77 21.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.999 ' O ' ' O ' ' A' ' 169' ' ' LEU . 8.2 tm-20 -74.48 127.23 32.54 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.828 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.999 ' O ' ' O ' ' A' ' 168' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.522 3.16 0 CA-C-O 121.959 0.885 . . . . 0.0 110.283 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.657 0.742 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -68.99 -67.16 0.49 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 123.051 1.405 . . . . 0.0 111.256 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.2 mtt -50.96 -49.1 60.66 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.313 -173.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.458 ' O ' ' C ' ' A' ' 49' ' ' ARG . 12.1 t -55.25 -35.93 65.51 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 48' ' ' THR . 62.5 ttt180 -40.67 -52.7 2.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.014 -1.054 . . . . 0.0 110.996 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.47 -60.44 2.19 Favored 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -73.31 -45.8 29.13 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -54.64 -44.69 73.42 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 120.422 2.111 . . . . 0.0 105.598 176.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.512 ' O ' ' CD1' ' A' ' 57' ' ' LEU . . . -53.24 -50.8 64.03 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 117.726 -1.59 . . . . 0.0 109.452 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -80.24 -55.87 4.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 119.73 -1.856 . . . . 0.0 111.656 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 51' ' ' GLY . 18.1 mtpp -63.96 -27.1 68.9 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.56 -37.59 10.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 119.787 -1.821 . . . . 0.0 108.871 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.512 ' CD1' ' O ' ' A' ' 53' ' ' ALA . 35.2 mt -53.93 -35.45 61.72 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.291 -1.364 . . . . 0.0 108.047 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 61' ' ' ARG . . . -80.97 -46.32 15.3 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -70.85 -26.6 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 118.665 -2.522 . . . . 0.0 106.197 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.07 -29.07 70.52 Favored 'General case' 0 C--N 1.27 -2.861 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.456 ' O ' ' CG ' ' A' ' 65' ' ' ASP . 4.3 ptt180 -72.65 -19.7 61.39 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 117.164 -1.814 . . . . 0.0 110.84 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 m -68.29 -47.62 67.15 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 124.116 3.144 . . . . 0.0 107.009 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' C ' ' N ' ' A' ' 65' ' ' ASP . 50.2 mt -87.53 -41.81 13.21 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.833 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.4 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -56.32 -19.04 12.63 Favored 'General case' 0 N--CA 1.508 2.475 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.456 ' CG ' ' O ' ' A' ' 61' ' ' ARG . 40.2 m-20 -85.14 -4.3 59.11 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.123 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.512 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.86 -158.05 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 119.983 -1.698 . . . . 0.0 110.239 -178.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' A' ' 69' ' ' ILE . 3.1 Cg_endo -104.07 -27.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 123.586 2.857 . . . . 0.0 113.399 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.514 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 16.8 pt-20 -75.43 25.09 0.11 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.591 ' H ' ' C ' ' A' ' 67' ' ' PRO . 44.0 mm -106.13 -80.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -46.3 -31.95 2.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.68 -14.37 51.93 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.506 -1.371 . . . . 0.0 110.244 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -102.69 -3.54 49.53 Favored Glycine 0 N--CA 1.504 3.186 0 N-CA-C 107.101 -2.399 . . . . 0.0 107.101 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.52 -52.76 7.25 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 100.406 -3.924 . . . . 0.0 100.406 173.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -8.83 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 113.238 -1.801 . . . . 0.0 112.619 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.71 ' O ' ' O ' ' A' ' 76' ' ' LYS . 4.0 tmtm? -124.07 40.56 3.7 Favored 'General case' 0 N--CA 1.523 3.177 0 CA-C-N 122.732 2.515 . . . . 0.0 111.036 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.726 ' HZ1' ' H ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER 35.24 157.23 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.915 0 C-N-CA 125.532 1.533 . . . . 0.0 112.516 177.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -33.29 -63.48 0.14 Allowed 'Trans proline' 0 N--CA 1.513 2.66 0 C-N-CA 123.943 3.095 . . . . 0.0 115.72 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.726 ' H ' ' HZ1' ' A' ' 76' ' ' LYS . 78.6 mt-30 -50.1 142.02 10.2 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.098 -1.441 . . . . 0.0 108.762 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 63.52 5.9 2.33 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.137 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 1.035 ' O ' ' N ' ' A' ' 82' ' ' ILE . 70.9 p -81.22 86.55 6.19 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.154 -2.217 . . . . 0.0 109.542 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.675 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -35.92 47.24 0.0 OUTLIER Glycine 1 N--CA 1.518 4.139 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.754 -177.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 1.035 ' N ' ' O ' ' A' ' 80' ' ' SER . 1.1 tp -68.04 28.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 122.516 1.151 . . . . 0.0 107.924 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.675 ' H ' ' C ' ' A' ' 81' ' ' GLY . 43.7 tp60 -82.91 -22.3 33.93 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.707 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -73.73 -94.25 0.02 OUTLIER 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.707 ' C ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -20.18 -55.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.157 0 CA-C-N 123.651 2.932 . . . . 0.0 111.554 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -51.9 -49.12 63.63 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 119.333 -2.104 . . . . 0.0 110.161 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.682 ' N ' ' O ' ' A' ' 84' ' ' ALA . 66.1 tt0 -55.96 -54.55 43.42 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 116.624 -1.655 . . . . 0.0 114.393 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -77.79 -42.75 32.84 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 124.699 3.409 . . . . 0.0 108.236 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 88' ' ' ALA . 64.7 t -51.65 -71.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 115.115 -2.634 . . . . 0.0 107.592 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.677 ' O ' ' N ' ' A' ' 93' ' ' ASN . 4.3 ppt_? -40.26 -34.13 0.3 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.959 -1.088 . . . . 0.0 110.608 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.549 ' C ' ' O ' ' A' ' 90' ' ' ARG . 29.0 ttmt -39.38 -28.97 0.04 OUTLIER 'General case' 0 N--CA 1.536 3.827 0 C-N-CA 116.758 -1.977 . . . . 0.0 106.092 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 90' ' ' ARG . 10.6 ttm105 -36.49 -59.56 0.65 Allowed 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 166.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.677 ' N ' ' O ' ' A' ' 90' ' ' ARG . 0.4 OUTLIER -153.33 -56.38 0.12 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.397 -1.439 . . . . 0.0 110.192 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 1.1 m-20 164.02 1.38 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.864 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -135.57 160.69 37.71 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 117.729 -1.588 . . . . 0.0 113.975 -175.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.451 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 2.8 pp 151.43 175.92 0.0 OUTLIER 'General case' 0 N--CA 1.534 3.738 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.426 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -139.66 86.58 2.12 Favored 'General case' 0 C--O 1.218 -0.603 1 N-CA-C 98.87 -4.493 . . . . 0.0 98.87 169.245 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.413 ' H ' HD11 ' A' ' 96' ' ' LEU . 19.7 tt -101.61 134.72 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 123.396 1.569 . . . . 0.0 108.212 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.507 HG11 ' H ' ' A' ' 164' ' ' ALA . 1.1 p -136.41 149.53 27.18 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -173.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.415 ' H ' HD12 ' A' ' 82' ' ' ILE . 4.2 p -111.28 131.35 62.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 1 N-CA-C 98.444 -4.65 . . . . 0.0 98.444 169.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.573 ' CG2' ' H ' ' A' ' 105' ' ' SER . 1.5 m -124.46 152.27 43.54 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 120.564 -1.335 . . . . 0.0 111.442 -175.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -87.2 -176.85 5.83 Favored 'General case' 0 C--N 1.284 -2.278 1 N-CA-C 98.033 -4.802 . . . . 0.0 98.033 169.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.522 ' O ' ' CG ' ' A' ' 103' ' ' MET . 1.8 ttt -77.67 73.53 4.23 Favored 'General case' 0 C--N 1.269 -2.9 0 C-N-CA 114.483 -2.887 . . . . 0.0 107.069 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 105' ' ' SER . 9.0 tm0? -141.75 -41.51 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 119.595 -1.941 . . . . 0.0 110.483 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.573 ' H ' ' CG2' ' A' ' 101' ' ' THR . 10.5 t 84.88 136.96 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.747 0.819 . . . . 0.0 109.48 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.8 OUTLIER 156.81 134.86 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.618 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 177.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.436 ' NH2' ' O ' ' A' ' 97' ' ' PHE . 9.6 mmm180 -71.9 100.87 2.52 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.494 ' H ' ' HB ' ' A' ' 99' ' ' VAL . 2.5 m-85 -54.4 -30.24 51.55 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.44 ' C ' ' ND1' ' A' ' 110' ' ' HIS . 12.0 t -101.17 144.78 29.63 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.44 ' ND1' ' C ' ' A' ' 109' ' ' SER . 1.5 m-70 -124.89 107.83 28.41 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -174.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.696 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 65.2 Cg_endo -85.81 -35.63 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 N-CA-C 103.882 -3.161 . . . . 0.0 103.882 172.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.696 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 13.5 mp0 -140.37 138.31 34.72 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 174.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.81 -48.18 64.21 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 118.303 2.705 . . . . 0.0 118.303 -172.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.488 ' CD ' ' H ' ' A' ' 114' ' ' GLN . 1.4 mp0 -66.2 -32.52 74.01 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.687 HH21 ' H ' ' A' ' 139' ' ' ARG . 19.3 tpt85 -61.54 -33.68 74.25 Favored 'General case' 0 C--O 1.201 -1.457 0 CA-C-N 122.358 2.345 . . . . 0.0 106.633 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.701 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.2 OUTLIER -53.17 -86.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.135 177.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.408 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -33.04 -11.63 0.0 OUTLIER Glycine 0 N--CA 1.499 2.866 0 C-N-CA 123.462 0.553 . . . . 0.0 113.748 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.701 ' N ' ' O ' ' A' ' 116' ' ' ILE . 1.3 mt-30 -79.33 -72.75 0.12 Allowed Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 120.017 1.909 . . . . 0.0 113.728 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -26.55 108.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 123.969 3.113 . . . . 0.0 114.939 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 120' ' ' PHE . 48.5 t80 174.86 28.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -174.93 -12.64 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.091 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.76 -21.51 2.29 Favored Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.6 t0 69.64 0.6 3.04 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 121.043 -1.269 . . . . 0.0 112.142 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.534 ' OD2' ' CE2' ' A' ' 149' ' ' PHE . 2.9 p-10 -82.45 -21.18 35.76 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.552 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 20.2 mt -79.42 -21.78 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.528 -0.733 . . . . 0.0 110.199 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -49.39 -37.09 23.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.577 -1.327 . . . . 0.0 108.418 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.631 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 59.0 mttp -74.32 -34.87 63.59 Favored 'General case' 0 C--O 1.194 -1.859 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.541 ' O ' ' ND2' ' A' ' 130' ' ' ASN . . . -89.43 -30.74 18.12 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 120.023 -1.673 . . . . 0.0 110.539 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.29 -26.35 1.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.858 -1.151 . . . . 0.0 109.705 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.861 ' ND2' ' N ' ' A' ' 131' ' ' GLY 0.278 0.0 OUTLIER -77.12 -92.49 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 108.904 179.408 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.861 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -164.66 42.8 0.3 Allowed Glycine 0 CA--C 1.565 3.166 0 C-N-CA 125.536 1.541 . . . . 0.0 110.106 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.462 ' H ' HD22 ' A' ' 130' ' ' ASN . 76.6 tt0 -145.06 164.72 30.35 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 120.316 2.058 . . . . 0.0 111.646 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -64.21 164.32 11.18 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 28.4 t-20 -170.97 138.16 1.27 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.298 -0.876 . . . . 0.0 109.267 176.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.3 t -130.83 138.43 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.315 -1.491 . . . . 0.0 108.776 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -151.51 167.6 27.54 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.644 -1.285 . . . . 0.0 110.213 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 mt -102.32 135.56 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.398 -0.814 . . . . 0.0 109.801 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.452 ' OD1' ' CZ ' ' A' ' 147' ' ' ARG . 0.9 OUTLIER -106.84 152.62 23.64 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.687 ' H ' HH21 ' A' ' 115' ' ' ARG . 3.5 ptm85 -159.68 97.94 1.34 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.604 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -150.61 109.04 0.41 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.07 -1.538 . . . . 0.0 109.92 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 9.3 t80 59.1 -67.47 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 122.034 -0.686 . . . . 0.0 110.14 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 140' ' ' GLY . 0.7 OUTLIER -131.44 6.69 4.47 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.249 -0.907 . . . . 0.0 110.083 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 145' ' ' ALA . . . -81.13 5.36 17.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 113.775 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -48.78 91.24 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.217 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.663 ' N ' ' O ' ' A' ' 143' ' ' ALA . . . -169.03 173.06 7.11 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.301 -170.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 tp -115.01 159.19 21.08 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.461 -1.399 . . . . 0.0 110.89 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.452 ' CZ ' ' OD1' ' A' ' 138' ' ' ASN . 0.8 OUTLIER -143.89 152.33 40.99 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.142 0.972 . . . . 0.0 110.896 178.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.41 138.22 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.925 0 CA-C-O 122.119 0.961 . . . . 0.0 109.985 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.534 ' CE2' ' OD2' ' A' ' 124' ' ' ASP . 70.6 m-85 -111.63 145.73 38.68 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.646 0.736 . . . . 0.0 109.686 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.02 156.56 65.07 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -96.54 154.88 1.25 Allowed 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 123.996 3.131 . . . . 0.0 114.195 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 72.6 mt -117.97 136.33 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.419 ' C ' ' H ' ' A' ' 155' ' ' GLU . 60.7 m-85 -107.73 149.16 28.49 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.827 ' O ' ' ND2' ' A' ' 156' ' ' ASN . 24.8 t0 -76.19 57.1 1.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 153' ' ' TYR . 36.9 mt-10 42.33 21.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 123.641 0.777 . . . . 0.0 112.463 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.827 ' ND2' ' O ' ' A' ' 154' ' ' ASP . 42.3 m-80 -140.28 35.42 1.89 Allowed 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.495 -1.378 . . . . 0.0 109.717 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 61.84 -2.92 0.25 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.584 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.8 mptt -80.45 122.05 26.5 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.628 ' N ' ' NE2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -58.2 -154.65 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.058 0 O-C-N 120.861 -1.149 . . . . 0.0 111.136 -177.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.612 ' CG2' ' O ' ' A' ' 159' ' ' GLN . 2.7 pp 151.9 -6.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 CA-C-N 120.175 1.352 . . . . 0.0 112.883 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -172.24 179.86 43.57 Favored Glycine 0 N--CA 1.507 3.407 0 C-N-CA 115.981 -3.009 . . . . 0.0 111.583 -175.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.452 ' O ' ' OG1' ' A' ' 101' ' ' THR . 75.3 t -139.6 139.22 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -1.225 . . . . 0.0 112.042 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.4 t -108.09 127.31 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.507 ' H ' HG11 ' A' ' 99' ' ' VAL . . . -115.99 144.23 44.37 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.2 mt -137.76 99.52 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.25 129.59 9.13 Favored Glycine 0 N--CA 1.485 1.947 0 CA-C-O 123.328 1.515 . . . . 0.0 112.762 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.54 ' O ' ' CB ' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -88.62 115.31 26.05 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 113.475 -1.363 . . . . 0.0 107.925 177.363 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.883 ' O ' ' O ' ' A' ' 169' ' ' LEU . 0.7 OUTLIER -74.95 132.25 41.28 Favored 'General case' 0 N--CA 1.529 3.491 0 O-C-N 124.084 0.865 . . . . 0.0 110.237 -179.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.883 ' O ' ' O ' ' A' ' 168' ' ' GLU . 1.5 pp . . . . . 0 N--CA 1.519 3.017 0 O-C-N 120.566 -1.334 . . . . 0.0 113.487 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.626 ' CG ' ' H ' ' A' ' 47' ' ' MET . 17.4 p-10 -66.29 -64.73 0.79 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.885 1.326 . . . . 0.0 110.786 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.626 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 16.3 mmm -43.54 -58.61 2.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.193 0.997 . . . . 0.0 111.443 -173.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' ARG . 6.4 t -53.18 -35.97 60.42 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 48' ' ' THR . 36.8 ttp180 -42.02 -51.05 4.59 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.805 -1.184 . . . . 0.0 111.841 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -80.77 -58.06 3.27 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -79.59 -45.3 8.7 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.436 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -54.96 -46.3 75.01 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 120.533 2.167 . . . . 0.0 105.525 176.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 52' ' ' LEU . . . -46.9 -57.98 4.4 Favored 'General case' 0 C--O 1.205 -1.275 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.345 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -81.87 -68.42 0.7 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.64 -1.288 . . . . 0.0 113.989 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 51' ' ' GLY . 57.4 mtpt -47.46 -27.53 1.77 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.094 -1.004 . . . . 0.0 111.647 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.46 -32.3 14.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.053 -1.654 . . . . 0.0 108.782 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.3 tp -55.22 -40.21 70.56 Favored 'General case' 0 C--N 1.284 -2.239 0 O-C-N 121.035 -1.041 . . . . 0.0 109.309 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.617 ' O ' ' CG ' ' A' ' 61' ' ' ARG . . . -80.42 -47.49 14.3 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -177.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -66.89 -32.95 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 117.616 -3.177 . . . . 0.0 104.618 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.598 ' O ' ' N ' ' A' ' 63' ' ' LEU . . . -58.84 -26.53 64.28 Favored 'General case' 0 C--N 1.265 -3.104 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.617 ' CG ' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -49.79 -24.45 2.39 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 116.665 -2.014 . . . . 0.0 105.882 174.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 59' ' ' VAL . 96.9 m -74.03 -39.76 63.34 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.598 ' N ' ' O ' ' A' ' 60' ' ' ALA 0.276 0.3 OUTLIER -48.2 -42.19 29.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 124.761 2.22 . . . . 0.0 107.921 175.58 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.66 -4.7 59.21 Favored 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 112.553 -2.112 . . . . 0.0 113.081 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 66' ' ' SER . 34.5 t0 -99.02 -27.46 13.84 Favored 'General case' 0 N--CA 1.517 2.921 0 CA-C-N 123.713 2.961 . . . . 0.0 115.618 -172.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.523 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -60.12 -161.47 0.0 OUTLIER Pre-proline 0 C--N 1.278 -2.525 0 O-C-N 119.668 -1.895 . . . . 0.0 109.928 -178.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.692 ' HD2' ' H ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -114.52 -25.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 124.399 3.399 . . . . 0.0 113.584 176.032 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.692 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 16.4 pt-20 -56.75 -30.45 63.59 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 117.829 -1.548 . . . . 0.0 107.52 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.5 mt -45.25 -83.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.062 -178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -47.33 -39.03 13.95 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.978 0.894 . . . . 0.0 109.914 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -78.04 -13.0 60.03 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.931 -1.105 . . . . 0.0 111.08 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . -97.52 -1.38 59.06 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 105.046 -3.222 . . . . 0.0 105.046 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.571 ' O ' ' OD2' ' A' ' 102' ' ' ASP . 1.4 mp -89.61 -23.22 21.99 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 173.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -62.83 -0.72 0.71 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.632 ' CG ' ' H ' ' A' ' 76' ' ' LYS . 3.5 tptm -136.37 -140.81 0.16 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.204 -1.56 . . . . 0.0 107.175 174.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.632 ' H ' ' CG ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -129.12 156.14 78.69 Favored Pre-proline 0 CA--C 1.578 2.041 0 O-C-N 121.481 -0.762 . . . . 0.0 109.625 179.381 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' O ' ' CE2' ' A' ' 108' ' ' TYR . 0.9 OUTLIER -31.56 -10.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.528 3.546 1 C-N-CA 126.236 4.624 . . . . 0.0 118.946 -179.082 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' LYS . 44.0 tp60 -96.33 -14.08 22.83 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 119.798 -1.814 . . . . 0.0 109.622 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -116.11 0.74 13.05 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.232 -0.918 . . . . 0.0 112.472 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.694 ' N ' ' OH ' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -76.36 -155.4 0.06 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 119.234 -2.166 . . . . 0.0 107.703 178.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.97 17.25 0.22 Allowed Glycine 0 N--CA 1.496 2.676 0 O-C-N 120.523 -1.36 . . . . 0.0 109.727 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.455 ' C ' ' H ' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -48.39 -24.37 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-O 121.898 0.856 . . . . 0.0 110.385 -179.12 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 7.3 tt0 -53.34 -7.74 0.1 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 82' ' ' ILE . . . -94.49 -52.81 4.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.002 -1.061 . . . . 0.0 112.689 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.455 ' CD1' ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -74.82 -34.2 32.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 177.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -57.97 -46.27 85.41 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 1.2 tt0 -49.67 -21.54 1.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.053 -1.43 . . . . 0.0 107.948 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.94 66.76 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 114.831 -2.748 . . . . 0.0 104.093 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 86' ' ' ALA . 37.7 t -54.62 -72.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 C-N-CA 116.776 -1.97 . . . . 0.0 110.185 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 93' ' ' ASN . 1.5 ttt-85 -48.13 -69.61 0.12 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 124.499 1.119 . . . . 0.0 113.118 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 90' ' ' ARG . 37.9 pttt -35.61 -36.87 0.08 Allowed 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.953 -1.092 . . . . 0.0 109.187 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 90' ' ' ARG . 62.3 mtm-85 -86.51 -21.88 26.71 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.723 -1.236 . . . . 0.0 111.585 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.644 ' N ' ' O ' ' A' ' 90' ' ' ARG . 54.7 t-20 -97.9 -16.42 19.75 Favored 'General case' 0 N--CA 1.511 2.582 0 CA-C-N 120.979 1.718 . . . . 0.0 108.374 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.0 t70 73.28 24.7 2.34 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.886 0.875 . . . . 0.0 110.835 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 0.4 OUTLIER 173.27 153.71 0.09 Allowed 'General case' 0 N--CA 1.514 2.755 0 CA-C-N 121.726 2.057 . . . . 0.0 107.796 176.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.501 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER 156.17 164.69 0.01 OUTLIER 'General case' 1 N--CA 1.542 4.133 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.2 179.828 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.566 ' CD1' ' NE ' ' A' ' 107' ' ' ARG . 0.9 OUTLIER -143.52 89.21 2.06 Favored 'General case' 0 C--O 1.214 -0.816 1 N-CA-C 99.119 -4.4 . . . . 0.0 99.119 168.552 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.629 ' N ' ' OG ' ' A' ' 109' ' ' SER . 0.4 OUTLIER -93.19 129.09 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -175.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.463 HG21 ' H ' ' A' ' 164' ' ' ALA . 1.1 m -119.08 130.54 73.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -173.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.64 124.47 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 1 N-CA-C 97.166 -5.124 . . . . 0.0 97.166 169.217 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.5 p -136.09 164.2 28.57 Favored 'General case' 0 C--N 1.281 -2.372 0 O-C-N 120.61 -1.306 . . . . 0.0 108.416 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.707 ' O ' ' N ' ' A' ' 104' ' ' GLN . 1.7 m-20 -78.86 -175.13 4.32 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 100.873 -3.751 . . . . 0.0 100.873 170.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.514 ' O ' ' CG ' ' A' ' 103' ' ' MET . 1.6 ttt -68.28 69.82 0.15 Allowed 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 114.843 -2.743 . . . . 0.0 103.963 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.707 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -137.16 -50.37 0.64 Allowed 'General case' 0 C--N 1.358 0.965 0 O-C-N 120.488 -1.382 . . . . 0.0 108.408 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 104' ' ' GLN . 1.5 t 92.74 138.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.9 OUTLIER 157.04 139.34 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 102.092 -3.299 . . . . 0.0 102.092 178.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.729 ' NH2' HH11 ' A' ' 147' ' ' ARG . 39.4 mtt180 -86.19 96.65 9.99 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.791 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.694 ' OH ' ' N ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -55.95 -19.94 14.26 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 123.81 1.767 . . . . 0.0 107.282 -176.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.629 ' OG ' ' N ' ' A' ' 98' ' ' ILE . 25.6 p -113.36 146.02 40.15 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.534 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.552 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 13.3 p80 -155.53 137.25 9.64 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -174.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.637 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 40.5 Cg_endo -88.57 -32.25 0.15 Allowed 'Trans proline' 0 N--CA 1.482 0.815 0 N-CA-C 104.666 -2.859 . . . . 0.0 104.666 171.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.637 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 34.9 tp10 -127.35 124.83 39.57 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.24 81.83 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -68.28 -28.97 67.65 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 119.882 -1.762 . . . . 0.0 115.629 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.548 ' CD ' ' CE2' ' A' ' 97' ' ' PHE . 11.7 ttt85 -55.26 -29.04 57.33 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 119.103 -2.248 . . . . 0.0 105.544 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.751 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.2 OUTLIER -63.92 -87.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.214 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -32.55 -13.41 0.0 OUTLIER Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.419 -0.801 . . . . 0.0 112.949 -175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.751 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.9 mt-30 -71.5 -72.64 0.21 Allowed Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 119.632 -2.099 . . . . 0.0 110.892 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.512 ' O ' ' CB ' ' A' ' 120' ' ' PHE . 96.0 Cg_exo -19.04 142.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 124.309 3.339 . . . . 0.0 113.878 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 120' ' ' PHE . 67.1 t80 140.89 21.64 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.441 ' C ' ' N ' ' A' ' 123' ' ' ASP . 23.7 ttmt -177.29 -2.8 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 O-C-N 121.434 -0.792 . . . . 0.0 110.196 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.6 -20.59 2.75 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.441 ' N ' ' C ' ' A' ' 121' ' ' LYS . 10.0 t70 72.6 -5.27 1.88 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -75.97 -21.1 57.33 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 119.756 -1.84 . . . . 0.0 108.861 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.7 pt -74.39 -23.67 18.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.02 -1.05 . . . . 0.0 109.947 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.76 -25.92 8.51 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -86.52 -39.14 16.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.671 -0.643 . . . . 0.0 111.594 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -79.73 -46.85 16.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 119.898 -1.752 . . . . 0.0 107.246 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.652 ' C ' HD21 ' A' ' 130' ' ' ASN . 0.1 OUTLIER -38.41 -41.93 0.69 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.652 HD21 ' C ' ' A' ' 129' ' ' LEU . 2.3 m120 -100.46 12.81 36.43 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.315 -1.311 . . . . 0.0 114.203 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.36 98.41 0.56 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 170.85 157.76 0.07 Allowed 'General case' 0 N--CA 1.514 2.746 0 CA-C-O 122.596 1.189 . . . . 0.0 111.399 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -101.53 144.74 29.92 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.303 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -159.75 144.34 15.01 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.824 -1.172 . . . . 0.0 109.693 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 147' ' ' ARG . 5.0 p -138.43 132.91 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 120.701 -1.249 . . . . 0.0 109.974 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -148.88 169.17 21.15 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.433 0.635 . . . . 0.0 110.452 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -97.42 139.22 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-O 121.361 0.6 . . . . 0.0 111.5 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.521 ' O ' ' NH2' ' A' ' 115' ' ' ARG . 28.1 t-20 -117.23 150.3 38.99 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.249 -0.907 . . . . 0.0 110.745 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -153.5 113.61 3.94 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 141' ' ' PHE . . . -150.28 112.61 0.55 Allowed Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.249 -1.453 . . . . 0.0 110.305 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 141' ' ' PHE . 54.5 t80 39.01 32.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.904 -0.762 . . . . 0.0 110.122 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.418 HD22 HH11 ' A' ' 115' ' ' ARG . 32.0 tp -152.98 -94.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.89 . . . . 0.0 110.736 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -172.55 154.27 3.06 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.535 -1.353 . . . . 0.0 112.029 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -52.49 144.59 13.12 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.673 1.225 . . . . 0.0 111.747 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.1 158.03 24.2 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 tp -108.97 159.52 16.76 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-N 121.351 1.887 . . . . 0.0 109.683 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.729 HH11 ' NH2' ' A' ' 107' ' ' ARG . 11.3 ptt180 -152.3 149.04 28.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.725 -1.234 . . . . 0.0 110.768 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.25 157.47 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-O 122.291 1.043 . . . . 0.0 109.673 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -124.92 135.96 53.32 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.844 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -142.63 161.16 50.93 Favored Pre-proline 0 C--N 1.31 -1.127 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -108.16 163.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 123.459 2.773 . . . . 0.0 116.027 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 48.9 mt -118.62 125.86 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -104.75 155.44 18.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 123.195 1.474 . . . . 0.0 110.666 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -53.08 -85.54 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -170.35 35.59 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -148.18 20.3 1.09 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 64.85 42.54 4.39 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 153' ' ' TYR . 0.6 OUTLIER -122.68 118.46 28.15 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.694 HE21 ' N ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -63.83 121.41 13.96 Favored 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -176.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.1 pp -140.31 13.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 120.536 -1.353 . . . . 0.0 113.749 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.48 178.93 40.73 Favored Glycine 1 N--CA 1.522 4.379 0 C-N-CA 118.816 -1.659 . . . . 0.0 112.361 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.8 t -123.3 134.02 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.26 0 CA-C-N 119.013 1.406 . . . . 0.0 112.593 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 150' ' ' THR . 2.7 t -123.9 107.19 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.463 ' H ' HG21 ' A' ' 99' ' ' VAL . . . -112.44 158.21 20.14 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.2 mt -143.33 101.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.05 127.56 7.71 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.403 -1.38 . . . . 0.0 113.11 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 13.4 tp -93.71 124.82 37.97 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.662 -1.269 . . . . 0.0 109.306 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.416 ' OE1' ' NH1' ' A' ' 115' ' ' ARG . 12.7 tp10 -73.79 134.38 43.39 Favored 'General case' 0 N--CA 1.521 3.086 0 C-N-CA 122.949 0.5 . . . . 0.0 109.942 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.502 2.14 0 O-C-N 119.327 -2.108 . . . . 0.0 109.167 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.6 p . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 49' ' ' ARG . 40.7 t0 -63.76 -64.56 0.86 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 123.871 1.796 . . . . 0.0 108.817 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.416 ' C ' ' O ' ' A' ' 46' ' ' ASP . 6.6 tmm? -32.12 -60.08 0.28 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 123.331 1.538 . . . . 0.0 111.116 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 52' ' ' LEU . 13.9 t -59.56 -32.62 70.51 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.448 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 46' ' ' ASP . 32.3 ttp85 -37.86 -51.98 1.31 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.699 -1.251 . . . . 0.0 111.81 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -84.49 -56.44 3.62 Favored 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -77.43 -43.36 15.9 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -176.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -54.63 -45.82 73.81 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 120.352 2.076 . . . . 0.0 106.344 176.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.402 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . -48.32 -57.23 6.31 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.625 -1.23 . . . . 0.0 108.999 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -78.35 -55.77 4.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.435 -1.416 . . . . 0.0 113.402 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -67.86 -21.95 65.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.862 . . . . 0.0 111.874 -175.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.68 -35.35 10.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 120.784 1.629 . . . . 0.0 110.572 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.03 -35.8 82.35 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.291 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.63 -45.38 21.66 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -72.64 -34.41 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 118.649 -2.532 . . . . 0.0 105.882 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.439 ' N ' HG12 ' A' ' 89' ' ' VAL . . . -60.84 -31.81 71.22 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 2.0 ptt180 -70.02 -16.64 63.19 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.614 -1.234 . . . . 0.0 110.318 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 m -63.58 -46.03 87.74 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 123.056 2.662 . . . . 0.0 105.734 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 54.1 mt -88.79 -37.6 15.3 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.897 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.86 -19.95 46.44 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 119.152 -2.218 . . . . 0.0 105.715 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 31.5 t70 -84.39 -4.33 58.84 Favored 'General case' 0 C--N 1.274 -2.717 0 O-C-N 121.367 -0.833 . . . . 0.0 110.517 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.516 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -74.84 -155.9 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 120.36 -1.462 . . . . 0.0 111.178 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -108.04 -20.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.316 2.677 . . . . 0.0 114.336 178.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.9 pt-20 -62.1 -36.34 81.44 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.621 -1.631 . . . . 0.0 106.938 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.571 ' O ' ' N ' ' A' ' 72' ' ' GLY . 7.9 mm -47.06 -88.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.828 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -45.35 -31.25 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -78.51 -17.81 55.69 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.732 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.772 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -83.26 -40.84 8.86 Favored Glycine 0 N--CA 1.507 3.375 1 N-CA-C 102.453 -4.259 . . . . 0.0 102.453 178.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mp -48.13 -35.64 11.9 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -78.59 5.57 10.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.779 ' O ' ' O ' ' A' ' 76' ' ' LYS . 31.4 mmtm -139.22 34.82 2.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.835 -1.165 . . . . 0.0 111.66 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.779 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 24.96 153.83 0.0 OUTLIER Pre-proline 0 N--CA 1.527 3.412 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 76' ' ' LYS . 5.7 Cg_exo -22.42 -62.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 124.411 3.407 . . . . 0.0 114.683 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -55.22 139.37 42.46 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 117.326 -1.75 . . . . 0.0 107.777 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 61.58 13.89 5.54 Favored 'General case' 0 C--N 1.282 -2.341 0 C-N-CA 119.353 -0.939 . . . . 0.0 113.336 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.641 ' O ' ' N ' ' A' ' 82' ' ' ILE . 22.4 m -88.88 82.09 6.81 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 120.247 -1.533 . . . . 0.0 109.636 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -43.98 10.42 0.0 OUTLIER Glycine 0 CA--C 1.577 3.918 0 CA-C-O 117.594 -1.67 . . . . 0.0 115.768 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 1.392 HG22 ' CG1' ' A' ' 100' ' ' VAL . 0.3 OUTLIER -49.06 -12.18 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 123.983 3.892 . . . . 0.0 110.849 -178.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.557 ' N ' HD11 ' A' ' 82' ' ' ILE . 1.1 tm0? -36.78 -19.47 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.707 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -63.87 -86.72 0.01 OUTLIER 'General case' 0 C--O 1.191 -1.995 1 N-CA-C 98.675 -4.565 . . . . 0.0 98.675 171.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.707 ' C ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -16.96 -56.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.531 3.597 0 CA-C-N 124.009 3.095 . . . . 0.0 109.336 177.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -53.1 -58.36 7.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.008 -1.682 . . . . 0.0 109.611 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 84' ' ' ALA . 56.0 tt0 -43.67 -56.65 3.62 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 117.156 -1.402 . . . . 0.0 111.563 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -65.15 -59.26 4.29 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 124.318 3.235 . . . . 0.0 109.182 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.465 ' C ' ' O ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -48.26 -59.57 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 C-N-CA 114.686 -2.805 . . . . 0.0 111.313 -175.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.829 ' O ' ' N ' ' A' ' 93' ' ' ASN . 24.6 ptt180 -52.14 -39.19 59.6 Favored 'General case' 0 C--O 1.193 -1.887 0 CA-C-N 120.567 1.53 . . . . 0.0 111.045 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.599 ' C ' ' O ' ' A' ' 90' ' ' ARG . 16.3 tttm -34.11 -44.75 0.19 Allowed 'General case' 0 N--CA 1.536 3.839 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 91' ' ' LYS . 16.0 mmm180 -35.63 -53.32 0.7 Allowed 'General case' 0 N--CA 1.516 2.873 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.829 ' N ' ' O ' ' A' ' 90' ' ' ARG . 74.6 m-80 -140.37 -66.65 0.44 Allowed 'General case' 0 N--CA 1.514 2.745 0 CA-C-N 121.737 2.062 . . . . 0.0 111.261 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 2.1 m-20 159.71 -7.85 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.054 0 CA-C-O 121.572 0.701 . . . . 0.0 109.732 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.76 155.82 22.91 Favored 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.919 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER 157.49 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.53 3.559 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.669 -178.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.86 83.14 1.94 Allowed 'General case' 0 C--O 1.215 -0.75 1 N-CA-C 98.532 -4.618 . . . . 0.0 98.532 169.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.6 tt -104.69 155.66 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 123.633 1.683 . . . . 0.0 109.461 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.453 HG23 ' OG1' ' A' ' 101' ' ' THR . 0.2 OUTLIER -151.15 139.28 14.3 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 CA-C-N 112.399 -2.182 . . . . 0.0 113.149 -171.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 1.392 ' CG1' HG22 ' A' ' 82' ' ' ILE . 7.3 p -105.53 130.95 56.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 1 N-CA-C 94.246 -6.205 . . . . 0.0 94.246 169.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.621 ' OG1' ' O ' ' A' ' 162' ' ' VAL . 1.6 m -121.6 151.91 39.86 Favored 'General case' 0 N--CA 1.508 2.471 0 CA-C-N 121.573 1.988 . . . . 0.0 111.607 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 103' ' ' MET . 37.4 t70 -96.16 -163.07 1.01 Allowed 'General case' 0 C--N 1.29 -1.989 1 N-CA-C 98.507 -4.627 . . . . 0.0 98.507 167.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.609 ' O ' ' HG3' ' A' ' 103' ' ' MET . 4.2 tpt -89.41 77.72 7.29 Favored 'General case' 0 C--N 1.268 -2.975 0 C-N-CA 116.074 -2.25 . . . . 0.0 109.852 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 105' ' ' SER . 64.3 tp60 -150.97 -30.4 0.18 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 119.193 -2.192 . . . . 0.0 109.046 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 26.7 t 60.95 138.13 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 105' ' ' SER . 1.1 tp 153.51 140.43 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 139.69 58.8 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.402 ' HD2' HG13 ' A' ' 82' ' ' ILE . 3.4 m-30 -97.68 -1.18 44.13 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 t -129.03 146.84 50.9 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.606 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.542 ' CD2' ' H ' ' A' ' 110' ' ' HIS . 0.4 OUTLIER -142.3 105.0 5.55 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -172.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.602 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 27.7 Cg_endo -93.11 -46.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 N-CA-C 106.11 -2.304 . . . . 0.0 106.11 172.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.602 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 2.5 tm-20 -108.54 130.01 55.29 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 175.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.67 -58.59 7.89 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.409 ' N ' ' OE2' ' A' ' 112' ' ' GLU . 99.0 mm-40 -71.62 -29.64 64.89 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -174.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -31.02 68.27 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 123.632 2.924 . . . . 0.0 106.437 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.818 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.7 OUTLIER -54.04 -89.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.219 178.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 116' ' ' ILE . . . -27.58 -8.61 0.0 OUTLIER Glycine 0 N--CA 1.493 2.436 0 C-N-CA 123.961 0.791 . . . . 0.0 114.647 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.818 ' N ' ' O ' ' A' ' 116' ' ' ILE . 3.6 mt-30 -76.56 -70.59 0.21 Allowed Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 118.954 -2.497 . . . . 0.0 114.034 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.432 ' C ' ' O ' ' A' ' 118' ' ' GLN . 51.9 Cg_exo -19.12 95.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 124.289 3.326 . . . . 0.0 115.536 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.492 ' CG ' ' O ' ' A' ' 120' ' ' PHE . 0.0 OUTLIER 175.0 11.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 123' ' ' ASP . 74.4 tttt -164.56 -27.44 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.1 -1.0 . . . . 0.0 109.471 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -41.6 -13.75 0.01 OUTLIER Glycine 1 N--CA 1.516 4.009 0 O-C-N 121.303 -0.873 . . . . 0.0 111.908 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 121' ' ' LYS . 39.1 m-20 65.01 43.65 3.7 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 118.712 1.256 . . . . 0.0 112.382 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -128.42 -26.98 2.7 Favored 'General case' 0 N--CA 1.518 2.931 0 C-N-CA 117.456 -1.697 . . . . 0.0 109.832 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.59 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 12.1 mt -80.02 -16.04 12.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 O-C-N 120.729 -1.232 . . . . 0.0 110.556 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -53.47 -44.21 68.77 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.432 -1.417 . . . . 0.0 110.276 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.543 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 59.3 mttm -73.54 -31.4 63.64 Favored 'General case' 0 C--O 1.193 -1.915 0 O-C-N 121.284 -0.885 . . . . 0.0 109.569 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.554 ' O ' ' ND2' ' A' ' 130' ' ' ASN . . . -83.07 -20.6 34.63 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.37 -1.456 . . . . 0.0 109.189 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.03 -18.7 5.58 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.565 -0.709 . . . . 0.0 109.291 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.767 ' CG ' ' H ' ' A' ' 131' ' ' GLY 0.348 0.0 OUTLIER -79.28 -105.87 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.341 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.767 ' H ' ' CG ' ' A' ' 130' ' ' ASN . . . -156.22 41.85 0.56 Allowed Glycine 0 CA--C 1.563 3.067 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.622 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 68.5 tt0 -146.47 161.17 41.0 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 119.409 -2.23 . . . . 0.0 110.891 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 133' ' ' GLU . 6.8 mp0 -73.8 165.15 25.63 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 122.091 0.948 . . . . 0.0 112.706 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -166.03 150.93 8.33 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.38 131.18 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 O-C-N 119.661 -1.9 . . . . 0.0 110.473 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.28 160.85 39.73 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.159 -0.963 . . . . 0.0 111.5 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.2 mt -102.39 142.45 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-O 121.835 0.826 . . . . 0.0 112.118 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.439 ' CG ' ' N ' ' A' ' 139' ' ' ARG . 4.1 t-20 -119.11 161.62 19.99 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 138' ' ' ASN . 2.6 ptm180 -164.27 109.05 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.405 -0.918 . . . . 0.0 108.57 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -162.76 114.61 0.61 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.722 -1.704 . . . . 0.0 110.56 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 3.4 t80 60.01 -73.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.572 -0.958 . . . . 0.0 109.444 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 1.283 HD11 ' OE2' ' A' ' 168' ' ' GLU . 33.7 mt -47.91 -79.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 142' ' ' LEU . . . 161.81 159.95 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.335 0.588 . . . . 0.0 110.606 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 143' ' ' ALA . 39.5 mt-30 -42.37 134.96 2.82 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 167' ' ' LEU . . . -156.44 155.29 31.83 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.14 152.88 25.48 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 121.117 1.781 . . . . 0.0 111.192 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 155.34 49.87 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.15 155.79 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -125.51 137.66 53.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.586 0.707 . . . . 0.0 109.375 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.09 146.54 43.72 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -92.42 154.82 3.03 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 123.812 3.008 . . . . 0.0 114.981 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.2 mt -117.29 133.45 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.773 -0.579 . . . . 0.0 109.934 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.55 ' C ' ' H ' ' A' ' 155' ' ' GLU . 77.4 m-85 -103.13 144.12 31.72 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.4 51.11 0.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 153' ' ' TYR . 9.2 tt0 41.1 25.06 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.187 -0.946 . . . . 0.0 111.657 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 158' ' ' LYS . 35.1 m120 -138.77 30.6 2.29 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 62.46 2.67 0.93 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 156' ' ' ASN . 2.4 mptm? -92.23 124.87 36.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.732 HE21 ' N ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -73.1 129.99 39.3 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -175.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.7 pp -138.94 14.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.24 -1.537 . . . . 0.0 114.404 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.23 176.09 45.98 Favored Glycine 0 N--CA 1.505 3.298 0 C-N-CA 116.042 -2.98 . . . . 0.0 112.798 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.621 ' O ' ' OG1' ' A' ' 101' ' ' THR . 55.5 t -136.61 133.73 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 121.771 0.796 . . . . 0.0 110.387 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 79.7 t -106.03 122.63 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.437 ' H ' HG11 ' A' ' 99' ' ' VAL . . . -119.35 141.93 48.59 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 22.3 mt -131.67 110.91 17.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.25 119.21 6.31 Favored Glycine 0 N--CA 1.487 2.039 0 C-N-CA 119.095 -1.526 . . . . 0.0 111.528 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -94.5 114.89 26.96 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 1.283 ' OE2' HD11 ' A' ' 142' ' ' LEU . 13.5 tp10 -74.86 134.88 41.6 Favored 'General case' 0 N--CA 1.518 2.951 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' A' ' 168' ' ' GLU . 11.0 tp . . . . . 0 N--CA 1.534 3.725 0 CA-C-N 119.04 0.836 . . . . 0.0 111.315 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.66 0.743 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -71.41 -65.6 0.73 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.336 -0.852 . . . . 0.0 108.957 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 24.6 ttt -41.42 -55.92 2.65 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.888 -1.132 . . . . 0.0 110.838 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.46 ' OG1' ' CD2' ' A' ' 52' ' ' LEU . 5.8 t -60.33 -32.61 71.4 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 122.181 0.991 . . . . 0.0 108.881 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.421 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 53.8 ttp180 -41.61 -60.86 1.21 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.25 -1.531 . . . . 0.0 112.538 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -76.57 -60.98 2.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.85 -49.55 22.58 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.915 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.46 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -51.81 -43.45 63.1 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 120.747 2.273 . . . . 0.0 108.194 178.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.82 -49.09 71.87 Favored 'General case' 0 C--O 1.204 -1.322 0 C-N-CA 117.407 -1.717 . . . . 0.0 109.481 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -78.72 -69.51 0.56 Allowed 'General case' 0 C--N 1.308 -1.214 0 O-C-N 120.099 -1.626 . . . . 0.0 111.434 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -47.31 -59.45 3.18 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.274 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.32 -36.34 82.69 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 123.389 2.813 . . . . 0.0 111.609 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.25 -42.41 73.45 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.062 -1.648 . . . . 0.0 108.678 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.427 ' O ' ' CG ' ' A' ' 61' ' ' ARG . . . -75.85 -51.2 13.05 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.37 -43.8 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 119.428 -2.045 . . . . 0.0 106.678 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.02 -28.62 39.42 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -76.81 -20.78 56.0 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.429 -0.909 . . . . 0.0 111.971 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.3 m -67.36 -45.7 75.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 118.893 -2.379 . . . . 0.0 106.843 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.442 ' O ' HD12 ' A' ' 69' ' ' ILE . 2.2 mt -90.2 -31.91 16.83 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 113.714 -1.585 . . . . 0.0 111.13 -177.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.02 -15.87 63.79 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 119.84 -1.788 . . . . 0.0 106.246 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 28.4 t70 -90.22 -9.17 49.03 Favored 'General case' 0 N--CA 1.528 3.427 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.861 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.492 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -70.18 -152.23 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.27 0 O-C-N 120.075 -1.641 . . . . 0.0 110.695 -178.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.702 ' C ' ' H ' ' A' ' 69' ' ' ILE . 2.0 Cg_endo -104.82 -30.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.079 2.519 . . . . 0.0 114.683 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.491 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 13.2 pt-20 -72.27 26.81 0.05 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.702 ' H ' ' C ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -100.72 -83.0 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 176.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -47.23 -31.2 3.51 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.364 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -80.15 -18.76 48.87 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.329 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -86.91 -38.0 8.2 Favored Glycine 0 CA--C 1.479 -2.21 1 N-CA-C 101.633 -4.587 . . . . 0.0 101.633 178.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tp -56.58 -34.21 66.93 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -77.74 0.51 23.3 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.829 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.799 ' O ' ' O ' ' A' ' 76' ' ' LYS . 4.7 tmtp? -131.95 45.9 2.72 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 120.319 1.418 . . . . 0.0 112.785 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.799 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 17.37 157.05 0.0 OUTLIER Pre-proline 0 N--CA 1.535 3.819 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -29.92 -60.58 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.364 2.709 . . . . 0.0 113.984 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -52.57 130.29 31.61 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 118.617 -1.233 . . . . 0.0 109.834 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' CD ' ' NZ ' ' A' ' 75' ' ' LYS . 31.5 tt0 65.49 13.8 9.08 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.877 176.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.831 ' O ' ' N ' ' A' ' 82' ' ' ILE . 15.3 t -79.56 97.9 6.65 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.499 -1.375 . . . . 0.0 110.094 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -43.76 66.73 0.0 OUTLIER Glycine 1 CA--C 1.578 4.018 0 C-N-CA 118.503 -1.808 . . . . 0.0 111.652 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.831 ' N ' ' O ' ' A' ' 80' ' ' SER . 7.7 tp -73.52 1.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.218 -1.754 . . . . 0.0 111.2 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -52.8 -29.06 25.44 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.7 -1.25 . . . . 0.0 113.161 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.847 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -81.26 -86.65 0.09 Allowed 'General case' 0 C--O 1.193 -1.911 0 N-CA-C 100.653 -3.832 . . . . 0.0 100.653 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.77 ' C ' ' O ' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -19.52 -63.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 121.548 1.977 . . . . 0.0 106.075 -178.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 1.002 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -42.56 -52.08 4.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.301 -1.5 . . . . 0.0 110.144 174.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.847 ' N ' ' O ' ' A' ' 84' ' ' ALA . 36.2 tp10 -36.86 -46.57 0.63 Allowed 'General case' 0 N--CA 1.536 3.828 0 C-N-CA 116.515 -2.074 . . . . 0.0 106.699 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.415 ' H ' HD11 ' A' ' 63' ' ' LEU . . . -49.64 -17.34 0.31 Allowed 'General case' 0 N--CA 1.512 2.667 0 O-C-N 119.446 -2.034 . . . . 0.0 108.796 171.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 1.002 ' N ' ' O ' ' A' ' 86' ' ' ALA . 22.7 m -60.8 -33.97 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 C-N-CA 115.879 -2.328 . . . . 0.0 109.101 174.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.41 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 33.1 ttm180 -85.51 -49.19 8.26 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 114.328 -1.305 . . . . 0.0 113.812 -174.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -60.58 -36.79 79.37 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.444 -1.303 . . . . 0.0 108.452 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.707 ' NH2' ' H ' ' A' ' 95' ' ' LEU . 36.1 ttp85 -60.94 -71.2 0.15 Allowed 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 94' ' ' ASP . 35.6 m120 -161.53 -27.69 0.05 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.673 -1.267 . . . . 0.0 112.007 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 18.9 t70 139.8 -28.54 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.836 0 CA-C-N 120.167 1.349 . . . . 0.0 110.141 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.707 ' H ' ' NH2' ' A' ' 92' ' ' ARG . 0.3 OUTLIER -122.54 151.57 41.25 Favored 'General case' 0 N--CA 1.521 3.075 0 CA-C-N 113.701 -1.59 . . . . 0.0 114.601 -177.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER 150.36 162.31 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.0 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 178.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -107.92 95.39 5.65 Favored 'General case' 0 C--O 1.207 -1.132 1 CA-C-N 126.509 4.231 . . . . 0.0 100.247 170.335 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.6 mt -90.36 117.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 106' ' ' LEU . 1.1 p -136.06 139.98 44.79 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.639 0 CA-C-N 111.402 -2.635 . . . . 0.0 112.568 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.64 141.2 22.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 1 N-CA-C 99.451 -4.277 . . . . 0.0 99.451 174.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.539 HG23 ' H ' ' A' ' 105' ' ' SER . 0.7 OUTLIER -131.49 153.38 49.84 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.534 -1.354 . . . . 0.0 110.664 -176.185 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -86.65 -172.52 4.05 Favored 'General case' 0 C--N 1.281 -2.376 1 N-CA-C 99.488 -4.264 . . . . 0.0 99.488 170.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.594 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -81.2 77.03 8.13 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 114.25 -2.98 . . . . 0.0 109.577 -177.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.473 ' O ' ' CB ' ' A' ' 105' ' ' SER . 8.2 tp-100 -147.85 -40.67 0.17 Allowed 'General case' 0 C--O 1.209 -1.026 0 O-C-N 119.375 -2.078 . . . . 0.0 111.14 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.568 ' OG ' ' CD1' ' A' ' 125' ' ' ILE . 7.6 t 89.56 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.337 1.055 . . . . 0.0 109.03 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.4 OUTLIER 157.81 121.87 0.0 OUTLIER 'General case' 0 C--O 1.191 -1.982 0 N-CA-C 103.884 -2.636 . . . . 0.0 103.884 177.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.582 ' N ' ' HE ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -64.41 103.95 0.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.84 -27.47 63.23 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.41 ' N ' ' C ' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -122.86 165.79 16.07 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.018 -178.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.479 ' CD2' ' CD1' ' A' ' 116' ' ' ILE . 14.5 p80 179.01 161.97 0.71 Allowed Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.343 -0.848 . . . . 0.0 110.907 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.463 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 87.2 Cg_endo -87.82 -44.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.483 0.885 0 N-CA-C 106.637 -2.101 . . . . 0.0 106.637 173.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.494 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -108.02 135.44 49.39 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 174.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.3 -25.17 64.1 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.171 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -65.19 -37.49 87.5 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 119.971 -1.705 . . . . 0.0 114.841 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -65.03 -30.21 71.17 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 119.434 -2.041 . . . . 0.0 107.818 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.483 HG23 ' N ' ' A' ' 117' ' ' GLY . 55.0 mt -40.42 -85.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.589 0 CA-C-O 122.601 1.191 . . . . 0.0 111.639 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.483 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -45.53 -10.83 0.02 OUTLIER Glycine 0 N--CA 1.494 2.513 0 CA-C-N 115.144 -0.934 . . . . 0.0 113.691 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.41 ' CB ' ' CD ' ' A' ' 119' ' ' PRO . 3.2 mt-30 -64.2 -68.58 0.76 Allowed Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 120.394 2.097 . . . . 0.0 112.047 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 2.7 Cg_exo -35.96 107.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 123.933 3.088 . . . . 0.0 115.274 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 120' ' ' PHE . 45.8 t80 173.1 28.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -176.28 -8.66 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.65 -19.3 1.25 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.5 t70 68.56 3.92 4.07 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.144 -1.21 . . . . 0.0 109.731 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.457 ' CG ' ' CB ' ' A' ' 136' ' ' ALA . 27.9 m-20 -90.66 -24.63 20.42 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.486 -0.886 . . . . 0.0 108.75 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.568 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 31.0 mt -86.49 -26.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.207 -0.933 . . . . 0.0 112.806 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 125' ' ' ILE . 3.7 mm? -37.57 -50.9 1.16 Allowed 'General case' 0 N--CA 1.517 2.884 0 O-C-N 121.01 -1.056 . . . . 0.0 109.918 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.673 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 54.6 mttm -70.53 -29.7 66.25 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.848 -1.157 . . . . 0.0 109.29 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.611 ' C ' ' ND2' ' A' ' 130' ' ' ASN . . . -90.54 -33.99 15.7 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.976 -1.077 . . . . 0.0 109.481 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 128' ' ' ALA . 0.4 OUTLIER -36.82 -38.13 0.17 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.829 ' ND2' ' N ' ' A' ' 131' ' ' GLY . 0.1 OUTLIER -74.31 -91.91 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 177.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.829 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -168.5 57.12 0.21 Allowed Glycine 0 CA--C 1.558 2.753 0 O-C-N 120.068 -1.645 . . . . 0.0 110.347 176.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -140.23 157.05 46.19 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.715 -1.462 . . . . 0.0 109.048 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.457 ' O ' ' CG ' ' A' ' 134' ' ' ASN . 28.3 mp0 -68.66 159.22 32.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.651 -0.655 . . . . 0.0 111.797 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 133' ' ' GLU . 22.6 m120 -166.28 142.06 4.74 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.74 131.38 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 O-C-N 119.646 -1.909 . . . . 0.0 110.419 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.457 ' CB ' ' CG ' ' A' ' 124' ' ' ASP . . . -152.49 163.19 40.06 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.418 -0.801 . . . . 0.0 110.884 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.2 mt -97.02 128.63 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.648 0 O-C-N 121.146 -0.971 . . . . 0.0 111.353 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -97.21 153.15 18.18 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -133.44 156.99 46.7 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -166.18 161.94 35.54 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -44.34 -23.99 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -1.177 . . . . 0.0 110.186 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -73.3 -80.66 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.833 -1.167 . . . . 0.0 108.679 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -173.38 159.14 3.67 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.0 111.993 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.606 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 25.2 mp0 -45.31 143.39 1.75 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.699 0.761 . . . . 0.0 109.555 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 167' ' ' LEU . . . -146.56 150.64 35.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 49' ' ' ARG . 2.4 tp -108.43 152.51 24.59 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 122.006 2.185 . . . . 0.0 109.788 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -142.92 134.97 27.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.996 -1.065 . . . . 0.0 110.705 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.2 m -104.87 136.37 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 CA-C-O 122.232 1.015 . . . . 0.0 109.91 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 89.8 m-85 -108.42 140.87 41.1 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.506 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.88 150.89 67.05 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -92.66 149.99 2.81 Favored 'Trans proline' 0 N--CA 1.515 2.769 0 C-N-CA 123.65 2.9 . . . . 0.0 116.757 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 61.3 mt -116.25 125.83 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.554 ' C ' ' H ' ' A' ' 155' ' ' GLU . 97.3 m-85 -95.28 142.73 27.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.17 -0.956 . . . . 0.0 110.846 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 47.3 t0 -55.09 -3.36 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.548 -1.345 . . . . 0.0 109.23 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.554 ' H ' ' C ' ' A' ' 153' ' ' TYR . 53.2 tt0 99.39 4.69 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.531 ' C ' ' H ' ' A' ' 158' ' ' LYS . 32.6 m120 -129.07 36.7 4.16 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.099 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 60.98 -2.39 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.5 mptt -81.27 126.3 31.39 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.632 ' O ' ' CD ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -73.88 125.71 28.8 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -175.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.7 pp -143.07 7.31 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 118.799 -2.438 . . . . 0.0 116.971 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.64 173.12 44.44 Favored Glycine 0 N--CA 1.513 3.801 0 C-N-CA 116.619 -2.705 . . . . 0.0 111.853 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.421 ' O ' ' OG1' ' A' ' 101' ' ' THR . 58.3 t -137.25 139.96 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 120.965 -1.314 . . . . 0.0 111.118 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 56.1 t -103.91 127.79 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.99 155.64 26.56 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.8 mt -151.29 95.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.06 135.37 12.52 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.354 -175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.525 ' O ' ' CB ' ' A' ' 145' ' ' ALA . 0.7 OUTLIER -100.74 112.09 24.43 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 113.897 -1.151 . . . . 0.0 108.633 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -48.64 77.15 Favored 'General case' 0 N--CA 1.524 3.227 0 CA-C-O 123.025 1.393 . . . . 0.0 109.565 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.509 2.502 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.811 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.534 ' H2 ' ' HG ' ' A' ' 45' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.73 0.776 . . . . 0.0 109.095 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -60.82 -51.43 69.36 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 124.269 1.985 . . . . 0.0 108.9 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -28.99 66.53 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.513 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -61.17 -36.94 81.19 Favored 'General case' 0 C--O 1.203 -1.367 0 O-C-N 118.106 -2.871 . . . . 0.0 104.478 175.274 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.464 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -54.87 -52.15 63.75 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 116.508 -2.077 . . . . 0.0 109.465 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.77 -65.67 0.65 Allowed 'General case' 0 N--CA 1.517 2.905 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 52' ' ' LEU . . . -65.38 -51.83 45.41 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.495 ' O ' ' CB ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -52.44 -37.9 57.98 Favored 'General case' 0 C--O 1.206 -1.234 0 O-C-N 120.34 -1.683 . . . . 0.0 106.9 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 57' ' ' LEU . . . -56.83 -65.08 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.228 -1.789 . . . . 0.0 108.045 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -55.34 -63.86 1.03 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.052 -1.655 . . . . 0.0 112.596 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -67.63 -20.0 65.28 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.868 -1.145 . . . . 0.0 112.352 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 52' ' ' LEU . . . -97.09 -35.7 10.72 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 121.226 1.83 . . . . 0.0 109.012 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 1.2 tt -64.76 -33.32 75.69 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 121.009 -1.057 . . . . 0.0 108.56 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.87 -43.58 44.82 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.334 -0.854 . . . . 0.0 112.865 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.41 -32.61 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 118.175 -2.828 . . . . 0.0 107.512 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.43 -25.11 61.83 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.423 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -72.03 -21.98 61.46 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 117.008 -1.877 . . . . 0.0 109.526 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 98.6 m -69.61 -53.96 16.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 118.111 -2.868 . . . . 0.0 108.616 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.488 ' C ' ' N ' ' A' ' 65' ' ' ASP . 4.1 mm? -79.16 -44.03 22.77 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.048 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.78 -18.0 4.19 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 119.932 -1.73 . . . . 0.0 106.744 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.488 ' N ' ' C ' ' A' ' 63' ' ' LEU . 18.5 t0 -87.56 -10.91 50.24 Favored 'General case' 0 N--CA 1.52 3.047 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.909 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.527 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -73.05 -157.96 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.938 0 O-C-N 120.484 -1.385 . . . . 0.0 109.04 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.527 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -109.21 -15.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.619 2.879 . . . . 0.0 113.837 176.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.45 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -74.87 -41.11 60.45 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.462 -0.774 . . . . 0.0 109.825 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.33 -75.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.318 -1.489 . . . . 0.0 109.896 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.4 ttt-85 -45.42 -35.79 3.91 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.399 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -77.88 -14.66 59.48 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 111.899 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.508 ' C ' ' N ' ' A' ' 74' ' ' GLN . . . -94.84 -47.97 2.58 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 103.538 -3.825 . . . . 0.0 103.538 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -49.23 -23.64 1.43 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.092 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.508 ' N ' ' C ' ' A' ' 72' ' ' GLY . 55.7 tp60 -50.76 -9.16 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.801 -1.545 . . . . 0.0 109.588 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.844 ' O ' ' O ' ' A' ' 76' ' ' LYS . 5.1 mmtp -150.51 85.46 1.38 Allowed 'General case' 0 N--CA 1.523 3.175 0 O-C-N 120.847 -1.158 . . . . 0.0 113.016 -177.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.844 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 23.91 164.13 0.0 OUTLIER Pre-proline 1 N--CA 1.539 4.008 0 CA-C-N 121.986 2.175 . . . . 0.0 116.19 179.668 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 78' ' ' GLN . 6.2 Cg_exo -32.36 -68.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.509 2.41 0 C-N-CA 124.255 3.304 . . . . 0.0 115.293 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 77' ' ' PRO . 91.8 mt-30 -35.98 133.1 0.47 Allowed 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.784 1.278 . . . . 0.0 111.024 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 63.04 19.28 11.55 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.716 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.9 ' O ' ' N ' ' A' ' 82' ' ' ILE . 33.8 m -90.0 83.66 6.12 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.347 -1.471 . . . . 0.0 109.341 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -38.88 52.31 0.0 OUTLIER Glycine 0 N--CA 1.508 3.464 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.569 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.9 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.4 tp -63.86 -1.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 120.514 -1.58 . . . . 0.0 108.038 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.454 ' H ' ' C ' ' A' ' 81' ' ' GLY . 17.7 mp0 -58.4 -21.92 52.14 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 120.974 -1.079 . . . . 0.0 112.199 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -85.84 -63.64 1.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 121.951 2.159 . . . . 0.0 112.061 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.471 ' C ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -48.27 -34.09 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 122.718 2.508 . . . . 0.0 107.067 172.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 90' ' ' ARG . . . -65.43 -48.36 73.02 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' ALA . 36.8 tt0 -48.22 -56.6 7.55 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 117.443 -1.265 . . . . 0.0 112.425 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.95 -44.16 23.06 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 123.553 2.888 . . . . 0.0 108.306 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.8 t -55.97 -76.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 116.071 -2.251 . . . . 0.0 108.977 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.623 ' O ' ' C ' ' A' ' 91' ' ' LYS . 45.8 ttm-85 -34.7 -58.53 0.5 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.55 0.74 . . . . 0.0 110.038 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.623 ' C ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -32.32 -49.04 0.19 Allowed 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 117.35 -1.74 . . . . 0.0 107.582 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -55.35 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 117.064 -1.446 . . . . 0.0 111.107 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.926 ' ND2' ' O ' ' A' ' 93' ' ' ASN . 0.3 OUTLIER -71.27 -3.61 21.33 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 113.864 -3.134 . . . . 0.0 108.903 -172.097 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.472 ' CG ' ' O ' ' A' ' 94' ' ' ASP . 7.6 t70 62.01 40.87 11.77 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -174.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.544 HD22 ' O ' ' A' ' 93' ' ' ASN . 0.6 OUTLIER 158.94 165.23 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.52 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 4.1 mt 150.07 163.34 0.0 OUTLIER 'General case' 1 N--CA 1.557 4.924 0 CA-C-N 121.194 1.815 . . . . 0.0 108.505 178.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -113.82 85.87 2.29 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 171.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.62 113.1 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 104.708 -2.331 . . . . 0.0 104.708 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -122.13 135.75 61.22 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.379 0 CA-C-N 112.808 -1.996 . . . . 0.0 112.454 -174.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.19 128.78 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 1 N-CA-C 98.679 -4.563 . . . . 0.0 98.679 171.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 162' ' ' VAL . 3.3 p -117.89 155.05 30.84 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.343 -1.473 . . . . 0.0 109.842 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.61 ' O ' ' N ' ' A' ' 104' ' ' GLN . 1.5 t70 -82.3 -175.85 5.89 Favored 'General case' 0 C--N 1.285 -2.201 1 N-CA-C 97.592 -4.966 . . . . 0.0 97.592 170.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.532 ' C ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -70.47 75.64 0.56 Allowed 'General case' 0 C--N 1.268 -2.951 0 C-N-CA 113.89 -3.124 . . . . 0.0 105.499 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.61 ' N ' ' O ' ' A' ' 102' ' ' ASP . 6.6 mm-40 -136.78 -51.54 0.68 Allowed 'General case' 0 C--O 1.214 -0.798 0 O-C-N 119.365 -2.085 . . . . 0.0 108.189 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.579 ' O ' ' CB ' ' A' ' 106' ' ' LEU . 0.5 OUTLIER 84.6 134.51 0.05 Allowed 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -178.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.66 ' H ' ' NH2' ' A' ' 107' ' ' ARG . 1.5 pp 148.41 147.4 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.66 ' NH2' ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -69.07 139.87 54.85 Favored 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 178.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -96.73 -35.8 10.87 Favored 'General case' 0 C--N 1.258 -3.387 0 N-CA-C 103.498 -2.778 . . . . 0.0 103.498 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.22 167.48 10.65 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 112.197 -2.274 . . . . 0.0 112.222 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -175.16 153.77 1.6 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.813 -1.179 . . . . 0.0 112.482 -176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.607 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 41.1 Cg_endo -90.75 -37.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 N-CA-C 106.191 -2.273 . . . . 0.0 106.191 172.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.607 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 57.0 tt0 -102.17 115.18 30.0 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.47 -47.43 38.5 Favored 'General case' 0 C--N 1.29 -1.99 0 O-C-N 121.011 -1.055 . . . . 0.0 112.084 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -64.39 -31.06 72.12 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.271 -1.518 . . . . 0.0 115.034 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.678 ' NE ' ' OE1' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -66.83 -22.21 66.01 Favored 'General case' 0 C--O 1.197 -1.687 0 O-C-N 119.35 -2.094 . . . . 0.0 107.969 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.596 ' CG2' ' N ' ' A' ' 117' ' ' GLY . 54.8 mt -35.11 -91.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.596 ' N ' ' CG2' ' A' ' 116' ' ' ILE . . . -85.81 -9.72 77.33 Favored Glycine 0 N--CA 1.502 3.078 0 O-C-N 121.025 -1.047 . . . . 0.0 114.034 -173.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.678 ' OE1' ' NE ' ' A' ' 115' ' ' ARG . 3.2 pt20 -60.5 -40.66 77.97 Favored Pre-proline 0 C--N 1.294 -1.807 0 C-N-CA 116.442 -2.103 . . . . 0.0 110.14 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 118' ' ' GLN . 8.3 Cg_endo -48.15 113.87 0.95 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.662 2.241 . . . . 0.0 112.894 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.445 ' O ' ' CD2' ' A' ' 120' ' ' PHE . 69.7 t80 -178.89 29.06 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -132.45 42.74 3.07 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.665 -0.647 . . . . 0.0 112.518 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.35 -46.94 0.1 Allowed Glycine 0 N--CA 1.51 3.59 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 75.32 20.03 2.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.917 -0.754 . . . . 0.0 111.421 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.468 ' OD2' ' CE2' ' A' ' 149' ' ' PHE . 19.7 p-10 -84.1 -2.68 57.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.213 -1.554 . . . . 0.0 108.563 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.649 ' O ' ' N ' ' A' ' 129' ' ' LEU . 12.3 pt -84.51 -23.73 7.52 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 O-C-N 120.941 -1.1 . . . . 0.0 110.684 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' A' ' 125' ' ' ILE . 71.6 mt -35.65 -46.09 0.4 Allowed 'General case' 0 N--CA 1.52 3.044 0 O-C-N 121.198 -0.938 . . . . 0.0 110.061 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -79.48 -40.95 28.54 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.351 -0.843 . . . . 0.0 110.81 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -83.1 -30.73 27.72 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.218 -1.551 . . . . 0.0 108.317 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.649 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -38.85 -34.18 0.14 Allowed 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 128' ' ' ALA . 1.6 m120 -99.42 -104.32 0.22 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -132.11 54.12 0.79 Allowed Glycine 0 N--CA 1.506 3.32 0 C-N-CA 119.801 -1.19 . . . . 0.0 115.27 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.55 142.84 30.49 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 120.515 2.157 . . . . 0.0 108.776 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.595 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 89.2 mt-10 -69.66 157.1 37.9 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 119.888 -1.758 . . . . 0.0 109.987 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 133' ' ' GLU . 20.3 m-80 -160.11 142.55 13.27 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.29 145.3 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.556 -1.34 . . . . 0.0 108.909 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.62 164.18 29.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 109.066 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.2 mt -99.6 139.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 O-C-N 120.717 -1.239 . . . . 0.0 111.029 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.441 ' OD1' ' NH1' ' A' ' 115' ' ' ARG . 8.3 t-20 -106.36 138.95 41.62 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.701 0.762 . . . . 0.0 109.709 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.576 ' N ' HH12 ' A' ' 115' ' ' ARG . 14.6 ptm180 -166.95 115.89 0.85 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.38 -1.328 . . . . 0.0 109.43 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 142' ' ' LEU . . . -162.27 109.21 0.38 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 107.729 -2.149 . . . . 0.0 107.729 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 50.4 13.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.997 -1.296 . . . . 0.0 108.405 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 140' ' ' GLY . 13.0 tp -134.34 172.5 12.8 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.52 -142.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.233 -1.542 . . . . 0.0 112.465 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -110.79 146.58 36.14 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 176.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 167' ' ' LEU . . . -150.62 142.61 23.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.957 -1.714 . . . . 0.0 107.191 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.7 tp -101.79 149.41 24.2 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 122.781 2.537 . . . . 0.0 106.89 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.593 ' NH2' ' CZ ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -144.81 150.55 37.36 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.409 1.099 . . . . 0.0 111.207 -178.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 23.9 m -113.14 143.23 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.717 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.468 ' CE2' ' OD2' ' A' ' 124' ' ' ASP . 28.2 m-85 -110.69 135.02 51.93 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.657 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -136.24 166.4 28.23 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -111.61 154.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.912 0 C-N-CA 124.306 3.338 . . . . 0.0 114.803 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 54.2 mt -118.89 127.68 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.568 ' C ' ' H ' ' A' ' 155' ' ' GLU . 83.4 m-85 -101.76 144.18 30.77 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.927 -1.108 . . . . 0.0 112.201 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 55.7 t0 -65.66 12.79 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.547 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.568 ' H ' ' C ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER 86.81 15.65 0.1 Allowed 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.98 -1.075 . . . . 0.0 108.455 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 158' ' ' LYS . 77.7 m-20 -139.27 36.16 2.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.84 -1.162 . . . . 0.0 108.303 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 59.56 3.36 0.41 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.6 mptt -85.91 130.81 34.44 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.745 ' O ' ' NE2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -85.01 125.62 32.87 Favored 'General case' 0 N--CA 1.512 2.655 0 CA-C-N 119.848 1.204 . . . . 0.0 113.571 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.08 5.49 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 O-C-N 119.926 -1.734 . . . . 0.0 113.88 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -171.26 173.6 44.81 Favored Glycine 0 N--CA 1.501 3.01 0 C-N-CA 118.18 -1.962 . . . . 0.0 112.033 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.571 ' O ' ' OG1' ' A' ' 101' ' ' THR . 1.5 t -133.21 141.99 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 O-C-N 121.799 -0.824 . . . . 0.0 110.708 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.443 ' O ' ' OG1' ' A' ' 150' ' ' THR . 9.2 t -113.25 119.64 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 120.961 -1.087 . . . . 0.0 108.179 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.461 ' H ' HG11 ' A' ' 99' ' ' VAL . . . -112.93 156.61 22.7 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 23.6 mt -152.14 109.64 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.8 137.09 13.49 Favored Glycine 0 N--CA 1.489 2.178 0 CA-C-O 122.805 1.225 . . . . 0.0 113.636 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.698 ' CD1' ' OD1' ' A' ' 93' ' ' ASN . 3.5 tp -95.45 103.27 15.13 Favored 'General case' 0 N--CA 1.514 2.763 0 CA-C-N 113.809 -1.196 . . . . 0.0 108.124 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 169' ' ' LEU . 7.1 tt0 -47.47 -60.27 2.64 Favored 'General case' 0 N--CA 1.523 3.208 0 O-C-N 124.384 1.053 . . . . 0.0 109.684 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.582 ' CB ' ' O ' ' A' ' 168' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.526 3.359 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.767 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.634 0.73 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 49' ' ' ARG . 55.1 t0 -65.28 -56.34 13.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 124.068 1.889 . . . . 0.0 107.303 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 46' ' ' ASP . 11.1 ttt -36.78 -56.92 0.83 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.896 -174.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -59.01 -36.44 74.94 Favored 'General case' 0 C--O 1.202 -1.405 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.089 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.484 ' C ' ' O ' ' A' ' 48' ' ' THR . 55.9 ttt-85 -35.79 -64.31 0.31 Allowed 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.044 0.926 . . . . 0.0 111.397 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -70.42 -57.73 4.49 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -81.96 -35.56 21.15 Favored Glycine 0 N--CA 1.497 2.759 0 C-N-CA 119.572 -1.299 . . . . 0.0 111.397 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.521 ' CB ' ' O ' ' A' ' 48' ' ' THR . 11.3 tp -53.36 -47.66 69.24 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 120.783 2.291 . . . . 0.0 107.145 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.7 -61.76 2.01 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.767 -1.173 . . . . 0.0 109.51 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.508 ' C ' HD21 ' A' ' 54' ' ' ASN . 0.4 OUTLIER -69.3 -56.37 7.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.268 -1.52 . . . . 0.0 113.359 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 51' ' ' GLY . 19.2 mtpp -69.58 -41.34 75.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -0.884 . . . . 0.0 112.335 -175.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.86 -35.23 67.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 119.715 -1.866 . . . . 0.0 110.11 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.408 ' CD2' ' C ' ' A' ' 57' ' ' LEU . 7.2 tt -65.22 -41.31 94.54 Favored 'General case' 0 C--N 1.288 -2.106 0 O-C-N 121.057 -1.027 . . . . 0.0 111.492 177.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.88 -44.42 49.01 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.297 -1.502 . . . . 0.0 114.885 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.38 -43.63 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 118.836 -2.415 . . . . 0.0 106.607 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.405 ' CB ' ' CD1' ' A' ' 98' ' ' ILE . . . -57.9 -26.42 62.14 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -71.08 -15.84 62.55 Favored 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 118.474 -1.29 . . . . 0.0 109.009 179.005 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -64.85 -42.47 94.87 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 115.105 -2.638 . . . . 0.0 104.143 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.0 mt -87.45 -42.02 13.12 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.801 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.77 -18.47 8.47 Favored 'General case' 0 N--CA 1.522 3.17 0 O-C-N 119.989 -1.694 . . . . 0.0 107.166 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 12.2 t0 -85.49 -22.72 28.08 Favored 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.959 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.51 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -58.38 -156.69 0.0 OUTLIER Pre-proline 0 C--N 1.281 -2.397 0 O-C-N 120.699 -1.251 . . . . 0.0 111.742 -177.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -107.4 -35.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.513 2.62 0 C-N-CA 124.476 3.451 . . . . 0.0 115.396 178.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 72' ' ' GLY . 7.4 pt-20 -55.74 -30.98 62.12 Favored 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 118.735 -1.186 . . . . 0.0 109.166 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -53.08 -76.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.267 1.032 . . . . 0.0 111.034 -179.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -49.94 -33.85 18.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -83.02 -18.75 38.66 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 118.817 -1.153 . . . . 0.0 112.763 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.783 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -86.31 -46.11 5.37 Favored Glycine 0 N--CA 1.498 2.816 1 N-CA-C 101.931 -4.468 . . . . 0.0 101.931 179.098 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 75' ' ' LYS . 15.2 tp -46.6 -39.2 10.71 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 175.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.88 6.2 0.94 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.091 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.783 ' N ' ' O ' ' A' ' 72' ' ' GLY . 4.3 tmtt? -143.56 52.84 1.33 Allowed 'General case' 0 N--CA 1.512 2.668 0 O-C-N 120.265 -1.522 . . . . 0.0 114.526 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.658 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 32.95 149.55 0.0 OUTLIER Pre-proline 0 N--CA 1.524 3.24 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 178.092 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -30.79 -70.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.513 2.644 0 C-N-CA 124.875 3.717 . . . . 0.0 118.232 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -44.27 -43.45 7.34 Favored 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -101.97 9.36 40.56 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.483 -1.386 . . . . 0.0 110.15 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.5 m -88.32 125.82 34.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.42 71.97 0.96 Allowed Glycine 0 N--CA 1.489 2.182 0 O-C-N 118.699 -2.501 . . . . 0.0 109.981 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.1 tp -63.89 -4.64 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 C-N-CA 125.078 1.351 . . . . 0.0 109.585 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.641 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 55.3 tt0 -50.09 -32.7 16.44 Favored 'General case' 0 C--N 1.279 -2.468 0 O-C-N 120.851 -1.155 . . . . 0.0 110.038 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -71.64 -98.5 0.01 OUTLIER 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.595 ' C ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -16.08 -44.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.952 0 CA-C-N 121.788 2.085 . . . . 0.0 111.904 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -73.2 -48.08 38.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 119.678 -1.889 . . . . 0.0 109.601 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.645 ' N ' ' O ' ' A' ' 84' ' ' ALA . 50.9 mm-40 -49.86 -49.8 47.95 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.718 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -66.33 -56.39 11.35 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 125.529 3.786 . . . . 0.0 108.564 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 92' ' ' ARG . 1.2 t -52.96 -65.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 115.638 -2.425 . . . . 0.0 108.945 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 1.075 ' HD3' ' H ' ' A' ' 96' ' ' LEU . 1.9 tpp85 -37.97 -46.05 0.94 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.467 -1.395 . . . . 0.0 109.218 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.605 ' C ' ' O ' ' A' ' 90' ' ' ARG . 14.4 ttmm -34.48 -43.45 0.17 Allowed 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 117.592 -1.643 . . . . 0.0 106.705 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.733 ' O ' ' HD3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -39.78 -39.53 0.81 Allowed 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 117.369 -1.3 . . . . 0.0 109.06 172.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.679 ' N ' ' O ' ' A' ' 90' ' ' ARG . 1.5 m120 -156.58 -62.93 0.1 Allowed 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 124.783 3.447 . . . . 0.0 111.106 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 1.1 m-20 166.11 -13.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.085 -1.009 . . . . 0.0 111.365 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.44 60.98 1.49 Allowed 'General case' 0 N--CA 1.533 3.696 0 C-N-CA 118.422 -1.311 . . . . 0.0 113.972 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.075 ' H ' ' HD3' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -120.14 142.23 49.12 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 116.793 -1.575 . . . . 0.0 110.773 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -119.95 100.22 7.09 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 124.752 3.433 . . . . 0.0 109.409 176.241 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.405 ' CD1' ' CB ' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -95.22 111.76 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 174.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.484 HG13 ' H ' ' A' ' 109' ' ' SER . 4.5 m -112.37 124.21 68.83 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.594 0 CA-C-N 112.097 -2.319 . . . . 0.0 110.199 -173.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.5 p -96.68 128.08 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 1 N-CA-C 98.754 -4.536 . . . . 0.0 98.754 176.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' A' ' 104' ' ' GLN . 81.0 p -119.99 151.49 38.88 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.464 -175.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 104' ' ' GLN . 38.8 t0 -81.91 -174.77 5.24 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 100.498 -3.89 . . . . 0.0 100.498 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 43.1 ttm -74.81 71.22 1.97 Allowed 'General case' 0 C--N 1.268 -2.976 0 C-N-CA 114.889 -2.724 . . . . 0.0 107.837 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.615 ' O ' ' HB ' ' A' ' 101' ' ' THR . 3.5 pp0? -171.82 136.07 0.89 Allowed 'General case' 0 N--CA 1.436 -1.132 1 N-CA-C 96.844 -5.243 . . . . 0.0 96.844 176.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.659 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 16.3 t -107.72 -179.95 4.05 Favored 'General case' 0 CA--C 1.47 -2.117 0 C-N-CA 116.741 -1.983 . . . . 0.0 106.581 -176.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' A' ' 105' ' ' SER . 3.3 tp 154.04 144.84 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.61 ' NH1' ' NH2' ' A' ' 147' ' ' ARG . 1.8 mmp_? -77.02 91.51 3.64 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.416 -1.713 . . . . 0.0 108.413 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 107' ' ' ARG . 3.2 m-85 -46.25 -31.14 2.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.484 ' H ' HG13 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -124.42 171.51 9.89 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 113.811 -1.54 . . . . 0.0 113.715 -178.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.56 ' HD1' ' CG1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER 172.09 166.6 0.24 Allowed Pre-proline 0 N--CA 1.51 2.531 0 O-C-N 121.511 -0.743 . . . . 0.0 109.576 -179.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.493 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 46.5 Cg_endo -88.48 -40.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 122.768 2.312 . . . . 0.0 107.31 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 18.4 tp10 -107.96 93.98 4.83 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.97 1.367 . . . . 0.0 107.663 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' GLU . . . -31.11 -45.78 0.08 Allowed 'General case' 0 N--CA 1.503 2.195 0 CA-C-N 113.27 -1.786 . . . . 0.0 113.007 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -60.01 -33.35 71.88 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 120.395 -1.441 . . . . 0.0 113.772 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -60.9 -36.82 80.23 Favored 'General case' 0 C--O 1.203 -1.387 0 O-C-N 120.114 -1.616 . . . . 0.0 108.151 -178.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.734 ' O ' ' N ' ' A' ' 118' ' ' GLN . 79.7 mt -41.88 -84.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.075 177.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.414 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -27.64 -17.1 0.0 OUTLIER Glycine 0 N--CA 1.497 2.713 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.81 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.734 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.4 mp0 -77.61 -73.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.836 0 CA-C-N 120.946 2.373 . . . . 0.0 114.205 -175.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -30.86 115.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 123.325 2.683 . . . . 0.0 115.224 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.518 ' CG ' ' O ' ' A' ' 120' ' ' PHE . 72.2 t80 171.73 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 123' ' ' ASP . 42.3 mttm -157.1 -26.13 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.41 -176.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 121' ' ' LYS . . . -41.06 -25.35 0.12 Allowed Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.041 -1.037 . . . . 0.0 110.549 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 121' ' ' LYS . 57.6 m-20 60.17 10.83 2.47 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.757 -0.849 . . . . 0.0 110.897 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -88.57 -23.64 23.07 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 128' ' ' ALA . 3.9 mt -80.68 -17.16 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.77 -1.206 . . . . 0.0 112.034 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 125' ' ' ILE . 54.4 mt -49.36 -32.97 12.46 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.556 -1.34 . . . . 0.0 107.481 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.619 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 94.8 mttt -79.65 -30.31 41.21 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.534 ' C ' ' ND2' ' A' ' 130' ' ' ASN . . . -92.44 -36.32 13.17 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 120.417 1.462 . . . . 0.0 109.262 -176.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.4 mt -41.15 -30.49 0.16 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.265 -0.897 . . . . 0.0 108.686 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.809 ' ND2' ' N ' ' A' ' 131' ' ' GLY . 0.0 OUTLIER -77.97 -95.56 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.809 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -160.88 33.22 0.39 Allowed Glycine 0 CA--C 1.562 2.978 0 O-C-N 120.594 -1.316 . . . . 0.0 111.131 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.433 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 63.6 tt0 -122.98 161.97 23.21 Favored 'General case' 0 N--CA 1.52 3.061 0 O-C-N 119.012 -2.463 . . . . 0.0 109.463 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -77.45 170.66 16.16 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.424 -0.798 . . . . 0.0 112.625 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.817 HD21 ' H ' ' A' ' 135' ' ' VAL . 0.2 OUTLIER -171.67 149.97 2.65 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.817 ' H ' HD21 ' A' ' 134' ' ' ASN . 0.9 OUTLIER -133.67 131.88 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 119.877 -1.764 . . . . 0.0 108.93 -178.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.01 177.17 9.81 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 121.068 -1.02 . . . . 0.0 110.969 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.78 134.61 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.895 -1.128 . . . . 0.0 111.297 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -98.77 120.19 38.78 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.479 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.599 ' NE ' HE22 ' A' ' 144' ' ' GLN . 6.8 ptp180 -141.41 110.02 6.04 Favored 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 117.871 -1.532 . . . . 0.0 112.062 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -156.81 105.91 0.28 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 58.44 -39.84 0.06 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.343 -0.504 . . . . 0.0 111.586 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.567 ' N ' ' O ' ' A' ' 140' ' ' GLY . 71.8 mt -72.81 -85.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.908 -1.12 . . . . 0.0 110.769 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -179.05 154.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.964 -1.094 . . . . 0.0 110.25 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.599 HE22 ' NE ' ' A' ' 139' ' ' ARG . 5.0 mm100 -46.46 136.14 7.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.092 -1.005 . . . . 0.0 108.496 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 167' ' ' LEU . . . -148.04 156.6 42.82 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tp -114.93 150.76 35.19 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 122.5 2.409 . . . . 0.0 109.621 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.61 ' NH2' ' NH1' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -150.41 129.32 12.53 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.849 1.309 . . . . 0.0 112.449 -179.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.0 m -91.91 150.15 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.317 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 46.3 m-85 -116.03 138.79 50.91 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.481 ' O ' ' N ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -138.3 138.75 23.39 Favored Pre-proline 0 C--O 1.208 -1.126 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -89.68 155.29 5.17 Favored 'Trans proline' 0 N--CA 1.515 2.782 0 C-N-CA 123.881 3.054 . . . . 0.0 115.136 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.8 mt -121.35 131.4 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.865 -0.522 . . . . 0.0 109.65 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.557 ' C ' ' H ' ' A' ' 155' ' ' GLU . 86.9 m-85 -101.29 144.15 30.48 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.022 -1.049 . . . . 0.0 111.283 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 57.0 t0 -58.86 2.49 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.768 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.557 ' H ' ' C ' ' A' ' 153' ' ' TYR . 17.9 tt0 86.24 29.62 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.825 -1.172 . . . . 0.0 108.629 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -149.36 18.6 0.94 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 71.63 9.78 6.36 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -88.55 116.79 27.04 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.707 ' N ' ' NE2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -68.69 117.54 10.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.087 -1.008 . . . . 0.0 113.332 -177.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.19 11.13 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -174.21 179.19 45.71 Favored Glycine 0 N--CA 1.504 3.208 0 C-N-CA 115.163 -3.399 . . . . 0.0 114.146 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.483 ' O ' ' OG1' ' A' ' 101' ' ' THR . 96.7 t -143.32 140.62 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-O 122.484 1.135 . . . . 0.0 111.779 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 150' ' ' THR . 63.6 t -111.36 127.39 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -115.72 153.13 31.91 Favored 'General case' 0 N--CA 1.51 2.563 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 24.5 mt -148.6 103.5 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 97' ' ' PHE . . . -114.25 140.97 16.72 Favored Glycine 0 N--CA 1.485 1.946 0 CA-C-O 123.399 1.555 . . . . 0.0 112.115 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.487 ' O ' ' CB ' ' A' ' 145' ' ' ALA . 50.6 tp -97.12 106.23 18.52 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 169' ' ' LEU . 0.5 OUTLIER -72.87 142.59 47.94 Favored 'General case' 0 N--CA 1.524 3.269 0 O-C-N 124.002 0.813 . . . . 0.0 109.414 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 168' ' ' GLU . 3.1 mt . . . . . 0 N--CA 1.515 2.777 0 O-C-N 120.039 -1.663 . . . . 0.0 113.935 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.0 p . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 121.988 0.899 . . . . 0.0 108.907 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 49' ' ' ARG . 35.0 t70 -60.92 -57.59 12.01 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.128 0.966 . . . . 0.0 110.97 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 15.5 mmm -39.4 -59.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.819 -1.175 . . . . 0.0 111.575 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.45 ' OG1' ' CD2' ' A' ' 52' ' ' LEU . 11.6 t -57.91 -31.73 67.07 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 62.3 ttt180 -42.32 -56.43 2.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.779 -1.201 . . . . 0.0 110.761 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -69.98 -63.39 1.09 Allowed 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 126.18 1.792 . . . . 0.0 114.511 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -83.14 -41.01 8.8 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 119.204 -1.474 . . . . 0.0 111.243 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.45 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -50.69 -45.61 58.35 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.596 2.698 . . . . 0.0 106.309 176.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.98 -65.94 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.995 -1.066 . . . . 0.0 110.004 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -67.14 -55.79 12.69 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.585 -1.322 . . . . 0.0 112.64 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' GLY . 55.0 mtpt -68.55 -49.6 58.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -174.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.66 -33.14 70.64 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 118.965 -2.334 . . . . 0.0 111.267 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.442 ' O ' HD22 ' A' ' 57' ' ' LEU . 4.8 tt -65.64 -37.89 87.84 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 120.505 -1.372 . . . . 0.0 110.921 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 61' ' ' ARG . . . -74.42 -47.46 33.69 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 119.201 -2.187 . . . . 0.0 115.703 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.68 -35.95 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 118.617 -2.552 . . . . 0.0 106.395 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.4 ' N ' HG21 ' A' ' 89' ' ' VAL . . . -55.96 -32.42 63.84 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -67.83 -22.58 65.15 Favored 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 117.726 -1.131 . . . . 0.0 111.093 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 m -59.77 -47.89 83.88 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 123.701 2.955 . . . . 0.0 106.429 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.1 mt -85.77 -36.49 20.09 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.314 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.73 -22.0 66.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 119.81 -1.807 . . . . 0.0 106.194 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 15.5 t0 -78.58 -11.08 59.95 Favored 'General case' 0 N--CA 1.53 3.529 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.732 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.513 ' CB ' ' CD ' ' A' ' 67' ' ' PRO 0.265 0.9 OUTLIER -71.62 -152.54 0.0 OUTLIER Pre-proline 0 C--N 1.277 -2.586 0 O-C-N 120.662 -1.274 . . . . 0.0 108.426 179.206 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.527 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 0.3 OUTLIER -103.27 -20.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 123.252 2.635 . . . . 0.0 111.542 176.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 9.6 pt-20 -58.06 -37.23 74.03 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.368 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.848 ' CG2' ' H ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -49.5 -78.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.771 0 O-C-N 120.228 -1.545 . . . . 0.0 111.403 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.848 ' H ' ' CG2' ' A' ' 69' ' ' ILE . 61.2 ttt180 -52.11 -31.3 30.13 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -174.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' CG ' ' O ' ' A' ' 71' ' ' GLN . 19.5 tt0 -84.83 -12.07 54.35 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.102 -1.439 . . . . 0.0 112.386 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -91.09 -51.35 2.62 Favored Glycine 0 N--CA 1.503 3.148 1 N-CA-C 101.72 -4.552 . . . . 0.0 101.72 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 tp -43.71 -38.87 3.35 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 112.837 -1.682 . . . . 0.0 107.403 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -64.97 -0.83 1.7 Allowed 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.384 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.894 ' O ' ' O ' ' A' ' 76' ' ' LYS . 21.1 tptp -135.44 68.59 1.45 Allowed 'General case' 0 N--CA 1.517 2.894 0 O-C-N 119.985 -1.697 . . . . 0.0 113.698 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.894 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 11.61 154.55 0.0 OUTLIER Pre-proline 0 N--CA 1.536 3.853 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -29.33 -56.05 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.4 2.733 . . . . 0.0 115.315 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -53.0 131.96 36.95 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 118.158 -1.417 . . . . 0.0 109.766 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 68.78 9.43 7.36 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.864 ' O ' ' N ' ' A' ' 82' ' ' ILE . 30.1 m -78.85 84.24 4.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.746 -1.846 . . . . 0.0 110.043 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -41.98 64.44 0.0 OUTLIER Glycine 0 N--CA 1.504 3.199 0 C-N-CA 119.721 -1.228 . . . . 0.0 111.248 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.864 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.8 tp -71.68 4.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.606 -1.526 . . . . 0.0 107.699 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.545 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 34.5 tp60 -53.99 -32.13 53.08 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.346 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.75 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -79.31 -99.75 0.03 OUTLIER 'General case' 0 C--O 1.189 -2.105 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.682 ' C ' ' O ' ' A' ' 84' ' ' ALA . 2.0 mp -9.58 -54.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.597 0 CA-C-N 122.592 2.451 . . . . 0.0 111.651 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -59.76 -53.64 55.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 119.977 -1.702 . . . . 0.0 109.477 176.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.75 ' N ' ' O ' ' A' ' 84' ' ' ALA . 87.6 tt0 -40.06 -55.02 2.17 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.319 -1.309 . . . . 0.0 112.074 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -66.11 -63.86 0.99 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 114.2 -3.0 . . . . 0.0 108.159 -177.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.529 ' C ' ' O ' ' A' ' 88' ' ' ALA . 2.1 t -45.09 -72.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 115.162 -2.615 . . . . 0.0 110.303 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 1.197 ' CG ' HD13 ' A' ' 96' ' ' LEU . 78.1 mtp180 -32.5 -49.76 0.22 Allowed 'General case' 0 N--CA 1.51 2.53 0 O-C-N 121.08 -1.012 . . . . 0.0 110.308 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.576 ' C ' ' O ' ' A' ' 90' ' ' ARG . 15.6 tptm -33.96 -36.45 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 118.291 -1.364 . . . . 0.0 108.037 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.561 ' N ' ' O ' ' A' ' 90' ' ' ARG . 60.5 mtm180 -56.01 -65.63 0.57 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 117.392 -1.29 . . . . 0.0 108.471 171.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.618 ' O ' ' CG ' ' A' ' 94' ' ' ASP . 2.1 p30 -115.9 -69.9 0.83 Allowed 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 113.869 -3.132 . . . . 0.0 109.673 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.618 ' CG ' ' O ' ' A' ' 93' ' ' ASN . 34.4 m-20 155.35 -9.49 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 121.972 0.892 . . . . 0.0 109.988 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' HD22 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -120.45 152.51 37.89 Favored 'General case' 0 C--O 1.182 -2.476 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.89 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.197 HD13 ' CG ' ' A' ' 90' ' ' ARG . 0.5 OUTLIER 142.2 152.37 0.0 OUTLIER 'General case' 1 N--CA 1.549 4.494 0 CA-C-O 115.971 -1.966 . . . . 0.0 109.379 -178.211 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 110' ' ' HIS . 0.1 OUTLIER -116.1 96.84 5.76 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 125.239 3.654 . . . . 0.0 103.754 171.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.31 107.03 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 m -131.44 143.89 39.19 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 124.2 1.953 . . . . 0.0 115.644 -171.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.416 ' O ' ' CZ ' ' A' ' 108' ' ' TYR . 38.3 t -109.62 138.34 37.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 101.901 -3.37 . . . . 0.0 101.901 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 162' ' ' VAL . 11.3 p -118.91 148.56 42.8 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 104' ' ' GLN . 32.8 t70 -80.21 -173.71 4.14 Favored 'General case' 0 C--N 1.288 -2.1 1 N-CA-C 98.992 -4.447 . . . . 0.0 98.992 171.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 ttp -74.55 71.02 1.83 Allowed 'General case' 0 C--N 1.27 -2.849 0 C-N-CA 113.978 -3.089 . . . . 0.0 105.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.2 tp-100 -145.14 -47.81 0.23 Allowed 'General case' 0 C--O 1.211 -0.965 0 O-C-N 120.31 -1.494 . . . . 0.0 110.116 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.7 t 86.9 138.0 0.05 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.4 OUTLIER 156.35 138.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.537 -3.135 . . . . 0.0 102.537 176.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.513 HH22 ' CG ' ' A' ' 138' ' ' ASN . 2.6 mpt_? -74.47 97.79 3.18 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.416 ' CZ ' ' O ' ' A' ' 100' ' ' VAL . 2.9 m-85 -49.21 -22.53 1.04 Allowed 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.504 ' N ' ' C ' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -131.58 163.44 28.04 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -175.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 97' ' ' PHE . 0.1 OUTLIER 170.96 143.99 0.11 Allowed Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 120.959 -1.088 . . . . 0.0 110.943 178.249 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.44 -44.32 6.68 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 N-CA-C 105.479 -2.546 . . . . 0.0 105.479 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -108.3 109.17 20.44 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.75 67.7 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.561 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.51 -36.94 74.58 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 119.153 -2.217 . . . . 0.0 113.179 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.488 ' NH1' ' N ' ' A' ' 140' ' ' GLY . 0.5 OUTLIER -56.5 -41.6 76.93 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.466 -2.021 . . . . 0.0 107.35 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.741 ' O ' ' N ' ' A' ' 118' ' ' GLN . 85.6 mt -40.66 -80.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.102 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 116' ' ' ILE . . . -27.58 -18.72 0.0 OUTLIER Glycine 0 N--CA 1.497 2.742 0 CA-C-O 119.451 -0.638 . . . . 0.0 113.431 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.741 ' N ' ' O ' ' A' ' 116' ' ' ILE . 5.5 mm-40 -73.43 -70.96 0.24 Allowed Pre-proline 0 N--CA 1.501 2.125 0 CA-C-N 120.942 2.371 . . . . 0.0 112.885 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.666 ' O ' ' O ' ' A' ' 118' ' ' GLN . 75.7 Cg_exo -20.11 156.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 124.05 3.166 . . . . 0.0 114.155 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.496 ' CB ' ' O ' ' A' ' 119' ' ' PRO . 28.4 t80 89.16 145.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.76 72.89 0.5 Allowed 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 117.375 -1.73 . . . . 0.0 111.358 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.665 ' O ' ' OD2' ' A' ' 123' ' ' ASP . . . -152.36 -58.23 0.01 OUTLIER Glycine 0 N--CA 1.507 3.393 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 176.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.665 ' OD2' ' O ' ' A' ' 122' ' ' GLY . 14.3 m-20 131.78 1.88 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.546 0 CA-C-N 117.653 0.727 . . . . 0.0 110.567 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -95.31 -26.7 15.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.572 -1.33 . . . . 0.0 108.683 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.486 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 0.3 OUTLIER -84.44 -18.11 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.272 -1.518 . . . . 0.0 109.928 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -50.42 -36.08 31.41 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.654 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 58.5 mttp -80.24 -33.76 37.73 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.27 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.497 ' C ' ' ND2' ' A' ' 130' ' ' ASN . . . -86.74 -28.68 22.9 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 119.788 -1.82 . . . . 0.0 110.321 -176.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.4 mt -50.11 -25.75 3.81 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.648 0.737 . . . . 0.0 109.127 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.831 ' ND2' ' N ' ' A' ' 131' ' ' GLY 0.269 0.0 OUTLIER -78.28 -97.05 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.61 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.831 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -161.75 49.15 0.35 Allowed Glycine 0 CA--C 1.549 2.218 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.46 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 93.2 mt-10 -142.31 163.46 32.79 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.178 -1.778 . . . . 0.0 109.632 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 149' ' ' PHE . 56.2 mm-40 -71.82 165.3 24.37 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.345 0.593 . . . . 0.0 112.054 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -168.69 144.62 3.55 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.49 131.12 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 120.24 -1.538 . . . . 0.0 109.848 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.28 168.18 24.02 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.327 -0.858 . . . . 0.0 109.911 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.83 139.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.85 0.833 . . . . 0.0 111.635 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.513 ' CG ' HH22 ' A' ' 107' ' ' ARG . 6.7 t-20 -101.93 130.14 48.37 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 122.231 1.015 . . . . 0.0 111.973 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -127.96 119.65 25.97 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.583 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.488 ' N ' ' NH1' ' A' ' 115' ' ' ARG . . . -156.0 167.66 33.32 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.455 ' C ' ' O ' ' A' ' 140' ' ' GLY . 73.2 m-85 -34.48 -36.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.915 -0.756 . . . . 0.0 110.973 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.512 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 47.5 mt -60.87 -67.92 0.36 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.896 -1.128 . . . . 0.0 110.076 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 142' ' ' LEU . . . 158.36 158.43 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.842 0.829 . . . . 0.0 110.718 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -44.77 137.25 4.06 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.085 0.945 . . . . 0.0 111.341 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 167' ' ' LEU . . . -151.48 150.88 30.91 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 tp -104.67 157.09 17.43 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-N 122.032 2.196 . . . . 0.0 108.896 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.418 ' HD2' HH21 ' A' ' 107' ' ' ARG . 12.4 ptt180 -146.21 153.82 41.05 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.423 1.106 . . . . 0.0 110.592 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 6.9 m -117.97 153.32 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.431 ' O ' ' OE1' ' A' ' 133' ' ' GLU . 68.7 m-85 -121.65 144.42 48.77 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.56 139.17 16.06 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -87.98 153.21 7.12 Favored 'Trans proline' 0 N--CA 1.513 2.618 0 C-N-CA 123.944 3.096 . . . . 0.0 114.88 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.5 mt -118.22 132.64 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 43.1 m-85 -103.24 148.91 25.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.947 -1.096 . . . . 0.0 113.532 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 156' ' ' ASN . 52.2 t0 -72.47 51.15 0.25 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 153' ' ' TYR . 31.1 tt0 42.98 17.28 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.231 -0.918 . . . . 0.0 111.033 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' A' ' 158' ' ' LYS . 36.2 m120 -132.99 30.77 3.95 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.885 -1.135 . . . . 0.0 109.073 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 61.82 3.64 0.94 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.8 mptt -86.19 133.76 33.83 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.657 ' O ' ' CD ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -85.72 129.09 34.92 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -175.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.13 8.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.813 0 O-C-N 118.841 -2.412 . . . . 0.0 117.305 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.28 -179.9 44.26 Favored Glycine 0 N--CA 1.515 3.915 0 C-N-CA 115.918 -3.039 . . . . 0.0 112.077 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.489 ' O ' ' OG1' ' A' ' 101' ' ' THR . 70.8 t -141.95 138.85 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.892 -1.358 . . . . 0.0 111.668 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.94 126.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.27 158.8 20.92 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 35.4 mt -151.43 101.04 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.225 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.98 131.03 10.46 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.264 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -93.14 110.35 21.85 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.46 ' CD ' ' N ' ' A' ' 169' ' ' LEU . 14.8 tm-20 -57.61 163.74 2.34 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.46 ' N ' ' CD ' ' A' ' 168' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.976 0 O-C-N 120.517 -1.365 . . . . 0.0 110.644 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.418 0.628 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 49' ' ' ARG . 27.3 m-20 -69.59 -56.74 6.47 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.832 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -51.73 -45.98 63.83 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.219 -1.551 . . . . 0.0 109.466 -173.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 52' ' ' LEU . 6.0 t -60.3 -32.3 71.08 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' THR . 69.2 ttt180 -42.48 -61.3 1.25 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.244 -1.535 . . . . 0.0 110.481 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.95 -59.93 2.51 Favored 'General case' 0 N--CA 1.507 2.391 0 C-N-CA 125.686 1.594 . . . . 0.0 114.496 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -79.13 -49.34 6.38 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.97 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -48.95 -44.65 40.83 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 121.273 2.537 . . . . 0.0 107.17 176.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 57' ' ' LEU . . . -48.94 -70.58 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.937 -1.102 . . . . 0.0 109.09 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -61.56 -55.72 27.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.825 0.822 . . . . 0.0 111.843 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 51' ' ' GLY . 68.4 mttt -63.32 -61.25 2.48 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -175.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.7 -27.48 68.37 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 121.947 2.158 . . . . 0.0 111.75 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 4.8 tt -66.02 -31.36 72.21 Favored 'General case' 0 C--N 1.283 -2.325 0 O-C-N 119.662 -1.899 . . . . 0.0 108.359 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.91 -46.36 14.17 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.63 -33.96 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 118.597 -2.564 . . . . 0.0 106.224 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 64' ' ' ALA . . . -59.43 -37.47 78.15 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 117.871 -1.531 . . . . 0.0 107.281 174.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.445 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 2.6 ptt180 -64.49 -15.03 60.09 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.741 -1.184 . . . . 0.0 108.397 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.7 m -67.49 -49.06 65.18 Favored 'General case' 0 CA--C 1.485 -1.526 0 C-N-CA 114.666 -2.814 . . . . 0.0 104.848 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.535 ' C ' ' N ' ' A' ' 65' ' ' ASP . 5.7 mp -84.02 -45.1 13.45 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.533 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 60' ' ' ALA . . . -50.59 -19.27 0.86 Allowed 'General case' 0 N--CA 1.524 3.269 0 CA-C-O 123.637 1.685 . . . . 0.0 106.544 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.535 ' N ' ' C ' ' A' ' 63' ' ' LEU . 17.7 t0 -88.03 -9.17 54.22 Favored 'General case' 0 N--CA 1.521 3.099 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.897 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.529 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -71.18 -154.2 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 120.46 -1.4 . . . . 0.0 110.523 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.568 ' C ' ' H ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -107.05 -32.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 123.626 2.884 . . . . 0.0 115.054 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 12.6 pt-20 -77.88 33.51 0.18 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.568 ' H ' ' C ' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -110.34 -84.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 175.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.437 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 78.8 ttt180 -45.19 -32.55 1.91 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.043 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 9.5 tt0 -85.56 -16.4 39.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.928 -1.107 . . . . 0.0 111.524 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -100.17 -10.46 45.32 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 104.77 -3.332 . . . . 0.0 104.77 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -85.17 -38.56 18.87 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 102.681 -3.081 . . . . 0.0 102.681 174.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.77 -6.6 1.82 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.832 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.748 ' O ' ' O ' ' A' ' 76' ' ' LYS . 18.8 mmtt -125.89 64.19 1.21 Allowed 'General case' 0 N--CA 1.526 3.355 0 CA-C-N 120.233 1.378 . . . . 0.0 112.228 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.748 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 25.4 153.38 0.0 OUTLIER Pre-proline 0 N--CA 1.524 3.253 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -31.93 -61.77 0.15 Allowed 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 123.027 2.485 . . . . 0.0 113.851 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.501 ' H ' ' HZ1' ' A' ' 76' ' ' LYS . 7.8 tt0 -52.47 137.44 29.82 Favored 'General case' 0 C--N 1.287 -2.109 0 C-N-CA 117.81 -1.556 . . . . 0.0 108.617 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' A' ' 78' ' ' GLN . 24.1 tt0 77.23 -29.31 0.17 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.304 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.773 ' O ' ' N ' ' A' ' 82' ' ' ILE . 8.6 t -46.1 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.334 -1.479 . . . . 0.0 112.674 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -54.44 48.22 0.01 OUTLIER Glycine 0 CA--C 1.562 3.008 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.258 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.773 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.2 tp -56.78 3.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -1.207 . . . . 0.0 109.995 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.591 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 35.0 tp60 -57.74 -22.22 45.44 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.498 -1.376 . . . . 0.0 110.969 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.612 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -77.8 -72.51 0.36 Allowed 'General case' 0 N--CA 1.506 2.375 0 O-C-N 119.85 -1.781 . . . . 0.0 111.353 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.701 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -39.76 -55.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 120.518 1.508 . . . . 0.0 110.159 171.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.1 -35.7 48.68 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 119.907 -1.746 . . . . 0.0 108.807 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 84' ' ' ALA . 69.9 tt0 -65.7 -56.09 13.92 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 114.075 -1.421 . . . . 0.0 112.03 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -61.71 -65.02 0.76 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 123.819 3.009 . . . . 0.0 109.412 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -45.78 -65.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 C-N-CA 115.021 -2.671 . . . . 0.0 110.769 -175.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.547 ' N ' ' HB2' ' A' ' 94' ' ' ASP . 48.4 ttp180 -34.52 -44.58 0.2 Allowed 'General case' 0 N--CA 1.516 2.853 0 O-C-N 121.012 -1.055 . . . . 0.0 109.622 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 90' ' ' ARG . 40.8 tptt -43.92 -60.11 1.98 Allowed 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 117.395 -1.722 . . . . 0.0 107.197 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 89' ' ' VAL . 38.7 mtm180 -61.99 -65.75 0.64 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.691 -1.204 . . . . 0.0 107.996 174.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 173.2 103.88 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.76 ' C ' ' H ' ' A' ' 96' ' ' LEU . 27.3 t70 -136.71 54.11 1.88 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.037 0.922 . . . . 0.0 109.2 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.3 mt -72.96 40.21 0.09 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 124.237 1.97 . . . . 0.0 106.609 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.882 HD12 HD11 ' A' ' 167' ' ' LEU 0.326 0.6 OUTLIER -107.17 175.43 5.5 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-N 111.312 -2.676 . . . . 0.0 109.65 -178.834 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -107.12 100.64 10.1 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 101.759 -3.423 . . . . 0.0 101.759 171.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.64 131.1 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.59 HG21 ' H ' ' A' ' 164' ' ' ALA . 0.9 OUTLIER -133.32 157.91 42.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 124.79 2.233 . . . . 0.0 113.525 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.15 125.23 38.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 1 N-CA-C 99.043 -4.428 . . . . 0.0 99.043 173.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.9 p -125.06 157.83 35.28 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 120.673 -1.267 . . . . 0.0 109.976 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -83.58 -175.17 5.69 Favored 'General case' 0 C--N 1.297 -1.707 1 N-CA-C 97.512 -4.995 . . . . 0.0 97.512 170.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -76.5 85.06 3.21 Favored 'General case' 0 C--N 1.267 -3.009 0 C-N-CA 114.877 -2.729 . . . . 0.0 105.312 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.524 ' O ' ' CB ' ' A' ' 105' ' ' SER . 3.0 tm0? -153.02 -42.25 0.1 Allowed 'General case' 0 CA--C 1.549 0.928 0 O-C-N 120.751 -1.218 . . . . 0.0 109.444 -176.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.586 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.1 t 83.23 138.32 0.06 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.767 ' H ' HH21 ' A' ' 107' ' ' ARG . 0.8 OUTLIER 154.15 134.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 177.201 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.767 HH21 ' H ' ' A' ' 106' ' ' LEU . 2.6 mmp_? -71.62 94.42 1.33 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 116.842 -1.943 . . . . 0.0 106.717 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -50.83 -37.08 40.84 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.12 167.55 11.38 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.024 -1.443 . . . . 0.0 112.441 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.593 ' HD1' ' C ' ' A' ' 112' ' ' GLU . 11.9 p80 178.51 151.19 0.45 Allowed Pre-proline 0 N--CA 1.496 1.854 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.204 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.64 -28.3 1.8 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 N-CA-C 107.397 -1.809 . . . . 0.0 107.397 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.593 ' C ' ' HD1' ' A' ' 110' ' ' HIS . 79.2 mm-40 -119.91 138.27 53.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.42 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.52 -50.38 38.34 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.022 -1.049 . . . . 0.0 113.555 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.15 -38.64 71.13 Favored 'General case' 0 CA--C 1.571 1.775 0 O-C-N 120.152 -1.593 . . . . 0.0 114.936 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.61 ' NH1' ' ND2' ' A' ' 138' ' ' ASN . 0.5 OUTLIER -57.87 -45.25 86.61 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.042 -2.286 . . . . 0.0 109.201 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.558 ' CG2' ' N ' ' A' ' 117' ' ' GLY . 89.6 mt -29.95 -91.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.558 ' N ' ' CG2' ' A' ' 116' ' ' ILE . . . -45.31 -16.78 0.1 Allowed Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.455 -0.778 . . . . 0.0 114.452 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -59.47 -65.7 1.89 Allowed Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 120.601 2.2 . . . . 0.0 112.439 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 116' ' ' ILE . 1.1 Cg_endo -39.41 103.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 123.487 2.791 . . . . 0.0 113.597 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 122' ' ' GLY . 35.4 t80 -162.43 141.51 9.18 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt 47.7 11.34 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.195 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 120' ' ' PHE . . . -60.45 -15.01 37.24 Favored Glycine 0 N--CA 1.505 3.282 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 122' ' ' GLY . 11.9 t70 71.99 -2.27 2.59 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.11 -1.229 . . . . 0.0 111.49 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.599 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 10.5 p-10 -92.56 -45.88 7.89 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.1 -15.84 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.548 -1.345 . . . . 0.0 110.095 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -55.24 -29.66 58.48 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.355 -1.466 . . . . 0.0 108.148 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 130' ' ' ASN . 68.5 mttm -79.91 -24.99 40.73 Favored 'General case' 0 C--O 1.194 -1.818 0 O-C-N 121.964 -0.46 . . . . 0.0 110.343 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.684 ' O ' ' ND2' ' A' ' 130' ' ' ASN . . . -90.09 -33.21 16.37 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 119.792 -1.818 . . . . 0.0 110.012 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 mt -48.98 -29.53 4.93 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.064 0.935 . . . . 0.0 109.009 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 1.053 ' ND2' ' H ' ' A' ' 131' ' ' GLY . 0.0 OUTLIER -56.9 -78.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 109.768 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 1.053 ' H ' ' ND2' ' A' ' 130' ' ' ASN . . . 167.34 35.05 0.02 OUTLIER Glycine 0 CA--C 1.539 1.578 0 C-N-CA 128.808 3.099 . . . . 0.0 107.586 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.606 ' H ' HD22 ' A' ' 130' ' ' ASN . 93.6 mt-10 -141.03 162.69 34.9 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 119.605 1.702 . . . . 0.0 109.767 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -76.08 165.68 24.58 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.621 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -168.98 153.33 5.59 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.45 136.44 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.016 -1.052 . . . . 0.0 110.556 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.57 172.16 13.37 Favored 'General case' 0 N--CA 1.518 2.96 0 O-C-N 120.528 -1.357 . . . . 0.0 109.682 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.6 136.0 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 120.641 -1.287 . . . . 0.0 110.349 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.61 ' ND2' ' NH1' ' A' ' 115' ' ' ARG . 3.8 t30 -103.98 133.61 48.65 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.462 -0.774 . . . . 0.0 109.005 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -132.75 100.91 5.08 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.676 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -116.47 164.13 12.35 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -44.35 -13.89 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.34 -1.094 . . . . 0.0 110.494 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -75.53 -72.37 0.31 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.984 -1.073 . . . . 0.0 108.7 -179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 144' ' ' GLN . . . 176.43 149.61 0.13 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.428 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' ALA . 97.2 mt-30 -35.06 152.55 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.481 0.658 . . . . 0.0 110.139 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.602 ' CB ' ' O ' ' A' ' 167' ' ' LEU . . . -157.2 152.4 26.17 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 117.357 -1.306 . . . . 0.0 107.855 -176.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.8 tp -116.37 144.23 44.54 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 123.149 2.704 . . . . 0.0 109.684 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -129.44 147.62 51.27 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.338 1.066 . . . . 0.0 110.97 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.3 m -114.05 158.35 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -132.88 138.96 47.18 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.67 138.76 29.03 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -86.45 155.31 9.24 Favored 'Trans proline' 0 C--N 1.295 -2.247 0 C-N-CA 122.555 2.17 . . . . 0.0 113.758 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 62.6 mt -118.2 135.44 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . 0.304 65.2 m-85 -106.24 151.77 24.36 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 155' ' ' GLU . 63.0 t0 -78.46 164.35 24.83 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.573 ' N ' ' OD1' ' A' ' 154' ' ' ASP . 18.5 tt0 -47.95 -9.31 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.241 -1.383 . . . . 0.0 112.976 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 154' ' ' ASP . 16.7 m120 -121.83 49.62 1.53 Allowed 'General case' 0 N--CA 1.518 2.971 0 O-C-N 120.348 -1.47 . . . . 0.0 114.268 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 57.39 9.32 0.73 Allowed 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.998 -1.064 . . . . 0.0 110.443 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -83.69 128.79 34.79 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.743 HE21 ' N ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -74.96 126.72 31.61 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.182 -0.949 . . . . 0.0 112.662 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.73 12.43 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.601 0 O-C-N 119.028 -2.295 . . . . 0.0 116.231 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.11 174.51 46.83 Favored Glycine 0 N--CA 1.501 3.025 0 C-N-CA 115.774 -3.108 . . . . 0.0 112.002 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.9 t -137.55 143.51 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.576 1.179 . . . . 0.0 113.215 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 40.6 t -109.6 129.2 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.59 ' H ' HG21 ' A' ' 99' ' ' VAL . . . -127.01 157.53 39.35 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.231 -0.918 . . . . 0.0 108.845 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 147' ' ' ARG . 16.3 mt -151.12 99.99 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.03 118.14 5.34 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.918 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.882 HD11 HD12 ' A' ' 96' ' ' LEU . 1.8 tp -72.38 120.23 17.71 Favored 'General case' 0 C--O 1.193 -1.914 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.07 -30.11 63.45 Favored 'General case' 1 N--CA 1.542 4.163 0 CA-C-O 123.11 1.433 . . . . 0.0 110.37 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.814 0 CA-C-N 113.67 -1.604 . . . . 0.0 114.399 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 46' ' ' ASP . 74.4 p . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.751 0.786 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 47' ' ' MET . 69.5 m-20 -74.75 -65.39 0.87 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.529 1.157 . . . . 0.0 109.967 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 46' ' ' ASP . 26.4 ttt -41.76 -54.76 3.23 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 122.267 1.032 . . . . 0.0 111.146 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 52' ' ' LEU . 13.5 t -58.77 -35.94 73.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.273 1.035 . . . . 0.0 110.158 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 48' ' ' THR . 67.1 ttp85 -39.04 -52.66 1.83 Allowed 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 122.253 1.025 . . . . 0.0 111.855 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -86.06 -55.44 3.94 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -78.2 -45.76 9.81 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.787 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.484 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -56.64 -41.82 77.82 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 120.894 2.347 . . . . 0.0 105.068 176.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.05 -59.39 4.22 Favored 'General case' 0 C--O 1.206 -1.184 0 C-N-CA 117.613 -1.635 . . . . 0.0 107.86 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -74.85 -68.36 0.55 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.457 -1.402 . . . . 0.0 112.457 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 51' ' ' GLY . 25.7 mtpp -47.75 -41.56 23.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 112.703 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' O ' ' HB1' ' A' ' 60' ' ' ALA . . . -86.62 -27.28 23.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 119.103 -2.248 . . . . 0.0 110.246 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.7 tp -62.93 -46.4 87.97 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 120.187 -1.571 . . . . 0.0 107.711 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.02 77.3 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 t -76.44 -30.72 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 119.378 -2.076 . . . . 0.0 107.261 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 56' ' ' ALA . . . -64.44 -28.55 69.75 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 176.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -78.85 -16.89 56.49 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.398 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.0 m -72.29 -43.61 63.97 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 115.499 -2.48 . . . . 0.0 107.149 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 3.8 mm? -85.71 -36.18 20.37 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.313 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 69' ' ' ILE . . . -62.21 -13.66 30.01 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.492 ' N ' ' C ' ' A' ' 63' ' ' LEU . 16.3 t0 -94.52 -11.35 29.77 Favored 'General case' 0 N--CA 1.518 2.975 0 CA-C-N 112.652 -2.067 . . . . 0.0 112.07 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.522 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -66.38 -152.83 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.97 0 O-C-N 120.054 -1.653 . . . . 0.0 109.695 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -104.11 -38.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.478 2.119 . . . . 0.0 113.582 178.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 7.1 pt-20 -48.32 -29.65 4.12 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.763 1.268 . . . . 0.0 108.104 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.824 HG23 ' O ' ' A' ' 64' ' ' ALA . 42.9 mm -56.44 -78.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.028 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' ILE . 45.2 ttt85 -46.19 -31.23 2.32 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -79.16 -14.24 59.22 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.683 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -83.69 -43.82 7.11 Favored Glycine 0 N--CA 1.487 2.085 1 N-CA-C 101.966 -4.454 . . . . 0.0 101.966 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 mp -49.31 -39.9 32.96 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.35 -2.87 4.95 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 72' ' ' GLY . 20.5 tptt -122.73 -158.15 0.77 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.238 -1.539 . . . . 0.0 108.306 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.458 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -133.69 168.78 16.18 Favored Pre-proline 0 CA--C 1.569 1.684 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -38.59 -73.53 0.04 OUTLIER 'Trans proline' 0 N--CA 1.521 3.12 0 C-N-CA 124.927 3.751 . . . . 0.0 117.996 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.492 ' CD ' ' H ' ' A' ' 78' ' ' GLN . 2.2 mp0 -56.08 -14.25 2.52 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -174.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.458 ' OE1' ' NZ ' ' A' ' 76' ' ' LYS . 44.3 tt0 -121.74 2.76 10.07 Favored 'General case' 0 N--CA 1.514 2.757 0 O-C-N 120.61 -1.306 . . . . 0.0 110.78 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.484 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 40.4 t -66.97 -154.78 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.889 -1.132 . . . . 0.0 109.218 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.484 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . -149.58 64.95 0.39 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.405 ' CD1' ' H ' ' A' ' 100' ' ' VAL . 3.7 tp -76.22 7.41 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.737 -0.86 . . . . 0.0 110.455 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -63.48 -26.78 68.88 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 120.329 -1.482 . . . . 0.0 112.837 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.893 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -83.12 -60.63 2.09 Favored 'General case' 0 C--O 1.202 -1.442 0 O-C-N 118.861 -2.399 . . . . 0.0 108.622 -176.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.876 ' O ' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -41.51 -43.88 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.249 0 CA-C-N 123.517 2.871 . . . . 0.0 105.756 172.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.678 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -44.25 -25.07 0.2 Allowed 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 121.498 1.954 . . . . 0.0 108.143 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.893 ' N ' ' O ' ' A' ' 84' ' ' ALA . 53.6 mt-10 -52.21 -33.89 43.1 Favored 'General case' 0 N--CA 1.536 3.849 0 N-CA-C 102.352 -3.203 . . . . 0.0 102.352 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.876 ' N ' ' O ' ' A' ' 85' ' ' ILE . . . -68.82 -29.81 68.22 Favored 'General case' 0 N--CA 1.52 3.028 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.609 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.678 ' N ' ' O ' ' A' ' 86' ' ' ALA . 1.8 t -55.0 -55.8 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 O-C-N 120.525 -1.359 . . . . 0.0 107.656 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -56.22 -59.9 4.27 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.66 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -54.89 -49.98 69.87 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.024 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -57.8 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.949 -1.094 . . . . 0.0 110.475 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -148.33 27.4 0.93 Allowed 'General case' 0 N--CA 1.513 2.676 0 CA-C-N 122.258 2.299 . . . . 0.0 113.029 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.9 t70 70.74 -1.34 2.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.973 -1.079 . . . . 0.0 108.742 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 1.3 pp -146.06 162.36 38.07 Favored 'General case' 0 N--CA 1.519 2.996 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.7 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.501 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER 152.91 170.69 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.361 0 CA-C-O 117.513 -1.232 . . . . 0.0 108.245 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.664 ' CD1' ' CD2' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -119.75 82.8 1.94 Allowed 'General case' 0 C--O 1.215 -0.752 1 N-CA-C 96.318 -5.438 . . . . 0.0 96.318 166.605 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.5 tt -87.94 110.46 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -120.56 137.69 53.51 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.975 0 CA-C-N 112.173 -2.285 . . . . 0.0 113.424 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.405 ' H ' ' CD1' ' A' ' 82' ' ' ILE . 38.9 t -113.98 140.18 35.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 1 N-CA-C 97.953 -4.832 . . . . 0.0 97.953 171.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 102' ' ' ASP . 38.0 p -122.06 145.28 48.3 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 120.767 1.621 . . . . 0.0 111.192 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 104' ' ' GLN . 66.3 t0 -74.18 -168.07 0.59 Allowed 'General case' 0 C--N 1.319 -0.746 1 N-CA-C 99.914 -4.106 . . . . 0.0 99.914 168.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.587 ' SD ' ' O ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -78.64 66.1 4.07 Favored 'General case' 0 C--N 1.274 -2.694 0 C-N-CA 115.207 -2.597 . . . . 0.0 104.985 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 102' ' ' ASP . 5.1 tm0? -170.89 107.93 0.29 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 101.179 -3.638 . . . . 0.0 101.179 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.694 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 29.1 t -61.67 161.17 10.33 Favored 'General case' 0 CA--C 1.462 -2.408 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.693 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.694 ' HB2' ' O ' ' A' ' 105' ' ' SER . 12.1 tp 153.5 142.27 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.475 ' CZ ' ' CE2' ' A' ' 97' ' ' PHE . 99.1 mtt180 -75.68 109.44 9.27 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -70.94 -34.68 71.73 Favored 'General case' 0 C--N 1.262 -3.216 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.493 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 1.1 t -119.84 157.75 28.03 Favored 'General case' 0 C--O 1.196 -1.746 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.657 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.765 ' HD1' ' N ' ' A' ' 112' ' ' GLU . 47.1 t-80 169.86 140.12 0.07 OUTLIER Pre-proline 0 N--CA 1.524 3.228 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.37 -55.86 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 CA-C-N 120.561 1.236 . . . . 0.0 109.136 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.765 ' N ' ' HD1' ' A' ' 110' ' ' HIS . 34.0 mt-10 -79.75 142.48 35.36 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.46 -42.91 24.3 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.548 -0.72 . . . . 0.0 112.638 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -60.87 -35.64 77.13 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.529 ' NH2' ' OE1' ' A' ' 112' ' ' GLU . 3.8 tpp180 -61.96 -31.72 72.08 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 119.39 -2.069 . . . . 0.0 108.151 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.657 ' O ' ' N ' ' A' ' 118' ' ' GLN . 55.6 mt -51.69 -82.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.242 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.428 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -33.96 -11.69 0.0 OUTLIER Glycine 0 N--CA 1.498 2.793 0 CA-C-O 119.156 -0.802 . . . . 0.0 113.97 -175.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 116' ' ' ILE . 6.2 mm-40 -80.79 -70.5 0.16 Allowed Pre-proline 0 N--CA 1.503 2.223 0 CA-C-N 121.383 2.591 . . . . 0.0 113.369 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 17.4 Cg_exo -29.91 117.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 124.196 3.264 . . . . 0.0 114.651 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.626 ' C ' ' H ' ' A' ' 122' ' ' GLY . 85.3 t80 -175.37 149.86 1.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 123' ' ' ASP . 27.3 ttpt 48.95 11.32 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.327 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.626 ' H ' ' C ' ' A' ' 120' ' ' PHE . . . -46.28 -12.54 0.06 OUTLIER Glycine 0 N--CA 1.501 2.967 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 121' ' ' LYS . 4.2 m-20 62.71 -11.88 0.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.585 -0.95 . . . . 0.0 111.232 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 122' ' ' GLY . 49.8 m-20 -75.34 -29.4 59.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.3 pt -78.03 -34.24 19.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.654 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -38.5 -32.62 0.08 Allowed 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.536 -0.727 . . . . 0.0 110.289 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -90.55 -40.23 12.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.157 -0.965 . . . . 0.0 109.571 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -78.74 -48.15 15.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.971 -1.08 . . . . 0.0 109.192 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.599 ' C ' HD21 ' A' ' 130' ' ' ASN . 1.5 mt -36.44 -42.03 0.32 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 123.171 1.463 . . . . 0.0 108.053 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.599 HD21 ' C ' ' A' ' 129' ' ' LEU . 3.8 m120 -102.44 22.04 14.14 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.078 -1.419 . . . . 0.0 113.388 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 132' ' ' GLU . . . 87.16 100.87 0.84 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 131' ' ' GLY . 4.1 tp10 167.75 140.47 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.069 0 CA-C-N 113.551 -1.325 . . . . 0.0 113.394 175.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -81.77 142.29 32.74 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.923 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 4.0 t-20 -162.55 144.9 10.84 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.248 -1.533 . . . . 0.0 110.592 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 147' ' ' ARG . 8.6 p -135.58 151.86 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 O-C-N 119.774 -1.829 . . . . 0.0 108.29 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -159.48 162.7 35.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.82 -1.175 . . . . 0.0 109.372 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.59 141.71 16.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 122.214 1.007 . . . . 0.0 112.49 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -106.9 159.63 16.11 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -147.97 103.04 3.45 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.082 -1.636 . . . . 0.0 110.376 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -143.15 161.52 27.59 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.311 -2.316 . . . . 0.0 107.311 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.596 ' C ' ' H ' ' A' ' 143' ' ' ALA . 84.0 m-85 -44.13 118.77 1.58 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.216 -1.167 . . . . 0.0 109.675 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.466 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 0.3 OUTLIER 62.7 -11.17 0.08 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.423 -0.798 . . . . 0.0 109.024 -179.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.596 ' H ' ' C ' ' A' ' 141' ' ' PHE . . . -81.31 -10.9 59.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.771 -1.206 . . . . 0.0 112.772 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 143' ' ' ALA . 93.0 mt-30 -40.9 114.44 0.48 Allowed 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 167' ' ' LEU . . . -158.85 160.15 35.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.111 -1.618 . . . . 0.0 111.238 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 tp -105.19 160.81 14.79 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.79 -1.194 . . . . 0.0 108.285 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.484 ' O ' ' CG2' ' A' ' 135' ' ' VAL . 12.4 ptt180 -150.01 146.21 26.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.766 -1.209 . . . . 0.0 109.294 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 m -105.53 167.65 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 CA-C-O 122.008 0.908 . . . . 0.0 109.152 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 32.6 m-85 -134.98 138.63 44.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 p -144.48 157.56 55.67 Favored Pre-proline 0 C--N 1.308 -1.238 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -102.33 152.6 0.29 Allowed 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.369 2.713 . . . . 0.0 114.983 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 83.2 mt -113.48 134.94 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.48 ' C ' ' H ' ' A' ' 155' ' ' GLU . 66.6 m-85 -102.04 142.45 33.3 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.455 -0.778 . . . . 0.0 111.884 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 26.7 t70 -58.87 -2.41 0.23 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.586 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 154' ' ' ASP . 56.1 tt0 98.25 21.52 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -140.78 19.13 2.33 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 15.3 t60 69.35 11.47 8.11 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -96.1 116.76 29.47 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.668 ' N ' ' NE2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -65.08 122.58 17.37 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.5 pp -137.62 1.89 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 O-C-N 120.841 -1.162 . . . . 0.0 113.541 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.75 176.08 41.91 Favored Glycine 0 N--CA 1.507 3.4 0 C-N-CA 119.243 -1.456 . . . . 0.0 110.587 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.18 145.92 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 O-C-N 121.175 -1.191 . . . . 0.0 112.939 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.65 116.07 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -113.07 157.51 21.5 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 48.9 mt -146.4 107.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.433 ' HA2' ' CD2' ' A' ' 97' ' ' PHE . . . -108.84 122.64 6.65 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.54 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.518 ' O ' ' CB ' ' A' ' 145' ' ' ALA . 27.1 tp -85.61 108.95 18.23 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 169' ' ' LEU . 10.8 tm-20 -53.94 -36.37 62.72 Favored 'General case' 0 N--CA 1.518 2.93 0 O-C-N 123.786 0.679 . . . . 0.0 110.239 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 170' ' ' SER . 4.4 tp 73.66 152.18 0.12 Allowed 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.794 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.738 ' O ' ' N ' ' A' ' 172' ' ' VAL . 2.1 t 151.3 -104.81 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.535 ' N ' ' OG ' ' A' ' 170' ' ' SER . 89.9 mtt180 -53.04 79.34 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.738 ' N ' ' O ' ' A' ' 170' ' ' SER . 1.3 m -175.12 -25.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.455 ' C ' ' O ' ' A' ' 172' ' ' VAL . 0.2 OUTLIER -35.56 -61.24 0.47 Allowed 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.786 -1.196 . . . . 0.0 110.881 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -43.36 -64.29 0.67 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.633 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -55.73 -39.94 71.79 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.129 0.966 . . . . 0.0 110.666 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 172' ' ' VAL . 5.5 mt -65.16 -33.76 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 120.838 -1.164 . . . . 0.0 110.477 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -81.49 -46.27 14.76 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 119.523 -1.986 . . . . 0.0 112.723 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -75.23 -62.6 1.5 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.149 -1.594 . . . . 0.0 109.759 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 59.9 p -58.23 -53.56 56.85 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.054 -1.029 . . . . 0.0 112.917 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 . . . . . 0 N--CA 1.504 2.269 0 O-C-N 119.876 -1.765 . . . . 0.0 109.346 179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' MET . 76.2 m-20 -75.61 -59.02 2.93 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.41 1.1 . . . . 0.0 108.648 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.499 ' C ' ' SD ' ' A' ' 47' ' ' MET . 0.9 OUTLIER -36.97 -62.27 0.5 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 123.066 1.412 . . . . 0.0 109.666 -177.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 52' ' ' LEU . 5.9 t -54.78 -41.37 70.46 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.092 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' THR . 50.7 ttp180 -35.57 -51.22 0.63 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.661 -1.274 . . . . 0.0 112.57 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -91.55 -53.77 4.18 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -71.96 -47.3 32.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -176.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 48' ' ' THR . 0.9 OUTLIER -56.99 -44.06 82.32 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 175.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.09 -55.8 13.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 118.081 -1.447 . . . . 0.0 109.932 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -83.53 -62.92 1.46 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.399 -1.438 . . . . 0.0 112.989 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.542 ' HZ2' ' NH1' ' A' ' 92' ' ' ARG . 5.3 ptmt -52.55 -34.69 51.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.456 -0.778 . . . . 0.0 111.217 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 57' ' ' LEU . . . -84.89 -31.62 23.6 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 119.443 -2.036 . . . . 0.0 109.176 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 56' ' ' ALA . 4.8 tt -47.24 -46.12 24.2 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.35 -1.469 . . . . 0.0 108.165 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 61' ' ' ARG . . . -67.86 -41.3 83.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.685 -1.884 . . . . 0.0 110.208 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.0 t -52.73 -45.89 49.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 O-C-N 120.065 -1.647 . . . . 0.0 107.504 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.77 -24.13 5.53 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -73.59 -37.15 65.56 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 115.799 -2.36 . . . . 0.0 111.647 -178.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 m -57.71 -29.21 64.52 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 119.58 -1.95 . . . . 0.0 107.595 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.752 ' HB3' HD11 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -74.56 -26.13 59.74 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 117.59 -1.644 . . . . 0.0 108.051 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.65 -12.28 59.51 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-O 117.668 -1.158 . . . . 0.0 110.952 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.456 ' OD2' ' NH1' ' A' ' 61' ' ' ARG . 3.9 m-20 -103.96 -24.8 13.21 Favored 'General case' 0 N--CA 1.51 2.555 0 CA-C-N 123.367 2.803 . . . . 0.0 113.853 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.534 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -76.61 -161.1 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 119.793 -1.817 . . . . 0.0 111.91 -175.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.606 ' HD2' ' H ' ' A' ' 68' ' ' GLU . 6.6 Cg_endo -109.92 -38.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 124.049 3.166 . . . . 0.0 114.172 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.606 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 2.5 pt-20 -52.01 -33.16 37.14 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.401 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.631 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.3 mp -58.71 -73.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.909 0.861 . . . . 0.0 111.744 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -48.46 -37.0 16.16 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -75.68 -14.08 60.34 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -82.01 -39.27 11.8 Favored Glycine 0 CA--C 1.486 -1.761 0 N-CA-C 103.324 -3.91 . . . . 0.0 103.324 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.412 ' C ' ' H ' ' A' ' 75' ' ' LYS . 6.3 mp -56.81 -29.62 62.93 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -64.18 -3.78 3.05 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' CG ' ' H ' ' A' ' 76' ' ' LYS . 26.5 tptt -134.97 -150.58 0.39 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 78' ' ' GLN . 2.1 pttt -122.41 157.95 57.41 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 123.943 0.897 . . . . 0.0 109.119 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.669 ' O ' ' CE2' ' A' ' 108' ' ' TYR . 7.3 Cg_exo -29.0 -16.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.516 2.821 1 C-N-CA 125.551 4.167 . . . . 0.0 118.281 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 76' ' ' LYS . 83.0 mt-30 -90.37 1.66 56.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.191 -2.193 . . . . 0.0 108.918 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -132.68 2.3 3.74 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.659 ' N ' ' OH ' ' A' ' 108' ' ' TYR . 2.5 m -68.57 -156.75 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.146 -2.221 . . . . 0.0 108.863 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -150.11 58.11 0.45 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.725 HD13 HD12 ' A' ' 85' ' ' ILE . 2.2 tp -49.55 -7.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 C-N-CA 123.203 0.601 . . . . 0.0 110.766 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.435 ' H ' ' C ' ' A' ' 81' ' ' GLY . 86.6 mt-30 -47.38 -43.67 23.58 Favored 'General case' 0 C--N 1.269 -2.908 0 O-C-N 120.046 -1.659 . . . . 0.0 114.397 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.823 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -87.88 -53.34 4.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 119.365 -2.085 . . . . 0.0 110.122 -173.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.892 ' O ' ' N ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -46.32 -51.64 3.98 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.707 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 172.007 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.785 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -44.41 -21.93 0.06 Allowed 'General case' 0 N--CA 1.507 2.399 0 O-C-N 119.237 -2.164 . . . . 0.0 107.225 174.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.823 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.5 tt0 -48.47 -28.83 3.56 Favored 'General case' 1 N--CA 1.544 4.245 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 171.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.892 ' N ' ' O ' ' A' ' 85' ' ' ILE . . . -71.28 -28.05 63.86 Favored 'General case' 0 N--CA 1.515 2.778 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.698 172.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.785 ' N ' ' O ' ' A' ' 86' ' ' ALA . 33.0 m -65.69 -43.95 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.255 0 C-N-CA 116.241 -2.184 . . . . 0.0 110.346 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.412 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 19.6 mtp-105 -56.19 -52.08 65.71 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -58.19 -30.69 66.64 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.383 -1.327 . . . . 0.0 108.63 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.542 ' NH1' ' HZ2' ' A' ' 55' ' ' LYS . 6.5 mmm180 -76.33 -93.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.193 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.679 ' N ' ' ND2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -144.44 31.12 1.21 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.679 -1.263 . . . . 0.0 111.724 -177.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 60.7 24.07 13.9 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.292 -1.505 . . . . 0.0 109.414 -175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 96' ' ' LEU . 2.7 pp -167.13 160.08 13.55 Favored 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.575 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.418 ' CD2' ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER 164.62 176.77 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.934 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -177.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 109' ' ' SER . 58.5 m-85 -136.75 80.51 1.82 Allowed 'General case' 0 C--O 1.214 -0.774 1 N-CA-C 99.295 -4.335 . . . . 0.0 99.295 170.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.7 tt -100.06 118.36 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.717 ' CG1' ' H ' ' A' ' 164' ' ' ALA . 10.9 p -98.7 131.93 44.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 CA-C-O 124.587 2.137 . . . . 0.0 111.067 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.435 HG22 HD12 ' A' ' 85' ' ' ILE . 97.1 t -132.9 109.95 14.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 1 N-CA-C 98.02 -4.807 . . . . 0.0 98.02 175.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.535 ' OG1' ' N ' ' A' ' 102' ' ' ASP . 1.2 t -130.6 170.69 13.94 Favored 'General case' 0 CA--C 1.461 -2.445 0 CA-C-O 122.386 1.088 . . . . 0.0 108.319 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 104' ' ' GLN . 44.4 t0 -78.9 -174.7 4.12 Favored 'General case' 0 C--N 1.269 -2.906 1 N-CA-C 99.458 -4.275 . . . . 0.0 99.458 169.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.89 72.35 0.09 Allowed 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 113.471 -3.292 . . . . 0.0 104.78 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.684 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.5 tp-100 -140.7 -52.24 0.47 Allowed 'General case' 0 C--N 1.364 1.198 0 O-C-N 119.453 -2.029 . . . . 0.0 111.057 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 104' ' ' GLN . 2.1 t 97.38 137.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.372 1.069 . . . . 0.0 108.794 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER 157.44 95.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 178.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.583 ' NH2' HH11 ' A' ' 147' ' ' ARG . 1.4 mtt180 -39.43 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 112.524 -2.125 . . . . 0.0 110.167 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.669 ' CE2' ' O ' ' A' ' 77' ' ' PRO . 1.1 t80 -57.22 -26.18 60.27 Favored 'General case' 0 C--N 1.284 -2.245 0 O-C-N 121.02 -1.05 . . . . 0.0 108.471 -177.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -113.61 148.44 36.21 Favored 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.429 ' ND1' ' CD1' ' A' ' 116' ' ' ILE 0.256 45.1 p-80 -174.44 149.68 1.39 Allowed Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 118.0 -1.48 . . . . 0.0 113.349 -176.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.527 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 32.9 Cg_endo -91.09 -22.35 0.59 Allowed 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.463 2.109 . . . . 0.0 106.801 171.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 38.8 tt0 -111.44 136.62 50.34 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.02 -42.35 48.18 Favored 'General case' 0 C--N 1.289 -2.054 0 O-C-N 119.965 -1.709 . . . . 0.0 111.985 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 118' ' ' GLN . 87.7 mt-30 -70.36 -24.28 62.94 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 119.768 -1.832 . . . . 0.0 115.871 -176.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -28.13 67.61 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 119.839 -1.788 . . . . 0.0 106.916 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 118' ' ' GLN . 87.9 mt -56.0 -88.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 117.453 -1.699 . . . . 0.0 109.991 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -37.02 -12.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 O-C-N 121.545 -0.722 . . . . 0.0 113.604 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.7 OUTLIER -69.64 -72.42 0.24 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 119.457 -2.202 . . . . 0.0 114.579 -174.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.426 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 19.2 Cg_exo -24.95 120.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 123.923 3.082 . . . . 0.0 113.82 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.649 ' C ' ' H ' ' A' ' 122' ' ' GLY . 0.8 OUTLIER -178.11 138.12 0.19 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 123' ' ' ASP . 85.6 mttt 50.47 4.98 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 CA-C-O 121.456 0.646 . . . . 0.0 109.389 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.649 ' H ' ' C ' ' A' ' 120' ' ' PHE . . . -42.94 -18.75 0.05 OUTLIER Glycine 0 N--CA 1.505 3.239 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 121' ' ' LYS . 11.1 t70 71.04 -17.98 0.29 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.292 -1.122 . . . . 0.0 111.233 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.22 -14.89 61.0 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 129' ' ' LEU . 20.2 mt -89.99 -28.48 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.637 -0.664 . . . . 0.0 111.629 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -40.04 -56.34 1.88 Allowed 'General case' 0 N--CA 1.515 2.802 0 O-C-N 120.842 -1.161 . . . . 0.0 110.137 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -74.11 -37.08 64.22 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.773 -1.205 . . . . 0.0 110.591 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -63.28 -47.31 82.88 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 128' ' ' ALA . 0.3 OUTLIER -28.85 -44.68 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 113.587 -1.642 . . . . 0.0 106.966 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 2.1 m120 -105.0 -99.94 0.32 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -128.63 120.35 3.3 Favored Glycine 0 N--CA 1.507 3.431 0 CA-C-O 122.985 1.325 . . . . 0.0 112.124 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 133' ' ' GLU . 5.9 tp10 178.49 169.47 0.83 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 113.379 -1.41 . . . . 0.0 111.728 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.511 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 22.9 mp0 -124.21 127.45 47.73 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 176.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 133' ' ' GLU . 32.1 m120 -150.71 138.51 19.88 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.245 1.021 . . . . 0.0 111.072 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 147' ' ' ARG . 8.5 p -134.44 126.3 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.473 -0.767 . . . . 0.0 109.011 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.51 169.06 18.3 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 121.724 0.773 . . . . 0.0 111.368 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.6 mt -101.17 141.91 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-O 121.716 0.77 . . . . 0.0 112.826 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -114.07 153.61 29.15 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -147.73 108.11 4.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.494 -1.379 . . . . 0.0 109.901 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 141' ' ' PHE . . . -158.06 106.23 0.29 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.531 ' C ' ' H ' ' A' ' 143' ' ' ALA . 84.1 t80 38.42 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.845 -0.797 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.44 ' C ' ' CD1' ' A' ' 142' ' ' LEU . 0.1 OUTLIER 70.77 -30.15 0.2 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.56 -0.713 . . . . 0.0 110.268 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 141' ' ' PHE . . . -53.49 -2.93 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.105 -1.038 . . . . 0.0 113.035 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 143' ' ' ALA . 5.3 pt20 -45.01 98.88 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 O-C-N 119.949 -1.72 . . . . 0.0 107.842 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 143' ' ' ALA . . . -149.17 163.36 37.82 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.599 -1.313 . . . . 0.0 110.024 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tp -108.45 155.51 20.51 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 120.777 -1.202 . . . . 0.0 110.912 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.583 HH11 ' NH2' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -136.47 155.42 50.01 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.605 -0.684 . . . . 0.0 110.174 178.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.49 151.76 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.298 0 CA-C-O 121.691 0.757 . . . . 0.0 109.924 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.425 ' N ' ' O ' ' A' ' 134' ' ' ASN . 27.7 m-85 -116.8 138.97 51.12 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.751 0.786 . . . . 0.0 110.356 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -152.72 160.33 31.25 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.4 ' CB ' ' O ' ' A' ' 130' ' ' ASN . 0.1 OUTLIER -104.44 162.74 0.2 Allowed 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 123.537 2.825 . . . . 0.0 116.224 -178.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 47.7 mt -123.59 136.9 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 0.0 OUTLIER -117.14 157.05 26.59 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.401 1.096 . . . . 0.0 112.339 -179.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.579 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 9.3 p30 -53.98 -95.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.232 -0.917 . . . . 0.0 110.327 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.579 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 9.6 pt-20 -160.11 28.71 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.522 HD21 ' C ' ' A' ' 155' ' ' GLU . 2.3 m-80 -143.49 23.01 1.82 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.0 m80 67.1 46.83 1.45 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.153 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.77 122.43 30.55 Favored 'General case' 0 N--CA 1.522 3.173 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.692 HE21 ' N ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -58.23 118.35 5.4 Favored 'General case' 0 N--CA 1.518 2.934 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -177.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 154' ' ' ASP . 1.7 pp -141.27 22.32 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 O-C-N 120.349 -1.469 . . . . 0.0 112.124 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.04 169.42 41.75 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.5 t -136.0 138.93 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 CA-C-N 119.614 1.707 . . . . 0.0 112.502 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.502 ' O ' ' OG1' ' A' ' 150' ' ' THR . 1.9 p -119.68 113.83 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.459 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.717 ' H ' ' CG1' ' A' ' 99' ' ' VAL . . . -116.85 165.77 12.93 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 3.3 mt -142.92 107.99 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.03 -1.669 . . . . 0.0 106.919 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.91 114.79 4.87 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.556 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.442 ' O ' ' CB ' ' A' ' 145' ' ' ALA . 5.1 tt -88.47 110.77 21.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.999 ' O ' ' O ' ' A' ' 169' ' ' LEU . 8.2 tm-20 -74.48 127.23 32.54 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.828 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.999 ' O ' ' O ' ' A' ' 168' ' ' GLU . 0.6 OUTLIER 34.05 148.56 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.16 0 CA-C-O 121.959 0.885 . . . . 0.0 110.283 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.591 ' C ' ' H ' ' A' ' 172' ' ' VAL . 19.9 m -113.83 76.43 0.98 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.242 -0.911 . . . . 0.0 112.111 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.409 ' H ' HD13 ' A' ' 169' ' ' LEU . 56.3 ttt-85 -63.26 30.8 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.893 -1.129 . . . . 0.0 109.786 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.591 ' H ' ' C ' ' A' ' 170' ' ' SER . 1.8 m -124.14 -9.92 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.401 -1.437 . . . . 0.0 111.662 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 177' ' ' ASN . 0.2 OUTLIER -35.42 -51.55 0.61 Allowed 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.017 -1.052 . . . . 0.0 110.284 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -41.8 -71.68 0.08 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.123 -0.985 . . . . 0.0 110.293 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -51.87 -37.56 52.63 Favored 'General case' 0 N--CA 1.509 2.516 0 CA-C-O 121.714 0.769 . . . . 0.0 112.448 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.3 mm -79.72 -14.93 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.406 0.682 . . . . 0.0 110.034 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 173' ' ' THR . 43.3 t30 -86.84 -40.13 15.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.136 -0.978 . . . . 0.0 109.033 -178.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.24 -70.01 0.32 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 119.756 -1.84 . . . . 0.0 109.802 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 14.5 t -47.79 -55.4 9.76 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 120.402 -1.436 . . . . 0.0 113.455 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.877 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.657 0.742 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -68.99 -67.16 0.49 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 123.051 1.405 . . . . 0.0 111.256 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.2 mtt -50.96 -49.1 60.66 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.313 -173.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.458 ' O ' ' C ' ' A' ' 49' ' ' ARG . 12.1 t -55.25 -35.93 65.51 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 48' ' ' THR . 62.5 ttt180 -40.67 -52.7 2.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.014 -1.054 . . . . 0.0 110.996 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.47 -60.44 2.19 Favored 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -73.31 -45.8 29.13 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -54.64 -44.69 73.42 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 120.422 2.111 . . . . 0.0 105.598 176.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.512 ' O ' ' CD1' ' A' ' 57' ' ' LEU . . . -53.24 -50.8 64.03 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 117.726 -1.59 . . . . 0.0 109.452 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -80.24 -55.87 4.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 119.73 -1.856 . . . . 0.0 111.656 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 51' ' ' GLY . 18.1 mtpp -63.96 -27.1 68.9 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.56 -37.59 10.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 119.787 -1.821 . . . . 0.0 108.871 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.512 ' CD1' ' O ' ' A' ' 53' ' ' ALA . 35.2 mt -53.93 -35.45 61.72 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.291 -1.364 . . . . 0.0 108.047 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 61' ' ' ARG . . . -80.97 -46.32 15.3 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -70.85 -26.6 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 118.665 -2.522 . . . . 0.0 106.197 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.07 -29.07 70.52 Favored 'General case' 0 C--N 1.27 -2.861 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.456 ' O ' ' CG ' ' A' ' 65' ' ' ASP . 4.3 ptt180 -72.65 -19.7 61.39 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 117.164 -1.814 . . . . 0.0 110.84 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 m -68.29 -47.62 67.15 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 124.116 3.144 . . . . 0.0 107.009 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' C ' ' N ' ' A' ' 65' ' ' ASP . 50.2 mt -87.53 -41.81 13.21 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.833 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -56.32 -19.04 12.63 Favored 'General case' 0 N--CA 1.508 2.475 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.456 ' CG ' ' O ' ' A' ' 61' ' ' ARG . 40.2 m-20 -85.14 -4.3 59.11 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.123 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.512 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.86 -158.05 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 119.983 -1.698 . . . . 0.0 110.239 -178.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' A' ' 69' ' ' ILE . 3.1 Cg_endo -104.07 -27.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 123.586 2.857 . . . . 0.0 113.399 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.514 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 16.8 pt-20 -75.43 25.09 0.11 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.591 ' H ' ' C ' ' A' ' 67' ' ' PRO . 44.0 mm -106.13 -80.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -46.3 -31.95 2.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.68 -14.37 51.93 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.506 -1.371 . . . . 0.0 110.244 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -102.69 -3.54 49.53 Favored Glycine 0 N--CA 1.504 3.186 0 N-CA-C 107.101 -2.399 . . . . 0.0 107.101 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.52 -52.76 7.25 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 100.406 -3.924 . . . . 0.0 100.406 173.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -8.83 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 113.238 -1.801 . . . . 0.0 112.619 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.71 ' O ' ' O ' ' A' ' 76' ' ' LYS . 4.0 tmtm? -124.07 40.56 3.7 Favored 'General case' 0 N--CA 1.523 3.177 0 CA-C-N 122.732 2.515 . . . . 0.0 111.036 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.726 ' HZ1' ' H ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER 35.24 157.23 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.915 0 C-N-CA 125.532 1.533 . . . . 0.0 112.516 177.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -33.29 -63.48 0.14 Allowed 'Trans proline' 0 N--CA 1.513 2.66 0 C-N-CA 123.943 3.095 . . . . 0.0 115.72 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.726 ' H ' ' HZ1' ' A' ' 76' ' ' LYS . 78.6 mt-30 -50.1 142.02 10.2 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.098 -1.441 . . . . 0.0 108.762 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 63.52 5.9 2.33 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.137 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 1.035 ' O ' ' N ' ' A' ' 82' ' ' ILE . 70.9 p -81.22 86.55 6.19 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.154 -2.217 . . . . 0.0 109.542 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.675 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -35.92 47.24 0.0 OUTLIER Glycine 1 N--CA 1.518 4.139 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.754 -177.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 1.035 ' N ' ' O ' ' A' ' 80' ' ' SER . 1.1 tp -68.04 28.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 122.516 1.151 . . . . 0.0 107.924 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.675 ' H ' ' C ' ' A' ' 81' ' ' GLY . 43.7 tp60 -82.91 -22.3 33.93 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.707 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -73.73 -94.25 0.02 OUTLIER 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.707 ' C ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -20.18 -55.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.157 0 CA-C-N 123.651 2.932 . . . . 0.0 111.554 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -51.9 -49.12 63.63 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 119.333 -2.104 . . . . 0.0 110.161 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.682 ' N ' ' O ' ' A' ' 84' ' ' ALA . 66.1 tt0 -55.96 -54.55 43.42 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 116.624 -1.655 . . . . 0.0 114.393 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -77.79 -42.75 32.84 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 124.699 3.409 . . . . 0.0 108.236 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 88' ' ' ALA . 64.7 t -51.65 -71.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 115.115 -2.634 . . . . 0.0 107.592 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.677 ' O ' ' N ' ' A' ' 93' ' ' ASN . 4.3 ppt_? -40.26 -34.13 0.3 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.959 -1.088 . . . . 0.0 110.608 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.549 ' C ' ' O ' ' A' ' 90' ' ' ARG . 29.0 ttmt -39.38 -28.97 0.04 OUTLIER 'General case' 0 N--CA 1.536 3.827 0 C-N-CA 116.758 -1.977 . . . . 0.0 106.092 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 90' ' ' ARG . 10.6 ttm105 -36.49 -59.56 0.65 Allowed 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 166.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.677 ' N ' ' O ' ' A' ' 90' ' ' ARG . 0.4 OUTLIER -153.33 -56.38 0.12 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.397 -1.439 . . . . 0.0 110.192 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 1.1 m-20 164.02 1.38 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.864 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -135.57 160.69 37.71 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 117.729 -1.588 . . . . 0.0 113.975 -175.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.451 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 2.8 pp 151.43 175.92 0.0 OUTLIER 'General case' 0 N--CA 1.534 3.738 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.426 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -139.66 86.58 2.12 Favored 'General case' 0 C--O 1.218 -0.603 1 N-CA-C 98.87 -4.493 . . . . 0.0 98.87 169.245 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.413 ' H ' HD11 ' A' ' 96' ' ' LEU . 19.7 tt -101.61 134.72 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 123.396 1.569 . . . . 0.0 108.212 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.507 HG11 ' H ' ' A' ' 164' ' ' ALA . 1.1 p -136.41 149.53 27.18 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -173.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.415 ' H ' HD12 ' A' ' 82' ' ' ILE . 4.2 p -111.28 131.35 62.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 1 N-CA-C 98.444 -4.65 . . . . 0.0 98.444 169.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.573 ' CG2' ' H ' ' A' ' 105' ' ' SER . 1.5 m -124.46 152.27 43.54 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 120.564 -1.335 . . . . 0.0 111.442 -175.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -87.2 -176.85 5.83 Favored 'General case' 0 C--N 1.284 -2.278 1 N-CA-C 98.033 -4.802 . . . . 0.0 98.033 169.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.522 ' O ' ' CG ' ' A' ' 103' ' ' MET . 1.8 ttt -77.67 73.53 4.23 Favored 'General case' 0 C--N 1.269 -2.9 0 C-N-CA 114.483 -2.887 . . . . 0.0 107.069 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 105' ' ' SER . 9.0 tm0? -141.75 -41.51 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 119.595 -1.941 . . . . 0.0 110.483 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.573 ' H ' ' CG2' ' A' ' 101' ' ' THR . 10.5 t 84.88 136.96 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.747 0.819 . . . . 0.0 109.48 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.8 OUTLIER 156.81 134.86 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.618 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 177.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.436 ' NH2' ' O ' ' A' ' 97' ' ' PHE . 9.6 mmm180 -71.9 100.87 2.52 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.494 ' H ' ' HB ' ' A' ' 99' ' ' VAL . 2.5 m-85 -54.4 -30.24 51.55 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.44 ' C ' ' ND1' ' A' ' 110' ' ' HIS . 12.0 t -101.17 144.78 29.63 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.44 ' ND1' ' C ' ' A' ' 109' ' ' SER . 1.5 m-70 -124.89 107.83 28.41 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -174.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.696 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 65.2 Cg_endo -85.81 -35.63 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 N-CA-C 103.882 -3.161 . . . . 0.0 103.882 172.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.696 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 13.5 mp0 -140.37 138.31 34.72 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 174.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.81 -48.18 64.21 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 118.303 2.705 . . . . 0.0 118.303 -172.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.488 ' CD ' ' H ' ' A' ' 114' ' ' GLN . 1.4 mp0 -66.2 -32.52 74.01 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.687 HH21 ' H ' ' A' ' 139' ' ' ARG . 19.3 tpt85 -61.54 -33.68 74.25 Favored 'General case' 0 C--O 1.201 -1.457 0 CA-C-N 122.358 2.345 . . . . 0.0 106.633 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.701 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.2 OUTLIER -53.17 -86.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.135 177.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.408 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -33.04 -11.63 0.0 OUTLIER Glycine 0 N--CA 1.499 2.866 0 C-N-CA 123.462 0.553 . . . . 0.0 113.748 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.701 ' N ' ' O ' ' A' ' 116' ' ' ILE . 1.3 mt-30 -79.33 -72.75 0.12 Allowed Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 120.017 1.909 . . . . 0.0 113.728 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -26.55 108.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 123.969 3.113 . . . . 0.0 114.939 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 120' ' ' PHE . 48.5 t80 174.86 28.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -174.93 -12.64 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.091 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.76 -21.51 2.29 Favored Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.6 t0 69.64 0.6 3.04 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 121.043 -1.269 . . . . 0.0 112.142 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.534 ' OD2' ' CE2' ' A' ' 149' ' ' PHE . 2.9 p-10 -82.45 -21.18 35.76 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.552 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 20.2 mt -79.42 -21.78 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.528 -0.733 . . . . 0.0 110.199 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -49.39 -37.09 23.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.577 -1.327 . . . . 0.0 108.418 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.631 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 59.0 mttp -74.32 -34.87 63.59 Favored 'General case' 0 C--O 1.194 -1.859 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.541 ' O ' ' ND2' ' A' ' 130' ' ' ASN . . . -89.43 -30.74 18.12 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 120.023 -1.673 . . . . 0.0 110.539 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.29 -26.35 1.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.858 -1.151 . . . . 0.0 109.705 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.861 ' ND2' ' N ' ' A' ' 131' ' ' GLY 0.278 0.0 OUTLIER -77.12 -92.49 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 108.904 179.408 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.861 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -164.66 42.8 0.3 Allowed Glycine 0 CA--C 1.565 3.166 0 C-N-CA 125.536 1.541 . . . . 0.0 110.106 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.462 ' H ' HD22 ' A' ' 130' ' ' ASN . 76.6 tt0 -145.06 164.72 30.35 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 120.316 2.058 . . . . 0.0 111.646 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -64.21 164.32 11.18 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 28.4 t-20 -170.97 138.16 1.27 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.298 -0.876 . . . . 0.0 109.267 176.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.3 t -130.83 138.43 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.315 -1.491 . . . . 0.0 108.776 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -151.51 167.6 27.54 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.644 -1.285 . . . . 0.0 110.213 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 mt -102.32 135.56 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.398 -0.814 . . . . 0.0 109.801 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.452 ' OD1' ' CZ ' ' A' ' 147' ' ' ARG . 0.9 OUTLIER -106.84 152.62 23.64 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.687 ' H ' HH21 ' A' ' 115' ' ' ARG . 3.5 ptm85 -159.68 97.94 1.34 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.604 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -150.61 109.04 0.41 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.07 -1.538 . . . . 0.0 109.92 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 9.3 t80 59.1 -67.47 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 122.034 -0.686 . . . . 0.0 110.14 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 140' ' ' GLY . 0.7 OUTLIER -131.44 6.69 4.47 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.249 -0.907 . . . . 0.0 110.083 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 145' ' ' ALA . . . -81.13 5.36 17.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 113.775 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -48.78 91.24 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.217 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.663 ' N ' ' O ' ' A' ' 143' ' ' ALA . . . -169.03 173.06 7.11 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.301 -170.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 tp -115.01 159.19 21.08 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.461 -1.399 . . . . 0.0 110.89 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.452 ' CZ ' ' OD1' ' A' ' 138' ' ' ASN . 0.8 OUTLIER -143.89 152.33 40.99 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.142 0.972 . . . . 0.0 110.896 178.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.41 138.22 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.925 0 CA-C-O 122.119 0.961 . . . . 0.0 109.985 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.534 ' CE2' ' OD2' ' A' ' 124' ' ' ASP . 70.6 m-85 -111.63 145.73 38.68 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.646 0.736 . . . . 0.0 109.686 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.02 156.56 65.07 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -96.54 154.88 1.25 Allowed 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 123.996 3.131 . . . . 0.0 114.195 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 72.6 mt -117.97 136.33 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.419 ' C ' ' H ' ' A' ' 155' ' ' GLU . 60.7 m-85 -107.73 149.16 28.49 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.827 ' O ' ' ND2' ' A' ' 156' ' ' ASN . 24.8 t0 -76.19 57.1 1.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 153' ' ' TYR . 36.9 mt-10 42.33 21.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 123.641 0.777 . . . . 0.0 112.463 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.827 ' ND2' ' O ' ' A' ' 154' ' ' ASP . 42.3 m-80 -140.28 35.42 1.89 Allowed 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.495 -1.378 . . . . 0.0 109.717 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 61.84 -2.92 0.25 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.584 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.8 mptt -80.45 122.05 26.5 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.628 ' N ' ' NE2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -58.2 -154.65 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.058 0 O-C-N 120.861 -1.149 . . . . 0.0 111.136 -177.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.612 ' CG2' ' O ' ' A' ' 159' ' ' GLN . 2.7 pp 151.9 -6.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 CA-C-N 120.175 1.352 . . . . 0.0 112.883 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -172.24 179.86 43.57 Favored Glycine 0 N--CA 1.507 3.407 0 C-N-CA 115.981 -3.009 . . . . 0.0 111.583 -175.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.452 ' O ' ' OG1' ' A' ' 101' ' ' THR . 75.3 t -139.6 139.22 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -1.225 . . . . 0.0 112.042 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.4 t -108.09 127.31 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.507 ' H ' HG11 ' A' ' 99' ' ' VAL . . . -115.99 144.23 44.37 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 6.2 mt -137.76 99.52 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.25 129.59 9.13 Favored Glycine 0 N--CA 1.485 1.947 0 CA-C-O 123.328 1.515 . . . . 0.0 112.762 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.54 ' O ' ' CB ' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -88.62 115.31 26.05 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 113.475 -1.363 . . . . 0.0 107.925 177.363 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.883 ' O ' ' O ' ' A' ' 169' ' ' LEU . 0.7 OUTLIER -74.95 132.25 41.28 Favored 'General case' 0 N--CA 1.529 3.491 0 O-C-N 124.084 0.865 . . . . 0.0 110.237 -179.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.883 ' O ' ' O ' ' A' ' 168' ' ' GLU . 1.5 pp 30.1 166.46 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.017 0 O-C-N 120.566 -1.334 . . . . 0.0 113.487 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 172' ' ' VAL . 0.1 OUTLIER -171.55 61.0 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.596 0.713 . . . . 0.0 110.192 -179.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.481 ' C ' ' O ' ' A' ' 170' ' ' SER . 80.2 mtm180 7.67 -37.0 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.062 0 C-N-CA 123.276 0.63 . . . . 0.0 112.606 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 1.157 ' N ' ' O ' ' A' ' 170' ' ' SER . 3.1 t -87.13 23.37 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.045 -1.66 . . . . 0.0 109.834 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.4 p -79.73 -39.34 31.34 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -74.75 -55.17 6.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.517 -1.365 . . . . 0.0 108.421 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.476 ' CG ' ' H ' ' A' ' 176' ' ' ILE . 4.7 pt20 -51.54 -68.66 0.15 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.813 ' CG2' ' H ' ' A' ' 177' ' ' ASN . 10.4 tp -41.84 -74.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.813 ' H ' ' CG2' ' A' ' 176' ' ' ILE . 21.7 m120 -46.17 -73.46 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.01 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 177' ' ' ASN . 50.1 m-20 -47.06 -59.4 3.15 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.821 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.476 ' OG ' ' N ' ' A' ' 180' ' ' ARG . 59.6 p -47.14 -70.62 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.722 -1.236 . . . . 0.0 109.639 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.476 ' N ' ' OG ' ' A' ' 179' ' ' SER . 97.8 mtt180 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 120.751 -1.218 . . . . 0.0 109.387 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.626 ' CG ' ' H ' ' A' ' 47' ' ' MET . 17.4 p-10 -66.29 -64.73 0.79 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.885 1.326 . . . . 0.0 110.786 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.626 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 16.3 mmm -43.54 -58.61 2.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.193 0.997 . . . . 0.0 111.443 -173.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' ARG . 6.4 t -53.18 -35.97 60.42 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 48' ' ' THR . 36.8 ttp180 -42.02 -51.05 4.59 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.805 -1.184 . . . . 0.0 111.841 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -80.77 -58.06 3.27 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -79.59 -45.3 8.7 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -54.96 -46.3 75.01 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 120.533 2.167 . . . . 0.0 105.525 176.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 52' ' ' LEU . . . -46.9 -57.98 4.4 Favored 'General case' 0 C--O 1.205 -1.275 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.345 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -81.87 -68.42 0.7 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.64 -1.288 . . . . 0.0 113.989 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 51' ' ' GLY . 57.4 mtpt -47.46 -27.53 1.77 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.094 -1.004 . . . . 0.0 111.647 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.46 -32.3 14.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.053 -1.654 . . . . 0.0 108.782 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.3 tp -55.22 -40.21 70.56 Favored 'General case' 0 C--N 1.284 -2.239 0 O-C-N 121.035 -1.041 . . . . 0.0 109.309 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.617 ' O ' ' CG ' ' A' ' 61' ' ' ARG . . . -80.42 -47.49 14.3 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -177.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -66.89 -32.95 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 117.616 -3.177 . . . . 0.0 104.618 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.598 ' O ' ' N ' ' A' ' 63' ' ' LEU . . . -58.84 -26.53 64.28 Favored 'General case' 0 C--N 1.265 -3.104 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.617 ' CG ' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -49.79 -24.45 2.39 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 116.665 -2.014 . . . . 0.0 105.882 174.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 59' ' ' VAL . 96.9 m -74.03 -39.76 63.34 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.598 ' N ' ' O ' ' A' ' 60' ' ' ALA 0.276 0.3 OUTLIER -48.2 -42.19 29.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 124.761 2.22 . . . . 0.0 107.921 175.58 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.66 -4.7 59.21 Favored 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 112.553 -2.112 . . . . 0.0 113.081 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 66' ' ' SER . 34.5 t0 -99.02 -27.46 13.84 Favored 'General case' 0 N--CA 1.517 2.921 0 CA-C-N 123.713 2.961 . . . . 0.0 115.618 -172.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.523 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -60.12 -161.47 0.0 OUTLIER Pre-proline 0 C--N 1.278 -2.525 0 O-C-N 119.668 -1.895 . . . . 0.0 109.928 -178.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.692 ' HD2' ' H ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -114.52 -25.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 124.399 3.399 . . . . 0.0 113.584 176.032 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.692 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 16.4 pt-20 -56.75 -30.45 63.59 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 117.829 -1.548 . . . . 0.0 107.52 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.5 mt -45.25 -83.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.062 -178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -47.33 -39.03 13.95 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.978 0.894 . . . . 0.0 109.914 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -78.04 -13.0 60.03 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.931 -1.105 . . . . 0.0 111.08 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . -97.52 -1.38 59.06 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 105.046 -3.222 . . . . 0.0 105.046 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.571 ' O ' ' OD2' ' A' ' 102' ' ' ASP . 1.4 mp -89.61 -23.22 21.99 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 173.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -62.83 -0.72 0.71 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.632 ' CG ' ' H ' ' A' ' 76' ' ' LYS . 3.5 tptm -136.37 -140.81 0.16 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.204 -1.56 . . . . 0.0 107.175 174.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.632 ' H ' ' CG ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -129.12 156.14 78.69 Favored Pre-proline 0 CA--C 1.578 2.041 0 O-C-N 121.481 -0.762 . . . . 0.0 109.625 179.381 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' O ' ' CE2' ' A' ' 108' ' ' TYR . 0.9 OUTLIER -31.56 -10.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.528 3.546 1 C-N-CA 126.236 4.624 . . . . 0.0 118.946 -179.082 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' LYS . 44.0 tp60 -96.33 -14.08 22.83 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 119.798 -1.814 . . . . 0.0 109.622 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -116.11 0.74 13.05 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.232 -0.918 . . . . 0.0 112.472 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.694 ' N ' ' OH ' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -76.36 -155.4 0.06 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 119.234 -2.166 . . . . 0.0 107.703 178.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.97 17.25 0.22 Allowed Glycine 0 N--CA 1.496 2.676 0 O-C-N 120.523 -1.36 . . . . 0.0 109.727 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.455 ' C ' ' H ' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -48.39 -24.37 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-O 121.898 0.856 . . . . 0.0 110.385 -179.12 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 7.3 tt0 -53.34 -7.74 0.1 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 82' ' ' ILE . . . -94.49 -52.81 4.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.002 -1.061 . . . . 0.0 112.689 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.455 ' CD1' ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -74.82 -34.2 32.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 177.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -57.97 -46.27 85.41 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 1.2 tt0 -49.67 -21.54 1.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.053 -1.43 . . . . 0.0 107.948 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.94 66.76 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 114.831 -2.748 . . . . 0.0 104.093 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 86' ' ' ALA . 37.7 t -54.62 -72.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 C-N-CA 116.776 -1.97 . . . . 0.0 110.185 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 93' ' ' ASN . 1.5 ttt-85 -48.13 -69.61 0.12 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 124.499 1.119 . . . . 0.0 113.118 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 90' ' ' ARG . 37.9 pttt -35.61 -36.87 0.08 Allowed 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.953 -1.092 . . . . 0.0 109.187 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 90' ' ' ARG . 62.3 mtm-85 -86.51 -21.88 26.71 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.723 -1.236 . . . . 0.0 111.585 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.644 ' N ' ' O ' ' A' ' 90' ' ' ARG . 54.7 t-20 -97.9 -16.42 19.75 Favored 'General case' 0 N--CA 1.511 2.582 0 CA-C-N 120.979 1.718 . . . . 0.0 108.374 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.0 t70 73.28 24.7 2.34 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.886 0.875 . . . . 0.0 110.835 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 0.4 OUTLIER 173.27 153.71 0.09 Allowed 'General case' 0 N--CA 1.514 2.755 0 CA-C-N 121.726 2.057 . . . . 0.0 107.796 176.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.501 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER 156.17 164.69 0.01 OUTLIER 'General case' 1 N--CA 1.542 4.133 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.2 179.828 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.566 ' CD1' ' NE ' ' A' ' 107' ' ' ARG . 0.9 OUTLIER -143.52 89.21 2.06 Favored 'General case' 0 C--O 1.214 -0.816 1 N-CA-C 99.119 -4.4 . . . . 0.0 99.119 168.552 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.629 ' N ' ' OG ' ' A' ' 109' ' ' SER . 0.4 OUTLIER -93.19 129.09 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -175.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.463 HG21 ' H ' ' A' ' 164' ' ' ALA . 1.1 m -119.08 130.54 73.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -173.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.64 124.47 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 1 N-CA-C 97.166 -5.124 . . . . 0.0 97.166 169.217 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.5 p -136.09 164.2 28.57 Favored 'General case' 0 C--N 1.281 -2.372 0 O-C-N 120.61 -1.306 . . . . 0.0 108.416 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.707 ' O ' ' N ' ' A' ' 104' ' ' GLN . 1.7 m-20 -78.86 -175.13 4.32 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 100.873 -3.751 . . . . 0.0 100.873 170.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.514 ' O ' ' CG ' ' A' ' 103' ' ' MET . 1.6 ttt -68.28 69.82 0.15 Allowed 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 114.843 -2.743 . . . . 0.0 103.963 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.707 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -137.16 -50.37 0.64 Allowed 'General case' 0 C--N 1.358 0.965 0 O-C-N 120.488 -1.382 . . . . 0.0 108.408 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 104' ' ' GLN . 1.5 t 92.74 138.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.9 OUTLIER 157.04 139.34 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 102.092 -3.299 . . . . 0.0 102.092 178.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.729 ' NH2' HH11 ' A' ' 147' ' ' ARG . 39.4 mtt180 -86.19 96.65 9.99 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.791 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.694 ' OH ' ' N ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -55.95 -19.94 14.26 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 123.81 1.767 . . . . 0.0 107.282 -176.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.629 ' OG ' ' N ' ' A' ' 98' ' ' ILE . 25.6 p -113.36 146.02 40.15 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.534 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.552 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 13.3 p80 -155.53 137.25 9.64 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -174.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.637 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 40.5 Cg_endo -88.57 -32.25 0.15 Allowed 'Trans proline' 0 N--CA 1.482 0.815 0 N-CA-C 104.666 -2.859 . . . . 0.0 104.666 171.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.637 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 34.9 tp10 -127.35 124.83 39.57 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.24 81.83 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -68.28 -28.97 67.65 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 119.882 -1.762 . . . . 0.0 115.629 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.548 ' CD ' ' CE2' ' A' ' 97' ' ' PHE . 11.7 ttt85 -55.26 -29.04 57.33 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 119.103 -2.248 . . . . 0.0 105.544 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.751 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.2 OUTLIER -63.92 -87.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.214 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -32.55 -13.41 0.0 OUTLIER Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.419 -0.801 . . . . 0.0 112.949 -175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.751 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.9 mt-30 -71.5 -72.64 0.21 Allowed Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 119.632 -2.099 . . . . 0.0 110.892 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.512 ' O ' ' CB ' ' A' ' 120' ' ' PHE . 96.0 Cg_exo -19.04 142.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 124.309 3.339 . . . . 0.0 113.878 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 120' ' ' PHE . 67.1 t80 140.89 21.64 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.441 ' C ' ' N ' ' A' ' 123' ' ' ASP . 23.7 ttmt -177.29 -2.8 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 O-C-N 121.434 -0.792 . . . . 0.0 110.196 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.6 -20.59 2.75 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.441 ' N ' ' C ' ' A' ' 121' ' ' LYS . 10.0 t70 72.6 -5.27 1.88 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -75.97 -21.1 57.33 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 119.756 -1.84 . . . . 0.0 108.861 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.7 pt -74.39 -23.67 18.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.02 -1.05 . . . . 0.0 109.947 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.76 -25.92 8.51 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -86.52 -39.14 16.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.671 -0.643 . . . . 0.0 111.594 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -79.73 -46.85 16.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 119.898 -1.752 . . . . 0.0 107.246 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.652 ' C ' HD21 ' A' ' 130' ' ' ASN . 0.1 OUTLIER -38.41 -41.93 0.69 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.652 HD21 ' C ' ' A' ' 129' ' ' LEU . 2.3 m120 -100.46 12.81 36.43 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.315 -1.311 . . . . 0.0 114.203 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.36 98.41 0.56 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 170.85 157.76 0.07 Allowed 'General case' 0 N--CA 1.514 2.746 0 CA-C-O 122.596 1.189 . . . . 0.0 111.399 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -101.53 144.74 29.92 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.303 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -159.75 144.34 15.01 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.824 -1.172 . . . . 0.0 109.693 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 147' ' ' ARG . 5.0 p -138.43 132.91 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 120.701 -1.249 . . . . 0.0 109.974 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -148.88 169.17 21.15 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.433 0.635 . . . . 0.0 110.452 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -97.42 139.22 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-O 121.361 0.6 . . . . 0.0 111.5 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.521 ' O ' ' NH2' ' A' ' 115' ' ' ARG . 28.1 t-20 -117.23 150.3 38.99 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.249 -0.907 . . . . 0.0 110.745 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -153.5 113.61 3.94 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 141' ' ' PHE . . . -150.28 112.61 0.55 Allowed Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.249 -1.453 . . . . 0.0 110.305 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 141' ' ' PHE . 54.5 t80 39.01 32.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.904 -0.762 . . . . 0.0 110.122 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.418 HD22 HH11 ' A' ' 115' ' ' ARG . 32.0 tp -152.98 -94.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.89 . . . . 0.0 110.736 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.42 ' CB ' ' OG ' ' A' ' 170' ' ' SER . . . -172.55 154.27 3.06 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.535 -1.353 . . . . 0.0 112.029 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -52.49 144.59 13.12 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.673 1.225 . . . . 0.0 111.747 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.1 158.03 24.2 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 tp -108.97 159.52 16.76 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-N 121.351 1.887 . . . . 0.0 109.683 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.729 HH11 ' NH2' ' A' ' 107' ' ' ARG . 11.3 ptt180 -152.3 149.04 28.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.725 -1.234 . . . . 0.0 110.768 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.25 157.47 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-O 122.291 1.043 . . . . 0.0 109.673 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -124.92 135.96 53.32 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.844 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -142.63 161.16 50.93 Favored Pre-proline 0 C--N 1.31 -1.127 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -108.16 163.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 123.459 2.773 . . . . 0.0 116.027 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 48.9 mt -118.62 125.86 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -104.75 155.44 18.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 123.195 1.474 . . . . 0.0 110.666 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -53.08 -85.54 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -170.35 35.59 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -148.18 20.3 1.09 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 64.85 42.54 4.39 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 153' ' ' TYR . 0.6 OUTLIER -122.68 118.46 28.15 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.694 HE21 ' N ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -63.83 121.41 13.96 Favored 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -176.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.1 pp -140.31 13.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 120.536 -1.353 . . . . 0.0 113.749 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.48 178.93 40.73 Favored Glycine 1 N--CA 1.522 4.379 0 C-N-CA 118.816 -1.659 . . . . 0.0 112.361 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.8 t -123.3 134.02 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.26 0 CA-C-N 119.013 1.406 . . . . 0.0 112.593 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 150' ' ' THR . 2.7 t -123.9 107.19 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.463 ' H ' HG21 ' A' ' 99' ' ' VAL . . . -112.44 158.21 20.14 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.2 mt -143.33 101.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.05 127.56 7.71 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.403 -1.38 . . . . 0.0 113.11 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 13.4 tp -93.71 124.82 37.97 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.662 -1.269 . . . . 0.0 109.306 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.416 ' OE1' ' NH1' ' A' ' 115' ' ' ARG . 12.7 tp10 -73.79 134.38 43.39 Favored 'General case' 0 N--CA 1.521 3.086 0 C-N-CA 122.949 0.5 . . . . 0.0 109.942 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.439 ' O ' ' OG ' ' A' ' 170' ' ' SER . 0.5 OUTLIER -154.99 -167.47 2.59 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 119.327 -2.108 . . . . 0.0 109.167 178.614 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 1.071 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 19.8 m -166.45 -126.21 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 110.089 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.56 ' C ' ' O ' ' A' ' 170' ' ' SER . 56.6 ttt85 -17.9 71.95 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.226 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 1.071 ' CG2' ' O ' ' A' ' 170' ' ' SER . 0.3 OUTLIER -165.88 -16.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.649 0 O-C-N 121.381 -0.824 . . . . 0.0 110.569 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.6 t -69.61 -45.3 68.88 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.477 -1.389 . . . . 0.0 113.859 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -73.95 -53.7 9.52 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.268 -1.52 . . . . 0.0 110.566 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -52.12 -70.65 0.08 Allowed 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.471 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.481 ' O ' ' N ' ' A' ' 180' ' ' ARG . 1.3 mp -42.5 -78.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.896 0.855 . . . . 0.0 111.438 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.4 ' N ' ' CG2' ' A' ' 176' ' ' ILE . 53.1 t30 -38.23 -78.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.868 -177.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -47.16 -60.85 2.2 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.593 -1.317 . . . . 0.0 110.645 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 9.7 m -55.53 -68.28 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.39 -1.443 . . . . 0.0 108.858 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 176' ' ' ILE . 63.5 ttp85 . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.331 -0.855 . . . . 0.0 109.818 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.6 p . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 49' ' ' ARG . 40.7 t0 -63.76 -64.56 0.86 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 123.871 1.796 . . . . 0.0 108.817 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.416 ' C ' ' O ' ' A' ' 46' ' ' ASP . 6.6 tmm? -32.12 -60.08 0.28 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 123.331 1.538 . . . . 0.0 111.116 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 52' ' ' LEU . 13.9 t -59.56 -32.62 70.51 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.448 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 46' ' ' ASP . 32.3 ttp85 -37.86 -51.98 1.31 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.699 -1.251 . . . . 0.0 111.81 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -84.49 -56.44 3.62 Favored 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -77.43 -43.36 15.9 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -176.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -54.63 -45.82 73.81 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 120.352 2.076 . . . . 0.0 106.344 176.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.402 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . -48.32 -57.23 6.31 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.625 -1.23 . . . . 0.0 108.999 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -78.35 -55.77 4.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.435 -1.416 . . . . 0.0 113.402 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -67.86 -21.95 65.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.862 . . . . 0.0 111.874 -175.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.68 -35.35 10.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 120.784 1.629 . . . . 0.0 110.572 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.03 -35.8 82.35 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.291 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.63 -45.38 21.66 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -72.64 -34.41 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 118.649 -2.532 . . . . 0.0 105.882 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.439 ' N ' HG12 ' A' ' 89' ' ' VAL . . . -60.84 -31.81 71.22 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 2.0 ptt180 -70.02 -16.64 63.19 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.614 -1.234 . . . . 0.0 110.318 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 m -63.58 -46.03 87.74 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 123.056 2.662 . . . . 0.0 105.734 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 85' ' ' ILE . 54.1 mt -88.79 -37.6 15.3 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.897 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.86 -19.95 46.44 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 119.152 -2.218 . . . . 0.0 105.715 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 31.5 t70 -84.39 -4.33 58.84 Favored 'General case' 0 C--N 1.274 -2.717 0 O-C-N 121.367 -0.833 . . . . 0.0 110.517 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.516 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -74.84 -155.9 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 120.36 -1.462 . . . . 0.0 111.178 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -108.04 -20.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.316 2.677 . . . . 0.0 114.336 178.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.9 pt-20 -62.1 -36.34 81.44 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.621 -1.631 . . . . 0.0 106.938 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.571 ' O ' ' N ' ' A' ' 72' ' ' GLY . 7.9 mm -47.06 -88.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.828 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -45.35 -31.25 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -78.51 -17.81 55.69 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.732 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.772 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -83.26 -40.84 8.86 Favored Glycine 0 N--CA 1.507 3.375 1 N-CA-C 102.453 -4.259 . . . . 0.0 102.453 178.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mp -48.13 -35.64 11.9 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -78.59 5.57 10.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.779 ' O ' ' O ' ' A' ' 76' ' ' LYS . 31.4 mmtm -139.22 34.82 2.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.835 -1.165 . . . . 0.0 111.66 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.779 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 24.96 153.83 0.0 OUTLIER Pre-proline 0 N--CA 1.527 3.412 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 76' ' ' LYS . 5.7 Cg_exo -22.42 -62.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 124.411 3.407 . . . . 0.0 114.683 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -55.22 139.37 42.46 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 117.326 -1.75 . . . . 0.0 107.777 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 61.58 13.89 5.54 Favored 'General case' 0 C--N 1.282 -2.341 0 C-N-CA 119.353 -0.939 . . . . 0.0 113.336 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.641 ' O ' ' N ' ' A' ' 82' ' ' ILE . 22.4 m -88.88 82.09 6.81 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 120.247 -1.533 . . . . 0.0 109.636 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -43.98 10.42 0.0 OUTLIER Glycine 0 CA--C 1.577 3.918 0 CA-C-O 117.594 -1.67 . . . . 0.0 115.768 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 1.392 HG22 ' CG1' ' A' ' 100' ' ' VAL . 0.3 OUTLIER -49.06 -12.18 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 123.983 3.892 . . . . 0.0 110.849 -178.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.557 ' N ' HD11 ' A' ' 82' ' ' ILE . 1.1 tm0? -36.78 -19.47 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.707 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -63.87 -86.72 0.01 OUTLIER 'General case' 0 C--O 1.191 -1.995 1 N-CA-C 98.675 -4.565 . . . . 0.0 98.675 171.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.707 ' C ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -16.96 -56.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.531 3.597 0 CA-C-N 124.009 3.095 . . . . 0.0 109.336 177.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -53.1 -58.36 7.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.008 -1.682 . . . . 0.0 109.611 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 84' ' ' ALA . 56.0 tt0 -43.67 -56.65 3.62 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 117.156 -1.402 . . . . 0.0 111.563 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -65.15 -59.26 4.29 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 124.318 3.235 . . . . 0.0 109.182 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.465 ' C ' ' O ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -48.26 -59.57 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 C-N-CA 114.686 -2.805 . . . . 0.0 111.313 -175.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.829 ' O ' ' N ' ' A' ' 93' ' ' ASN . 24.6 ptt180 -52.14 -39.19 59.6 Favored 'General case' 0 C--O 1.193 -1.887 0 CA-C-N 120.567 1.53 . . . . 0.0 111.045 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.599 ' C ' ' O ' ' A' ' 90' ' ' ARG . 16.3 tttm -34.11 -44.75 0.19 Allowed 'General case' 0 N--CA 1.536 3.839 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 91' ' ' LYS . 16.0 mmm180 -35.63 -53.32 0.7 Allowed 'General case' 0 N--CA 1.516 2.873 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.829 ' N ' ' O ' ' A' ' 90' ' ' ARG . 74.6 m-80 -140.37 -66.65 0.44 Allowed 'General case' 0 N--CA 1.514 2.745 0 CA-C-N 121.737 2.062 . . . . 0.0 111.261 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 2.1 m-20 159.71 -7.85 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.054 0 CA-C-O 121.572 0.701 . . . . 0.0 109.732 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.76 155.82 22.91 Favored 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.919 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER 157.49 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.53 3.559 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.669 -178.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.86 83.14 1.94 Allowed 'General case' 0 C--O 1.215 -0.75 1 N-CA-C 98.532 -4.618 . . . . 0.0 98.532 169.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.6 tt -104.69 155.66 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 123.633 1.683 . . . . 0.0 109.461 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.453 HG23 ' OG1' ' A' ' 101' ' ' THR . 0.2 OUTLIER -151.15 139.28 14.3 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 CA-C-N 112.399 -2.182 . . . . 0.0 113.149 -171.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 1.392 ' CG1' HG22 ' A' ' 82' ' ' ILE . 7.3 p -105.53 130.95 56.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 1 N-CA-C 94.246 -6.205 . . . . 0.0 94.246 169.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.621 ' OG1' ' O ' ' A' ' 162' ' ' VAL . 1.6 m -121.6 151.91 39.86 Favored 'General case' 0 N--CA 1.508 2.471 0 CA-C-N 121.573 1.988 . . . . 0.0 111.607 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 103' ' ' MET . 37.4 t70 -96.16 -163.07 1.01 Allowed 'General case' 0 C--N 1.29 -1.989 1 N-CA-C 98.507 -4.627 . . . . 0.0 98.507 167.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.609 ' O ' ' HG3' ' A' ' 103' ' ' MET . 4.2 tpt -89.41 77.72 7.29 Favored 'General case' 0 C--N 1.268 -2.975 0 C-N-CA 116.074 -2.25 . . . . 0.0 109.852 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 105' ' ' SER . 64.3 tp60 -150.97 -30.4 0.18 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 119.193 -2.192 . . . . 0.0 109.046 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 26.7 t 60.95 138.13 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 105' ' ' SER . 1.1 tp 153.51 140.43 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 139.69 58.8 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.402 ' HD2' HG13 ' A' ' 82' ' ' ILE . 3.4 m-30 -97.68 -1.18 44.13 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 t -129.03 146.84 50.9 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.606 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.542 ' CD2' ' H ' ' A' ' 110' ' ' HIS . 0.4 OUTLIER -142.3 105.0 5.55 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -172.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.602 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 27.7 Cg_endo -93.11 -46.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 N-CA-C 106.11 -2.304 . . . . 0.0 106.11 172.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.602 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 2.5 tm-20 -108.54 130.01 55.29 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 175.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.67 -58.59 7.89 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.409 ' N ' ' OE2' ' A' ' 112' ' ' GLU . 99.0 mm-40 -71.62 -29.64 64.89 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -174.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -31.02 68.27 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 123.632 2.924 . . . . 0.0 106.437 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.818 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.7 OUTLIER -54.04 -89.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.219 178.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 116' ' ' ILE . . . -27.58 -8.61 0.0 OUTLIER Glycine 0 N--CA 1.493 2.436 0 C-N-CA 123.961 0.791 . . . . 0.0 114.647 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.818 ' N ' ' O ' ' A' ' 116' ' ' ILE . 3.6 mt-30 -76.56 -70.59 0.21 Allowed Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 118.954 -2.497 . . . . 0.0 114.034 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.432 ' C ' ' O ' ' A' ' 118' ' ' GLN . 51.9 Cg_exo -19.12 95.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 124.289 3.326 . . . . 0.0 115.536 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.492 ' CG ' ' O ' ' A' ' 120' ' ' PHE . 0.0 OUTLIER 175.0 11.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 123' ' ' ASP . 74.4 tttt -164.56 -27.44 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.1 -1.0 . . . . 0.0 109.471 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -41.6 -13.75 0.01 OUTLIER Glycine 1 N--CA 1.516 4.009 0 O-C-N 121.303 -0.873 . . . . 0.0 111.908 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 121' ' ' LYS . 39.1 m-20 65.01 43.65 3.7 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 118.712 1.256 . . . . 0.0 112.382 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -128.42 -26.98 2.7 Favored 'General case' 0 N--CA 1.518 2.931 0 C-N-CA 117.456 -1.697 . . . . 0.0 109.832 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.59 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 12.1 mt -80.02 -16.04 12.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 O-C-N 120.729 -1.232 . . . . 0.0 110.556 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -53.47 -44.21 68.77 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.432 -1.417 . . . . 0.0 110.276 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.543 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 59.3 mttm -73.54 -31.4 63.64 Favored 'General case' 0 C--O 1.193 -1.915 0 O-C-N 121.284 -0.885 . . . . 0.0 109.569 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.554 ' O ' ' ND2' ' A' ' 130' ' ' ASN . . . -83.07 -20.6 34.63 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.37 -1.456 . . . . 0.0 109.189 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.03 -18.7 5.58 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.565 -0.709 . . . . 0.0 109.291 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.767 ' CG ' ' H ' ' A' ' 131' ' ' GLY 0.348 0.0 OUTLIER -79.28 -105.87 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.341 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.767 ' H ' ' CG ' ' A' ' 130' ' ' ASN . . . -156.22 41.85 0.56 Allowed Glycine 0 CA--C 1.563 3.067 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.622 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 68.5 tt0 -146.47 161.17 41.0 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 119.409 -2.23 . . . . 0.0 110.891 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 133' ' ' GLU . 6.8 mp0 -73.8 165.15 25.63 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 122.091 0.948 . . . . 0.0 112.706 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -166.03 150.93 8.33 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.38 131.18 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 O-C-N 119.661 -1.9 . . . . 0.0 110.473 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.28 160.85 39.73 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.159 -0.963 . . . . 0.0 111.5 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.2 mt -102.39 142.45 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-O 121.835 0.826 . . . . 0.0 112.118 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.439 ' CG ' ' N ' ' A' ' 139' ' ' ARG . 4.1 t-20 -119.11 161.62 19.99 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 138' ' ' ASN . 2.6 ptm180 -164.27 109.05 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.405 -0.918 . . . . 0.0 108.57 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -162.76 114.61 0.61 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.722 -1.704 . . . . 0.0 110.56 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 3.4 t80 60.01 -73.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.572 -0.958 . . . . 0.0 109.444 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 1.283 HD11 ' OE2' ' A' ' 168' ' ' GLU . 33.7 mt -47.91 -79.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 142' ' ' LEU . . . 161.81 159.95 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.335 0.588 . . . . 0.0 110.606 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 143' ' ' ALA . 39.5 mt-30 -42.37 134.96 2.82 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 167' ' ' LEU . . . -156.44 155.29 31.83 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.14 152.88 25.48 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 121.117 1.781 . . . . 0.0 111.192 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 155.34 49.87 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.15 155.79 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -125.51 137.66 53.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.586 0.707 . . . . 0.0 109.375 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.09 146.54 43.72 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -92.42 154.82 3.03 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 123.812 3.008 . . . . 0.0 114.981 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.2 mt -117.29 133.45 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.773 -0.579 . . . . 0.0 109.934 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.55 ' C ' ' H ' ' A' ' 155' ' ' GLU . 77.4 m-85 -103.13 144.12 31.72 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.4 51.11 0.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 153' ' ' TYR . 9.2 tt0 41.1 25.06 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.187 -0.946 . . . . 0.0 111.657 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 158' ' ' LYS . 35.1 m120 -138.77 30.6 2.29 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 62.46 2.67 0.93 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 156' ' ' ASN . 2.4 mptm? -92.23 124.87 36.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.732 HE21 ' N ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -73.1 129.99 39.3 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -175.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.7 pp -138.94 14.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.24 -1.537 . . . . 0.0 114.404 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.23 176.09 45.98 Favored Glycine 0 N--CA 1.505 3.298 0 C-N-CA 116.042 -2.98 . . . . 0.0 112.798 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.621 ' O ' ' OG1' ' A' ' 101' ' ' THR . 55.5 t -136.61 133.73 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 121.771 0.796 . . . . 0.0 110.387 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 79.7 t -106.03 122.63 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.437 ' H ' HG11 ' A' ' 99' ' ' VAL . . . -119.35 141.93 48.59 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 22.3 mt -131.67 110.91 17.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.25 119.21 6.31 Favored Glycine 0 N--CA 1.487 2.039 0 C-N-CA 119.095 -1.526 . . . . 0.0 111.528 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -94.5 114.89 26.96 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 1.283 ' OE2' HD11 ' A' ' 142' ' ' LEU . 13.5 tp10 -74.86 134.88 41.6 Favored 'General case' 0 N--CA 1.518 2.951 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 170' ' ' SER . 11.0 tp 25.44 -109.58 0.02 OUTLIER 'General case' 0 N--CA 1.534 3.725 0 CA-C-N 119.04 0.836 . . . . 0.0 111.315 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 172' ' ' VAL . 22.7 t 108.61 76.01 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 CA-C-O 122.657 1.218 . . . . 0.0 109.677 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 49.6 mmt-85 1.54 -53.69 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 112.8 -2.0 . . . . 0.0 114.41 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 170' ' ' SER . 2.2 t -81.56 23.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 O-C-N 119.819 -1.801 . . . . 0.0 112.883 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.2 p -82.04 -35.84 28.35 Favored 'General case' 0 C--N 1.274 -2.688 0 O-C-N 121.912 -0.493 . . . . 0.0 111.271 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 7.6 tm0? -73.74 -58.97 2.94 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 117.487 -1.685 . . . . 0.0 108.758 -176.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.474 ' CG ' ' H ' ' A' ' 176' ' ' ILE . 4.8 pt20 -51.16 -70.04 0.1 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.289 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.753 ' CG2' ' H ' ' A' ' 177' ' ' ASN . 9.1 tp -41.01 -70.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.753 ' H ' ' CG2' ' A' ' 176' ' ' ILE . 26.3 t-20 -41.4 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.964 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 179' ' ' SER . 60.6 t0 -51.51 -63.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.999 -1.063 . . . . 0.0 111.992 -177.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 180' ' ' ARG . 1.7 t -48.05 -73.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.224 -1.39 . . . . 0.0 107.834 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 179' ' ' SER . 2.8 tmm_? . . . . . 0 N--CA 1.514 2.749 0 O-C-N 121.08 -1.013 . . . . 0.0 109.716 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.66 0.743 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -71.41 -65.6 0.73 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.336 -0.852 . . . . 0.0 108.957 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 24.6 ttt -41.42 -55.92 2.65 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.888 -1.132 . . . . 0.0 110.838 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.46 ' OG1' ' CD2' ' A' ' 52' ' ' LEU . 5.8 t -60.33 -32.61 71.4 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 122.181 0.991 . . . . 0.0 108.881 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.421 ' HA ' ' CD2' ' A' ' 146' ' ' LEU . 53.8 ttp180 -41.61 -60.86 1.21 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.25 -1.531 . . . . 0.0 112.538 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -76.57 -60.98 2.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.85 -49.55 22.58 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.915 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.46 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -51.81 -43.45 63.1 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 120.747 2.273 . . . . 0.0 108.194 178.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.82 -49.09 71.87 Favored 'General case' 0 C--O 1.204 -1.322 0 C-N-CA 117.407 -1.717 . . . . 0.0 109.481 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -78.72 -69.51 0.56 Allowed 'General case' 0 C--N 1.308 -1.214 0 O-C-N 120.099 -1.626 . . . . 0.0 111.434 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -47.31 -59.45 3.18 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.274 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.32 -36.34 82.69 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 123.389 2.813 . . . . 0.0 111.609 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.25 -42.41 73.45 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.062 -1.648 . . . . 0.0 108.678 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.427 ' O ' ' CG ' ' A' ' 61' ' ' ARG . . . -75.85 -51.2 13.05 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.37 -43.8 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 119.428 -2.045 . . . . 0.0 106.678 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.02 -28.62 39.42 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -76.81 -20.78 56.0 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.429 -0.909 . . . . 0.0 111.971 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.3 m -67.36 -45.7 75.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 118.893 -2.379 . . . . 0.0 106.843 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.442 ' O ' HD12 ' A' ' 69' ' ' ILE . 2.2 mt -90.2 -31.91 16.83 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 113.714 -1.585 . . . . 0.0 111.13 -177.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.02 -15.87 63.79 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 119.84 -1.788 . . . . 0.0 106.246 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 28.4 t70 -90.22 -9.17 49.03 Favored 'General case' 0 N--CA 1.528 3.427 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.861 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.492 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -70.18 -152.23 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.27 0 O-C-N 120.075 -1.641 . . . . 0.0 110.695 -178.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.702 ' C ' ' H ' ' A' ' 69' ' ' ILE . 2.0 Cg_endo -104.82 -30.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.079 2.519 . . . . 0.0 114.683 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.491 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 13.2 pt-20 -72.27 26.81 0.05 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.702 ' H ' ' C ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -100.72 -83.0 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 176.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -47.23 -31.2 3.51 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.364 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -80.15 -18.76 48.87 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.329 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -86.91 -38.0 8.2 Favored Glycine 0 CA--C 1.479 -2.21 1 N-CA-C 101.633 -4.587 . . . . 0.0 101.633 178.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tp -56.58 -34.21 66.93 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -77.74 0.51 23.3 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.829 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.799 ' O ' ' O ' ' A' ' 76' ' ' LYS . 4.7 tmtp? -131.95 45.9 2.72 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 120.319 1.418 . . . . 0.0 112.785 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.799 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 17.37 157.05 0.0 OUTLIER Pre-proline 0 N--CA 1.535 3.819 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -29.92 -60.58 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.364 2.709 . . . . 0.0 113.984 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -52.57 130.29 31.61 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 118.617 -1.233 . . . . 0.0 109.834 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' CD ' ' NZ ' ' A' ' 75' ' ' LYS . 31.5 tt0 65.49 13.8 9.08 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.877 176.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.831 ' O ' ' N ' ' A' ' 82' ' ' ILE . 15.3 t -79.56 97.9 6.65 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.499 -1.375 . . . . 0.0 110.094 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -43.76 66.73 0.0 OUTLIER Glycine 1 CA--C 1.578 4.018 0 C-N-CA 118.503 -1.808 . . . . 0.0 111.652 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.831 ' N ' ' O ' ' A' ' 80' ' ' SER . 7.7 tp -73.52 1.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.218 -1.754 . . . . 0.0 111.2 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -52.8 -29.06 25.44 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.7 -1.25 . . . . 0.0 113.161 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.847 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -81.26 -86.65 0.09 Allowed 'General case' 0 C--O 1.193 -1.911 0 N-CA-C 100.653 -3.832 . . . . 0.0 100.653 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.77 ' C ' ' O ' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -19.52 -63.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 121.548 1.977 . . . . 0.0 106.075 -178.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 1.002 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -42.56 -52.08 4.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.301 -1.5 . . . . 0.0 110.144 174.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.847 ' N ' ' O ' ' A' ' 84' ' ' ALA . 36.2 tp10 -36.86 -46.57 0.63 Allowed 'General case' 0 N--CA 1.536 3.828 0 C-N-CA 116.515 -2.074 . . . . 0.0 106.699 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.415 ' H ' HD11 ' A' ' 63' ' ' LEU . . . -49.64 -17.34 0.31 Allowed 'General case' 0 N--CA 1.512 2.667 0 O-C-N 119.446 -2.034 . . . . 0.0 108.796 171.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 1.002 ' N ' ' O ' ' A' ' 86' ' ' ALA . 22.7 m -60.8 -33.97 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 C-N-CA 115.879 -2.328 . . . . 0.0 109.101 174.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.41 ' N ' ' CG2' ' A' ' 89' ' ' VAL . 33.1 ttm180 -85.51 -49.19 8.26 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 114.328 -1.305 . . . . 0.0 113.812 -174.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -60.58 -36.79 79.37 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.444 -1.303 . . . . 0.0 108.452 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.707 ' NH2' ' H ' ' A' ' 95' ' ' LEU . 36.1 ttp85 -60.94 -71.2 0.15 Allowed 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 94' ' ' ASP . 35.6 m120 -161.53 -27.69 0.05 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.673 -1.267 . . . . 0.0 112.007 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 18.9 t70 139.8 -28.54 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.836 0 CA-C-N 120.167 1.349 . . . . 0.0 110.141 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.707 ' H ' ' NH2' ' A' ' 92' ' ' ARG . 0.3 OUTLIER -122.54 151.57 41.25 Favored 'General case' 0 N--CA 1.521 3.075 0 CA-C-N 113.701 -1.59 . . . . 0.0 114.601 -177.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER 150.36 162.31 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.0 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 178.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -107.92 95.39 5.65 Favored 'General case' 0 C--O 1.207 -1.132 1 CA-C-N 126.509 4.231 . . . . 0.0 100.247 170.335 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.6 mt -90.36 117.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 106' ' ' LEU . 1.1 p -136.06 139.98 44.79 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.639 0 CA-C-N 111.402 -2.635 . . . . 0.0 112.568 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.64 141.2 22.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 1 N-CA-C 99.451 -4.277 . . . . 0.0 99.451 174.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.539 HG23 ' H ' ' A' ' 105' ' ' SER . 0.7 OUTLIER -131.49 153.38 49.84 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.534 -1.354 . . . . 0.0 110.664 -176.185 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -86.65 -172.52 4.05 Favored 'General case' 0 C--N 1.281 -2.376 1 N-CA-C 99.488 -4.264 . . . . 0.0 99.488 170.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.594 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -81.2 77.03 8.13 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 114.25 -2.98 . . . . 0.0 109.577 -177.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.473 ' O ' ' CB ' ' A' ' 105' ' ' SER . 8.2 tp-100 -147.85 -40.67 0.17 Allowed 'General case' 0 C--O 1.209 -1.026 0 O-C-N 119.375 -2.078 . . . . 0.0 111.14 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.568 ' OG ' ' CD1' ' A' ' 125' ' ' ILE . 7.6 t 89.56 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.337 1.055 . . . . 0.0 109.03 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.4 OUTLIER 157.81 121.87 0.0 OUTLIER 'General case' 0 C--O 1.191 -1.982 0 N-CA-C 103.884 -2.636 . . . . 0.0 103.884 177.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.582 ' N ' ' HE ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -64.41 103.95 0.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.84 -27.47 63.23 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.41 ' N ' ' C ' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -122.86 165.79 16.07 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.018 -178.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.479 ' CD2' ' CD1' ' A' ' 116' ' ' ILE . 14.5 p80 179.01 161.97 0.71 Allowed Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.343 -0.848 . . . . 0.0 110.907 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.463 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 87.2 Cg_endo -87.82 -44.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.483 0.885 0 N-CA-C 106.637 -2.101 . . . . 0.0 106.637 173.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.494 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -108.02 135.44 49.39 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 174.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.3 -25.17 64.1 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.171 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -65.19 -37.49 87.5 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 119.971 -1.705 . . . . 0.0 114.841 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -65.03 -30.21 71.17 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 119.434 -2.041 . . . . 0.0 107.818 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.483 HG23 ' N ' ' A' ' 117' ' ' GLY . 55.0 mt -40.42 -85.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.589 0 CA-C-O 122.601 1.191 . . . . 0.0 111.639 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.483 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -45.53 -10.83 0.02 OUTLIER Glycine 0 N--CA 1.494 2.513 0 CA-C-N 115.144 -0.934 . . . . 0.0 113.691 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.41 ' CB ' ' CD ' ' A' ' 119' ' ' PRO . 3.2 mt-30 -64.2 -68.58 0.76 Allowed Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 120.394 2.097 . . . . 0.0 112.047 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 2.7 Cg_exo -35.96 107.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 123.933 3.088 . . . . 0.0 115.274 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 120' ' ' PHE . 45.8 t80 173.1 28.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -176.28 -8.66 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.65 -19.3 1.25 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.5 t70 68.56 3.92 4.07 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.144 -1.21 . . . . 0.0 109.731 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.457 ' CG ' ' CB ' ' A' ' 136' ' ' ALA . 27.9 m-20 -90.66 -24.63 20.42 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.486 -0.886 . . . . 0.0 108.75 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.568 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 31.0 mt -86.49 -26.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.207 -0.933 . . . . 0.0 112.806 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 125' ' ' ILE . 3.7 mm? -37.57 -50.9 1.16 Allowed 'General case' 0 N--CA 1.517 2.884 0 O-C-N 121.01 -1.056 . . . . 0.0 109.918 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.673 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 54.6 mttm -70.53 -29.7 66.25 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.848 -1.157 . . . . 0.0 109.29 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.611 ' C ' ' ND2' ' A' ' 130' ' ' ASN . . . -90.54 -33.99 15.7 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.976 -1.077 . . . . 0.0 109.481 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 128' ' ' ALA . 0.4 OUTLIER -36.82 -38.13 0.17 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.829 ' ND2' ' N ' ' A' ' 131' ' ' GLY . 0.1 OUTLIER -74.31 -91.91 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 177.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.829 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -168.5 57.12 0.21 Allowed Glycine 0 CA--C 1.558 2.753 0 O-C-N 120.068 -1.645 . . . . 0.0 110.347 176.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -140.23 157.05 46.19 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.715 -1.462 . . . . 0.0 109.048 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.457 ' O ' ' CG ' ' A' ' 134' ' ' ASN . 28.3 mp0 -68.66 159.22 32.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.651 -0.655 . . . . 0.0 111.797 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 133' ' ' GLU . 22.6 m120 -166.28 142.06 4.74 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.74 131.38 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 O-C-N 119.646 -1.909 . . . . 0.0 110.419 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.457 ' CB ' ' CG ' ' A' ' 124' ' ' ASP . . . -152.49 163.19 40.06 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.418 -0.801 . . . . 0.0 110.884 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.2 mt -97.02 128.63 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.648 0 O-C-N 121.146 -0.971 . . . . 0.0 111.353 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -97.21 153.15 18.18 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -133.44 156.99 46.7 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -166.18 161.94 35.54 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -44.34 -23.99 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -1.177 . . . . 0.0 110.186 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -73.3 -80.66 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.833 -1.167 . . . . 0.0 108.679 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -173.38 159.14 3.67 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.0 111.993 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.606 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 25.2 mp0 -45.31 143.39 1.75 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.699 0.761 . . . . 0.0 109.555 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 167' ' ' LEU . . . -146.56 150.64 35.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 49' ' ' ARG . 2.4 tp -108.43 152.51 24.59 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 122.006 2.185 . . . . 0.0 109.788 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -142.92 134.97 27.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.996 -1.065 . . . . 0.0 110.705 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.2 m -104.87 136.37 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 CA-C-O 122.232 1.015 . . . . 0.0 109.91 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 89.8 m-85 -108.42 140.87 41.1 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.506 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.88 150.89 67.05 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -92.66 149.99 2.81 Favored 'Trans proline' 0 N--CA 1.515 2.769 0 C-N-CA 123.65 2.9 . . . . 0.0 116.757 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 61.3 mt -116.25 125.83 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.554 ' C ' ' H ' ' A' ' 155' ' ' GLU . 97.3 m-85 -95.28 142.73 27.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.17 -0.956 . . . . 0.0 110.846 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 47.3 t0 -55.09 -3.36 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.548 -1.345 . . . . 0.0 109.23 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.554 ' H ' ' C ' ' A' ' 153' ' ' TYR . 53.2 tt0 99.39 4.69 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.531 ' C ' ' H ' ' A' ' 158' ' ' LYS . 32.6 m120 -129.07 36.7 4.16 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.099 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 60.98 -2.39 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.5 mptt -81.27 126.3 31.39 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.632 ' O ' ' CD ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -73.88 125.71 28.8 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -175.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.7 pp -143.07 7.31 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 118.799 -2.438 . . . . 0.0 116.971 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.64 173.12 44.44 Favored Glycine 0 N--CA 1.513 3.801 0 C-N-CA 116.619 -2.705 . . . . 0.0 111.853 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.421 ' O ' ' OG1' ' A' ' 101' ' ' THR . 58.3 t -137.25 139.96 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 120.965 -1.314 . . . . 0.0 111.118 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 56.1 t -103.91 127.79 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.99 155.64 26.56 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.8 mt -151.29 95.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.06 135.37 12.52 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.354 -175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.525 ' O ' ' CB ' ' A' ' 145' ' ' ALA . 0.7 OUTLIER -100.74 112.09 24.43 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 113.897 -1.151 . . . . 0.0 108.633 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -48.64 77.15 Favored 'General case' 0 N--CA 1.524 3.227 0 CA-C-O 123.025 1.393 . . . . 0.0 109.565 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -163.68 179.02 7.45 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.811 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.745 ' O ' ' N ' ' A' ' 172' ' ' VAL . 1.2 m -162.96 60.14 0.19 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.58 ' C ' ' H ' ' A' ' 173' ' ' THR . 65.1 mtm180 15.08 -63.53 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.932 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.874 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.745 ' N ' ' O ' ' A' ' 170' ' ' SER . 3.1 t -68.69 32.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.519 -1.363 . . . . 0.0 109.645 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.58 ' H ' ' C ' ' A' ' 171' ' ' ARG . 10.9 p -83.05 -31.18 27.5 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.818 -0.551 . . . . 0.0 110.586 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . 0.435 ' O ' ' OD1' ' A' ' 178' ' ' ASP . 0.9 OUTLIER -77.9 -57.52 3.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.441 -1.412 . . . . 0.0 108.432 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.575 ' CD ' ' H ' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -50.3 -68.71 0.15 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.763 ' CG2' ' H ' ' A' ' 177' ' ' ASN . 2.9 tp -45.41 -71.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.763 ' H ' ' CG2' ' A' ' 176' ' ' ILE . 12.0 t-20 -36.17 -78.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.211 -0.931 . . . . 0.0 112.448 -176.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.474 ' CG ' ' N ' ' A' ' 179' ' ' SER . 23.5 p-10 -50.02 -59.67 3.67 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.38 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.474 ' N ' ' CG ' ' A' ' 178' ' ' ASP . 28.8 p -53.73 -67.62 0.24 Allowed 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.362 -1.462 . . . . 0.0 109.135 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.443 ' N ' ' OG ' ' A' ' 179' ' ' SER . 16.4 tpt180 . . . . . 0 C--N 1.3 -1.547 0 O-C-N 121.078 -1.014 . . . . 0.0 109.615 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.534 ' H2 ' ' HG ' ' A' ' 45' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.73 0.776 . . . . 0.0 109.095 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -60.82 -51.43 69.36 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 124.269 1.985 . . . . 0.0 108.9 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -28.99 66.53 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.513 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -61.17 -36.94 81.19 Favored 'General case' 0 C--O 1.203 -1.367 0 O-C-N 118.106 -2.871 . . . . 0.0 104.478 175.274 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.464 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -54.87 -52.15 63.75 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 116.508 -2.077 . . . . 0.0 109.465 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.77 -65.67 0.65 Allowed 'General case' 0 N--CA 1.517 2.905 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 52' ' ' LEU . . . -65.38 -51.83 45.41 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.495 ' O ' ' CB ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -52.44 -37.9 57.98 Favored 'General case' 0 C--O 1.206 -1.234 0 O-C-N 120.34 -1.683 . . . . 0.0 106.9 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 57' ' ' LEU . . . -56.83 -65.08 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.228 -1.789 . . . . 0.0 108.045 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -55.34 -63.86 1.03 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.052 -1.655 . . . . 0.0 112.596 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -67.63 -20.0 65.28 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.868 -1.145 . . . . 0.0 112.352 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 52' ' ' LEU . . . -97.09 -35.7 10.72 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 121.226 1.83 . . . . 0.0 109.012 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 1.2 tt -64.76 -33.32 75.69 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 121.009 -1.057 . . . . 0.0 108.56 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.87 -43.58 44.82 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.334 -0.854 . . . . 0.0 112.865 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.41 -32.61 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 118.175 -2.828 . . . . 0.0 107.512 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.43 -25.11 61.83 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.423 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -72.03 -21.98 61.46 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 117.008 -1.877 . . . . 0.0 109.526 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 98.6 m -69.61 -53.96 16.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 118.111 -2.868 . . . . 0.0 108.616 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.488 ' C ' ' N ' ' A' ' 65' ' ' ASP . 4.1 mm? -79.16 -44.03 22.77 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.048 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.78 -18.0 4.19 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 119.932 -1.73 . . . . 0.0 106.744 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.488 ' N ' ' C ' ' A' ' 63' ' ' LEU . 18.5 t0 -87.56 -10.91 50.24 Favored 'General case' 0 N--CA 1.52 3.047 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.909 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.527 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -73.05 -157.96 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.938 0 O-C-N 120.484 -1.385 . . . . 0.0 109.04 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.527 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -109.21 -15.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.619 2.879 . . . . 0.0 113.837 176.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.45 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -74.87 -41.11 60.45 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.462 -0.774 . . . . 0.0 109.825 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.33 -75.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.318 -1.489 . . . . 0.0 109.896 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.4 ttt-85 -45.42 -35.79 3.91 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.399 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -77.88 -14.66 59.48 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 111.899 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.508 ' C ' ' N ' ' A' ' 74' ' ' GLN . . . -94.84 -47.97 2.58 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 103.538 -3.825 . . . . 0.0 103.538 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -49.23 -23.64 1.43 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.092 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.508 ' N ' ' C ' ' A' ' 72' ' ' GLY . 55.7 tp60 -50.76 -9.16 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.801 -1.545 . . . . 0.0 109.588 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.844 ' O ' ' O ' ' A' ' 76' ' ' LYS . 5.1 mmtp -150.51 85.46 1.38 Allowed 'General case' 0 N--CA 1.523 3.175 0 O-C-N 120.847 -1.158 . . . . 0.0 113.016 -177.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.844 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 23.91 164.13 0.0 OUTLIER Pre-proline 1 N--CA 1.539 4.008 0 CA-C-N 121.986 2.175 . . . . 0.0 116.19 179.668 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 78' ' ' GLN . 6.2 Cg_exo -32.36 -68.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.509 2.41 0 C-N-CA 124.255 3.304 . . . . 0.0 115.293 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 77' ' ' PRO . 91.8 mt-30 -35.98 133.1 0.47 Allowed 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.784 1.278 . . . . 0.0 111.024 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 63.04 19.28 11.55 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.716 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.9 ' O ' ' N ' ' A' ' 82' ' ' ILE . 33.8 m -90.0 83.66 6.12 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.347 -1.471 . . . . 0.0 109.341 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -38.88 52.31 0.0 OUTLIER Glycine 0 N--CA 1.508 3.464 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.569 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.9 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.4 tp -63.86 -1.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 120.514 -1.58 . . . . 0.0 108.038 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.454 ' H ' ' C ' ' A' ' 81' ' ' GLY . 17.7 mp0 -58.4 -21.92 52.14 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 120.974 -1.079 . . . . 0.0 112.199 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -85.84 -63.64 1.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 121.951 2.159 . . . . 0.0 112.061 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.471 ' C ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -48.27 -34.09 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 122.718 2.508 . . . . 0.0 107.067 172.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 90' ' ' ARG . . . -65.43 -48.36 73.02 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' ALA . 36.8 tt0 -48.22 -56.6 7.55 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 117.443 -1.265 . . . . 0.0 112.425 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.95 -44.16 23.06 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 123.553 2.888 . . . . 0.0 108.306 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.8 t -55.97 -76.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 116.071 -2.251 . . . . 0.0 108.977 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.623 ' O ' ' C ' ' A' ' 91' ' ' LYS . 45.8 ttm-85 -34.7 -58.53 0.5 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.55 0.74 . . . . 0.0 110.038 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.623 ' C ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -32.32 -49.04 0.19 Allowed 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 117.35 -1.74 . . . . 0.0 107.582 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -55.35 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 117.064 -1.446 . . . . 0.0 111.107 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.926 ' ND2' ' O ' ' A' ' 93' ' ' ASN . 0.3 OUTLIER -71.27 -3.61 21.33 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 113.864 -3.134 . . . . 0.0 108.903 -172.097 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.472 ' CG ' ' O ' ' A' ' 94' ' ' ASP . 7.6 t70 62.01 40.87 11.77 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -174.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.544 HD22 ' O ' ' A' ' 93' ' ' ASN . 0.6 OUTLIER 158.94 165.23 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.52 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 4.1 mt 150.07 163.34 0.0 OUTLIER 'General case' 1 N--CA 1.557 4.924 0 CA-C-N 121.194 1.815 . . . . 0.0 108.505 178.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -113.82 85.87 2.29 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 171.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.62 113.1 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 104.708 -2.331 . . . . 0.0 104.708 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 106' ' ' LEU . 0.7 OUTLIER -122.13 135.75 61.22 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.379 0 CA-C-N 112.808 -1.996 . . . . 0.0 112.454 -174.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.19 128.78 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 1 N-CA-C 98.679 -4.563 . . . . 0.0 98.679 171.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 162' ' ' VAL . 3.3 p -117.89 155.05 30.84 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.343 -1.473 . . . . 0.0 109.842 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.61 ' O ' ' N ' ' A' ' 104' ' ' GLN . 1.5 t70 -82.3 -175.85 5.89 Favored 'General case' 0 C--N 1.285 -2.201 1 N-CA-C 97.592 -4.966 . . . . 0.0 97.592 170.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.532 ' C ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -70.47 75.64 0.56 Allowed 'General case' 0 C--N 1.268 -2.951 0 C-N-CA 113.89 -3.124 . . . . 0.0 105.499 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.61 ' N ' ' O ' ' A' ' 102' ' ' ASP . 6.6 mm-40 -136.78 -51.54 0.68 Allowed 'General case' 0 C--O 1.214 -0.798 0 O-C-N 119.365 -2.085 . . . . 0.0 108.189 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.579 ' O ' ' CB ' ' A' ' 106' ' ' LEU . 0.5 OUTLIER 84.6 134.51 0.05 Allowed 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -178.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.66 ' H ' ' NH2' ' A' ' 107' ' ' ARG . 1.5 pp 148.41 147.4 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.66 ' NH2' ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -69.07 139.87 54.85 Favored 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 178.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -96.73 -35.8 10.87 Favored 'General case' 0 C--N 1.258 -3.387 0 N-CA-C 103.498 -2.778 . . . . 0.0 103.498 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.22 167.48 10.65 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 112.197 -2.274 . . . . 0.0 112.222 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -175.16 153.77 1.6 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.813 -1.179 . . . . 0.0 112.482 -176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.607 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 41.1 Cg_endo -90.75 -37.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 N-CA-C 106.191 -2.273 . . . . 0.0 106.191 172.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.607 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 57.0 tt0 -102.17 115.18 30.0 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.47 -47.43 38.5 Favored 'General case' 0 C--N 1.29 -1.99 0 O-C-N 121.011 -1.055 . . . . 0.0 112.084 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -64.39 -31.06 72.12 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.271 -1.518 . . . . 0.0 115.034 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.678 ' NE ' ' OE1' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -66.83 -22.21 66.01 Favored 'General case' 0 C--O 1.197 -1.687 0 O-C-N 119.35 -2.094 . . . . 0.0 107.969 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.596 ' CG2' ' N ' ' A' ' 117' ' ' GLY . 54.8 mt -35.11 -91.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.596 ' N ' ' CG2' ' A' ' 116' ' ' ILE . . . -85.81 -9.72 77.33 Favored Glycine 0 N--CA 1.502 3.078 0 O-C-N 121.025 -1.047 . . . . 0.0 114.034 -173.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.678 ' OE1' ' NE ' ' A' ' 115' ' ' ARG . 3.2 pt20 -60.5 -40.66 77.97 Favored Pre-proline 0 C--N 1.294 -1.807 0 C-N-CA 116.442 -2.103 . . . . 0.0 110.14 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 118' ' ' GLN . 8.3 Cg_endo -48.15 113.87 0.95 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.662 2.241 . . . . 0.0 112.894 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.445 ' O ' ' CD2' ' A' ' 120' ' ' PHE . 69.7 t80 -178.89 29.06 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -132.45 42.74 3.07 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.665 -0.647 . . . . 0.0 112.518 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.35 -46.94 0.1 Allowed Glycine 0 N--CA 1.51 3.59 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 75.32 20.03 2.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.917 -0.754 . . . . 0.0 111.421 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.468 ' OD2' ' CE2' ' A' ' 149' ' ' PHE . 19.7 p-10 -84.1 -2.68 57.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.213 -1.554 . . . . 0.0 108.563 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.649 ' O ' ' N ' ' A' ' 129' ' ' LEU . 12.3 pt -84.51 -23.73 7.52 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 O-C-N 120.941 -1.1 . . . . 0.0 110.684 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' A' ' 125' ' ' ILE . 71.6 mt -35.65 -46.09 0.4 Allowed 'General case' 0 N--CA 1.52 3.044 0 O-C-N 121.198 -0.938 . . . . 0.0 110.061 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -79.48 -40.95 28.54 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.351 -0.843 . . . . 0.0 110.81 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -83.1 -30.73 27.72 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.218 -1.551 . . . . 0.0 108.317 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.649 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -38.85 -34.18 0.14 Allowed 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 128' ' ' ALA . 1.6 m120 -99.42 -104.32 0.22 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -132.11 54.12 0.79 Allowed Glycine 0 N--CA 1.506 3.32 0 C-N-CA 119.801 -1.19 . . . . 0.0 115.27 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.55 142.84 30.49 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 120.515 2.157 . . . . 0.0 108.776 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.595 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 89.2 mt-10 -69.66 157.1 37.9 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 119.888 -1.758 . . . . 0.0 109.987 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 133' ' ' GLU . 20.3 m-80 -160.11 142.55 13.27 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.29 145.3 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.556 -1.34 . . . . 0.0 108.909 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.62 164.18 29.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 109.066 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.2 mt -99.6 139.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 O-C-N 120.717 -1.239 . . . . 0.0 111.029 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.441 ' OD1' ' NH1' ' A' ' 115' ' ' ARG . 8.3 t-20 -106.36 138.95 41.62 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.701 0.762 . . . . 0.0 109.709 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.576 ' N ' HH12 ' A' ' 115' ' ' ARG . 14.6 ptm180 -166.95 115.89 0.85 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.38 -1.328 . . . . 0.0 109.43 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 142' ' ' LEU . . . -162.27 109.21 0.38 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 107.729 -2.149 . . . . 0.0 107.729 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 50.4 13.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.997 -1.296 . . . . 0.0 108.405 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 140' ' ' GLY . 13.0 tp -134.34 172.5 12.8 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.52 -142.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.233 -1.542 . . . . 0.0 112.465 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -110.79 146.58 36.14 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 176.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.595 ' CB ' ' O ' ' A' ' 167' ' ' LEU . . . -150.62 142.61 23.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.957 -1.714 . . . . 0.0 107.191 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.7 tp -101.79 149.41 24.2 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 122.781 2.537 . . . . 0.0 106.89 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.593 ' NH2' ' CZ ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -144.81 150.55 37.36 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.409 1.099 . . . . 0.0 111.207 -178.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 23.9 m -113.14 143.23 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.717 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.468 ' CE2' ' OD2' ' A' ' 124' ' ' ASP . 28.2 m-85 -110.69 135.02 51.93 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.657 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -136.24 166.4 28.23 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -111.61 154.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.912 0 C-N-CA 124.306 3.338 . . . . 0.0 114.803 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 54.2 mt -118.89 127.68 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.568 ' C ' ' H ' ' A' ' 155' ' ' GLU . 83.4 m-85 -101.76 144.18 30.77 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.927 -1.108 . . . . 0.0 112.201 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 55.7 t0 -65.66 12.79 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.547 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.568 ' H ' ' C ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER 86.81 15.65 0.1 Allowed 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.98 -1.075 . . . . 0.0 108.455 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 158' ' ' LYS . 77.7 m-20 -139.27 36.16 2.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.84 -1.162 . . . . 0.0 108.303 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 59.56 3.36 0.41 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.6 mptt -85.91 130.81 34.44 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.745 ' O ' ' NE2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -85.01 125.62 32.87 Favored 'General case' 0 N--CA 1.512 2.655 0 CA-C-N 119.848 1.204 . . . . 0.0 113.571 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.08 5.49 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 O-C-N 119.926 -1.734 . . . . 0.0 113.88 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -171.26 173.6 44.81 Favored Glycine 0 N--CA 1.501 3.01 0 C-N-CA 118.18 -1.962 . . . . 0.0 112.033 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.571 ' O ' ' OG1' ' A' ' 101' ' ' THR . 1.5 t -133.21 141.99 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 O-C-N 121.799 -0.824 . . . . 0.0 110.708 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.443 ' O ' ' OG1' ' A' ' 150' ' ' THR . 9.2 t -113.25 119.64 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 120.961 -1.087 . . . . 0.0 108.179 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.461 ' H ' HG11 ' A' ' 99' ' ' VAL . . . -112.93 156.61 22.7 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 23.6 mt -152.14 109.64 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.8 137.09 13.49 Favored Glycine 0 N--CA 1.489 2.178 0 CA-C-O 122.805 1.225 . . . . 0.0 113.636 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.698 ' CD1' ' OD1' ' A' ' 93' ' ' ASN . 3.5 tp -95.45 103.27 15.13 Favored 'General case' 0 N--CA 1.514 2.763 0 CA-C-N 113.809 -1.196 . . . . 0.0 108.124 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 169' ' ' LEU . 7.1 tt0 -47.47 -60.27 2.64 Favored 'General case' 0 N--CA 1.523 3.208 0 O-C-N 124.384 1.053 . . . . 0.0 109.684 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.582 ' CB ' ' O ' ' A' ' 168' ' ' GLU . 0.2 OUTLIER 150.44 156.05 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.359 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.767 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.581 ' H ' ' CD2' ' A' ' 169' ' ' LEU . 49.9 m -163.56 -37.57 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.821 -0.549 . . . . 0.0 110.233 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.497 ' CB ' ' O ' ' A' ' 170' ' ' SER . 48.7 ttp85 149.15 146.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.496 ' CB ' ' O ' ' A' ' 171' ' ' ARG . 82.1 t 102.03 -2.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 44.7 p -74.79 -48.51 25.03 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.339 0.59 . . . . 0.0 111.422 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -75.94 -47.11 26.46 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.113 -0.992 . . . . 0.0 109.452 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.409 ' H ' ' NE2' ' A' ' 175' ' ' GLN . 4.5 mp0 -50.52 -75.44 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 177' ' ' ASN . 3.7 mm -41.81 -77.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-O 121.317 0.58 . . . . 0.0 112.456 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.438 ' N ' ' CG2' ' A' ' 176' ' ' ILE . 57.0 t-20 -40.51 -77.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 177' ' ' ASN . 3.8 m-20 -45.55 -61.08 1.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.72 -1.238 . . . . 0.0 110.724 -176.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 180' ' ' ARG . 59.9 p -50.91 -69.24 0.12 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.83 -1.169 . . . . 0.0 109.385 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.523 ' N ' ' OG ' ' A' ' 179' ' ' SER . 59.2 ttt-85 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.48 -0.763 . . . . 0.0 109.552 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.634 0.73 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 49' ' ' ARG . 55.1 t0 -65.28 -56.34 13.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 124.068 1.889 . . . . 0.0 107.303 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 46' ' ' ASP . 11.1 ttt -36.78 -56.92 0.83 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.896 -174.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -59.01 -36.44 74.94 Favored 'General case' 0 C--O 1.202 -1.405 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.089 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.484 ' C ' ' O ' ' A' ' 48' ' ' THR . 55.9 ttt-85 -35.79 -64.31 0.31 Allowed 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.044 0.926 . . . . 0.0 111.397 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -70.42 -57.73 4.49 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -81.96 -35.56 21.15 Favored Glycine 0 N--CA 1.497 2.759 0 C-N-CA 119.572 -1.299 . . . . 0.0 111.397 -176.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.521 ' CB ' ' O ' ' A' ' 48' ' ' THR . 11.3 tp -53.36 -47.66 69.24 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 120.783 2.291 . . . . 0.0 107.145 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.7 -61.76 2.01 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.767 -1.173 . . . . 0.0 109.51 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.508 ' C ' HD21 ' A' ' 54' ' ' ASN . 0.4 OUTLIER -69.3 -56.37 7.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.268 -1.52 . . . . 0.0 113.359 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 51' ' ' GLY . 19.2 mtpp -69.58 -41.34 75.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -0.884 . . . . 0.0 112.335 -175.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.86 -35.23 67.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 119.715 -1.866 . . . . 0.0 110.11 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.408 ' CD2' ' C ' ' A' ' 57' ' ' LEU . 7.2 tt -65.22 -41.31 94.54 Favored 'General case' 0 C--N 1.288 -2.106 0 O-C-N 121.057 -1.027 . . . . 0.0 111.492 177.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.88 -44.42 49.01 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.297 -1.502 . . . . 0.0 114.885 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.38 -43.63 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 118.836 -2.415 . . . . 0.0 106.607 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.405 ' CB ' ' CD1' ' A' ' 98' ' ' ILE . . . -57.9 -26.42 62.14 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -71.08 -15.84 62.55 Favored 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 118.474 -1.29 . . . . 0.0 109.009 179.005 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -64.85 -42.47 94.87 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 115.105 -2.638 . . . . 0.0 104.143 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.0 mt -87.45 -42.02 13.12 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.801 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.77 -18.47 8.47 Favored 'General case' 0 N--CA 1.522 3.17 0 O-C-N 119.989 -1.694 . . . . 0.0 107.166 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 12.2 t0 -85.49 -22.72 28.08 Favored 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.959 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.51 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -58.38 -156.69 0.0 OUTLIER Pre-proline 0 C--N 1.281 -2.397 0 O-C-N 120.699 -1.251 . . . . 0.0 111.742 -177.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -107.4 -35.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.513 2.62 0 C-N-CA 124.476 3.451 . . . . 0.0 115.396 178.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 72' ' ' GLY . 7.4 pt-20 -55.74 -30.98 62.12 Favored 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 118.735 -1.186 . . . . 0.0 109.166 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -53.08 -76.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.267 1.032 . . . . 0.0 111.034 -179.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -49.94 -33.85 18.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -83.02 -18.75 38.66 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 118.817 -1.153 . . . . 0.0 112.763 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.783 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -86.31 -46.11 5.37 Favored Glycine 0 N--CA 1.498 2.816 1 N-CA-C 101.931 -4.468 . . . . 0.0 101.931 179.098 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 75' ' ' LYS . 15.2 tp -46.6 -39.2 10.71 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 175.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.88 6.2 0.94 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.091 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.783 ' N ' ' O ' ' A' ' 72' ' ' GLY . 4.3 tmtt? -143.56 52.84 1.33 Allowed 'General case' 0 N--CA 1.512 2.668 0 O-C-N 120.265 -1.522 . . . . 0.0 114.526 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.658 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 32.95 149.55 0.0 OUTLIER Pre-proline 0 N--CA 1.524 3.24 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 178.092 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -30.79 -70.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.513 2.644 0 C-N-CA 124.875 3.717 . . . . 0.0 118.232 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -44.27 -43.45 7.34 Favored 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -101.97 9.36 40.56 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.483 -1.386 . . . . 0.0 110.15 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.5 m -88.32 125.82 34.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.42 71.97 0.96 Allowed Glycine 0 N--CA 1.489 2.182 0 O-C-N 118.699 -2.501 . . . . 0.0 109.981 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.1 tp -63.89 -4.64 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 C-N-CA 125.078 1.351 . . . . 0.0 109.585 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.641 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 55.3 tt0 -50.09 -32.7 16.44 Favored 'General case' 0 C--N 1.279 -2.468 0 O-C-N 120.851 -1.155 . . . . 0.0 110.038 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -71.64 -98.5 0.01 OUTLIER 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.595 ' C ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -16.08 -44.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.952 0 CA-C-N 121.788 2.085 . . . . 0.0 111.904 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -73.2 -48.08 38.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 119.678 -1.889 . . . . 0.0 109.601 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.645 ' N ' ' O ' ' A' ' 84' ' ' ALA . 50.9 mm-40 -49.86 -49.8 47.95 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.718 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -66.33 -56.39 11.35 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 125.529 3.786 . . . . 0.0 108.564 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 92' ' ' ARG . 1.2 t -52.96 -65.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 115.638 -2.425 . . . . 0.0 108.945 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 1.075 ' HD3' ' H ' ' A' ' 96' ' ' LEU . 1.9 tpp85 -37.97 -46.05 0.94 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.467 -1.395 . . . . 0.0 109.218 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.605 ' C ' ' O ' ' A' ' 90' ' ' ARG . 14.4 ttmm -34.48 -43.45 0.17 Allowed 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 117.592 -1.643 . . . . 0.0 106.705 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.733 ' O ' ' HD3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -39.78 -39.53 0.81 Allowed 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 117.369 -1.3 . . . . 0.0 109.06 172.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.679 ' N ' ' O ' ' A' ' 90' ' ' ARG . 1.5 m120 -156.58 -62.93 0.1 Allowed 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 124.783 3.447 . . . . 0.0 111.106 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 1.1 m-20 166.11 -13.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.085 -1.009 . . . . 0.0 111.365 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.44 60.98 1.49 Allowed 'General case' 0 N--CA 1.533 3.696 0 C-N-CA 118.422 -1.311 . . . . 0.0 113.972 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.075 ' H ' ' HD3' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -120.14 142.23 49.12 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 116.793 -1.575 . . . . 0.0 110.773 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -119.95 100.22 7.09 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 124.752 3.433 . . . . 0.0 109.409 176.241 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.405 ' CD1' ' CB ' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -95.22 111.76 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 174.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.484 HG13 ' H ' ' A' ' 109' ' ' SER . 4.5 m -112.37 124.21 68.83 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.594 0 CA-C-N 112.097 -2.319 . . . . 0.0 110.199 -173.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.5 p -96.68 128.08 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 1 N-CA-C 98.754 -4.536 . . . . 0.0 98.754 176.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' A' ' 104' ' ' GLN . 81.0 p -119.99 151.49 38.88 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.464 -175.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 104' ' ' GLN . 38.8 t0 -81.91 -174.77 5.24 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 100.498 -3.89 . . . . 0.0 100.498 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 43.1 ttm -74.81 71.22 1.97 Allowed 'General case' 0 C--N 1.268 -2.976 0 C-N-CA 114.889 -2.724 . . . . 0.0 107.837 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.615 ' O ' ' HB ' ' A' ' 101' ' ' THR . 3.5 pp0? -171.82 136.07 0.89 Allowed 'General case' 0 N--CA 1.436 -1.132 1 N-CA-C 96.844 -5.243 . . . . 0.0 96.844 176.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.659 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 16.3 t -107.72 -179.95 4.05 Favored 'General case' 0 CA--C 1.47 -2.117 0 C-N-CA 116.741 -1.983 . . . . 0.0 106.581 -176.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' A' ' 105' ' ' SER . 3.3 tp 154.04 144.84 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.61 ' NH1' ' NH2' ' A' ' 147' ' ' ARG . 1.8 mmp_? -77.02 91.51 3.64 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.416 -1.713 . . . . 0.0 108.413 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 107' ' ' ARG . 3.2 m-85 -46.25 -31.14 2.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.484 ' H ' HG13 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -124.42 171.51 9.89 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 113.811 -1.54 . . . . 0.0 113.715 -178.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.56 ' HD1' ' CG1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER 172.09 166.6 0.24 Allowed Pre-proline 0 N--CA 1.51 2.531 0 O-C-N 121.511 -0.743 . . . . 0.0 109.576 -179.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.493 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 46.5 Cg_endo -88.48 -40.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 122.768 2.312 . . . . 0.0 107.31 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 18.4 tp10 -107.96 93.98 4.83 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.97 1.367 . . . . 0.0 107.663 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' GLU . . . -31.11 -45.78 0.08 Allowed 'General case' 0 N--CA 1.503 2.195 0 CA-C-N 113.27 -1.786 . . . . 0.0 113.007 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -60.01 -33.35 71.88 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 120.395 -1.441 . . . . 0.0 113.772 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -60.9 -36.82 80.23 Favored 'General case' 0 C--O 1.203 -1.387 0 O-C-N 120.114 -1.616 . . . . 0.0 108.151 -178.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.734 ' O ' ' N ' ' A' ' 118' ' ' GLN . 79.7 mt -41.88 -84.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.075 177.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.414 ' N ' HG23 ' A' ' 116' ' ' ILE . . . -27.64 -17.1 0.0 OUTLIER Glycine 0 N--CA 1.497 2.713 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.81 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.734 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.4 mp0 -77.61 -73.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.836 0 CA-C-N 120.946 2.373 . . . . 0.0 114.205 -175.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -30.86 115.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 123.325 2.683 . . . . 0.0 115.224 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.518 ' CG ' ' O ' ' A' ' 120' ' ' PHE . 72.2 t80 171.73 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 123' ' ' ASP . 42.3 mttm -157.1 -26.13 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.41 -176.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 121' ' ' LYS . . . -41.06 -25.35 0.12 Allowed Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.041 -1.037 . . . . 0.0 110.549 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 121' ' ' LYS . 57.6 m-20 60.17 10.83 2.47 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.757 -0.849 . . . . 0.0 110.897 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -88.57 -23.64 23.07 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 128' ' ' ALA . 3.9 mt -80.68 -17.16 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.77 -1.206 . . . . 0.0 112.034 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 125' ' ' ILE . 54.4 mt -49.36 -32.97 12.46 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.556 -1.34 . . . . 0.0 107.481 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.619 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 94.8 mttt -79.65 -30.31 41.21 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.534 ' C ' ' ND2' ' A' ' 130' ' ' ASN . . . -92.44 -36.32 13.17 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 120.417 1.462 . . . . 0.0 109.262 -176.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.4 mt -41.15 -30.49 0.16 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.265 -0.897 . . . . 0.0 108.686 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.809 ' ND2' ' N ' ' A' ' 131' ' ' GLY . 0.0 OUTLIER -77.97 -95.56 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.809 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -160.88 33.22 0.39 Allowed Glycine 0 CA--C 1.562 2.978 0 O-C-N 120.594 -1.316 . . . . 0.0 111.131 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.433 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 63.6 tt0 -122.98 161.97 23.21 Favored 'General case' 0 N--CA 1.52 3.061 0 O-C-N 119.012 -2.463 . . . . 0.0 109.463 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -77.45 170.66 16.16 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.424 -0.798 . . . . 0.0 112.625 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.817 HD21 ' H ' ' A' ' 135' ' ' VAL . 0.2 OUTLIER -171.67 149.97 2.65 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.817 ' H ' HD21 ' A' ' 134' ' ' ASN . 0.9 OUTLIER -133.67 131.88 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 119.877 -1.764 . . . . 0.0 108.93 -178.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.01 177.17 9.81 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 121.068 -1.02 . . . . 0.0 110.969 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.78 134.61 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.895 -1.128 . . . . 0.0 111.297 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -98.77 120.19 38.78 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.479 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.599 ' NE ' HE22 ' A' ' 144' ' ' GLN . 6.8 ptp180 -141.41 110.02 6.04 Favored 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 117.871 -1.532 . . . . 0.0 112.062 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -156.81 105.91 0.28 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 58.44 -39.84 0.06 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.343 -0.504 . . . . 0.0 111.586 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.567 ' N ' ' O ' ' A' ' 140' ' ' GLY . 71.8 mt -72.81 -85.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.908 -1.12 . . . . 0.0 110.769 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -179.05 154.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.964 -1.094 . . . . 0.0 110.25 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.599 HE22 ' NE ' ' A' ' 139' ' ' ARG . 5.0 mm100 -46.46 136.14 7.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.092 -1.005 . . . . 0.0 108.496 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 167' ' ' LEU . . . -148.04 156.6 42.82 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tp -114.93 150.76 35.19 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 122.5 2.409 . . . . 0.0 109.621 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.61 ' NH2' ' NH1' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -150.41 129.32 12.53 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.849 1.309 . . . . 0.0 112.449 -179.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.0 m -91.91 150.15 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.317 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 46.3 m-85 -116.03 138.79 50.91 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.481 ' O ' ' N ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -138.3 138.75 23.39 Favored Pre-proline 0 C--O 1.208 -1.126 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -89.68 155.29 5.17 Favored 'Trans proline' 0 N--CA 1.515 2.782 0 C-N-CA 123.881 3.054 . . . . 0.0 115.136 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.8 mt -121.35 131.4 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.865 -0.522 . . . . 0.0 109.65 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.557 ' C ' ' H ' ' A' ' 155' ' ' GLU . 86.9 m-85 -101.29 144.15 30.48 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.022 -1.049 . . . . 0.0 111.283 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 57.0 t0 -58.86 2.49 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.768 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.557 ' H ' ' C ' ' A' ' 153' ' ' TYR . 17.9 tt0 86.24 29.62 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.825 -1.172 . . . . 0.0 108.629 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -149.36 18.6 0.94 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 71.63 9.78 6.36 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -88.55 116.79 27.04 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.707 ' N ' ' NE2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -68.69 117.54 10.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.087 -1.008 . . . . 0.0 113.332 -177.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.19 11.13 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -174.21 179.19 45.71 Favored Glycine 0 N--CA 1.504 3.208 0 C-N-CA 115.163 -3.399 . . . . 0.0 114.146 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.483 ' O ' ' OG1' ' A' ' 101' ' ' THR . 96.7 t -143.32 140.62 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-O 122.484 1.135 . . . . 0.0 111.779 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 150' ' ' THR . 63.6 t -111.36 127.39 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -115.72 153.13 31.91 Favored 'General case' 0 N--CA 1.51 2.563 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 24.5 mt -148.6 103.5 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 97' ' ' PHE . . . -114.25 140.97 16.72 Favored Glycine 0 N--CA 1.485 1.946 0 CA-C-O 123.399 1.555 . . . . 0.0 112.115 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.487 ' O ' ' CB ' ' A' ' 145' ' ' ALA . 50.6 tp -97.12 106.23 18.52 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 169' ' ' LEU . 0.5 OUTLIER -72.87 142.59 47.94 Favored 'General case' 0 N--CA 1.524 3.269 0 O-C-N 124.002 0.813 . . . . 0.0 109.414 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 168' ' ' GLU . 3.1 mt 38.9 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.777 0 O-C-N 120.039 -1.663 . . . . 0.0 113.935 175.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 171' ' ' ARG . 1.9 t 166.72 -86.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.28 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 170' ' ' SER . 0.3 OUTLIER 151.53 -28.31 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.222 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.746 178.063 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 1.8 t -95.11 30.95 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.375 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 67.5 p -77.16 -46.57 22.95 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.189 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -69.89 -52.08 27.74 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -52.79 -69.13 0.12 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.477 HD12 ' H ' ' A' ' 46' ' ' ASP . 68.6 mt -44.59 -80.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 121.552 -0.717 . . . . 0.0 112.179 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -36.45 -80.0 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -44.27 -52.53 7.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.961 -1.087 . . . . 0.0 110.76 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 180' ' ' ARG . 28.7 p -57.69 -65.5 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.894 -1.128 . . . . 0.0 109.715 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.512 ' N ' ' OG ' ' A' ' 179' ' ' SER . 48.6 ttt85 . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.083 -1.011 . . . . 0.0 109.306 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.0 p . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 121.988 0.899 . . . . 0.0 108.907 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 49' ' ' ARG . 35.0 t70 -60.92 -57.59 12.01 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.128 0.966 . . . . 0.0 110.97 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 15.5 mmm -39.4 -59.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.819 -1.175 . . . . 0.0 111.575 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.45 ' OG1' ' CD2' ' A' ' 52' ' ' LEU . 11.6 t -57.91 -31.73 67.07 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 62.3 ttt180 -42.32 -56.43 2.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.779 -1.201 . . . . 0.0 110.761 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -69.98 -63.39 1.09 Allowed 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 126.18 1.792 . . . . 0.0 114.511 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -83.14 -41.01 8.8 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 119.204 -1.474 . . . . 0.0 111.243 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.45 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -50.69 -45.61 58.35 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.596 2.698 . . . . 0.0 106.309 176.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.98 -65.94 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.995 -1.066 . . . . 0.0 110.004 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -67.14 -55.79 12.69 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.585 -1.322 . . . . 0.0 112.64 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' GLY . 55.0 mtpt -68.55 -49.6 58.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -174.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.66 -33.14 70.64 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 118.965 -2.334 . . . . 0.0 111.267 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.442 ' O ' HD22 ' A' ' 57' ' ' LEU . 4.8 tt -65.64 -37.89 87.84 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 120.505 -1.372 . . . . 0.0 110.921 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 61' ' ' ARG . . . -74.42 -47.46 33.69 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 119.201 -2.187 . . . . 0.0 115.703 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.68 -35.95 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 118.617 -2.552 . . . . 0.0 106.395 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.4 ' N ' HG21 ' A' ' 89' ' ' VAL . . . -55.96 -32.42 63.84 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -67.83 -22.58 65.15 Favored 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 117.726 -1.131 . . . . 0.0 111.093 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 m -59.77 -47.89 83.88 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 123.701 2.955 . . . . 0.0 106.429 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.1 mt -85.77 -36.49 20.09 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.314 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.73 -22.0 66.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 119.81 -1.807 . . . . 0.0 106.194 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 15.5 t0 -78.58 -11.08 59.95 Favored 'General case' 0 N--CA 1.53 3.529 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.732 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.513 ' CB ' ' CD ' ' A' ' 67' ' ' PRO 0.265 0.9 OUTLIER -71.62 -152.54 0.0 OUTLIER Pre-proline 0 C--N 1.277 -2.586 0 O-C-N 120.662 -1.274 . . . . 0.0 108.426 179.206 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.527 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 0.3 OUTLIER -103.27 -20.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 123.252 2.635 . . . . 0.0 111.542 176.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 9.6 pt-20 -58.06 -37.23 74.03 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.368 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.848 ' CG2' ' H ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -49.5 -78.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.771 0 O-C-N 120.228 -1.545 . . . . 0.0 111.403 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.848 ' H ' ' CG2' ' A' ' 69' ' ' ILE . 61.2 ttt180 -52.11 -31.3 30.13 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -174.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' CG ' ' O ' ' A' ' 71' ' ' GLN . 19.5 tt0 -84.83 -12.07 54.35 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.102 -1.439 . . . . 0.0 112.386 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -91.09 -51.35 2.62 Favored Glycine 0 N--CA 1.503 3.148 1 N-CA-C 101.72 -4.552 . . . . 0.0 101.72 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 tp -43.71 -38.87 3.35 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 112.837 -1.682 . . . . 0.0 107.403 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -64.97 -0.83 1.7 Allowed 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.384 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.894 ' O ' ' O ' ' A' ' 76' ' ' LYS . 21.1 tptp -135.44 68.59 1.45 Allowed 'General case' 0 N--CA 1.517 2.894 0 O-C-N 119.985 -1.697 . . . . 0.0 113.698 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.894 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 11.61 154.55 0.0 OUTLIER Pre-proline 0 N--CA 1.536 3.853 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -29.33 -56.05 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.4 2.733 . . . . 0.0 115.315 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -53.0 131.96 36.95 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 118.158 -1.417 . . . . 0.0 109.766 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 68.78 9.43 7.36 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.864 ' O ' ' N ' ' A' ' 82' ' ' ILE . 30.1 m -78.85 84.24 4.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.746 -1.846 . . . . 0.0 110.043 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -41.98 64.44 0.0 OUTLIER Glycine 0 N--CA 1.504 3.199 0 C-N-CA 119.721 -1.228 . . . . 0.0 111.248 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.864 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.8 tp -71.68 4.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.606 -1.526 . . . . 0.0 107.699 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.545 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 34.5 tp60 -53.99 -32.13 53.08 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.346 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.75 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -79.31 -99.75 0.03 OUTLIER 'General case' 0 C--O 1.189 -2.105 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.682 ' C ' ' O ' ' A' ' 84' ' ' ALA . 2.0 mp -9.58 -54.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.597 0 CA-C-N 122.592 2.451 . . . . 0.0 111.651 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -59.76 -53.64 55.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 119.977 -1.702 . . . . 0.0 109.477 176.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.75 ' N ' ' O ' ' A' ' 84' ' ' ALA . 87.6 tt0 -40.06 -55.02 2.17 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.319 -1.309 . . . . 0.0 112.074 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -66.11 -63.86 0.99 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 114.2 -3.0 . . . . 0.0 108.159 -177.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.529 ' C ' ' O ' ' A' ' 88' ' ' ALA . 2.1 t -45.09 -72.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 115.162 -2.615 . . . . 0.0 110.303 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 1.197 ' CG ' HD13 ' A' ' 96' ' ' LEU . 78.1 mtp180 -32.5 -49.76 0.22 Allowed 'General case' 0 N--CA 1.51 2.53 0 O-C-N 121.08 -1.012 . . . . 0.0 110.308 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.576 ' C ' ' O ' ' A' ' 90' ' ' ARG . 15.6 tptm -33.96 -36.45 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 118.291 -1.364 . . . . 0.0 108.037 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.561 ' N ' ' O ' ' A' ' 90' ' ' ARG . 60.5 mtm180 -56.01 -65.63 0.57 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 117.392 -1.29 . . . . 0.0 108.471 171.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.618 ' O ' ' CG ' ' A' ' 94' ' ' ASP . 2.1 p30 -115.9 -69.9 0.83 Allowed 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 113.869 -3.132 . . . . 0.0 109.673 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.618 ' CG ' ' O ' ' A' ' 93' ' ' ASN . 34.4 m-20 155.35 -9.49 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 121.972 0.892 . . . . 0.0 109.988 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' HD22 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -120.45 152.51 37.89 Favored 'General case' 0 C--O 1.182 -2.476 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.89 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.197 HD13 ' CG ' ' A' ' 90' ' ' ARG . 0.5 OUTLIER 142.2 152.37 0.0 OUTLIER 'General case' 1 N--CA 1.549 4.494 0 CA-C-O 115.971 -1.966 . . . . 0.0 109.379 -178.211 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 110' ' ' HIS . 0.1 OUTLIER -116.1 96.84 5.76 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 125.239 3.654 . . . . 0.0 103.754 171.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.31 107.03 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 m -131.44 143.89 39.19 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 124.2 1.953 . . . . 0.0 115.644 -171.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.416 ' O ' ' CZ ' ' A' ' 108' ' ' TYR . 38.3 t -109.62 138.34 37.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 101.901 -3.37 . . . . 0.0 101.901 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 162' ' ' VAL . 11.3 p -118.91 148.56 42.8 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 104' ' ' GLN . 32.8 t70 -80.21 -173.71 4.14 Favored 'General case' 0 C--N 1.288 -2.1 1 N-CA-C 98.992 -4.447 . . . . 0.0 98.992 171.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 ttp -74.55 71.02 1.83 Allowed 'General case' 0 C--N 1.27 -2.849 0 C-N-CA 113.978 -3.089 . . . . 0.0 105.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.2 tp-100 -145.14 -47.81 0.23 Allowed 'General case' 0 C--O 1.211 -0.965 0 O-C-N 120.31 -1.494 . . . . 0.0 110.116 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.7 t 86.9 138.0 0.05 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.4 OUTLIER 156.35 138.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.537 -3.135 . . . . 0.0 102.537 176.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.513 HH22 ' CG ' ' A' ' 138' ' ' ASN . 2.6 mpt_? -74.47 97.79 3.18 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.416 ' CZ ' ' O ' ' A' ' 100' ' ' VAL . 2.9 m-85 -49.21 -22.53 1.04 Allowed 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.504 ' N ' ' C ' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -131.58 163.44 28.04 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -175.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 97' ' ' PHE . 0.1 OUTLIER 170.96 143.99 0.11 Allowed Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 120.959 -1.088 . . . . 0.0 110.943 178.249 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.44 -44.32 6.68 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 N-CA-C 105.479 -2.546 . . . . 0.0 105.479 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -108.3 109.17 20.44 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.75 67.7 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.561 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.51 -36.94 74.58 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 119.153 -2.217 . . . . 0.0 113.179 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.488 ' NH1' ' N ' ' A' ' 140' ' ' GLY . 0.5 OUTLIER -56.5 -41.6 76.93 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.466 -2.021 . . . . 0.0 107.35 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.741 ' O ' ' N ' ' A' ' 118' ' ' GLN . 85.6 mt -40.66 -80.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.102 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 116' ' ' ILE . . . -27.58 -18.72 0.0 OUTLIER Glycine 0 N--CA 1.497 2.742 0 CA-C-O 119.451 -0.638 . . . . 0.0 113.431 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.741 ' N ' ' O ' ' A' ' 116' ' ' ILE . 5.5 mm-40 -73.43 -70.96 0.24 Allowed Pre-proline 0 N--CA 1.501 2.125 0 CA-C-N 120.942 2.371 . . . . 0.0 112.885 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.666 ' O ' ' O ' ' A' ' 118' ' ' GLN . 75.7 Cg_exo -20.11 156.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 124.05 3.166 . . . . 0.0 114.155 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.496 ' CB ' ' O ' ' A' ' 119' ' ' PRO . 28.4 t80 89.16 145.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.76 72.89 0.5 Allowed 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 117.375 -1.73 . . . . 0.0 111.358 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.665 ' O ' ' OD2' ' A' ' 123' ' ' ASP . . . -152.36 -58.23 0.01 OUTLIER Glycine 0 N--CA 1.507 3.393 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 176.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.665 ' OD2' ' O ' ' A' ' 122' ' ' GLY . 14.3 m-20 131.78 1.88 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.546 0 CA-C-N 117.653 0.727 . . . . 0.0 110.567 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -95.31 -26.7 15.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.572 -1.33 . . . . 0.0 108.683 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.486 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 0.3 OUTLIER -84.44 -18.11 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.272 -1.518 . . . . 0.0 109.928 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -50.42 -36.08 31.41 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.654 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 58.5 mttp -80.24 -33.76 37.73 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.27 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.497 ' C ' ' ND2' ' A' ' 130' ' ' ASN . . . -86.74 -28.68 22.9 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 119.788 -1.82 . . . . 0.0 110.321 -176.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.4 mt -50.11 -25.75 3.81 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.648 0.737 . . . . 0.0 109.127 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.831 ' ND2' ' N ' ' A' ' 131' ' ' GLY 0.269 0.0 OUTLIER -78.28 -97.05 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.61 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.831 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -161.75 49.15 0.35 Allowed Glycine 0 CA--C 1.549 2.218 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.46 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 93.2 mt-10 -142.31 163.46 32.79 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.178 -1.778 . . . . 0.0 109.632 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 149' ' ' PHE . 56.2 mm-40 -71.82 165.3 24.37 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.345 0.593 . . . . 0.0 112.054 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -168.69 144.62 3.55 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.49 131.12 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 120.24 -1.538 . . . . 0.0 109.848 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.28 168.18 24.02 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.327 -0.858 . . . . 0.0 109.911 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.83 139.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.85 0.833 . . . . 0.0 111.635 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.513 ' CG ' HH22 ' A' ' 107' ' ' ARG . 6.7 t-20 -101.93 130.14 48.37 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 122.231 1.015 . . . . 0.0 111.973 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -127.96 119.65 25.97 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.583 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.488 ' N ' ' NH1' ' A' ' 115' ' ' ARG . . . -156.0 167.66 33.32 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.455 ' C ' ' O ' ' A' ' 140' ' ' GLY . 73.2 m-85 -34.48 -36.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.915 -0.756 . . . . 0.0 110.973 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.512 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 47.5 mt -60.87 -67.92 0.36 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.896 -1.128 . . . . 0.0 110.076 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 142' ' ' LEU . . . 158.36 158.43 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.842 0.829 . . . . 0.0 110.718 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -44.77 137.25 4.06 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.085 0.945 . . . . 0.0 111.341 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 167' ' ' LEU . . . -151.48 150.88 30.91 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 tp -104.67 157.09 17.43 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-N 122.032 2.196 . . . . 0.0 108.896 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.418 ' HD2' HH21 ' A' ' 107' ' ' ARG . 12.4 ptt180 -146.21 153.82 41.05 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.423 1.106 . . . . 0.0 110.592 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 6.9 m -117.97 153.32 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.431 ' O ' ' OE1' ' A' ' 133' ' ' GLU . 68.7 m-85 -121.65 144.42 48.77 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.56 139.17 16.06 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -87.98 153.21 7.12 Favored 'Trans proline' 0 N--CA 1.513 2.618 0 C-N-CA 123.944 3.096 . . . . 0.0 114.88 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.5 mt -118.22 132.64 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 43.1 m-85 -103.24 148.91 25.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.947 -1.096 . . . . 0.0 113.532 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 156' ' ' ASN . 52.2 t0 -72.47 51.15 0.25 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 153' ' ' TYR . 31.1 tt0 42.98 17.28 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.231 -0.918 . . . . 0.0 111.033 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' A' ' 158' ' ' LYS . 36.2 m120 -132.99 30.77 3.95 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.885 -1.135 . . . . 0.0 109.073 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 61.82 3.64 0.94 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.8 mptt -86.19 133.76 33.83 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.657 ' O ' ' CD ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -85.72 129.09 34.92 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -175.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.13 8.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.813 0 O-C-N 118.841 -2.412 . . . . 0.0 117.305 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.28 -179.9 44.26 Favored Glycine 0 N--CA 1.515 3.915 0 C-N-CA 115.918 -3.039 . . . . 0.0 112.077 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.489 ' O ' ' OG1' ' A' ' 101' ' ' THR . 70.8 t -141.95 138.85 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.892 -1.358 . . . . 0.0 111.668 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.94 126.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.27 158.8 20.92 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 35.4 mt -151.43 101.04 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.225 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.98 131.03 10.46 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.264 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -93.14 110.35 21.85 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.46 ' CD ' ' N ' ' A' ' 169' ' ' LEU . 14.8 tm-20 -57.61 163.74 2.34 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.46 ' N ' ' CD ' ' A' ' 168' ' ' GLU . 0.8 OUTLIER -43.95 144.02 0.99 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.517 -1.365 . . . . 0.0 110.644 -179.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 171' ' ' ARG . 1.5 t -109.36 -59.16 1.94 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 120.817 -1.177 . . . . 0.0 110.718 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.466 ' CB ' ' O ' ' A' ' 170' ' ' SER . 22.9 ttm180 148.99 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.6 0 CA-C-N 113.138 -1.846 . . . . 0.0 109.305 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.52 ' O ' ' CG2' ' A' ' 176' ' ' ILE . 2.6 t -87.72 24.41 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 O-C-N 120.336 -1.478 . . . . 0.0 108.939 -177.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 65.7 p -80.09 -39.16 30.18 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -75.47 -57.87 3.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.501 -1.374 . . . . 0.0 108.542 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.548 ' CG ' ' H ' ' A' ' 176' ' ' ILE . 7.8 pt20 -50.09 -69.93 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.764 ' CG2' ' H ' ' A' ' 177' ' ' ASN . 7.7 tp -42.7 -73.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.764 ' H ' ' CG2' ' A' ' 176' ' ' ILE . 26.2 t30 -43.28 -73.17 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.919 -0.488 . . . . 0.0 110.682 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 179' ' ' SER . 65.0 t0 -46.95 -60.53 2.38 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.155 -0.966 . . . . 0.0 109.82 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 178' ' ' ASP . 81.1 p -43.78 -71.68 0.07 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.114 -0.991 . . . . 0.0 109.741 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.541 178.496 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.418 0.628 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 49' ' ' ARG . 27.3 m-20 -69.59 -56.74 6.47 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.832 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -51.73 -45.98 63.83 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.219 -1.551 . . . . 0.0 109.466 -173.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 52' ' ' LEU . 6.0 t -60.3 -32.3 71.08 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' THR . 69.2 ttt180 -42.48 -61.3 1.25 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.244 -1.535 . . . . 0.0 110.481 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.95 -59.93 2.51 Favored 'General case' 0 N--CA 1.507 2.391 0 C-N-CA 125.686 1.594 . . . . 0.0 114.496 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -79.13 -49.34 6.38 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.97 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -48.95 -44.65 40.83 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 121.273 2.537 . . . . 0.0 107.17 176.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 57' ' ' LEU . . . -48.94 -70.58 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.937 -1.102 . . . . 0.0 109.09 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -61.56 -55.72 27.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.825 0.822 . . . . 0.0 111.843 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 51' ' ' GLY . 68.4 mttt -63.32 -61.25 2.48 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -175.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.7 -27.48 68.37 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 121.947 2.158 . . . . 0.0 111.75 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 4.8 tt -66.02 -31.36 72.21 Favored 'General case' 0 C--N 1.283 -2.325 0 O-C-N 119.662 -1.899 . . . . 0.0 108.359 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.91 -46.36 14.17 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.63 -33.96 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 118.597 -2.564 . . . . 0.0 106.224 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 64' ' ' ALA . . . -59.43 -37.47 78.15 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 117.871 -1.531 . . . . 0.0 107.281 174.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.445 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 2.6 ptt180 -64.49 -15.03 60.09 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.741 -1.184 . . . . 0.0 108.397 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.7 m -67.49 -49.06 65.18 Favored 'General case' 0 CA--C 1.485 -1.526 0 C-N-CA 114.666 -2.814 . . . . 0.0 104.848 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.535 ' C ' ' N ' ' A' ' 65' ' ' ASP . 5.7 mp -84.02 -45.1 13.45 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.533 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 60' ' ' ALA . . . -50.59 -19.27 0.86 Allowed 'General case' 0 N--CA 1.524 3.269 0 CA-C-O 123.637 1.685 . . . . 0.0 106.544 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.535 ' N ' ' C ' ' A' ' 63' ' ' LEU . 17.7 t0 -88.03 -9.17 54.22 Favored 'General case' 0 N--CA 1.521 3.099 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.897 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.529 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -71.18 -154.2 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 120.46 -1.4 . . . . 0.0 110.523 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.568 ' C ' ' H ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -107.05 -32.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 123.626 2.884 . . . . 0.0 115.054 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 12.6 pt-20 -77.88 33.51 0.18 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.568 ' H ' ' C ' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -110.34 -84.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 175.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.437 ' N ' ' CG2' ' A' ' 69' ' ' ILE . 78.8 ttt180 -45.19 -32.55 1.91 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.043 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 9.5 tt0 -85.56 -16.4 39.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.928 -1.107 . . . . 0.0 111.524 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -100.17 -10.46 45.32 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 104.77 -3.332 . . . . 0.0 104.77 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -85.17 -38.56 18.87 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 102.681 -3.081 . . . . 0.0 102.681 174.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.77 -6.6 1.82 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.832 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.748 ' O ' ' O ' ' A' ' 76' ' ' LYS . 18.8 mmtt -125.89 64.19 1.21 Allowed 'General case' 0 N--CA 1.526 3.355 0 CA-C-N 120.233 1.378 . . . . 0.0 112.228 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.748 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 25.4 153.38 0.0 OUTLIER Pre-proline 0 N--CA 1.524 3.253 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -31.93 -61.77 0.15 Allowed 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 123.027 2.485 . . . . 0.0 113.851 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.501 ' H ' ' HZ1' ' A' ' 76' ' ' LYS . 7.8 tt0 -52.47 137.44 29.82 Favored 'General case' 0 C--N 1.287 -2.109 0 C-N-CA 117.81 -1.556 . . . . 0.0 108.617 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' A' ' 78' ' ' GLN . 24.1 tt0 77.23 -29.31 0.17 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.304 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.773 ' O ' ' N ' ' A' ' 82' ' ' ILE . 8.6 t -46.1 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.334 -1.479 . . . . 0.0 112.674 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -54.44 48.22 0.01 OUTLIER Glycine 0 CA--C 1.562 3.008 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.258 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.773 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.2 tp -56.78 3.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -1.207 . . . . 0.0 109.995 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.591 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 35.0 tp60 -57.74 -22.22 45.44 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.498 -1.376 . . . . 0.0 110.969 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.612 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -77.8 -72.51 0.36 Allowed 'General case' 0 N--CA 1.506 2.375 0 O-C-N 119.85 -1.781 . . . . 0.0 111.353 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.701 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -39.76 -55.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 120.518 1.508 . . . . 0.0 110.159 171.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.1 -35.7 48.68 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 119.907 -1.746 . . . . 0.0 108.807 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 84' ' ' ALA . 69.9 tt0 -65.7 -56.09 13.92 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 114.075 -1.421 . . . . 0.0 112.03 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -61.71 -65.02 0.76 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 123.819 3.009 . . . . 0.0 109.412 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -45.78 -65.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 C-N-CA 115.021 -2.671 . . . . 0.0 110.769 -175.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.547 ' N ' ' HB2' ' A' ' 94' ' ' ASP . 48.4 ttp180 -34.52 -44.58 0.2 Allowed 'General case' 0 N--CA 1.516 2.853 0 O-C-N 121.012 -1.055 . . . . 0.0 109.622 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 90' ' ' ARG . 40.8 tptt -43.92 -60.11 1.98 Allowed 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 117.395 -1.722 . . . . 0.0 107.197 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 89' ' ' VAL . 38.7 mtm180 -61.99 -65.75 0.64 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.691 -1.204 . . . . 0.0 107.996 174.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 173.2 103.88 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.76 ' C ' ' H ' ' A' ' 96' ' ' LEU . 27.3 t70 -136.71 54.11 1.88 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.037 0.922 . . . . 0.0 109.2 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.3 mt -72.96 40.21 0.09 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 124.237 1.97 . . . . 0.0 106.609 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.882 HD12 HD11 ' A' ' 167' ' ' LEU 0.326 0.6 OUTLIER -107.17 175.43 5.5 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-N 111.312 -2.676 . . . . 0.0 109.65 -178.834 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -107.12 100.64 10.1 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 101.759 -3.423 . . . . 0.0 101.759 171.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.64 131.1 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.59 HG21 ' H ' ' A' ' 164' ' ' ALA . 0.9 OUTLIER -133.32 157.91 42.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 124.79 2.233 . . . . 0.0 113.525 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.15 125.23 38.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 1 N-CA-C 99.043 -4.428 . . . . 0.0 99.043 173.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.9 p -125.06 157.83 35.28 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 120.673 -1.267 . . . . 0.0 109.976 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -83.58 -175.17 5.69 Favored 'General case' 0 C--N 1.297 -1.707 1 N-CA-C 97.512 -4.995 . . . . 0.0 97.512 170.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -76.5 85.06 3.21 Favored 'General case' 0 C--N 1.267 -3.009 0 C-N-CA 114.877 -2.729 . . . . 0.0 105.312 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.524 ' O ' ' CB ' ' A' ' 105' ' ' SER . 3.0 tm0? -153.02 -42.25 0.1 Allowed 'General case' 0 CA--C 1.549 0.928 0 O-C-N 120.751 -1.218 . . . . 0.0 109.444 -176.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.586 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.1 t 83.23 138.32 0.06 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.767 ' H ' HH21 ' A' ' 107' ' ' ARG . 0.8 OUTLIER 154.15 134.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 177.201 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.767 HH21 ' H ' ' A' ' 106' ' ' LEU . 2.6 mmp_? -71.62 94.42 1.33 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 116.842 -1.943 . . . . 0.0 106.717 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -50.83 -37.08 40.84 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.12 167.55 11.38 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.024 -1.443 . . . . 0.0 112.441 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.593 ' HD1' ' C ' ' A' ' 112' ' ' GLU . 11.9 p80 178.51 151.19 0.45 Allowed Pre-proline 0 N--CA 1.496 1.854 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.204 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.64 -28.3 1.8 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 N-CA-C 107.397 -1.809 . . . . 0.0 107.397 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.593 ' C ' ' HD1' ' A' ' 110' ' ' HIS . 79.2 mm-40 -119.91 138.27 53.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.42 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.52 -50.38 38.34 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.022 -1.049 . . . . 0.0 113.555 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.15 -38.64 71.13 Favored 'General case' 0 CA--C 1.571 1.775 0 O-C-N 120.152 -1.593 . . . . 0.0 114.936 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.61 ' NH1' ' ND2' ' A' ' 138' ' ' ASN . 0.5 OUTLIER -57.87 -45.25 86.61 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.042 -2.286 . . . . 0.0 109.201 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.558 ' CG2' ' N ' ' A' ' 117' ' ' GLY . 89.6 mt -29.95 -91.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.558 ' N ' ' CG2' ' A' ' 116' ' ' ILE . . . -45.31 -16.78 0.1 Allowed Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.455 -0.778 . . . . 0.0 114.452 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -59.47 -65.7 1.89 Allowed Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 120.601 2.2 . . . . 0.0 112.439 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 116' ' ' ILE . 1.1 Cg_endo -39.41 103.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 123.487 2.791 . . . . 0.0 113.597 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 122' ' ' GLY . 35.4 t80 -162.43 141.51 9.18 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt 47.7 11.34 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.195 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 120' ' ' PHE . . . -60.45 -15.01 37.24 Favored Glycine 0 N--CA 1.505 3.282 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 122' ' ' GLY . 11.9 t70 71.99 -2.27 2.59 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.11 -1.229 . . . . 0.0 111.49 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.599 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 10.5 p-10 -92.56 -45.88 7.89 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.1 -15.84 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.548 -1.345 . . . . 0.0 110.095 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -55.24 -29.66 58.48 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.355 -1.466 . . . . 0.0 108.148 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 130' ' ' ASN . 68.5 mttm -79.91 -24.99 40.73 Favored 'General case' 0 C--O 1.194 -1.818 0 O-C-N 121.964 -0.46 . . . . 0.0 110.343 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.684 ' O ' ' ND2' ' A' ' 130' ' ' ASN . . . -90.09 -33.21 16.37 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 119.792 -1.818 . . . . 0.0 110.012 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 mt -48.98 -29.53 4.93 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.064 0.935 . . . . 0.0 109.009 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 1.053 ' ND2' ' H ' ' A' ' 131' ' ' GLY . 0.0 OUTLIER -56.9 -78.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 109.768 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 1.053 ' H ' ' ND2' ' A' ' 130' ' ' ASN . . . 167.34 35.05 0.02 OUTLIER Glycine 0 CA--C 1.539 1.578 0 C-N-CA 128.808 3.099 . . . . 0.0 107.586 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.606 ' H ' HD22 ' A' ' 130' ' ' ASN . 93.6 mt-10 -141.03 162.69 34.9 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 119.605 1.702 . . . . 0.0 109.767 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -76.08 165.68 24.58 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.621 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -168.98 153.33 5.59 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.45 136.44 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.016 -1.052 . . . . 0.0 110.556 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.57 172.16 13.37 Favored 'General case' 0 N--CA 1.518 2.96 0 O-C-N 120.528 -1.357 . . . . 0.0 109.682 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.6 136.0 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 120.641 -1.287 . . . . 0.0 110.349 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.61 ' ND2' ' NH1' ' A' ' 115' ' ' ARG . 3.8 t30 -103.98 133.61 48.65 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.462 -0.774 . . . . 0.0 109.005 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -132.75 100.91 5.08 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.676 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -116.47 164.13 12.35 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -44.35 -13.89 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.34 -1.094 . . . . 0.0 110.494 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -75.53 -72.37 0.31 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.984 -1.073 . . . . 0.0 108.7 -179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 144' ' ' GLN . . . 176.43 149.61 0.13 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.428 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' ALA . 97.2 mt-30 -35.06 152.55 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.481 0.658 . . . . 0.0 110.139 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.602 ' CB ' ' O ' ' A' ' 167' ' ' LEU . . . -157.2 152.4 26.17 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 117.357 -1.306 . . . . 0.0 107.855 -176.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.8 tp -116.37 144.23 44.54 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 123.149 2.704 . . . . 0.0 109.684 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -129.44 147.62 51.27 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.338 1.066 . . . . 0.0 110.97 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.3 m -114.05 158.35 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -132.88 138.96 47.18 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.67 138.76 29.03 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -86.45 155.31 9.24 Favored 'Trans proline' 0 C--N 1.295 -2.247 0 C-N-CA 122.555 2.17 . . . . 0.0 113.758 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 62.6 mt -118.2 135.44 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . 0.304 65.2 m-85 -106.24 151.77 24.36 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 155' ' ' GLU . 63.0 t0 -78.46 164.35 24.83 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.573 ' N ' ' OD1' ' A' ' 154' ' ' ASP . 18.5 tt0 -47.95 -9.31 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.241 -1.383 . . . . 0.0 112.976 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 154' ' ' ASP . 16.7 m120 -121.83 49.62 1.53 Allowed 'General case' 0 N--CA 1.518 2.971 0 O-C-N 120.348 -1.47 . . . . 0.0 114.268 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 57.39 9.32 0.73 Allowed 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.998 -1.064 . . . . 0.0 110.443 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -83.69 128.79 34.79 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.743 HE21 ' N ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -74.96 126.72 31.61 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.182 -0.949 . . . . 0.0 112.662 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.73 12.43 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.601 0 O-C-N 119.028 -2.295 . . . . 0.0 116.231 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.11 174.51 46.83 Favored Glycine 0 N--CA 1.501 3.025 0 C-N-CA 115.774 -3.108 . . . . 0.0 112.002 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.9 t -137.55 143.51 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.576 1.179 . . . . 0.0 113.215 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 40.6 t -109.6 129.2 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.59 ' H ' HG21 ' A' ' 99' ' ' VAL . . . -127.01 157.53 39.35 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.231 -0.918 . . . . 0.0 108.845 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 147' ' ' ARG . 16.3 mt -151.12 99.99 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.03 118.14 5.34 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.918 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.882 HD11 HD12 ' A' ' 96' ' ' LEU . 1.8 tp -72.38 120.23 17.71 Favored 'General case' 0 C--O 1.193 -1.914 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.07 -30.11 63.45 Favored 'General case' 1 N--CA 1.542 4.163 0 CA-C-O 123.11 1.433 . . . . 0.0 110.37 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -170.78 176.95 4.01 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 113.67 -1.604 . . . . 0.0 114.399 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 1.004 ' O ' ' N ' ' A' ' 172' ' ' VAL . 2.9 t -179.76 64.05 0.01 OUTLIER 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.115 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 14.55 -32.3 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 125.2 1.4 . . . . 0.0 114.624 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 1.004 ' N ' ' O ' ' A' ' 170' ' ' SER . 3.0 t -93.18 36.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.197 -1.564 . . . . 0.0 108.24 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 82.2 p -84.85 -35.36 22.29 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -77.42 -51.56 10.59 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -54.43 -69.1 0.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.047 0.927 . . . . 0.0 110.058 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.805 ' CG2' ' H ' ' A' ' 177' ' ' ASN . 9.8 tp -41.57 -72.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 O-C-N 121.071 -1.018 . . . . 0.0 112.042 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.805 ' H ' ' CG2' ' A' ' 176' ' ' ILE . 29.8 m120 -44.16 -77.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.403 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -48.38 -58.4 4.66 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.454 -1.404 . . . . 0.0 112.091 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.471 ' OG ' ' N ' ' A' ' 180' ' ' ARG . 56.1 p -44.75 -66.35 0.41 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.747 -1.22 . . . . 0.0 111.191 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.471 ' N ' ' OG ' ' A' ' 179' ' ' SER . 67.0 ttt180 . . . . . 0 C--N 1.302 -1.477 0 O-C-N 121.025 -1.047 . . . . 0.0 109.874 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 46' ' ' ASP . 74.4 p . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.751 0.786 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 47' ' ' MET . 69.5 m-20 -74.75 -65.39 0.87 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.529 1.157 . . . . 0.0 109.967 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 46' ' ' ASP . 26.4 ttt -41.76 -54.76 3.23 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 122.267 1.032 . . . . 0.0 111.146 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.539 ' OG1' ' HB3' ' A' ' 52' ' ' LEU . 13.5 t -58.77 -35.94 73.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.273 1.035 . . . . 0.0 110.158 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.447 ' N ' HG23 ' A' ' 48' ' ' THR . 67.1 ttp85 -39.04 -52.66 1.83 Allowed 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 122.253 1.025 . . . . 0.0 111.855 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -86.06 -55.44 3.94 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -78.2 -45.76 9.81 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.787 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.539 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -56.64 -41.82 77.82 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 120.894 2.347 . . . . 0.0 105.068 176.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 49' ' ' ARG . . . -51.05 -59.39 4.22 Favored 'General case' 0 C--O 1.206 -1.184 0 C-N-CA 117.613 -1.635 . . . . 0.0 107.86 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -74.85 -68.36 0.55 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.457 -1.402 . . . . 0.0 112.457 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 51' ' ' GLY . 25.7 mtpp -47.75 -41.56 23.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 112.703 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.593 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -86.62 -27.28 23.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 119.103 -2.248 . . . . 0.0 110.246 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.7 tp -62.93 -46.4 87.97 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 120.187 -1.571 . . . . 0.0 107.711 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.02 77.3 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 t -76.44 -30.72 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 119.378 -2.076 . . . . 0.0 107.261 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.973 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -64.44 -28.55 69.75 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 176.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -78.85 -16.89 56.49 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.398 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.0 m -72.29 -43.61 63.97 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 115.499 -2.48 . . . . 0.0 107.149 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.808 HD12 ' HB1' ' A' ' 84' ' ' ALA . 3.8 mm? -85.71 -36.18 20.37 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.313 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.846 ' O ' HG21 ' A' ' 69' ' ' ILE . . . -62.21 -13.66 30.01 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.492 ' N ' ' C ' ' A' ' 63' ' ' LEU . 16.3 t0 -94.52 -11.35 29.77 Favored 'General case' 0 N--CA 1.518 2.975 0 CA-C-N 112.652 -2.067 . . . . 0.0 112.07 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.522 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -66.38 -152.83 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.97 0 O-C-N 120.054 -1.653 . . . . 0.0 109.695 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -104.11 -38.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.478 2.119 . . . . 0.0 113.582 178.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 7.1 pt-20 -48.32 -29.65 4.12 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.763 1.268 . . . . 0.0 108.104 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.846 HG21 ' O ' ' A' ' 64' ' ' ALA . 42.9 mm -56.44 -78.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.028 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' ILE . 45.2 ttt85 -46.19 -31.23 2.32 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -79.16 -14.24 59.22 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.683 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.703 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -83.69 -43.82 7.11 Favored Glycine 0 N--CA 1.487 2.085 1 N-CA-C 101.966 -4.454 . . . . 0.0 101.966 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 152' ' ' ILE . 7.5 mp -49.31 -39.9 32.96 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -66.35 -2.87 4.95 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 72' ' ' GLY . 20.5 tptt -122.73 -158.15 0.77 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.238 -1.539 . . . . 0.0 108.306 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.458 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -133.69 168.78 16.18 Favored Pre-proline 0 CA--C 1.569 1.684 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -38.59 -73.53 0.04 OUTLIER 'Trans proline' 0 N--CA 1.521 3.12 0 C-N-CA 124.927 3.751 . . . . 0.0 117.996 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.523 ' H ' ' CD ' ' A' ' 78' ' ' GLN . 25.2 mp0 -56.08 -14.25 2.52 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -174.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.458 ' OE1' ' NZ ' ' A' ' 76' ' ' LYS . 44.3 tt0 -121.74 2.76 10.07 Favored 'General case' 0 N--CA 1.514 2.757 0 O-C-N 120.61 -1.306 . . . . 0.0 110.78 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 40.4 t -66.97 -154.78 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.889 -1.132 . . . . 0.0 109.218 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.492 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . -149.58 64.95 0.39 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.532 ' CD1' ' H ' ' A' ' 100' ' ' VAL . 3.7 tp -76.22 7.41 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.737 -0.86 . . . . 0.0 110.455 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.701 ' O ' ' HB3' ' A' ' 86' ' ' ALA . 13.5 pt20 -63.48 -26.78 68.88 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 120.329 -1.482 . . . . 0.0 112.837 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.893 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -83.12 -60.63 2.09 Favored 'General case' 0 C--O 1.202 -1.442 0 O-C-N 118.861 -2.399 . . . . 0.0 108.622 -176.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.994 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -41.51 -43.88 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.249 0 CA-C-N 123.517 2.871 . . . . 0.0 105.756 172.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 83' ' ' GLN . . . -44.25 -25.07 0.2 Allowed 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 121.498 1.954 . . . . 0.0 108.143 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.893 ' N ' ' O ' ' A' ' 84' ' ' ALA . 53.6 mt-10 -52.21 -33.89 43.1 Favored 'General case' 0 N--CA 1.536 3.849 0 N-CA-C 102.352 -3.203 . . . . 0.0 102.352 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.876 ' N ' ' O ' ' A' ' 85' ' ' ILE . . . -68.82 -29.81 68.22 Favored 'General case' 0 N--CA 1.52 3.028 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.609 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.678 ' N ' ' O ' ' A' ' 86' ' ' ALA . 1.8 t -55.0 -55.8 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 O-C-N 120.525 -1.359 . . . . 0.0 107.656 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -56.22 -59.9 4.27 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.66 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -54.89 -49.98 69.87 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.024 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -57.8 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.949 -1.094 . . . . 0.0 110.475 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.33 27.4 0.93 Allowed 'General case' 0 N--CA 1.513 2.676 0 CA-C-N 122.258 2.299 . . . . 0.0 113.029 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.9 t70 70.74 -1.34 2.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.973 -1.079 . . . . 0.0 108.742 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 1.3 pp -146.06 162.36 38.07 Favored 'General case' 0 N--CA 1.519 2.996 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.7 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.501 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER 152.91 170.69 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.361 0 CA-C-O 117.513 -1.232 . . . . 0.0 108.245 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.664 ' CD1' ' CD2' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -119.75 82.8 1.94 Allowed 'General case' 0 C--O 1.215 -0.752 1 N-CA-C 96.318 -5.438 . . . . 0.0 96.318 166.605 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.973 HD11 ' HB2' ' A' ' 60' ' ' ALA . 1.5 tt -87.94 110.46 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.64 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 5.1 p -120.56 137.69 53.51 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.975 0 CA-C-N 112.173 -2.285 . . . . 0.0 113.424 -172.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.532 ' H ' ' CD1' ' A' ' 82' ' ' ILE . 38.9 t -113.98 140.18 35.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 1 N-CA-C 97.953 -4.832 . . . . 0.0 97.953 171.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 102' ' ' ASP . 38.0 p -122.06 145.28 48.3 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 120.767 1.621 . . . . 0.0 111.192 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 104' ' ' GLN . 66.3 t0 -74.18 -168.07 0.59 Allowed 'General case' 0 C--N 1.319 -0.746 1 N-CA-C 99.914 -4.106 . . . . 0.0 99.914 168.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.587 ' O ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -78.64 66.1 4.07 Favored 'General case' 0 C--N 1.274 -2.694 0 C-N-CA 115.207 -2.597 . . . . 0.0 104.985 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 102' ' ' ASP . 5.1 tm0? -170.89 107.93 0.29 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 101.179 -3.638 . . . . 0.0 101.179 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.738 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 29.1 t -61.67 161.17 10.33 Favored 'General case' 0 CA--C 1.462 -2.408 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.693 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.738 ' HB2' ' O ' ' A' ' 105' ' ' SER . 12.1 tp 153.5 142.27 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 116' ' ' ILE . 99.1 mtt180 -75.68 109.44 9.27 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 101' ' ' THR . 4.6 m-30 -70.94 -34.68 71.73 Favored 'General case' 0 C--N 1.262 -3.216 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 1.1 t -119.84 157.75 28.03 Favored 'General case' 0 C--O 1.196 -1.746 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.657 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.664 ' CD2' ' CD1' ' A' ' 97' ' ' PHE . 47.1 t-80 169.86 140.12 0.07 OUTLIER Pre-proline 0 N--CA 1.524 3.228 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.37 -55.86 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 CA-C-N 120.561 1.236 . . . . 0.0 109.136 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.529 ' OE1' ' NH2' ' A' ' 115' ' ' ARG . 34.0 mt-10 -79.75 142.48 35.36 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.46 -42.91 24.3 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.548 -0.72 . . . . 0.0 112.638 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -60.87 -35.64 77.13 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.529 ' NH2' ' OE1' ' A' ' 112' ' ' GLU . 3.8 tpp180 -61.96 -31.72 72.08 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 119.39 -2.069 . . . . 0.0 108.151 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.657 ' O ' ' N ' ' A' ' 118' ' ' GLN . 55.6 mt -51.69 -82.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.242 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.595 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -33.96 -11.69 0.0 OUTLIER Glycine 0 N--CA 1.498 2.793 0 CA-C-O 119.156 -0.802 . . . . 0.0 113.97 -175.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 116' ' ' ILE . 6.2 mm-40 -80.79 -70.5 0.16 Allowed Pre-proline 0 N--CA 1.503 2.223 0 CA-C-N 121.383 2.591 . . . . 0.0 113.369 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 17.4 Cg_exo -29.91 117.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 124.196 3.264 . . . . 0.0 114.651 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 122' ' ' GLY . 85.3 t80 -175.37 149.86 1.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 123' ' ' ASP . 27.3 ttpt 48.95 11.32 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.327 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 120' ' ' PHE . . . -46.28 -12.54 0.06 OUTLIER Glycine 0 N--CA 1.501 2.967 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 121' ' ' LYS . 4.2 m-20 62.71 -11.88 0.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.585 -0.95 . . . . 0.0 111.232 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 122' ' ' GLY . 49.8 m-20 -75.34 -29.4 59.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' LEU . 16.3 pt -78.03 -34.24 19.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.654 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -38.5 -32.62 0.08 Allowed 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.536 -0.727 . . . . 0.0 110.289 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -90.55 -40.23 12.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.157 -0.965 . . . . 0.0 109.571 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -78.74 -48.15 15.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.971 -1.08 . . . . 0.0 109.192 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -36.44 -42.03 0.32 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 123.171 1.463 . . . . 0.0 108.053 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 -102.44 22.04 14.14 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.078 -1.419 . . . . 0.0 113.388 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 132' ' ' GLU . . . 87.16 100.87 0.84 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 131' ' ' GLY . 4.1 tp10 167.75 140.47 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.069 0 CA-C-N 113.551 -1.325 . . . . 0.0 113.394 175.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -81.77 142.29 32.74 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.923 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 4.0 t-20 -162.55 144.9 10.84 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.248 -1.533 . . . . 0.0 110.592 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 147' ' ' ARG . 8.6 p -135.58 151.86 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 O-C-N 119.774 -1.829 . . . . 0.0 108.29 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -159.48 162.7 35.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.82 -1.175 . . . . 0.0 109.372 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.59 141.71 16.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 122.214 1.007 . . . . 0.0 112.49 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -106.9 159.63 16.11 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -147.97 103.04 3.45 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.082 -1.636 . . . . 0.0 110.376 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.511 ' CA ' ' HB3' ' A' ' 143' ' ' ALA . . . -143.15 161.52 27.59 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.311 -2.316 . . . . 0.0 107.311 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.582 ' C ' ' H ' ' A' ' 143' ' ' ALA . 84.0 m-85 -44.13 118.77 1.58 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.216 -1.167 . . . . 0.0 109.675 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER 62.7 -11.17 0.08 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.423 -0.798 . . . . 0.0 109.024 -179.06 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 141' ' ' PHE . . . -81.31 -10.9 59.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.771 -1.206 . . . . 0.0 112.772 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 143' ' ' ALA . 93.0 mt-30 -40.9 114.44 0.48 Allowed 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.92 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -158.85 160.15 35.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.111 -1.618 . . . . 0.0 111.238 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 tp -105.19 160.81 14.79 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.79 -1.194 . . . . 0.0 108.285 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.781 ' O ' HG23 ' A' ' 135' ' ' VAL . 12.4 ptt180 -150.01 146.21 26.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.766 -1.209 . . . . 0.0 109.294 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 m -105.53 167.65 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 CA-C-O 122.008 0.908 . . . . 0.0 109.152 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 32.6 m-85 -134.98 138.63 44.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 p -144.48 157.56 55.67 Favored Pre-proline 0 C--N 1.308 -1.238 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -102.33 152.6 0.29 Allowed 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.369 2.713 . . . . 0.0 114.983 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.544 HG21 HD21 ' A' ' 73' ' ' LEU . 83.2 mt -113.48 134.94 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.461 ' C ' ' H ' ' A' ' 155' ' ' GLU . 66.6 m-85 -102.04 142.45 33.3 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.455 -0.778 . . . . 0.0 111.884 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 26.7 t70 -58.87 -2.41 0.23 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.586 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 154' ' ' ASP . 56.1 tt0 98.25 21.52 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -140.78 19.13 2.33 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 15.3 t60 69.35 11.47 8.11 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -96.1 116.76 29.47 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.668 ' NE2' ' N ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -65.08 122.58 17.37 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.445 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.5 pp -137.62 1.89 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 O-C-N 120.841 -1.162 . . . . 0.0 113.541 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.419 ' N ' HD12 ' A' ' 160' ' ' ILE . . . -166.75 176.08 41.91 Favored Glycine 0 N--CA 1.507 3.4 0 C-N-CA 119.243 -1.456 . . . . 0.0 110.587 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.18 145.92 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 O-C-N 121.175 -1.191 . . . . 0.0 112.939 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.65 116.07 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.64 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -113.07 157.51 21.5 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.593 HG21 ' HB1' ' A' ' 56' ' ' ALA . 48.9 mt -146.4 107.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.44 ' HA3' ' CD2' ' A' ' 97' ' ' PHE . . . -108.84 122.64 6.65 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.54 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.92 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 27.1 tp -85.61 108.95 18.23 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 169' ' ' LEU . 10.8 tm-20 -53.94 -36.37 62.72 Favored 'General case' 0 N--CA 1.518 2.93 0 O-C-N 123.786 0.679 . . . . 0.0 110.239 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.48 ' CB ' ' O ' ' A' ' 168' ' ' GLU . 4.4 tp . . . . . 0 N--CA 1.51 2.553 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.794 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' MET . 76.2 m-20 -75.61 -59.02 2.93 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.41 1.1 . . . . 0.0 108.648 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.499 ' C ' ' SD ' ' A' ' 47' ' ' MET . 0.9 OUTLIER -36.97 -62.27 0.5 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 123.066 1.412 . . . . 0.0 109.666 -177.538 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.502 ' O ' ' HB3' ' A' ' 52' ' ' LEU . 5.9 t -54.78 -41.37 70.46 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.092 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' THR . 50.7 ttp180 -35.57 -51.22 0.63 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.661 -1.274 . . . . 0.0 112.57 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -91.55 -53.77 4.18 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -71.96 -47.3 32.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -176.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' A' ' 167' ' ' LEU . 0.9 OUTLIER -56.99 -44.06 82.32 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 175.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 49' ' ' ARG . . . -50.09 -55.8 13.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 118.081 -1.447 . . . . 0.0 109.932 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -83.53 -62.92 1.46 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.399 -1.438 . . . . 0.0 112.989 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' GLY . 5.3 ptmt -52.55 -34.69 51.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.456 -0.778 . . . . 0.0 111.217 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -84.89 -31.62 23.6 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 119.443 -2.036 . . . . 0.0 109.176 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.8 tt -47.24 -46.12 24.2 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.35 -1.469 . . . . 0.0 108.165 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 61' ' ' ARG . . . -67.86 -41.3 83.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.685 -1.884 . . . . 0.0 110.208 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.987 HG13 ' HB1' ' A' ' 88' ' ' ALA . 25.0 t -52.73 -45.89 49.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 O-C-N 120.065 -1.647 . . . . 0.0 107.504 177.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.843 ' HB2' HD11 ' A' ' 165' ' ' ILE . . . -51.77 -24.13 5.53 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -73.59 -37.15 65.56 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 115.799 -2.36 . . . . 0.0 111.647 -178.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 m -57.71 -29.21 64.52 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 119.58 -1.95 . . . . 0.0 107.595 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.767 ' HB3' HD12 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -74.56 -26.13 59.74 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 117.59 -1.644 . . . . 0.0 108.051 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.65 -12.28 59.51 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-O 117.668 -1.158 . . . . 0.0 110.952 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.456 ' OD2' ' NH1' ' A' ' 61' ' ' ARG . 3.9 m-20 -103.96 -24.8 13.21 Favored 'General case' 0 N--CA 1.51 2.555 0 CA-C-N 123.367 2.803 . . . . 0.0 113.853 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.534 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -76.61 -161.1 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 119.793 -1.817 . . . . 0.0 111.91 -175.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 68' ' ' GLU . 6.6 Cg_endo -109.92 -38.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 124.049 3.166 . . . . 0.0 114.172 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.609 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 2.5 pt-20 -52.01 -33.16 37.14 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.401 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.631 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.3 mp -58.71 -73.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.909 0.861 . . . . 0.0 111.744 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -48.46 -37.0 16.16 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -75.68 -14.08 60.34 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -82.01 -39.27 11.8 Favored Glycine 0 CA--C 1.486 -1.761 0 N-CA-C 103.324 -3.91 . . . . 0.0 103.324 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.81 -29.62 62.93 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -64.18 -3.78 3.05 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' CG ' ' H ' ' A' ' 76' ' ' LYS . 26.5 tptt -134.97 -150.58 0.39 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 78' ' ' GLN . 2.1 pttt -122.41 157.95 57.41 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 123.943 0.897 . . . . 0.0 109.119 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.669 ' O ' ' CE2' ' A' ' 108' ' ' TYR . 7.3 Cg_exo -29.0 -16.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.516 2.821 1 C-N-CA 125.551 4.167 . . . . 0.0 118.281 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 76' ' ' LYS . 83.0 mt-30 -90.37 1.66 56.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.191 -2.193 . . . . 0.0 108.918 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -132.68 2.3 3.74 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.659 ' N ' ' OH ' ' A' ' 108' ' ' TYR . 2.5 m -68.57 -156.75 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.146 -2.221 . . . . 0.0 108.863 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 83' ' ' GLN . . . -150.11 58.11 0.45 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.552 HD11 HD11 ' A' ' 85' ' ' ILE . 2.2 tp -49.55 -7.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 C-N-CA 123.203 0.601 . . . . 0.0 110.766 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 81' ' ' GLY . 86.6 mt-30 -47.38 -43.67 23.58 Favored 'General case' 0 C--N 1.269 -2.908 0 O-C-N 120.046 -1.659 . . . . 0.0 114.397 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.823 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -87.88 -53.34 4.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 119.365 -2.085 . . . . 0.0 110.122 -173.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.892 ' O ' ' N ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -46.32 -51.64 3.98 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.707 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 172.007 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.785 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -44.41 -21.93 0.06 Allowed 'General case' 0 N--CA 1.507 2.399 0 O-C-N 119.237 -2.164 . . . . 0.0 107.225 174.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.823 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.5 tt0 -48.47 -28.83 3.56 Favored 'General case' 1 N--CA 1.544 4.245 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 171.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.987 ' HB1' HG13 ' A' ' 59' ' ' VAL . . . -71.28 -28.05 63.86 Favored 'General case' 0 N--CA 1.515 2.778 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.698 172.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.785 ' N ' ' O ' ' A' ' 86' ' ' ALA . 33.0 m -65.69 -43.95 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.255 0 C-N-CA 116.241 -2.184 . . . . 0.0 110.346 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.512 ' N ' HG23 ' A' ' 89' ' ' VAL . 19.6 mtp-105 -56.19 -52.08 65.71 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -58.19 -30.69 66.64 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.383 -1.327 . . . . 0.0 108.63 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.437 ' NH2' ' ND2' ' A' ' 93' ' ' ASN . 6.5 mmm180 -76.33 -93.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.193 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -144.44 31.12 1.21 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.679 -1.263 . . . . 0.0 111.724 -177.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 60.7 24.07 13.9 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.292 -1.505 . . . . 0.0 109.414 -175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 96' ' ' LEU . 2.7 pp -167.13 160.08 13.55 Favored 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.575 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.418 ' CD2' ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER 164.62 176.77 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.934 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -177.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 109' ' ' SER . 58.5 m-85 -136.75 80.51 1.82 Allowed 'General case' 0 C--O 1.214 -0.774 1 N-CA-C 99.295 -4.335 . . . . 0.0 99.295 170.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.62 ' CD1' HG12 ' A' ' 59' ' ' VAL . 11.7 tt -100.06 118.36 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -177.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.819 ' CG1' ' H ' ' A' ' 164' ' ' ALA . 10.9 p -98.7 131.93 44.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 CA-C-O 124.587 2.137 . . . . 0.0 111.067 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.686 HG22 HD22 ' A' ' 63' ' ' LEU . 97.1 t -132.9 109.95 14.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 1 N-CA-C 98.02 -4.807 . . . . 0.0 98.02 175.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.554 ' HG1' ' H ' ' A' ' 104' ' ' GLN . 1.2 t -130.6 170.69 13.94 Favored 'General case' 0 CA--C 1.461 -2.445 0 CA-C-O 122.386 1.088 . . . . 0.0 108.319 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 104' ' ' GLN . 44.4 t0 -78.9 -174.7 4.12 Favored 'General case' 0 C--N 1.269 -2.906 1 N-CA-C 99.458 -4.275 . . . . 0.0 99.458 169.053 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.89 72.35 0.09 Allowed 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 113.471 -3.292 . . . . 0.0 104.78 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.684 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.5 tp-100 -140.7 -52.24 0.47 Allowed 'General case' 0 C--N 1.364 1.198 0 O-C-N 119.453 -2.029 . . . . 0.0 111.057 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 104' ' ' GLN . 2.1 t 97.38 137.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.372 1.069 . . . . 0.0 108.794 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER 157.44 95.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 178.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.591 ' NH2' HH11 ' A' ' 147' ' ' ARG . 1.4 mtt180 -39.43 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 112.524 -2.125 . . . . 0.0 110.167 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.669 ' CE2' ' O ' ' A' ' 77' ' ' PRO . 1.1 t80 -57.22 -26.18 60.27 Favored 'General case' 0 C--N 1.284 -2.245 0 O-C-N 121.02 -1.05 . . . . 0.0 108.471 -177.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -113.61 148.44 36.21 Favored 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.961 ' ND1' HD11 ' A' ' 116' ' ' ILE 0.256 45.1 p-80 -174.44 149.68 1.39 Allowed Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 118.0 -1.48 . . . . 0.0 113.349 -176.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.505 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 32.9 Cg_endo -91.09 -22.35 0.59 Allowed 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.463 2.109 . . . . 0.0 106.801 171.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.505 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 38.8 tt0 -111.44 136.62 50.34 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.02 -42.35 48.18 Favored 'General case' 0 C--N 1.289 -2.054 0 O-C-N 119.965 -1.709 . . . . 0.0 111.985 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 118' ' ' GLN . 87.7 mt-30 -70.36 -24.28 62.94 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 119.768 -1.832 . . . . 0.0 115.871 -176.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.415 HH21 ' C ' ' A' ' 139' ' ' ARG . 0.1 OUTLIER -67.47 -28.13 67.61 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 119.839 -1.788 . . . . 0.0 106.916 -178.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.961 HD11 ' ND1' ' A' ' 110' ' ' HIS . 87.9 mt -56.0 -88.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 117.453 -1.699 . . . . 0.0 109.991 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.571 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -37.02 -12.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 O-C-N 121.545 -0.722 . . . . 0.0 113.604 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.7 OUTLIER -69.64 -72.42 0.24 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 119.457 -2.202 . . . . 0.0 114.579 -174.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.426 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 19.2 Cg_exo -24.95 120.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 123.923 3.082 . . . . 0.0 113.82 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.587 ' C ' ' H ' ' A' ' 122' ' ' GLY . 0.8 OUTLIER -178.11 138.12 0.19 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 123' ' ' ASP . 85.6 mttt 50.47 4.98 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 CA-C-O 121.456 0.646 . . . . 0.0 109.389 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 120' ' ' PHE . . . -42.94 -18.75 0.05 OUTLIER Glycine 0 N--CA 1.505 3.239 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 121' ' ' LYS . 11.1 t70 71.04 -17.98 0.29 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.292 -1.122 . . . . 0.0 111.233 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.22 -14.89 61.0 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.402 ' HA ' ' HB3' ' A' ' 128' ' ' ALA . 20.2 mt -89.99 -28.48 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.637 -0.664 . . . . 0.0 111.629 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -40.04 -56.34 1.88 Allowed 'General case' 0 N--CA 1.515 2.802 0 O-C-N 120.842 -1.161 . . . . 0.0 110.137 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -74.11 -37.08 64.22 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.773 -1.205 . . . . 0.0 110.591 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -63.28 -47.31 82.88 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 128' ' ' ALA . 0.3 OUTLIER -28.85 -44.68 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 113.587 -1.642 . . . . 0.0 106.966 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 32.9 m-20 -105.0 -99.94 0.32 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -128.63 120.35 3.3 Favored Glycine 0 N--CA 1.507 3.431 0 CA-C-O 122.985 1.325 . . . . 0.0 112.124 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 133' ' ' GLU . 5.9 tp10 178.49 169.47 0.83 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 113.379 -1.41 . . . . 0.0 111.728 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.404 ' CD ' ' N ' ' A' ' 133' ' ' GLU . 22.9 mp0 -124.21 127.45 47.73 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 176.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 149' ' ' PHE . 79.9 m-20 -150.71 138.51 19.88 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.245 1.021 . . . . 0.0 111.072 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 147' ' ' ARG . 8.5 p -134.44 126.3 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.473 -0.767 . . . . 0.0 109.011 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.51 169.06 18.3 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 121.724 0.773 . . . . 0.0 111.368 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.6 mt -101.17 141.91 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-O 121.716 0.77 . . . . 0.0 112.826 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -114.07 153.61 29.15 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.415 ' C ' HH21 ' A' ' 115' ' ' ARG . 68.5 mtt85 -147.73 108.11 4.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.494 -1.379 . . . . 0.0 109.901 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.487 ' H ' ' HB3' ' A' ' 143' ' ' ALA . . . -158.06 106.23 0.29 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.498 ' C ' ' H ' ' A' ' 143' ' ' ALA . 84.1 t80 38.42 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.845 -0.797 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.918 HD12 ' O ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER 70.77 -30.15 0.2 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.56 -0.713 . . . . 0.0 110.268 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 145' ' ' ALA . . . -53.49 -2.93 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.105 -1.038 . . . . 0.0 113.035 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 143' ' ' ALA . 5.3 pt20 -45.01 98.88 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 O-C-N 119.949 -1.72 . . . . 0.0 107.842 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.948 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -149.17 163.36 37.82 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.599 -1.313 . . . . 0.0 110.024 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tp -108.45 155.51 20.51 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 120.777 -1.202 . . . . 0.0 110.912 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.693 ' O ' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -136.47 155.42 50.01 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.605 -0.684 . . . . 0.0 110.174 178.238 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.49 151.76 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.298 0 CA-C-O 121.691 0.757 . . . . 0.0 109.924 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.425 ' N ' ' O ' ' A' ' 134' ' ' ASN . 27.7 m-85 -116.8 138.97 51.12 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.751 0.786 . . . . 0.0 110.356 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 160.33 31.25 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 0.1 OUTLIER -104.44 162.74 0.2 Allowed 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 123.537 2.825 . . . . 0.0 116.224 -178.304 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 47.7 mt -123.59 136.9 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 0.0 OUTLIER -117.14 157.05 26.59 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.401 1.096 . . . . 0.0 112.339 -179.311 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 9.3 p30 -53.98 -95.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.232 -0.917 . . . . 0.0 110.327 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.537 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 9.6 pt-20 -160.11 28.71 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -143.49 23.01 1.82 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.0 m80 67.1 46.83 1.45 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.153 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.77 122.43 30.55 Favored 'General case' 0 N--CA 1.522 3.173 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -58.23 118.35 5.4 Favored 'General case' 0 N--CA 1.518 2.934 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -177.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 160' ' ' ILE . 1.7 pp -141.27 22.32 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 O-C-N 120.349 -1.469 . . . . 0.0 112.124 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.04 169.42 41.75 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 101' ' ' THR . 5.5 t -136.0 138.93 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 CA-C-N 119.614 1.707 . . . . 0.0 112.502 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.447 ' CG2' HD21 ' A' ' 63' ' ' LEU . 1.9 p -119.68 113.83 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.459 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.819 ' H ' ' CG1' ' A' ' 99' ' ' VAL . . . -116.85 165.77 12.93 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.843 HD11 ' HB2' ' A' ' 60' ' ' ALA . 3.3 mt -142.92 107.99 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.03 -1.669 . . . . 0.0 106.919 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.91 114.79 4.87 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.556 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.948 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 5.1 tt -88.47 110.77 21.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.999 ' O ' ' O ' ' A' ' 169' ' ' LEU . 8.2 tm-20 -74.48 127.23 32.54 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.828 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.999 ' O ' ' O ' ' A' ' 168' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.522 3.16 0 CA-C-O 121.959 0.885 . . . . 0.0 110.283 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.657 0.742 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -68.99 -67.16 0.49 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 123.051 1.405 . . . . 0.0 111.256 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.2 mtt -50.96 -49.1 60.66 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.313 -173.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.458 ' O ' ' C ' ' A' ' 49' ' ' ARG . 12.1 t -55.25 -35.93 65.51 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 48' ' ' THR . 62.5 ttt180 -40.67 -52.7 2.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.014 -1.054 . . . . 0.0 110.996 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.47 -60.44 2.19 Favored 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -73.31 -45.8 29.13 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.481 HD12 ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -54.64 -44.69 73.42 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 120.422 2.111 . . . . 0.0 105.598 176.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.716 ' O ' HD12 ' A' ' 57' ' ' LEU . . . -53.24 -50.8 64.03 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 117.726 -1.59 . . . . 0.0 109.452 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -80.24 -55.87 4.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 119.73 -1.856 . . . . 0.0 111.656 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 51' ' ' GLY . 18.1 mtpp -63.96 -27.1 68.9 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB3' HD12 ' A' ' 52' ' ' LEU . . . -95.56 -37.59 10.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 119.787 -1.821 . . . . 0.0 108.871 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.716 HD12 ' O ' ' A' ' 53' ' ' ALA . 35.2 mt -53.93 -35.45 61.72 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.291 -1.364 . . . . 0.0 108.047 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 61' ' ' ARG . . . -80.97 -46.32 15.3 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -70.85 -26.6 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 118.665 -2.522 . . . . 0.0 106.197 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.443 ' CB ' HD11 ' A' ' 98' ' ' ILE . . . -63.07 -29.07 70.52 Favored 'General case' 0 C--N 1.27 -2.861 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.456 ' O ' ' CG ' ' A' ' 65' ' ' ASP . 4.3 ptt180 -72.65 -19.7 61.39 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 117.164 -1.814 . . . . 0.0 110.84 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 m -68.29 -47.62 67.15 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 124.116 3.144 . . . . 0.0 107.009 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.691 HD22 ' HB1' ' A' ' 84' ' ' ALA . 50.2 mt -87.53 -41.81 13.21 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.833 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.4 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -56.32 -19.04 12.63 Favored 'General case' 0 N--CA 1.508 2.475 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.456 ' CG ' ' O ' ' A' ' 61' ' ' ARG . 40.2 m-20 -85.14 -4.3 59.11 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.123 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.512 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.86 -158.05 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 119.983 -1.698 . . . . 0.0 110.239 -178.679 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.555 ' C ' ' H ' ' A' ' 69' ' ' ILE . 3.1 Cg_endo -104.07 -27.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 123.586 2.857 . . . . 0.0 113.399 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 16.8 pt-20 -75.43 25.09 0.11 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.555 ' H ' ' C ' ' A' ' 67' ' ' PRO . 44.0 mm -106.13 -80.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -46.3 -31.95 2.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.68 -14.37 51.93 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.506 -1.371 . . . . 0.0 110.244 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -102.69 -3.54 49.53 Favored Glycine 0 N--CA 1.504 3.186 0 N-CA-C 107.101 -2.399 . . . . 0.0 107.101 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.52 -52.76 7.25 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 100.406 -3.924 . . . . 0.0 100.406 173.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -8.83 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 113.238 -1.801 . . . . 0.0 112.619 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.71 ' O ' ' O ' ' A' ' 76' ' ' LYS . 4.0 tmtm? -124.07 40.56 3.7 Favored 'General case' 0 N--CA 1.523 3.177 0 CA-C-N 122.732 2.515 . . . . 0.0 111.036 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.791 ' HZ2' ' H ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER 35.24 157.23 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.915 0 C-N-CA 125.532 1.533 . . . . 0.0 112.516 177.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -33.29 -63.48 0.14 Allowed 'Trans proline' 0 N--CA 1.513 2.66 0 C-N-CA 123.943 3.095 . . . . 0.0 115.72 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.791 ' H ' ' HZ2' ' A' ' 76' ' ' LYS . 78.6 mt-30 -50.1 142.02 10.2 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.098 -1.441 . . . . 0.0 108.762 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 63.52 5.9 2.33 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.137 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 1.035 ' O ' ' N ' ' A' ' 82' ' ' ILE . 70.9 p -81.22 86.55 6.19 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.154 -2.217 . . . . 0.0 109.542 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.696 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -35.92 47.24 0.0 OUTLIER Glycine 1 N--CA 1.518 4.139 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.754 -177.576 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.035 ' N ' ' O ' ' A' ' 80' ' ' SER . 1.1 tp -68.04 28.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 122.516 1.151 . . . . 0.0 107.924 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.696 ' H ' ' C ' ' A' ' 81' ' ' GLY . 43.7 tp60 -82.91 -22.3 33.93 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.707 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -73.73 -94.25 0.02 OUTLIER 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.707 ' C ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -20.18 -55.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.157 0 CA-C-N 123.651 2.932 . . . . 0.0 111.554 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -51.9 -49.12 63.63 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 119.333 -2.104 . . . . 0.0 110.161 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.682 ' N ' ' O ' ' A' ' 84' ' ' ALA . 66.1 tt0 -55.96 -54.55 43.42 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 116.624 -1.655 . . . . 0.0 114.393 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -77.79 -42.75 32.84 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 124.699 3.409 . . . . 0.0 108.236 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 88' ' ' ALA . 64.7 t -51.65 -71.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 115.115 -2.634 . . . . 0.0 107.592 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.677 ' O ' ' N ' ' A' ' 93' ' ' ASN . 4.3 ppt_? -40.26 -34.13 0.3 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.959 -1.088 . . . . 0.0 110.608 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.549 ' C ' ' O ' ' A' ' 90' ' ' ARG . 29.0 ttmt -39.38 -28.97 0.04 OUTLIER 'General case' 0 N--CA 1.536 3.827 0 C-N-CA 116.758 -1.977 . . . . 0.0 106.092 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 90' ' ' ARG . 10.6 ttm105 -36.49 -59.56 0.65 Allowed 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 166.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.677 ' N ' ' O ' ' A' ' 90' ' ' ARG . 17.6 t-20 -153.33 -56.38 0.12 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.397 -1.439 . . . . 0.0 110.192 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 1.1 m-20 164.02 1.38 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.864 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -135.57 160.69 37.71 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 117.729 -1.588 . . . . 0.0 113.975 -175.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 96' ' ' LEU . 2.8 pp 151.43 175.92 0.0 OUTLIER 'General case' 0 N--CA 1.534 3.738 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.426 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -139.66 86.58 2.12 Favored 'General case' 0 C--O 1.218 -0.603 1 N-CA-C 98.87 -4.493 . . . . 0.0 98.87 169.245 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.758 HD12 HG23 ' A' ' 165' ' ' ILE . 19.7 tt -101.61 134.72 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 123.396 1.569 . . . . 0.0 108.212 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.792 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 1.1 p -136.41 149.53 27.18 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -173.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.473 ' H ' ' CD1' ' A' ' 82' ' ' ILE . 4.2 p -111.28 131.35 62.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 1 N-CA-C 98.444 -4.65 . . . . 0.0 98.444 169.642 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.672 ' CG2' ' H ' ' A' ' 105' ' ' SER . 1.5 m -124.46 152.27 43.54 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 120.564 -1.335 . . . . 0.0 111.442 -175.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.612 ' O ' HG22 ' A' ' 101' ' ' THR . 24.5 t70 -87.2 -176.85 5.83 Favored 'General case' 0 C--N 1.284 -2.278 1 N-CA-C 98.033 -4.802 . . . . 0.0 98.033 169.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 103' ' ' MET . 1.8 ttt -77.67 73.53 4.23 Favored 'General case' 0 C--N 1.269 -2.9 0 C-N-CA 114.483 -2.887 . . . . 0.0 107.069 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' A' ' 105' ' ' SER . 9.0 tm0? -141.75 -41.51 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 119.595 -1.941 . . . . 0.0 110.483 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.672 ' H ' ' CG2' ' A' ' 101' ' ' THR . 10.5 t 84.88 136.96 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.747 0.819 . . . . 0.0 109.48 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.8 OUTLIER 156.81 134.86 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.618 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 177.314 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.465 ' HE ' ' HB2' ' A' ' 97' ' ' PHE . 9.6 mmm180 -71.9 100.87 2.52 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.628 ' C ' HG21 ' A' ' 82' ' ' ILE . 2.5 m-85 -54.4 -30.24 51.55 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.44 ' C ' ' ND1' ' A' ' 110' ' ' HIS . 12.0 t -101.17 144.78 29.63 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.44 ' ND1' ' C ' ' A' ' 109' ' ' SER . 1.5 m-70 -124.89 107.83 28.41 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -174.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.659 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 65.2 Cg_endo -85.81 -35.63 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 N-CA-C 103.882 -3.161 . . . . 0.0 103.882 172.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.659 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 13.5 mp0 -140.37 138.31 34.72 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 174.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.81 -48.18 64.21 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 118.303 2.705 . . . . 0.0 118.303 -172.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.535 ' H ' ' CD ' ' A' ' 114' ' ' GLN . 1.4 mp0 -66.2 -32.52 74.01 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.78 HH21 ' H ' ' A' ' 139' ' ' ARG . 19.3 tpt85 -61.54 -33.68 74.25 Favored 'General case' 0 C--O 1.201 -1.457 0 CA-C-N 122.358 2.345 . . . . 0.0 106.633 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.701 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.2 OUTLIER -53.17 -86.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.135 177.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.603 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -33.04 -11.63 0.0 OUTLIER Glycine 0 N--CA 1.499 2.866 0 C-N-CA 123.462 0.553 . . . . 0.0 113.748 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.701 ' N ' ' O ' ' A' ' 116' ' ' ILE . 1.3 mt-30 -79.33 -72.75 0.12 Allowed Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 120.017 1.909 . . . . 0.0 113.728 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 115' ' ' ARG . 6.6 Cg_exo -26.55 108.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 123.969 3.113 . . . . 0.0 114.939 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.555 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 48.5 t80 174.86 28.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -174.93 -12.64 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.091 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.76 -21.51 2.29 Favored Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.6 t0 69.64 0.6 3.04 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 121.043 -1.269 . . . . 0.0 112.142 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.534 ' OD2' ' CE2' ' A' ' 149' ' ' PHE . 2.9 p-10 -82.45 -21.18 35.76 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.552 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 20.2 mt -79.42 -21.78 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.528 -0.733 . . . . 0.0 110.199 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -49.39 -37.09 23.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.577 -1.327 . . . . 0.0 108.418 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.791 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 59.0 mttp -74.32 -34.87 63.59 Favored 'General case' 0 C--O 1.194 -1.859 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 125' ' ' ILE . . . -89.43 -30.74 18.12 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 120.023 -1.673 . . . . 0.0 110.539 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.29 -26.35 1.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.858 -1.151 . . . . 0.0 109.705 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.793 ' CG ' ' H ' ' A' ' 131' ' ' GLY 0.278 32.8 p30 -77.12 -92.49 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 108.904 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.793 ' H ' ' CG ' ' A' ' 130' ' ' ASN . . . -164.66 42.8 0.3 Allowed Glycine 0 CA--C 1.565 3.166 0 C-N-CA 125.536 1.541 . . . . 0.0 110.106 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -145.06 164.72 30.35 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 120.316 2.058 . . . . 0.0 111.646 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -64.21 164.32 11.18 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 28.4 t-20 -170.97 138.16 1.27 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.298 -0.876 . . . . 0.0 109.267 176.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.638 HG22 HG12 ' A' ' 148' ' ' VAL . 1.3 t -130.83 138.43 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.315 -1.491 . . . . 0.0 108.776 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -151.51 167.6 27.54 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.644 -1.285 . . . . 0.0 110.213 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 mt -102.32 135.56 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.398 -0.814 . . . . 0.0 109.801 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.452 ' OD1' ' CZ ' ' A' ' 147' ' ' ARG . 0.9 OUTLIER -106.84 152.62 23.64 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.502 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.78 ' H ' HH21 ' A' ' 115' ' ' ARG . 3.5 ptm85 -159.68 97.94 1.34 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.734 ' H ' ' HB3' ' A' ' 143' ' ' ALA . . . -150.61 109.04 0.41 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.07 -1.538 . . . . 0.0 109.92 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 9.3 t80 59.1 -67.47 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 122.034 -0.686 . . . . 0.0 110.14 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 143' ' ' ALA . 0.7 OUTLIER -131.44 6.69 4.47 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.249 -0.907 . . . . 0.0 110.083 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.734 ' HB3' ' H ' ' A' ' 140' ' ' GLY . . . -81.13 5.36 17.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 113.775 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -48.78 91.24 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.217 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 1.029 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -169.03 173.06 7.11 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.301 -170.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 tp -115.01 159.19 21.08 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.461 -1.399 . . . . 0.0 110.89 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.452 ' CZ ' ' OD1' ' A' ' 138' ' ' ASN . 0.8 OUTLIER -143.89 152.33 40.99 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.142 0.972 . . . . 0.0 110.896 178.23 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.638 HG12 HG22 ' A' ' 135' ' ' VAL . 15.5 m -119.41 138.22 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.925 0 CA-C-O 122.119 0.961 . . . . 0.0 109.985 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.534 ' CE2' ' OD2' ' A' ' 124' ' ' ASP . 70.6 m-85 -111.63 145.73 38.68 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.646 0.736 . . . . 0.0 109.686 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.449 HG21 ' CD2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -142.02 156.56 65.07 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -96.54 154.88 1.25 Allowed 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 123.996 3.131 . . . . 0.0 114.195 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 72.6 mt -117.97 136.33 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -107.73 149.16 28.49 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.827 ' O ' ' ND2' ' A' ' 156' ' ' ASN . 24.8 t0 -76.19 57.1 1.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 42.33 21.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 123.641 0.777 . . . . 0.0 112.463 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.827 ' ND2' ' O ' ' A' ' 154' ' ' ASP . 42.3 m-80 -140.28 35.42 1.89 Allowed 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.495 -1.378 . . . . 0.0 109.717 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 61.84 -2.92 0.25 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.571 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.8 mptt -80.45 122.05 26.5 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.924 ' O ' HG23 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -58.2 -154.65 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.058 0 O-C-N 120.861 -1.149 . . . . 0.0 111.136 -177.397 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.924 HG23 ' O ' ' A' ' 159' ' ' GLN . 2.7 pp 151.9 -6.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 CA-C-N 120.175 1.352 . . . . 0.0 112.883 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -172.24 179.86 43.57 Favored Glycine 0 N--CA 1.507 3.407 0 C-N-CA 115.981 -3.009 . . . . 0.0 111.583 -175.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -139.6 139.22 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -1.225 . . . . 0.0 112.042 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.4 t -108.09 127.31 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.792 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -115.99 144.23 44.37 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.758 HG23 HD12 ' A' ' 98' ' ' ILE . 6.2 mt -137.76 99.52 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.25 129.59 9.13 Favored Glycine 0 N--CA 1.485 1.947 0 CA-C-O 123.328 1.515 . . . . 0.0 112.762 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 1.029 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -88.62 115.31 26.05 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 113.475 -1.363 . . . . 0.0 107.925 177.363 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.883 ' O ' ' O ' ' A' ' 169' ' ' LEU . 0.7 OUTLIER -74.95 132.25 41.28 Favored 'General case' 0 N--CA 1.529 3.491 0 O-C-N 124.084 0.865 . . . . 0.0 110.237 -179.179 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.883 ' O ' ' O ' ' A' ' 168' ' ' GLU . 1.5 pp . . . . . 0 N--CA 1.519 3.017 0 O-C-N 120.566 -1.334 . . . . 0.0 113.487 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.544 ' CG ' ' H ' ' A' ' 47' ' ' MET . 17.4 p-10 -66.29 -64.73 0.79 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.885 1.326 . . . . 0.0 110.786 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.544 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 16.3 mmm -43.54 -58.61 2.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.193 0.997 . . . . 0.0 111.443 -173.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' ARG . 6.4 t -53.18 -35.97 60.42 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 36.8 ttp180 -42.02 -51.05 4.59 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.805 -1.184 . . . . 0.0 111.841 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -80.77 -58.06 3.27 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -79.59 -45.3 8.7 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.541 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -54.96 -46.3 75.01 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 120.533 2.167 . . . . 0.0 105.525 176.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 49' ' ' ARG . . . -46.9 -57.98 4.4 Favored 'General case' 0 C--O 1.205 -1.275 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.345 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -81.87 -68.42 0.7 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.64 -1.288 . . . . 0.0 113.989 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 51' ' ' GLY . 57.4 mtpt -47.46 -27.53 1.77 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.094 -1.004 . . . . 0.0 111.647 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 52' ' ' LEU . . . -93.46 -32.3 14.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.053 -1.654 . . . . 0.0 108.782 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.3 tp -55.22 -40.21 70.56 Favored 'General case' 0 C--N 1.284 -2.239 0 O-C-N 121.035 -1.041 . . . . 0.0 109.309 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.617 ' O ' ' CG ' ' A' ' 61' ' ' ARG . . . -80.42 -47.49 14.3 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -177.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.664 ' HB ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -66.89 -32.95 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 117.616 -3.177 . . . . 0.0 104.618 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.599 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -58.84 -26.53 64.28 Favored 'General case' 0 C--N 1.265 -3.104 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.617 ' CG ' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -49.79 -24.45 2.39 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 116.665 -2.014 . . . . 0.0 105.882 174.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.519 HG22 HG22 ' A' ' 85' ' ' ILE . 96.9 m -74.03 -39.76 63.34 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.826 ' O ' HD12 ' A' ' 85' ' ' ILE 0.276 0.3 OUTLIER -48.2 -42.19 29.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 124.761 2.22 . . . . 0.0 107.921 175.58 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.66 -4.7 59.21 Favored 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 112.553 -2.112 . . . . 0.0 113.081 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 66' ' ' SER . 34.5 t0 -99.02 -27.46 13.84 Favored 'General case' 0 N--CA 1.517 2.921 0 CA-C-N 123.713 2.961 . . . . 0.0 115.618 -172.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.577 ' HB2' HD13 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -60.12 -161.47 0.0 OUTLIER Pre-proline 0 C--N 1.278 -2.525 0 O-C-N 119.668 -1.895 . . . . 0.0 109.928 -178.395 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.725 ' HD2' ' H ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -114.52 -25.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 124.399 3.399 . . . . 0.0 113.584 176.032 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.725 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 16.4 pt-20 -56.75 -30.45 63.59 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 117.829 -1.548 . . . . 0.0 107.52 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.5 mt -45.25 -83.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.062 -178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -47.33 -39.03 13.95 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.978 0.894 . . . . 0.0 109.914 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -78.04 -13.0 60.03 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.931 -1.105 . . . . 0.0 111.08 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . -97.52 -1.38 59.06 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 105.046 -3.222 . . . . 0.0 105.046 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.571 ' O ' ' OD2' ' A' ' 102' ' ' ASP . 1.4 mp -89.61 -23.22 21.99 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 173.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -62.83 -0.72 0.71 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.642 ' CG ' ' H ' ' A' ' 76' ' ' LYS . 3.5 tptm -136.37 -140.81 0.16 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.204 -1.56 . . . . 0.0 107.175 174.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.642 ' H ' ' CG ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -129.12 156.14 78.69 Favored Pre-proline 0 CA--C 1.578 2.041 0 O-C-N 121.481 -0.762 . . . . 0.0 109.625 179.381 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' O ' ' CE2' ' A' ' 108' ' ' TYR . 0.9 OUTLIER -31.56 -10.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.528 3.546 1 C-N-CA 126.236 4.624 . . . . 0.0 118.946 -179.082 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' LYS . 44.0 tp60 -96.33 -14.08 22.83 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 119.798 -1.814 . . . . 0.0 109.622 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -116.11 0.74 13.05 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.232 -0.918 . . . . 0.0 112.472 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.694 ' N ' ' OH ' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -76.36 -155.4 0.06 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 119.234 -2.166 . . . . 0.0 107.703 178.374 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.97 17.25 0.22 Allowed Glycine 0 N--CA 1.496 2.676 0 O-C-N 120.523 -1.36 . . . . 0.0 109.727 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.624 HD12 ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -48.39 -24.37 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-O 121.898 0.856 . . . . 0.0 110.385 -179.12 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 55.4 tt0 -53.34 -7.74 0.1 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 82' ' ' ILE . . . -94.49 -52.81 4.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.002 -1.061 . . . . 0.0 112.689 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.826 HD12 ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -74.82 -34.2 32.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 177.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -57.97 -46.27 85.41 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 1.2 tt0 -49.67 -21.54 1.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.053 -1.43 . . . . 0.0 107.948 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.94 66.76 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 114.831 -2.748 . . . . 0.0 104.093 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.664 HG22 ' HB ' ' A' ' 59' ' ' VAL . 37.7 t -54.62 -72.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 C-N-CA 116.776 -1.97 . . . . 0.0 110.185 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 93' ' ' ASN . 1.5 ttt-85 -48.13 -69.61 0.12 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 124.499 1.119 . . . . 0.0 113.118 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 90' ' ' ARG . 37.9 pttt -35.61 -36.87 0.08 Allowed 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.953 -1.092 . . . . 0.0 109.187 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 90' ' ' ARG . 62.3 mtm-85 -86.51 -21.88 26.71 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.723 -1.236 . . . . 0.0 111.585 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.644 ' N ' ' O ' ' A' ' 90' ' ' ARG . 54.7 t-20 -97.9 -16.42 19.75 Favored 'General case' 0 N--CA 1.511 2.582 0 CA-C-N 120.979 1.718 . . . . 0.0 108.374 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.0 t70 73.28 24.7 2.34 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.886 0.875 . . . . 0.0 110.835 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 0.4 OUTLIER 173.27 153.71 0.09 Allowed 'General case' 0 N--CA 1.514 2.755 0 CA-C-N 121.726 2.057 . . . . 0.0 107.796 176.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.636 HD13 HG12 ' A' ' 89' ' ' VAL . 0.3 OUTLIER 156.17 164.69 0.01 OUTLIER 'General case' 1 N--CA 1.542 4.133 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.2 179.828 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.566 ' CD1' ' NE ' ' A' ' 107' ' ' ARG . 0.9 OUTLIER -143.52 89.21 2.06 Favored 'General case' 0 C--O 1.214 -0.816 1 N-CA-C 99.119 -4.4 . . . . 0.0 99.119 168.552 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.629 ' N ' ' OG ' ' A' ' 109' ' ' SER . 0.4 OUTLIER -93.19 129.09 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -175.29 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 164' ' ' ALA . 1.1 m -119.08 130.54 73.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -173.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.624 ' HB ' HD12 ' A' ' 82' ' ' ILE . 0.9 OUTLIER -123.64 124.47 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 1 N-CA-C 97.166 -5.124 . . . . 0.0 97.166 169.217 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.649 HG21 ' HA ' ' A' ' 105' ' ' SER . 11.5 p -136.09 164.2 28.57 Favored 'General case' 0 C--N 1.281 -2.372 0 O-C-N 120.61 -1.306 . . . . 0.0 108.416 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.707 ' O ' ' N ' ' A' ' 104' ' ' GLN . 1.7 m-20 -78.86 -175.13 4.32 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 100.873 -3.751 . . . . 0.0 100.873 170.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.514 ' CG ' ' O ' ' A' ' 103' ' ' MET . 1.6 ttt -68.28 69.82 0.15 Allowed 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 114.843 -2.743 . . . . 0.0 103.963 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.707 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -137.16 -50.37 0.64 Allowed 'General case' 0 C--N 1.358 0.965 0 O-C-N 120.488 -1.382 . . . . 0.0 108.408 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.649 ' HA ' HG21 ' A' ' 101' ' ' THR . 1.5 t 92.74 138.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.9 OUTLIER 157.04 139.34 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 102.092 -3.299 . . . . 0.0 102.092 178.447 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.74 ' NH2' HH11 ' A' ' 147' ' ' ARG . 39.4 mtt180 -86.19 96.65 9.99 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.791 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.694 ' OH ' ' N ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -55.95 -19.94 14.26 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 123.81 1.767 . . . . 0.0 107.282 -176.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.629 ' OG ' ' N ' ' A' ' 98' ' ' ILE . 25.6 p -113.36 146.02 40.15 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.534 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.552 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 13.3 p80 -155.53 137.25 9.64 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -174.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.622 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 40.5 Cg_endo -88.57 -32.25 0.15 Allowed 'Trans proline' 0 N--CA 1.482 0.815 0 N-CA-C 104.666 -2.859 . . . . 0.0 104.666 171.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.622 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 34.9 tp10 -127.35 124.83 39.57 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.24 81.83 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -68.28 -28.97 67.65 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 119.882 -1.762 . . . . 0.0 115.629 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.548 ' CD ' ' CE2' ' A' ' 97' ' ' PHE . 11.7 ttt85 -55.26 -29.04 57.33 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 119.103 -2.248 . . . . 0.0 105.544 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.751 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.2 OUTLIER -63.92 -87.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.214 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.437 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -32.55 -13.41 0.0 OUTLIER Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.419 -0.801 . . . . 0.0 112.949 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.751 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.9 mt-30 -71.5 -72.64 0.21 Allowed Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 119.632 -2.099 . . . . 0.0 110.892 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.512 ' O ' ' CB ' ' A' ' 120' ' ' PHE . 96.0 Cg_exo -19.04 142.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 124.309 3.339 . . . . 0.0 113.878 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.592 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 67.1 t80 140.89 21.64 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.441 ' C ' ' N ' ' A' ' 123' ' ' ASP . 23.7 ttmt -177.29 -2.8 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 O-C-N 121.434 -0.792 . . . . 0.0 110.196 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.6 -20.59 2.75 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.441 ' N ' ' C ' ' A' ' 121' ' ' LYS . 10.0 t70 72.6 -5.27 1.88 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -75.97 -21.1 57.33 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 119.756 -1.84 . . . . 0.0 108.861 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.469 ' HB ' HG21 ' A' ' 162' ' ' VAL . 14.7 pt -74.39 -23.67 18.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.02 -1.05 . . . . 0.0 109.947 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.76 -25.92 8.51 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -86.52 -39.14 16.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.671 -0.643 . . . . 0.0 111.594 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 150' ' ' THR . . . -79.73 -46.85 16.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 119.898 -1.752 . . . . 0.0 107.246 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.544 HD22 HG23 ' A' ' 162' ' ' VAL . 0.1 OUTLIER -38.41 -41.93 0.69 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 16.1 m-20 -100.46 12.81 36.43 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.315 -1.311 . . . . 0.0 114.203 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.36 98.41 0.56 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 170.85 157.76 0.07 Allowed 'General case' 0 N--CA 1.514 2.746 0 CA-C-O 122.596 1.189 . . . . 0.0 111.399 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -101.53 144.74 29.92 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.303 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -159.75 144.34 15.01 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.824 -1.172 . . . . 0.0 109.693 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 147' ' ' ARG . 5.0 p -138.43 132.91 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 120.701 -1.249 . . . . 0.0 109.974 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -148.88 169.17 21.15 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.433 0.635 . . . . 0.0 110.452 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.444 HG22 ' OE1' ' A' ' 144' ' ' GLN . 0.8 OUTLIER -97.42 139.22 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-O 121.361 0.6 . . . . 0.0 111.5 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.536 ' CG ' HH22 ' A' ' 107' ' ' ARG . 28.1 t-20 -117.23 150.3 38.99 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.249 -0.907 . . . . 0.0 110.745 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -153.5 113.61 3.94 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 141' ' ' PHE . . . -150.28 112.61 0.55 Allowed Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.249 -1.453 . . . . 0.0 110.305 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 141' ' ' PHE . 54.5 t80 39.01 32.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.904 -0.762 . . . . 0.0 110.122 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.451 HD23 HH11 ' A' ' 115' ' ' ARG . 32.0 tp -152.98 -94.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.89 . . . . 0.0 110.736 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -172.55 154.27 3.06 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.535 -1.353 . . . . 0.0 112.029 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.444 ' OE1' HG22 ' A' ' 137' ' ' ILE . 36.0 mm-40 -52.49 144.59 13.12 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.673 1.225 . . . . 0.0 111.747 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.922 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -162.1 158.03 24.2 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -177.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 tp -108.97 159.52 16.76 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-N 121.351 1.887 . . . . 0.0 109.683 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.759 ' O ' HG23 ' A' ' 135' ' ' VAL . 11.3 ptt180 -152.3 149.04 28.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.725 -1.234 . . . . 0.0 110.768 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.25 157.47 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-O 122.291 1.043 . . . . 0.0 109.673 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 164' ' ' ALA . 26.1 m-85 -124.92 135.96 53.32 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.844 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.557 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -142.63 161.16 50.93 Favored Pre-proline 0 C--N 1.31 -1.127 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -108.16 163.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 123.459 2.773 . . . . 0.0 116.027 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.519 ' CG1' HG23 ' A' ' 163' ' ' VAL . 48.9 mt -118.62 125.86 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -104.75 155.44 18.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 123.195 1.474 . . . . 0.0 110.666 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -53.08 -85.54 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -170.35 35.59 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -148.18 20.3 1.09 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 64.85 42.54 4.39 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 153' ' ' TYR . 0.6 OUTLIER -122.68 118.46 28.15 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.506 ' N ' ' OE1' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -63.83 121.41 13.96 Favored 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -176.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.1 pp -140.31 13.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 120.536 -1.353 . . . . 0.0 113.749 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.48 178.93 40.73 Favored Glycine 1 N--CA 1.522 4.379 0 C-N-CA 118.816 -1.659 . . . . 0.0 112.361 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.544 HG23 HD22 ' A' ' 129' ' ' LEU . 16.8 t -123.3 134.02 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.26 0 CA-C-N 119.013 1.406 . . . . 0.0 112.593 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 152' ' ' ILE . 2.7 t -123.9 107.19 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.687 ' HB3' HG22 ' A' ' 99' ' ' VAL . . . -112.44 158.21 20.14 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.6 HG23 ' CG1' ' A' ' 98' ' ' ILE . 4.2 mt -143.33 101.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 97' ' ' PHE . . . -115.05 127.56 7.71 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.403 -1.38 . . . . 0.0 113.11 -175.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.922 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 13.4 tp -93.71 124.82 37.97 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.662 -1.269 . . . . 0.0 109.306 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.416 ' OE1' ' NH1' ' A' ' 115' ' ' ARG . 12.7 tp10 -73.79 134.38 43.39 Favored 'General case' 0 N--CA 1.521 3.086 0 C-N-CA 122.949 0.5 . . . . 0.0 109.942 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.489 ' H ' ' HB2' ' A' ' 145' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.502 2.14 0 O-C-N 119.327 -2.108 . . . . 0.0 109.167 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.421 ' O ' HG22 ' A' ' 48' ' ' THR . 50.6 p . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 49' ' ' ARG . 40.7 t0 -63.76 -64.56 0.86 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 123.871 1.796 . . . . 0.0 108.817 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.416 ' C ' ' O ' ' A' ' 46' ' ' ASP . 6.6 tmm? -32.12 -60.08 0.28 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 123.331 1.538 . . . . 0.0 111.116 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 52' ' ' LEU . 13.9 t -59.56 -32.62 70.51 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.448 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 46' ' ' ASP . 32.3 ttp85 -37.86 -51.98 1.31 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.699 -1.251 . . . . 0.0 111.81 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -84.49 -56.44 3.62 Favored 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -77.43 -43.36 15.9 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -176.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.635 HD11 HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -54.63 -45.82 73.81 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 120.352 2.076 . . . . 0.0 106.344 176.512 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.426 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . -48.32 -57.23 6.31 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.625 -1.23 . . . . 0.0 108.999 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -78.35 -55.77 4.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.435 -1.416 . . . . 0.0 113.402 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -67.86 -21.95 65.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.862 . . . . 0.0 111.874 -175.069 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.676 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -97.68 -35.35 10.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 120.784 1.629 . . . . 0.0 110.572 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.4 tt -65.03 -35.8 82.35 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.291 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.63 -45.38 21.66 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -72.64 -34.41 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 118.649 -2.532 . . . . 0.0 105.882 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.447 ' N ' HG13 ' A' ' 89' ' ' VAL . . . -60.84 -31.81 71.22 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.631 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 2.0 ptt180 -70.02 -16.64 63.19 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.614 -1.234 . . . . 0.0 110.318 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 m -63.58 -46.03 87.74 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 123.056 2.662 . . . . 0.0 105.734 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.724 HD22 ' HB1' ' A' ' 84' ' ' ALA . 54.1 mt -88.79 -37.6 15.3 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.897 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.631 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -58.86 -19.95 46.44 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 119.152 -2.218 . . . . 0.0 105.715 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 31.5 t70 -84.39 -4.33 58.84 Favored 'General case' 0 C--N 1.274 -2.717 0 O-C-N 121.367 -0.833 . . . . 0.0 110.517 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.516 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -74.84 -155.9 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 120.36 -1.462 . . . . 0.0 111.178 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -108.04 -20.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.316 2.677 . . . . 0.0 114.336 178.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.9 pt-20 -62.1 -36.34 81.44 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.621 -1.631 . . . . 0.0 106.938 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.762 ' CG2' HG21 ' A' ' 100' ' ' VAL . 7.9 mm -47.06 -88.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.828 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' H ' ' HB ' ' A' ' 69' ' ' ILE . 73.8 ttt180 -45.35 -31.25 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -78.51 -17.81 55.69 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.732 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.772 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -83.26 -40.84 8.86 Favored Glycine 0 N--CA 1.507 3.375 1 N-CA-C 102.453 -4.259 . . . . 0.0 102.453 178.427 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.466 HD11 HG22 ' A' ' 100' ' ' VAL . 5.7 mp -48.13 -35.64 11.9 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -78.59 5.57 10.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.779 ' O ' ' O ' ' A' ' 76' ' ' LYS . 31.4 mmtm -139.22 34.82 2.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.835 -1.165 . . . . 0.0 111.66 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.779 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 24.96 153.83 0.0 OUTLIER Pre-proline 0 N--CA 1.527 3.412 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.119 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 76' ' ' LYS . 5.7 Cg_exo -22.42 -62.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 124.411 3.407 . . . . 0.0 114.683 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -55.22 139.37 42.46 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 117.326 -1.75 . . . . 0.0 107.777 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 61.58 13.89 5.54 Favored 'General case' 0 C--N 1.282 -2.341 0 C-N-CA 119.353 -0.939 . . . . 0.0 113.336 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.641 ' O ' ' N ' ' A' ' 82' ' ' ILE . 22.4 m -88.88 82.09 6.81 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 120.247 -1.533 . . . . 0.0 109.636 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 83' ' ' GLN . . . -43.98 10.42 0.0 OUTLIER Glycine 0 CA--C 1.577 3.918 0 CA-C-O 117.594 -1.67 . . . . 0.0 115.768 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.403 HG21 ' CG1' ' A' ' 100' ' ' VAL . 0.3 OUTLIER -49.06 -12.18 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 123.983 3.892 . . . . 0.0 110.849 -178.571 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.831 ' N ' HD12 ' A' ' 82' ' ' ILE . 1.1 tm0? -36.78 -19.47 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.724 ' HB1' HD22 ' A' ' 63' ' ' LEU . . . -63.87 -86.72 0.01 OUTLIER 'General case' 0 C--O 1.191 -1.995 1 N-CA-C 98.675 -4.565 . . . . 0.0 98.675 171.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.719 HD13 HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -16.96 -56.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.531 3.597 0 CA-C-N 124.009 3.095 . . . . 0.0 109.336 177.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -53.1 -58.36 7.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.008 -1.682 . . . . 0.0 109.611 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 84' ' ' ALA . 56.0 tt0 -43.67 -56.65 3.62 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 117.156 -1.402 . . . . 0.0 111.563 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -65.15 -59.26 4.29 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 124.318 3.235 . . . . 0.0 109.182 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -48.26 -59.57 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 C-N-CA 114.686 -2.805 . . . . 0.0 111.313 -175.526 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.829 ' O ' ' N ' ' A' ' 93' ' ' ASN . 24.6 ptt180 -52.14 -39.19 59.6 Favored 'General case' 0 C--O 1.193 -1.887 0 CA-C-N 120.567 1.53 . . . . 0.0 111.045 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.599 ' C ' ' O ' ' A' ' 90' ' ' ARG . 16.3 tttm -34.11 -44.75 0.19 Allowed 'General case' 0 N--CA 1.536 3.839 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 91' ' ' LYS . 16.0 mmm180 -35.63 -53.32 0.7 Allowed 'General case' 0 N--CA 1.516 2.873 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.829 ' N ' ' O ' ' A' ' 90' ' ' ARG . 74.6 m-80 -140.37 -66.65 0.44 Allowed 'General case' 0 N--CA 1.514 2.745 0 CA-C-N 121.737 2.062 . . . . 0.0 111.261 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 2.1 m-20 159.71 -7.85 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.054 0 CA-C-O 121.572 0.701 . . . . 0.0 109.732 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.76 155.82 22.91 Favored 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.919 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER 157.49 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.53 3.559 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.669 -178.06 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.86 83.14 1.94 Allowed 'General case' 0 C--O 1.215 -0.75 1 N-CA-C 98.532 -4.618 . . . . 0.0 98.532 169.664 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.58 HD12 HG23 ' A' ' 165' ' ' ILE . 16.6 tt -104.69 155.66 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 123.633 1.683 . . . . 0.0 109.461 -175.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.647 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -151.15 139.28 14.3 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 CA-C-N 112.399 -2.182 . . . . 0.0 113.149 -171.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 1.403 ' CG1' HG21 ' A' ' 82' ' ' ILE . 7.3 p -105.53 130.95 56.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 1 N-CA-C 94.246 -6.205 . . . . 0.0 94.246 169.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 102' ' ' ASP . 1.6 m -121.6 151.91 39.86 Favored 'General case' 0 N--CA 1.508 2.471 0 CA-C-N 121.573 1.988 . . . . 0.0 111.607 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.677 ' O ' HG22 ' A' ' 101' ' ' THR . 37.4 t70 -96.16 -163.07 1.01 Allowed 'General case' 0 C--N 1.29 -1.989 1 N-CA-C 98.507 -4.627 . . . . 0.0 98.507 167.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.674 ' SD ' HD21 ' A' ' 129' ' ' LEU . 4.2 tpt -89.41 77.72 7.29 Favored 'General case' 0 C--N 1.268 -2.975 0 C-N-CA 116.074 -2.25 . . . . 0.0 109.852 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 105' ' ' SER . 64.3 tp60 -150.97 -30.4 0.18 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 119.193 -2.192 . . . . 0.0 109.046 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.634 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 26.7 t 60.95 138.13 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 105' ' ' SER . 1.1 tp 153.51 140.43 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 139.69 58.8 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.477 ' HB3' HG13 ' A' ' 82' ' ' ILE . 3.4 m-30 -97.68 -1.18 44.13 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 t -129.03 146.84 50.9 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.606 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -142.3 105.0 5.55 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -172.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.556 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 27.7 Cg_endo -93.11 -46.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 N-CA-C 106.11 -2.304 . . . . 0.0 106.11 172.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.556 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 2.5 tm-20 -108.54 130.01 55.29 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 175.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.67 -58.59 7.89 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.409 ' N ' ' OE2' ' A' ' 112' ' ' GLU . 99.0 mm-40 -71.62 -29.64 64.89 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -174.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -58.92 -31.02 68.27 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 123.632 2.924 . . . . 0.0 106.437 -178.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.818 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.7 OUTLIER -54.04 -89.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.219 178.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.688 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -27.58 -8.61 0.0 OUTLIER Glycine 0 N--CA 1.493 2.436 0 C-N-CA 123.961 0.791 . . . . 0.0 114.647 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.818 ' N ' ' O ' ' A' ' 116' ' ' ILE . 3.6 mt-30 -76.56 -70.59 0.21 Allowed Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 118.954 -2.497 . . . . 0.0 114.034 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.432 ' C ' ' O ' ' A' ' 118' ' ' GLN . 51.9 Cg_exo -19.12 95.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 124.289 3.326 . . . . 0.0 115.536 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.492 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 0.0 OUTLIER 175.0 11.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 123' ' ' ASP . 74.4 tttt -164.56 -27.44 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.1 -1.0 . . . . 0.0 109.471 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -41.6 -13.75 0.01 OUTLIER Glycine 1 N--CA 1.516 4.009 0 O-C-N 121.303 -0.873 . . . . 0.0 111.908 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 121' ' ' LYS . 39.1 m-20 65.01 43.65 3.7 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 118.712 1.256 . . . . 0.0 112.382 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -128.42 -26.98 2.7 Favored 'General case' 0 N--CA 1.518 2.931 0 C-N-CA 117.456 -1.697 . . . . 0.0 109.832 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.59 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 12.1 mt -80.02 -16.04 12.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 O-C-N 120.729 -1.232 . . . . 0.0 110.556 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -53.47 -44.21 68.77 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.432 -1.417 . . . . 0.0 110.276 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.697 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 59.3 mttm -73.54 -31.4 63.64 Favored 'General case' 0 C--O 1.193 -1.915 0 O-C-N 121.284 -0.885 . . . . 0.0 109.569 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.405 ' O ' ' OD1' ' A' ' 130' ' ' ASN . . . -83.07 -20.6 34.63 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.37 -1.456 . . . . 0.0 109.189 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.674 HD21 ' SD ' ' A' ' 103' ' ' MET . 0.6 OUTLIER -55.03 -18.7 5.58 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.565 -0.709 . . . . 0.0 109.291 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.709 ' CG ' ' H ' ' A' ' 131' ' ' GLY 0.348 43.3 p-10 -79.28 -105.87 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.709 ' H ' ' CG ' ' A' ' 130' ' ' ASN . . . -156.22 41.85 0.56 Allowed Glycine 0 CA--C 1.563 3.067 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.405 ' HB3' HD22 ' A' ' 130' ' ' ASN . 68.5 tt0 -146.47 161.17 41.0 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 119.409 -2.23 . . . . 0.0 110.891 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 133' ' ' GLU . 6.8 mp0 -73.8 165.15 25.63 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 122.091 0.948 . . . . 0.0 112.706 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 53.7 t30 -166.03 150.93 8.33 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.658 ' CG2' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -134.38 131.18 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 O-C-N 119.661 -1.9 . . . . 0.0 110.473 -177.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.28 160.85 39.73 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.159 -0.963 . . . . 0.0 111.5 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.2 mt -102.39 142.45 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-O 121.835 0.826 . . . . 0.0 112.118 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.439 ' CG ' ' N ' ' A' ' 139' ' ' ARG . 4.1 t-20 -119.11 161.62 19.99 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 138' ' ' ASN . 2.6 ptm180 -164.27 109.05 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.405 -0.918 . . . . 0.0 108.57 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -162.76 114.61 0.61 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.722 -1.704 . . . . 0.0 110.56 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 3.4 t80 60.01 -73.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.572 -0.958 . . . . 0.0 109.444 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.134 HD13 ' OE2' ' A' ' 168' ' ' GLU . 33.7 mt -47.91 -79.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 142' ' ' LEU . . . 161.81 159.95 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.335 0.588 . . . . 0.0 110.606 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 143' ' ' ALA . 39.5 mt-30 -42.37 134.96 2.82 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.951 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -156.44 155.29 31.83 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.14 152.88 25.48 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 121.117 1.781 . . . . 0.0 111.192 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 155.34 49.87 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.658 HG12 ' CG2' ' A' ' 135' ' ' VAL . 3.6 m -118.15 155.79 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 47.3 m-85 -125.51 137.66 53.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.586 0.707 . . . . 0.0 109.375 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.09 146.54 43.72 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -92.42 154.82 3.03 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 123.812 3.008 . . . . 0.0 114.981 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.2 mt -117.29 133.45 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.773 -0.579 . . . . 0.0 109.934 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 155' ' ' GLU . 77.4 m-85 -103.13 144.12 31.72 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.4 51.11 0.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 153' ' ' TYR . 9.2 tt0 41.1 25.06 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.187 -0.946 . . . . 0.0 111.657 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -138.77 30.6 2.29 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 62.46 2.67 0.93 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -92.23 124.87 36.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.586 ' O ' ' CD ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -73.1 129.99 39.3 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -175.509 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.422 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.7 pp -138.94 14.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.24 -1.537 . . . . 0.0 114.404 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.23 176.09 45.98 Favored Glycine 0 N--CA 1.505 3.298 0 C-N-CA 116.042 -2.98 . . . . 0.0 112.798 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.5 ' O ' ' OG1' ' A' ' 101' ' ' THR . 55.5 t -136.61 133.73 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 121.771 0.796 . . . . 0.0 110.387 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 79.7 t -106.03 122.63 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.647 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -119.35 141.93 48.59 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.676 HG21 ' HB1' ' A' ' 56' ' ' ALA . 22.3 mt -131.67 110.91 17.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.25 119.21 6.31 Favored Glycine 0 N--CA 1.487 2.039 0 C-N-CA 119.095 -1.526 . . . . 0.0 111.528 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.951 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -94.5 114.89 26.96 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 1.134 ' OE2' HD13 ' A' ' 142' ' ' LEU . 13.5 tp10 -74.86 134.88 41.6 Favored 'General case' 0 N--CA 1.518 2.951 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' A' ' 168' ' ' GLU . 11.0 tp . . . . . 0 N--CA 1.534 3.725 0 CA-C-N 119.04 0.836 . . . . 0.0 111.315 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.66 0.743 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -71.41 -65.6 0.73 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.336 -0.852 . . . . 0.0 108.957 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 24.6 ttt -41.42 -55.92 2.65 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.888 -1.132 . . . . 0.0 110.838 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.46 ' OG1' ' CD2' ' A' ' 52' ' ' LEU . 5.8 t -60.33 -32.61 71.4 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 122.181 0.991 . . . . 0.0 108.881 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' THR . 53.8 ttp180 -41.61 -60.86 1.21 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.25 -1.531 . . . . 0.0 112.538 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -76.57 -60.98 2.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.85 -49.55 22.58 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.915 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.545 HD11 HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -51.81 -43.45 63.1 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 120.747 2.273 . . . . 0.0 108.194 178.319 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.82 -49.09 71.87 Favored 'General case' 0 C--O 1.204 -1.322 0 C-N-CA 117.407 -1.717 . . . . 0.0 109.481 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -78.72 -69.51 0.56 Allowed 'General case' 0 C--N 1.308 -1.214 0 O-C-N 120.099 -1.626 . . . . 0.0 111.434 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -47.31 -59.45 3.18 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.274 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -66.32 -36.34 82.69 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 123.389 2.813 . . . . 0.0 111.609 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.25 -42.41 73.45 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.062 -1.648 . . . . 0.0 108.678 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.433 ' O ' ' HG3' ' A' ' 61' ' ' ARG . . . -75.85 -51.2 13.05 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' A' ' 88' ' ' ALA . 39.0 t -63.37 -43.8 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 119.428 -2.045 . . . . 0.0 106.678 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.02 -28.62 39.42 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -76.81 -20.78 56.0 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.429 -0.909 . . . . 0.0 111.971 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.3 m -67.36 -45.7 75.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 118.893 -2.379 . . . . 0.0 106.843 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.535 ' CD2' ' HB1' ' A' ' 84' ' ' ALA . 2.2 mt -90.2 -31.91 16.83 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 113.714 -1.585 . . . . 0.0 111.13 -177.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.653 ' O ' HG21 ' A' ' 69' ' ' ILE . . . -68.02 -15.87 63.79 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 119.84 -1.788 . . . . 0.0 106.246 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 28.4 t70 -90.22 -9.17 49.03 Favored 'General case' 0 N--CA 1.528 3.427 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.861 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.492 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -70.18 -152.23 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.27 0 O-C-N 120.075 -1.641 . . . . 0.0 110.695 -178.334 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.712 ' C ' ' H ' ' A' ' 69' ' ' ILE . 2.0 Cg_endo -104.82 -30.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.079 2.519 . . . . 0.0 114.683 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.474 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 13.2 pt-20 -72.27 26.81 0.05 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.712 ' H ' ' C ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -100.72 -83.0 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 176.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -47.23 -31.2 3.51 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.364 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -80.15 -18.76 48.87 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.329 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -86.91 -38.0 8.2 Favored Glycine 0 CA--C 1.479 -2.21 1 N-CA-C 101.633 -4.587 . . . . 0.0 101.633 178.39 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.422 HD11 ' O ' ' A' ' 101' ' ' THR . 1.9 tp -56.58 -34.21 66.93 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -77.74 0.51 23.3 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.829 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.799 ' O ' ' O ' ' A' ' 76' ' ' LYS . 4.7 tmtp? -131.95 45.9 2.72 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 120.319 1.418 . . . . 0.0 112.785 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.799 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 17.37 157.05 0.0 OUTLIER Pre-proline 0 N--CA 1.535 3.819 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -29.92 -60.58 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.364 2.709 . . . . 0.0 113.984 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -52.57 130.29 31.61 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 118.617 -1.233 . . . . 0.0 109.834 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.519 ' CD ' ' HZ1' ' A' ' 75' ' ' LYS . 31.5 tt0 65.49 13.8 9.08 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.877 176.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.831 ' O ' ' N ' ' A' ' 82' ' ' ILE . 15.3 t -79.56 97.9 6.65 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.499 -1.375 . . . . 0.0 110.094 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -43.76 66.73 0.0 OUTLIER Glycine 1 CA--C 1.578 4.018 0 C-N-CA 118.503 -1.808 . . . . 0.0 111.652 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.831 ' N ' ' O ' ' A' ' 80' ' ' SER . 7.7 tp -73.52 1.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.218 -1.754 . . . . 0.0 111.2 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -52.8 -29.06 25.44 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.7 -1.25 . . . . 0.0 113.161 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.847 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -81.26 -86.65 0.09 Allowed 'General case' 0 C--O 1.193 -1.911 0 N-CA-C 100.653 -3.832 . . . . 0.0 100.653 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.866 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -19.52 -63.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 121.548 1.977 . . . . 0.0 106.075 -178.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 1.002 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -42.56 -52.08 4.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.301 -1.5 . . . . 0.0 110.144 174.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.847 ' N ' ' O ' ' A' ' 84' ' ' ALA . 36.2 tp10 -36.86 -46.57 0.63 Allowed 'General case' 0 N--CA 1.536 3.828 0 C-N-CA 116.515 -2.074 . . . . 0.0 106.699 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.447 ' CB ' HG12 ' A' ' 59' ' ' VAL . . . -49.64 -17.34 0.31 Allowed 'General case' 0 N--CA 1.512 2.667 0 O-C-N 119.446 -2.034 . . . . 0.0 108.796 171.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 1.002 ' N ' ' O ' ' A' ' 86' ' ' ALA . 22.7 m -60.8 -33.97 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 C-N-CA 115.879 -2.328 . . . . 0.0 109.101 174.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 89' ' ' VAL . 33.1 ttm180 -85.51 -49.19 8.26 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 114.328 -1.305 . . . . 0.0 113.812 -174.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -60.58 -36.79 79.37 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.444 -1.303 . . . . 0.0 108.452 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.765 ' NH2' ' H ' ' A' ' 95' ' ' LEU . 36.1 ttp85 -60.94 -71.2 0.15 Allowed 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 94' ' ' ASP . 35.6 m120 -161.53 -27.69 0.05 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.673 -1.267 . . . . 0.0 112.007 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 18.9 t70 139.8 -28.54 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.836 0 CA-C-N 120.167 1.349 . . . . 0.0 110.141 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.765 ' H ' ' NH2' ' A' ' 92' ' ' ARG . 0.3 OUTLIER -122.54 151.57 41.25 Favored 'General case' 0 N--CA 1.521 3.075 0 CA-C-N 113.701 -1.59 . . . . 0.0 114.601 -177.366 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.668 ' CD1' HG22 ' A' ' 165' ' ' ILE . 0.2 OUTLIER 150.36 162.31 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.0 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 178.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -107.92 95.39 5.65 Favored 'General case' 0 C--O 1.207 -1.132 1 CA-C-N 126.509 4.231 . . . . 0.0 100.247 170.335 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.567 HG13 HG23 ' A' ' 165' ' ' ILE . 1.6 mt -90.36 117.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 1.1 p -136.06 139.98 44.79 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.639 0 CA-C-N 111.402 -2.635 . . . . 0.0 112.568 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.64 141.2 22.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 1 N-CA-C 99.451 -4.277 . . . . 0.0 99.451 174.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.441 ' CG2' ' H ' ' A' ' 105' ' ' SER . 0.7 OUTLIER -131.49 153.38 49.84 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.534 -1.354 . . . . 0.0 110.664 -176.185 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -86.65 -172.52 4.05 Favored 'General case' 0 C--N 1.281 -2.376 1 N-CA-C 99.488 -4.264 . . . . 0.0 99.488 170.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.594 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -81.2 77.03 8.13 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 114.25 -2.98 . . . . 0.0 109.577 -177.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.473 ' O ' ' CB ' ' A' ' 105' ' ' SER . 8.2 tp-100 -147.85 -40.67 0.17 Allowed 'General case' 0 C--O 1.209 -1.026 0 O-C-N 119.375 -2.078 . . . . 0.0 111.14 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.568 ' OG ' ' CD1' ' A' ' 125' ' ' ILE . 7.6 t 89.56 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.337 1.055 . . . . 0.0 109.03 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.4 OUTLIER 157.81 121.87 0.0 OUTLIER 'General case' 0 C--O 1.191 -1.982 0 N-CA-C 103.884 -2.636 . . . . 0.0 103.884 177.561 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.613 ' HE ' ' N ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -64.41 103.95 0.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.523 ' CD1' HG23 ' A' ' 99' ' ' VAL . 3.1 m-85 -57.84 -27.47 63.23 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -122.86 165.79 16.07 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.018 -178.646 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.953 ' CD2' HD11 ' A' ' 116' ' ' ILE . 14.5 p80 179.01 161.97 0.71 Allowed Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.343 -0.848 . . . . 0.0 110.907 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -87.82 -44.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.483 0.885 0 N-CA-C 106.637 -2.101 . . . . 0.0 106.637 173.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.494 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -108.02 135.44 49.39 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 174.234 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.3 -25.17 64.1 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.171 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -65.19 -37.49 87.5 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 119.971 -1.705 . . . . 0.0 114.841 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -65.03 -30.21 71.17 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 119.434 -2.041 . . . . 0.0 107.818 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.953 HD11 ' CD2' ' A' ' 110' ' ' HIS . 55.0 mt -40.42 -85.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.589 0 CA-C-O 122.601 1.191 . . . . 0.0 111.639 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.67 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -45.53 -10.83 0.02 OUTLIER Glycine 0 N--CA 1.494 2.513 0 CA-C-N 115.144 -0.934 . . . . 0.0 113.691 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.41 ' CB ' ' CD ' ' A' ' 119' ' ' PRO . 2.0 mt-30 -64.2 -68.58 0.76 Allowed Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 120.394 2.097 . . . . 0.0 112.047 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 2.7 Cg_exo -35.96 107.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 123.933 3.088 . . . . 0.0 115.274 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.586 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 45.8 t80 173.1 28.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -176.28 -8.66 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.65 -19.3 1.25 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.5 t70 68.56 3.92 4.07 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.144 -1.21 . . . . 0.0 109.731 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.457 ' CG ' ' CB ' ' A' ' 136' ' ' ALA . 27.9 m-20 -90.66 -24.63 20.42 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.486 -0.886 . . . . 0.0 108.75 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.568 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 31.0 mt -86.49 -26.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.207 -0.933 . . . . 0.0 112.806 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 125' ' ' ILE . 3.7 mm? -37.57 -50.9 1.16 Allowed 'General case' 0 N--CA 1.517 2.884 0 O-C-N 121.01 -1.056 . . . . 0.0 109.918 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.723 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 54.6 mttm -70.53 -29.7 66.25 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.848 -1.157 . . . . 0.0 109.29 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 125' ' ' ILE . . . -90.54 -33.99 15.7 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.976 -1.077 . . . . 0.0 109.481 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.4 OUTLIER -36.82 -38.13 0.17 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.413 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.723 ' ND2' ' O ' ' A' ' 127' ' ' LYS . 20.9 p30 -74.31 -91.91 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.679 ' N ' ' OD1' ' A' ' 130' ' ' ASN . . . -168.5 57.12 0.21 Allowed Glycine 0 CA--C 1.558 2.753 0 O-C-N 120.068 -1.645 . . . . 0.0 110.347 176.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -140.23 157.05 46.19 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.715 -1.462 . . . . 0.0 109.048 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.457 ' O ' ' CG ' ' A' ' 134' ' ' ASN . 28.3 mp0 -68.66 159.22 32.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.651 -0.655 . . . . 0.0 111.797 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 133' ' ' GLU . 22.6 m120 -166.28 142.06 4.74 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.656 ' CG2' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -132.74 131.38 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 O-C-N 119.646 -1.909 . . . . 0.0 110.419 -178.401 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.457 ' CB ' ' CG ' ' A' ' 124' ' ' ASP . . . -152.49 163.19 40.06 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.418 -0.801 . . . . 0.0 110.884 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.2 mt -97.02 128.63 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.648 0 O-C-N 121.146 -0.971 . . . . 0.0 111.353 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -97.21 153.15 18.18 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -133.44 156.99 46.7 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -166.18 161.94 35.54 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -44.34 -23.99 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -1.177 . . . . 0.0 110.186 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -73.3 -80.66 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.833 -1.167 . . . . 0.0 108.679 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -173.38 159.14 3.67 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.0 111.993 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.662 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 25.2 mp0 -45.31 143.39 1.75 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.699 0.761 . . . . 0.0 109.555 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.872 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -146.56 150.64 35.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 tp -108.43 152.51 24.59 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 122.006 2.185 . . . . 0.0 109.788 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -142.92 134.97 27.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.996 -1.065 . . . . 0.0 110.705 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.656 HG12 ' CG2' ' A' ' 135' ' ' VAL . 16.2 m -104.87 136.37 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 CA-C-O 122.232 1.015 . . . . 0.0 109.91 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 89.8 m-85 -108.42 140.87 41.1 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.506 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.88 150.89 67.05 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.4 ' HB3' ' C ' ' A' ' 131' ' ' GLY . 0.8 OUTLIER -92.66 149.99 2.81 Favored 'Trans proline' 0 N--CA 1.515 2.769 0 C-N-CA 123.65 2.9 . . . . 0.0 116.757 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 61.3 mt -116.25 125.83 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.528 ' C ' ' H ' ' A' ' 155' ' ' GLU . 97.3 m-85 -95.28 142.73 27.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.17 -0.956 . . . . 0.0 110.846 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 47.3 t0 -55.09 -3.36 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.548 -1.345 . . . . 0.0 109.23 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 154' ' ' ASP . 53.2 tt0 99.39 4.69 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 158' ' ' LYS . 32.6 m120 -129.07 36.7 4.16 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.099 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 60.98 -2.39 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.5 mptt -81.27 126.3 31.39 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.632 ' O ' ' CD ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -73.88 125.71 28.8 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -175.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.7 pp -143.07 7.31 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 118.799 -2.438 . . . . 0.0 116.971 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.64 173.12 44.44 Favored Glycine 0 N--CA 1.513 3.801 0 C-N-CA 116.619 -2.705 . . . . 0.0 111.853 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 101' ' ' THR . 58.3 t -137.25 139.96 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 120.965 -1.314 . . . . 0.0 111.118 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 56.1 t -103.91 127.79 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.561 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -114.99 155.64 26.56 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.668 HG22 ' CD1' ' A' ' 96' ' ' LEU . 12.8 mt -151.29 95.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.615 ' C ' HD13 ' A' ' 96' ' ' LEU . . . -105.06 135.37 12.52 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.354 -175.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.872 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 0.7 OUTLIER -100.74 112.09 24.43 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 113.897 -1.151 . . . . 0.0 108.633 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -48.64 77.15 Favored 'General case' 0 N--CA 1.524 3.227 0 CA-C-O 123.025 1.393 . . . . 0.0 109.565 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.509 2.502 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.811 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.73 0.776 . . . . 0.0 109.095 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -60.82 -51.43 69.36 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 124.269 1.985 . . . . 0.0 108.9 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -28.99 66.53 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.513 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.726 HG23 HD23 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -61.17 -36.94 81.19 Favored 'General case' 0 C--O 1.203 -1.367 0 O-C-N 118.106 -2.871 . . . . 0.0 104.478 175.274 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -54.87 -52.15 63.75 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 116.508 -2.077 . . . . 0.0 109.465 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.77 -65.67 0.65 Allowed 'General case' 0 N--CA 1.517 2.905 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 52' ' ' LEU . . . -65.38 -51.83 45.41 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.726 HD23 HG23 ' A' ' 48' ' ' THR . 0.2 OUTLIER -52.44 -37.9 57.98 Favored 'General case' 0 C--O 1.206 -1.234 0 O-C-N 120.34 -1.683 . . . . 0.0 106.9 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 57' ' ' LEU . . . -56.83 -65.08 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.228 -1.789 . . . . 0.0 108.045 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -55.34 -63.86 1.03 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.052 -1.655 . . . . 0.0 112.596 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -67.63 -20.0 65.28 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.868 -1.145 . . . . 0.0 112.352 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 52' ' ' LEU . . . -97.09 -35.7 10.72 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 121.226 1.83 . . . . 0.0 109.012 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 1.2 tt -64.76 -33.32 75.69 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 121.009 -1.057 . . . . 0.0 108.56 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.87 -43.58 44.82 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.334 -0.854 . . . . 0.0 112.865 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.41 -32.61 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 118.175 -2.828 . . . . 0.0 107.512 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.924 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -58.43 -25.11 61.83 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.423 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -72.03 -21.98 61.46 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 117.008 -1.877 . . . . 0.0 109.526 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 98.6 m -69.61 -53.96 16.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 118.111 -2.868 . . . . 0.0 108.616 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.587 ' N ' HD22 ' A' ' 63' ' ' LEU . 4.1 mm? -79.16 -44.03 22.77 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.048 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.78 -18.0 4.19 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 119.932 -1.73 . . . . 0.0 106.744 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.488 ' N ' ' C ' ' A' ' 63' ' ' LEU . 18.5 t0 -87.56 -10.91 50.24 Favored 'General case' 0 N--CA 1.52 3.047 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.909 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.527 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -73.05 -157.96 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.938 0 O-C-N 120.484 -1.385 . . . . 0.0 109.04 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.527 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -109.21 -15.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.619 2.879 . . . . 0.0 113.837 176.238 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.458 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -74.87 -41.11 60.45 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.462 -0.774 . . . . 0.0 109.825 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 70' ' ' ARG . 1.7 mp -57.33 -75.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.318 -1.489 . . . . 0.0 109.896 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.607 ' N ' HG22 ' A' ' 69' ' ' ILE . 62.4 ttt-85 -45.42 -35.79 3.91 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.399 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -77.88 -14.66 59.48 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 111.899 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.508 ' C ' ' N ' ' A' ' 74' ' ' GLN . . . -94.84 -47.97 2.58 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 103.538 -3.825 . . . . 0.0 103.538 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -49.23 -23.64 1.43 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.092 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.508 ' N ' ' C ' ' A' ' 72' ' ' GLY . 55.7 tp60 -50.76 -9.16 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.801 -1.545 . . . . 0.0 109.588 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.844 ' O ' ' O ' ' A' ' 76' ' ' LYS . 5.1 mmtp -150.51 85.46 1.38 Allowed 'General case' 0 N--CA 1.523 3.175 0 O-C-N 120.847 -1.158 . . . . 0.0 113.016 -177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.844 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 23.91 164.13 0.0 OUTLIER Pre-proline 1 N--CA 1.539 4.008 0 CA-C-N 121.986 2.175 . . . . 0.0 116.19 179.668 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 78' ' ' GLN . 6.2 Cg_exo -32.36 -68.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.509 2.41 0 C-N-CA 124.255 3.304 . . . . 0.0 115.293 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 77' ' ' PRO . 91.8 mt-30 -35.98 133.1 0.47 Allowed 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.784 1.278 . . . . 0.0 111.024 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 63.04 19.28 11.55 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.716 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.9 ' O ' ' N ' ' A' ' 82' ' ' ILE . 33.8 m -90.0 83.66 6.12 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.347 -1.471 . . . . 0.0 109.341 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -38.88 52.31 0.0 OUTLIER Glycine 0 N--CA 1.508 3.464 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.569 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.9 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.4 tp -63.86 -1.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 120.514 -1.58 . . . . 0.0 108.038 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.44 ' H ' ' C ' ' A' ' 81' ' ' GLY . 17.7 mp0 -58.4 -21.92 52.14 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 120.974 -1.079 . . . . 0.0 112.199 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -85.84 -63.64 1.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 121.951 2.159 . . . . 0.0 112.061 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.568 HD11 HD12 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -48.27 -34.09 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 122.718 2.508 . . . . 0.0 107.067 172.232 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 90' ' ' ARG . . . -65.43 -48.36 73.02 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' ALA . 36.8 tt0 -48.22 -56.6 7.55 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 117.443 -1.265 . . . . 0.0 112.425 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.95 -44.16 23.06 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 123.553 2.888 . . . . 0.0 108.306 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 85' ' ' ILE . 98.8 t -55.97 -76.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 116.071 -2.251 . . . . 0.0 108.977 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.623 ' O ' ' C ' ' A' ' 91' ' ' LYS . 45.8 ttm-85 -34.7 -58.53 0.5 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.55 0.74 . . . . 0.0 110.038 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.623 ' C ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -32.32 -49.04 0.19 Allowed 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 117.35 -1.74 . . . . 0.0 107.582 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -55.35 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 117.064 -1.446 . . . . 0.0 111.107 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.926 ' O ' ' ND2' ' A' ' 93' ' ' ASN . 0.3 OUTLIER -71.27 -3.61 21.33 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 113.864 -3.134 . . . . 0.0 108.903 -172.097 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.539 ' O ' HD23 ' A' ' 95' ' ' LEU . 7.6 t70 62.01 40.87 11.77 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -174.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 158.94 165.23 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.605 HD22 HG22 ' A' ' 165' ' ' ILE . 4.1 mt 150.07 163.34 0.0 OUTLIER 'General case' 1 N--CA 1.557 4.924 0 CA-C-N 121.194 1.815 . . . . 0.0 108.505 178.407 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -113.82 85.87 2.29 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 171.15 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.924 HD11 ' HB2' ' A' ' 60' ' ' ALA . 0.9 OUTLIER -91.62 113.1 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 104.708 -2.331 . . . . 0.0 104.708 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.662 ' CG2' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -122.13 135.75 61.22 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.379 0 CA-C-N 112.808 -1.996 . . . . 0.0 112.454 -174.099 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.489 HG11 HG23 ' A' ' 69' ' ' ILE . 7.1 p -111.19 128.78 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 1 N-CA-C 98.679 -4.563 . . . . 0.0 98.679 171.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.662 HG23 ' CG2' ' A' ' 99' ' ' VAL . 3.3 p -117.89 155.05 30.84 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.343 -1.473 . . . . 0.0 109.842 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.61 ' O ' ' N ' ' A' ' 104' ' ' GLN . 1.5 t70 -82.3 -175.85 5.89 Favored 'General case' 0 C--N 1.285 -2.201 1 N-CA-C 97.592 -4.966 . . . . 0.0 97.592 170.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.532 ' C ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -70.47 75.64 0.56 Allowed 'General case' 0 C--N 1.268 -2.951 0 C-N-CA 113.89 -3.124 . . . . 0.0 105.499 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.61 ' N ' ' O ' ' A' ' 102' ' ' ASP . 6.6 mm-40 -136.78 -51.54 0.68 Allowed 'General case' 0 C--O 1.214 -0.798 0 O-C-N 119.365 -2.085 . . . . 0.0 108.189 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.766 ' OG ' HD13 ' A' ' 125' ' ' ILE . 0.5 OUTLIER 84.6 134.51 0.05 Allowed 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -178.548 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.647 ' H ' ' NH2' ' A' ' 107' ' ' ARG . 1.5 pp 148.41 147.4 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.647 ' NH2' ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -69.07 139.87 54.85 Favored 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 178.712 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.512 ' CD2' HD13 ' A' ' 82' ' ' ILE . 1.6 m-85 -96.73 -35.8 10.87 Favored 'General case' 0 C--N 1.258 -3.387 0 N-CA-C 103.498 -2.778 . . . . 0.0 103.498 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.22 167.48 10.65 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 112.197 -2.274 . . . . 0.0 112.222 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.512 ' CD2' HD11 ' A' ' 116' ' ' ILE . 17.3 p80 -175.16 153.77 1.6 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.813 -1.179 . . . . 0.0 112.482 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.578 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 41.1 Cg_endo -90.75 -37.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 N-CA-C 106.191 -2.273 . . . . 0.0 106.191 172.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.578 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 57.0 tt0 -102.17 115.18 30.0 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.404 ' HA ' ' ND1' ' A' ' 110' ' ' HIS . . . -48.47 -47.43 38.5 Favored 'General case' 0 C--N 1.29 -1.99 0 O-C-N 121.011 -1.055 . . . . 0.0 112.084 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -64.39 -31.06 72.12 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.271 -1.518 . . . . 0.0 115.034 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.678 ' NE ' ' OE1' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -66.83 -22.21 66.01 Favored 'General case' 0 C--O 1.197 -1.687 0 O-C-N 119.35 -2.094 . . . . 0.0 107.969 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.84 HG22 ' N ' ' A' ' 117' ' ' GLY . 54.8 mt -35.11 -91.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.84 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -85.81 -9.72 77.33 Favored Glycine 0 N--CA 1.502 3.078 0 O-C-N 121.025 -1.047 . . . . 0.0 114.034 -173.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.688 ' N ' ' HD2' ' A' ' 119' ' ' PRO . 3.2 pt20 -60.5 -40.66 77.97 Favored Pre-proline 0 C--N 1.294 -1.807 0 C-N-CA 116.442 -2.103 . . . . 0.0 110.14 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 118' ' ' GLN . 8.3 Cg_endo -48.15 113.87 0.95 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.662 2.241 . . . . 0.0 112.894 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.445 ' CD2' ' O ' ' A' ' 120' ' ' PHE . 69.7 t80 -178.89 29.06 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -132.45 42.74 3.07 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.665 -0.647 . . . . 0.0 112.518 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.35 -46.94 0.1 Allowed Glycine 0 N--CA 1.51 3.59 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 75.32 20.03 2.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.917 -0.754 . . . . 0.0 111.421 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.468 ' OD2' ' CE2' ' A' ' 149' ' ' PHE . 19.7 p-10 -84.1 -2.68 57.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.213 -1.554 . . . . 0.0 108.563 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.766 HD13 ' OG ' ' A' ' 105' ' ' SER . 12.3 pt -84.51 -23.73 7.52 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 O-C-N 120.941 -1.1 . . . . 0.0 110.684 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' A' ' 125' ' ' ILE . 71.6 mt -35.65 -46.09 0.4 Allowed 'General case' 0 N--CA 1.52 3.044 0 O-C-N 121.198 -0.938 . . . . 0.0 110.061 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -79.48 -40.95 28.54 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.351 -0.843 . . . . 0.0 110.81 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -83.1 -30.73 27.72 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.218 -1.551 . . . . 0.0 108.317 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.584 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -38.85 -34.18 0.14 Allowed 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 128' ' ' ALA . 20.3 m-20 -99.42 -104.32 0.22 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -132.11 54.12 0.79 Allowed Glycine 0 N--CA 1.506 3.32 0 C-N-CA 119.801 -1.19 . . . . 0.0 115.27 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -144.55 142.84 30.49 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 120.515 2.157 . . . . 0.0 108.776 178.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.433 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 89.2 mt-10 -69.66 157.1 37.9 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 119.888 -1.758 . . . . 0.0 109.987 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 133' ' ' GLU . 9.3 m120 -160.11 142.55 13.27 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.532 HG22 HG12 ' A' ' 148' ' ' VAL . 2.3 t -131.29 145.3 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.556 -1.34 . . . . 0.0 108.909 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.62 164.18 29.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 109.066 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.2 mt -99.6 139.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 O-C-N 120.717 -1.239 . . . . 0.0 111.029 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.446 HD21 ' CZ ' ' A' ' 115' ' ' ARG . 8.3 t-20 -106.36 138.95 41.62 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.701 0.762 . . . . 0.0 109.709 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.594 ' N ' HH12 ' A' ' 115' ' ' ARG . 14.6 ptm180 -166.95 115.89 0.85 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.38 -1.328 . . . . 0.0 109.43 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.51 ' C ' ' N ' ' A' ' 142' ' ' LEU . . . -162.27 109.21 0.38 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 107.729 -2.149 . . . . 0.0 107.729 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 50.4 13.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.997 -1.296 . . . . 0.0 108.405 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.51 ' N ' ' C ' ' A' ' 140' ' ' GLY . 13.0 tp -134.34 172.5 12.8 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.52 -142.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.233 -1.542 . . . . 0.0 112.465 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -110.79 146.58 36.14 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 176.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.762 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -150.62 142.61 23.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.957 -1.714 . . . . 0.0 107.191 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.423 ' HA ' HD12 ' A' ' 146' ' ' LEU . 9.7 tp -101.79 149.41 24.2 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 122.781 2.537 . . . . 0.0 106.89 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.593 ' NH2' ' CZ ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -144.81 150.55 37.36 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.409 1.099 . . . . 0.0 111.207 -178.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 53' ' ' ALA . 23.9 m -113.14 143.23 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.717 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.49 ' CD1' HG22 ' A' ' 125' ' ' ILE . 28.2 m-85 -110.69 135.02 51.93 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.657 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -136.24 166.4 28.23 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -111.61 154.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.912 0 C-N-CA 124.306 3.338 . . . . 0.0 114.803 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 54.2 mt -118.89 127.68 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.544 ' C ' ' H ' ' A' ' 155' ' ' GLU . 83.4 m-85 -101.76 144.18 30.77 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.927 -1.108 . . . . 0.0 112.201 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 55.7 t0 -65.66 12.79 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.547 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER 86.81 15.65 0.1 Allowed 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.98 -1.075 . . . . 0.0 108.455 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 158' ' ' LYS . 77.7 m-20 -139.27 36.16 2.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.84 -1.162 . . . . 0.0 108.303 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 59.56 3.36 0.41 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.512 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.6 mptt -85.91 130.81 34.44 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.745 ' O ' ' NE2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -85.01 125.62 32.87 Favored 'General case' 0 N--CA 1.512 2.655 0 CA-C-N 119.848 1.204 . . . . 0.0 113.571 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.08 5.49 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 O-C-N 119.926 -1.734 . . . . 0.0 113.88 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -171.26 173.6 44.81 Favored Glycine 0 N--CA 1.501 3.01 0 C-N-CA 118.18 -1.962 . . . . 0.0 112.033 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.569 ' O ' ' OG1' ' A' ' 101' ' ' THR . 1.5 t -133.21 141.99 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 O-C-N 121.799 -0.824 . . . . 0.0 110.708 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.443 ' O ' ' OG1' ' A' ' 150' ' ' THR . 9.2 t -113.25 119.64 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 120.961 -1.087 . . . . 0.0 108.179 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.64 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -112.93 156.61 22.7 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.605 HG22 HD22 ' A' ' 96' ' ' LEU . 23.6 mt -152.14 109.64 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.596 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -115.8 137.09 13.49 Favored Glycine 0 N--CA 1.489 2.178 0 CA-C-O 122.805 1.225 . . . . 0.0 113.636 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.762 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 3.5 tp -95.45 103.27 15.13 Favored 'General case' 0 N--CA 1.514 2.763 0 CA-C-N 113.809 -1.196 . . . . 0.0 108.124 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 169' ' ' LEU . 7.1 tt0 -47.47 -60.27 2.64 Favored 'General case' 0 N--CA 1.523 3.208 0 O-C-N 124.384 1.053 . . . . 0.0 109.684 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.711 ' C ' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.526 3.359 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.767 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.634 0.73 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 49' ' ' ARG . 55.1 t0 -65.28 -56.34 13.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 124.068 1.889 . . . . 0.0 107.303 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 46' ' ' ASP . 11.1 ttt -36.78 -56.92 0.83 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.896 -174.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.542 ' OG1' HD13 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -59.01 -36.44 74.94 Favored 'General case' 0 C--O 1.202 -1.405 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.089 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.484 ' C ' ' O ' ' A' ' 48' ' ' THR . 55.9 ttt-85 -35.79 -64.31 0.31 Allowed 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.044 0.926 . . . . 0.0 111.397 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -70.42 -57.73 4.49 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.96 -35.56 21.15 Favored Glycine 0 N--CA 1.497 2.759 0 C-N-CA 119.572 -1.299 . . . . 0.0 111.397 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.785 HD11 HD21 ' A' ' 96' ' ' LEU . 11.3 tp -53.36 -47.66 69.24 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 120.783 2.291 . . . . 0.0 107.145 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.565 ' HB2' HG11 ' A' ' 148' ' ' VAL . . . -50.7 -61.76 2.01 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.767 -1.173 . . . . 0.0 109.51 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -69.3 -56.37 7.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.268 -1.52 . . . . 0.0 113.359 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -69.58 -41.34 75.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -0.884 . . . . 0.0 112.335 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.63 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -72.86 -35.23 67.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 119.715 -1.866 . . . . 0.0 110.11 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 57' ' ' LEU . 7.2 tt -65.22 -41.31 94.54 Favored 'General case' 0 C--N 1.288 -2.106 0 O-C-N 121.057 -1.027 . . . . 0.0 111.492 177.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.88 -44.42 49.01 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.297 -1.502 . . . . 0.0 114.885 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.38 -43.63 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 118.836 -2.415 . . . . 0.0 106.607 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.875 ' CB ' HD13 ' A' ' 98' ' ' ILE . . . -57.9 -26.42 62.14 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.641 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -71.08 -15.84 62.55 Favored 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 118.474 -1.29 . . . . 0.0 109.009 179.005 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -64.85 -42.47 94.87 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 115.105 -2.638 . . . . 0.0 104.143 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.613 HD22 ' HB1' ' A' ' 84' ' ' ALA . 49.0 mt -87.45 -42.02 13.12 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.801 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.641 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -55.77 -18.47 8.47 Favored 'General case' 0 N--CA 1.522 3.17 0 O-C-N 119.989 -1.694 . . . . 0.0 107.166 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 12.2 t0 -85.49 -22.72 28.08 Favored 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.959 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.51 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -58.38 -156.69 0.0 OUTLIER Pre-proline 0 C--N 1.281 -2.397 0 O-C-N 120.699 -1.251 . . . . 0.0 111.742 -177.65 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -107.4 -35.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.513 2.62 0 C-N-CA 124.476 3.451 . . . . 0.0 115.396 178.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 72' ' ' GLY . 7.4 pt-20 -55.74 -30.98 62.12 Favored 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 118.735 -1.186 . . . . 0.0 109.166 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -53.08 -76.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.267 1.032 . . . . 0.0 111.034 -179.05 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.486 ' N ' HG22 ' A' ' 69' ' ' ILE . 72.5 ttt180 -49.94 -33.85 18.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -83.02 -18.75 38.66 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 118.817 -1.153 . . . . 0.0 112.763 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.783 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -86.31 -46.11 5.37 Favored Glycine 0 N--CA 1.498 2.816 1 N-CA-C 101.931 -4.468 . . . . 0.0 101.931 179.098 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.421 HD11 ' HA ' ' A' ' 102' ' ' ASP . 15.2 tp -46.6 -39.2 10.71 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 175.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.88 6.2 0.94 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.091 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.783 ' N ' ' O ' ' A' ' 72' ' ' GLY . 4.3 tmtt? -143.56 52.84 1.33 Allowed 'General case' 0 N--CA 1.512 2.668 0 O-C-N 120.265 -1.522 . . . . 0.0 114.526 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.658 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 32.95 149.55 0.0 OUTLIER Pre-proline 0 N--CA 1.524 3.24 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 178.092 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -30.79 -70.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.513 2.644 0 C-N-CA 124.875 3.717 . . . . 0.0 118.232 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' HB2' ' HZ2' ' A' ' 76' ' ' LYS . 86.2 mt-30 -44.27 -43.45 7.34 Favored 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -101.97 9.36 40.56 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.483 -1.386 . . . . 0.0 110.15 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.5 m -88.32 125.82 34.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.42 71.97 0.96 Allowed Glycine 0 N--CA 1.489 2.182 0 O-C-N 118.699 -2.501 . . . . 0.0 109.981 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.523 HD11 ' H ' ' A' ' 100' ' ' VAL . 3.1 tp -63.89 -4.64 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 C-N-CA 125.078 1.351 . . . . 0.0 109.585 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.649 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 55.3 tt0 -50.09 -32.7 16.44 Favored 'General case' 0 C--N 1.279 -2.468 0 O-C-N 120.851 -1.155 . . . . 0.0 110.038 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -71.64 -98.5 0.01 OUTLIER 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.787 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -16.08 -44.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.952 0 CA-C-N 121.788 2.085 . . . . 0.0 111.904 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -73.2 -48.08 38.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 119.678 -1.889 . . . . 0.0 109.601 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.649 ' HG2' ' O ' ' A' ' 83' ' ' GLN . 50.9 mm-40 -49.86 -49.8 47.95 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.718 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -66.33 -56.39 11.35 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 125.529 3.786 . . . . 0.0 108.564 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.755 HG13 HD13 ' A' ' 96' ' ' LEU . 1.2 t -52.96 -65.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 115.638 -2.425 . . . . 0.0 108.945 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 1.027 ' HD3' ' H ' ' A' ' 96' ' ' LEU . 1.9 tpp85 -37.97 -46.05 0.94 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.467 -1.395 . . . . 0.0 109.218 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.605 ' C ' ' O ' ' A' ' 90' ' ' ARG . 14.4 ttmm -34.48 -43.45 0.17 Allowed 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 117.592 -1.643 . . . . 0.0 106.705 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.753 ' HD3' ' O ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -39.78 -39.53 0.81 Allowed 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 117.369 -1.3 . . . . 0.0 109.06 172.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 90' ' ' ARG . 1.5 m120 -156.58 -62.93 0.1 Allowed 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 124.783 3.447 . . . . 0.0 111.106 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 1.1 m-20 166.11 -13.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.085 -1.009 . . . . 0.0 111.365 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.44 60.98 1.49 Allowed 'General case' 0 N--CA 1.533 3.696 0 C-N-CA 118.422 -1.311 . . . . 0.0 113.972 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.027 ' H ' ' HD3' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -120.14 142.23 49.12 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 116.793 -1.575 . . . . 0.0 110.773 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -119.95 100.22 7.09 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 124.752 3.433 . . . . 0.0 109.409 176.241 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.875 HD13 ' CB ' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -95.22 111.76 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 174.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.675 ' CG2' ' HB3' ' A' ' 164' ' ' ALA . 4.5 m -112.37 124.21 68.83 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.594 0 CA-C-N 112.097 -2.319 . . . . 0.0 110.199 -173.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.523 ' H ' HD11 ' A' ' 82' ' ' ILE . 9.5 p -96.68 128.08 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 1 N-CA-C 98.754 -4.536 . . . . 0.0 98.754 176.298 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 104' ' ' GLN . 81.0 p -119.99 151.49 38.88 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.464 -175.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 104' ' ' GLN . 38.8 t0 -81.91 -174.77 5.24 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 100.498 -3.89 . . . . 0.0 100.498 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 43.1 ttm -74.81 71.22 1.97 Allowed 'General case' 0 C--N 1.268 -2.976 0 C-N-CA 114.889 -2.724 . . . . 0.0 107.837 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.625 ' O ' ' HB ' ' A' ' 101' ' ' THR . 3.5 pp0? -171.82 136.07 0.89 Allowed 'General case' 0 N--CA 1.436 -1.132 1 N-CA-C 96.844 -5.243 . . . . 0.0 96.844 176.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.698 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 16.3 t -107.72 -179.95 4.05 Favored 'General case' 0 CA--C 1.47 -2.117 0 C-N-CA 116.741 -1.983 . . . . 0.0 106.581 -176.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.698 ' HB2' ' O ' ' A' ' 105' ' ' SER . 3.3 tp 154.04 144.84 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.673 ' HA ' HG11 ' A' ' 99' ' ' VAL . 1.8 mmp_? -77.02 91.51 3.64 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.416 -1.713 . . . . 0.0 108.413 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 107' ' ' ARG . 3.2 m-85 -46.25 -31.14 2.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.416 ' N ' ' C ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -124.42 171.51 9.89 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 113.811 -1.54 . . . . 0.0 113.715 -178.161 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.421 ' CE1' ' HG3' ' A' ' 107' ' ' ARG . 0.1 OUTLIER 172.09 166.6 0.24 Allowed Pre-proline 0 N--CA 1.51 2.531 0 O-C-N 121.511 -0.743 . . . . 0.0 109.576 -179.22 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.447 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 46.5 Cg_endo -88.48 -40.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 122.768 2.312 . . . . 0.0 107.31 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 18.4 tp10 -107.96 93.98 4.83 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.97 1.367 . . . . 0.0 107.663 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' GLU . . . -31.11 -45.78 0.08 Allowed 'General case' 0 N--CA 1.503 2.195 0 CA-C-N 113.27 -1.786 . . . . 0.0 113.007 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -60.01 -33.35 71.88 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 120.395 -1.441 . . . . 0.0 113.772 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -60.9 -36.82 80.23 Favored 'General case' 0 C--O 1.203 -1.387 0 O-C-N 120.114 -1.616 . . . . 0.0 108.151 -178.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.734 ' O ' ' N ' ' A' ' 118' ' ' GLN . 79.7 mt -41.88 -84.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.075 177.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.466 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -27.64 -17.1 0.0 OUTLIER Glycine 0 N--CA 1.497 2.713 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.81 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.734 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.4 mp0 -77.61 -73.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.836 0 CA-C-N 120.946 2.373 . . . . 0.0 114.205 -175.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -30.86 115.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 123.325 2.683 . . . . 0.0 115.224 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.518 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 72.2 t80 171.73 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 123' ' ' ASP . 42.3 mttm -157.1 -26.13 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.41 -176.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 121' ' ' LYS . . . -41.06 -25.35 0.12 Allowed Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.041 -1.037 . . . . 0.0 110.549 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 121' ' ' LYS . 57.6 m-20 60.17 10.83 2.47 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.757 -0.849 . . . . 0.0 110.897 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -88.57 -23.64 23.07 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 128' ' ' ALA . 3.9 mt -80.68 -17.16 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.77 -1.206 . . . . 0.0 112.034 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 125' ' ' ILE . 54.4 mt -49.36 -32.97 12.46 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.556 -1.34 . . . . 0.0 107.481 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.737 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 94.8 mttt -79.65 -30.31 41.21 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 125' ' ' ILE . . . -92.44 -36.32 13.17 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 120.417 1.462 . . . . 0.0 109.262 -176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.4 mt -41.15 -30.49 0.16 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.265 -0.897 . . . . 0.0 108.686 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.737 ' ND2' ' O ' ' A' ' 127' ' ' LYS . 20.4 p30 -77.97 -95.56 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.66 ' N ' ' OD1' ' A' ' 130' ' ' ASN . . . -160.88 33.22 0.39 Allowed Glycine 0 CA--C 1.562 2.978 0 O-C-N 120.594 -1.316 . . . . 0.0 111.131 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -122.98 161.97 23.21 Favored 'General case' 0 N--CA 1.52 3.061 0 O-C-N 119.012 -2.463 . . . . 0.0 109.463 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -77.45 170.66 16.16 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.424 -0.798 . . . . 0.0 112.625 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.684 HD21 ' HB2' ' A' ' 127' ' ' LYS . 10.5 t-20 -171.67 149.97 2.65 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.491 ' CG2' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -133.67 131.88 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 119.877 -1.764 . . . . 0.0 108.93 -178.707 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.01 177.17 9.81 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 121.068 -1.02 . . . . 0.0 110.969 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.78 134.61 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.895 -1.128 . . . . 0.0 111.297 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -98.77 120.19 38.78 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.479 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.611 ' NE ' HE22 ' A' ' 144' ' ' GLN . 6.8 ptp180 -141.41 110.02 6.04 Favored 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 117.871 -1.532 . . . . 0.0 112.062 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -156.81 105.91 0.28 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 58.44 -39.84 0.06 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.343 -0.504 . . . . 0.0 111.586 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 140' ' ' GLY . 71.8 mt -72.81 -85.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.908 -1.12 . . . . 0.0 110.769 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.405 ' CB ' HD23 ' A' ' 169' ' ' LEU . . . -179.05 154.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.964 -1.094 . . . . 0.0 110.25 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.611 HE22 ' NE ' ' A' ' 139' ' ' ARG . 5.0 mm100 -46.46 136.14 7.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.092 -1.005 . . . . 0.0 108.496 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.88 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -148.04 156.6 42.82 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tp -114.93 150.76 35.19 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 122.5 2.409 . . . . 0.0 109.621 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.61 ' NH2' ' NH1' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -150.41 129.32 12.53 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.849 1.309 . . . . 0.0 112.449 -179.195 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 53' ' ' ALA . 10.0 m -91.91 150.15 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.317 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 46.3 m-85 -116.03 138.79 50.91 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.481 ' O ' ' N ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -138.3 138.75 23.39 Favored Pre-proline 0 C--O 1.208 -1.126 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -89.68 155.29 5.17 Favored 'Trans proline' 0 N--CA 1.515 2.782 0 C-N-CA 123.881 3.054 . . . . 0.0 115.136 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.8 mt -121.35 131.4 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.865 -0.522 . . . . 0.0 109.65 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.522 ' C ' ' H ' ' A' ' 155' ' ' GLU . 86.9 m-85 -101.29 144.15 30.48 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.022 -1.049 . . . . 0.0 111.283 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 57.0 t0 -58.86 2.49 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.768 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 153' ' ' TYR . 17.9 tt0 86.24 29.62 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.825 -1.172 . . . . 0.0 108.629 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -149.36 18.6 0.94 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 71.63 9.78 6.36 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -88.55 116.79 27.04 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.553 ' N ' ' OE1' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -68.69 117.54 10.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.087 -1.008 . . . . 0.0 113.332 -177.134 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.421 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.8 pp -134.19 11.13 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -174.21 179.19 45.71 Favored Glycine 0 N--CA 1.504 3.208 0 C-N-CA 115.163 -3.399 . . . . 0.0 114.146 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 96.7 t -143.32 140.62 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-O 122.484 1.135 . . . . 0.0 111.779 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 150' ' ' THR . 63.6 t -111.36 127.39 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.675 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . . . -115.72 153.13 31.91 Favored 'General case' 0 N--CA 1.51 2.563 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.63 HG21 ' HB1' ' A' ' 56' ' ' ALA . 24.5 mt -148.6 103.5 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -114.25 140.97 16.72 Favored Glycine 0 N--CA 1.485 1.946 0 CA-C-O 123.399 1.555 . . . . 0.0 112.115 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.88 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 50.6 tp -97.12 106.23 18.52 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 169' ' ' LEU . 0.5 OUTLIER -72.87 142.59 47.94 Favored 'General case' 0 N--CA 1.524 3.269 0 O-C-N 124.002 0.813 . . . . 0.0 109.414 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 168' ' ' GLU . 3.1 mt . . . . . 0 N--CA 1.515 2.777 0 O-C-N 120.039 -1.663 . . . . 0.0 113.935 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 48' ' ' THR . 62.0 p . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 121.988 0.899 . . . . 0.0 108.907 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 49' ' ' ARG . 35.0 t70 -60.92 -57.59 12.01 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.128 0.966 . . . . 0.0 110.97 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 15.5 mmm -39.4 -59.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.819 -1.175 . . . . 0.0 111.575 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.45 ' OG1' ' CD2' ' A' ' 52' ' ' LEU . 11.6 t -57.91 -31.73 67.07 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 62.3 ttt180 -42.32 -56.43 2.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.779 -1.201 . . . . 0.0 110.761 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -69.98 -63.39 1.09 Allowed 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 126.18 1.792 . . . . 0.0 114.511 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -83.14 -41.01 8.8 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 119.204 -1.474 . . . . 0.0 111.243 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.572 HD11 HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -50.69 -45.61 58.35 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.596 2.698 . . . . 0.0 106.309 176.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.435 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . -48.98 -65.94 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.995 -1.066 . . . . 0.0 110.004 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -67.14 -55.79 12.69 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.585 -1.322 . . . . 0.0 112.64 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' GLY . 55.0 mtpt -68.55 -49.6 58.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -174.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.66 -33.14 70.64 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 118.965 -2.334 . . . . 0.0 111.267 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.881 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.8 tt -65.64 -37.89 87.84 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 120.505 -1.372 . . . . 0.0 110.921 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 61' ' ' ARG . . . -74.42 -47.46 33.69 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 119.201 -2.187 . . . . 0.0 115.703 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.68 -35.95 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 118.617 -2.552 . . . . 0.0 106.395 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.528 ' HB2' HD12 ' A' ' 98' ' ' ILE . . . -55.96 -32.42 63.84 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.606 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -67.83 -22.58 65.15 Favored 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 117.726 -1.131 . . . . 0.0 111.093 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 m -59.77 -47.89 83.88 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 123.701 2.955 . . . . 0.0 106.429 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.684 HD22 ' HB1' ' A' ' 84' ' ' ALA . 26.1 mt -85.77 -36.49 20.09 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.314 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -64.73 -22.0 66.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 119.81 -1.807 . . . . 0.0 106.194 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 15.5 t0 -78.58 -11.08 59.95 Favored 'General case' 0 N--CA 1.53 3.529 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.732 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.513 ' CB ' ' CD ' ' A' ' 67' ' ' PRO 0.265 0.9 OUTLIER -71.62 -152.54 0.0 OUTLIER Pre-proline 0 C--N 1.277 -2.586 0 O-C-N 120.662 -1.274 . . . . 0.0 108.426 179.206 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.3 OUTLIER -103.27 -20.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 123.252 2.635 . . . . 0.0 111.542 176.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.504 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 9.6 pt-20 -58.06 -37.23 74.03 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.368 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.799 HG22 ' H ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -49.5 -78.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.771 0 O-C-N 120.228 -1.545 . . . . 0.0 111.403 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.799 ' H ' HG22 ' A' ' 69' ' ' ILE . 61.2 ttt180 -52.11 -31.3 30.13 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -174.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 19.5 tt0 -84.83 -12.07 54.35 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.102 -1.439 . . . . 0.0 112.386 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -91.09 -51.35 2.62 Favored Glycine 0 N--CA 1.503 3.148 1 N-CA-C 101.72 -4.552 . . . . 0.0 101.72 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.448 HD13 HG12 ' A' ' 100' ' ' VAL . 6.2 tp -43.71 -38.87 3.35 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 112.837 -1.682 . . . . 0.0 107.403 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 23.4 tt0 -64.97 -0.83 1.7 Allowed 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.384 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.894 ' O ' ' O ' ' A' ' 76' ' ' LYS . 21.1 tptp -135.44 68.59 1.45 Allowed 'General case' 0 N--CA 1.517 2.894 0 O-C-N 119.985 -1.697 . . . . 0.0 113.698 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.894 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 11.61 154.55 0.0 OUTLIER Pre-proline 0 N--CA 1.536 3.853 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -29.33 -56.05 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.4 2.733 . . . . 0.0 115.315 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -53.0 131.96 36.95 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 118.158 -1.417 . . . . 0.0 109.766 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 68.78 9.43 7.36 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.864 ' O ' ' N ' ' A' ' 82' ' ' ILE . 30.1 m -78.85 84.24 4.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.746 -1.846 . . . . 0.0 110.043 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -41.98 64.44 0.0 OUTLIER Glycine 0 N--CA 1.504 3.199 0 C-N-CA 119.721 -1.228 . . . . 0.0 111.248 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.864 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.8 tp -71.68 4.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.606 -1.526 . . . . 0.0 107.699 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.579 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 34.5 tp60 -53.99 -32.13 53.08 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.346 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.75 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -79.31 -99.75 0.03 OUTLIER 'General case' 0 C--O 1.189 -2.105 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.682 ' C ' ' O ' ' A' ' 84' ' ' ALA . 2.0 mp -9.58 -54.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.597 0 CA-C-N 122.592 2.451 . . . . 0.0 111.651 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -59.76 -53.64 55.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 119.977 -1.702 . . . . 0.0 109.477 176.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.75 ' N ' ' O ' ' A' ' 84' ' ' ALA . 87.6 tt0 -40.06 -55.02 2.17 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.319 -1.309 . . . . 0.0 112.074 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -66.11 -63.86 0.99 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 114.2 -3.0 . . . . 0.0 108.159 -177.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 90' ' ' ARG . 2.1 t -45.09 -72.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 115.162 -2.615 . . . . 0.0 110.303 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 1.213 ' CG ' HD11 ' A' ' 96' ' ' LEU . 78.1 mtp180 -32.5 -49.76 0.22 Allowed 'General case' 0 N--CA 1.51 2.53 0 O-C-N 121.08 -1.012 . . . . 0.0 110.308 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.576 ' C ' ' O ' ' A' ' 90' ' ' ARG . 15.6 tptm -33.96 -36.45 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 118.291 -1.364 . . . . 0.0 108.037 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.561 ' N ' ' O ' ' A' ' 90' ' ' ARG . 60.5 mtm180 -56.01 -65.63 0.57 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 117.392 -1.29 . . . . 0.0 108.471 171.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.618 ' O ' ' CG ' ' A' ' 94' ' ' ASP . 2.1 p30 -115.9 -69.9 0.83 Allowed 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 113.869 -3.132 . . . . 0.0 109.673 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.618 ' CG ' ' O ' ' A' ' 93' ' ' ASN . 34.4 m-20 155.35 -9.49 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 121.972 0.892 . . . . 0.0 109.988 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.692 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -120.45 152.51 37.89 Favored 'General case' 0 C--O 1.182 -2.476 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.89 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.213 HD11 ' CG ' ' A' ' 90' ' ' ARG . 0.5 OUTLIER 142.2 152.37 0.0 OUTLIER 'General case' 1 N--CA 1.549 4.494 0 CA-C-O 115.971 -1.966 . . . . 0.0 109.379 -178.211 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 110' ' ' HIS . 0.1 OUTLIER -116.1 96.84 5.76 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 125.239 3.654 . . . . 0.0 103.754 171.495 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -90.31 107.03 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 178.558 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 164' ' ' ALA . 22.0 m -131.44 143.89 39.19 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 124.2 1.953 . . . . 0.0 115.644 -171.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.753 HG21 HD11 ' A' ' 69' ' ' ILE . 38.3 t -109.62 138.34 37.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 101.901 -3.37 . . . . 0.0 101.901 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.436 ' HA ' ' CE1' ' A' ' 108' ' ' TYR . 11.3 p -118.91 148.56 42.8 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 104' ' ' GLN . 32.8 t70 -80.21 -173.71 4.14 Favored 'General case' 0 C--N 1.288 -2.1 1 N-CA-C 98.992 -4.447 . . . . 0.0 98.992 171.534 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 ttp -74.55 71.02 1.83 Allowed 'General case' 0 C--N 1.27 -2.849 0 C-N-CA 113.978 -3.089 . . . . 0.0 105.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.2 tp-100 -145.14 -47.81 0.23 Allowed 'General case' 0 C--O 1.211 -0.965 0 O-C-N 120.31 -1.494 . . . . 0.0 110.116 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.566 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.7 t 86.9 138.0 0.05 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.4 OUTLIER 156.35 138.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.537 -3.135 . . . . 0.0 102.537 176.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.529 HH22 ' CG ' ' A' ' 138' ' ' ASN . 2.6 mpt_? -74.47 97.79 3.18 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.436 ' CE1' ' HA ' ' A' ' 101' ' ' THR . 2.9 m-85 -49.21 -22.53 1.04 Allowed 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.504 ' N ' ' C ' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -131.58 163.44 28.04 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -175.449 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 97' ' ' PHE . 0.1 OUTLIER 170.96 143.99 0.11 Allowed Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 120.959 -1.088 . . . . 0.0 110.943 178.249 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.44 -44.32 6.68 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 N-CA-C 105.479 -2.546 . . . . 0.0 105.479 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -108.3 109.17 20.44 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.75 67.7 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.561 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.51 -36.94 74.58 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 119.153 -2.217 . . . . 0.0 113.179 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.488 ' NH1' ' N ' ' A' ' 140' ' ' GLY . 0.5 OUTLIER -56.5 -41.6 76.93 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.466 -2.021 . . . . 0.0 107.35 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.741 ' O ' ' N ' ' A' ' 118' ' ' GLN . 85.6 mt -40.66 -80.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.102 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 116' ' ' ILE . . . -27.58 -18.72 0.0 OUTLIER Glycine 0 N--CA 1.497 2.742 0 CA-C-O 119.451 -0.638 . . . . 0.0 113.431 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.741 ' N ' ' O ' ' A' ' 116' ' ' ILE . 5.5 mm-40 -73.43 -70.96 0.24 Allowed Pre-proline 0 N--CA 1.501 2.125 0 CA-C-N 120.942 2.371 . . . . 0.0 112.885 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.666 ' O ' ' O ' ' A' ' 118' ' ' GLN . 75.7 Cg_exo -20.11 156.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 124.05 3.166 . . . . 0.0 114.155 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.496 ' CB ' ' O ' ' A' ' 119' ' ' PRO . 28.4 t80 89.16 145.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.76 72.89 0.5 Allowed 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 117.375 -1.73 . . . . 0.0 111.358 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.665 ' O ' ' OD2' ' A' ' 123' ' ' ASP . . . -152.36 -58.23 0.01 OUTLIER Glycine 0 N--CA 1.507 3.393 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 176.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.665 ' OD2' ' O ' ' A' ' 122' ' ' GLY . 14.3 m-20 131.78 1.88 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.546 0 CA-C-N 117.653 0.727 . . . . 0.0 110.567 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -95.31 -26.7 15.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.572 -1.33 . . . . 0.0 108.683 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.486 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 0.3 OUTLIER -84.44 -18.11 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.272 -1.518 . . . . 0.0 109.928 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -50.42 -36.08 31.41 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.808 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 58.5 mttp -80.24 -33.76 37.73 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.27 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.74 -28.68 22.9 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 119.788 -1.82 . . . . 0.0 110.321 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.4 mt -50.11 -25.75 3.81 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.648 0.737 . . . . 0.0 109.127 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.808 ' ND2' ' O ' ' A' ' 127' ' ' LYS 0.269 24.7 p30 -78.28 -97.05 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.61 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.719 ' H ' ' CG ' ' A' ' 130' ' ' ASN . . . -161.75 49.15 0.35 Allowed Glycine 0 CA--C 1.549 2.218 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -142.31 163.46 32.79 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.178 -1.778 . . . . 0.0 109.632 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 149' ' ' PHE . 56.2 mm-40 -71.82 165.3 24.37 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.345 0.593 . . . . 0.0 112.054 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 5.2 t30 -168.69 144.62 3.55 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.599 ' CG2' HG12 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -132.49 131.12 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 120.24 -1.538 . . . . 0.0 109.848 -178.273 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.28 168.18 24.02 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.327 -0.858 . . . . 0.0 109.911 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.83 139.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.85 0.833 . . . . 0.0 111.635 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.529 ' CG ' HH22 ' A' ' 107' ' ' ARG . 6.7 t-20 -101.93 130.14 48.37 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 122.231 1.015 . . . . 0.0 111.973 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -127.96 119.65 25.97 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.583 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.488 ' N ' ' NH1' ' A' ' 115' ' ' ARG . . . -156.0 167.66 33.32 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.455 ' C ' ' O ' ' A' ' 140' ' ' GLY . 73.2 m-85 -34.48 -36.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.915 -0.756 . . . . 0.0 110.973 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.71 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 47.5 mt -60.87 -67.92 0.36 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.896 -1.128 . . . . 0.0 110.076 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 142' ' ' LEU . . . 158.36 158.43 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.842 0.829 . . . . 0.0 110.718 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -44.77 137.25 4.06 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.085 0.945 . . . . 0.0 111.341 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.817 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -151.48 150.88 30.91 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 tp -104.67 157.09 17.43 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-N 122.032 2.196 . . . . 0.0 108.896 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.456 ' HD2' HH21 ' A' ' 107' ' ' ARG . 12.4 ptt180 -146.21 153.82 41.05 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.423 1.106 . . . . 0.0 110.592 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.599 HG12 ' CG2' ' A' ' 135' ' ' VAL . 6.9 m -117.97 153.32 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.431 ' O ' ' OE1' ' A' ' 133' ' ' GLU . 68.7 m-85 -121.65 144.42 48.77 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.56 139.17 16.06 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -87.98 153.21 7.12 Favored 'Trans proline' 0 N--CA 1.513 2.618 0 C-N-CA 123.944 3.096 . . . . 0.0 114.88 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.5 mt -118.22 132.64 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 43.1 m-85 -103.24 148.91 25.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.947 -1.096 . . . . 0.0 113.532 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 156' ' ' ASN . 52.2 t0 -72.47 51.15 0.25 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 153' ' ' TYR . 31.1 tt0 42.98 17.28 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.231 -0.918 . . . . 0.0 111.033 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 158' ' ' LYS . 36.2 m120 -132.99 30.77 3.95 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.885 -1.135 . . . . 0.0 109.073 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 61.82 3.64 0.94 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.8 mptt -86.19 133.76 33.83 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.657 ' O ' ' CD ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -85.72 129.09 34.92 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -175.724 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.13 8.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.813 0 O-C-N 118.841 -2.412 . . . . 0.0 117.305 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.28 -179.9 44.26 Favored Glycine 0 N--CA 1.515 3.915 0 C-N-CA 115.918 -3.039 . . . . 0.0 112.077 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 101' ' ' THR . 70.8 t -141.95 138.85 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.892 -1.358 . . . . 0.0 111.668 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.94 126.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.547 ' O ' HG22 ' A' ' 99' ' ' VAL . . . -114.27 158.8 20.92 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 147' ' ' ARG . 35.4 mt -151.43 101.04 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.225 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.98 131.03 10.46 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.264 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.817 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -93.14 110.35 21.85 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.46 ' CD ' ' N ' ' A' ' 169' ' ' LEU . 14.8 tm-20 -57.61 163.74 2.34 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 143' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.976 0 O-C-N 120.517 -1.365 . . . . 0.0 110.644 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 48' ' ' THR . 48.9 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.418 0.628 . . . . 0.0 109.366 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 49' ' ' ARG . 27.3 m-20 -69.59 -56.74 6.47 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.832 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -51.73 -45.98 63.83 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.219 -1.551 . . . . 0.0 109.466 -173.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 45' ' ' SER . 6.0 t -60.3 -32.3 71.08 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' THR . 69.2 ttt180 -42.48 -61.3 1.25 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.244 -1.535 . . . . 0.0 110.481 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.95 -59.93 2.51 Favored 'General case' 0 N--CA 1.507 2.391 0 C-N-CA 125.686 1.594 . . . . 0.0 114.496 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 52' ' ' LEU . . . -79.13 -49.34 6.38 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.97 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -48.95 -44.65 40.83 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 121.273 2.537 . . . . 0.0 107.17 176.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 57' ' ' LEU . . . -48.94 -70.58 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.937 -1.102 . . . . 0.0 109.09 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -61.56 -55.72 27.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.825 0.822 . . . . 0.0 111.843 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -63.32 -61.25 2.48 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' HB3' HD12 ' A' ' 52' ' ' LEU . . . -65.7 -27.48 68.37 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 121.947 2.158 . . . . 0.0 111.75 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.8 tt -66.02 -31.36 72.21 Favored 'General case' 0 C--N 1.283 -2.325 0 O-C-N 119.662 -1.899 . . . . 0.0 108.359 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.91 -46.36 14.17 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.63 -33.96 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 118.597 -2.564 . . . . 0.0 106.224 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 98' ' ' ILE . . . -59.43 -37.47 78.15 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 117.871 -1.531 . . . . 0.0 107.281 174.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.559 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 2.6 ptt180 -64.49 -15.03 60.09 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.741 -1.184 . . . . 0.0 108.397 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.683 HG22 HD12 ' A' ' 63' ' ' LEU . 6.7 m -67.49 -49.06 65.18 Favored 'General case' 0 CA--C 1.485 -1.526 0 C-N-CA 114.666 -2.814 . . . . 0.0 104.848 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 62' ' ' THR . 5.7 mp -84.02 -45.1 13.45 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.533 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -50.59 -19.27 0.86 Allowed 'General case' 0 N--CA 1.524 3.269 0 CA-C-O 123.637 1.685 . . . . 0.0 106.544 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.535 ' N ' ' C ' ' A' ' 63' ' ' LEU . 17.7 t0 -88.03 -9.17 54.22 Favored 'General case' 0 N--CA 1.521 3.099 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.897 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.529 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -71.18 -154.2 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 120.46 -1.4 . . . . 0.0 110.523 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.567 ' C ' ' H ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -107.05 -32.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 123.626 2.884 . . . . 0.0 115.054 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.511 ' C ' HD12 ' A' ' 69' ' ' ILE . 12.6 pt-20 -77.88 33.51 0.18 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.658 HG22 ' N ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -110.34 -84.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 175.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.658 ' N ' HG22 ' A' ' 69' ' ' ILE . 78.8 ttt180 -45.19 -32.55 1.91 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.043 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 9.5 tt0 -85.56 -16.4 39.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.928 -1.107 . . . . 0.0 111.524 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -100.17 -10.46 45.32 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 104.77 -3.332 . . . . 0.0 104.77 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -85.17 -38.56 18.87 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 102.681 -3.081 . . . . 0.0 102.681 174.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.77 -6.6 1.82 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.832 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.748 ' O ' ' O ' ' A' ' 76' ' ' LYS . 18.8 mmtt -125.89 64.19 1.21 Allowed 'General case' 0 N--CA 1.526 3.355 0 CA-C-N 120.233 1.378 . . . . 0.0 112.228 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.748 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 25.4 153.38 0.0 OUTLIER Pre-proline 0 N--CA 1.524 3.253 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -31.93 -61.77 0.15 Allowed 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 123.027 2.485 . . . . 0.0 113.851 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.618 ' H ' ' HZ2' ' A' ' 76' ' ' LYS . 62.0 tt0 -52.47 137.44 29.82 Favored 'General case' 0 C--N 1.287 -2.109 0 C-N-CA 117.81 -1.556 . . . . 0.0 108.617 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' A' ' 78' ' ' GLN . 24.1 tt0 77.23 -29.31 0.17 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.304 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.773 ' O ' ' N ' ' A' ' 82' ' ' ILE . 8.6 t -46.1 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.334 -1.479 . . . . 0.0 112.674 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -54.44 48.22 0.01 OUTLIER Glycine 0 CA--C 1.562 3.008 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.258 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.773 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.2 tp -56.78 3.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -1.207 . . . . 0.0 109.995 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.63 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 35.0 tp60 -57.74 -22.22 45.44 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.498 -1.376 . . . . 0.0 110.969 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.647 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -77.8 -72.51 0.36 Allowed 'General case' 0 N--CA 1.506 2.375 0 O-C-N 119.85 -1.781 . . . . 0.0 111.353 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -39.76 -55.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 120.518 1.508 . . . . 0.0 110.159 171.327 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.1 -35.7 48.68 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 119.907 -1.746 . . . . 0.0 108.807 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 69.9 tt0 -65.7 -56.09 13.92 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 114.075 -1.421 . . . . 0.0 112.03 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -61.71 -65.02 0.76 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 123.819 3.009 . . . . 0.0 109.412 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -45.78 -65.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 C-N-CA 115.021 -2.671 . . . . 0.0 110.769 -175.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.594 ' N ' ' HB2' ' A' ' 94' ' ' ASP . 48.4 ttp180 -34.52 -44.58 0.2 Allowed 'General case' 0 N--CA 1.516 2.853 0 O-C-N 121.012 -1.055 . . . . 0.0 109.622 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 90' ' ' ARG . 40.8 tptt -43.92 -60.11 1.98 Allowed 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 117.395 -1.722 . . . . 0.0 107.197 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 89' ' ' VAL . 38.7 mtm180 -61.99 -65.75 0.64 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.691 -1.204 . . . . 0.0 107.996 174.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 39.1 t30 173.2 103.88 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.751 ' C ' ' H ' ' A' ' 96' ' ' LEU . 27.3 t70 -136.71 54.11 1.88 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.037 0.922 . . . . 0.0 109.2 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.3 mt -72.96 40.21 0.09 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 124.237 1.97 . . . . 0.0 106.609 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.965 HD11 HD12 ' A' ' 167' ' ' LEU 0.326 0.6 OUTLIER -107.17 175.43 5.5 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-N 111.312 -2.676 . . . . 0.0 109.65 -178.834 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -107.12 100.64 10.1 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 101.759 -3.423 . . . . 0.0 101.759 171.072 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.409 ' CD1' ' HB2' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -88.64 131.1 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.624 HG22 ' H ' ' A' ' 164' ' ' ALA . 0.9 OUTLIER -133.32 157.91 42.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 124.79 2.233 . . . . 0.0 113.525 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.15 125.23 38.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 1 N-CA-C 99.043 -4.428 . . . . 0.0 99.043 173.549 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.554 HG23 HG23 ' A' ' 99' ' ' VAL . 26.9 p -125.06 157.83 35.28 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 120.673 -1.267 . . . . 0.0 109.976 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -83.58 -175.17 5.69 Favored 'General case' 0 C--N 1.297 -1.707 1 N-CA-C 97.512 -4.995 . . . . 0.0 97.512 170.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -76.5 85.06 3.21 Favored 'General case' 0 C--N 1.267 -3.009 0 C-N-CA 114.877 -2.729 . . . . 0.0 105.312 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.524 ' O ' ' CB ' ' A' ' 105' ' ' SER . 3.0 tm0? -153.02 -42.25 0.1 Allowed 'General case' 0 CA--C 1.549 0.928 0 O-C-N 120.751 -1.218 . . . . 0.0 109.444 -176.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.625 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.1 t 83.23 138.32 0.06 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.724 ' H ' HH21 ' A' ' 107' ' ' ARG . 0.8 OUTLIER 154.15 134.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 177.201 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.724 HH21 ' H ' ' A' ' 106' ' ' LEU . 2.6 mmp_? -71.62 94.42 1.33 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 116.842 -1.943 . . . . 0.0 106.717 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.601 ' C ' HG21 ' A' ' 82' ' ' ILE . 2.6 m-85 -50.83 -37.08 40.84 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -118.12 167.55 11.38 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.024 -1.443 . . . . 0.0 112.441 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 1.004 ' CD2' HD11 ' A' ' 116' ' ' ILE . 11.9 p80 178.51 151.19 0.45 Allowed Pre-proline 0 N--CA 1.496 1.854 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.204 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.64 -28.3 1.8 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 N-CA-C 107.397 -1.809 . . . . 0.0 107.397 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -119.91 138.27 53.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.42 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.52 -50.38 38.34 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.022 -1.049 . . . . 0.0 113.555 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.15 -38.64 71.13 Favored 'General case' 0 CA--C 1.571 1.775 0 O-C-N 120.152 -1.593 . . . . 0.0 114.936 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.61 ' NH1' ' ND2' ' A' ' 138' ' ' ASN . 0.5 OUTLIER -57.87 -45.25 86.61 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.042 -2.286 . . . . 0.0 109.201 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 1.004 HD11 ' CD2' ' A' ' 110' ' ' HIS . 89.6 mt -29.95 -91.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.745 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -45.31 -16.78 0.1 Allowed Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.455 -0.778 . . . . 0.0 114.452 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -59.47 -65.7 1.89 Allowed Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 120.601 2.2 . . . . 0.0 112.439 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 116' ' ' ILE . 1.1 Cg_endo -39.41 103.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 123.487 2.791 . . . . 0.0 113.597 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 122' ' ' GLY . 35.4 t80 -162.43 141.51 9.18 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt 47.7 11.34 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.195 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 120' ' ' PHE . . . -60.45 -15.01 37.24 Favored Glycine 0 N--CA 1.505 3.282 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 122' ' ' GLY . 11.9 t70 71.99 -2.27 2.59 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.11 -1.229 . . . . 0.0 111.49 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.599 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 10.5 p-10 -92.56 -45.88 7.89 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.1 -15.84 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.548 -1.345 . . . . 0.0 110.095 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -55.24 -29.66 58.48 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.355 -1.466 . . . . 0.0 108.148 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.642 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 68.5 mttm -79.91 -24.99 40.73 Favored 'General case' 0 C--O 1.194 -1.818 0 O-C-N 121.964 -0.46 . . . . 0.0 110.343 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.534 ' O ' ' OD1' ' A' ' 130' ' ' ASN . . . -90.09 -33.21 16.37 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 119.792 -1.818 . . . . 0.0 110.012 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 mt -48.98 -29.53 4.93 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.064 0.935 . . . . 0.0 109.009 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.821 ' CG ' ' H ' ' A' ' 131' ' ' GLY . 41.6 p-10 -56.9 -78.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 109.768 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.821 ' H ' ' CG ' ' A' ' 130' ' ' ASN . . . 167.34 35.05 0.02 OUTLIER Glycine 0 CA--C 1.539 1.578 0 C-N-CA 128.808 3.099 . . . . 0.0 107.586 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.619 ' HB2' HD22 ' A' ' 130' ' ' ASN . 93.6 mt-10 -141.03 162.69 34.9 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 119.605 1.702 . . . . 0.0 109.767 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -76.08 165.68 24.58 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.621 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -168.98 153.33 5.59 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -133.45 136.44 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.016 -1.052 . . . . 0.0 110.556 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.57 172.16 13.37 Favored 'General case' 0 N--CA 1.518 2.96 0 O-C-N 120.528 -1.357 . . . . 0.0 109.682 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.6 136.0 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 120.641 -1.287 . . . . 0.0 110.349 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.61 ' ND2' ' NH1' ' A' ' 115' ' ' ARG . 3.8 t30 -103.98 133.61 48.65 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.462 -0.774 . . . . 0.0 109.005 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -132.75 100.91 5.08 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.676 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -116.47 164.13 12.35 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -44.35 -13.89 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.34 -1.094 . . . . 0.0 110.494 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -75.53 -72.37 0.31 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.984 -1.073 . . . . 0.0 108.7 -179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 144' ' ' GLN . . . 176.43 149.61 0.13 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.428 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' ALA . 97.2 mt-30 -35.06 152.55 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.481 0.658 . . . . 0.0 110.139 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.974 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -157.2 152.4 26.17 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 117.357 -1.306 . . . . 0.0 107.855 -176.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.8 tp -116.37 144.23 44.54 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 123.149 2.704 . . . . 0.0 109.684 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -129.44 147.62 51.27 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.338 1.066 . . . . 0.0 110.97 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.52 HG12 ' CG2' ' A' ' 135' ' ' VAL . 7.3 m -114.05 158.35 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -132.88 138.96 47.18 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.67 138.76 29.03 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -86.45 155.31 9.24 Favored 'Trans proline' 0 C--N 1.295 -2.247 0 C-N-CA 122.555 2.17 . . . . 0.0 113.758 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 62.6 mt -118.2 135.44 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . 0.304 65.2 m-85 -106.24 151.77 24.36 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 155' ' ' GLU . 63.0 t0 -78.46 164.35 24.83 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.573 ' N ' ' OD1' ' A' ' 154' ' ' ASP . 18.5 tt0 -47.95 -9.31 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.241 -1.383 . . . . 0.0 112.976 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 154' ' ' ASP . 16.7 m120 -121.83 49.62 1.53 Allowed 'General case' 0 N--CA 1.518 2.971 0 O-C-N 120.348 -1.47 . . . . 0.0 114.268 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 57.39 9.32 0.73 Allowed 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.998 -1.064 . . . . 0.0 110.443 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -83.69 128.79 34.79 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.595 ' O ' ' CD ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -74.96 126.72 31.61 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.182 -0.949 . . . . 0.0 112.662 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.419 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.7 pp -141.73 12.43 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.601 0 O-C-N 119.028 -2.295 . . . . 0.0 116.231 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.11 174.51 46.83 Favored Glycine 0 N--CA 1.501 3.025 0 C-N-CA 115.774 -3.108 . . . . 0.0 112.002 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.9 t -137.55 143.51 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.576 1.179 . . . . 0.0 113.215 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 40.6 t -109.6 129.2 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.624 ' H ' HG22 ' A' ' 99' ' ' VAL . . . -127.01 157.53 39.35 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.231 -0.918 . . . . 0.0 108.845 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 147' ' ' ARG . 16.3 mt -151.12 99.99 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 96' ' ' LEU . . . -108.03 118.14 5.34 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.918 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.974 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.8 tp -72.38 120.23 17.71 Favored 'General case' 0 C--O 1.193 -1.914 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.07 -30.11 63.45 Favored 'General case' 1 N--CA 1.542 4.163 0 CA-C-O 123.11 1.433 . . . . 0.0 110.37 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.814 0 CA-C-N 113.67 -1.604 . . . . 0.0 114.399 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 46' ' ' ASP . 74.4 p . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.751 0.786 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 47' ' ' MET . 69.5 m-20 -74.75 -65.39 0.87 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.529 1.157 . . . . 0.0 109.967 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 46' ' ' ASP . 26.4 ttt -41.76 -54.76 3.23 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 122.267 1.032 . . . . 0.0 111.146 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.539 ' OG1' ' HB3' ' A' ' 52' ' ' LEU . 13.5 t -58.77 -35.94 73.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.273 1.035 . . . . 0.0 110.158 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.447 ' N ' HG23 ' A' ' 48' ' ' THR . 67.1 ttp85 -39.04 -52.66 1.83 Allowed 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 122.253 1.025 . . . . 0.0 111.855 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -86.06 -55.44 3.94 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -78.2 -45.76 9.81 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.787 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.539 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -56.64 -41.82 77.82 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 120.894 2.347 . . . . 0.0 105.068 176.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 49' ' ' ARG . . . -51.05 -59.39 4.22 Favored 'General case' 0 C--O 1.206 -1.184 0 C-N-CA 117.613 -1.635 . . . . 0.0 107.86 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -74.85 -68.36 0.55 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.457 -1.402 . . . . 0.0 112.457 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 51' ' ' GLY . 25.7 mtpp -47.75 -41.56 23.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 112.703 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.593 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -86.62 -27.28 23.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 119.103 -2.248 . . . . 0.0 110.246 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.7 tp -62.93 -46.4 87.97 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 120.187 -1.571 . . . . 0.0 107.711 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.02 77.3 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 t -76.44 -30.72 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 119.378 -2.076 . . . . 0.0 107.261 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.973 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -64.44 -28.55 69.75 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 176.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -78.85 -16.89 56.49 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.398 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.0 m -72.29 -43.61 63.97 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 115.499 -2.48 . . . . 0.0 107.149 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.808 HD12 ' HB1' ' A' ' 84' ' ' ALA . 3.8 mm? -85.71 -36.18 20.37 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.313 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.846 ' O ' HG21 ' A' ' 69' ' ' ILE . . . -62.21 -13.66 30.01 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.492 ' N ' ' C ' ' A' ' 63' ' ' LEU . 16.3 t0 -94.52 -11.35 29.77 Favored 'General case' 0 N--CA 1.518 2.975 0 CA-C-N 112.652 -2.067 . . . . 0.0 112.07 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.522 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -66.38 -152.83 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.97 0 O-C-N 120.054 -1.653 . . . . 0.0 109.695 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -104.11 -38.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.478 2.119 . . . . 0.0 113.582 178.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 7.1 pt-20 -48.32 -29.65 4.12 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.763 1.268 . . . . 0.0 108.104 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.846 HG21 ' O ' ' A' ' 64' ' ' ALA . 42.9 mm -56.44 -78.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.028 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' ILE . 45.2 ttt85 -46.19 -31.23 2.32 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -79.16 -14.24 59.22 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.683 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.703 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -83.69 -43.82 7.11 Favored Glycine 0 N--CA 1.487 2.085 1 N-CA-C 101.966 -4.454 . . . . 0.0 101.966 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 152' ' ' ILE . 7.5 mp -49.31 -39.9 32.96 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -66.35 -2.87 4.95 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 72' ' ' GLY . 20.5 tptt -122.73 -158.15 0.77 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.238 -1.539 . . . . 0.0 108.306 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.458 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -133.69 168.78 16.18 Favored Pre-proline 0 CA--C 1.569 1.684 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -38.59 -73.53 0.04 OUTLIER 'Trans proline' 0 N--CA 1.521 3.12 0 C-N-CA 124.927 3.751 . . . . 0.0 117.996 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.523 ' H ' ' CD ' ' A' ' 78' ' ' GLN . 25.2 mp0 -56.08 -14.25 2.52 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -174.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.458 ' OE1' ' NZ ' ' A' ' 76' ' ' LYS . 44.3 tt0 -121.74 2.76 10.07 Favored 'General case' 0 N--CA 1.514 2.757 0 O-C-N 120.61 -1.306 . . . . 0.0 110.78 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 40.4 t -66.97 -154.78 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.889 -1.132 . . . . 0.0 109.218 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.492 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . -149.58 64.95 0.39 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.532 ' CD1' ' H ' ' A' ' 100' ' ' VAL . 3.7 tp -76.22 7.41 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.737 -0.86 . . . . 0.0 110.455 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.701 ' O ' ' HB3' ' A' ' 86' ' ' ALA . 13.5 pt20 -63.48 -26.78 68.88 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 120.329 -1.482 . . . . 0.0 112.837 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.893 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -83.12 -60.63 2.09 Favored 'General case' 0 C--O 1.202 -1.442 0 O-C-N 118.861 -2.399 . . . . 0.0 108.622 -176.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.994 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -41.51 -43.88 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.249 0 CA-C-N 123.517 2.871 . . . . 0.0 105.756 172.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 83' ' ' GLN . . . -44.25 -25.07 0.2 Allowed 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 121.498 1.954 . . . . 0.0 108.143 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.893 ' N ' ' O ' ' A' ' 84' ' ' ALA . 53.6 mt-10 -52.21 -33.89 43.1 Favored 'General case' 0 N--CA 1.536 3.849 0 N-CA-C 102.352 -3.203 . . . . 0.0 102.352 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.876 ' N ' ' O ' ' A' ' 85' ' ' ILE . . . -68.82 -29.81 68.22 Favored 'General case' 0 N--CA 1.52 3.028 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.609 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.678 ' N ' ' O ' ' A' ' 86' ' ' ALA . 1.8 t -55.0 -55.8 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 O-C-N 120.525 -1.359 . . . . 0.0 107.656 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -56.22 -59.9 4.27 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.66 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -54.89 -49.98 69.87 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.024 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -57.8 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.949 -1.094 . . . . 0.0 110.475 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.33 27.4 0.93 Allowed 'General case' 0 N--CA 1.513 2.676 0 CA-C-N 122.258 2.299 . . . . 0.0 113.029 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.9 t70 70.74 -1.34 2.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.973 -1.079 . . . . 0.0 108.742 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 1.3 pp -146.06 162.36 38.07 Favored 'General case' 0 N--CA 1.519 2.996 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.7 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.501 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER 152.91 170.69 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.361 0 CA-C-O 117.513 -1.232 . . . . 0.0 108.245 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.664 ' CD1' ' CD2' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -119.75 82.8 1.94 Allowed 'General case' 0 C--O 1.215 -0.752 1 N-CA-C 96.318 -5.438 . . . . 0.0 96.318 166.605 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.973 HD11 ' HB2' ' A' ' 60' ' ' ALA . 1.5 tt -87.94 110.46 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.64 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 5.1 p -120.56 137.69 53.51 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.975 0 CA-C-N 112.173 -2.285 . . . . 0.0 113.424 -172.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.532 ' H ' ' CD1' ' A' ' 82' ' ' ILE . 38.9 t -113.98 140.18 35.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 1 N-CA-C 97.953 -4.832 . . . . 0.0 97.953 171.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 102' ' ' ASP . 38.0 p -122.06 145.28 48.3 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 120.767 1.621 . . . . 0.0 111.192 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 104' ' ' GLN . 66.3 t0 -74.18 -168.07 0.59 Allowed 'General case' 0 C--N 1.319 -0.746 1 N-CA-C 99.914 -4.106 . . . . 0.0 99.914 168.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.587 ' O ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -78.64 66.1 4.07 Favored 'General case' 0 C--N 1.274 -2.694 0 C-N-CA 115.207 -2.597 . . . . 0.0 104.985 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 102' ' ' ASP . 5.1 tm0? -170.89 107.93 0.29 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 101.179 -3.638 . . . . 0.0 101.179 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.738 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 29.1 t -61.67 161.17 10.33 Favored 'General case' 0 CA--C 1.462 -2.408 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.693 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.738 ' HB2' ' O ' ' A' ' 105' ' ' SER . 12.1 tp 153.5 142.27 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 116' ' ' ILE . 99.1 mtt180 -75.68 109.44 9.27 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 101' ' ' THR . 4.6 m-30 -70.94 -34.68 71.73 Favored 'General case' 0 C--N 1.262 -3.216 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 1.1 t -119.84 157.75 28.03 Favored 'General case' 0 C--O 1.196 -1.746 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.657 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.664 ' CD2' ' CD1' ' A' ' 97' ' ' PHE . 47.1 t-80 169.86 140.12 0.07 OUTLIER Pre-proline 0 N--CA 1.524 3.228 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.37 -55.86 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 CA-C-N 120.561 1.236 . . . . 0.0 109.136 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.529 ' OE1' ' NH2' ' A' ' 115' ' ' ARG . 34.0 mt-10 -79.75 142.48 35.36 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.46 -42.91 24.3 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.548 -0.72 . . . . 0.0 112.638 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -60.87 -35.64 77.13 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.529 ' NH2' ' OE1' ' A' ' 112' ' ' GLU . 3.8 tpp180 -61.96 -31.72 72.08 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 119.39 -2.069 . . . . 0.0 108.151 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.657 ' O ' ' N ' ' A' ' 118' ' ' GLN . 55.6 mt -51.69 -82.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.242 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.595 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -33.96 -11.69 0.0 OUTLIER Glycine 0 N--CA 1.498 2.793 0 CA-C-O 119.156 -0.802 . . . . 0.0 113.97 -175.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 116' ' ' ILE . 6.2 mm-40 -80.79 -70.5 0.16 Allowed Pre-proline 0 N--CA 1.503 2.223 0 CA-C-N 121.383 2.591 . . . . 0.0 113.369 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 17.4 Cg_exo -29.91 117.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 124.196 3.264 . . . . 0.0 114.651 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 122' ' ' GLY . 85.3 t80 -175.37 149.86 1.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 123' ' ' ASP . 27.3 ttpt 48.95 11.32 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.327 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 120' ' ' PHE . . . -46.28 -12.54 0.06 OUTLIER Glycine 0 N--CA 1.501 2.967 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 121' ' ' LYS . 4.2 m-20 62.71 -11.88 0.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.585 -0.95 . . . . 0.0 111.232 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 122' ' ' GLY . 49.8 m-20 -75.34 -29.4 59.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' LEU . 16.3 pt -78.03 -34.24 19.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.654 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -38.5 -32.62 0.08 Allowed 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.536 -0.727 . . . . 0.0 110.289 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -90.55 -40.23 12.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.157 -0.965 . . . . 0.0 109.571 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -78.74 -48.15 15.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.971 -1.08 . . . . 0.0 109.192 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -36.44 -42.03 0.32 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 123.171 1.463 . . . . 0.0 108.053 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 -102.44 22.04 14.14 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.078 -1.419 . . . . 0.0 113.388 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 132' ' ' GLU . . . 87.16 100.87 0.84 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 131' ' ' GLY . 4.1 tp10 167.75 140.47 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.069 0 CA-C-N 113.551 -1.325 . . . . 0.0 113.394 175.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -81.77 142.29 32.74 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.923 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 4.0 t-20 -162.55 144.9 10.84 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.248 -1.533 . . . . 0.0 110.592 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 147' ' ' ARG . 8.6 p -135.58 151.86 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 O-C-N 119.774 -1.829 . . . . 0.0 108.29 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -159.48 162.7 35.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.82 -1.175 . . . . 0.0 109.372 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.59 141.71 16.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 122.214 1.007 . . . . 0.0 112.49 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -106.9 159.63 16.11 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -147.97 103.04 3.45 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.082 -1.636 . . . . 0.0 110.376 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.511 ' CA ' ' HB3' ' A' ' 143' ' ' ALA . . . -143.15 161.52 27.59 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.311 -2.316 . . . . 0.0 107.311 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.582 ' C ' ' H ' ' A' ' 143' ' ' ALA . 84.0 m-85 -44.13 118.77 1.58 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.216 -1.167 . . . . 0.0 109.675 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER 62.7 -11.17 0.08 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.423 -0.798 . . . . 0.0 109.024 -179.06 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 141' ' ' PHE . . . -81.31 -10.9 59.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.771 -1.206 . . . . 0.0 112.772 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 143' ' ' ALA . 93.0 mt-30 -40.9 114.44 0.48 Allowed 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.92 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -158.85 160.15 35.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.111 -1.618 . . . . 0.0 111.238 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 tp -105.19 160.81 14.79 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.79 -1.194 . . . . 0.0 108.285 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.781 ' O ' HG23 ' A' ' 135' ' ' VAL . 12.4 ptt180 -150.01 146.21 26.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.766 -1.209 . . . . 0.0 109.294 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 m -105.53 167.65 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 CA-C-O 122.008 0.908 . . . . 0.0 109.152 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 32.6 m-85 -134.98 138.63 44.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 p -144.48 157.56 55.67 Favored Pre-proline 0 C--N 1.308 -1.238 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -102.33 152.6 0.29 Allowed 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.369 2.713 . . . . 0.0 114.983 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.544 HG21 HD21 ' A' ' 73' ' ' LEU . 83.2 mt -113.48 134.94 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.461 ' C ' ' H ' ' A' ' 155' ' ' GLU . 66.6 m-85 -102.04 142.45 33.3 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.455 -0.778 . . . . 0.0 111.884 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 26.7 t70 -58.87 -2.41 0.23 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.586 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 154' ' ' ASP . 56.1 tt0 98.25 21.52 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -140.78 19.13 2.33 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 15.3 t60 69.35 11.47 8.11 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -96.1 116.76 29.47 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.668 ' NE2' ' N ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -65.08 122.58 17.37 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.445 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.5 pp -137.62 1.89 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 O-C-N 120.841 -1.162 . . . . 0.0 113.541 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.419 ' N ' HD12 ' A' ' 160' ' ' ILE . . . -166.75 176.08 41.91 Favored Glycine 0 N--CA 1.507 3.4 0 C-N-CA 119.243 -1.456 . . . . 0.0 110.587 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.18 145.92 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 O-C-N 121.175 -1.191 . . . . 0.0 112.939 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.65 116.07 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.64 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -113.07 157.51 21.5 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.593 HG21 ' HB1' ' A' ' 56' ' ' ALA . 48.9 mt -146.4 107.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.44 ' HA3' ' CD2' ' A' ' 97' ' ' PHE . . . -108.84 122.64 6.65 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.54 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.92 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 27.1 tp -85.61 108.95 18.23 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 169' ' ' LEU . 10.8 tm-20 -53.94 -36.37 62.72 Favored 'General case' 0 N--CA 1.518 2.93 0 O-C-N 123.786 0.679 . . . . 0.0 110.239 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 170' ' ' SER . 4.4 tp 73.66 152.18 0.12 Allowed 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.794 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.738 ' O ' ' N ' ' A' ' 172' ' ' VAL . 2.1 t 151.3 -104.81 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.847 ' O ' HG13 ' A' ' 172' ' ' VAL . 89.9 mtt180 -53.04 79.34 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.847 HG13 ' O ' ' A' ' 171' ' ' ARG . 1.3 m -175.12 -25.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.455 ' C ' ' O ' ' A' ' 172' ' ' VAL . 0.2 OUTLIER -35.56 -61.24 0.47 Allowed 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.786 -1.196 . . . . 0.0 110.881 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -43.36 -64.29 0.67 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.633 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -55.73 -39.94 71.79 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.129 0.966 . . . . 0.0 110.666 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 172' ' ' VAL . 5.5 mt -65.16 -33.76 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 120.838 -1.164 . . . . 0.0 110.477 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -81.49 -46.27 14.76 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 119.523 -1.986 . . . . 0.0 112.723 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -75.23 -62.6 1.5 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.149 -1.594 . . . . 0.0 109.759 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 59.9 p -58.23 -53.56 56.85 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.054 -1.029 . . . . 0.0 112.917 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 . . . . . 0 N--CA 1.504 2.269 0 O-C-N 119.876 -1.765 . . . . 0.0 109.346 179.972 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' MET . 76.2 m-20 -75.61 -59.02 2.93 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.41 1.1 . . . . 0.0 108.648 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.499 ' C ' ' SD ' ' A' ' 47' ' ' MET . 0.9 OUTLIER -36.97 -62.27 0.5 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 123.066 1.412 . . . . 0.0 109.666 -177.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.502 ' O ' ' HB3' ' A' ' 52' ' ' LEU . 5.9 t -54.78 -41.37 70.46 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.092 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' THR . 50.7 ttp180 -35.57 -51.22 0.63 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.661 -1.274 . . . . 0.0 112.57 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -91.55 -53.77 4.18 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -71.96 -47.3 32.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -176.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' A' ' 167' ' ' LEU . 0.9 OUTLIER -56.99 -44.06 82.32 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 175.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 49' ' ' ARG . . . -50.09 -55.8 13.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 118.081 -1.447 . . . . 0.0 109.932 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -83.53 -62.92 1.46 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.399 -1.438 . . . . 0.0 112.989 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' GLY . 5.3 ptmt -52.55 -34.69 51.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.456 -0.778 . . . . 0.0 111.217 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -84.89 -31.62 23.6 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 119.443 -2.036 . . . . 0.0 109.176 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.8 tt -47.24 -46.12 24.2 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.35 -1.469 . . . . 0.0 108.165 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 61' ' ' ARG . . . -67.86 -41.3 83.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.685 -1.884 . . . . 0.0 110.208 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.987 HG13 ' HB1' ' A' ' 88' ' ' ALA . 25.0 t -52.73 -45.89 49.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 O-C-N 120.065 -1.647 . . . . 0.0 107.504 177.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.843 ' HB2' HD11 ' A' ' 165' ' ' ILE . . . -51.77 -24.13 5.53 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -73.59 -37.15 65.56 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 115.799 -2.36 . . . . 0.0 111.647 -178.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 m -57.71 -29.21 64.52 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 119.58 -1.95 . . . . 0.0 107.595 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.767 ' HB3' HD12 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -74.56 -26.13 59.74 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 117.59 -1.644 . . . . 0.0 108.051 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.65 -12.28 59.51 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-O 117.668 -1.158 . . . . 0.0 110.952 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.456 ' OD2' ' NH1' ' A' ' 61' ' ' ARG . 3.9 m-20 -103.96 -24.8 13.21 Favored 'General case' 0 N--CA 1.51 2.555 0 CA-C-N 123.367 2.803 . . . . 0.0 113.853 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.534 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -76.61 -161.1 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 119.793 -1.817 . . . . 0.0 111.91 -175.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 68' ' ' GLU . 6.6 Cg_endo -109.92 -38.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 124.049 3.166 . . . . 0.0 114.172 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.609 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 2.5 pt-20 -52.01 -33.16 37.14 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.401 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.631 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.3 mp -58.71 -73.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.909 0.861 . . . . 0.0 111.744 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -48.46 -37.0 16.16 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -75.68 -14.08 60.34 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -82.01 -39.27 11.8 Favored Glycine 0 CA--C 1.486 -1.761 0 N-CA-C 103.324 -3.91 . . . . 0.0 103.324 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.81 -29.62 62.93 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -64.18 -3.78 3.05 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' CG ' ' H ' ' A' ' 76' ' ' LYS . 26.5 tptt -134.97 -150.58 0.39 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 78' ' ' GLN . 2.1 pttt -122.41 157.95 57.41 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 123.943 0.897 . . . . 0.0 109.119 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.669 ' O ' ' CE2' ' A' ' 108' ' ' TYR . 7.3 Cg_exo -29.0 -16.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.516 2.821 1 C-N-CA 125.551 4.167 . . . . 0.0 118.281 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 76' ' ' LYS . 83.0 mt-30 -90.37 1.66 56.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.191 -2.193 . . . . 0.0 108.918 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -132.68 2.3 3.74 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.659 ' N ' ' OH ' ' A' ' 108' ' ' TYR . 2.5 m -68.57 -156.75 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.146 -2.221 . . . . 0.0 108.863 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 83' ' ' GLN . . . -150.11 58.11 0.45 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.552 HD11 HD11 ' A' ' 85' ' ' ILE . 2.2 tp -49.55 -7.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 C-N-CA 123.203 0.601 . . . . 0.0 110.766 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 81' ' ' GLY . 86.6 mt-30 -47.38 -43.67 23.58 Favored 'General case' 0 C--N 1.269 -2.908 0 O-C-N 120.046 -1.659 . . . . 0.0 114.397 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.823 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -87.88 -53.34 4.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 119.365 -2.085 . . . . 0.0 110.122 -173.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.892 ' O ' ' N ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -46.32 -51.64 3.98 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.707 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 172.007 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.785 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -44.41 -21.93 0.06 Allowed 'General case' 0 N--CA 1.507 2.399 0 O-C-N 119.237 -2.164 . . . . 0.0 107.225 174.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.823 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.5 tt0 -48.47 -28.83 3.56 Favored 'General case' 1 N--CA 1.544 4.245 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 171.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.987 ' HB1' HG13 ' A' ' 59' ' ' VAL . . . -71.28 -28.05 63.86 Favored 'General case' 0 N--CA 1.515 2.778 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.698 172.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.785 ' N ' ' O ' ' A' ' 86' ' ' ALA . 33.0 m -65.69 -43.95 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.255 0 C-N-CA 116.241 -2.184 . . . . 0.0 110.346 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.512 ' N ' HG23 ' A' ' 89' ' ' VAL . 19.6 mtp-105 -56.19 -52.08 65.71 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -58.19 -30.69 66.64 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.383 -1.327 . . . . 0.0 108.63 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.437 ' NH2' ' ND2' ' A' ' 93' ' ' ASN . 6.5 mmm180 -76.33 -93.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.193 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -144.44 31.12 1.21 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.679 -1.263 . . . . 0.0 111.724 -177.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 60.7 24.07 13.9 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.292 -1.505 . . . . 0.0 109.414 -175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 96' ' ' LEU . 2.7 pp -167.13 160.08 13.55 Favored 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.575 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.418 ' CD2' ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER 164.62 176.77 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.934 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -177.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 109' ' ' SER . 58.5 m-85 -136.75 80.51 1.82 Allowed 'General case' 0 C--O 1.214 -0.774 1 N-CA-C 99.295 -4.335 . . . . 0.0 99.295 170.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.62 ' CD1' HG12 ' A' ' 59' ' ' VAL . 11.7 tt -100.06 118.36 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -177.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.819 ' CG1' ' H ' ' A' ' 164' ' ' ALA . 10.9 p -98.7 131.93 44.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 CA-C-O 124.587 2.137 . . . . 0.0 111.067 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.686 HG22 HD22 ' A' ' 63' ' ' LEU . 97.1 t -132.9 109.95 14.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 1 N-CA-C 98.02 -4.807 . . . . 0.0 98.02 175.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.554 ' HG1' ' H ' ' A' ' 104' ' ' GLN . 1.2 t -130.6 170.69 13.94 Favored 'General case' 0 CA--C 1.461 -2.445 0 CA-C-O 122.386 1.088 . . . . 0.0 108.319 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 104' ' ' GLN . 44.4 t0 -78.9 -174.7 4.12 Favored 'General case' 0 C--N 1.269 -2.906 1 N-CA-C 99.458 -4.275 . . . . 0.0 99.458 169.053 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.89 72.35 0.09 Allowed 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 113.471 -3.292 . . . . 0.0 104.78 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.684 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.5 tp-100 -140.7 -52.24 0.47 Allowed 'General case' 0 C--N 1.364 1.198 0 O-C-N 119.453 -2.029 . . . . 0.0 111.057 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 104' ' ' GLN . 2.1 t 97.38 137.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.372 1.069 . . . . 0.0 108.794 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER 157.44 95.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 178.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.591 ' NH2' HH11 ' A' ' 147' ' ' ARG . 1.4 mtt180 -39.43 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 112.524 -2.125 . . . . 0.0 110.167 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.669 ' CE2' ' O ' ' A' ' 77' ' ' PRO . 1.1 t80 -57.22 -26.18 60.27 Favored 'General case' 0 C--N 1.284 -2.245 0 O-C-N 121.02 -1.05 . . . . 0.0 108.471 -177.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -113.61 148.44 36.21 Favored 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.961 ' ND1' HD11 ' A' ' 116' ' ' ILE 0.256 45.1 p-80 -174.44 149.68 1.39 Allowed Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 118.0 -1.48 . . . . 0.0 113.349 -176.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.505 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 32.9 Cg_endo -91.09 -22.35 0.59 Allowed 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.463 2.109 . . . . 0.0 106.801 171.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.505 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 38.8 tt0 -111.44 136.62 50.34 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.02 -42.35 48.18 Favored 'General case' 0 C--N 1.289 -2.054 0 O-C-N 119.965 -1.709 . . . . 0.0 111.985 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 118' ' ' GLN . 87.7 mt-30 -70.36 -24.28 62.94 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 119.768 -1.832 . . . . 0.0 115.871 -176.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.415 HH21 ' C ' ' A' ' 139' ' ' ARG . 0.1 OUTLIER -67.47 -28.13 67.61 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 119.839 -1.788 . . . . 0.0 106.916 -178.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.961 HD11 ' ND1' ' A' ' 110' ' ' HIS . 87.9 mt -56.0 -88.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 117.453 -1.699 . . . . 0.0 109.991 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.571 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -37.02 -12.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 O-C-N 121.545 -0.722 . . . . 0.0 113.604 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.7 OUTLIER -69.64 -72.42 0.24 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 119.457 -2.202 . . . . 0.0 114.579 -174.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.426 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 19.2 Cg_exo -24.95 120.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 123.923 3.082 . . . . 0.0 113.82 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.587 ' C ' ' H ' ' A' ' 122' ' ' GLY . 0.8 OUTLIER -178.11 138.12 0.19 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 123' ' ' ASP . 85.6 mttt 50.47 4.98 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 CA-C-O 121.456 0.646 . . . . 0.0 109.389 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 120' ' ' PHE . . . -42.94 -18.75 0.05 OUTLIER Glycine 0 N--CA 1.505 3.239 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 121' ' ' LYS . 11.1 t70 71.04 -17.98 0.29 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.292 -1.122 . . . . 0.0 111.233 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.22 -14.89 61.0 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.402 ' HA ' ' HB3' ' A' ' 128' ' ' ALA . 20.2 mt -89.99 -28.48 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.637 -0.664 . . . . 0.0 111.629 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -40.04 -56.34 1.88 Allowed 'General case' 0 N--CA 1.515 2.802 0 O-C-N 120.842 -1.161 . . . . 0.0 110.137 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -74.11 -37.08 64.22 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.773 -1.205 . . . . 0.0 110.591 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -63.28 -47.31 82.88 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 128' ' ' ALA . 0.3 OUTLIER -28.85 -44.68 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 113.587 -1.642 . . . . 0.0 106.966 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 32.9 m-20 -105.0 -99.94 0.32 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -128.63 120.35 3.3 Favored Glycine 0 N--CA 1.507 3.431 0 CA-C-O 122.985 1.325 . . . . 0.0 112.124 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 133' ' ' GLU . 5.9 tp10 178.49 169.47 0.83 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 113.379 -1.41 . . . . 0.0 111.728 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.404 ' CD ' ' N ' ' A' ' 133' ' ' GLU . 22.9 mp0 -124.21 127.45 47.73 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 176.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 149' ' ' PHE . 79.9 m-20 -150.71 138.51 19.88 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.245 1.021 . . . . 0.0 111.072 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 147' ' ' ARG . 8.5 p -134.44 126.3 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.473 -0.767 . . . . 0.0 109.011 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.51 169.06 18.3 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 121.724 0.773 . . . . 0.0 111.368 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.6 mt -101.17 141.91 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-O 121.716 0.77 . . . . 0.0 112.826 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -114.07 153.61 29.15 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.415 ' C ' HH21 ' A' ' 115' ' ' ARG . 68.5 mtt85 -147.73 108.11 4.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.494 -1.379 . . . . 0.0 109.901 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.487 ' H ' ' HB3' ' A' ' 143' ' ' ALA . . . -158.06 106.23 0.29 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.498 ' C ' ' H ' ' A' ' 143' ' ' ALA . 84.1 t80 38.42 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.845 -0.797 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.918 HD12 ' O ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER 70.77 -30.15 0.2 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.56 -0.713 . . . . 0.0 110.268 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 145' ' ' ALA . . . -53.49 -2.93 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.105 -1.038 . . . . 0.0 113.035 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 143' ' ' ALA . 5.3 pt20 -45.01 98.88 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 O-C-N 119.949 -1.72 . . . . 0.0 107.842 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.948 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -149.17 163.36 37.82 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.599 -1.313 . . . . 0.0 110.024 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tp -108.45 155.51 20.51 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 120.777 -1.202 . . . . 0.0 110.912 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.693 ' O ' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -136.47 155.42 50.01 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.605 -0.684 . . . . 0.0 110.174 178.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.49 151.76 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.298 0 CA-C-O 121.691 0.757 . . . . 0.0 109.924 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.425 ' N ' ' O ' ' A' ' 134' ' ' ASN . 27.7 m-85 -116.8 138.97 51.12 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.751 0.786 . . . . 0.0 110.356 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 160.33 31.25 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 0.1 OUTLIER -104.44 162.74 0.2 Allowed 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 123.537 2.825 . . . . 0.0 116.224 -178.304 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 47.7 mt -123.59 136.9 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 0.0 OUTLIER -117.14 157.05 26.59 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.401 1.096 . . . . 0.0 112.339 -179.311 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 9.3 p30 -53.98 -95.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.232 -0.917 . . . . 0.0 110.327 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.537 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 9.6 pt-20 -160.11 28.71 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -143.49 23.01 1.82 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.0 m80 67.1 46.83 1.45 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.153 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.77 122.43 30.55 Favored 'General case' 0 N--CA 1.522 3.173 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -58.23 118.35 5.4 Favored 'General case' 0 N--CA 1.518 2.934 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -177.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 160' ' ' ILE . 1.7 pp -141.27 22.32 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 O-C-N 120.349 -1.469 . . . . 0.0 112.124 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.04 169.42 41.75 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 101' ' ' THR . 5.5 t -136.0 138.93 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 CA-C-N 119.614 1.707 . . . . 0.0 112.502 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.447 ' CG2' HD21 ' A' ' 63' ' ' LEU . 1.9 p -119.68 113.83 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.459 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.819 ' H ' ' CG1' ' A' ' 99' ' ' VAL . . . -116.85 165.77 12.93 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.843 HD11 ' HB2' ' A' ' 60' ' ' ALA . 3.3 mt -142.92 107.99 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.03 -1.669 . . . . 0.0 106.919 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.91 114.79 4.87 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.556 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.948 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 5.1 tt -88.47 110.77 21.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.999 ' O ' ' O ' ' A' ' 169' ' ' LEU . 8.2 tm-20 -74.48 127.23 32.54 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.828 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.999 ' O ' ' O ' ' A' ' 168' ' ' GLU . 0.6 OUTLIER 34.05 148.56 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.16 0 CA-C-O 121.959 0.885 . . . . 0.0 110.283 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 172' ' ' VAL . 19.9 m -113.83 76.43 0.98 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.242 -0.911 . . . . 0.0 112.111 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.412 ' N ' HD12 ' A' ' 169' ' ' LEU . 56.3 ttt-85 -63.26 30.8 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.893 -1.129 . . . . 0.0 109.786 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.563 ' H ' ' C ' ' A' ' 170' ' ' SER . 1.8 m -124.14 -9.92 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.401 -1.437 . . . . 0.0 111.662 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 177' ' ' ASN . 0.2 OUTLIER -35.42 -51.55 0.61 Allowed 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.017 -1.052 . . . . 0.0 110.284 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -41.8 -71.68 0.08 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.123 -0.985 . . . . 0.0 110.293 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -51.87 -37.56 52.63 Favored 'General case' 0 N--CA 1.509 2.516 0 CA-C-O 121.714 0.769 . . . . 0.0 112.448 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.3 mm -79.72 -14.93 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.406 0.682 . . . . 0.0 110.034 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 173' ' ' THR . 43.3 t30 -86.84 -40.13 15.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.136 -0.978 . . . . 0.0 109.033 -178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.24 -70.01 0.32 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 119.756 -1.84 . . . . 0.0 109.802 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 14.5 t -47.79 -55.4 9.76 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 120.402 -1.436 . . . . 0.0 113.455 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.877 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.657 0.742 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -68.99 -67.16 0.49 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 123.051 1.405 . . . . 0.0 111.256 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.2 mtt -50.96 -49.1 60.66 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.313 -173.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.458 ' O ' ' C ' ' A' ' 49' ' ' ARG . 12.1 t -55.25 -35.93 65.51 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 48' ' ' THR . 62.5 ttt180 -40.67 -52.7 2.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.014 -1.054 . . . . 0.0 110.996 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.47 -60.44 2.19 Favored 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -73.31 -45.8 29.13 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.481 HD12 ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -54.64 -44.69 73.42 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 120.422 2.111 . . . . 0.0 105.598 176.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.716 ' O ' HD12 ' A' ' 57' ' ' LEU . . . -53.24 -50.8 64.03 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 117.726 -1.59 . . . . 0.0 109.452 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -80.24 -55.87 4.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 119.73 -1.856 . . . . 0.0 111.656 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 51' ' ' GLY . 18.1 mtpp -63.96 -27.1 68.9 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB3' HD12 ' A' ' 52' ' ' LEU . . . -95.56 -37.59 10.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 119.787 -1.821 . . . . 0.0 108.871 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.716 HD12 ' O ' ' A' ' 53' ' ' ALA . 35.2 mt -53.93 -35.45 61.72 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.291 -1.364 . . . . 0.0 108.047 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 61' ' ' ARG . . . -80.97 -46.32 15.3 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -70.85 -26.6 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 118.665 -2.522 . . . . 0.0 106.197 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.443 ' CB ' HD11 ' A' ' 98' ' ' ILE . . . -63.07 -29.07 70.52 Favored 'General case' 0 C--N 1.27 -2.861 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.456 ' O ' ' CG ' ' A' ' 65' ' ' ASP . 4.3 ptt180 -72.65 -19.7 61.39 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 117.164 -1.814 . . . . 0.0 110.84 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 m -68.29 -47.62 67.15 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 124.116 3.144 . . . . 0.0 107.009 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.691 HD22 ' HB1' ' A' ' 84' ' ' ALA . 50.2 mt -87.53 -41.81 13.21 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.833 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -56.32 -19.04 12.63 Favored 'General case' 0 N--CA 1.508 2.475 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.456 ' CG ' ' O ' ' A' ' 61' ' ' ARG . 40.2 m-20 -85.14 -4.3 59.11 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.123 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.512 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.86 -158.05 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 119.983 -1.698 . . . . 0.0 110.239 -178.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.555 ' C ' ' H ' ' A' ' 69' ' ' ILE . 3.1 Cg_endo -104.07 -27.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 123.586 2.857 . . . . 0.0 113.399 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 16.8 pt-20 -75.43 25.09 0.11 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.555 ' H ' ' C ' ' A' ' 67' ' ' PRO . 44.0 mm -106.13 -80.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -46.3 -31.95 2.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.68 -14.37 51.93 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.506 -1.371 . . . . 0.0 110.244 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -102.69 -3.54 49.53 Favored Glycine 0 N--CA 1.504 3.186 0 N-CA-C 107.101 -2.399 . . . . 0.0 107.101 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.52 -52.76 7.25 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 100.406 -3.924 . . . . 0.0 100.406 173.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -8.83 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 113.238 -1.801 . . . . 0.0 112.619 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.71 ' O ' ' O ' ' A' ' 76' ' ' LYS . 4.0 tmtm? -124.07 40.56 3.7 Favored 'General case' 0 N--CA 1.523 3.177 0 CA-C-N 122.732 2.515 . . . . 0.0 111.036 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.791 ' HZ2' ' H ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER 35.24 157.23 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.915 0 C-N-CA 125.532 1.533 . . . . 0.0 112.516 177.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -33.29 -63.48 0.14 Allowed 'Trans proline' 0 N--CA 1.513 2.66 0 C-N-CA 123.943 3.095 . . . . 0.0 115.72 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.791 ' H ' ' HZ2' ' A' ' 76' ' ' LYS . 78.6 mt-30 -50.1 142.02 10.2 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.098 -1.441 . . . . 0.0 108.762 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 63.52 5.9 2.33 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.137 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 1.035 ' O ' ' N ' ' A' ' 82' ' ' ILE . 70.9 p -81.22 86.55 6.19 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.154 -2.217 . . . . 0.0 109.542 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.696 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -35.92 47.24 0.0 OUTLIER Glycine 1 N--CA 1.518 4.139 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.754 -177.576 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.035 ' N ' ' O ' ' A' ' 80' ' ' SER . 1.1 tp -68.04 28.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 122.516 1.151 . . . . 0.0 107.924 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.696 ' H ' ' C ' ' A' ' 81' ' ' GLY . 43.7 tp60 -82.91 -22.3 33.93 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.707 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -73.73 -94.25 0.02 OUTLIER 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.707 ' C ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -20.18 -55.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.157 0 CA-C-N 123.651 2.932 . . . . 0.0 111.554 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -51.9 -49.12 63.63 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 119.333 -2.104 . . . . 0.0 110.161 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.682 ' N ' ' O ' ' A' ' 84' ' ' ALA . 66.1 tt0 -55.96 -54.55 43.42 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 116.624 -1.655 . . . . 0.0 114.393 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -77.79 -42.75 32.84 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 124.699 3.409 . . . . 0.0 108.236 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 88' ' ' ALA . 64.7 t -51.65 -71.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 115.115 -2.634 . . . . 0.0 107.592 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.677 ' O ' ' N ' ' A' ' 93' ' ' ASN . 4.3 ppt_? -40.26 -34.13 0.3 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.959 -1.088 . . . . 0.0 110.608 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.549 ' C ' ' O ' ' A' ' 90' ' ' ARG . 29.0 ttmt -39.38 -28.97 0.04 OUTLIER 'General case' 0 N--CA 1.536 3.827 0 C-N-CA 116.758 -1.977 . . . . 0.0 106.092 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 90' ' ' ARG . 10.6 ttm105 -36.49 -59.56 0.65 Allowed 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 166.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.677 ' N ' ' O ' ' A' ' 90' ' ' ARG . 17.6 t-20 -153.33 -56.38 0.12 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.397 -1.439 . . . . 0.0 110.192 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 1.1 m-20 164.02 1.38 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.864 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -135.57 160.69 37.71 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 117.729 -1.588 . . . . 0.0 113.975 -175.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 96' ' ' LEU . 2.8 pp 151.43 175.92 0.0 OUTLIER 'General case' 0 N--CA 1.534 3.738 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.426 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -139.66 86.58 2.12 Favored 'General case' 0 C--O 1.218 -0.603 1 N-CA-C 98.87 -4.493 . . . . 0.0 98.87 169.245 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.758 HD12 HG23 ' A' ' 165' ' ' ILE . 19.7 tt -101.61 134.72 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 123.396 1.569 . . . . 0.0 108.212 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.792 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 1.1 p -136.41 149.53 27.18 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -173.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.473 ' H ' ' CD1' ' A' ' 82' ' ' ILE . 4.2 p -111.28 131.35 62.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 1 N-CA-C 98.444 -4.65 . . . . 0.0 98.444 169.642 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.672 ' CG2' ' H ' ' A' ' 105' ' ' SER . 1.5 m -124.46 152.27 43.54 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 120.564 -1.335 . . . . 0.0 111.442 -175.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.612 ' O ' HG22 ' A' ' 101' ' ' THR . 24.5 t70 -87.2 -176.85 5.83 Favored 'General case' 0 C--N 1.284 -2.278 1 N-CA-C 98.033 -4.802 . . . . 0.0 98.033 169.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 103' ' ' MET . 1.8 ttt -77.67 73.53 4.23 Favored 'General case' 0 C--N 1.269 -2.9 0 C-N-CA 114.483 -2.887 . . . . 0.0 107.069 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' A' ' 105' ' ' SER . 9.0 tm0? -141.75 -41.51 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 119.595 -1.941 . . . . 0.0 110.483 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.672 ' H ' ' CG2' ' A' ' 101' ' ' THR . 10.5 t 84.88 136.96 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.747 0.819 . . . . 0.0 109.48 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.8 OUTLIER 156.81 134.86 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.618 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 177.314 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.465 ' HE ' ' HB2' ' A' ' 97' ' ' PHE . 9.6 mmm180 -71.9 100.87 2.52 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.628 ' C ' HG21 ' A' ' 82' ' ' ILE . 2.5 m-85 -54.4 -30.24 51.55 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.44 ' C ' ' ND1' ' A' ' 110' ' ' HIS . 12.0 t -101.17 144.78 29.63 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.44 ' ND1' ' C ' ' A' ' 109' ' ' SER . 1.5 m-70 -124.89 107.83 28.41 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -174.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.659 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 65.2 Cg_endo -85.81 -35.63 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 N-CA-C 103.882 -3.161 . . . . 0.0 103.882 172.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.659 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 13.5 mp0 -140.37 138.31 34.72 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 174.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.81 -48.18 64.21 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 118.303 2.705 . . . . 0.0 118.303 -172.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.535 ' H ' ' CD ' ' A' ' 114' ' ' GLN . 1.4 mp0 -66.2 -32.52 74.01 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.78 HH21 ' H ' ' A' ' 139' ' ' ARG . 19.3 tpt85 -61.54 -33.68 74.25 Favored 'General case' 0 C--O 1.201 -1.457 0 CA-C-N 122.358 2.345 . . . . 0.0 106.633 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.701 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.2 OUTLIER -53.17 -86.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.135 177.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.603 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -33.04 -11.63 0.0 OUTLIER Glycine 0 N--CA 1.499 2.866 0 C-N-CA 123.462 0.553 . . . . 0.0 113.748 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.701 ' N ' ' O ' ' A' ' 116' ' ' ILE . 1.3 mt-30 -79.33 -72.75 0.12 Allowed Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 120.017 1.909 . . . . 0.0 113.728 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 115' ' ' ARG . 6.6 Cg_exo -26.55 108.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 123.969 3.113 . . . . 0.0 114.939 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.555 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 48.5 t80 174.86 28.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -174.93 -12.64 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.091 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.76 -21.51 2.29 Favored Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.6 t0 69.64 0.6 3.04 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 121.043 -1.269 . . . . 0.0 112.142 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.534 ' OD2' ' CE2' ' A' ' 149' ' ' PHE . 2.9 p-10 -82.45 -21.18 35.76 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.552 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 20.2 mt -79.42 -21.78 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.528 -0.733 . . . . 0.0 110.199 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -49.39 -37.09 23.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.577 -1.327 . . . . 0.0 108.418 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.791 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 59.0 mttp -74.32 -34.87 63.59 Favored 'General case' 0 C--O 1.194 -1.859 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 125' ' ' ILE . . . -89.43 -30.74 18.12 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 120.023 -1.673 . . . . 0.0 110.539 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.29 -26.35 1.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.858 -1.151 . . . . 0.0 109.705 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.793 ' CG ' ' H ' ' A' ' 131' ' ' GLY 0.278 32.8 p30 -77.12 -92.49 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 108.904 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.793 ' H ' ' CG ' ' A' ' 130' ' ' ASN . . . -164.66 42.8 0.3 Allowed Glycine 0 CA--C 1.565 3.166 0 C-N-CA 125.536 1.541 . . . . 0.0 110.106 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -145.06 164.72 30.35 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 120.316 2.058 . . . . 0.0 111.646 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -64.21 164.32 11.18 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 28.4 t-20 -170.97 138.16 1.27 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.298 -0.876 . . . . 0.0 109.267 176.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.638 HG22 HG12 ' A' ' 148' ' ' VAL . 1.3 t -130.83 138.43 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.315 -1.491 . . . . 0.0 108.776 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -151.51 167.6 27.54 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.644 -1.285 . . . . 0.0 110.213 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 mt -102.32 135.56 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.398 -0.814 . . . . 0.0 109.801 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.452 ' OD1' ' CZ ' ' A' ' 147' ' ' ARG . 0.9 OUTLIER -106.84 152.62 23.64 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.502 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.78 ' H ' HH21 ' A' ' 115' ' ' ARG . 3.5 ptm85 -159.68 97.94 1.34 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.734 ' H ' ' HB3' ' A' ' 143' ' ' ALA . . . -150.61 109.04 0.41 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.07 -1.538 . . . . 0.0 109.92 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 9.3 t80 59.1 -67.47 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 122.034 -0.686 . . . . 0.0 110.14 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 143' ' ' ALA . 0.7 OUTLIER -131.44 6.69 4.47 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.249 -0.907 . . . . 0.0 110.083 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.734 ' HB3' ' H ' ' A' ' 140' ' ' GLY . . . -81.13 5.36 17.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 113.775 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -48.78 91.24 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.217 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 1.029 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -169.03 173.06 7.11 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.301 -170.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 tp -115.01 159.19 21.08 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.461 -1.399 . . . . 0.0 110.89 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.452 ' CZ ' ' OD1' ' A' ' 138' ' ' ASN . 0.8 OUTLIER -143.89 152.33 40.99 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.142 0.972 . . . . 0.0 110.896 178.23 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.638 HG12 HG22 ' A' ' 135' ' ' VAL . 15.5 m -119.41 138.22 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.925 0 CA-C-O 122.119 0.961 . . . . 0.0 109.985 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.534 ' CE2' ' OD2' ' A' ' 124' ' ' ASP . 70.6 m-85 -111.63 145.73 38.68 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.646 0.736 . . . . 0.0 109.686 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.449 HG21 ' CD2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -142.02 156.56 65.07 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -96.54 154.88 1.25 Allowed 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 123.996 3.131 . . . . 0.0 114.195 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 72.6 mt -117.97 136.33 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -107.73 149.16 28.49 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.827 ' O ' ' ND2' ' A' ' 156' ' ' ASN . 24.8 t0 -76.19 57.1 1.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 42.33 21.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 123.641 0.777 . . . . 0.0 112.463 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.827 ' ND2' ' O ' ' A' ' 154' ' ' ASP . 42.3 m-80 -140.28 35.42 1.89 Allowed 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.495 -1.378 . . . . 0.0 109.717 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 61.84 -2.92 0.25 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.571 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.8 mptt -80.45 122.05 26.5 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.924 ' O ' HG23 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -58.2 -154.65 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.058 0 O-C-N 120.861 -1.149 . . . . 0.0 111.136 -177.397 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.924 HG23 ' O ' ' A' ' 159' ' ' GLN . 2.7 pp 151.9 -6.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 CA-C-N 120.175 1.352 . . . . 0.0 112.883 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -172.24 179.86 43.57 Favored Glycine 0 N--CA 1.507 3.407 0 C-N-CA 115.981 -3.009 . . . . 0.0 111.583 -175.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -139.6 139.22 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -1.225 . . . . 0.0 112.042 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.4 t -108.09 127.31 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.792 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -115.99 144.23 44.37 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.758 HG23 HD12 ' A' ' 98' ' ' ILE . 6.2 mt -137.76 99.52 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.25 129.59 9.13 Favored Glycine 0 N--CA 1.485 1.947 0 CA-C-O 123.328 1.515 . . . . 0.0 112.762 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.029 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -88.62 115.31 26.05 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 113.475 -1.363 . . . . 0.0 107.925 177.363 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.883 ' O ' ' O ' ' A' ' 169' ' ' LEU . 0.7 OUTLIER -74.95 132.25 41.28 Favored 'General case' 0 N--CA 1.529 3.491 0 O-C-N 124.084 0.865 . . . . 0.0 110.237 -179.179 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.883 ' O ' ' O ' ' A' ' 168' ' ' GLU . 1.5 pp 30.1 166.46 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.017 0 O-C-N 120.566 -1.334 . . . . 0.0 113.487 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 172' ' ' VAL . 0.1 OUTLIER -171.55 61.0 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.596 0.713 . . . . 0.0 110.192 -179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.481 ' C ' ' O ' ' A' ' 170' ' ' SER . 80.2 mtm180 7.67 -37.0 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.062 0 C-N-CA 123.276 0.63 . . . . 0.0 112.606 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 1.157 ' N ' ' O ' ' A' ' 170' ' ' SER . 3.1 t -87.13 23.37 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.045 -1.66 . . . . 0.0 109.834 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.482 ' O ' ' ND2' ' A' ' 177' ' ' ASN . 32.4 p -79.73 -39.34 31.34 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -74.75 -55.17 6.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.517 -1.365 . . . . 0.0 108.421 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.436 ' CG ' ' H ' ' A' ' 176' ' ' ILE . 4.7 pt20 -51.54 -68.66 0.15 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.883 HG23 ' H ' ' A' ' 177' ' ' ASN . 10.4 tp -41.84 -74.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.883 ' H ' HG23 ' A' ' 176' ' ' ILE . 77.5 m-20 -46.17 -73.46 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.01 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 177' ' ' ASN . 50.1 m-20 -47.06 -59.4 3.15 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.821 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.476 ' OG ' ' N ' ' A' ' 180' ' ' ARG . 59.6 p -47.14 -70.62 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.722 -1.236 . . . . 0.0 109.639 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.476 ' N ' ' OG ' ' A' ' 179' ' ' SER . 97.8 mtt180 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 120.751 -1.218 . . . . 0.0 109.387 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.544 ' CG ' ' H ' ' A' ' 47' ' ' MET . 17.4 p-10 -66.29 -64.73 0.79 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.885 1.326 . . . . 0.0 110.786 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.544 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 16.3 mmm -43.54 -58.61 2.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.193 0.997 . . . . 0.0 111.443 -173.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' ARG . 6.4 t -53.18 -35.97 60.42 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 36.8 ttp180 -42.02 -51.05 4.59 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.805 -1.184 . . . . 0.0 111.841 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -80.77 -58.06 3.27 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -79.59 -45.3 8.7 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.541 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -54.96 -46.3 75.01 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 120.533 2.167 . . . . 0.0 105.525 176.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 49' ' ' ARG . . . -46.9 -57.98 4.4 Favored 'General case' 0 C--O 1.205 -1.275 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.345 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -81.87 -68.42 0.7 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.64 -1.288 . . . . 0.0 113.989 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 51' ' ' GLY . 57.4 mtpt -47.46 -27.53 1.77 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.094 -1.004 . . . . 0.0 111.647 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 52' ' ' LEU . . . -93.46 -32.3 14.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.053 -1.654 . . . . 0.0 108.782 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.3 tp -55.22 -40.21 70.56 Favored 'General case' 0 C--N 1.284 -2.239 0 O-C-N 121.035 -1.041 . . . . 0.0 109.309 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.617 ' O ' ' CG ' ' A' ' 61' ' ' ARG . . . -80.42 -47.49 14.3 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -177.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.664 ' HB ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -66.89 -32.95 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 117.616 -3.177 . . . . 0.0 104.618 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.599 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -58.84 -26.53 64.28 Favored 'General case' 0 C--N 1.265 -3.104 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.617 ' CG ' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -49.79 -24.45 2.39 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 116.665 -2.014 . . . . 0.0 105.882 174.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.519 HG22 HG22 ' A' ' 85' ' ' ILE . 96.9 m -74.03 -39.76 63.34 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.826 ' O ' HD12 ' A' ' 85' ' ' ILE 0.276 0.3 OUTLIER -48.2 -42.19 29.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 124.761 2.22 . . . . 0.0 107.921 175.58 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.66 -4.7 59.21 Favored 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 112.553 -2.112 . . . . 0.0 113.081 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 66' ' ' SER . 34.5 t0 -99.02 -27.46 13.84 Favored 'General case' 0 N--CA 1.517 2.921 0 CA-C-N 123.713 2.961 . . . . 0.0 115.618 -172.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.577 ' HB2' HD13 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -60.12 -161.47 0.0 OUTLIER Pre-proline 0 C--N 1.278 -2.525 0 O-C-N 119.668 -1.895 . . . . 0.0 109.928 -178.395 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.725 ' HD2' ' H ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -114.52 -25.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 124.399 3.399 . . . . 0.0 113.584 176.032 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.725 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 16.4 pt-20 -56.75 -30.45 63.59 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 117.829 -1.548 . . . . 0.0 107.52 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.5 mt -45.25 -83.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.062 -178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -47.33 -39.03 13.95 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.978 0.894 . . . . 0.0 109.914 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -78.04 -13.0 60.03 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.931 -1.105 . . . . 0.0 111.08 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . -97.52 -1.38 59.06 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 105.046 -3.222 . . . . 0.0 105.046 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.571 ' O ' ' OD2' ' A' ' 102' ' ' ASP . 1.4 mp -89.61 -23.22 21.99 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 173.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -62.83 -0.72 0.71 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.642 ' CG ' ' H ' ' A' ' 76' ' ' LYS . 3.5 tptm -136.37 -140.81 0.16 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.204 -1.56 . . . . 0.0 107.175 174.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.642 ' H ' ' CG ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -129.12 156.14 78.69 Favored Pre-proline 0 CA--C 1.578 2.041 0 O-C-N 121.481 -0.762 . . . . 0.0 109.625 179.381 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' O ' ' CE2' ' A' ' 108' ' ' TYR . 0.9 OUTLIER -31.56 -10.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.528 3.546 1 C-N-CA 126.236 4.624 . . . . 0.0 118.946 -179.082 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' LYS . 44.0 tp60 -96.33 -14.08 22.83 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 119.798 -1.814 . . . . 0.0 109.622 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -116.11 0.74 13.05 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.232 -0.918 . . . . 0.0 112.472 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.694 ' N ' ' OH ' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -76.36 -155.4 0.06 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 119.234 -2.166 . . . . 0.0 107.703 178.374 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.97 17.25 0.22 Allowed Glycine 0 N--CA 1.496 2.676 0 O-C-N 120.523 -1.36 . . . . 0.0 109.727 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.624 HD12 ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -48.39 -24.37 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-O 121.898 0.856 . . . . 0.0 110.385 -179.12 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 55.4 tt0 -53.34 -7.74 0.1 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 82' ' ' ILE . . . -94.49 -52.81 4.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.002 -1.061 . . . . 0.0 112.689 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.826 HD12 ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -74.82 -34.2 32.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 177.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -57.97 -46.27 85.41 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 1.2 tt0 -49.67 -21.54 1.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.053 -1.43 . . . . 0.0 107.948 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.94 66.76 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 114.831 -2.748 . . . . 0.0 104.093 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.664 HG22 ' HB ' ' A' ' 59' ' ' VAL . 37.7 t -54.62 -72.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 C-N-CA 116.776 -1.97 . . . . 0.0 110.185 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 93' ' ' ASN . 1.5 ttt-85 -48.13 -69.61 0.12 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 124.499 1.119 . . . . 0.0 113.118 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 90' ' ' ARG . 37.9 pttt -35.61 -36.87 0.08 Allowed 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.953 -1.092 . . . . 0.0 109.187 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 90' ' ' ARG . 62.3 mtm-85 -86.51 -21.88 26.71 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.723 -1.236 . . . . 0.0 111.585 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.644 ' N ' ' O ' ' A' ' 90' ' ' ARG . 54.7 t-20 -97.9 -16.42 19.75 Favored 'General case' 0 N--CA 1.511 2.582 0 CA-C-N 120.979 1.718 . . . . 0.0 108.374 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.0 t70 73.28 24.7 2.34 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.886 0.875 . . . . 0.0 110.835 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 0.4 OUTLIER 173.27 153.71 0.09 Allowed 'General case' 0 N--CA 1.514 2.755 0 CA-C-N 121.726 2.057 . . . . 0.0 107.796 176.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.636 HD13 HG12 ' A' ' 89' ' ' VAL . 0.3 OUTLIER 156.17 164.69 0.01 OUTLIER 'General case' 1 N--CA 1.542 4.133 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.2 179.828 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.566 ' CD1' ' NE ' ' A' ' 107' ' ' ARG . 0.9 OUTLIER -143.52 89.21 2.06 Favored 'General case' 0 C--O 1.214 -0.816 1 N-CA-C 99.119 -4.4 . . . . 0.0 99.119 168.552 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.629 ' N ' ' OG ' ' A' ' 109' ' ' SER . 0.4 OUTLIER -93.19 129.09 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -175.29 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 164' ' ' ALA . 1.1 m -119.08 130.54 73.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -173.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.624 ' HB ' HD12 ' A' ' 82' ' ' ILE . 0.9 OUTLIER -123.64 124.47 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 1 N-CA-C 97.166 -5.124 . . . . 0.0 97.166 169.217 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.649 HG21 ' HA ' ' A' ' 105' ' ' SER . 11.5 p -136.09 164.2 28.57 Favored 'General case' 0 C--N 1.281 -2.372 0 O-C-N 120.61 -1.306 . . . . 0.0 108.416 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.707 ' O ' ' N ' ' A' ' 104' ' ' GLN . 1.7 m-20 -78.86 -175.13 4.32 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 100.873 -3.751 . . . . 0.0 100.873 170.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.514 ' CG ' ' O ' ' A' ' 103' ' ' MET . 1.6 ttt -68.28 69.82 0.15 Allowed 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 114.843 -2.743 . . . . 0.0 103.963 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.707 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -137.16 -50.37 0.64 Allowed 'General case' 0 C--N 1.358 0.965 0 O-C-N 120.488 -1.382 . . . . 0.0 108.408 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.649 ' HA ' HG21 ' A' ' 101' ' ' THR . 1.5 t 92.74 138.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.9 OUTLIER 157.04 139.34 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 102.092 -3.299 . . . . 0.0 102.092 178.447 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.74 ' NH2' HH11 ' A' ' 147' ' ' ARG . 39.4 mtt180 -86.19 96.65 9.99 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.791 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.694 ' OH ' ' N ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -55.95 -19.94 14.26 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 123.81 1.767 . . . . 0.0 107.282 -176.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.629 ' OG ' ' N ' ' A' ' 98' ' ' ILE . 25.6 p -113.36 146.02 40.15 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.534 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.552 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 13.3 p80 -155.53 137.25 9.64 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -174.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.622 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 40.5 Cg_endo -88.57 -32.25 0.15 Allowed 'Trans proline' 0 N--CA 1.482 0.815 0 N-CA-C 104.666 -2.859 . . . . 0.0 104.666 171.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.622 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 34.9 tp10 -127.35 124.83 39.57 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.24 81.83 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -68.28 -28.97 67.65 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 119.882 -1.762 . . . . 0.0 115.629 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.548 ' CD ' ' CE2' ' A' ' 97' ' ' PHE . 11.7 ttt85 -55.26 -29.04 57.33 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 119.103 -2.248 . . . . 0.0 105.544 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.751 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.2 OUTLIER -63.92 -87.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.214 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.437 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -32.55 -13.41 0.0 OUTLIER Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.419 -0.801 . . . . 0.0 112.949 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.751 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.9 mt-30 -71.5 -72.64 0.21 Allowed Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 119.632 -2.099 . . . . 0.0 110.892 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.512 ' O ' ' CB ' ' A' ' 120' ' ' PHE . 96.0 Cg_exo -19.04 142.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 124.309 3.339 . . . . 0.0 113.878 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.592 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 67.1 t80 140.89 21.64 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.441 ' C ' ' N ' ' A' ' 123' ' ' ASP . 23.7 ttmt -177.29 -2.8 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 O-C-N 121.434 -0.792 . . . . 0.0 110.196 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.6 -20.59 2.75 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.441 ' N ' ' C ' ' A' ' 121' ' ' LYS . 10.0 t70 72.6 -5.27 1.88 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -75.97 -21.1 57.33 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 119.756 -1.84 . . . . 0.0 108.861 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.469 ' HB ' HG21 ' A' ' 162' ' ' VAL . 14.7 pt -74.39 -23.67 18.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.02 -1.05 . . . . 0.0 109.947 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.76 -25.92 8.51 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -86.52 -39.14 16.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.671 -0.643 . . . . 0.0 111.594 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 150' ' ' THR . . . -79.73 -46.85 16.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 119.898 -1.752 . . . . 0.0 107.246 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.544 HD22 HG23 ' A' ' 162' ' ' VAL . 0.1 OUTLIER -38.41 -41.93 0.69 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 16.1 m-20 -100.46 12.81 36.43 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.315 -1.311 . . . . 0.0 114.203 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.36 98.41 0.56 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 170.85 157.76 0.07 Allowed 'General case' 0 N--CA 1.514 2.746 0 CA-C-O 122.596 1.189 . . . . 0.0 111.399 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -101.53 144.74 29.92 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.303 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -159.75 144.34 15.01 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.824 -1.172 . . . . 0.0 109.693 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 147' ' ' ARG . 5.0 p -138.43 132.91 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 120.701 -1.249 . . . . 0.0 109.974 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -148.88 169.17 21.15 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.433 0.635 . . . . 0.0 110.452 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.444 HG22 ' OE1' ' A' ' 144' ' ' GLN . 0.8 OUTLIER -97.42 139.22 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-O 121.361 0.6 . . . . 0.0 111.5 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.536 ' CG ' HH22 ' A' ' 107' ' ' ARG . 28.1 t-20 -117.23 150.3 38.99 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.249 -0.907 . . . . 0.0 110.745 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -153.5 113.61 3.94 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 141' ' ' PHE . . . -150.28 112.61 0.55 Allowed Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.249 -1.453 . . . . 0.0 110.305 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 141' ' ' PHE . 54.5 t80 39.01 32.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.904 -0.762 . . . . 0.0 110.122 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.451 HD23 HH11 ' A' ' 115' ' ' ARG . 32.0 tp -152.98 -94.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.89 . . . . 0.0 110.736 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.486 ' CB ' ' HG ' ' A' ' 170' ' ' SER . . . -172.55 154.27 3.06 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.535 -1.353 . . . . 0.0 112.029 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.444 ' OE1' HG22 ' A' ' 137' ' ' ILE . 36.0 mm-40 -52.49 144.59 13.12 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.673 1.225 . . . . 0.0 111.747 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.922 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -162.1 158.03 24.2 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -177.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 tp -108.97 159.52 16.76 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-N 121.351 1.887 . . . . 0.0 109.683 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.759 ' O ' HG23 ' A' ' 135' ' ' VAL . 11.3 ptt180 -152.3 149.04 28.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.725 -1.234 . . . . 0.0 110.768 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.25 157.47 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-O 122.291 1.043 . . . . 0.0 109.673 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 164' ' ' ALA . 26.1 m-85 -124.92 135.96 53.32 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.844 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.557 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -142.63 161.16 50.93 Favored Pre-proline 0 C--N 1.31 -1.127 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -108.16 163.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 123.459 2.773 . . . . 0.0 116.027 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.519 ' CG1' HG23 ' A' ' 163' ' ' VAL . 48.9 mt -118.62 125.86 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -104.75 155.44 18.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 123.195 1.474 . . . . 0.0 110.666 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -53.08 -85.54 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -170.35 35.59 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -148.18 20.3 1.09 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 64.85 42.54 4.39 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 153' ' ' TYR . 0.6 OUTLIER -122.68 118.46 28.15 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.506 ' N ' ' OE1' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -63.83 121.41 13.96 Favored 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -176.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.1 pp -140.31 13.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 120.536 -1.353 . . . . 0.0 113.749 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.48 178.93 40.73 Favored Glycine 1 N--CA 1.522 4.379 0 C-N-CA 118.816 -1.659 . . . . 0.0 112.361 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.544 HG23 HD22 ' A' ' 129' ' ' LEU . 16.8 t -123.3 134.02 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.26 0 CA-C-N 119.013 1.406 . . . . 0.0 112.593 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 152' ' ' ILE . 2.7 t -123.9 107.19 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.687 ' HB3' HG22 ' A' ' 99' ' ' VAL . . . -112.44 158.21 20.14 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.6 HG23 ' CG1' ' A' ' 98' ' ' ILE . 4.2 mt -143.33 101.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 97' ' ' PHE . . . -115.05 127.56 7.71 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.403 -1.38 . . . . 0.0 113.11 -175.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.922 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 13.4 tp -93.71 124.82 37.97 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.662 -1.269 . . . . 0.0 109.306 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.416 ' OE1' ' NH1' ' A' ' 115' ' ' ARG . 12.7 tp10 -73.79 134.38 43.39 Favored 'General case' 0 N--CA 1.521 3.086 0 C-N-CA 122.949 0.5 . . . . 0.0 109.942 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.489 ' H ' ' HB2' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -154.99 -167.47 2.59 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 119.327 -2.108 . . . . 0.0 109.167 178.614 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . 1.354 ' O ' HG22 ' A' ' 172' ' ' VAL . 19.8 m -166.45 -126.21 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 110.089 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.597 ' O ' HG13 ' A' ' 172' ' ' VAL . 56.6 ttt85 -17.9 71.95 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.226 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 1.354 HG22 ' O ' ' A' ' 170' ' ' SER . 0.3 OUTLIER -165.88 -16.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.649 0 O-C-N 121.381 -0.824 . . . . 0.0 110.569 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.528 HG23 ' N ' ' A' ' 174' ' ' GLN . 9.6 t -69.61 -45.3 68.88 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.477 -1.389 . . . . 0.0 113.859 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLN . . . . . 0.528 ' N ' HG23 ' A' ' 173' ' ' THR . 67.4 tp60 -73.95 -53.7 9.52 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.268 -1.52 . . . . 0.0 110.566 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -52.12 -70.65 0.08 Allowed 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.471 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.616 HG22 ' N ' ' A' ' 177' ' ' ASN . 1.3 mp -42.5 -78.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.896 0.855 . . . . 0.0 111.438 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.616 ' N ' HG22 ' A' ' 176' ' ' ILE . 53.1 t30 -38.23 -78.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.868 -177.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -47.16 -60.85 2.2 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.593 -1.317 . . . . 0.0 110.645 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 9.7 m -55.53 -68.28 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.39 -1.443 . . . . 0.0 108.858 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 176' ' ' ILE . 63.5 ttp85 . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.331 -0.855 . . . . 0.0 109.818 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.421 ' O ' HG22 ' A' ' 48' ' ' THR . 50.6 p . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 49' ' ' ARG . 40.7 t0 -63.76 -64.56 0.86 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 123.871 1.796 . . . . 0.0 108.817 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.416 ' C ' ' O ' ' A' ' 46' ' ' ASP . 6.6 tmm? -32.12 -60.08 0.28 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 123.331 1.538 . . . . 0.0 111.116 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 52' ' ' LEU . 13.9 t -59.56 -32.62 70.51 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.448 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 46' ' ' ASP . 32.3 ttp85 -37.86 -51.98 1.31 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.699 -1.251 . . . . 0.0 111.81 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -84.49 -56.44 3.62 Favored 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -77.43 -43.36 15.9 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -176.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.635 HD11 HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -54.63 -45.82 73.81 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 120.352 2.076 . . . . 0.0 106.344 176.512 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.426 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . -48.32 -57.23 6.31 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.625 -1.23 . . . . 0.0 108.999 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -78.35 -55.77 4.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.435 -1.416 . . . . 0.0 113.402 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -67.86 -21.95 65.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.862 . . . . 0.0 111.874 -175.069 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.676 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -97.68 -35.35 10.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 120.784 1.629 . . . . 0.0 110.572 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.4 tt -65.03 -35.8 82.35 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.291 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.63 -45.38 21.66 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -72.64 -34.41 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 118.649 -2.532 . . . . 0.0 105.882 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.447 ' N ' HG13 ' A' ' 89' ' ' VAL . . . -60.84 -31.81 71.22 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.631 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 2.0 ptt180 -70.02 -16.64 63.19 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.614 -1.234 . . . . 0.0 110.318 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 m -63.58 -46.03 87.74 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 123.056 2.662 . . . . 0.0 105.734 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.724 HD22 ' HB1' ' A' ' 84' ' ' ALA . 54.1 mt -88.79 -37.6 15.3 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.897 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.631 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -58.86 -19.95 46.44 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 119.152 -2.218 . . . . 0.0 105.715 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 31.5 t70 -84.39 -4.33 58.84 Favored 'General case' 0 C--N 1.274 -2.717 0 O-C-N 121.367 -0.833 . . . . 0.0 110.517 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.516 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -74.84 -155.9 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 120.36 -1.462 . . . . 0.0 111.178 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -108.04 -20.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.316 2.677 . . . . 0.0 114.336 178.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.9 pt-20 -62.1 -36.34 81.44 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.621 -1.631 . . . . 0.0 106.938 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.762 ' CG2' HG21 ' A' ' 100' ' ' VAL . 7.9 mm -47.06 -88.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.828 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' H ' ' HB ' ' A' ' 69' ' ' ILE . 73.8 ttt180 -45.35 -31.25 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -78.51 -17.81 55.69 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.732 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.772 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -83.26 -40.84 8.86 Favored Glycine 0 N--CA 1.507 3.375 1 N-CA-C 102.453 -4.259 . . . . 0.0 102.453 178.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.466 HD11 HG22 ' A' ' 100' ' ' VAL . 5.7 mp -48.13 -35.64 11.9 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -78.59 5.57 10.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.779 ' O ' ' O ' ' A' ' 76' ' ' LYS . 31.4 mmtm -139.22 34.82 2.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.835 -1.165 . . . . 0.0 111.66 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.779 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 24.96 153.83 0.0 OUTLIER Pre-proline 0 N--CA 1.527 3.412 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.119 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 76' ' ' LYS . 5.7 Cg_exo -22.42 -62.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 124.411 3.407 . . . . 0.0 114.683 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -55.22 139.37 42.46 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 117.326 -1.75 . . . . 0.0 107.777 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 61.58 13.89 5.54 Favored 'General case' 0 C--N 1.282 -2.341 0 C-N-CA 119.353 -0.939 . . . . 0.0 113.336 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.641 ' O ' ' N ' ' A' ' 82' ' ' ILE . 22.4 m -88.88 82.09 6.81 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 120.247 -1.533 . . . . 0.0 109.636 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 83' ' ' GLN . . . -43.98 10.42 0.0 OUTLIER Glycine 0 CA--C 1.577 3.918 0 CA-C-O 117.594 -1.67 . . . . 0.0 115.768 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.403 HG21 ' CG1' ' A' ' 100' ' ' VAL . 0.3 OUTLIER -49.06 -12.18 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 123.983 3.892 . . . . 0.0 110.849 -178.571 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.831 ' N ' HD12 ' A' ' 82' ' ' ILE . 1.1 tm0? -36.78 -19.47 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.724 ' HB1' HD22 ' A' ' 63' ' ' LEU . . . -63.87 -86.72 0.01 OUTLIER 'General case' 0 C--O 1.191 -1.995 1 N-CA-C 98.675 -4.565 . . . . 0.0 98.675 171.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.719 HD13 HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -16.96 -56.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.531 3.597 0 CA-C-N 124.009 3.095 . . . . 0.0 109.336 177.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -53.1 -58.36 7.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.008 -1.682 . . . . 0.0 109.611 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 84' ' ' ALA . 56.0 tt0 -43.67 -56.65 3.62 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 117.156 -1.402 . . . . 0.0 111.563 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -65.15 -59.26 4.29 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 124.318 3.235 . . . . 0.0 109.182 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -48.26 -59.57 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 C-N-CA 114.686 -2.805 . . . . 0.0 111.313 -175.526 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.829 ' O ' ' N ' ' A' ' 93' ' ' ASN . 24.6 ptt180 -52.14 -39.19 59.6 Favored 'General case' 0 C--O 1.193 -1.887 0 CA-C-N 120.567 1.53 . . . . 0.0 111.045 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.599 ' C ' ' O ' ' A' ' 90' ' ' ARG . 16.3 tttm -34.11 -44.75 0.19 Allowed 'General case' 0 N--CA 1.536 3.839 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 91' ' ' LYS . 16.0 mmm180 -35.63 -53.32 0.7 Allowed 'General case' 0 N--CA 1.516 2.873 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.829 ' N ' ' O ' ' A' ' 90' ' ' ARG . 74.6 m-80 -140.37 -66.65 0.44 Allowed 'General case' 0 N--CA 1.514 2.745 0 CA-C-N 121.737 2.062 . . . . 0.0 111.261 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 2.1 m-20 159.71 -7.85 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.054 0 CA-C-O 121.572 0.701 . . . . 0.0 109.732 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.76 155.82 22.91 Favored 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.919 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER 157.49 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.53 3.559 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.669 -178.06 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.86 83.14 1.94 Allowed 'General case' 0 C--O 1.215 -0.75 1 N-CA-C 98.532 -4.618 . . . . 0.0 98.532 169.664 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.58 HD12 HG23 ' A' ' 165' ' ' ILE . 16.6 tt -104.69 155.66 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 123.633 1.683 . . . . 0.0 109.461 -175.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.647 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -151.15 139.28 14.3 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 CA-C-N 112.399 -2.182 . . . . 0.0 113.149 -171.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 1.403 ' CG1' HG21 ' A' ' 82' ' ' ILE . 7.3 p -105.53 130.95 56.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 1 N-CA-C 94.246 -6.205 . . . . 0.0 94.246 169.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 102' ' ' ASP . 1.6 m -121.6 151.91 39.86 Favored 'General case' 0 N--CA 1.508 2.471 0 CA-C-N 121.573 1.988 . . . . 0.0 111.607 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.677 ' O ' HG22 ' A' ' 101' ' ' THR . 37.4 t70 -96.16 -163.07 1.01 Allowed 'General case' 0 C--N 1.29 -1.989 1 N-CA-C 98.507 -4.627 . . . . 0.0 98.507 167.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.674 ' SD ' HD21 ' A' ' 129' ' ' LEU . 4.2 tpt -89.41 77.72 7.29 Favored 'General case' 0 C--N 1.268 -2.975 0 C-N-CA 116.074 -2.25 . . . . 0.0 109.852 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 105' ' ' SER . 64.3 tp60 -150.97 -30.4 0.18 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 119.193 -2.192 . . . . 0.0 109.046 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.634 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 26.7 t 60.95 138.13 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 105' ' ' SER . 1.1 tp 153.51 140.43 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 139.69 58.8 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.477 ' HB3' HG13 ' A' ' 82' ' ' ILE . 3.4 m-30 -97.68 -1.18 44.13 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 t -129.03 146.84 50.9 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.606 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -142.3 105.0 5.55 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -172.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.556 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 27.7 Cg_endo -93.11 -46.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 N-CA-C 106.11 -2.304 . . . . 0.0 106.11 172.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.556 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 2.5 tm-20 -108.54 130.01 55.29 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 175.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.67 -58.59 7.89 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.409 ' N ' ' OE2' ' A' ' 112' ' ' GLU . 99.0 mm-40 -71.62 -29.64 64.89 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -174.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -58.92 -31.02 68.27 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 123.632 2.924 . . . . 0.0 106.437 -178.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.818 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.7 OUTLIER -54.04 -89.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.219 178.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.688 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -27.58 -8.61 0.0 OUTLIER Glycine 0 N--CA 1.493 2.436 0 C-N-CA 123.961 0.791 . . . . 0.0 114.647 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.818 ' N ' ' O ' ' A' ' 116' ' ' ILE . 3.6 mt-30 -76.56 -70.59 0.21 Allowed Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 118.954 -2.497 . . . . 0.0 114.034 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.432 ' C ' ' O ' ' A' ' 118' ' ' GLN . 51.9 Cg_exo -19.12 95.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 124.289 3.326 . . . . 0.0 115.536 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.492 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 0.0 OUTLIER 175.0 11.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 123' ' ' ASP . 74.4 tttt -164.56 -27.44 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.1 -1.0 . . . . 0.0 109.471 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -41.6 -13.75 0.01 OUTLIER Glycine 1 N--CA 1.516 4.009 0 O-C-N 121.303 -0.873 . . . . 0.0 111.908 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 121' ' ' LYS . 39.1 m-20 65.01 43.65 3.7 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 118.712 1.256 . . . . 0.0 112.382 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -128.42 -26.98 2.7 Favored 'General case' 0 N--CA 1.518 2.931 0 C-N-CA 117.456 -1.697 . . . . 0.0 109.832 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.59 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 12.1 mt -80.02 -16.04 12.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 O-C-N 120.729 -1.232 . . . . 0.0 110.556 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -53.47 -44.21 68.77 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.432 -1.417 . . . . 0.0 110.276 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.697 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 59.3 mttm -73.54 -31.4 63.64 Favored 'General case' 0 C--O 1.193 -1.915 0 O-C-N 121.284 -0.885 . . . . 0.0 109.569 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.405 ' O ' ' OD1' ' A' ' 130' ' ' ASN . . . -83.07 -20.6 34.63 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.37 -1.456 . . . . 0.0 109.189 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.674 HD21 ' SD ' ' A' ' 103' ' ' MET . 0.6 OUTLIER -55.03 -18.7 5.58 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.565 -0.709 . . . . 0.0 109.291 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.709 ' CG ' ' H ' ' A' ' 131' ' ' GLY 0.348 43.3 p-10 -79.28 -105.87 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.709 ' H ' ' CG ' ' A' ' 130' ' ' ASN . . . -156.22 41.85 0.56 Allowed Glycine 0 CA--C 1.563 3.067 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.405 ' HB3' HD22 ' A' ' 130' ' ' ASN . 68.5 tt0 -146.47 161.17 41.0 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 119.409 -2.23 . . . . 0.0 110.891 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 133' ' ' GLU . 6.8 mp0 -73.8 165.15 25.63 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 122.091 0.948 . . . . 0.0 112.706 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 53.7 t30 -166.03 150.93 8.33 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.658 ' CG2' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -134.38 131.18 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 O-C-N 119.661 -1.9 . . . . 0.0 110.473 -177.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.28 160.85 39.73 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.159 -0.963 . . . . 0.0 111.5 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.2 mt -102.39 142.45 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-O 121.835 0.826 . . . . 0.0 112.118 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.439 ' CG ' ' N ' ' A' ' 139' ' ' ARG . 4.1 t-20 -119.11 161.62 19.99 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 138' ' ' ASN . 2.6 ptm180 -164.27 109.05 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.405 -0.918 . . . . 0.0 108.57 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -162.76 114.61 0.61 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.722 -1.704 . . . . 0.0 110.56 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 3.4 t80 60.01 -73.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.572 -0.958 . . . . 0.0 109.444 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.134 HD13 ' OE2' ' A' ' 168' ' ' GLU . 33.7 mt -47.91 -79.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 142' ' ' LEU . . . 161.81 159.95 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.335 0.588 . . . . 0.0 110.606 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 143' ' ' ALA . 39.5 mt-30 -42.37 134.96 2.82 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.951 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -156.44 155.29 31.83 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.14 152.88 25.48 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 121.117 1.781 . . . . 0.0 111.192 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 155.34 49.87 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.658 HG12 ' CG2' ' A' ' 135' ' ' VAL . 3.6 m -118.15 155.79 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 47.3 m-85 -125.51 137.66 53.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.586 0.707 . . . . 0.0 109.375 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.09 146.54 43.72 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -92.42 154.82 3.03 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 123.812 3.008 . . . . 0.0 114.981 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.2 mt -117.29 133.45 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.773 -0.579 . . . . 0.0 109.934 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 155' ' ' GLU . 77.4 m-85 -103.13 144.12 31.72 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.4 51.11 0.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 153' ' ' TYR . 9.2 tt0 41.1 25.06 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.187 -0.946 . . . . 0.0 111.657 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -138.77 30.6 2.29 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 62.46 2.67 0.93 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -92.23 124.87 36.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.586 ' O ' ' CD ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -73.1 129.99 39.3 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -175.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.422 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.7 pp -138.94 14.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.24 -1.537 . . . . 0.0 114.404 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.23 176.09 45.98 Favored Glycine 0 N--CA 1.505 3.298 0 C-N-CA 116.042 -2.98 . . . . 0.0 112.798 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.5 ' O ' ' OG1' ' A' ' 101' ' ' THR . 55.5 t -136.61 133.73 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 121.771 0.796 . . . . 0.0 110.387 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 79.7 t -106.03 122.63 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.647 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -119.35 141.93 48.59 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.676 HG21 ' HB1' ' A' ' 56' ' ' ALA . 22.3 mt -131.67 110.91 17.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.25 119.21 6.31 Favored Glycine 0 N--CA 1.487 2.039 0 C-N-CA 119.095 -1.526 . . . . 0.0 111.528 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.951 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -94.5 114.89 26.96 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 1.134 ' OE2' HD13 ' A' ' 142' ' ' LEU . 13.5 tp10 -74.86 134.88 41.6 Favored 'General case' 0 N--CA 1.518 2.951 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 170' ' ' SER . 11.0 tp 25.44 -109.58 0.02 OUTLIER 'General case' 0 N--CA 1.534 3.725 0 CA-C-N 119.04 0.836 . . . . 0.0 111.315 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 172' ' ' VAL . 22.7 t 108.61 76.01 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 CA-C-O 122.657 1.218 . . . . 0.0 109.677 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 49.6 mmt-85 1.54 -53.69 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 112.8 -2.0 . . . . 0.0 114.41 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 170' ' ' SER . 2.2 t -81.56 23.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 O-C-N 119.819 -1.801 . . . . 0.0 112.883 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.2 p -82.04 -35.84 28.35 Favored 'General case' 0 C--N 1.274 -2.688 0 O-C-N 121.912 -0.493 . . . . 0.0 111.271 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 7.6 tm0? -73.74 -58.97 2.94 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 117.487 -1.685 . . . . 0.0 108.758 -176.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.439 ' CG ' ' H ' ' A' ' 176' ' ' ILE . 4.8 pt20 -51.16 -70.04 0.1 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.289 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.751 HG23 ' N ' ' A' ' 177' ' ' ASN . 9.1 tp -41.01 -70.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.751 ' N ' HG23 ' A' ' 176' ' ' ILE . 26.3 t-20 -41.4 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.964 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 179' ' ' SER . 60.6 t0 -51.51 -63.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.999 -1.063 . . . . 0.0 111.992 -177.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 180' ' ' ARG . 1.7 t -48.05 -73.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.224 -1.39 . . . . 0.0 107.834 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 179' ' ' SER . 2.8 tmm_? . . . . . 0 N--CA 1.514 2.749 0 O-C-N 121.08 -1.013 . . . . 0.0 109.716 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.66 0.743 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -71.41 -65.6 0.73 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.336 -0.852 . . . . 0.0 108.957 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 24.6 ttt -41.42 -55.92 2.65 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.888 -1.132 . . . . 0.0 110.838 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.46 ' OG1' ' CD2' ' A' ' 52' ' ' LEU . 5.8 t -60.33 -32.61 71.4 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 122.181 0.991 . . . . 0.0 108.881 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' THR . 53.8 ttp180 -41.61 -60.86 1.21 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.25 -1.531 . . . . 0.0 112.538 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -76.57 -60.98 2.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.85 -49.55 22.58 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.915 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.545 HD11 HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -51.81 -43.45 63.1 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 120.747 2.273 . . . . 0.0 108.194 178.319 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.82 -49.09 71.87 Favored 'General case' 0 C--O 1.204 -1.322 0 C-N-CA 117.407 -1.717 . . . . 0.0 109.481 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -78.72 -69.51 0.56 Allowed 'General case' 0 C--N 1.308 -1.214 0 O-C-N 120.099 -1.626 . . . . 0.0 111.434 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -47.31 -59.45 3.18 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.274 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -66.32 -36.34 82.69 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 123.389 2.813 . . . . 0.0 111.609 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.25 -42.41 73.45 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.062 -1.648 . . . . 0.0 108.678 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.433 ' O ' ' HG3' ' A' ' 61' ' ' ARG . . . -75.85 -51.2 13.05 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' A' ' 88' ' ' ALA . 39.0 t -63.37 -43.8 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 119.428 -2.045 . . . . 0.0 106.678 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.02 -28.62 39.42 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -76.81 -20.78 56.0 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.429 -0.909 . . . . 0.0 111.971 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.3 m -67.36 -45.7 75.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 118.893 -2.379 . . . . 0.0 106.843 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.535 ' CD2' ' HB1' ' A' ' 84' ' ' ALA . 2.2 mt -90.2 -31.91 16.83 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 113.714 -1.585 . . . . 0.0 111.13 -177.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.653 ' O ' HG21 ' A' ' 69' ' ' ILE . . . -68.02 -15.87 63.79 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 119.84 -1.788 . . . . 0.0 106.246 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 28.4 t70 -90.22 -9.17 49.03 Favored 'General case' 0 N--CA 1.528 3.427 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.861 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.492 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -70.18 -152.23 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.27 0 O-C-N 120.075 -1.641 . . . . 0.0 110.695 -178.334 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.712 ' C ' ' H ' ' A' ' 69' ' ' ILE . 2.0 Cg_endo -104.82 -30.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.079 2.519 . . . . 0.0 114.683 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.474 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 13.2 pt-20 -72.27 26.81 0.05 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.712 ' H ' ' C ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -100.72 -83.0 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 176.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -47.23 -31.2 3.51 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.364 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -80.15 -18.76 48.87 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.329 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -86.91 -38.0 8.2 Favored Glycine 0 CA--C 1.479 -2.21 1 N-CA-C 101.633 -4.587 . . . . 0.0 101.633 178.39 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.422 HD11 ' O ' ' A' ' 101' ' ' THR . 1.9 tp -56.58 -34.21 66.93 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -77.74 0.51 23.3 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.829 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.799 ' O ' ' O ' ' A' ' 76' ' ' LYS . 4.7 tmtp? -131.95 45.9 2.72 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 120.319 1.418 . . . . 0.0 112.785 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.799 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 17.37 157.05 0.0 OUTLIER Pre-proline 0 N--CA 1.535 3.819 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -29.92 -60.58 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.364 2.709 . . . . 0.0 113.984 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -52.57 130.29 31.61 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 118.617 -1.233 . . . . 0.0 109.834 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.519 ' CD ' ' HZ1' ' A' ' 75' ' ' LYS . 31.5 tt0 65.49 13.8 9.08 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.877 176.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.831 ' O ' ' N ' ' A' ' 82' ' ' ILE . 15.3 t -79.56 97.9 6.65 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.499 -1.375 . . . . 0.0 110.094 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -43.76 66.73 0.0 OUTLIER Glycine 1 CA--C 1.578 4.018 0 C-N-CA 118.503 -1.808 . . . . 0.0 111.652 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.831 ' N ' ' O ' ' A' ' 80' ' ' SER . 7.7 tp -73.52 1.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.218 -1.754 . . . . 0.0 111.2 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -52.8 -29.06 25.44 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.7 -1.25 . . . . 0.0 113.161 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.847 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -81.26 -86.65 0.09 Allowed 'General case' 0 C--O 1.193 -1.911 0 N-CA-C 100.653 -3.832 . . . . 0.0 100.653 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.866 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -19.52 -63.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 121.548 1.977 . . . . 0.0 106.075 -178.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 1.002 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -42.56 -52.08 4.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.301 -1.5 . . . . 0.0 110.144 174.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.847 ' N ' ' O ' ' A' ' 84' ' ' ALA . 36.2 tp10 -36.86 -46.57 0.63 Allowed 'General case' 0 N--CA 1.536 3.828 0 C-N-CA 116.515 -2.074 . . . . 0.0 106.699 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.447 ' CB ' HG12 ' A' ' 59' ' ' VAL . . . -49.64 -17.34 0.31 Allowed 'General case' 0 N--CA 1.512 2.667 0 O-C-N 119.446 -2.034 . . . . 0.0 108.796 171.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 1.002 ' N ' ' O ' ' A' ' 86' ' ' ALA . 22.7 m -60.8 -33.97 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 C-N-CA 115.879 -2.328 . . . . 0.0 109.101 174.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 89' ' ' VAL . 33.1 ttm180 -85.51 -49.19 8.26 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 114.328 -1.305 . . . . 0.0 113.812 -174.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -60.58 -36.79 79.37 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.444 -1.303 . . . . 0.0 108.452 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.765 ' NH2' ' H ' ' A' ' 95' ' ' LEU . 36.1 ttp85 -60.94 -71.2 0.15 Allowed 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 94' ' ' ASP . 35.6 m120 -161.53 -27.69 0.05 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.673 -1.267 . . . . 0.0 112.007 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 18.9 t70 139.8 -28.54 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.836 0 CA-C-N 120.167 1.349 . . . . 0.0 110.141 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.765 ' H ' ' NH2' ' A' ' 92' ' ' ARG . 0.3 OUTLIER -122.54 151.57 41.25 Favored 'General case' 0 N--CA 1.521 3.075 0 CA-C-N 113.701 -1.59 . . . . 0.0 114.601 -177.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.668 ' CD1' HG22 ' A' ' 165' ' ' ILE . 0.2 OUTLIER 150.36 162.31 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.0 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 178.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -107.92 95.39 5.65 Favored 'General case' 0 C--O 1.207 -1.132 1 CA-C-N 126.509 4.231 . . . . 0.0 100.247 170.335 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.567 HG13 HG23 ' A' ' 165' ' ' ILE . 1.6 mt -90.36 117.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 1.1 p -136.06 139.98 44.79 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.639 0 CA-C-N 111.402 -2.635 . . . . 0.0 112.568 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.64 141.2 22.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 1 N-CA-C 99.451 -4.277 . . . . 0.0 99.451 174.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.441 ' CG2' ' H ' ' A' ' 105' ' ' SER . 0.7 OUTLIER -131.49 153.38 49.84 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.534 -1.354 . . . . 0.0 110.664 -176.185 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -86.65 -172.52 4.05 Favored 'General case' 0 C--N 1.281 -2.376 1 N-CA-C 99.488 -4.264 . . . . 0.0 99.488 170.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.594 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -81.2 77.03 8.13 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 114.25 -2.98 . . . . 0.0 109.577 -177.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.473 ' O ' ' CB ' ' A' ' 105' ' ' SER . 8.2 tp-100 -147.85 -40.67 0.17 Allowed 'General case' 0 C--O 1.209 -1.026 0 O-C-N 119.375 -2.078 . . . . 0.0 111.14 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.568 ' OG ' ' CD1' ' A' ' 125' ' ' ILE . 7.6 t 89.56 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.337 1.055 . . . . 0.0 109.03 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.4 OUTLIER 157.81 121.87 0.0 OUTLIER 'General case' 0 C--O 1.191 -1.982 0 N-CA-C 103.884 -2.636 . . . . 0.0 103.884 177.561 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.613 ' HE ' ' N ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -64.41 103.95 0.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.523 ' CD1' HG23 ' A' ' 99' ' ' VAL . 3.1 m-85 -57.84 -27.47 63.23 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -122.86 165.79 16.07 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.018 -178.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.953 ' CD2' HD11 ' A' ' 116' ' ' ILE . 14.5 p80 179.01 161.97 0.71 Allowed Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.343 -0.848 . . . . 0.0 110.907 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -87.82 -44.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.483 0.885 0 N-CA-C 106.637 -2.101 . . . . 0.0 106.637 173.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.494 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -108.02 135.44 49.39 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 174.234 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.3 -25.17 64.1 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.171 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -65.19 -37.49 87.5 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 119.971 -1.705 . . . . 0.0 114.841 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -65.03 -30.21 71.17 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 119.434 -2.041 . . . . 0.0 107.818 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.953 HD11 ' CD2' ' A' ' 110' ' ' HIS . 55.0 mt -40.42 -85.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.589 0 CA-C-O 122.601 1.191 . . . . 0.0 111.639 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.67 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -45.53 -10.83 0.02 OUTLIER Glycine 0 N--CA 1.494 2.513 0 CA-C-N 115.144 -0.934 . . . . 0.0 113.691 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.41 ' CB ' ' CD ' ' A' ' 119' ' ' PRO . 2.0 mt-30 -64.2 -68.58 0.76 Allowed Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 120.394 2.097 . . . . 0.0 112.047 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 2.7 Cg_exo -35.96 107.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 123.933 3.088 . . . . 0.0 115.274 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.586 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 45.8 t80 173.1 28.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -176.28 -8.66 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.65 -19.3 1.25 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.5 t70 68.56 3.92 4.07 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.144 -1.21 . . . . 0.0 109.731 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.457 ' CG ' ' CB ' ' A' ' 136' ' ' ALA . 27.9 m-20 -90.66 -24.63 20.42 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.486 -0.886 . . . . 0.0 108.75 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.568 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 31.0 mt -86.49 -26.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.207 -0.933 . . . . 0.0 112.806 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 125' ' ' ILE . 3.7 mm? -37.57 -50.9 1.16 Allowed 'General case' 0 N--CA 1.517 2.884 0 O-C-N 121.01 -1.056 . . . . 0.0 109.918 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.723 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 54.6 mttm -70.53 -29.7 66.25 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.848 -1.157 . . . . 0.0 109.29 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 125' ' ' ILE . . . -90.54 -33.99 15.7 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.976 -1.077 . . . . 0.0 109.481 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.4 OUTLIER -36.82 -38.13 0.17 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.413 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.723 ' ND2' ' O ' ' A' ' 127' ' ' LYS . 20.9 p30 -74.31 -91.91 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.679 ' N ' ' OD1' ' A' ' 130' ' ' ASN . . . -168.5 57.12 0.21 Allowed Glycine 0 CA--C 1.558 2.753 0 O-C-N 120.068 -1.645 . . . . 0.0 110.347 176.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -140.23 157.05 46.19 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.715 -1.462 . . . . 0.0 109.048 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.457 ' O ' ' CG ' ' A' ' 134' ' ' ASN . 28.3 mp0 -68.66 159.22 32.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.651 -0.655 . . . . 0.0 111.797 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 133' ' ' GLU . 22.6 m120 -166.28 142.06 4.74 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.656 ' CG2' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -132.74 131.38 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 O-C-N 119.646 -1.909 . . . . 0.0 110.419 -178.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.457 ' CB ' ' CG ' ' A' ' 124' ' ' ASP . . . -152.49 163.19 40.06 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.418 -0.801 . . . . 0.0 110.884 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.2 mt -97.02 128.63 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.648 0 O-C-N 121.146 -0.971 . . . . 0.0 111.353 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -97.21 153.15 18.18 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -133.44 156.99 46.7 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -166.18 161.94 35.54 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -44.34 -23.99 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -1.177 . . . . 0.0 110.186 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -73.3 -80.66 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.833 -1.167 . . . . 0.0 108.679 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -173.38 159.14 3.67 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.0 111.993 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.662 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 25.2 mp0 -45.31 143.39 1.75 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.699 0.761 . . . . 0.0 109.555 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.872 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -146.56 150.64 35.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 tp -108.43 152.51 24.59 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 122.006 2.185 . . . . 0.0 109.788 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -142.92 134.97 27.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.996 -1.065 . . . . 0.0 110.705 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.656 HG12 ' CG2' ' A' ' 135' ' ' VAL . 16.2 m -104.87 136.37 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 CA-C-O 122.232 1.015 . . . . 0.0 109.91 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 89.8 m-85 -108.42 140.87 41.1 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.506 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.88 150.89 67.05 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.4 ' HB3' ' C ' ' A' ' 131' ' ' GLY . 0.8 OUTLIER -92.66 149.99 2.81 Favored 'Trans proline' 0 N--CA 1.515 2.769 0 C-N-CA 123.65 2.9 . . . . 0.0 116.757 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 61.3 mt -116.25 125.83 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.528 ' C ' ' H ' ' A' ' 155' ' ' GLU . 97.3 m-85 -95.28 142.73 27.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.17 -0.956 . . . . 0.0 110.846 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 47.3 t0 -55.09 -3.36 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.548 -1.345 . . . . 0.0 109.23 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 154' ' ' ASP . 53.2 tt0 99.39 4.69 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 158' ' ' LYS . 32.6 m120 -129.07 36.7 4.16 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.099 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 60.98 -2.39 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.5 mptt -81.27 126.3 31.39 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.632 ' O ' ' CD ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -73.88 125.71 28.8 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -175.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.7 pp -143.07 7.31 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 118.799 -2.438 . . . . 0.0 116.971 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.64 173.12 44.44 Favored Glycine 0 N--CA 1.513 3.801 0 C-N-CA 116.619 -2.705 . . . . 0.0 111.853 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 101' ' ' THR . 58.3 t -137.25 139.96 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 120.965 -1.314 . . . . 0.0 111.118 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 56.1 t -103.91 127.79 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.561 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -114.99 155.64 26.56 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.668 HG22 ' CD1' ' A' ' 96' ' ' LEU . 12.8 mt -151.29 95.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.615 ' C ' HD13 ' A' ' 96' ' ' LEU . . . -105.06 135.37 12.52 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.354 -175.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.872 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 0.7 OUTLIER -100.74 112.09 24.43 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 113.897 -1.151 . . . . 0.0 108.633 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -48.64 77.15 Favored 'General case' 0 N--CA 1.524 3.227 0 CA-C-O 123.025 1.393 . . . . 0.0 109.565 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -163.68 179.02 7.45 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.811 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.745 ' O ' ' N ' ' A' ' 172' ' ' VAL . 1.2 m -162.96 60.14 0.19 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.545 ' C ' ' H ' ' A' ' 173' ' ' THR . 65.1 mtm180 15.08 -63.53 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.932 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.874 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.745 ' N ' ' O ' ' A' ' 170' ' ' SER . 3.1 t -68.69 32.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.519 -1.363 . . . . 0.0 109.645 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 171' ' ' ARG . 10.9 p -83.05 -31.18 27.5 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.818 -0.551 . . . . 0.0 110.586 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLN . . . . . 0.435 ' O ' ' OD1' ' A' ' 178' ' ' ASP . 0.9 OUTLIER -77.9 -57.52 3.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.441 -1.412 . . . . 0.0 108.432 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.664 ' H ' ' CD ' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -50.3 -68.71 0.15 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.309 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.782 HG23 ' N ' ' A' ' 177' ' ' ASN . 2.9 tp -45.41 -71.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.782 ' N ' HG23 ' A' ' 176' ' ' ILE . 12.0 t-20 -36.17 -78.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.211 -0.931 . . . . 0.0 112.448 -176.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 179' ' ' SER . 23.5 p-10 -50.02 -59.67 3.67 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.38 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 178' ' ' ASP . 28.8 p -53.73 -67.62 0.24 Allowed 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.362 -1.462 . . . . 0.0 109.135 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.443 ' N ' ' OG ' ' A' ' 179' ' ' SER . 16.4 tpt180 . . . . . 0 C--N 1.3 -1.547 0 O-C-N 121.078 -1.014 . . . . 0.0 109.615 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.73 0.776 . . . . 0.0 109.095 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.457 ' OD2' HG22 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -60.82 -51.43 69.36 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 124.269 1.985 . . . . 0.0 108.9 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -28.99 66.53 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.513 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.726 HG23 HD23 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -61.17 -36.94 81.19 Favored 'General case' 0 C--O 1.203 -1.367 0 O-C-N 118.106 -2.871 . . . . 0.0 104.478 175.274 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -54.87 -52.15 63.75 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 116.508 -2.077 . . . . 0.0 109.465 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.77 -65.67 0.65 Allowed 'General case' 0 N--CA 1.517 2.905 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 52' ' ' LEU . . . -65.38 -51.83 45.41 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.726 HD23 HG23 ' A' ' 48' ' ' THR . 0.2 OUTLIER -52.44 -37.9 57.98 Favored 'General case' 0 C--O 1.206 -1.234 0 O-C-N 120.34 -1.683 . . . . 0.0 106.9 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 57' ' ' LEU . . . -56.83 -65.08 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.228 -1.789 . . . . 0.0 108.045 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -55.34 -63.86 1.03 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.052 -1.655 . . . . 0.0 112.596 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -67.63 -20.0 65.28 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.868 -1.145 . . . . 0.0 112.352 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 52' ' ' LEU . . . -97.09 -35.7 10.72 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 121.226 1.83 . . . . 0.0 109.012 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 1.2 tt -64.76 -33.32 75.69 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 121.009 -1.057 . . . . 0.0 108.56 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.87 -43.58 44.82 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.334 -0.854 . . . . 0.0 112.865 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.41 -32.61 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 118.175 -2.828 . . . . 0.0 107.512 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.924 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -58.43 -25.11 61.83 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.423 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -72.03 -21.98 61.46 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 117.008 -1.877 . . . . 0.0 109.526 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 98.6 m -69.61 -53.96 16.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 118.111 -2.868 . . . . 0.0 108.616 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.587 ' N ' HD22 ' A' ' 63' ' ' LEU . 4.1 mm? -79.16 -44.03 22.77 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.048 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.78 -18.0 4.19 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 119.932 -1.73 . . . . 0.0 106.744 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.488 ' N ' ' C ' ' A' ' 63' ' ' LEU . 18.5 t0 -87.56 -10.91 50.24 Favored 'General case' 0 N--CA 1.52 3.047 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.909 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.527 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -73.05 -157.96 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.938 0 O-C-N 120.484 -1.385 . . . . 0.0 109.04 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.527 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -109.21 -15.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.619 2.879 . . . . 0.0 113.837 176.238 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -74.87 -41.11 60.45 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.462 -0.774 . . . . 0.0 109.825 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 70' ' ' ARG . 1.7 mp -57.33 -75.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.318 -1.489 . . . . 0.0 109.896 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.607 ' N ' HG22 ' A' ' 69' ' ' ILE . 62.4 ttt-85 -45.42 -35.79 3.91 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.399 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -77.88 -14.66 59.48 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 111.899 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.508 ' C ' ' N ' ' A' ' 74' ' ' GLN . . . -94.84 -47.97 2.58 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 103.538 -3.825 . . . . 0.0 103.538 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -49.23 -23.64 1.43 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.092 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.508 ' N ' ' C ' ' A' ' 72' ' ' GLY . 55.7 tp60 -50.76 -9.16 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.801 -1.545 . . . . 0.0 109.588 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.844 ' O ' ' O ' ' A' ' 76' ' ' LYS . 5.1 mmtp -150.51 85.46 1.38 Allowed 'General case' 0 N--CA 1.523 3.175 0 O-C-N 120.847 -1.158 . . . . 0.0 113.016 -177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.844 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 23.91 164.13 0.0 OUTLIER Pre-proline 1 N--CA 1.539 4.008 0 CA-C-N 121.986 2.175 . . . . 0.0 116.19 179.668 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 78' ' ' GLN . 6.2 Cg_exo -32.36 -68.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.509 2.41 0 C-N-CA 124.255 3.304 . . . . 0.0 115.293 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 77' ' ' PRO . 91.8 mt-30 -35.98 133.1 0.47 Allowed 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.784 1.278 . . . . 0.0 111.024 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 63.04 19.28 11.55 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.716 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.9 ' O ' ' N ' ' A' ' 82' ' ' ILE . 33.8 m -90.0 83.66 6.12 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.347 -1.471 . . . . 0.0 109.341 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -38.88 52.31 0.0 OUTLIER Glycine 0 N--CA 1.508 3.464 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.569 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.9 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.4 tp -63.86 -1.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 120.514 -1.58 . . . . 0.0 108.038 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.44 ' H ' ' C ' ' A' ' 81' ' ' GLY . 17.7 mp0 -58.4 -21.92 52.14 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 120.974 -1.079 . . . . 0.0 112.199 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -85.84 -63.64 1.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 121.951 2.159 . . . . 0.0 112.061 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.568 HD11 HD12 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -48.27 -34.09 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 122.718 2.508 . . . . 0.0 107.067 172.232 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 90' ' ' ARG . . . -65.43 -48.36 73.02 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' ALA . 36.8 tt0 -48.22 -56.6 7.55 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 117.443 -1.265 . . . . 0.0 112.425 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.95 -44.16 23.06 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 123.553 2.888 . . . . 0.0 108.306 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 85' ' ' ILE . 98.8 t -55.97 -76.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 116.071 -2.251 . . . . 0.0 108.977 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.623 ' O ' ' C ' ' A' ' 91' ' ' LYS . 45.8 ttm-85 -34.7 -58.53 0.5 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.55 0.74 . . . . 0.0 110.038 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.623 ' C ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -32.32 -49.04 0.19 Allowed 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 117.35 -1.74 . . . . 0.0 107.582 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -55.35 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 117.064 -1.446 . . . . 0.0 111.107 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.926 ' O ' ' ND2' ' A' ' 93' ' ' ASN . 0.3 OUTLIER -71.27 -3.61 21.33 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 113.864 -3.134 . . . . 0.0 108.903 -172.097 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.539 ' O ' HD23 ' A' ' 95' ' ' LEU . 7.6 t70 62.01 40.87 11.77 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -174.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 158.94 165.23 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.605 HD22 HG22 ' A' ' 165' ' ' ILE . 4.1 mt 150.07 163.34 0.0 OUTLIER 'General case' 1 N--CA 1.557 4.924 0 CA-C-N 121.194 1.815 . . . . 0.0 108.505 178.407 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -113.82 85.87 2.29 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 171.15 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.924 HD11 ' HB2' ' A' ' 60' ' ' ALA . 0.9 OUTLIER -91.62 113.1 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 104.708 -2.331 . . . . 0.0 104.708 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.662 ' CG2' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -122.13 135.75 61.22 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.379 0 CA-C-N 112.808 -1.996 . . . . 0.0 112.454 -174.099 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.489 HG11 HG23 ' A' ' 69' ' ' ILE . 7.1 p -111.19 128.78 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 1 N-CA-C 98.679 -4.563 . . . . 0.0 98.679 171.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.662 HG23 ' CG2' ' A' ' 99' ' ' VAL . 3.3 p -117.89 155.05 30.84 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.343 -1.473 . . . . 0.0 109.842 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.61 ' O ' ' N ' ' A' ' 104' ' ' GLN . 1.5 t70 -82.3 -175.85 5.89 Favored 'General case' 0 C--N 1.285 -2.201 1 N-CA-C 97.592 -4.966 . . . . 0.0 97.592 170.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.532 ' C ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -70.47 75.64 0.56 Allowed 'General case' 0 C--N 1.268 -2.951 0 C-N-CA 113.89 -3.124 . . . . 0.0 105.499 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.61 ' N ' ' O ' ' A' ' 102' ' ' ASP . 6.6 mm-40 -136.78 -51.54 0.68 Allowed 'General case' 0 C--O 1.214 -0.798 0 O-C-N 119.365 -2.085 . . . . 0.0 108.189 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.766 ' OG ' HD13 ' A' ' 125' ' ' ILE . 0.5 OUTLIER 84.6 134.51 0.05 Allowed 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -178.548 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.647 ' H ' ' NH2' ' A' ' 107' ' ' ARG . 1.5 pp 148.41 147.4 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.647 ' NH2' ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -69.07 139.87 54.85 Favored 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 178.712 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.512 ' CD2' HD13 ' A' ' 82' ' ' ILE . 1.6 m-85 -96.73 -35.8 10.87 Favored 'General case' 0 C--N 1.258 -3.387 0 N-CA-C 103.498 -2.778 . . . . 0.0 103.498 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.22 167.48 10.65 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 112.197 -2.274 . . . . 0.0 112.222 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.512 ' CD2' HD11 ' A' ' 116' ' ' ILE . 17.3 p80 -175.16 153.77 1.6 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.813 -1.179 . . . . 0.0 112.482 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.578 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 41.1 Cg_endo -90.75 -37.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 N-CA-C 106.191 -2.273 . . . . 0.0 106.191 172.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.578 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 57.0 tt0 -102.17 115.18 30.0 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.404 ' HA ' ' ND1' ' A' ' 110' ' ' HIS . . . -48.47 -47.43 38.5 Favored 'General case' 0 C--N 1.29 -1.99 0 O-C-N 121.011 -1.055 . . . . 0.0 112.084 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -64.39 -31.06 72.12 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.271 -1.518 . . . . 0.0 115.034 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.678 ' NE ' ' OE1' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -66.83 -22.21 66.01 Favored 'General case' 0 C--O 1.197 -1.687 0 O-C-N 119.35 -2.094 . . . . 0.0 107.969 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.84 HG22 ' N ' ' A' ' 117' ' ' GLY . 54.8 mt -35.11 -91.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.84 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -85.81 -9.72 77.33 Favored Glycine 0 N--CA 1.502 3.078 0 O-C-N 121.025 -1.047 . . . . 0.0 114.034 -173.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.688 ' N ' ' HD2' ' A' ' 119' ' ' PRO . 3.2 pt20 -60.5 -40.66 77.97 Favored Pre-proline 0 C--N 1.294 -1.807 0 C-N-CA 116.442 -2.103 . . . . 0.0 110.14 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 118' ' ' GLN . 8.3 Cg_endo -48.15 113.87 0.95 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.662 2.241 . . . . 0.0 112.894 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.445 ' CD2' ' O ' ' A' ' 120' ' ' PHE . 69.7 t80 -178.89 29.06 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -132.45 42.74 3.07 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.665 -0.647 . . . . 0.0 112.518 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.35 -46.94 0.1 Allowed Glycine 0 N--CA 1.51 3.59 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 75.32 20.03 2.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.917 -0.754 . . . . 0.0 111.421 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.468 ' OD2' ' CE2' ' A' ' 149' ' ' PHE . 19.7 p-10 -84.1 -2.68 57.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.213 -1.554 . . . . 0.0 108.563 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.766 HD13 ' OG ' ' A' ' 105' ' ' SER . 12.3 pt -84.51 -23.73 7.52 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 O-C-N 120.941 -1.1 . . . . 0.0 110.684 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' A' ' 125' ' ' ILE . 71.6 mt -35.65 -46.09 0.4 Allowed 'General case' 0 N--CA 1.52 3.044 0 O-C-N 121.198 -0.938 . . . . 0.0 110.061 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -79.48 -40.95 28.54 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.351 -0.843 . . . . 0.0 110.81 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -83.1 -30.73 27.72 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.218 -1.551 . . . . 0.0 108.317 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.584 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -38.85 -34.18 0.14 Allowed 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 128' ' ' ALA . 20.3 m-20 -99.42 -104.32 0.22 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -132.11 54.12 0.79 Allowed Glycine 0 N--CA 1.506 3.32 0 C-N-CA 119.801 -1.19 . . . . 0.0 115.27 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -144.55 142.84 30.49 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 120.515 2.157 . . . . 0.0 108.776 178.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.433 ' O ' ' OD1' ' A' ' 134' ' ' ASN . 89.2 mt-10 -69.66 157.1 37.9 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 119.888 -1.758 . . . . 0.0 109.987 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 133' ' ' GLU . 9.3 m120 -160.11 142.55 13.27 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.532 HG22 HG12 ' A' ' 148' ' ' VAL . 2.3 t -131.29 145.3 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.556 -1.34 . . . . 0.0 108.909 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.62 164.18 29.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 109.066 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.2 mt -99.6 139.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 O-C-N 120.717 -1.239 . . . . 0.0 111.029 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.446 HD21 ' CZ ' ' A' ' 115' ' ' ARG . 8.3 t-20 -106.36 138.95 41.62 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.701 0.762 . . . . 0.0 109.709 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.594 ' N ' HH12 ' A' ' 115' ' ' ARG . 14.6 ptm180 -166.95 115.89 0.85 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.38 -1.328 . . . . 0.0 109.43 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.51 ' C ' ' N ' ' A' ' 142' ' ' LEU . . . -162.27 109.21 0.38 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 107.729 -2.149 . . . . 0.0 107.729 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 50.4 13.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.997 -1.296 . . . . 0.0 108.405 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.51 ' N ' ' C ' ' A' ' 140' ' ' GLY . 13.0 tp -134.34 172.5 12.8 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.52 -142.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.233 -1.542 . . . . 0.0 112.465 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -110.79 146.58 36.14 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 176.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.762 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -150.62 142.61 23.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.957 -1.714 . . . . 0.0 107.191 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.423 ' HA ' HD12 ' A' ' 146' ' ' LEU . 9.7 tp -101.79 149.41 24.2 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 122.781 2.537 . . . . 0.0 106.89 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.593 ' NH2' ' CZ ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -144.81 150.55 37.36 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.409 1.099 . . . . 0.0 111.207 -178.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 53' ' ' ALA . 23.9 m -113.14 143.23 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.717 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.49 ' CD1' HG22 ' A' ' 125' ' ' ILE . 28.2 m-85 -110.69 135.02 51.93 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.657 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -136.24 166.4 28.23 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -111.61 154.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.912 0 C-N-CA 124.306 3.338 . . . . 0.0 114.803 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 54.2 mt -118.89 127.68 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.544 ' C ' ' H ' ' A' ' 155' ' ' GLU . 83.4 m-85 -101.76 144.18 30.77 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.927 -1.108 . . . . 0.0 112.201 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 55.7 t0 -65.66 12.79 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.547 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER 86.81 15.65 0.1 Allowed 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.98 -1.075 . . . . 0.0 108.455 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 158' ' ' LYS . 77.7 m-20 -139.27 36.16 2.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.84 -1.162 . . . . 0.0 108.303 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 59.56 3.36 0.41 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.512 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.6 mptt -85.91 130.81 34.44 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.745 ' O ' ' NE2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -85.01 125.62 32.87 Favored 'General case' 0 N--CA 1.512 2.655 0 CA-C-N 119.848 1.204 . . . . 0.0 113.571 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.08 5.49 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 O-C-N 119.926 -1.734 . . . . 0.0 113.88 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -171.26 173.6 44.81 Favored Glycine 0 N--CA 1.501 3.01 0 C-N-CA 118.18 -1.962 . . . . 0.0 112.033 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.569 ' O ' ' OG1' ' A' ' 101' ' ' THR . 1.5 t -133.21 141.99 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 O-C-N 121.799 -0.824 . . . . 0.0 110.708 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.443 ' O ' ' OG1' ' A' ' 150' ' ' THR . 9.2 t -113.25 119.64 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 120.961 -1.087 . . . . 0.0 108.179 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.64 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -112.93 156.61 22.7 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.605 HG22 HD22 ' A' ' 96' ' ' LEU . 23.6 mt -152.14 109.64 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.596 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -115.8 137.09 13.49 Favored Glycine 0 N--CA 1.489 2.178 0 CA-C-O 122.805 1.225 . . . . 0.0 113.636 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.762 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 3.5 tp -95.45 103.27 15.13 Favored 'General case' 0 N--CA 1.514 2.763 0 CA-C-N 113.809 -1.196 . . . . 0.0 108.124 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 169' ' ' LEU . 7.1 tt0 -47.47 -60.27 2.64 Favored 'General case' 0 N--CA 1.523 3.208 0 O-C-N 124.384 1.053 . . . . 0.0 109.684 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 1.062 HD22 ' H ' ' A' ' 170' ' ' SER . 0.2 OUTLIER 150.44 156.05 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.359 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.767 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . 1.062 ' H ' HD22 ' A' ' 169' ' ' LEU . 49.9 m -163.56 -37.57 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.821 -0.549 . . . . 0.0 110.233 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.525 ' O ' ' HB ' ' A' ' 172' ' ' VAL . 48.7 ttp85 149.15 146.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 171' ' ' ARG . 82.1 t 102.03 -2.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 44.7 p -74.79 -48.51 25.03 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.339 0.59 . . . . 0.0 111.422 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -75.94 -47.11 26.46 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.113 -0.992 . . . . 0.0 109.452 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.43 ' H ' ' CD ' ' A' ' 175' ' ' GLN . 18.6 mp0 -50.52 -75.44 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.66 HG22 ' N ' ' A' ' 177' ' ' ASN . 3.7 mm -41.81 -77.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-O 121.317 0.58 . . . . 0.0 112.456 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.66 ' N ' HG22 ' A' ' 176' ' ' ILE . 57.0 t-20 -40.51 -77.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 177' ' ' ASN . 3.8 m-20 -45.55 -61.08 1.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.72 -1.238 . . . . 0.0 110.724 -176.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 180' ' ' ARG . 59.9 p -50.91 -69.24 0.12 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.83 -1.169 . . . . 0.0 109.385 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.523 ' N ' ' OG ' ' A' ' 179' ' ' SER . 59.2 ttt-85 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.48 -0.763 . . . . 0.0 109.552 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.634 0.73 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.593 ' H ' HD13 ' A' ' 176' ' ' ILE . 55.1 t0 -65.28 -56.34 13.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 124.068 1.889 . . . . 0.0 107.303 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 46' ' ' ASP . 11.1 ttt -36.78 -56.92 0.83 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.896 -174.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.542 ' OG1' HD13 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -59.01 -36.44 74.94 Favored 'General case' 0 C--O 1.202 -1.405 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.089 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.484 ' C ' ' O ' ' A' ' 48' ' ' THR . 55.9 ttt-85 -35.79 -64.31 0.31 Allowed 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.044 0.926 . . . . 0.0 111.397 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -70.42 -57.73 4.49 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.96 -35.56 21.15 Favored Glycine 0 N--CA 1.497 2.759 0 C-N-CA 119.572 -1.299 . . . . 0.0 111.397 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.785 HD11 HD21 ' A' ' 96' ' ' LEU . 11.3 tp -53.36 -47.66 69.24 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 120.783 2.291 . . . . 0.0 107.145 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.565 ' HB2' HG11 ' A' ' 148' ' ' VAL . . . -50.7 -61.76 2.01 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.767 -1.173 . . . . 0.0 109.51 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -69.3 -56.37 7.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.268 -1.52 . . . . 0.0 113.359 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -69.58 -41.34 75.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -0.884 . . . . 0.0 112.335 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.63 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -72.86 -35.23 67.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 119.715 -1.866 . . . . 0.0 110.11 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 57' ' ' LEU . 7.2 tt -65.22 -41.31 94.54 Favored 'General case' 0 C--N 1.288 -2.106 0 O-C-N 121.057 -1.027 . . . . 0.0 111.492 177.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.88 -44.42 49.01 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.297 -1.502 . . . . 0.0 114.885 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.38 -43.63 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 118.836 -2.415 . . . . 0.0 106.607 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.875 ' CB ' HD13 ' A' ' 98' ' ' ILE . . . -57.9 -26.42 62.14 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.641 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -71.08 -15.84 62.55 Favored 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 118.474 -1.29 . . . . 0.0 109.009 179.005 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -64.85 -42.47 94.87 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 115.105 -2.638 . . . . 0.0 104.143 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.613 HD22 ' HB1' ' A' ' 84' ' ' ALA . 49.0 mt -87.45 -42.02 13.12 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.801 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.641 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -55.77 -18.47 8.47 Favored 'General case' 0 N--CA 1.522 3.17 0 O-C-N 119.989 -1.694 . . . . 0.0 107.166 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 12.2 t0 -85.49 -22.72 28.08 Favored 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.959 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.51 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -58.38 -156.69 0.0 OUTLIER Pre-proline 0 C--N 1.281 -2.397 0 O-C-N 120.699 -1.251 . . . . 0.0 111.742 -177.65 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -107.4 -35.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.513 2.62 0 C-N-CA 124.476 3.451 . . . . 0.0 115.396 178.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 72' ' ' GLY . 7.4 pt-20 -55.74 -30.98 62.12 Favored 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 118.735 -1.186 . . . . 0.0 109.166 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -53.08 -76.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.267 1.032 . . . . 0.0 111.034 -179.05 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.486 ' N ' HG22 ' A' ' 69' ' ' ILE . 72.5 ttt180 -49.94 -33.85 18.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -83.02 -18.75 38.66 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 118.817 -1.153 . . . . 0.0 112.763 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.783 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -86.31 -46.11 5.37 Favored Glycine 0 N--CA 1.498 2.816 1 N-CA-C 101.931 -4.468 . . . . 0.0 101.931 179.098 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.421 HD11 ' HA ' ' A' ' 102' ' ' ASP . 15.2 tp -46.6 -39.2 10.71 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 175.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.88 6.2 0.94 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.091 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.783 ' N ' ' O ' ' A' ' 72' ' ' GLY . 4.3 tmtt? -143.56 52.84 1.33 Allowed 'General case' 0 N--CA 1.512 2.668 0 O-C-N 120.265 -1.522 . . . . 0.0 114.526 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.658 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 32.95 149.55 0.0 OUTLIER Pre-proline 0 N--CA 1.524 3.24 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 178.092 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -30.79 -70.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.513 2.644 0 C-N-CA 124.875 3.717 . . . . 0.0 118.232 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' HB2' ' HZ2' ' A' ' 76' ' ' LYS . 86.2 mt-30 -44.27 -43.45 7.34 Favored 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -101.97 9.36 40.56 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.483 -1.386 . . . . 0.0 110.15 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.5 m -88.32 125.82 34.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.42 71.97 0.96 Allowed Glycine 0 N--CA 1.489 2.182 0 O-C-N 118.699 -2.501 . . . . 0.0 109.981 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.523 HD11 ' H ' ' A' ' 100' ' ' VAL . 3.1 tp -63.89 -4.64 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 C-N-CA 125.078 1.351 . . . . 0.0 109.585 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.649 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 55.3 tt0 -50.09 -32.7 16.44 Favored 'General case' 0 C--N 1.279 -2.468 0 O-C-N 120.851 -1.155 . . . . 0.0 110.038 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -71.64 -98.5 0.01 OUTLIER 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.787 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -16.08 -44.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.952 0 CA-C-N 121.788 2.085 . . . . 0.0 111.904 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -73.2 -48.08 38.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 119.678 -1.889 . . . . 0.0 109.601 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.649 ' HG2' ' O ' ' A' ' 83' ' ' GLN . 50.9 mm-40 -49.86 -49.8 47.95 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.718 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -66.33 -56.39 11.35 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 125.529 3.786 . . . . 0.0 108.564 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.755 HG13 HD13 ' A' ' 96' ' ' LEU . 1.2 t -52.96 -65.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 115.638 -2.425 . . . . 0.0 108.945 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 1.027 ' HD3' ' H ' ' A' ' 96' ' ' LEU . 1.9 tpp85 -37.97 -46.05 0.94 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.467 -1.395 . . . . 0.0 109.218 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.605 ' C ' ' O ' ' A' ' 90' ' ' ARG . 14.4 ttmm -34.48 -43.45 0.17 Allowed 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 117.592 -1.643 . . . . 0.0 106.705 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.753 ' HD3' ' O ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -39.78 -39.53 0.81 Allowed 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 117.369 -1.3 . . . . 0.0 109.06 172.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 90' ' ' ARG . 1.5 m120 -156.58 -62.93 0.1 Allowed 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 124.783 3.447 . . . . 0.0 111.106 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 1.1 m-20 166.11 -13.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.085 -1.009 . . . . 0.0 111.365 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.44 60.98 1.49 Allowed 'General case' 0 N--CA 1.533 3.696 0 C-N-CA 118.422 -1.311 . . . . 0.0 113.972 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.027 ' H ' ' HD3' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -120.14 142.23 49.12 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 116.793 -1.575 . . . . 0.0 110.773 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -119.95 100.22 7.09 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 124.752 3.433 . . . . 0.0 109.409 176.241 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.875 HD13 ' CB ' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -95.22 111.76 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 174.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.675 ' CG2' ' HB3' ' A' ' 164' ' ' ALA . 4.5 m -112.37 124.21 68.83 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.594 0 CA-C-N 112.097 -2.319 . . . . 0.0 110.199 -173.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.523 ' H ' HD11 ' A' ' 82' ' ' ILE . 9.5 p -96.68 128.08 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 1 N-CA-C 98.754 -4.536 . . . . 0.0 98.754 176.298 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 104' ' ' GLN . 81.0 p -119.99 151.49 38.88 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.464 -175.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 104' ' ' GLN . 38.8 t0 -81.91 -174.77 5.24 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 100.498 -3.89 . . . . 0.0 100.498 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 43.1 ttm -74.81 71.22 1.97 Allowed 'General case' 0 C--N 1.268 -2.976 0 C-N-CA 114.889 -2.724 . . . . 0.0 107.837 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.625 ' O ' ' HB ' ' A' ' 101' ' ' THR . 3.5 pp0? -171.82 136.07 0.89 Allowed 'General case' 0 N--CA 1.436 -1.132 1 N-CA-C 96.844 -5.243 . . . . 0.0 96.844 176.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.698 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 16.3 t -107.72 -179.95 4.05 Favored 'General case' 0 CA--C 1.47 -2.117 0 C-N-CA 116.741 -1.983 . . . . 0.0 106.581 -176.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.698 ' HB2' ' O ' ' A' ' 105' ' ' SER . 3.3 tp 154.04 144.84 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.673 ' HA ' HG11 ' A' ' 99' ' ' VAL . 1.8 mmp_? -77.02 91.51 3.64 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.416 -1.713 . . . . 0.0 108.413 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 107' ' ' ARG . 3.2 m-85 -46.25 -31.14 2.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.416 ' N ' ' C ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -124.42 171.51 9.89 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 113.811 -1.54 . . . . 0.0 113.715 -178.161 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.421 ' CE1' ' HG3' ' A' ' 107' ' ' ARG . 0.1 OUTLIER 172.09 166.6 0.24 Allowed Pre-proline 0 N--CA 1.51 2.531 0 O-C-N 121.511 -0.743 . . . . 0.0 109.576 -179.22 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.447 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 46.5 Cg_endo -88.48 -40.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 122.768 2.312 . . . . 0.0 107.31 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 18.4 tp10 -107.96 93.98 4.83 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.97 1.367 . . . . 0.0 107.663 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' GLU . . . -31.11 -45.78 0.08 Allowed 'General case' 0 N--CA 1.503 2.195 0 CA-C-N 113.27 -1.786 . . . . 0.0 113.007 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -60.01 -33.35 71.88 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 120.395 -1.441 . . . . 0.0 113.772 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -60.9 -36.82 80.23 Favored 'General case' 0 C--O 1.203 -1.387 0 O-C-N 120.114 -1.616 . . . . 0.0 108.151 -178.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.734 ' O ' ' N ' ' A' ' 118' ' ' GLN . 79.7 mt -41.88 -84.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.075 177.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.466 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -27.64 -17.1 0.0 OUTLIER Glycine 0 N--CA 1.497 2.713 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.81 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.734 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.4 mp0 -77.61 -73.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.836 0 CA-C-N 120.946 2.373 . . . . 0.0 114.205 -175.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -30.86 115.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 123.325 2.683 . . . . 0.0 115.224 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.518 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 72.2 t80 171.73 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 123' ' ' ASP . 42.3 mttm -157.1 -26.13 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.41 -176.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 121' ' ' LYS . . . -41.06 -25.35 0.12 Allowed Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.041 -1.037 . . . . 0.0 110.549 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 121' ' ' LYS . 57.6 m-20 60.17 10.83 2.47 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.757 -0.849 . . . . 0.0 110.897 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -88.57 -23.64 23.07 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 128' ' ' ALA . 3.9 mt -80.68 -17.16 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.77 -1.206 . . . . 0.0 112.034 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 125' ' ' ILE . 54.4 mt -49.36 -32.97 12.46 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.556 -1.34 . . . . 0.0 107.481 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.737 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 94.8 mttt -79.65 -30.31 41.21 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 125' ' ' ILE . . . -92.44 -36.32 13.17 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 120.417 1.462 . . . . 0.0 109.262 -176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.4 mt -41.15 -30.49 0.16 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.265 -0.897 . . . . 0.0 108.686 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.737 ' ND2' ' O ' ' A' ' 127' ' ' LYS . 20.4 p30 -77.97 -95.56 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.66 ' N ' ' OD1' ' A' ' 130' ' ' ASN . . . -160.88 33.22 0.39 Allowed Glycine 0 CA--C 1.562 2.978 0 O-C-N 120.594 -1.316 . . . . 0.0 111.131 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -122.98 161.97 23.21 Favored 'General case' 0 N--CA 1.52 3.061 0 O-C-N 119.012 -2.463 . . . . 0.0 109.463 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -77.45 170.66 16.16 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.424 -0.798 . . . . 0.0 112.625 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.684 HD21 ' HB2' ' A' ' 127' ' ' LYS . 10.5 t-20 -171.67 149.97 2.65 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.491 ' CG2' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -133.67 131.88 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 119.877 -1.764 . . . . 0.0 108.93 -178.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.01 177.17 9.81 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 121.068 -1.02 . . . . 0.0 110.969 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.78 134.61 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.895 -1.128 . . . . 0.0 111.297 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -98.77 120.19 38.78 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.479 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.611 ' NE ' HE22 ' A' ' 144' ' ' GLN . 6.8 ptp180 -141.41 110.02 6.04 Favored 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 117.871 -1.532 . . . . 0.0 112.062 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -156.81 105.91 0.28 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 58.44 -39.84 0.06 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.343 -0.504 . . . . 0.0 111.586 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 140' ' ' GLY . 71.8 mt -72.81 -85.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.908 -1.12 . . . . 0.0 110.769 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.405 ' CB ' HD23 ' A' ' 169' ' ' LEU . . . -179.05 154.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.964 -1.094 . . . . 0.0 110.25 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.611 HE22 ' NE ' ' A' ' 139' ' ' ARG . 5.0 mm100 -46.46 136.14 7.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.092 -1.005 . . . . 0.0 108.496 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.88 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -148.04 156.6 42.82 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tp -114.93 150.76 35.19 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 122.5 2.409 . . . . 0.0 109.621 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.61 ' NH2' ' NH1' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -150.41 129.32 12.53 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.849 1.309 . . . . 0.0 112.449 -179.195 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 53' ' ' ALA . 10.0 m -91.91 150.15 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.317 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 46.3 m-85 -116.03 138.79 50.91 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.481 ' O ' ' N ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -138.3 138.75 23.39 Favored Pre-proline 0 C--O 1.208 -1.126 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -89.68 155.29 5.17 Favored 'Trans proline' 0 N--CA 1.515 2.782 0 C-N-CA 123.881 3.054 . . . . 0.0 115.136 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.8 mt -121.35 131.4 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.865 -0.522 . . . . 0.0 109.65 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.522 ' C ' ' H ' ' A' ' 155' ' ' GLU . 86.9 m-85 -101.29 144.15 30.48 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.022 -1.049 . . . . 0.0 111.283 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 57.0 t0 -58.86 2.49 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.768 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 153' ' ' TYR . 17.9 tt0 86.24 29.62 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.825 -1.172 . . . . 0.0 108.629 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -149.36 18.6 0.94 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 71.63 9.78 6.36 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -88.55 116.79 27.04 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.553 ' N ' ' OE1' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -68.69 117.54 10.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.087 -1.008 . . . . 0.0 113.332 -177.134 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.421 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.8 pp -134.19 11.13 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -174.21 179.19 45.71 Favored Glycine 0 N--CA 1.504 3.208 0 C-N-CA 115.163 -3.399 . . . . 0.0 114.146 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 96.7 t -143.32 140.62 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-O 122.484 1.135 . . . . 0.0 111.779 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 150' ' ' THR . 63.6 t -111.36 127.39 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.675 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . . . -115.72 153.13 31.91 Favored 'General case' 0 N--CA 1.51 2.563 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.63 HG21 ' HB1' ' A' ' 56' ' ' ALA . 24.5 mt -148.6 103.5 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -114.25 140.97 16.72 Favored Glycine 0 N--CA 1.485 1.946 0 CA-C-O 123.399 1.555 . . . . 0.0 112.115 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.88 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 50.6 tp -97.12 106.23 18.52 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 169' ' ' LEU . 0.5 OUTLIER -72.87 142.59 47.94 Favored 'General case' 0 N--CA 1.524 3.269 0 O-C-N 124.002 0.813 . . . . 0.0 109.414 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 168' ' ' GLU . 3.1 mt 38.9 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.777 0 O-C-N 120.039 -1.663 . . . . 0.0 113.935 175.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 171' ' ' ARG . 1.9 t 166.72 -86.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.28 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 170' ' ' SER . 0.3 OUTLIER 151.53 -28.31 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.222 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.746 178.063 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.467 ' O ' HD12 ' A' ' 176' ' ' ILE . 1.8 t -95.11 30.95 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.375 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 67.5 p -77.16 -46.57 22.95 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.189 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -69.89 -52.08 27.74 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -52.79 -69.13 0.12 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.593 HD13 ' H ' ' A' ' 46' ' ' ASP . 68.6 mt -44.59 -80.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 121.552 -0.717 . . . . 0.0 112.179 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.521 ' N ' HG22 ' A' ' 176' ' ' ILE . 87.2 m-20 -36.45 -80.0 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -176.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -44.27 -52.53 7.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.961 -1.087 . . . . 0.0 110.76 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 180' ' ' ARG . 28.7 p -57.69 -65.5 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.894 -1.128 . . . . 0.0 109.715 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.512 ' N ' ' OG ' ' A' ' 179' ' ' SER . 48.6 ttt85 . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.083 -1.011 . . . . 0.0 109.306 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 48' ' ' THR . 62.0 p . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 121.988 0.899 . . . . 0.0 108.907 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 49' ' ' ARG . 35.0 t70 -60.92 -57.59 12.01 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.128 0.966 . . . . 0.0 110.97 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 15.5 mmm -39.4 -59.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.819 -1.175 . . . . 0.0 111.575 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.45 ' OG1' ' CD2' ' A' ' 52' ' ' LEU . 11.6 t -57.91 -31.73 67.07 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 62.3 ttt180 -42.32 -56.43 2.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.779 -1.201 . . . . 0.0 110.761 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -69.98 -63.39 1.09 Allowed 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 126.18 1.792 . . . . 0.0 114.511 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -83.14 -41.01 8.8 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 119.204 -1.474 . . . . 0.0 111.243 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.572 HD11 HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -50.69 -45.61 58.35 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.596 2.698 . . . . 0.0 106.309 176.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.435 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . -48.98 -65.94 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.995 -1.066 . . . . 0.0 110.004 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -67.14 -55.79 12.69 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.585 -1.322 . . . . 0.0 112.64 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' GLY . 55.0 mtpt -68.55 -49.6 58.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -174.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.66 -33.14 70.64 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 118.965 -2.334 . . . . 0.0 111.267 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.881 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.8 tt -65.64 -37.89 87.84 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 120.505 -1.372 . . . . 0.0 110.921 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 61' ' ' ARG . . . -74.42 -47.46 33.69 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 119.201 -2.187 . . . . 0.0 115.703 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.68 -35.95 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 118.617 -2.552 . . . . 0.0 106.395 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.528 ' HB2' HD12 ' A' ' 98' ' ' ILE . . . -55.96 -32.42 63.84 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.606 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -67.83 -22.58 65.15 Favored 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 117.726 -1.131 . . . . 0.0 111.093 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 m -59.77 -47.89 83.88 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 123.701 2.955 . . . . 0.0 106.429 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.684 HD22 ' HB1' ' A' ' 84' ' ' ALA . 26.1 mt -85.77 -36.49 20.09 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.314 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -64.73 -22.0 66.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 119.81 -1.807 . . . . 0.0 106.194 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 15.5 t0 -78.58 -11.08 59.95 Favored 'General case' 0 N--CA 1.53 3.529 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.732 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.513 ' CB ' ' CD ' ' A' ' 67' ' ' PRO 0.265 0.9 OUTLIER -71.62 -152.54 0.0 OUTLIER Pre-proline 0 C--N 1.277 -2.586 0 O-C-N 120.662 -1.274 . . . . 0.0 108.426 179.206 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.3 OUTLIER -103.27 -20.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 123.252 2.635 . . . . 0.0 111.542 176.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.504 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 9.6 pt-20 -58.06 -37.23 74.03 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.368 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.799 HG22 ' H ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -49.5 -78.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.771 0 O-C-N 120.228 -1.545 . . . . 0.0 111.403 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.799 ' H ' HG22 ' A' ' 69' ' ' ILE . 61.2 ttt180 -52.11 -31.3 30.13 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -174.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 19.5 tt0 -84.83 -12.07 54.35 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.102 -1.439 . . . . 0.0 112.386 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -91.09 -51.35 2.62 Favored Glycine 0 N--CA 1.503 3.148 1 N-CA-C 101.72 -4.552 . . . . 0.0 101.72 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.448 HD13 HG12 ' A' ' 100' ' ' VAL . 6.2 tp -43.71 -38.87 3.35 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 112.837 -1.682 . . . . 0.0 107.403 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 23.4 tt0 -64.97 -0.83 1.7 Allowed 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.384 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.894 ' O ' ' O ' ' A' ' 76' ' ' LYS . 21.1 tptp -135.44 68.59 1.45 Allowed 'General case' 0 N--CA 1.517 2.894 0 O-C-N 119.985 -1.697 . . . . 0.0 113.698 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.894 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 11.61 154.55 0.0 OUTLIER Pre-proline 0 N--CA 1.536 3.853 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -29.33 -56.05 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.4 2.733 . . . . 0.0 115.315 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -53.0 131.96 36.95 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 118.158 -1.417 . . . . 0.0 109.766 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 68.78 9.43 7.36 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.864 ' O ' ' N ' ' A' ' 82' ' ' ILE . 30.1 m -78.85 84.24 4.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.746 -1.846 . . . . 0.0 110.043 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -41.98 64.44 0.0 OUTLIER Glycine 0 N--CA 1.504 3.199 0 C-N-CA 119.721 -1.228 . . . . 0.0 111.248 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.864 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.8 tp -71.68 4.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.606 -1.526 . . . . 0.0 107.699 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.579 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 34.5 tp60 -53.99 -32.13 53.08 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.346 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.75 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -79.31 -99.75 0.03 OUTLIER 'General case' 0 C--O 1.189 -2.105 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.682 ' C ' ' O ' ' A' ' 84' ' ' ALA . 2.0 mp -9.58 -54.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.597 0 CA-C-N 122.592 2.451 . . . . 0.0 111.651 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -59.76 -53.64 55.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 119.977 -1.702 . . . . 0.0 109.477 176.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.75 ' N ' ' O ' ' A' ' 84' ' ' ALA . 87.6 tt0 -40.06 -55.02 2.17 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.319 -1.309 . . . . 0.0 112.074 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -66.11 -63.86 0.99 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 114.2 -3.0 . . . . 0.0 108.159 -177.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 90' ' ' ARG . 2.1 t -45.09 -72.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 115.162 -2.615 . . . . 0.0 110.303 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 1.213 ' CG ' HD11 ' A' ' 96' ' ' LEU . 78.1 mtp180 -32.5 -49.76 0.22 Allowed 'General case' 0 N--CA 1.51 2.53 0 O-C-N 121.08 -1.012 . . . . 0.0 110.308 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.576 ' C ' ' O ' ' A' ' 90' ' ' ARG . 15.6 tptm -33.96 -36.45 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 118.291 -1.364 . . . . 0.0 108.037 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.561 ' N ' ' O ' ' A' ' 90' ' ' ARG . 60.5 mtm180 -56.01 -65.63 0.57 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 117.392 -1.29 . . . . 0.0 108.471 171.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.618 ' O ' ' CG ' ' A' ' 94' ' ' ASP . 2.1 p30 -115.9 -69.9 0.83 Allowed 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 113.869 -3.132 . . . . 0.0 109.673 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.618 ' CG ' ' O ' ' A' ' 93' ' ' ASN . 34.4 m-20 155.35 -9.49 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 121.972 0.892 . . . . 0.0 109.988 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.692 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -120.45 152.51 37.89 Favored 'General case' 0 C--O 1.182 -2.476 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.89 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.213 HD11 ' CG ' ' A' ' 90' ' ' ARG . 0.5 OUTLIER 142.2 152.37 0.0 OUTLIER 'General case' 1 N--CA 1.549 4.494 0 CA-C-O 115.971 -1.966 . . . . 0.0 109.379 -178.211 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 110' ' ' HIS . 0.1 OUTLIER -116.1 96.84 5.76 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 125.239 3.654 . . . . 0.0 103.754 171.495 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -90.31 107.03 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 178.558 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 164' ' ' ALA . 22.0 m -131.44 143.89 39.19 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 124.2 1.953 . . . . 0.0 115.644 -171.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.753 HG21 HD11 ' A' ' 69' ' ' ILE . 38.3 t -109.62 138.34 37.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 101.901 -3.37 . . . . 0.0 101.901 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.436 ' HA ' ' CE1' ' A' ' 108' ' ' TYR . 11.3 p -118.91 148.56 42.8 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 104' ' ' GLN . 32.8 t70 -80.21 -173.71 4.14 Favored 'General case' 0 C--N 1.288 -2.1 1 N-CA-C 98.992 -4.447 . . . . 0.0 98.992 171.534 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 ttp -74.55 71.02 1.83 Allowed 'General case' 0 C--N 1.27 -2.849 0 C-N-CA 113.978 -3.089 . . . . 0.0 105.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.2 tp-100 -145.14 -47.81 0.23 Allowed 'General case' 0 C--O 1.211 -0.965 0 O-C-N 120.31 -1.494 . . . . 0.0 110.116 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.566 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.7 t 86.9 138.0 0.05 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.4 OUTLIER 156.35 138.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.537 -3.135 . . . . 0.0 102.537 176.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.529 HH22 ' CG ' ' A' ' 138' ' ' ASN . 2.6 mpt_? -74.47 97.79 3.18 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.436 ' CE1' ' HA ' ' A' ' 101' ' ' THR . 2.9 m-85 -49.21 -22.53 1.04 Allowed 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.504 ' N ' ' C ' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -131.58 163.44 28.04 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -175.449 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 97' ' ' PHE . 0.1 OUTLIER 170.96 143.99 0.11 Allowed Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 120.959 -1.088 . . . . 0.0 110.943 178.249 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.44 -44.32 6.68 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 N-CA-C 105.479 -2.546 . . . . 0.0 105.479 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -108.3 109.17 20.44 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.75 67.7 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.561 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.51 -36.94 74.58 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 119.153 -2.217 . . . . 0.0 113.179 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.488 ' NH1' ' N ' ' A' ' 140' ' ' GLY . 0.5 OUTLIER -56.5 -41.6 76.93 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.466 -2.021 . . . . 0.0 107.35 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.741 ' O ' ' N ' ' A' ' 118' ' ' GLN . 85.6 mt -40.66 -80.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.102 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 116' ' ' ILE . . . -27.58 -18.72 0.0 OUTLIER Glycine 0 N--CA 1.497 2.742 0 CA-C-O 119.451 -0.638 . . . . 0.0 113.431 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.741 ' N ' ' O ' ' A' ' 116' ' ' ILE . 5.5 mm-40 -73.43 -70.96 0.24 Allowed Pre-proline 0 N--CA 1.501 2.125 0 CA-C-N 120.942 2.371 . . . . 0.0 112.885 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.666 ' O ' ' O ' ' A' ' 118' ' ' GLN . 75.7 Cg_exo -20.11 156.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 124.05 3.166 . . . . 0.0 114.155 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.496 ' CB ' ' O ' ' A' ' 119' ' ' PRO . 28.4 t80 89.16 145.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.76 72.89 0.5 Allowed 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 117.375 -1.73 . . . . 0.0 111.358 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.665 ' O ' ' OD2' ' A' ' 123' ' ' ASP . . . -152.36 -58.23 0.01 OUTLIER Glycine 0 N--CA 1.507 3.393 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 176.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.665 ' OD2' ' O ' ' A' ' 122' ' ' GLY . 14.3 m-20 131.78 1.88 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.546 0 CA-C-N 117.653 0.727 . . . . 0.0 110.567 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -95.31 -26.7 15.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.572 -1.33 . . . . 0.0 108.683 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.486 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 0.3 OUTLIER -84.44 -18.11 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.272 -1.518 . . . . 0.0 109.928 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -50.42 -36.08 31.41 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.808 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 58.5 mttp -80.24 -33.76 37.73 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.27 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.74 -28.68 22.9 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 119.788 -1.82 . . . . 0.0 110.321 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.4 mt -50.11 -25.75 3.81 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.648 0.737 . . . . 0.0 109.127 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.808 ' ND2' ' O ' ' A' ' 127' ' ' LYS 0.269 24.7 p30 -78.28 -97.05 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.61 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.719 ' H ' ' CG ' ' A' ' 130' ' ' ASN . . . -161.75 49.15 0.35 Allowed Glycine 0 CA--C 1.549 2.218 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -142.31 163.46 32.79 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.178 -1.778 . . . . 0.0 109.632 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 149' ' ' PHE . 56.2 mm-40 -71.82 165.3 24.37 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.345 0.593 . . . . 0.0 112.054 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 5.2 t30 -168.69 144.62 3.55 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.599 ' CG2' HG12 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -132.49 131.12 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 120.24 -1.538 . . . . 0.0 109.848 -178.273 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.28 168.18 24.02 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.327 -0.858 . . . . 0.0 109.911 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.83 139.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.85 0.833 . . . . 0.0 111.635 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.529 ' CG ' HH22 ' A' ' 107' ' ' ARG . 6.7 t-20 -101.93 130.14 48.37 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 122.231 1.015 . . . . 0.0 111.973 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -127.96 119.65 25.97 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.583 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.488 ' N ' ' NH1' ' A' ' 115' ' ' ARG . . . -156.0 167.66 33.32 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.455 ' C ' ' O ' ' A' ' 140' ' ' GLY . 73.2 m-85 -34.48 -36.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.915 -0.756 . . . . 0.0 110.973 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.71 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 47.5 mt -60.87 -67.92 0.36 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.896 -1.128 . . . . 0.0 110.076 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 142' ' ' LEU . . . 158.36 158.43 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.842 0.829 . . . . 0.0 110.718 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -44.77 137.25 4.06 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.085 0.945 . . . . 0.0 111.341 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.817 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -151.48 150.88 30.91 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 tp -104.67 157.09 17.43 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-N 122.032 2.196 . . . . 0.0 108.896 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.456 ' HD2' HH21 ' A' ' 107' ' ' ARG . 12.4 ptt180 -146.21 153.82 41.05 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.423 1.106 . . . . 0.0 110.592 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.599 HG12 ' CG2' ' A' ' 135' ' ' VAL . 6.9 m -117.97 153.32 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.431 ' O ' ' OE1' ' A' ' 133' ' ' GLU . 68.7 m-85 -121.65 144.42 48.77 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.56 139.17 16.06 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -87.98 153.21 7.12 Favored 'Trans proline' 0 N--CA 1.513 2.618 0 C-N-CA 123.944 3.096 . . . . 0.0 114.88 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.5 mt -118.22 132.64 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 43.1 m-85 -103.24 148.91 25.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.947 -1.096 . . . . 0.0 113.532 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 156' ' ' ASN . 52.2 t0 -72.47 51.15 0.25 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 153' ' ' TYR . 31.1 tt0 42.98 17.28 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.231 -0.918 . . . . 0.0 111.033 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 158' ' ' LYS . 36.2 m120 -132.99 30.77 3.95 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.885 -1.135 . . . . 0.0 109.073 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 61.82 3.64 0.94 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.8 mptt -86.19 133.76 33.83 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.657 ' O ' ' CD ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -85.72 129.09 34.92 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -175.724 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.13 8.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.813 0 O-C-N 118.841 -2.412 . . . . 0.0 117.305 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.28 -179.9 44.26 Favored Glycine 0 N--CA 1.515 3.915 0 C-N-CA 115.918 -3.039 . . . . 0.0 112.077 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 101' ' ' THR . 70.8 t -141.95 138.85 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.892 -1.358 . . . . 0.0 111.668 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.94 126.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.547 ' O ' HG22 ' A' ' 99' ' ' VAL . . . -114.27 158.8 20.92 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 147' ' ' ARG . 35.4 mt -151.43 101.04 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.225 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.98 131.03 10.46 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.264 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.817 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -93.14 110.35 21.85 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.46 ' CD ' ' N ' ' A' ' 169' ' ' LEU . 14.8 tm-20 -57.61 163.74 2.34 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 143' ' ' ALA . 0.8 OUTLIER -43.95 144.02 0.99 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.517 -1.365 . . . . 0.0 110.644 -179.037 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 171' ' ' ARG . 1.5 t -109.36 -59.16 1.94 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 120.817 -1.177 . . . . 0.0 110.718 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 170' ' ' SER . 22.9 ttm180 148.99 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.6 0 CA-C-N 113.138 -1.846 . . . . 0.0 109.305 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 176' ' ' ILE . 2.6 t -87.72 24.41 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 O-C-N 120.336 -1.478 . . . . 0.0 108.939 -177.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 65.7 p -80.09 -39.16 30.18 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -75.47 -57.87 3.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.501 -1.374 . . . . 0.0 108.542 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.512 ' CG ' ' H ' ' A' ' 176' ' ' ILE . 7.8 pt20 -50.09 -69.93 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.747 HG23 ' N ' ' A' ' 177' ' ' ASN . 7.7 tp -42.7 -73.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.747 ' N ' HG23 ' A' ' 176' ' ' ILE . 26.2 t30 -43.28 -73.17 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.919 -0.488 . . . . 0.0 110.682 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 179' ' ' SER . 65.0 t0 -46.95 -60.53 2.38 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.155 -0.966 . . . . 0.0 109.82 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 178' ' ' ASP . 81.1 p -43.78 -71.68 0.07 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.114 -0.991 . . . . 0.0 109.741 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.541 178.496 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 48' ' ' THR . 48.9 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.418 0.628 . . . . 0.0 109.366 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 49' ' ' ARG . 27.3 m-20 -69.59 -56.74 6.47 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.832 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -51.73 -45.98 63.83 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.219 -1.551 . . . . 0.0 109.466 -173.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 45' ' ' SER . 6.0 t -60.3 -32.3 71.08 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' THR . 69.2 ttt180 -42.48 -61.3 1.25 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.244 -1.535 . . . . 0.0 110.481 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.95 -59.93 2.51 Favored 'General case' 0 N--CA 1.507 2.391 0 C-N-CA 125.686 1.594 . . . . 0.0 114.496 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 52' ' ' LEU . . . -79.13 -49.34 6.38 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.97 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -48.95 -44.65 40.83 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 121.273 2.537 . . . . 0.0 107.17 176.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 57' ' ' LEU . . . -48.94 -70.58 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.937 -1.102 . . . . 0.0 109.09 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -61.56 -55.72 27.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.825 0.822 . . . . 0.0 111.843 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -63.32 -61.25 2.48 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' HB3' HD12 ' A' ' 52' ' ' LEU . . . -65.7 -27.48 68.37 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 121.947 2.158 . . . . 0.0 111.75 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.8 tt -66.02 -31.36 72.21 Favored 'General case' 0 C--N 1.283 -2.325 0 O-C-N 119.662 -1.899 . . . . 0.0 108.359 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.91 -46.36 14.17 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.63 -33.96 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 118.597 -2.564 . . . . 0.0 106.224 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 98' ' ' ILE . . . -59.43 -37.47 78.15 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 117.871 -1.531 . . . . 0.0 107.281 174.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.559 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 2.6 ptt180 -64.49 -15.03 60.09 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.741 -1.184 . . . . 0.0 108.397 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.683 HG22 HD12 ' A' ' 63' ' ' LEU . 6.7 m -67.49 -49.06 65.18 Favored 'General case' 0 CA--C 1.485 -1.526 0 C-N-CA 114.666 -2.814 . . . . 0.0 104.848 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 62' ' ' THR . 5.7 mp -84.02 -45.1 13.45 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.533 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -50.59 -19.27 0.86 Allowed 'General case' 0 N--CA 1.524 3.269 0 CA-C-O 123.637 1.685 . . . . 0.0 106.544 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.535 ' N ' ' C ' ' A' ' 63' ' ' LEU . 17.7 t0 -88.03 -9.17 54.22 Favored 'General case' 0 N--CA 1.521 3.099 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.897 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.529 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -71.18 -154.2 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 120.46 -1.4 . . . . 0.0 110.523 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.567 ' C ' ' H ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -107.05 -32.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 123.626 2.884 . . . . 0.0 115.054 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.511 ' C ' HD12 ' A' ' 69' ' ' ILE . 12.6 pt-20 -77.88 33.51 0.18 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.658 HG22 ' N ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -110.34 -84.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 175.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.658 ' N ' HG22 ' A' ' 69' ' ' ILE . 78.8 ttt180 -45.19 -32.55 1.91 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.043 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 9.5 tt0 -85.56 -16.4 39.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.928 -1.107 . . . . 0.0 111.524 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -100.17 -10.46 45.32 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 104.77 -3.332 . . . . 0.0 104.77 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -85.17 -38.56 18.87 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 102.681 -3.081 . . . . 0.0 102.681 174.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.77 -6.6 1.82 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.832 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.748 ' O ' ' O ' ' A' ' 76' ' ' LYS . 18.8 mmtt -125.89 64.19 1.21 Allowed 'General case' 0 N--CA 1.526 3.355 0 CA-C-N 120.233 1.378 . . . . 0.0 112.228 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.748 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 25.4 153.38 0.0 OUTLIER Pre-proline 0 N--CA 1.524 3.253 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -31.93 -61.77 0.15 Allowed 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 123.027 2.485 . . . . 0.0 113.851 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.618 ' H ' ' HZ2' ' A' ' 76' ' ' LYS . 62.0 tt0 -52.47 137.44 29.82 Favored 'General case' 0 C--N 1.287 -2.109 0 C-N-CA 117.81 -1.556 . . . . 0.0 108.617 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' A' ' 78' ' ' GLN . 24.1 tt0 77.23 -29.31 0.17 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.304 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.773 ' O ' ' N ' ' A' ' 82' ' ' ILE . 8.6 t -46.1 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.334 -1.479 . . . . 0.0 112.674 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -54.44 48.22 0.01 OUTLIER Glycine 0 CA--C 1.562 3.008 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.258 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.773 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.2 tp -56.78 3.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -1.207 . . . . 0.0 109.995 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.63 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 35.0 tp60 -57.74 -22.22 45.44 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.498 -1.376 . . . . 0.0 110.969 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.647 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -77.8 -72.51 0.36 Allowed 'General case' 0 N--CA 1.506 2.375 0 O-C-N 119.85 -1.781 . . . . 0.0 111.353 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -39.76 -55.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 120.518 1.508 . . . . 0.0 110.159 171.327 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.1 -35.7 48.68 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 119.907 -1.746 . . . . 0.0 108.807 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 69.9 tt0 -65.7 -56.09 13.92 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 114.075 -1.421 . . . . 0.0 112.03 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -61.71 -65.02 0.76 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 123.819 3.009 . . . . 0.0 109.412 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -45.78 -65.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 C-N-CA 115.021 -2.671 . . . . 0.0 110.769 -175.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.594 ' N ' ' HB2' ' A' ' 94' ' ' ASP . 48.4 ttp180 -34.52 -44.58 0.2 Allowed 'General case' 0 N--CA 1.516 2.853 0 O-C-N 121.012 -1.055 . . . . 0.0 109.622 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 90' ' ' ARG . 40.8 tptt -43.92 -60.11 1.98 Allowed 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 117.395 -1.722 . . . . 0.0 107.197 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 89' ' ' VAL . 38.7 mtm180 -61.99 -65.75 0.64 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.691 -1.204 . . . . 0.0 107.996 174.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 39.1 t30 173.2 103.88 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.751 ' C ' ' H ' ' A' ' 96' ' ' LEU . 27.3 t70 -136.71 54.11 1.88 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.037 0.922 . . . . 0.0 109.2 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.3 mt -72.96 40.21 0.09 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 124.237 1.97 . . . . 0.0 106.609 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.965 HD11 HD12 ' A' ' 167' ' ' LEU 0.326 0.6 OUTLIER -107.17 175.43 5.5 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-N 111.312 -2.676 . . . . 0.0 109.65 -178.834 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -107.12 100.64 10.1 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 101.759 -3.423 . . . . 0.0 101.759 171.072 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.409 ' CD1' ' HB2' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -88.64 131.1 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.624 HG22 ' H ' ' A' ' 164' ' ' ALA . 0.9 OUTLIER -133.32 157.91 42.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 124.79 2.233 . . . . 0.0 113.525 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.15 125.23 38.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 1 N-CA-C 99.043 -4.428 . . . . 0.0 99.043 173.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.554 HG23 HG23 ' A' ' 99' ' ' VAL . 26.9 p -125.06 157.83 35.28 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 120.673 -1.267 . . . . 0.0 109.976 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -83.58 -175.17 5.69 Favored 'General case' 0 C--N 1.297 -1.707 1 N-CA-C 97.512 -4.995 . . . . 0.0 97.512 170.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -76.5 85.06 3.21 Favored 'General case' 0 C--N 1.267 -3.009 0 C-N-CA 114.877 -2.729 . . . . 0.0 105.312 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.524 ' O ' ' CB ' ' A' ' 105' ' ' SER . 3.0 tm0? -153.02 -42.25 0.1 Allowed 'General case' 0 CA--C 1.549 0.928 0 O-C-N 120.751 -1.218 . . . . 0.0 109.444 -176.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.625 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.1 t 83.23 138.32 0.06 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.724 ' H ' HH21 ' A' ' 107' ' ' ARG . 0.8 OUTLIER 154.15 134.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 177.201 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.724 HH21 ' H ' ' A' ' 106' ' ' LEU . 2.6 mmp_? -71.62 94.42 1.33 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 116.842 -1.943 . . . . 0.0 106.717 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.601 ' C ' HG21 ' A' ' 82' ' ' ILE . 2.6 m-85 -50.83 -37.08 40.84 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -118.12 167.55 11.38 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.024 -1.443 . . . . 0.0 112.441 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 1.004 ' CD2' HD11 ' A' ' 116' ' ' ILE . 11.9 p80 178.51 151.19 0.45 Allowed Pre-proline 0 N--CA 1.496 1.854 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.204 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.64 -28.3 1.8 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 N-CA-C 107.397 -1.809 . . . . 0.0 107.397 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -119.91 138.27 53.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.42 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.52 -50.38 38.34 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.022 -1.049 . . . . 0.0 113.555 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.15 -38.64 71.13 Favored 'General case' 0 CA--C 1.571 1.775 0 O-C-N 120.152 -1.593 . . . . 0.0 114.936 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.61 ' NH1' ' ND2' ' A' ' 138' ' ' ASN . 0.5 OUTLIER -57.87 -45.25 86.61 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.042 -2.286 . . . . 0.0 109.201 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 1.004 HD11 ' CD2' ' A' ' 110' ' ' HIS . 89.6 mt -29.95 -91.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.745 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -45.31 -16.78 0.1 Allowed Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.455 -0.778 . . . . 0.0 114.452 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -59.47 -65.7 1.89 Allowed Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 120.601 2.2 . . . . 0.0 112.439 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 116' ' ' ILE . 1.1 Cg_endo -39.41 103.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 123.487 2.791 . . . . 0.0 113.597 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 122' ' ' GLY . 35.4 t80 -162.43 141.51 9.18 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt 47.7 11.34 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.195 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 120' ' ' PHE . . . -60.45 -15.01 37.24 Favored Glycine 0 N--CA 1.505 3.282 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 122' ' ' GLY . 11.9 t70 71.99 -2.27 2.59 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.11 -1.229 . . . . 0.0 111.49 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.599 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 10.5 p-10 -92.56 -45.88 7.89 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.1 -15.84 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.548 -1.345 . . . . 0.0 110.095 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -55.24 -29.66 58.48 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.355 -1.466 . . . . 0.0 108.148 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.642 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 68.5 mttm -79.91 -24.99 40.73 Favored 'General case' 0 C--O 1.194 -1.818 0 O-C-N 121.964 -0.46 . . . . 0.0 110.343 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.534 ' O ' ' OD1' ' A' ' 130' ' ' ASN . . . -90.09 -33.21 16.37 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 119.792 -1.818 . . . . 0.0 110.012 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 mt -48.98 -29.53 4.93 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.064 0.935 . . . . 0.0 109.009 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.821 ' CG ' ' H ' ' A' ' 131' ' ' GLY . 41.6 p-10 -56.9 -78.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 109.768 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.821 ' H ' ' CG ' ' A' ' 130' ' ' ASN . . . 167.34 35.05 0.02 OUTLIER Glycine 0 CA--C 1.539 1.578 0 C-N-CA 128.808 3.099 . . . . 0.0 107.586 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.619 ' HB2' HD22 ' A' ' 130' ' ' ASN . 93.6 mt-10 -141.03 162.69 34.9 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 119.605 1.702 . . . . 0.0 109.767 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -76.08 165.68 24.58 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.621 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -168.98 153.33 5.59 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -133.45 136.44 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.016 -1.052 . . . . 0.0 110.556 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.57 172.16 13.37 Favored 'General case' 0 N--CA 1.518 2.96 0 O-C-N 120.528 -1.357 . . . . 0.0 109.682 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.6 136.0 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 120.641 -1.287 . . . . 0.0 110.349 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.61 ' ND2' ' NH1' ' A' ' 115' ' ' ARG . 3.8 t30 -103.98 133.61 48.65 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.462 -0.774 . . . . 0.0 109.005 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -132.75 100.91 5.08 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.676 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -116.47 164.13 12.35 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -44.35 -13.89 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.34 -1.094 . . . . 0.0 110.494 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -75.53 -72.37 0.31 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.984 -1.073 . . . . 0.0 108.7 -179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 144' ' ' GLN . . . 176.43 149.61 0.13 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.428 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' ALA . 97.2 mt-30 -35.06 152.55 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.481 0.658 . . . . 0.0 110.139 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.974 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -157.2 152.4 26.17 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 117.357 -1.306 . . . . 0.0 107.855 -176.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.8 tp -116.37 144.23 44.54 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 123.149 2.704 . . . . 0.0 109.684 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -129.44 147.62 51.27 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.338 1.066 . . . . 0.0 110.97 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.52 HG12 ' CG2' ' A' ' 135' ' ' VAL . 7.3 m -114.05 158.35 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -132.88 138.96 47.18 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.67 138.76 29.03 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -86.45 155.31 9.24 Favored 'Trans proline' 0 C--N 1.295 -2.247 0 C-N-CA 122.555 2.17 . . . . 0.0 113.758 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 62.6 mt -118.2 135.44 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . 0.304 65.2 m-85 -106.24 151.77 24.36 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 155' ' ' GLU . 63.0 t0 -78.46 164.35 24.83 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.573 ' N ' ' OD1' ' A' ' 154' ' ' ASP . 18.5 tt0 -47.95 -9.31 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.241 -1.383 . . . . 0.0 112.976 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 154' ' ' ASP . 16.7 m120 -121.83 49.62 1.53 Allowed 'General case' 0 N--CA 1.518 2.971 0 O-C-N 120.348 -1.47 . . . . 0.0 114.268 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 57.39 9.32 0.73 Allowed 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.998 -1.064 . . . . 0.0 110.443 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -83.69 128.79 34.79 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.595 ' O ' ' CD ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -74.96 126.72 31.61 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.182 -0.949 . . . . 0.0 112.662 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.419 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.7 pp -141.73 12.43 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.601 0 O-C-N 119.028 -2.295 . . . . 0.0 116.231 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.11 174.51 46.83 Favored Glycine 0 N--CA 1.501 3.025 0 C-N-CA 115.774 -3.108 . . . . 0.0 112.002 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.9 t -137.55 143.51 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.576 1.179 . . . . 0.0 113.215 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 40.6 t -109.6 129.2 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.624 ' H ' HG22 ' A' ' 99' ' ' VAL . . . -127.01 157.53 39.35 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.231 -0.918 . . . . 0.0 108.845 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 147' ' ' ARG . 16.3 mt -151.12 99.99 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 96' ' ' LEU . . . -108.03 118.14 5.34 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.918 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.974 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.8 tp -72.38 120.23 17.71 Favored 'General case' 0 C--O 1.193 -1.914 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.07 -30.11 63.45 Favored 'General case' 1 N--CA 1.542 4.163 0 CA-C-O 123.11 1.433 . . . . 0.0 110.37 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -170.78 176.95 4.01 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 113.67 -1.604 . . . . 0.0 114.399 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . 1.004 ' O ' ' N ' ' A' ' 172' ' ' VAL . 2.9 t -179.76 64.05 0.01 OUTLIER 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.115 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 14.55 -32.3 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 125.2 1.4 . . . . 0.0 114.624 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 1.004 ' N ' ' O ' ' A' ' 170' ' ' SER . 3.0 t -93.18 36.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.197 -1.564 . . . . 0.0 108.24 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 82.2 p -84.85 -35.36 22.29 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -77.42 -51.56 10.59 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -54.43 -69.1 0.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.047 0.927 . . . . 0.0 110.058 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.843 HG23 ' H ' ' A' ' 177' ' ' ASN . 9.8 tp -41.57 -72.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 O-C-N 121.071 -1.018 . . . . 0.0 112.042 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.843 ' H ' HG23 ' A' ' 176' ' ' ILE . 75.9 m-20 -44.16 -77.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.403 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -48.38 -58.4 4.66 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.454 -1.404 . . . . 0.0 112.091 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.471 ' OG ' ' N ' ' A' ' 180' ' ' ARG . 56.1 p -44.75 -66.35 0.41 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.747 -1.22 . . . . 0.0 111.191 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.471 ' N ' ' OG ' ' A' ' 179' ' ' SER . 67.0 ttt180 . . . . . 0 C--N 1.302 -1.477 0 O-C-N 121.025 -1.047 . . . . 0.0 109.874 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 46' ' ' ASP . 74.4 p . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.751 0.786 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 47' ' ' MET . 69.5 m-20 -74.75 -65.39 0.87 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.529 1.157 . . . . 0.0 109.967 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 46' ' ' ASP . 26.4 ttt -41.76 -54.76 3.23 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 122.267 1.032 . . . . 0.0 111.146 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.539 ' OG1' ' HB3' ' A' ' 52' ' ' LEU . 13.5 t -58.77 -35.94 73.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.273 1.035 . . . . 0.0 110.158 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.447 ' N ' HG23 ' A' ' 48' ' ' THR . 67.1 ttp85 -39.04 -52.66 1.83 Allowed 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 122.253 1.025 . . . . 0.0 111.855 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -86.06 -55.44 3.94 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -78.2 -45.76 9.81 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.787 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.539 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -56.64 -41.82 77.82 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 120.894 2.347 . . . . 0.0 105.068 176.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 49' ' ' ARG . . . -51.05 -59.39 4.22 Favored 'General case' 0 C--O 1.206 -1.184 0 C-N-CA 117.613 -1.635 . . . . 0.0 107.86 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -74.85 -68.36 0.55 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.457 -1.402 . . . . 0.0 112.457 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 51' ' ' GLY . 25.7 mtpp -47.75 -41.56 23.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 112.703 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.593 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -86.62 -27.28 23.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 119.103 -2.248 . . . . 0.0 110.246 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.7 tp -62.93 -46.4 87.97 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 120.187 -1.571 . . . . 0.0 107.711 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.02 77.3 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 t -76.44 -30.72 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 119.378 -2.076 . . . . 0.0 107.261 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.973 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -64.44 -28.55 69.75 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 176.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -78.85 -16.89 56.49 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.398 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.0 m -72.29 -43.61 63.97 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 115.499 -2.48 . . . . 0.0 107.149 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.808 HD12 ' HB1' ' A' ' 84' ' ' ALA . 3.8 mm? -85.71 -36.18 20.37 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.313 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.846 ' O ' HG21 ' A' ' 69' ' ' ILE . . . -62.21 -13.66 30.01 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.492 ' N ' ' C ' ' A' ' 63' ' ' LEU . 16.3 t0 -94.52 -11.35 29.77 Favored 'General case' 0 N--CA 1.518 2.975 0 CA-C-N 112.652 -2.067 . . . . 0.0 112.07 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.522 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -66.38 -152.83 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.97 0 O-C-N 120.054 -1.653 . . . . 0.0 109.695 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -104.11 -38.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.478 2.119 . . . . 0.0 113.582 178.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 7.1 pt-20 -48.32 -29.65 4.12 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.763 1.268 . . . . 0.0 108.104 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.846 HG21 ' O ' ' A' ' 64' ' ' ALA . 42.9 mm -56.44 -78.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.028 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' ILE . 45.2 ttt85 -46.19 -31.23 2.32 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -79.16 -14.24 59.22 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.683 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.703 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -83.69 -43.82 7.11 Favored Glycine 0 N--CA 1.487 2.085 1 N-CA-C 101.966 -4.454 . . . . 0.0 101.966 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 152' ' ' ILE . 7.5 mp -49.31 -39.9 32.96 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.35 -2.87 4.95 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 72' ' ' GLY . 20.5 tptt -122.73 -158.15 0.77 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.238 -1.539 . . . . 0.0 108.306 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.458 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -133.69 168.78 16.18 Favored Pre-proline 0 CA--C 1.569 1.684 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -38.59 -73.53 0.04 OUTLIER 'Trans proline' 0 N--CA 1.521 3.12 0 C-N-CA 124.927 3.751 . . . . 0.0 117.996 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.523 ' H ' ' CD ' ' A' ' 78' ' ' GLN . 2.2 mp0 -56.08 -14.25 2.52 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -174.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.458 ' OE1' ' NZ ' ' A' ' 76' ' ' LYS . 44.3 tt0 -121.74 2.76 10.07 Favored 'General case' 0 N--CA 1.514 2.757 0 O-C-N 120.61 -1.306 . . . . 0.0 110.78 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 40.4 t -66.97 -154.78 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.889 -1.132 . . . . 0.0 109.218 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.492 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . -149.58 64.95 0.39 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.532 ' CD1' ' H ' ' A' ' 100' ' ' VAL . 3.7 tp -76.22 7.41 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.737 -0.86 . . . . 0.0 110.455 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.701 ' O ' ' HB3' ' A' ' 86' ' ' ALA . 13.5 pt20 -63.48 -26.78 68.88 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 120.329 -1.482 . . . . 0.0 112.837 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.893 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -83.12 -60.63 2.09 Favored 'General case' 0 C--O 1.202 -1.442 0 O-C-N 118.861 -2.399 . . . . 0.0 108.622 -176.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.994 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -41.51 -43.88 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.249 0 CA-C-N 123.517 2.871 . . . . 0.0 105.756 172.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 83' ' ' GLN . . . -44.25 -25.07 0.2 Allowed 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 121.498 1.954 . . . . 0.0 108.143 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.893 ' N ' ' O ' ' A' ' 84' ' ' ALA . 53.6 mt-10 -52.21 -33.89 43.1 Favored 'General case' 0 N--CA 1.536 3.849 0 N-CA-C 102.352 -3.203 . . . . 0.0 102.352 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.876 ' N ' ' O ' ' A' ' 85' ' ' ILE . . . -68.82 -29.81 68.22 Favored 'General case' 0 N--CA 1.52 3.028 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.609 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.678 ' N ' ' O ' ' A' ' 86' ' ' ALA . 1.8 t -55.0 -55.8 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 O-C-N 120.525 -1.359 . . . . 0.0 107.656 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -56.22 -59.9 4.27 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.66 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -54.89 -49.98 69.87 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.024 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -57.8 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.949 -1.094 . . . . 0.0 110.475 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.33 27.4 0.93 Allowed 'General case' 0 N--CA 1.513 2.676 0 CA-C-N 122.258 2.299 . . . . 0.0 113.029 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.9 t70 70.74 -1.34 2.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.973 -1.079 . . . . 0.0 108.742 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 1.3 pp -146.06 162.36 38.07 Favored 'General case' 0 N--CA 1.519 2.996 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.7 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.501 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER 152.91 170.69 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.361 0 CA-C-O 117.513 -1.232 . . . . 0.0 108.245 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.664 ' CD1' ' CD2' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -119.75 82.8 1.94 Allowed 'General case' 0 C--O 1.215 -0.752 1 N-CA-C 96.318 -5.438 . . . . 0.0 96.318 166.605 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.973 HD11 ' HB2' ' A' ' 60' ' ' ALA . 1.5 tt -87.94 110.46 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.64 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 5.1 p -120.56 137.69 53.51 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.975 0 CA-C-N 112.173 -2.285 . . . . 0.0 113.424 -172.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.532 ' H ' ' CD1' ' A' ' 82' ' ' ILE . 38.9 t -113.98 140.18 35.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 1 N-CA-C 97.953 -4.832 . . . . 0.0 97.953 171.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 102' ' ' ASP . 38.0 p -122.06 145.28 48.3 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 120.767 1.621 . . . . 0.0 111.192 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 104' ' ' GLN . 66.3 t0 -74.18 -168.07 0.59 Allowed 'General case' 0 C--N 1.319 -0.746 1 N-CA-C 99.914 -4.106 . . . . 0.0 99.914 168.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.587 ' O ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -78.64 66.1 4.07 Favored 'General case' 0 C--N 1.274 -2.694 0 C-N-CA 115.207 -2.597 . . . . 0.0 104.985 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 102' ' ' ASP . 5.1 tm0? -170.89 107.93 0.29 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 101.179 -3.638 . . . . 0.0 101.179 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.738 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 29.1 t -61.67 161.17 10.33 Favored 'General case' 0 CA--C 1.462 -2.408 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.693 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.738 ' HB2' ' O ' ' A' ' 105' ' ' SER . 12.1 tp 153.5 142.27 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 116' ' ' ILE . 99.1 mtt180 -75.68 109.44 9.27 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 101' ' ' THR . 4.6 m-30 -70.94 -34.68 71.73 Favored 'General case' 0 C--N 1.262 -3.216 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 1.1 t -119.84 157.75 28.03 Favored 'General case' 0 C--O 1.196 -1.746 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.657 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.664 ' CD2' ' CD1' ' A' ' 97' ' ' PHE . 47.1 t-80 169.86 140.12 0.07 OUTLIER Pre-proline 0 N--CA 1.524 3.228 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.37 -55.86 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 CA-C-N 120.561 1.236 . . . . 0.0 109.136 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.529 ' OE1' ' NH2' ' A' ' 115' ' ' ARG . 34.0 mt-10 -79.75 142.48 35.36 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.46 -42.91 24.3 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.548 -0.72 . . . . 0.0 112.638 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -60.87 -35.64 77.13 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.529 ' NH2' ' OE1' ' A' ' 112' ' ' GLU . 3.8 tpp180 -61.96 -31.72 72.08 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 119.39 -2.069 . . . . 0.0 108.151 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.657 ' O ' ' N ' ' A' ' 118' ' ' GLN . 55.6 mt -51.69 -82.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.242 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.595 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -33.96 -11.69 0.0 OUTLIER Glycine 0 N--CA 1.498 2.793 0 CA-C-O 119.156 -0.802 . . . . 0.0 113.97 -175.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 116' ' ' ILE . 6.2 mm-40 -80.79 -70.5 0.16 Allowed Pre-proline 0 N--CA 1.503 2.223 0 CA-C-N 121.383 2.591 . . . . 0.0 113.369 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 17.4 Cg_exo -29.91 117.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 124.196 3.264 . . . . 0.0 114.651 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 122' ' ' GLY . 85.3 t80 -175.37 149.86 1.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 123' ' ' ASP . 27.3 ttpt 48.95 11.32 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.327 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 120' ' ' PHE . . . -46.28 -12.54 0.06 OUTLIER Glycine 0 N--CA 1.501 2.967 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 121' ' ' LYS . 4.2 m-20 62.71 -11.88 0.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.585 -0.95 . . . . 0.0 111.232 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 122' ' ' GLY . 49.8 m-20 -75.34 -29.4 59.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' LEU . 16.3 pt -78.03 -34.24 19.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.654 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -38.5 -32.62 0.08 Allowed 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.536 -0.727 . . . . 0.0 110.289 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -90.55 -40.23 12.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.157 -0.965 . . . . 0.0 109.571 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -78.74 -48.15 15.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.971 -1.08 . . . . 0.0 109.192 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.622 ' C ' HD22 ' A' ' 130' ' ' ASN . 1.5 mt -36.44 -42.03 0.32 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 123.171 1.463 . . . . 0.0 108.053 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.622 HD22 ' C ' ' A' ' 129' ' ' LEU . 3.8 m120 -102.44 22.04 14.14 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.078 -1.419 . . . . 0.0 113.388 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 132' ' ' GLU . . . 87.16 100.87 0.84 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 131' ' ' GLY . 4.1 tp10 167.75 140.47 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.069 0 CA-C-N 113.551 -1.325 . . . . 0.0 113.394 175.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -81.77 142.29 32.74 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.923 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 4.0 t-20 -162.55 144.9 10.84 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.248 -1.533 . . . . 0.0 110.592 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 147' ' ' ARG . 8.6 p -135.58 151.86 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 O-C-N 119.774 -1.829 . . . . 0.0 108.29 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -159.48 162.7 35.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.82 -1.175 . . . . 0.0 109.372 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.59 141.71 16.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 122.214 1.007 . . . . 0.0 112.49 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -106.9 159.63 16.11 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -147.97 103.04 3.45 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.082 -1.636 . . . . 0.0 110.376 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.511 ' CA ' ' HB3' ' A' ' 143' ' ' ALA . . . -143.15 161.52 27.59 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.311 -2.316 . . . . 0.0 107.311 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.582 ' C ' ' H ' ' A' ' 143' ' ' ALA . 84.0 m-85 -44.13 118.77 1.58 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.216 -1.167 . . . . 0.0 109.675 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER 62.7 -11.17 0.08 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.423 -0.798 . . . . 0.0 109.024 -179.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 141' ' ' PHE . . . -81.31 -10.9 59.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.771 -1.206 . . . . 0.0 112.772 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 143' ' ' ALA . 93.0 mt-30 -40.9 114.44 0.48 Allowed 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.92 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -158.85 160.15 35.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.111 -1.618 . . . . 0.0 111.238 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 tp -105.19 160.81 14.79 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.79 -1.194 . . . . 0.0 108.285 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.781 ' O ' HG23 ' A' ' 135' ' ' VAL . 12.4 ptt180 -150.01 146.21 26.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.766 -1.209 . . . . 0.0 109.294 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 m -105.53 167.65 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 CA-C-O 122.008 0.908 . . . . 0.0 109.152 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 32.6 m-85 -134.98 138.63 44.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 p -144.48 157.56 55.67 Favored Pre-proline 0 C--N 1.308 -1.238 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -102.33 152.6 0.29 Allowed 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.369 2.713 . . . . 0.0 114.983 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.544 HG21 HD21 ' A' ' 73' ' ' LEU . 83.2 mt -113.48 134.94 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.461 ' C ' ' H ' ' A' ' 155' ' ' GLU . 66.6 m-85 -102.04 142.45 33.3 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.455 -0.778 . . . . 0.0 111.884 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 26.7 t70 -58.87 -2.41 0.23 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.586 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 154' ' ' ASP . 56.1 tt0 98.25 21.52 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -140.78 19.13 2.33 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 15.3 t60 69.35 11.47 8.11 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -96.1 116.76 29.47 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.668 ' NE2' ' N ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -65.08 122.58 17.37 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.445 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.5 pp -137.62 1.89 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 O-C-N 120.841 -1.162 . . . . 0.0 113.541 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.419 ' N ' HD12 ' A' ' 160' ' ' ILE . . . -166.75 176.08 41.91 Favored Glycine 0 N--CA 1.507 3.4 0 C-N-CA 119.243 -1.456 . . . . 0.0 110.587 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.18 145.92 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 O-C-N 121.175 -1.191 . . . . 0.0 112.939 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.65 116.07 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.64 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -113.07 157.51 21.5 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.593 HG21 ' HB1' ' A' ' 56' ' ' ALA . 48.9 mt -146.4 107.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.44 ' HA3' ' CD2' ' A' ' 97' ' ' PHE . . . -108.84 122.64 6.65 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.54 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.92 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 27.1 tp -85.61 108.95 18.23 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 169' ' ' LEU . 10.8 tm-20 -53.94 -36.37 62.72 Favored 'General case' 0 N--CA 1.518 2.93 0 O-C-N 123.786 0.679 . . . . 0.0 110.239 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.48 ' CB ' ' O ' ' A' ' 168' ' ' GLU . 4.4 tp . . . . . 0 N--CA 1.51 2.553 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.794 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' MET . 76.2 m-20 -75.61 -59.02 2.93 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.41 1.1 . . . . 0.0 108.648 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.499 ' C ' ' SD ' ' A' ' 47' ' ' MET . 0.9 OUTLIER -36.97 -62.27 0.5 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 123.066 1.412 . . . . 0.0 109.666 -177.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.502 ' O ' ' HB3' ' A' ' 52' ' ' LEU . 5.9 t -54.78 -41.37 70.46 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.092 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' THR . 50.7 ttp180 -35.57 -51.22 0.63 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.661 -1.274 . . . . 0.0 112.57 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -91.55 -53.77 4.18 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -71.96 -47.3 32.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -176.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' A' ' 167' ' ' LEU . 0.9 OUTLIER -56.99 -44.06 82.32 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 175.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 49' ' ' ARG . . . -50.09 -55.8 13.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 118.081 -1.447 . . . . 0.0 109.932 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -83.53 -62.92 1.46 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.399 -1.438 . . . . 0.0 112.989 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' GLY . 5.3 ptmt -52.55 -34.69 51.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.456 -0.778 . . . . 0.0 111.217 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -84.89 -31.62 23.6 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 119.443 -2.036 . . . . 0.0 109.176 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.8 tt -47.24 -46.12 24.2 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.35 -1.469 . . . . 0.0 108.165 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 61' ' ' ARG . . . -67.86 -41.3 83.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.685 -1.884 . . . . 0.0 110.208 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.987 HG13 ' HB1' ' A' ' 88' ' ' ALA . 25.0 t -52.73 -45.89 49.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 O-C-N 120.065 -1.647 . . . . 0.0 107.504 177.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.843 ' HB2' HD11 ' A' ' 165' ' ' ILE . . . -51.77 -24.13 5.53 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -73.59 -37.15 65.56 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 115.799 -2.36 . . . . 0.0 111.647 -178.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 m -57.71 -29.21 64.52 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 119.58 -1.95 . . . . 0.0 107.595 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.767 ' HB3' HD12 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -74.56 -26.13 59.74 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 117.59 -1.644 . . . . 0.0 108.051 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.65 -12.28 59.51 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-O 117.668 -1.158 . . . . 0.0 110.952 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.456 ' OD2' ' NH1' ' A' ' 61' ' ' ARG . 3.9 m-20 -103.96 -24.8 13.21 Favored 'General case' 0 N--CA 1.51 2.555 0 CA-C-N 123.367 2.803 . . . . 0.0 113.853 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.534 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -76.61 -161.1 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 119.793 -1.817 . . . . 0.0 111.91 -175.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 68' ' ' GLU . 6.6 Cg_endo -109.92 -38.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 124.049 3.166 . . . . 0.0 114.172 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.609 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 2.5 pt-20 -52.01 -33.16 37.14 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.401 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.631 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.3 mp -58.71 -73.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.909 0.861 . . . . 0.0 111.744 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -48.46 -37.0 16.16 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -75.68 -14.08 60.34 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -82.01 -39.27 11.8 Favored Glycine 0 CA--C 1.486 -1.761 0 N-CA-C 103.324 -3.91 . . . . 0.0 103.324 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.81 -29.62 62.93 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -64.18 -3.78 3.05 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' CG ' ' H ' ' A' ' 76' ' ' LYS . 26.5 tptt -134.97 -150.58 0.39 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 78' ' ' GLN . 2.1 pttt -122.41 157.95 57.41 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 123.943 0.897 . . . . 0.0 109.119 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.669 ' O ' ' CE2' ' A' ' 108' ' ' TYR . 7.3 Cg_exo -29.0 -16.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.516 2.821 1 C-N-CA 125.551 4.167 . . . . 0.0 118.281 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 76' ' ' LYS . 83.0 mt-30 -90.37 1.66 56.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.191 -2.193 . . . . 0.0 108.918 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -132.68 2.3 3.74 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.659 ' N ' ' OH ' ' A' ' 108' ' ' TYR . 2.5 m -68.57 -156.75 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.146 -2.221 . . . . 0.0 108.863 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 83' ' ' GLN . . . -150.11 58.11 0.45 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.552 HD11 HD11 ' A' ' 85' ' ' ILE . 2.2 tp -49.55 -7.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 C-N-CA 123.203 0.601 . . . . 0.0 110.766 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 81' ' ' GLY . 86.6 mt-30 -47.38 -43.67 23.58 Favored 'General case' 0 C--N 1.269 -2.908 0 O-C-N 120.046 -1.659 . . . . 0.0 114.397 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.823 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -87.88 -53.34 4.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 119.365 -2.085 . . . . 0.0 110.122 -173.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.892 ' O ' ' N ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -46.32 -51.64 3.98 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.707 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 172.007 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.785 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -44.41 -21.93 0.06 Allowed 'General case' 0 N--CA 1.507 2.399 0 O-C-N 119.237 -2.164 . . . . 0.0 107.225 174.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.823 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.5 tt0 -48.47 -28.83 3.56 Favored 'General case' 1 N--CA 1.544 4.245 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 171.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.987 ' HB1' HG13 ' A' ' 59' ' ' VAL . . . -71.28 -28.05 63.86 Favored 'General case' 0 N--CA 1.515 2.778 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.698 172.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.785 ' N ' ' O ' ' A' ' 86' ' ' ALA . 33.0 m -65.69 -43.95 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.255 0 C-N-CA 116.241 -2.184 . . . . 0.0 110.346 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.512 ' N ' HG23 ' A' ' 89' ' ' VAL . 19.6 mtp-105 -56.19 -52.08 65.71 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -58.19 -30.69 66.64 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.383 -1.327 . . . . 0.0 108.63 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.435 ' NH2' HD11 ' A' ' 167' ' ' LEU . 6.5 mmm180 -76.33 -93.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.193 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.679 ' ND2' ' N ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -144.44 31.12 1.21 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.679 -1.263 . . . . 0.0 111.724 -177.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 60.7 24.07 13.9 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.292 -1.505 . . . . 0.0 109.414 -175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 96' ' ' LEU . 2.7 pp -167.13 160.08 13.55 Favored 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.575 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.418 ' CD2' ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER 164.62 176.77 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.934 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -177.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 109' ' ' SER . 58.5 m-85 -136.75 80.51 1.82 Allowed 'General case' 0 C--O 1.214 -0.774 1 N-CA-C 99.295 -4.335 . . . . 0.0 99.295 170.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.62 ' CD1' HG12 ' A' ' 59' ' ' VAL . 11.7 tt -100.06 118.36 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -177.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.819 ' CG1' ' H ' ' A' ' 164' ' ' ALA . 10.9 p -98.7 131.93 44.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 CA-C-O 124.587 2.137 . . . . 0.0 111.067 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.686 HG22 HD22 ' A' ' 63' ' ' LEU . 97.1 t -132.9 109.95 14.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 1 N-CA-C 98.02 -4.807 . . . . 0.0 98.02 175.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.554 ' HG1' ' H ' ' A' ' 104' ' ' GLN . 1.2 t -130.6 170.69 13.94 Favored 'General case' 0 CA--C 1.461 -2.445 0 CA-C-O 122.386 1.088 . . . . 0.0 108.319 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 104' ' ' GLN . 44.4 t0 -78.9 -174.7 4.12 Favored 'General case' 0 C--N 1.269 -2.906 1 N-CA-C 99.458 -4.275 . . . . 0.0 99.458 169.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.89 72.35 0.09 Allowed 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 113.471 -3.292 . . . . 0.0 104.78 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.684 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.5 tp-100 -140.7 -52.24 0.47 Allowed 'General case' 0 C--N 1.364 1.198 0 O-C-N 119.453 -2.029 . . . . 0.0 111.057 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 104' ' ' GLN . 2.1 t 97.38 137.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.372 1.069 . . . . 0.0 108.794 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER 157.44 95.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 178.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.591 ' NH2' HH11 ' A' ' 147' ' ' ARG . 1.4 mtt180 -39.43 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 112.524 -2.125 . . . . 0.0 110.167 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.669 ' CE2' ' O ' ' A' ' 77' ' ' PRO . 1.1 t80 -57.22 -26.18 60.27 Favored 'General case' 0 C--N 1.284 -2.245 0 O-C-N 121.02 -1.05 . . . . 0.0 108.471 -177.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -113.61 148.44 36.21 Favored 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.961 ' ND1' HD11 ' A' ' 116' ' ' ILE 0.256 45.1 p-80 -174.44 149.68 1.39 Allowed Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 118.0 -1.48 . . . . 0.0 113.349 -176.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.505 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 32.9 Cg_endo -91.09 -22.35 0.59 Allowed 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.463 2.109 . . . . 0.0 106.801 171.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.505 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 38.8 tt0 -111.44 136.62 50.34 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.02 -42.35 48.18 Favored 'General case' 0 C--N 1.289 -2.054 0 O-C-N 119.965 -1.709 . . . . 0.0 111.985 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 118' ' ' GLN . 87.7 mt-30 -70.36 -24.28 62.94 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 119.768 -1.832 . . . . 0.0 115.871 -176.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.415 HH21 ' C ' ' A' ' 139' ' ' ARG . 0.1 OUTLIER -67.47 -28.13 67.61 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 119.839 -1.788 . . . . 0.0 106.916 -178.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.961 HD11 ' ND1' ' A' ' 110' ' ' HIS . 87.9 mt -56.0 -88.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 117.453 -1.699 . . . . 0.0 109.991 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.571 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -37.02 -12.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 O-C-N 121.545 -0.722 . . . . 0.0 113.604 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.7 OUTLIER -69.64 -72.42 0.24 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 119.457 -2.202 . . . . 0.0 114.579 -174.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.426 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 19.2 Cg_exo -24.95 120.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 123.923 3.082 . . . . 0.0 113.82 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.587 ' C ' ' H ' ' A' ' 122' ' ' GLY . 0.8 OUTLIER -178.11 138.12 0.19 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 123' ' ' ASP . 85.6 mttt 50.47 4.98 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 CA-C-O 121.456 0.646 . . . . 0.0 109.389 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 120' ' ' PHE . . . -42.94 -18.75 0.05 OUTLIER Glycine 0 N--CA 1.505 3.239 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 121' ' ' LYS . 11.1 t70 71.04 -17.98 0.29 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.292 -1.122 . . . . 0.0 111.233 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.22 -14.89 61.0 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.402 ' HA ' ' HB3' ' A' ' 128' ' ' ALA . 20.2 mt -89.99 -28.48 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.637 -0.664 . . . . 0.0 111.629 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -40.04 -56.34 1.88 Allowed 'General case' 0 N--CA 1.515 2.802 0 O-C-N 120.842 -1.161 . . . . 0.0 110.137 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -74.11 -37.08 64.22 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.773 -1.205 . . . . 0.0 110.591 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -63.28 -47.31 82.88 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 128' ' ' ALA . 0.3 OUTLIER -28.85 -44.68 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 113.587 -1.642 . . . . 0.0 106.966 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 2.1 m120 -105.0 -99.94 0.32 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -128.63 120.35 3.3 Favored Glycine 0 N--CA 1.507 3.431 0 CA-C-O 122.985 1.325 . . . . 0.0 112.124 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 133' ' ' GLU . 5.9 tp10 178.49 169.47 0.83 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 113.379 -1.41 . . . . 0.0 111.728 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.511 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 22.9 mp0 -124.21 127.45 47.73 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 176.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 133' ' ' GLU . 32.1 m120 -150.71 138.51 19.88 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.245 1.021 . . . . 0.0 111.072 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 147' ' ' ARG . 8.5 p -134.44 126.3 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.473 -0.767 . . . . 0.0 109.011 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.51 169.06 18.3 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 121.724 0.773 . . . . 0.0 111.368 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.6 mt -101.17 141.91 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-O 121.716 0.77 . . . . 0.0 112.826 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -114.07 153.61 29.15 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.415 ' C ' HH21 ' A' ' 115' ' ' ARG . 68.5 mtt85 -147.73 108.11 4.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.494 -1.379 . . . . 0.0 109.901 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.487 ' H ' ' HB3' ' A' ' 143' ' ' ALA . . . -158.06 106.23 0.29 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.498 ' C ' ' H ' ' A' ' 143' ' ' ALA . 84.1 t80 38.42 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.845 -0.797 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.918 HD12 ' O ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER 70.77 -30.15 0.2 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.56 -0.713 . . . . 0.0 110.268 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 145' ' ' ALA . . . -53.49 -2.93 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.105 -1.038 . . . . 0.0 113.035 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 143' ' ' ALA . 5.3 pt20 -45.01 98.88 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 O-C-N 119.949 -1.72 . . . . 0.0 107.842 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.948 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -149.17 163.36 37.82 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.599 -1.313 . . . . 0.0 110.024 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tp -108.45 155.51 20.51 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 120.777 -1.202 . . . . 0.0 110.912 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.693 ' O ' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -136.47 155.42 50.01 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.605 -0.684 . . . . 0.0 110.174 178.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.49 151.76 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.298 0 CA-C-O 121.691 0.757 . . . . 0.0 109.924 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.425 ' N ' ' O ' ' A' ' 134' ' ' ASN . 27.7 m-85 -116.8 138.97 51.12 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.751 0.786 . . . . 0.0 110.356 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 160.33 31.25 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 0.1 OUTLIER -104.44 162.74 0.2 Allowed 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 123.537 2.825 . . . . 0.0 116.224 -178.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 47.7 mt -123.59 136.9 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 0.0 OUTLIER -117.14 157.05 26.59 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.401 1.096 . . . . 0.0 112.339 -179.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 9.3 p30 -53.98 -95.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.232 -0.917 . . . . 0.0 110.327 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.537 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 9.6 pt-20 -160.11 28.71 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.534 HD22 ' C ' ' A' ' 155' ' ' GLU . 2.3 m-80 -143.49 23.01 1.82 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.0 m80 67.1 46.83 1.45 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.153 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.77 122.43 30.55 Favored 'General case' 0 N--CA 1.522 3.173 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.71 ' N ' HE21 ' A' ' 159' ' ' GLN . 0.0 OUTLIER -58.23 118.35 5.4 Favored 'General case' 0 N--CA 1.518 2.934 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -177.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 160' ' ' ILE . 1.7 pp -141.27 22.32 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 O-C-N 120.349 -1.469 . . . . 0.0 112.124 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.04 169.42 41.75 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 101' ' ' THR . 5.5 t -136.0 138.93 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 CA-C-N 119.614 1.707 . . . . 0.0 112.502 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.447 ' CG2' HD21 ' A' ' 63' ' ' LEU . 1.9 p -119.68 113.83 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.459 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.819 ' H ' ' CG1' ' A' ' 99' ' ' VAL . . . -116.85 165.77 12.93 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.843 HD11 ' HB2' ' A' ' 60' ' ' ALA . 3.3 mt -142.92 107.99 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.03 -1.669 . . . . 0.0 106.919 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.91 114.79 4.87 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.556 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.948 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 5.1 tt -88.47 110.77 21.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.999 ' O ' ' O ' ' A' ' 169' ' ' LEU . 8.2 tm-20 -74.48 127.23 32.54 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.828 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.999 ' O ' ' O ' ' A' ' 168' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.522 3.16 0 CA-C-O 121.959 0.885 . . . . 0.0 110.283 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.657 0.742 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -68.99 -67.16 0.49 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 123.051 1.405 . . . . 0.0 111.256 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.2 mtt -50.96 -49.1 60.66 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.313 -173.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.458 ' O ' ' C ' ' A' ' 49' ' ' ARG . 12.1 t -55.25 -35.93 65.51 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 48' ' ' THR . 62.5 ttt180 -40.67 -52.7 2.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.014 -1.054 . . . . 0.0 110.996 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.47 -60.44 2.19 Favored 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -73.31 -45.8 29.13 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.481 HD12 ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -54.64 -44.69 73.42 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 120.422 2.111 . . . . 0.0 105.598 176.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.716 ' O ' HD12 ' A' ' 57' ' ' LEU . . . -53.24 -50.8 64.03 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 117.726 -1.59 . . . . 0.0 109.452 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -80.24 -55.87 4.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 119.73 -1.856 . . . . 0.0 111.656 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 51' ' ' GLY . 18.1 mtpp -63.96 -27.1 68.9 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB3' HD12 ' A' ' 52' ' ' LEU . . . -95.56 -37.59 10.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 119.787 -1.821 . . . . 0.0 108.871 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.716 HD12 ' O ' ' A' ' 53' ' ' ALA . 35.2 mt -53.93 -35.45 61.72 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.291 -1.364 . . . . 0.0 108.047 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 61' ' ' ARG . . . -80.97 -46.32 15.3 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -70.85 -26.6 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 118.665 -2.522 . . . . 0.0 106.197 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.443 ' CB ' HD11 ' A' ' 98' ' ' ILE . . . -63.07 -29.07 70.52 Favored 'General case' 0 C--N 1.27 -2.861 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.456 ' O ' ' CG ' ' A' ' 65' ' ' ASP . 4.3 ptt180 -72.65 -19.7 61.39 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 117.164 -1.814 . . . . 0.0 110.84 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 m -68.29 -47.62 67.15 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 124.116 3.144 . . . . 0.0 107.009 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.691 HD22 ' HB1' ' A' ' 84' ' ' ALA . 50.2 mt -87.53 -41.81 13.21 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.833 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.4 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -56.32 -19.04 12.63 Favored 'General case' 0 N--CA 1.508 2.475 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.456 ' CG ' ' O ' ' A' ' 61' ' ' ARG . 40.2 m-20 -85.14 -4.3 59.11 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.123 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.512 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.86 -158.05 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 119.983 -1.698 . . . . 0.0 110.239 -178.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.555 ' C ' ' H ' ' A' ' 69' ' ' ILE . 3.1 Cg_endo -104.07 -27.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 123.586 2.857 . . . . 0.0 113.399 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 16.8 pt-20 -75.43 25.09 0.11 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.555 ' H ' ' C ' ' A' ' 67' ' ' PRO . 44.0 mm -106.13 -80.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -46.3 -31.95 2.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.68 -14.37 51.93 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.506 -1.371 . . . . 0.0 110.244 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -102.69 -3.54 49.53 Favored Glycine 0 N--CA 1.504 3.186 0 N-CA-C 107.101 -2.399 . . . . 0.0 107.101 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.52 -52.76 7.25 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 100.406 -3.924 . . . . 0.0 100.406 173.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -8.83 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 113.238 -1.801 . . . . 0.0 112.619 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.71 ' O ' ' O ' ' A' ' 76' ' ' LYS . 4.0 tmtm? -124.07 40.56 3.7 Favored 'General case' 0 N--CA 1.523 3.177 0 CA-C-N 122.732 2.515 . . . . 0.0 111.036 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.791 ' HZ2' ' H ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER 35.24 157.23 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.915 0 C-N-CA 125.532 1.533 . . . . 0.0 112.516 177.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -33.29 -63.48 0.14 Allowed 'Trans proline' 0 N--CA 1.513 2.66 0 C-N-CA 123.943 3.095 . . . . 0.0 115.72 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.791 ' H ' ' HZ2' ' A' ' 76' ' ' LYS . 78.6 mt-30 -50.1 142.02 10.2 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.098 -1.441 . . . . 0.0 108.762 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 63.52 5.9 2.33 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.137 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 1.035 ' O ' ' N ' ' A' ' 82' ' ' ILE . 70.9 p -81.22 86.55 6.19 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.154 -2.217 . . . . 0.0 109.542 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.696 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -35.92 47.24 0.0 OUTLIER Glycine 1 N--CA 1.518 4.139 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.754 -177.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.035 ' N ' ' O ' ' A' ' 80' ' ' SER . 1.1 tp -68.04 28.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 122.516 1.151 . . . . 0.0 107.924 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.696 ' H ' ' C ' ' A' ' 81' ' ' GLY . 43.7 tp60 -82.91 -22.3 33.93 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.707 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -73.73 -94.25 0.02 OUTLIER 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.707 ' C ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -20.18 -55.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.157 0 CA-C-N 123.651 2.932 . . . . 0.0 111.554 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -51.9 -49.12 63.63 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 119.333 -2.104 . . . . 0.0 110.161 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.682 ' N ' ' O ' ' A' ' 84' ' ' ALA . 66.1 tt0 -55.96 -54.55 43.42 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 116.624 -1.655 . . . . 0.0 114.393 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -77.79 -42.75 32.84 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 124.699 3.409 . . . . 0.0 108.236 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 88' ' ' ALA . 64.7 t -51.65 -71.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 115.115 -2.634 . . . . 0.0 107.592 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.677 ' O ' ' N ' ' A' ' 93' ' ' ASN . 4.3 ppt_? -40.26 -34.13 0.3 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.959 -1.088 . . . . 0.0 110.608 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.549 ' C ' ' O ' ' A' ' 90' ' ' ARG . 29.0 ttmt -39.38 -28.97 0.04 OUTLIER 'General case' 0 N--CA 1.536 3.827 0 C-N-CA 116.758 -1.977 . . . . 0.0 106.092 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 90' ' ' ARG . 10.6 ttm105 -36.49 -59.56 0.65 Allowed 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 166.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.677 ' N ' ' O ' ' A' ' 90' ' ' ARG . 0.4 OUTLIER -153.33 -56.38 0.12 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.397 -1.439 . . . . 0.0 110.192 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 1.1 m-20 164.02 1.38 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.864 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -135.57 160.69 37.71 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 117.729 -1.588 . . . . 0.0 113.975 -175.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 96' ' ' LEU . 2.8 pp 151.43 175.92 0.0 OUTLIER 'General case' 0 N--CA 1.534 3.738 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.426 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -139.66 86.58 2.12 Favored 'General case' 0 C--O 1.218 -0.603 1 N-CA-C 98.87 -4.493 . . . . 0.0 98.87 169.245 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.758 HD12 HG23 ' A' ' 165' ' ' ILE . 19.7 tt -101.61 134.72 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 123.396 1.569 . . . . 0.0 108.212 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.792 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 1.1 p -136.41 149.53 27.18 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -173.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.473 ' H ' ' CD1' ' A' ' 82' ' ' ILE . 4.2 p -111.28 131.35 62.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 1 N-CA-C 98.444 -4.65 . . . . 0.0 98.444 169.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.672 ' CG2' ' H ' ' A' ' 105' ' ' SER . 1.5 m -124.46 152.27 43.54 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 120.564 -1.335 . . . . 0.0 111.442 -175.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.612 ' O ' HG22 ' A' ' 101' ' ' THR . 24.5 t70 -87.2 -176.85 5.83 Favored 'General case' 0 C--N 1.284 -2.278 1 N-CA-C 98.033 -4.802 . . . . 0.0 98.033 169.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 103' ' ' MET . 1.8 ttt -77.67 73.53 4.23 Favored 'General case' 0 C--N 1.269 -2.9 0 C-N-CA 114.483 -2.887 . . . . 0.0 107.069 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' A' ' 105' ' ' SER . 9.0 tm0? -141.75 -41.51 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 119.595 -1.941 . . . . 0.0 110.483 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.672 ' H ' ' CG2' ' A' ' 101' ' ' THR . 10.5 t 84.88 136.96 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.747 0.819 . . . . 0.0 109.48 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.8 OUTLIER 156.81 134.86 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.618 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 177.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.465 ' HE ' ' HB2' ' A' ' 97' ' ' PHE . 9.6 mmm180 -71.9 100.87 2.52 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.628 ' C ' HG21 ' A' ' 82' ' ' ILE . 2.5 m-85 -54.4 -30.24 51.55 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.44 ' C ' ' ND1' ' A' ' 110' ' ' HIS . 12.0 t -101.17 144.78 29.63 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.44 ' ND1' ' C ' ' A' ' 109' ' ' SER . 1.5 m-70 -124.89 107.83 28.41 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -174.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.659 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 65.2 Cg_endo -85.81 -35.63 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 N-CA-C 103.882 -3.161 . . . . 0.0 103.882 172.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.659 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 13.5 mp0 -140.37 138.31 34.72 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 174.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.81 -48.18 64.21 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 118.303 2.705 . . . . 0.0 118.303 -172.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.535 ' H ' ' CD ' ' A' ' 114' ' ' GLN . 1.4 mp0 -66.2 -32.52 74.01 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.78 HH21 ' H ' ' A' ' 139' ' ' ARG . 19.3 tpt85 -61.54 -33.68 74.25 Favored 'General case' 0 C--O 1.201 -1.457 0 CA-C-N 122.358 2.345 . . . . 0.0 106.633 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.701 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.2 OUTLIER -53.17 -86.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.135 177.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.603 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -33.04 -11.63 0.0 OUTLIER Glycine 0 N--CA 1.499 2.866 0 C-N-CA 123.462 0.553 . . . . 0.0 113.748 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.701 ' N ' ' O ' ' A' ' 116' ' ' ILE . 1.3 mt-30 -79.33 -72.75 0.12 Allowed Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 120.017 1.909 . . . . 0.0 113.728 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 115' ' ' ARG . 6.6 Cg_exo -26.55 108.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 123.969 3.113 . . . . 0.0 114.939 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.555 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 48.5 t80 174.86 28.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -174.93 -12.64 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.091 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.76 -21.51 2.29 Favored Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.6 t0 69.64 0.6 3.04 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 121.043 -1.269 . . . . 0.0 112.142 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.534 ' OD2' ' CE2' ' A' ' 149' ' ' PHE . 2.9 p-10 -82.45 -21.18 35.76 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.552 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 20.2 mt -79.42 -21.78 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.528 -0.733 . . . . 0.0 110.199 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -49.39 -37.09 23.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.577 -1.327 . . . . 0.0 108.418 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.631 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 59.0 mttp -74.32 -34.87 63.59 Favored 'General case' 0 C--O 1.194 -1.859 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.541 ' O ' ' ND2' ' A' ' 130' ' ' ASN . . . -89.43 -30.74 18.12 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 120.023 -1.673 . . . . 0.0 110.539 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.29 -26.35 1.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.858 -1.151 . . . . 0.0 109.705 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.861 ' ND2' ' N ' ' A' ' 131' ' ' GLY 0.278 0.0 OUTLIER -77.12 -92.49 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 108.904 179.408 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.861 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -164.66 42.8 0.3 Allowed Glycine 0 CA--C 1.565 3.166 0 C-N-CA 125.536 1.541 . . . . 0.0 110.106 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.517 ' H ' HD21 ' A' ' 130' ' ' ASN . 76.6 tt0 -145.06 164.72 30.35 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 120.316 2.058 . . . . 0.0 111.646 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -64.21 164.32 11.18 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 28.4 t-20 -170.97 138.16 1.27 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.298 -0.876 . . . . 0.0 109.267 176.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.638 HG22 HG12 ' A' ' 148' ' ' VAL . 1.3 t -130.83 138.43 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.315 -1.491 . . . . 0.0 108.776 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -151.51 167.6 27.54 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.644 -1.285 . . . . 0.0 110.213 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 mt -102.32 135.56 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.398 -0.814 . . . . 0.0 109.801 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.452 ' OD1' ' CZ ' ' A' ' 147' ' ' ARG . 0.9 OUTLIER -106.84 152.62 23.64 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.78 ' H ' HH21 ' A' ' 115' ' ' ARG . 3.5 ptm85 -159.68 97.94 1.34 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.734 ' H ' ' HB3' ' A' ' 143' ' ' ALA . . . -150.61 109.04 0.41 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.07 -1.538 . . . . 0.0 109.92 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 9.3 t80 59.1 -67.47 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 122.034 -0.686 . . . . 0.0 110.14 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 143' ' ' ALA . 0.7 OUTLIER -131.44 6.69 4.47 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.249 -0.907 . . . . 0.0 110.083 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.734 ' HB3' ' H ' ' A' ' 140' ' ' GLY . . . -81.13 5.36 17.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 113.775 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -48.78 91.24 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.217 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 1.029 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -169.03 173.06 7.11 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.301 -170.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 tp -115.01 159.19 21.08 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.461 -1.399 . . . . 0.0 110.89 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.452 ' CZ ' ' OD1' ' A' ' 138' ' ' ASN . 0.8 OUTLIER -143.89 152.33 40.99 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.142 0.972 . . . . 0.0 110.896 178.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.638 HG12 HG22 ' A' ' 135' ' ' VAL . 15.5 m -119.41 138.22 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.925 0 CA-C-O 122.119 0.961 . . . . 0.0 109.985 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.534 ' CE2' ' OD2' ' A' ' 124' ' ' ASP . 70.6 m-85 -111.63 145.73 38.68 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.646 0.736 . . . . 0.0 109.686 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.449 HG21 ' CD2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -142.02 156.56 65.07 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -96.54 154.88 1.25 Allowed 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 123.996 3.131 . . . . 0.0 114.195 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 72.6 mt -117.97 136.33 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -107.73 149.16 28.49 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.827 ' O ' ' ND2' ' A' ' 156' ' ' ASN . 24.8 t0 -76.19 57.1 1.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 42.33 21.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 123.641 0.777 . . . . 0.0 112.463 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.827 ' ND2' ' O ' ' A' ' 154' ' ' ASP . 42.3 m-80 -140.28 35.42 1.89 Allowed 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.495 -1.378 . . . . 0.0 109.717 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 61.84 -2.92 0.25 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.571 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.8 mptt -80.45 122.05 26.5 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.924 ' O ' HG23 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -58.2 -154.65 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.058 0 O-C-N 120.861 -1.149 . . . . 0.0 111.136 -177.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.924 HG23 ' O ' ' A' ' 159' ' ' GLN . 2.7 pp 151.9 -6.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 CA-C-N 120.175 1.352 . . . . 0.0 112.883 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -172.24 179.86 43.57 Favored Glycine 0 N--CA 1.507 3.407 0 C-N-CA 115.981 -3.009 . . . . 0.0 111.583 -175.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -139.6 139.22 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -1.225 . . . . 0.0 112.042 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.4 t -108.09 127.31 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.792 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -115.99 144.23 44.37 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.758 HG23 HD12 ' A' ' 98' ' ' ILE . 6.2 mt -137.76 99.52 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.25 129.59 9.13 Favored Glycine 0 N--CA 1.485 1.947 0 CA-C-O 123.328 1.515 . . . . 0.0 112.762 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 1.029 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -88.62 115.31 26.05 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 113.475 -1.363 . . . . 0.0 107.925 177.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.883 ' O ' ' O ' ' A' ' 169' ' ' LEU . 0.7 OUTLIER -74.95 132.25 41.28 Favored 'General case' 0 N--CA 1.529 3.491 0 O-C-N 124.084 0.865 . . . . 0.0 110.237 -179.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.883 ' O ' ' O ' ' A' ' 168' ' ' GLU . 1.5 pp . . . . . 0 N--CA 1.519 3.017 0 O-C-N 120.566 -1.334 . . . . 0.0 113.487 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.544 ' CG ' ' H ' ' A' ' 47' ' ' MET . 17.4 p-10 -66.29 -64.73 0.79 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.885 1.326 . . . . 0.0 110.786 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.544 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 16.3 mmm -43.54 -58.61 2.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.193 0.997 . . . . 0.0 111.443 -173.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' ARG . 6.4 t -53.18 -35.97 60.42 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 36.8 ttp180 -42.02 -51.05 4.59 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.805 -1.184 . . . . 0.0 111.841 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -80.77 -58.06 3.27 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -79.59 -45.3 8.7 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.541 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -54.96 -46.3 75.01 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 120.533 2.167 . . . . 0.0 105.525 176.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 49' ' ' ARG . . . -46.9 -57.98 4.4 Favored 'General case' 0 C--O 1.205 -1.275 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.345 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -81.87 -68.42 0.7 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.64 -1.288 . . . . 0.0 113.989 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 51' ' ' GLY . 57.4 mtpt -47.46 -27.53 1.77 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.094 -1.004 . . . . 0.0 111.647 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 52' ' ' LEU . . . -93.46 -32.3 14.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.053 -1.654 . . . . 0.0 108.782 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.3 tp -55.22 -40.21 70.56 Favored 'General case' 0 C--N 1.284 -2.239 0 O-C-N 121.035 -1.041 . . . . 0.0 109.309 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.617 ' O ' ' CG ' ' A' ' 61' ' ' ARG . . . -80.42 -47.49 14.3 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -177.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.664 ' HB ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -66.89 -32.95 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 117.616 -3.177 . . . . 0.0 104.618 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.599 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -58.84 -26.53 64.28 Favored 'General case' 0 C--N 1.265 -3.104 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.617 ' CG ' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -49.79 -24.45 2.39 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 116.665 -2.014 . . . . 0.0 105.882 174.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.519 HG22 HG22 ' A' ' 85' ' ' ILE . 96.9 m -74.03 -39.76 63.34 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.826 ' O ' HD12 ' A' ' 85' ' ' ILE 0.276 0.3 OUTLIER -48.2 -42.19 29.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 124.761 2.22 . . . . 0.0 107.921 175.58 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.66 -4.7 59.21 Favored 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 112.553 -2.112 . . . . 0.0 113.081 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 66' ' ' SER . 34.5 t0 -99.02 -27.46 13.84 Favored 'General case' 0 N--CA 1.517 2.921 0 CA-C-N 123.713 2.961 . . . . 0.0 115.618 -172.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.577 ' HB2' HD13 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -60.12 -161.47 0.0 OUTLIER Pre-proline 0 C--N 1.278 -2.525 0 O-C-N 119.668 -1.895 . . . . 0.0 109.928 -178.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.725 ' HD2' ' H ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -114.52 -25.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 124.399 3.399 . . . . 0.0 113.584 176.032 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.725 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 16.4 pt-20 -56.75 -30.45 63.59 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 117.829 -1.548 . . . . 0.0 107.52 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.5 mt -45.25 -83.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.062 -178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -47.33 -39.03 13.95 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.978 0.894 . . . . 0.0 109.914 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -78.04 -13.0 60.03 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.931 -1.105 . . . . 0.0 111.08 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . -97.52 -1.38 59.06 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 105.046 -3.222 . . . . 0.0 105.046 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.571 ' O ' ' OD2' ' A' ' 102' ' ' ASP . 1.4 mp -89.61 -23.22 21.99 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 173.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -62.83 -0.72 0.71 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.642 ' CG ' ' H ' ' A' ' 76' ' ' LYS . 3.5 tptm -136.37 -140.81 0.16 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.204 -1.56 . . . . 0.0 107.175 174.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.642 ' H ' ' CG ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -129.12 156.14 78.69 Favored Pre-proline 0 CA--C 1.578 2.041 0 O-C-N 121.481 -0.762 . . . . 0.0 109.625 179.381 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' O ' ' CE2' ' A' ' 108' ' ' TYR . 0.9 OUTLIER -31.56 -10.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.528 3.546 1 C-N-CA 126.236 4.624 . . . . 0.0 118.946 -179.082 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' LYS . 44.0 tp60 -96.33 -14.08 22.83 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 119.798 -1.814 . . . . 0.0 109.622 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -116.11 0.74 13.05 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.232 -0.918 . . . . 0.0 112.472 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.694 ' N ' ' OH ' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -76.36 -155.4 0.06 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 119.234 -2.166 . . . . 0.0 107.703 178.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.97 17.25 0.22 Allowed Glycine 0 N--CA 1.496 2.676 0 O-C-N 120.523 -1.36 . . . . 0.0 109.727 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.624 HD12 ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -48.39 -24.37 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-O 121.898 0.856 . . . . 0.0 110.385 -179.12 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 7.3 tt0 -53.34 -7.74 0.1 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 82' ' ' ILE . . . -94.49 -52.81 4.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.002 -1.061 . . . . 0.0 112.689 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.826 HD12 ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -74.82 -34.2 32.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 177.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -57.97 -46.27 85.41 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 1.2 tt0 -49.67 -21.54 1.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.053 -1.43 . . . . 0.0 107.948 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.94 66.76 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 114.831 -2.748 . . . . 0.0 104.093 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.664 HG22 ' HB ' ' A' ' 59' ' ' VAL . 37.7 t -54.62 -72.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 C-N-CA 116.776 -1.97 . . . . 0.0 110.185 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 93' ' ' ASN . 1.5 ttt-85 -48.13 -69.61 0.12 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 124.499 1.119 . . . . 0.0 113.118 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 90' ' ' ARG . 37.9 pttt -35.61 -36.87 0.08 Allowed 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.953 -1.092 . . . . 0.0 109.187 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 90' ' ' ARG . 62.3 mtm-85 -86.51 -21.88 26.71 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.723 -1.236 . . . . 0.0 111.585 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.644 ' N ' ' O ' ' A' ' 90' ' ' ARG . 54.7 t-20 -97.9 -16.42 19.75 Favored 'General case' 0 N--CA 1.511 2.582 0 CA-C-N 120.979 1.718 . . . . 0.0 108.374 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.0 t70 73.28 24.7 2.34 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.886 0.875 . . . . 0.0 110.835 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 0.4 OUTLIER 173.27 153.71 0.09 Allowed 'General case' 0 N--CA 1.514 2.755 0 CA-C-N 121.726 2.057 . . . . 0.0 107.796 176.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.636 HD13 HG12 ' A' ' 89' ' ' VAL . 0.3 OUTLIER 156.17 164.69 0.01 OUTLIER 'General case' 1 N--CA 1.542 4.133 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.2 179.828 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.566 ' CD1' ' NE ' ' A' ' 107' ' ' ARG . 0.9 OUTLIER -143.52 89.21 2.06 Favored 'General case' 0 C--O 1.214 -0.816 1 N-CA-C 99.119 -4.4 . . . . 0.0 99.119 168.552 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.629 ' N ' ' OG ' ' A' ' 109' ' ' SER . 0.4 OUTLIER -93.19 129.09 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -175.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 164' ' ' ALA . 1.1 m -119.08 130.54 73.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -173.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.624 ' HB ' HD12 ' A' ' 82' ' ' ILE . 0.9 OUTLIER -123.64 124.47 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 1 N-CA-C 97.166 -5.124 . . . . 0.0 97.166 169.217 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.649 HG21 ' HA ' ' A' ' 105' ' ' SER . 11.5 p -136.09 164.2 28.57 Favored 'General case' 0 C--N 1.281 -2.372 0 O-C-N 120.61 -1.306 . . . . 0.0 108.416 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.707 ' O ' ' N ' ' A' ' 104' ' ' GLN . 1.7 m-20 -78.86 -175.13 4.32 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 100.873 -3.751 . . . . 0.0 100.873 170.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.514 ' CG ' ' O ' ' A' ' 103' ' ' MET . 1.6 ttt -68.28 69.82 0.15 Allowed 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 114.843 -2.743 . . . . 0.0 103.963 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.707 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -137.16 -50.37 0.64 Allowed 'General case' 0 C--N 1.358 0.965 0 O-C-N 120.488 -1.382 . . . . 0.0 108.408 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.649 ' HA ' HG21 ' A' ' 101' ' ' THR . 1.5 t 92.74 138.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.9 OUTLIER 157.04 139.34 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 102.092 -3.299 . . . . 0.0 102.092 178.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.74 ' NH2' HH11 ' A' ' 147' ' ' ARG . 39.4 mtt180 -86.19 96.65 9.99 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.791 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.694 ' OH ' ' N ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -55.95 -19.94 14.26 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 123.81 1.767 . . . . 0.0 107.282 -176.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.629 ' OG ' ' N ' ' A' ' 98' ' ' ILE . 25.6 p -113.36 146.02 40.15 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.534 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.552 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 13.3 p80 -155.53 137.25 9.64 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -174.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.622 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 40.5 Cg_endo -88.57 -32.25 0.15 Allowed 'Trans proline' 0 N--CA 1.482 0.815 0 N-CA-C 104.666 -2.859 . . . . 0.0 104.666 171.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.622 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 34.9 tp10 -127.35 124.83 39.57 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.24 81.83 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -68.28 -28.97 67.65 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 119.882 -1.762 . . . . 0.0 115.629 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.548 ' CD ' ' CE2' ' A' ' 97' ' ' PHE . 11.7 ttt85 -55.26 -29.04 57.33 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 119.103 -2.248 . . . . 0.0 105.544 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.751 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.2 OUTLIER -63.92 -87.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.214 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.437 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -32.55 -13.41 0.0 OUTLIER Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.419 -0.801 . . . . 0.0 112.949 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.751 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.9 mt-30 -71.5 -72.64 0.21 Allowed Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 119.632 -2.099 . . . . 0.0 110.892 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.512 ' O ' ' CB ' ' A' ' 120' ' ' PHE . 96.0 Cg_exo -19.04 142.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 124.309 3.339 . . . . 0.0 113.878 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.592 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 67.1 t80 140.89 21.64 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.441 ' C ' ' N ' ' A' ' 123' ' ' ASP . 23.7 ttmt -177.29 -2.8 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 O-C-N 121.434 -0.792 . . . . 0.0 110.196 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.6 -20.59 2.75 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.441 ' N ' ' C ' ' A' ' 121' ' ' LYS . 10.0 t70 72.6 -5.27 1.88 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -75.97 -21.1 57.33 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 119.756 -1.84 . . . . 0.0 108.861 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.469 ' HB ' HG21 ' A' ' 162' ' ' VAL . 14.7 pt -74.39 -23.67 18.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.02 -1.05 . . . . 0.0 109.947 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.76 -25.92 8.51 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -86.52 -39.14 16.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.671 -0.643 . . . . 0.0 111.594 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 150' ' ' THR . . . -79.73 -46.85 16.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 119.898 -1.752 . . . . 0.0 107.246 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.683 ' C ' HD22 ' A' ' 130' ' ' ASN . 0.1 OUTLIER -38.41 -41.93 0.69 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.683 HD22 ' C ' ' A' ' 129' ' ' LEU . 2.3 m120 -100.46 12.81 36.43 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.315 -1.311 . . . . 0.0 114.203 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.36 98.41 0.56 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 170.85 157.76 0.07 Allowed 'General case' 0 N--CA 1.514 2.746 0 CA-C-O 122.596 1.189 . . . . 0.0 111.399 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -101.53 144.74 29.92 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.303 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -159.75 144.34 15.01 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.824 -1.172 . . . . 0.0 109.693 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 147' ' ' ARG . 5.0 p -138.43 132.91 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 120.701 -1.249 . . . . 0.0 109.974 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -148.88 169.17 21.15 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.433 0.635 . . . . 0.0 110.452 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.444 HG22 ' OE1' ' A' ' 144' ' ' GLN . 0.8 OUTLIER -97.42 139.22 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-O 121.361 0.6 . . . . 0.0 111.5 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.536 ' CG ' HH22 ' A' ' 107' ' ' ARG . 28.1 t-20 -117.23 150.3 38.99 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.249 -0.907 . . . . 0.0 110.745 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -153.5 113.61 3.94 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 141' ' ' PHE . . . -150.28 112.61 0.55 Allowed Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.249 -1.453 . . . . 0.0 110.305 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 141' ' ' PHE . 54.5 t80 39.01 32.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.904 -0.762 . . . . 0.0 110.122 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.451 HD23 HH11 ' A' ' 115' ' ' ARG . 32.0 tp -152.98 -94.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.89 . . . . 0.0 110.736 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -172.55 154.27 3.06 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.535 -1.353 . . . . 0.0 112.029 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.444 ' OE1' HG22 ' A' ' 137' ' ' ILE . 36.0 mm-40 -52.49 144.59 13.12 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.673 1.225 . . . . 0.0 111.747 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.922 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -162.1 158.03 24.2 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -177.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 tp -108.97 159.52 16.76 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-N 121.351 1.887 . . . . 0.0 109.683 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.759 ' O ' HG23 ' A' ' 135' ' ' VAL . 11.3 ptt180 -152.3 149.04 28.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.725 -1.234 . . . . 0.0 110.768 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.25 157.47 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-O 122.291 1.043 . . . . 0.0 109.673 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 164' ' ' ALA . 26.1 m-85 -124.92 135.96 53.32 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.844 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.557 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -142.63 161.16 50.93 Favored Pre-proline 0 C--N 1.31 -1.127 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -108.16 163.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 123.459 2.773 . . . . 0.0 116.027 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.519 ' CG1' HG23 ' A' ' 163' ' ' VAL . 48.9 mt -118.62 125.86 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -104.75 155.44 18.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 123.195 1.474 . . . . 0.0 110.666 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -53.08 -85.54 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -170.35 35.59 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -148.18 20.3 1.09 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 64.85 42.54 4.39 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 153' ' ' TYR . 0.6 OUTLIER -122.68 118.46 28.15 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.723 ' N ' HE21 ' A' ' 159' ' ' GLN . 0.0 OUTLIER -63.83 121.41 13.96 Favored 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -176.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.1 pp -140.31 13.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 120.536 -1.353 . . . . 0.0 113.749 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.48 178.93 40.73 Favored Glycine 1 N--CA 1.522 4.379 0 C-N-CA 118.816 -1.659 . . . . 0.0 112.361 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.544 HG23 HD22 ' A' ' 129' ' ' LEU . 16.8 t -123.3 134.02 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.26 0 CA-C-N 119.013 1.406 . . . . 0.0 112.593 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 152' ' ' ILE . 2.7 t -123.9 107.19 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.687 ' HB3' HG22 ' A' ' 99' ' ' VAL . . . -112.44 158.21 20.14 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.6 HG23 ' CG1' ' A' ' 98' ' ' ILE . 4.2 mt -143.33 101.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 97' ' ' PHE . . . -115.05 127.56 7.71 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.403 -1.38 . . . . 0.0 113.11 -175.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.922 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 13.4 tp -93.71 124.82 37.97 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.662 -1.269 . . . . 0.0 109.306 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.416 ' OE1' ' NH1' ' A' ' 115' ' ' ARG . 12.7 tp10 -73.79 134.38 43.39 Favored 'General case' 0 N--CA 1.521 3.086 0 C-N-CA 122.949 0.5 . . . . 0.0 109.942 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.489 ' H ' ' HB2' ' A' ' 145' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.502 2.14 0 O-C-N 119.327 -2.108 . . . . 0.0 109.167 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.421 ' O ' HG22 ' A' ' 48' ' ' THR . 50.6 p . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 49' ' ' ARG . 40.7 t0 -63.76 -64.56 0.86 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 123.871 1.796 . . . . 0.0 108.817 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.416 ' C ' ' O ' ' A' ' 46' ' ' ASP . 6.6 tmm? -32.12 -60.08 0.28 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 123.331 1.538 . . . . 0.0 111.116 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 52' ' ' LEU . 13.9 t -59.56 -32.62 70.51 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.448 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 46' ' ' ASP . 32.3 ttp85 -37.86 -51.98 1.31 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.699 -1.251 . . . . 0.0 111.81 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -84.49 -56.44 3.62 Favored 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -77.43 -43.36 15.9 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -176.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.635 HD11 HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -54.63 -45.82 73.81 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 120.352 2.076 . . . . 0.0 106.344 176.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.426 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . -48.32 -57.23 6.31 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.625 -1.23 . . . . 0.0 108.999 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -78.35 -55.77 4.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.435 -1.416 . . . . 0.0 113.402 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -67.86 -21.95 65.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.862 . . . . 0.0 111.874 -175.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.676 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -97.68 -35.35 10.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 120.784 1.629 . . . . 0.0 110.572 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.4 tt -65.03 -35.8 82.35 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.291 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.63 -45.38 21.66 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -72.64 -34.41 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 118.649 -2.532 . . . . 0.0 105.882 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.447 ' N ' HG13 ' A' ' 89' ' ' VAL . . . -60.84 -31.81 71.22 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.631 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 2.0 ptt180 -70.02 -16.64 63.19 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.614 -1.234 . . . . 0.0 110.318 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 m -63.58 -46.03 87.74 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 123.056 2.662 . . . . 0.0 105.734 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.724 HD22 ' HB1' ' A' ' 84' ' ' ALA . 54.1 mt -88.79 -37.6 15.3 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.897 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.631 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -58.86 -19.95 46.44 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 119.152 -2.218 . . . . 0.0 105.715 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 31.5 t70 -84.39 -4.33 58.84 Favored 'General case' 0 C--N 1.274 -2.717 0 O-C-N 121.367 -0.833 . . . . 0.0 110.517 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.516 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -74.84 -155.9 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 120.36 -1.462 . . . . 0.0 111.178 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -108.04 -20.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.316 2.677 . . . . 0.0 114.336 178.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.9 pt-20 -62.1 -36.34 81.44 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.621 -1.631 . . . . 0.0 106.938 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.762 ' CG2' HG21 ' A' ' 100' ' ' VAL . 7.9 mm -47.06 -88.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.828 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' H ' ' HB ' ' A' ' 69' ' ' ILE . 73.8 ttt180 -45.35 -31.25 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -78.51 -17.81 55.69 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.732 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.772 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -83.26 -40.84 8.86 Favored Glycine 0 N--CA 1.507 3.375 1 N-CA-C 102.453 -4.259 . . . . 0.0 102.453 178.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.466 HD11 HG22 ' A' ' 100' ' ' VAL . 5.7 mp -48.13 -35.64 11.9 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -78.59 5.57 10.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.779 ' O ' ' O ' ' A' ' 76' ' ' LYS . 31.4 mmtm -139.22 34.82 2.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.835 -1.165 . . . . 0.0 111.66 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.779 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 24.96 153.83 0.0 OUTLIER Pre-proline 0 N--CA 1.527 3.412 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 76' ' ' LYS . 5.7 Cg_exo -22.42 -62.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 124.411 3.407 . . . . 0.0 114.683 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -55.22 139.37 42.46 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 117.326 -1.75 . . . . 0.0 107.777 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 61.58 13.89 5.54 Favored 'General case' 0 C--N 1.282 -2.341 0 C-N-CA 119.353 -0.939 . . . . 0.0 113.336 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.641 ' O ' ' N ' ' A' ' 82' ' ' ILE . 22.4 m -88.88 82.09 6.81 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 120.247 -1.533 . . . . 0.0 109.636 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 83' ' ' GLN . . . -43.98 10.42 0.0 OUTLIER Glycine 0 CA--C 1.577 3.918 0 CA-C-O 117.594 -1.67 . . . . 0.0 115.768 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.403 HG21 ' CG1' ' A' ' 100' ' ' VAL . 0.3 OUTLIER -49.06 -12.18 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 123.983 3.892 . . . . 0.0 110.849 -178.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.831 ' N ' HD12 ' A' ' 82' ' ' ILE . 1.1 tm0? -36.78 -19.47 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.724 ' HB1' HD22 ' A' ' 63' ' ' LEU . . . -63.87 -86.72 0.01 OUTLIER 'General case' 0 C--O 1.191 -1.995 1 N-CA-C 98.675 -4.565 . . . . 0.0 98.675 171.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.719 HD13 HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -16.96 -56.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.531 3.597 0 CA-C-N 124.009 3.095 . . . . 0.0 109.336 177.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -53.1 -58.36 7.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.008 -1.682 . . . . 0.0 109.611 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 84' ' ' ALA . 56.0 tt0 -43.67 -56.65 3.62 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 117.156 -1.402 . . . . 0.0 111.563 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -65.15 -59.26 4.29 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 124.318 3.235 . . . . 0.0 109.182 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -48.26 -59.57 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 C-N-CA 114.686 -2.805 . . . . 0.0 111.313 -175.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.829 ' O ' ' N ' ' A' ' 93' ' ' ASN . 24.6 ptt180 -52.14 -39.19 59.6 Favored 'General case' 0 C--O 1.193 -1.887 0 CA-C-N 120.567 1.53 . . . . 0.0 111.045 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.599 ' C ' ' O ' ' A' ' 90' ' ' ARG . 16.3 tttm -34.11 -44.75 0.19 Allowed 'General case' 0 N--CA 1.536 3.839 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 91' ' ' LYS . 16.0 mmm180 -35.63 -53.32 0.7 Allowed 'General case' 0 N--CA 1.516 2.873 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.829 ' N ' ' O ' ' A' ' 90' ' ' ARG . 74.6 m-80 -140.37 -66.65 0.44 Allowed 'General case' 0 N--CA 1.514 2.745 0 CA-C-N 121.737 2.062 . . . . 0.0 111.261 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 2.1 m-20 159.71 -7.85 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.054 0 CA-C-O 121.572 0.701 . . . . 0.0 109.732 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.76 155.82 22.91 Favored 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.919 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER 157.49 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.53 3.559 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.669 -178.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.86 83.14 1.94 Allowed 'General case' 0 C--O 1.215 -0.75 1 N-CA-C 98.532 -4.618 . . . . 0.0 98.532 169.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.58 HD12 HG23 ' A' ' 165' ' ' ILE . 16.6 tt -104.69 155.66 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 123.633 1.683 . . . . 0.0 109.461 -175.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.647 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -151.15 139.28 14.3 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 CA-C-N 112.399 -2.182 . . . . 0.0 113.149 -171.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 1.403 ' CG1' HG21 ' A' ' 82' ' ' ILE . 7.3 p -105.53 130.95 56.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 1 N-CA-C 94.246 -6.205 . . . . 0.0 94.246 169.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 102' ' ' ASP . 1.6 m -121.6 151.91 39.86 Favored 'General case' 0 N--CA 1.508 2.471 0 CA-C-N 121.573 1.988 . . . . 0.0 111.607 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.677 ' O ' HG22 ' A' ' 101' ' ' THR . 37.4 t70 -96.16 -163.07 1.01 Allowed 'General case' 0 C--N 1.29 -1.989 1 N-CA-C 98.507 -4.627 . . . . 0.0 98.507 167.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.674 ' SD ' HD21 ' A' ' 129' ' ' LEU . 4.2 tpt -89.41 77.72 7.29 Favored 'General case' 0 C--N 1.268 -2.975 0 C-N-CA 116.074 -2.25 . . . . 0.0 109.852 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 105' ' ' SER . 64.3 tp60 -150.97 -30.4 0.18 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 119.193 -2.192 . . . . 0.0 109.046 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.634 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 26.7 t 60.95 138.13 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 105' ' ' SER . 1.1 tp 153.51 140.43 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 139.69 58.8 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.477 ' HB3' HG13 ' A' ' 82' ' ' ILE . 3.4 m-30 -97.68 -1.18 44.13 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 t -129.03 146.84 50.9 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.606 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.527 ' H ' ' CD2' ' A' ' 110' ' ' HIS . 0.4 OUTLIER -142.3 105.0 5.55 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -172.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.556 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 27.7 Cg_endo -93.11 -46.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 N-CA-C 106.11 -2.304 . . . . 0.0 106.11 172.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.556 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 2.5 tm-20 -108.54 130.01 55.29 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 175.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.67 -58.59 7.89 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.409 ' N ' ' OE2' ' A' ' 112' ' ' GLU . 99.0 mm-40 -71.62 -29.64 64.89 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -174.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -58.92 -31.02 68.27 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 123.632 2.924 . . . . 0.0 106.437 -178.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.818 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.7 OUTLIER -54.04 -89.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.219 178.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.688 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -27.58 -8.61 0.0 OUTLIER Glycine 0 N--CA 1.493 2.436 0 C-N-CA 123.961 0.791 . . . . 0.0 114.647 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.818 ' N ' ' O ' ' A' ' 116' ' ' ILE . 3.6 mt-30 -76.56 -70.59 0.21 Allowed Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 118.954 -2.497 . . . . 0.0 114.034 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.432 ' C ' ' O ' ' A' ' 118' ' ' GLN . 51.9 Cg_exo -19.12 95.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 124.289 3.326 . . . . 0.0 115.536 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.492 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 0.0 OUTLIER 175.0 11.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 123' ' ' ASP . 74.4 tttt -164.56 -27.44 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.1 -1.0 . . . . 0.0 109.471 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -41.6 -13.75 0.01 OUTLIER Glycine 1 N--CA 1.516 4.009 0 O-C-N 121.303 -0.873 . . . . 0.0 111.908 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 121' ' ' LYS . 39.1 m-20 65.01 43.65 3.7 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 118.712 1.256 . . . . 0.0 112.382 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -128.42 -26.98 2.7 Favored 'General case' 0 N--CA 1.518 2.931 0 C-N-CA 117.456 -1.697 . . . . 0.0 109.832 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.59 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 12.1 mt -80.02 -16.04 12.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 O-C-N 120.729 -1.232 . . . . 0.0 110.556 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -53.47 -44.21 68.77 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.432 -1.417 . . . . 0.0 110.276 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.543 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 59.3 mttm -73.54 -31.4 63.64 Favored 'General case' 0 C--O 1.193 -1.915 0 O-C-N 121.284 -0.885 . . . . 0.0 109.569 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.554 ' O ' ' ND2' ' A' ' 130' ' ' ASN . . . -83.07 -20.6 34.63 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.37 -1.456 . . . . 0.0 109.189 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.674 HD21 ' SD ' ' A' ' 103' ' ' MET . 0.6 OUTLIER -55.03 -18.7 5.58 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.565 -0.709 . . . . 0.0 109.291 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.753 ' ND2' ' N ' ' A' ' 131' ' ' GLY 0.348 0.0 OUTLIER -79.28 -105.87 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.341 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.753 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -156.22 41.85 0.56 Allowed Glycine 0 CA--C 1.563 3.067 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.635 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 68.5 tt0 -146.47 161.17 41.0 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 119.409 -2.23 . . . . 0.0 110.891 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 133' ' ' GLU . 6.8 mp0 -73.8 165.15 25.63 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 122.091 0.948 . . . . 0.0 112.706 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 53.7 t30 -166.03 150.93 8.33 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.658 ' CG2' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -134.38 131.18 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 O-C-N 119.661 -1.9 . . . . 0.0 110.473 -177.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.28 160.85 39.73 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.159 -0.963 . . . . 0.0 111.5 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.2 mt -102.39 142.45 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-O 121.835 0.826 . . . . 0.0 112.118 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.439 ' CG ' ' N ' ' A' ' 139' ' ' ARG . 4.1 t-20 -119.11 161.62 19.99 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 138' ' ' ASN . 2.6 ptm180 -164.27 109.05 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.405 -0.918 . . . . 0.0 108.57 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -162.76 114.61 0.61 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.722 -1.704 . . . . 0.0 110.56 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 3.4 t80 60.01 -73.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.572 -0.958 . . . . 0.0 109.444 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.134 HD13 ' OE2' ' A' ' 168' ' ' GLU . 33.7 mt -47.91 -79.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 142' ' ' LEU . . . 161.81 159.95 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.335 0.588 . . . . 0.0 110.606 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 143' ' ' ALA . 39.5 mt-30 -42.37 134.96 2.82 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.951 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -156.44 155.29 31.83 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.14 152.88 25.48 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 121.117 1.781 . . . . 0.0 111.192 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 155.34 49.87 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.658 HG12 ' CG2' ' A' ' 135' ' ' VAL . 3.6 m -118.15 155.79 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 47.3 m-85 -125.51 137.66 53.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.586 0.707 . . . . 0.0 109.375 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.09 146.54 43.72 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -92.42 154.82 3.03 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 123.812 3.008 . . . . 0.0 114.981 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.2 mt -117.29 133.45 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.773 -0.579 . . . . 0.0 109.934 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 155' ' ' GLU . 77.4 m-85 -103.13 144.12 31.72 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.4 51.11 0.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 153' ' ' TYR . 9.2 tt0 41.1 25.06 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.187 -0.946 . . . . 0.0 111.657 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -138.77 30.6 2.29 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 62.46 2.67 0.93 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -92.23 124.87 36.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.754 ' N ' HE21 ' A' ' 159' ' ' GLN . 0.0 OUTLIER -73.1 129.99 39.3 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -175.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.422 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.7 pp -138.94 14.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.24 -1.537 . . . . 0.0 114.404 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.23 176.09 45.98 Favored Glycine 0 N--CA 1.505 3.298 0 C-N-CA 116.042 -2.98 . . . . 0.0 112.798 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.5 ' O ' ' OG1' ' A' ' 101' ' ' THR . 55.5 t -136.61 133.73 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 121.771 0.796 . . . . 0.0 110.387 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 79.7 t -106.03 122.63 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.647 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -119.35 141.93 48.59 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.676 HG21 ' HB1' ' A' ' 56' ' ' ALA . 22.3 mt -131.67 110.91 17.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.25 119.21 6.31 Favored Glycine 0 N--CA 1.487 2.039 0 C-N-CA 119.095 -1.526 . . . . 0.0 111.528 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.951 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -94.5 114.89 26.96 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 1.134 ' OE2' HD13 ' A' ' 142' ' ' LEU . 13.5 tp10 -74.86 134.88 41.6 Favored 'General case' 0 N--CA 1.518 2.951 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' A' ' 168' ' ' GLU . 11.0 tp . . . . . 0 N--CA 1.534 3.725 0 CA-C-N 119.04 0.836 . . . . 0.0 111.315 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.66 0.743 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -71.41 -65.6 0.73 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.336 -0.852 . . . . 0.0 108.957 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 24.6 ttt -41.42 -55.92 2.65 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.888 -1.132 . . . . 0.0 110.838 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.46 ' OG1' ' CD2' ' A' ' 52' ' ' LEU . 5.8 t -60.33 -32.61 71.4 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 122.181 0.991 . . . . 0.0 108.881 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' THR . 53.8 ttp180 -41.61 -60.86 1.21 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.25 -1.531 . . . . 0.0 112.538 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -76.57 -60.98 2.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.85 -49.55 22.58 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.915 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.545 HD11 HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -51.81 -43.45 63.1 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 120.747 2.273 . . . . 0.0 108.194 178.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.82 -49.09 71.87 Favored 'General case' 0 C--O 1.204 -1.322 0 C-N-CA 117.407 -1.717 . . . . 0.0 109.481 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -78.72 -69.51 0.56 Allowed 'General case' 0 C--N 1.308 -1.214 0 O-C-N 120.099 -1.626 . . . . 0.0 111.434 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -47.31 -59.45 3.18 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.274 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -66.32 -36.34 82.69 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 123.389 2.813 . . . . 0.0 111.609 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.25 -42.41 73.45 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.062 -1.648 . . . . 0.0 108.678 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.433 ' O ' ' HG3' ' A' ' 61' ' ' ARG . . . -75.85 -51.2 13.05 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' A' ' 88' ' ' ALA . 39.0 t -63.37 -43.8 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 119.428 -2.045 . . . . 0.0 106.678 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.02 -28.62 39.42 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -76.81 -20.78 56.0 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.429 -0.909 . . . . 0.0 111.971 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.3 m -67.36 -45.7 75.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 118.893 -2.379 . . . . 0.0 106.843 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.535 ' CD2' ' HB1' ' A' ' 84' ' ' ALA . 2.2 mt -90.2 -31.91 16.83 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 113.714 -1.585 . . . . 0.0 111.13 -177.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.653 ' O ' HG21 ' A' ' 69' ' ' ILE . . . -68.02 -15.87 63.79 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 119.84 -1.788 . . . . 0.0 106.246 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 28.4 t70 -90.22 -9.17 49.03 Favored 'General case' 0 N--CA 1.528 3.427 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.861 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.492 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -70.18 -152.23 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.27 0 O-C-N 120.075 -1.641 . . . . 0.0 110.695 -178.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.712 ' C ' ' H ' ' A' ' 69' ' ' ILE . 2.0 Cg_endo -104.82 -30.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.079 2.519 . . . . 0.0 114.683 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.474 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 13.2 pt-20 -72.27 26.81 0.05 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.712 ' H ' ' C ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -100.72 -83.0 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 176.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -47.23 -31.2 3.51 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.364 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -80.15 -18.76 48.87 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.329 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -86.91 -38.0 8.2 Favored Glycine 0 CA--C 1.479 -2.21 1 N-CA-C 101.633 -4.587 . . . . 0.0 101.633 178.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.422 HD11 ' O ' ' A' ' 101' ' ' THR . 1.9 tp -56.58 -34.21 66.93 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -77.74 0.51 23.3 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.829 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.799 ' O ' ' O ' ' A' ' 76' ' ' LYS . 4.7 tmtp? -131.95 45.9 2.72 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 120.319 1.418 . . . . 0.0 112.785 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.799 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 17.37 157.05 0.0 OUTLIER Pre-proline 0 N--CA 1.535 3.819 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -29.92 -60.58 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.364 2.709 . . . . 0.0 113.984 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -52.57 130.29 31.61 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 118.617 -1.233 . . . . 0.0 109.834 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.519 ' CD ' ' HZ1' ' A' ' 75' ' ' LYS . 31.5 tt0 65.49 13.8 9.08 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.877 176.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.831 ' O ' ' N ' ' A' ' 82' ' ' ILE . 15.3 t -79.56 97.9 6.65 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.499 -1.375 . . . . 0.0 110.094 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -43.76 66.73 0.0 OUTLIER Glycine 1 CA--C 1.578 4.018 0 C-N-CA 118.503 -1.808 . . . . 0.0 111.652 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.831 ' N ' ' O ' ' A' ' 80' ' ' SER . 7.7 tp -73.52 1.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.218 -1.754 . . . . 0.0 111.2 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -52.8 -29.06 25.44 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.7 -1.25 . . . . 0.0 113.161 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.847 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -81.26 -86.65 0.09 Allowed 'General case' 0 C--O 1.193 -1.911 0 N-CA-C 100.653 -3.832 . . . . 0.0 100.653 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.866 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -19.52 -63.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 121.548 1.977 . . . . 0.0 106.075 -178.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 1.002 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -42.56 -52.08 4.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.301 -1.5 . . . . 0.0 110.144 174.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.847 ' N ' ' O ' ' A' ' 84' ' ' ALA . 36.2 tp10 -36.86 -46.57 0.63 Allowed 'General case' 0 N--CA 1.536 3.828 0 C-N-CA 116.515 -2.074 . . . . 0.0 106.699 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.447 ' CB ' HG12 ' A' ' 59' ' ' VAL . . . -49.64 -17.34 0.31 Allowed 'General case' 0 N--CA 1.512 2.667 0 O-C-N 119.446 -2.034 . . . . 0.0 108.796 171.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 1.002 ' N ' ' O ' ' A' ' 86' ' ' ALA . 22.7 m -60.8 -33.97 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 C-N-CA 115.879 -2.328 . . . . 0.0 109.101 174.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 89' ' ' VAL . 33.1 ttm180 -85.51 -49.19 8.26 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 114.328 -1.305 . . . . 0.0 113.812 -174.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -60.58 -36.79 79.37 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.444 -1.303 . . . . 0.0 108.452 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.765 ' NH2' ' H ' ' A' ' 95' ' ' LEU . 36.1 ttp85 -60.94 -71.2 0.15 Allowed 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 94' ' ' ASP . 35.6 m120 -161.53 -27.69 0.05 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.673 -1.267 . . . . 0.0 112.007 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 18.9 t70 139.8 -28.54 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.836 0 CA-C-N 120.167 1.349 . . . . 0.0 110.141 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.765 ' H ' ' NH2' ' A' ' 92' ' ' ARG . 0.3 OUTLIER -122.54 151.57 41.25 Favored 'General case' 0 N--CA 1.521 3.075 0 CA-C-N 113.701 -1.59 . . . . 0.0 114.601 -177.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.668 ' CD1' HG22 ' A' ' 165' ' ' ILE . 0.2 OUTLIER 150.36 162.31 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.0 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 178.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -107.92 95.39 5.65 Favored 'General case' 0 C--O 1.207 -1.132 1 CA-C-N 126.509 4.231 . . . . 0.0 100.247 170.335 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.567 HG13 HG23 ' A' ' 165' ' ' ILE . 1.6 mt -90.36 117.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 1.1 p -136.06 139.98 44.79 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.639 0 CA-C-N 111.402 -2.635 . . . . 0.0 112.568 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.64 141.2 22.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 1 N-CA-C 99.451 -4.277 . . . . 0.0 99.451 174.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.441 ' CG2' ' H ' ' A' ' 105' ' ' SER . 0.7 OUTLIER -131.49 153.38 49.84 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.534 -1.354 . . . . 0.0 110.664 -176.185 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -86.65 -172.52 4.05 Favored 'General case' 0 C--N 1.281 -2.376 1 N-CA-C 99.488 -4.264 . . . . 0.0 99.488 170.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.594 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -81.2 77.03 8.13 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 114.25 -2.98 . . . . 0.0 109.577 -177.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.473 ' O ' ' CB ' ' A' ' 105' ' ' SER . 8.2 tp-100 -147.85 -40.67 0.17 Allowed 'General case' 0 C--O 1.209 -1.026 0 O-C-N 119.375 -2.078 . . . . 0.0 111.14 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.568 ' OG ' ' CD1' ' A' ' 125' ' ' ILE . 7.6 t 89.56 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.337 1.055 . . . . 0.0 109.03 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.4 OUTLIER 157.81 121.87 0.0 OUTLIER 'General case' 0 C--O 1.191 -1.982 0 N-CA-C 103.884 -2.636 . . . . 0.0 103.884 177.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.613 ' HE ' ' N ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -64.41 103.95 0.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.523 ' CD1' HG23 ' A' ' 99' ' ' VAL . 3.1 m-85 -57.84 -27.47 63.23 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -122.86 165.79 16.07 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.018 -178.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.953 ' CD2' HD11 ' A' ' 116' ' ' ILE . 14.5 p80 179.01 161.97 0.71 Allowed Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.343 -0.848 . . . . 0.0 110.907 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -87.82 -44.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.483 0.885 0 N-CA-C 106.637 -2.101 . . . . 0.0 106.637 173.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.494 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -108.02 135.44 49.39 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 174.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.3 -25.17 64.1 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.171 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -65.19 -37.49 87.5 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 119.971 -1.705 . . . . 0.0 114.841 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.432 ' HE ' ' NE2' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -65.03 -30.21 71.17 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 119.434 -2.041 . . . . 0.0 107.818 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.953 HD11 ' CD2' ' A' ' 110' ' ' HIS . 55.0 mt -40.42 -85.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.589 0 CA-C-O 122.601 1.191 . . . . 0.0 111.639 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.67 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -45.53 -10.83 0.02 OUTLIER Glycine 0 N--CA 1.494 2.513 0 CA-C-N 115.144 -0.934 . . . . 0.0 113.691 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.432 ' NE2' ' HE ' ' A' ' 115' ' ' ARG . 3.2 mt-30 -64.2 -68.58 0.76 Allowed Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 120.394 2.097 . . . . 0.0 112.047 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 2.7 Cg_exo -35.96 107.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 123.933 3.088 . . . . 0.0 115.274 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.586 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 45.8 t80 173.1 28.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -176.28 -8.66 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.65 -19.3 1.25 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.5 t70 68.56 3.92 4.07 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.144 -1.21 . . . . 0.0 109.731 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.457 ' CG ' ' CB ' ' A' ' 136' ' ' ALA . 27.9 m-20 -90.66 -24.63 20.42 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.486 -0.886 . . . . 0.0 108.75 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.568 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 31.0 mt -86.49 -26.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.207 -0.933 . . . . 0.0 112.806 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 125' ' ' ILE . 3.7 mm? -37.57 -50.9 1.16 Allowed 'General case' 0 N--CA 1.517 2.884 0 O-C-N 121.01 -1.056 . . . . 0.0 109.918 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.663 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 54.6 mttm -70.53 -29.7 66.25 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.848 -1.157 . . . . 0.0 109.29 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.611 ' C ' ' ND2' ' A' ' 130' ' ' ASN . . . -90.54 -33.99 15.7 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.976 -1.077 . . . . 0.0 109.481 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.4 OUTLIER -36.82 -38.13 0.17 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.829 ' ND2' ' N ' ' A' ' 131' ' ' GLY . 0.1 OUTLIER -74.31 -91.91 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 177.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.829 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -168.5 57.12 0.21 Allowed Glycine 0 CA--C 1.558 2.753 0 O-C-N 120.068 -1.645 . . . . 0.0 110.347 176.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -140.23 157.05 46.19 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.715 -1.462 . . . . 0.0 109.048 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.457 ' O ' ' CG ' ' A' ' 134' ' ' ASN . 28.3 mp0 -68.66 159.22 32.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.651 -0.655 . . . . 0.0 111.797 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 133' ' ' GLU . 22.6 m120 -166.28 142.06 4.74 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.656 ' CG2' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -132.74 131.38 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 O-C-N 119.646 -1.909 . . . . 0.0 110.419 -178.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.457 ' CB ' ' CG ' ' A' ' 124' ' ' ASP . . . -152.49 163.19 40.06 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.418 -0.801 . . . . 0.0 110.884 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.2 mt -97.02 128.63 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.648 0 O-C-N 121.146 -0.971 . . . . 0.0 111.353 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -97.21 153.15 18.18 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -133.44 156.99 46.7 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -166.18 161.94 35.54 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -44.34 -23.99 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -1.177 . . . . 0.0 110.186 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -73.3 -80.66 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.833 -1.167 . . . . 0.0 108.679 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -173.38 159.14 3.67 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.0 111.993 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.662 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 25.2 mp0 -45.31 143.39 1.75 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.699 0.761 . . . . 0.0 109.555 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.872 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -146.56 150.64 35.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 tp -108.43 152.51 24.59 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 122.006 2.185 . . . . 0.0 109.788 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -142.92 134.97 27.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.996 -1.065 . . . . 0.0 110.705 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.656 HG12 ' CG2' ' A' ' 135' ' ' VAL . 16.2 m -104.87 136.37 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 CA-C-O 122.232 1.015 . . . . 0.0 109.91 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 89.8 m-85 -108.42 140.87 41.1 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.506 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.88 150.89 67.05 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.4 ' HB3' ' C ' ' A' ' 131' ' ' GLY . 0.8 OUTLIER -92.66 149.99 2.81 Favored 'Trans proline' 0 N--CA 1.515 2.769 0 C-N-CA 123.65 2.9 . . . . 0.0 116.757 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 61.3 mt -116.25 125.83 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.528 ' C ' ' H ' ' A' ' 155' ' ' GLU . 97.3 m-85 -95.28 142.73 27.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.17 -0.956 . . . . 0.0 110.846 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 47.3 t0 -55.09 -3.36 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.548 -1.345 . . . . 0.0 109.23 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 154' ' ' ASP . 53.2 tt0 99.39 4.69 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 158' ' ' LYS . 32.6 m120 -129.07 36.7 4.16 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.099 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 60.98 -2.39 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.5 mptt -81.27 126.3 31.39 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.632 ' O ' ' CD ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -73.88 125.71 28.8 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -175.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.7 pp -143.07 7.31 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 118.799 -2.438 . . . . 0.0 116.971 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.64 173.12 44.44 Favored Glycine 0 N--CA 1.513 3.801 0 C-N-CA 116.619 -2.705 . . . . 0.0 111.853 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 101' ' ' THR . 58.3 t -137.25 139.96 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 120.965 -1.314 . . . . 0.0 111.118 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 56.1 t -103.91 127.79 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.561 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -114.99 155.64 26.56 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.668 HG22 ' CD1' ' A' ' 96' ' ' LEU . 12.8 mt -151.29 95.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.615 ' C ' HD13 ' A' ' 96' ' ' LEU . . . -105.06 135.37 12.52 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.354 -175.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.872 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 0.7 OUTLIER -100.74 112.09 24.43 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 113.897 -1.151 . . . . 0.0 108.633 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -48.64 77.15 Favored 'General case' 0 N--CA 1.524 3.227 0 CA-C-O 123.025 1.393 . . . . 0.0 109.565 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.509 2.502 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.811 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.73 0.776 . . . . 0.0 109.095 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -60.82 -51.43 69.36 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 124.269 1.985 . . . . 0.0 108.9 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -28.99 66.53 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.513 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.726 HG23 HD23 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -61.17 -36.94 81.19 Favored 'General case' 0 C--O 1.203 -1.367 0 O-C-N 118.106 -2.871 . . . . 0.0 104.478 175.274 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -54.87 -52.15 63.75 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 116.508 -2.077 . . . . 0.0 109.465 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.77 -65.67 0.65 Allowed 'General case' 0 N--CA 1.517 2.905 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 52' ' ' LEU . . . -65.38 -51.83 45.41 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.726 HD23 HG23 ' A' ' 48' ' ' THR . 0.2 OUTLIER -52.44 -37.9 57.98 Favored 'General case' 0 C--O 1.206 -1.234 0 O-C-N 120.34 -1.683 . . . . 0.0 106.9 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 57' ' ' LEU . . . -56.83 -65.08 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.228 -1.789 . . . . 0.0 108.045 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -55.34 -63.86 1.03 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.052 -1.655 . . . . 0.0 112.596 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -67.63 -20.0 65.28 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.868 -1.145 . . . . 0.0 112.352 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 52' ' ' LEU . . . -97.09 -35.7 10.72 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 121.226 1.83 . . . . 0.0 109.012 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 1.2 tt -64.76 -33.32 75.69 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 121.009 -1.057 . . . . 0.0 108.56 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.87 -43.58 44.82 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.334 -0.854 . . . . 0.0 112.865 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.41 -32.61 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 118.175 -2.828 . . . . 0.0 107.512 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.924 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -58.43 -25.11 61.83 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.423 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -72.03 -21.98 61.46 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 117.008 -1.877 . . . . 0.0 109.526 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 98.6 m -69.61 -53.96 16.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 118.111 -2.868 . . . . 0.0 108.616 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.587 ' N ' HD22 ' A' ' 63' ' ' LEU . 4.1 mm? -79.16 -44.03 22.77 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.048 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.78 -18.0 4.19 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 119.932 -1.73 . . . . 0.0 106.744 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.488 ' N ' ' C ' ' A' ' 63' ' ' LEU . 18.5 t0 -87.56 -10.91 50.24 Favored 'General case' 0 N--CA 1.52 3.047 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.909 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.527 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -73.05 -157.96 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.938 0 O-C-N 120.484 -1.385 . . . . 0.0 109.04 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.527 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -109.21 -15.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.619 2.879 . . . . 0.0 113.837 176.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.458 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -74.87 -41.11 60.45 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.462 -0.774 . . . . 0.0 109.825 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 70' ' ' ARG . 1.7 mp -57.33 -75.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.318 -1.489 . . . . 0.0 109.896 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.607 ' N ' HG22 ' A' ' 69' ' ' ILE . 62.4 ttt-85 -45.42 -35.79 3.91 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.399 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -77.88 -14.66 59.48 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 111.899 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.508 ' C ' ' N ' ' A' ' 74' ' ' GLN . . . -94.84 -47.97 2.58 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 103.538 -3.825 . . . . 0.0 103.538 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -49.23 -23.64 1.43 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.092 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.508 ' N ' ' C ' ' A' ' 72' ' ' GLY . 55.7 tp60 -50.76 -9.16 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.801 -1.545 . . . . 0.0 109.588 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.844 ' O ' ' O ' ' A' ' 76' ' ' LYS . 5.1 mmtp -150.51 85.46 1.38 Allowed 'General case' 0 N--CA 1.523 3.175 0 O-C-N 120.847 -1.158 . . . . 0.0 113.016 -177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.844 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 23.91 164.13 0.0 OUTLIER Pre-proline 1 N--CA 1.539 4.008 0 CA-C-N 121.986 2.175 . . . . 0.0 116.19 179.668 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 78' ' ' GLN . 6.2 Cg_exo -32.36 -68.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.509 2.41 0 C-N-CA 124.255 3.304 . . . . 0.0 115.293 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 77' ' ' PRO . 91.8 mt-30 -35.98 133.1 0.47 Allowed 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.784 1.278 . . . . 0.0 111.024 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 63.04 19.28 11.55 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.716 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.9 ' O ' ' N ' ' A' ' 82' ' ' ILE . 33.8 m -90.0 83.66 6.12 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.347 -1.471 . . . . 0.0 109.341 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -38.88 52.31 0.0 OUTLIER Glycine 0 N--CA 1.508 3.464 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.569 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.9 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.4 tp -63.86 -1.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 120.514 -1.58 . . . . 0.0 108.038 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.44 ' H ' ' C ' ' A' ' 81' ' ' GLY . 17.7 mp0 -58.4 -21.92 52.14 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 120.974 -1.079 . . . . 0.0 112.199 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -85.84 -63.64 1.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 121.951 2.159 . . . . 0.0 112.061 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.568 HD11 HD12 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -48.27 -34.09 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 122.718 2.508 . . . . 0.0 107.067 172.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 90' ' ' ARG . . . -65.43 -48.36 73.02 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' ALA . 36.8 tt0 -48.22 -56.6 7.55 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 117.443 -1.265 . . . . 0.0 112.425 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.95 -44.16 23.06 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 123.553 2.888 . . . . 0.0 108.306 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 85' ' ' ILE . 98.8 t -55.97 -76.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 116.071 -2.251 . . . . 0.0 108.977 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.623 ' O ' ' C ' ' A' ' 91' ' ' LYS . 45.8 ttm-85 -34.7 -58.53 0.5 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.55 0.74 . . . . 0.0 110.038 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.623 ' C ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -32.32 -49.04 0.19 Allowed 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 117.35 -1.74 . . . . 0.0 107.582 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -55.35 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 117.064 -1.446 . . . . 0.0 111.107 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.926 ' O ' ' ND2' ' A' ' 93' ' ' ASN . 0.3 OUTLIER -71.27 -3.61 21.33 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 113.864 -3.134 . . . . 0.0 108.903 -172.097 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.539 ' O ' HD23 ' A' ' 95' ' ' LEU . 7.6 t70 62.01 40.87 11.77 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -174.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 158.94 165.23 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.605 HD22 HG22 ' A' ' 165' ' ' ILE . 4.1 mt 150.07 163.34 0.0 OUTLIER 'General case' 1 N--CA 1.557 4.924 0 CA-C-N 121.194 1.815 . . . . 0.0 108.505 178.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -113.82 85.87 2.29 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 171.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.924 HD11 ' HB2' ' A' ' 60' ' ' ALA . 0.9 OUTLIER -91.62 113.1 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 104.708 -2.331 . . . . 0.0 104.708 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.662 ' CG2' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -122.13 135.75 61.22 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.379 0 CA-C-N 112.808 -1.996 . . . . 0.0 112.454 -174.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.489 HG11 HG23 ' A' ' 69' ' ' ILE . 7.1 p -111.19 128.78 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 1 N-CA-C 98.679 -4.563 . . . . 0.0 98.679 171.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.662 HG23 ' CG2' ' A' ' 99' ' ' VAL . 3.3 p -117.89 155.05 30.84 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.343 -1.473 . . . . 0.0 109.842 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.61 ' O ' ' N ' ' A' ' 104' ' ' GLN . 1.5 t70 -82.3 -175.85 5.89 Favored 'General case' 0 C--N 1.285 -2.201 1 N-CA-C 97.592 -4.966 . . . . 0.0 97.592 170.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.532 ' C ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -70.47 75.64 0.56 Allowed 'General case' 0 C--N 1.268 -2.951 0 C-N-CA 113.89 -3.124 . . . . 0.0 105.499 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.61 ' N ' ' O ' ' A' ' 102' ' ' ASP . 6.6 mm-40 -136.78 -51.54 0.68 Allowed 'General case' 0 C--O 1.214 -0.798 0 O-C-N 119.365 -2.085 . . . . 0.0 108.189 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.766 ' OG ' HD13 ' A' ' 125' ' ' ILE . 0.5 OUTLIER 84.6 134.51 0.05 Allowed 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -178.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.647 ' H ' ' NH2' ' A' ' 107' ' ' ARG . 1.5 pp 148.41 147.4 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.647 ' NH2' ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -69.07 139.87 54.85 Favored 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 178.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.512 ' CD2' HD13 ' A' ' 82' ' ' ILE . 1.6 m-85 -96.73 -35.8 10.87 Favored 'General case' 0 C--N 1.258 -3.387 0 N-CA-C 103.498 -2.778 . . . . 0.0 103.498 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.22 167.48 10.65 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 112.197 -2.274 . . . . 0.0 112.222 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.512 ' CD2' HD11 ' A' ' 116' ' ' ILE . 17.3 p80 -175.16 153.77 1.6 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.813 -1.179 . . . . 0.0 112.482 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.578 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 41.1 Cg_endo -90.75 -37.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 N-CA-C 106.191 -2.273 . . . . 0.0 106.191 172.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.578 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 57.0 tt0 -102.17 115.18 30.0 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.404 ' HA ' ' ND1' ' A' ' 110' ' ' HIS . . . -48.47 -47.43 38.5 Favored 'General case' 0 C--N 1.29 -1.99 0 O-C-N 121.011 -1.055 . . . . 0.0 112.084 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -64.39 -31.06 72.12 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.271 -1.518 . . . . 0.0 115.034 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.678 ' NE ' ' OE1' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -66.83 -22.21 66.01 Favored 'General case' 0 C--O 1.197 -1.687 0 O-C-N 119.35 -2.094 . . . . 0.0 107.969 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.84 HG22 ' N ' ' A' ' 117' ' ' GLY . 54.8 mt -35.11 -91.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.84 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -85.81 -9.72 77.33 Favored Glycine 0 N--CA 1.502 3.078 0 O-C-N 121.025 -1.047 . . . . 0.0 114.034 -173.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.688 ' N ' ' HD2' ' A' ' 119' ' ' PRO . 3.2 pt20 -60.5 -40.66 77.97 Favored Pre-proline 0 C--N 1.294 -1.807 0 C-N-CA 116.442 -2.103 . . . . 0.0 110.14 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 118' ' ' GLN . 8.3 Cg_endo -48.15 113.87 0.95 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.662 2.241 . . . . 0.0 112.894 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.445 ' CD2' ' O ' ' A' ' 120' ' ' PHE . 69.7 t80 -178.89 29.06 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -132.45 42.74 3.07 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.665 -0.647 . . . . 0.0 112.518 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.35 -46.94 0.1 Allowed Glycine 0 N--CA 1.51 3.59 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 75.32 20.03 2.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.917 -0.754 . . . . 0.0 111.421 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.468 ' OD2' ' CE2' ' A' ' 149' ' ' PHE . 19.7 p-10 -84.1 -2.68 57.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.213 -1.554 . . . . 0.0 108.563 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.766 HD13 ' OG ' ' A' ' 105' ' ' SER . 12.3 pt -84.51 -23.73 7.52 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 O-C-N 120.941 -1.1 . . . . 0.0 110.684 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' A' ' 125' ' ' ILE . 71.6 mt -35.65 -46.09 0.4 Allowed 'General case' 0 N--CA 1.52 3.044 0 O-C-N 121.198 -0.938 . . . . 0.0 110.061 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -79.48 -40.95 28.54 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.351 -0.843 . . . . 0.0 110.81 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -83.1 -30.73 27.72 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.218 -1.551 . . . . 0.0 108.317 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.584 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -38.85 -34.18 0.14 Allowed 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 128' ' ' ALA . 1.6 m120 -99.42 -104.32 0.22 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -132.11 54.12 0.79 Allowed Glycine 0 N--CA 1.506 3.32 0 C-N-CA 119.801 -1.19 . . . . 0.0 115.27 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -144.55 142.84 30.49 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 120.515 2.157 . . . . 0.0 108.776 178.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.595 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 89.2 mt-10 -69.66 157.1 37.9 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 119.888 -1.758 . . . . 0.0 109.987 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 133' ' ' GLU . 20.3 m-80 -160.11 142.55 13.27 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.532 HG22 HG12 ' A' ' 148' ' ' VAL . 2.3 t -131.29 145.3 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.556 -1.34 . . . . 0.0 108.909 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.62 164.18 29.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 109.066 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.2 mt -99.6 139.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 O-C-N 120.717 -1.239 . . . . 0.0 111.029 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.446 HD21 ' CZ ' ' A' ' 115' ' ' ARG . 8.3 t-20 -106.36 138.95 41.62 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.701 0.762 . . . . 0.0 109.709 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.594 ' N ' HH12 ' A' ' 115' ' ' ARG . 14.6 ptm180 -166.95 115.89 0.85 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.38 -1.328 . . . . 0.0 109.43 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.51 ' C ' ' N ' ' A' ' 142' ' ' LEU . . . -162.27 109.21 0.38 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 107.729 -2.149 . . . . 0.0 107.729 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 50.4 13.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.997 -1.296 . . . . 0.0 108.405 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.51 ' N ' ' C ' ' A' ' 140' ' ' GLY . 13.0 tp -134.34 172.5 12.8 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.52 -142.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.233 -1.542 . . . . 0.0 112.465 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -110.79 146.58 36.14 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 176.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.762 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -150.62 142.61 23.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.957 -1.714 . . . . 0.0 107.191 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.423 ' HA ' HD12 ' A' ' 146' ' ' LEU . 9.7 tp -101.79 149.41 24.2 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 122.781 2.537 . . . . 0.0 106.89 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.593 ' NH2' ' CZ ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -144.81 150.55 37.36 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.409 1.099 . . . . 0.0 111.207 -178.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 53' ' ' ALA . 23.9 m -113.14 143.23 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.717 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.49 ' CD1' HG22 ' A' ' 125' ' ' ILE . 28.2 m-85 -110.69 135.02 51.93 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.657 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -136.24 166.4 28.23 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -111.61 154.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.912 0 C-N-CA 124.306 3.338 . . . . 0.0 114.803 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 54.2 mt -118.89 127.68 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.544 ' C ' ' H ' ' A' ' 155' ' ' GLU . 83.4 m-85 -101.76 144.18 30.77 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.927 -1.108 . . . . 0.0 112.201 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 55.7 t0 -65.66 12.79 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.547 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER 86.81 15.65 0.1 Allowed 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.98 -1.075 . . . . 0.0 108.455 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 158' ' ' LYS . 77.7 m-20 -139.27 36.16 2.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.84 -1.162 . . . . 0.0 108.303 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 59.56 3.36 0.41 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.512 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.6 mptt -85.91 130.81 34.44 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.745 ' O ' ' NE2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -85.01 125.62 32.87 Favored 'General case' 0 N--CA 1.512 2.655 0 CA-C-N 119.848 1.204 . . . . 0.0 113.571 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.08 5.49 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 O-C-N 119.926 -1.734 . . . . 0.0 113.88 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -171.26 173.6 44.81 Favored Glycine 0 N--CA 1.501 3.01 0 C-N-CA 118.18 -1.962 . . . . 0.0 112.033 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.569 ' O ' ' OG1' ' A' ' 101' ' ' THR . 1.5 t -133.21 141.99 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 O-C-N 121.799 -0.824 . . . . 0.0 110.708 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.443 ' O ' ' OG1' ' A' ' 150' ' ' THR . 9.2 t -113.25 119.64 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 120.961 -1.087 . . . . 0.0 108.179 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.64 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -112.93 156.61 22.7 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.605 HG22 HD22 ' A' ' 96' ' ' LEU . 23.6 mt -152.14 109.64 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.596 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -115.8 137.09 13.49 Favored Glycine 0 N--CA 1.489 2.178 0 CA-C-O 122.805 1.225 . . . . 0.0 113.636 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.762 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 3.5 tp -95.45 103.27 15.13 Favored 'General case' 0 N--CA 1.514 2.763 0 CA-C-N 113.809 -1.196 . . . . 0.0 108.124 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 169' ' ' LEU . 7.1 tt0 -47.47 -60.27 2.64 Favored 'General case' 0 N--CA 1.523 3.208 0 O-C-N 124.384 1.053 . . . . 0.0 109.684 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.711 ' C ' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.526 3.359 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.767 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.634 0.73 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 49' ' ' ARG . 55.1 t0 -65.28 -56.34 13.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 124.068 1.889 . . . . 0.0 107.303 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 46' ' ' ASP . 11.1 ttt -36.78 -56.92 0.83 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.896 -174.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.542 ' OG1' HD13 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -59.01 -36.44 74.94 Favored 'General case' 0 C--O 1.202 -1.405 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.089 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.484 ' C ' ' O ' ' A' ' 48' ' ' THR . 55.9 ttt-85 -35.79 -64.31 0.31 Allowed 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.044 0.926 . . . . 0.0 111.397 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -70.42 -57.73 4.49 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.96 -35.56 21.15 Favored Glycine 0 N--CA 1.497 2.759 0 C-N-CA 119.572 -1.299 . . . . 0.0 111.397 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.785 HD11 HD21 ' A' ' 96' ' ' LEU . 11.3 tp -53.36 -47.66 69.24 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 120.783 2.291 . . . . 0.0 107.145 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.565 ' HB2' HG11 ' A' ' 148' ' ' VAL . . . -50.7 -61.76 2.01 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.767 -1.173 . . . . 0.0 109.51 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.529 ' C ' HD22 ' A' ' 54' ' ' ASN . 0.4 OUTLIER -69.3 -56.37 7.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.268 -1.52 . . . . 0.0 113.359 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -69.58 -41.34 75.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -0.884 . . . . 0.0 112.335 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.63 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -72.86 -35.23 67.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 119.715 -1.866 . . . . 0.0 110.11 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 57' ' ' LEU . 7.2 tt -65.22 -41.31 94.54 Favored 'General case' 0 C--N 1.288 -2.106 0 O-C-N 121.057 -1.027 . . . . 0.0 111.492 177.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.88 -44.42 49.01 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.297 -1.502 . . . . 0.0 114.885 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.38 -43.63 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 118.836 -2.415 . . . . 0.0 106.607 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.875 ' CB ' HD13 ' A' ' 98' ' ' ILE . . . -57.9 -26.42 62.14 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.641 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -71.08 -15.84 62.55 Favored 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 118.474 -1.29 . . . . 0.0 109.009 179.005 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -64.85 -42.47 94.87 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 115.105 -2.638 . . . . 0.0 104.143 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.613 HD22 ' HB1' ' A' ' 84' ' ' ALA . 49.0 mt -87.45 -42.02 13.12 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.801 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.641 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -55.77 -18.47 8.47 Favored 'General case' 0 N--CA 1.522 3.17 0 O-C-N 119.989 -1.694 . . . . 0.0 107.166 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 12.2 t0 -85.49 -22.72 28.08 Favored 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.959 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.51 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -58.38 -156.69 0.0 OUTLIER Pre-proline 0 C--N 1.281 -2.397 0 O-C-N 120.699 -1.251 . . . . 0.0 111.742 -177.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -107.4 -35.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.513 2.62 0 C-N-CA 124.476 3.451 . . . . 0.0 115.396 178.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 72' ' ' GLY . 7.4 pt-20 -55.74 -30.98 62.12 Favored 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 118.735 -1.186 . . . . 0.0 109.166 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -53.08 -76.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.267 1.032 . . . . 0.0 111.034 -179.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.486 ' N ' HG22 ' A' ' 69' ' ' ILE . 72.5 ttt180 -49.94 -33.85 18.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -83.02 -18.75 38.66 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 118.817 -1.153 . . . . 0.0 112.763 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.783 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -86.31 -46.11 5.37 Favored Glycine 0 N--CA 1.498 2.816 1 N-CA-C 101.931 -4.468 . . . . 0.0 101.931 179.098 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.421 HD11 ' HA ' ' A' ' 102' ' ' ASP . 15.2 tp -46.6 -39.2 10.71 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 175.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.88 6.2 0.94 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.091 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.783 ' N ' ' O ' ' A' ' 72' ' ' GLY . 4.3 tmtt? -143.56 52.84 1.33 Allowed 'General case' 0 N--CA 1.512 2.668 0 O-C-N 120.265 -1.522 . . . . 0.0 114.526 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.658 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 32.95 149.55 0.0 OUTLIER Pre-proline 0 N--CA 1.524 3.24 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 178.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -30.79 -70.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.513 2.644 0 C-N-CA 124.875 3.717 . . . . 0.0 118.232 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' HB2' ' HZ2' ' A' ' 76' ' ' LYS . 26.5 mt-30 -44.27 -43.45 7.34 Favored 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -101.97 9.36 40.56 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.483 -1.386 . . . . 0.0 110.15 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.5 m -88.32 125.82 34.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.42 71.97 0.96 Allowed Glycine 0 N--CA 1.489 2.182 0 O-C-N 118.699 -2.501 . . . . 0.0 109.981 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.523 HD11 ' H ' ' A' ' 100' ' ' VAL . 3.1 tp -63.89 -4.64 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 C-N-CA 125.078 1.351 . . . . 0.0 109.585 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.649 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 55.3 tt0 -50.09 -32.7 16.44 Favored 'General case' 0 C--N 1.279 -2.468 0 O-C-N 120.851 -1.155 . . . . 0.0 110.038 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -71.64 -98.5 0.01 OUTLIER 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.787 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -16.08 -44.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.952 0 CA-C-N 121.788 2.085 . . . . 0.0 111.904 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -73.2 -48.08 38.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 119.678 -1.889 . . . . 0.0 109.601 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.649 ' HG2' ' O ' ' A' ' 83' ' ' GLN . 50.9 mm-40 -49.86 -49.8 47.95 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.718 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -66.33 -56.39 11.35 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 125.529 3.786 . . . . 0.0 108.564 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.755 HG13 HD13 ' A' ' 96' ' ' LEU . 1.2 t -52.96 -65.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 115.638 -2.425 . . . . 0.0 108.945 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 1.027 ' HD3' ' H ' ' A' ' 96' ' ' LEU . 1.9 tpp85 -37.97 -46.05 0.94 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.467 -1.395 . . . . 0.0 109.218 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.605 ' C ' ' O ' ' A' ' 90' ' ' ARG . 14.4 ttmm -34.48 -43.45 0.17 Allowed 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 117.592 -1.643 . . . . 0.0 106.705 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.753 ' HD3' ' O ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -39.78 -39.53 0.81 Allowed 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 117.369 -1.3 . . . . 0.0 109.06 172.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 90' ' ' ARG . 1.5 m120 -156.58 -62.93 0.1 Allowed 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 124.783 3.447 . . . . 0.0 111.106 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 1.1 m-20 166.11 -13.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.085 -1.009 . . . . 0.0 111.365 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.44 60.98 1.49 Allowed 'General case' 0 N--CA 1.533 3.696 0 C-N-CA 118.422 -1.311 . . . . 0.0 113.972 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.027 ' H ' ' HD3' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -120.14 142.23 49.12 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 116.793 -1.575 . . . . 0.0 110.773 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -119.95 100.22 7.09 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 124.752 3.433 . . . . 0.0 109.409 176.241 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.875 HD13 ' CB ' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -95.22 111.76 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 174.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.675 ' CG2' ' HB3' ' A' ' 164' ' ' ALA . 4.5 m -112.37 124.21 68.83 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.594 0 CA-C-N 112.097 -2.319 . . . . 0.0 110.199 -173.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.523 ' H ' HD11 ' A' ' 82' ' ' ILE . 9.5 p -96.68 128.08 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 1 N-CA-C 98.754 -4.536 . . . . 0.0 98.754 176.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 104' ' ' GLN . 81.0 p -119.99 151.49 38.88 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.464 -175.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 104' ' ' GLN . 38.8 t0 -81.91 -174.77 5.24 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 100.498 -3.89 . . . . 0.0 100.498 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 43.1 ttm -74.81 71.22 1.97 Allowed 'General case' 0 C--N 1.268 -2.976 0 C-N-CA 114.889 -2.724 . . . . 0.0 107.837 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.625 ' O ' ' HB ' ' A' ' 101' ' ' THR . 3.5 pp0? -171.82 136.07 0.89 Allowed 'General case' 0 N--CA 1.436 -1.132 1 N-CA-C 96.844 -5.243 . . . . 0.0 96.844 176.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.698 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 16.3 t -107.72 -179.95 4.05 Favored 'General case' 0 CA--C 1.47 -2.117 0 C-N-CA 116.741 -1.983 . . . . 0.0 106.581 -176.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.698 ' HB2' ' O ' ' A' ' 105' ' ' SER . 3.3 tp 154.04 144.84 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.673 ' HA ' HG11 ' A' ' 99' ' ' VAL . 1.8 mmp_? -77.02 91.51 3.64 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.416 -1.713 . . . . 0.0 108.413 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 107' ' ' ARG . 3.2 m-85 -46.25 -31.14 2.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.416 ' N ' ' C ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -124.42 171.51 9.89 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 113.811 -1.54 . . . . 0.0 113.715 -178.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.421 ' CE1' ' HG3' ' A' ' 107' ' ' ARG . 0.1 OUTLIER 172.09 166.6 0.24 Allowed Pre-proline 0 N--CA 1.51 2.531 0 O-C-N 121.511 -0.743 . . . . 0.0 109.576 -179.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.447 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 46.5 Cg_endo -88.48 -40.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 122.768 2.312 . . . . 0.0 107.31 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 18.4 tp10 -107.96 93.98 4.83 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.97 1.367 . . . . 0.0 107.663 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' GLU . . . -31.11 -45.78 0.08 Allowed 'General case' 0 N--CA 1.503 2.195 0 CA-C-N 113.27 -1.786 . . . . 0.0 113.007 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -60.01 -33.35 71.88 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 120.395 -1.441 . . . . 0.0 113.772 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -60.9 -36.82 80.23 Favored 'General case' 0 C--O 1.203 -1.387 0 O-C-N 120.114 -1.616 . . . . 0.0 108.151 -178.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.734 ' O ' ' N ' ' A' ' 118' ' ' GLN . 79.7 mt -41.88 -84.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.075 177.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.466 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -27.64 -17.1 0.0 OUTLIER Glycine 0 N--CA 1.497 2.713 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.81 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.734 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.4 mp0 -77.61 -73.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.836 0 CA-C-N 120.946 2.373 . . . . 0.0 114.205 -175.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -30.86 115.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 123.325 2.683 . . . . 0.0 115.224 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.518 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 72.2 t80 171.73 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 123' ' ' ASP . 42.3 mttm -157.1 -26.13 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.41 -176.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 121' ' ' LYS . . . -41.06 -25.35 0.12 Allowed Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.041 -1.037 . . . . 0.0 110.549 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 121' ' ' LYS . 57.6 m-20 60.17 10.83 2.47 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.757 -0.849 . . . . 0.0 110.897 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -88.57 -23.64 23.07 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 128' ' ' ALA . 3.9 mt -80.68 -17.16 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.77 -1.206 . . . . 0.0 112.034 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 125' ' ' ILE . 54.4 mt -49.36 -32.97 12.46 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.556 -1.34 . . . . 0.0 107.481 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.608 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 94.8 mttt -79.65 -30.31 41.21 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.534 ' C ' ' ND2' ' A' ' 130' ' ' ASN . . . -92.44 -36.32 13.17 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 120.417 1.462 . . . . 0.0 109.262 -176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.4 mt -41.15 -30.49 0.16 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.265 -0.897 . . . . 0.0 108.686 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.809 ' ND2' ' N ' ' A' ' 131' ' ' GLY . 0.0 OUTLIER -77.97 -95.56 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.809 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -160.88 33.22 0.39 Allowed Glycine 0 CA--C 1.562 2.978 0 O-C-N 120.594 -1.316 . . . . 0.0 111.131 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.454 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 63.6 tt0 -122.98 161.97 23.21 Favored 'General case' 0 N--CA 1.52 3.061 0 O-C-N 119.012 -2.463 . . . . 0.0 109.463 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -77.45 170.66 16.16 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.424 -0.798 . . . . 0.0 112.625 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.855 HD22 ' H ' ' A' ' 135' ' ' VAL . 0.2 OUTLIER -171.67 149.97 2.65 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.855 ' H ' HD22 ' A' ' 134' ' ' ASN . 0.9 OUTLIER -133.67 131.88 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 119.877 -1.764 . . . . 0.0 108.93 -178.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.01 177.17 9.81 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 121.068 -1.02 . . . . 0.0 110.969 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.78 134.61 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.895 -1.128 . . . . 0.0 111.297 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -98.77 120.19 38.78 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.479 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.611 ' NE ' HE22 ' A' ' 144' ' ' GLN . 6.8 ptp180 -141.41 110.02 6.04 Favored 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 117.871 -1.532 . . . . 0.0 112.062 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -156.81 105.91 0.28 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 58.44 -39.84 0.06 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.343 -0.504 . . . . 0.0 111.586 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 140' ' ' GLY . 71.8 mt -72.81 -85.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.908 -1.12 . . . . 0.0 110.769 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.405 ' CB ' HD23 ' A' ' 169' ' ' LEU . . . -179.05 154.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.964 -1.094 . . . . 0.0 110.25 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.611 HE22 ' NE ' ' A' ' 139' ' ' ARG . 5.0 mm100 -46.46 136.14 7.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.092 -1.005 . . . . 0.0 108.496 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.88 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -148.04 156.6 42.82 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tp -114.93 150.76 35.19 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 122.5 2.409 . . . . 0.0 109.621 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.61 ' NH2' ' NH1' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -150.41 129.32 12.53 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.849 1.309 . . . . 0.0 112.449 -179.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 53' ' ' ALA . 10.0 m -91.91 150.15 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.317 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 46.3 m-85 -116.03 138.79 50.91 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.481 ' O ' ' N ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -138.3 138.75 23.39 Favored Pre-proline 0 C--O 1.208 -1.126 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -89.68 155.29 5.17 Favored 'Trans proline' 0 N--CA 1.515 2.782 0 C-N-CA 123.881 3.054 . . . . 0.0 115.136 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.8 mt -121.35 131.4 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.865 -0.522 . . . . 0.0 109.65 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.522 ' C ' ' H ' ' A' ' 155' ' ' GLU . 86.9 m-85 -101.29 144.15 30.48 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.022 -1.049 . . . . 0.0 111.283 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 57.0 t0 -58.86 2.49 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.768 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 153' ' ' TYR . 17.9 tt0 86.24 29.62 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.825 -1.172 . . . . 0.0 108.629 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -149.36 18.6 0.94 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 71.63 9.78 6.36 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -88.55 116.79 27.04 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.707 ' NE2' ' N ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -68.69 117.54 10.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.087 -1.008 . . . . 0.0 113.332 -177.134 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.421 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.8 pp -134.19 11.13 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -174.21 179.19 45.71 Favored Glycine 0 N--CA 1.504 3.208 0 C-N-CA 115.163 -3.399 . . . . 0.0 114.146 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 96.7 t -143.32 140.62 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-O 122.484 1.135 . . . . 0.0 111.779 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 150' ' ' THR . 63.6 t -111.36 127.39 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.675 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . . . -115.72 153.13 31.91 Favored 'General case' 0 N--CA 1.51 2.563 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.63 HG21 ' HB1' ' A' ' 56' ' ' ALA . 24.5 mt -148.6 103.5 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -114.25 140.97 16.72 Favored Glycine 0 N--CA 1.485 1.946 0 CA-C-O 123.399 1.555 . . . . 0.0 112.115 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.88 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 50.6 tp -97.12 106.23 18.52 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 169' ' ' LEU . 0.5 OUTLIER -72.87 142.59 47.94 Favored 'General case' 0 N--CA 1.524 3.269 0 O-C-N 124.002 0.813 . . . . 0.0 109.414 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 168' ' ' GLU . 3.1 mt . . . . . 0 N--CA 1.515 2.777 0 O-C-N 120.039 -1.663 . . . . 0.0 113.935 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 48' ' ' THR . 62.0 p . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 121.988 0.899 . . . . 0.0 108.907 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 49' ' ' ARG . 35.0 t70 -60.92 -57.59 12.01 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.128 0.966 . . . . 0.0 110.97 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 15.5 mmm -39.4 -59.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.819 -1.175 . . . . 0.0 111.575 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.45 ' OG1' ' CD2' ' A' ' 52' ' ' LEU . 11.6 t -57.91 -31.73 67.07 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 62.3 ttt180 -42.32 -56.43 2.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.779 -1.201 . . . . 0.0 110.761 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -69.98 -63.39 1.09 Allowed 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 126.18 1.792 . . . . 0.0 114.511 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -83.14 -41.01 8.8 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 119.204 -1.474 . . . . 0.0 111.243 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.572 HD11 HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -50.69 -45.61 58.35 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.596 2.698 . . . . 0.0 106.309 176.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.435 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . -48.98 -65.94 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.995 -1.066 . . . . 0.0 110.004 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -67.14 -55.79 12.69 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.585 -1.322 . . . . 0.0 112.64 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' GLY . 55.0 mtpt -68.55 -49.6 58.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -174.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.66 -33.14 70.64 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 118.965 -2.334 . . . . 0.0 111.267 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.881 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.8 tt -65.64 -37.89 87.84 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 120.505 -1.372 . . . . 0.0 110.921 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 61' ' ' ARG . . . -74.42 -47.46 33.69 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 119.201 -2.187 . . . . 0.0 115.703 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.68 -35.95 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 118.617 -2.552 . . . . 0.0 106.395 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.528 ' HB2' HD12 ' A' ' 98' ' ' ILE . . . -55.96 -32.42 63.84 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.606 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -67.83 -22.58 65.15 Favored 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 117.726 -1.131 . . . . 0.0 111.093 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 m -59.77 -47.89 83.88 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 123.701 2.955 . . . . 0.0 106.429 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.684 HD22 ' HB1' ' A' ' 84' ' ' ALA . 26.1 mt -85.77 -36.49 20.09 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.314 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -64.73 -22.0 66.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 119.81 -1.807 . . . . 0.0 106.194 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 15.5 t0 -78.58 -11.08 59.95 Favored 'General case' 0 N--CA 1.53 3.529 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.732 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.513 ' CB ' ' CD ' ' A' ' 67' ' ' PRO 0.265 0.9 OUTLIER -71.62 -152.54 0.0 OUTLIER Pre-proline 0 C--N 1.277 -2.586 0 O-C-N 120.662 -1.274 . . . . 0.0 108.426 179.206 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.3 OUTLIER -103.27 -20.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 123.252 2.635 . . . . 0.0 111.542 176.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.504 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 9.6 pt-20 -58.06 -37.23 74.03 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.368 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.799 HG22 ' H ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -49.5 -78.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.771 0 O-C-N 120.228 -1.545 . . . . 0.0 111.403 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.799 ' H ' HG22 ' A' ' 69' ' ' ILE . 61.2 ttt180 -52.11 -31.3 30.13 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -174.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 19.5 tt0 -84.83 -12.07 54.35 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.102 -1.439 . . . . 0.0 112.386 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -91.09 -51.35 2.62 Favored Glycine 0 N--CA 1.503 3.148 1 N-CA-C 101.72 -4.552 . . . . 0.0 101.72 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.448 HD13 HG12 ' A' ' 100' ' ' VAL . 6.2 tp -43.71 -38.87 3.35 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 112.837 -1.682 . . . . 0.0 107.403 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 23.4 tt0 -64.97 -0.83 1.7 Allowed 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.384 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.894 ' O ' ' O ' ' A' ' 76' ' ' LYS . 21.1 tptp -135.44 68.59 1.45 Allowed 'General case' 0 N--CA 1.517 2.894 0 O-C-N 119.985 -1.697 . . . . 0.0 113.698 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.894 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 11.61 154.55 0.0 OUTLIER Pre-proline 0 N--CA 1.536 3.853 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -29.33 -56.05 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.4 2.733 . . . . 0.0 115.315 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -53.0 131.96 36.95 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 118.158 -1.417 . . . . 0.0 109.766 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 68.78 9.43 7.36 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.864 ' O ' ' N ' ' A' ' 82' ' ' ILE . 30.1 m -78.85 84.24 4.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.746 -1.846 . . . . 0.0 110.043 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -41.98 64.44 0.0 OUTLIER Glycine 0 N--CA 1.504 3.199 0 C-N-CA 119.721 -1.228 . . . . 0.0 111.248 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.864 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.8 tp -71.68 4.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.606 -1.526 . . . . 0.0 107.699 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.579 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 34.5 tp60 -53.99 -32.13 53.08 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.346 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.75 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -79.31 -99.75 0.03 OUTLIER 'General case' 0 C--O 1.189 -2.105 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.682 ' C ' ' O ' ' A' ' 84' ' ' ALA . 2.0 mp -9.58 -54.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.597 0 CA-C-N 122.592 2.451 . . . . 0.0 111.651 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -59.76 -53.64 55.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 119.977 -1.702 . . . . 0.0 109.477 176.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.75 ' N ' ' O ' ' A' ' 84' ' ' ALA . 87.6 tt0 -40.06 -55.02 2.17 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.319 -1.309 . . . . 0.0 112.074 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -66.11 -63.86 0.99 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 114.2 -3.0 . . . . 0.0 108.159 -177.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 90' ' ' ARG . 2.1 t -45.09 -72.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 115.162 -2.615 . . . . 0.0 110.303 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 1.213 ' CG ' HD11 ' A' ' 96' ' ' LEU . 78.1 mtp180 -32.5 -49.76 0.22 Allowed 'General case' 0 N--CA 1.51 2.53 0 O-C-N 121.08 -1.012 . . . . 0.0 110.308 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.576 ' C ' ' O ' ' A' ' 90' ' ' ARG . 15.6 tptm -33.96 -36.45 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 118.291 -1.364 . . . . 0.0 108.037 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.561 ' N ' ' O ' ' A' ' 90' ' ' ARG . 60.5 mtm180 -56.01 -65.63 0.57 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 117.392 -1.29 . . . . 0.0 108.471 171.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.618 ' O ' ' CG ' ' A' ' 94' ' ' ASP . 2.1 p30 -115.9 -69.9 0.83 Allowed 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 113.869 -3.132 . . . . 0.0 109.673 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.618 ' CG ' ' O ' ' A' ' 93' ' ' ASN . 34.4 m-20 155.35 -9.49 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 121.972 0.892 . . . . 0.0 109.988 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.692 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -120.45 152.51 37.89 Favored 'General case' 0 C--O 1.182 -2.476 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.89 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.213 HD11 ' CG ' ' A' ' 90' ' ' ARG . 0.5 OUTLIER 142.2 152.37 0.0 OUTLIER 'General case' 1 N--CA 1.549 4.494 0 CA-C-O 115.971 -1.966 . . . . 0.0 109.379 -178.211 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 110' ' ' HIS . 0.1 OUTLIER -116.1 96.84 5.76 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 125.239 3.654 . . . . 0.0 103.754 171.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -90.31 107.03 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 178.558 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 164' ' ' ALA . 22.0 m -131.44 143.89 39.19 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 124.2 1.953 . . . . 0.0 115.644 -171.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.753 HG21 HD11 ' A' ' 69' ' ' ILE . 38.3 t -109.62 138.34 37.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 101.901 -3.37 . . . . 0.0 101.901 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.436 ' HA ' ' CE1' ' A' ' 108' ' ' TYR . 11.3 p -118.91 148.56 42.8 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 104' ' ' GLN . 32.8 t70 -80.21 -173.71 4.14 Favored 'General case' 0 C--N 1.288 -2.1 1 N-CA-C 98.992 -4.447 . . . . 0.0 98.992 171.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 ttp -74.55 71.02 1.83 Allowed 'General case' 0 C--N 1.27 -2.849 0 C-N-CA 113.978 -3.089 . . . . 0.0 105.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.2 tp-100 -145.14 -47.81 0.23 Allowed 'General case' 0 C--O 1.211 -0.965 0 O-C-N 120.31 -1.494 . . . . 0.0 110.116 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.566 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.7 t 86.9 138.0 0.05 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.4 OUTLIER 156.35 138.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.537 -3.135 . . . . 0.0 102.537 176.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.529 HH22 ' CG ' ' A' ' 138' ' ' ASN . 2.6 mpt_? -74.47 97.79 3.18 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.436 ' CE1' ' HA ' ' A' ' 101' ' ' THR . 2.9 m-85 -49.21 -22.53 1.04 Allowed 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.504 ' N ' ' C ' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -131.58 163.44 28.04 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -175.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 97' ' ' PHE . 0.1 OUTLIER 170.96 143.99 0.11 Allowed Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 120.959 -1.088 . . . . 0.0 110.943 178.249 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.44 -44.32 6.68 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 N-CA-C 105.479 -2.546 . . . . 0.0 105.479 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -108.3 109.17 20.44 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.75 67.7 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.561 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.51 -36.94 74.58 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 119.153 -2.217 . . . . 0.0 113.179 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.488 ' NH1' ' N ' ' A' ' 140' ' ' GLY . 0.5 OUTLIER -56.5 -41.6 76.93 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.466 -2.021 . . . . 0.0 107.35 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.741 ' O ' ' N ' ' A' ' 118' ' ' GLN . 85.6 mt -40.66 -80.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.102 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 116' ' ' ILE . . . -27.58 -18.72 0.0 OUTLIER Glycine 0 N--CA 1.497 2.742 0 CA-C-O 119.451 -0.638 . . . . 0.0 113.431 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.741 ' N ' ' O ' ' A' ' 116' ' ' ILE . 5.5 mm-40 -73.43 -70.96 0.24 Allowed Pre-proline 0 N--CA 1.501 2.125 0 CA-C-N 120.942 2.371 . . . . 0.0 112.885 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.666 ' O ' ' O ' ' A' ' 118' ' ' GLN . 75.7 Cg_exo -20.11 156.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 124.05 3.166 . . . . 0.0 114.155 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.496 ' CB ' ' O ' ' A' ' 119' ' ' PRO . 28.4 t80 89.16 145.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.76 72.89 0.5 Allowed 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 117.375 -1.73 . . . . 0.0 111.358 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.665 ' O ' ' OD2' ' A' ' 123' ' ' ASP . . . -152.36 -58.23 0.01 OUTLIER Glycine 0 N--CA 1.507 3.393 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 176.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.665 ' OD2' ' O ' ' A' ' 122' ' ' GLY . 14.3 m-20 131.78 1.88 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.546 0 CA-C-N 117.653 0.727 . . . . 0.0 110.567 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -95.31 -26.7 15.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.572 -1.33 . . . . 0.0 108.683 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.486 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 0.3 OUTLIER -84.44 -18.11 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.272 -1.518 . . . . 0.0 109.928 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -50.42 -36.08 31.41 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.654 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 58.5 mttp -80.24 -33.76 37.73 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.27 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.497 ' C ' ' ND2' ' A' ' 130' ' ' ASN . . . -86.74 -28.68 22.9 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 119.788 -1.82 . . . . 0.0 110.321 -176.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.4 mt -50.11 -25.75 3.81 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.648 0.737 . . . . 0.0 109.127 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.831 ' ND2' ' N ' ' A' ' 131' ' ' GLY 0.269 0.0 OUTLIER -78.28 -97.05 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.61 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.831 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -161.75 49.15 0.35 Allowed Glycine 0 CA--C 1.549 2.218 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.478 ' H ' HD21 ' A' ' 130' ' ' ASN . 93.2 mt-10 -142.31 163.46 32.79 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.178 -1.778 . . . . 0.0 109.632 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 149' ' ' PHE . 56.2 mm-40 -71.82 165.3 24.37 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.345 0.593 . . . . 0.0 112.054 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 5.2 t30 -168.69 144.62 3.55 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.599 ' CG2' HG12 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -132.49 131.12 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 120.24 -1.538 . . . . 0.0 109.848 -178.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.28 168.18 24.02 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.327 -0.858 . . . . 0.0 109.911 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.83 139.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.85 0.833 . . . . 0.0 111.635 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.529 ' CG ' HH22 ' A' ' 107' ' ' ARG . 6.7 t-20 -101.93 130.14 48.37 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 122.231 1.015 . . . . 0.0 111.973 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -127.96 119.65 25.97 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.583 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.488 ' N ' ' NH1' ' A' ' 115' ' ' ARG . . . -156.0 167.66 33.32 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.455 ' C ' ' O ' ' A' ' 140' ' ' GLY . 73.2 m-85 -34.48 -36.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.915 -0.756 . . . . 0.0 110.973 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.71 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 47.5 mt -60.87 -67.92 0.36 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.896 -1.128 . . . . 0.0 110.076 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 142' ' ' LEU . . . 158.36 158.43 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.842 0.829 . . . . 0.0 110.718 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -44.77 137.25 4.06 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.085 0.945 . . . . 0.0 111.341 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.817 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -151.48 150.88 30.91 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 tp -104.67 157.09 17.43 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-N 122.032 2.196 . . . . 0.0 108.896 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.456 ' HD2' HH21 ' A' ' 107' ' ' ARG . 12.4 ptt180 -146.21 153.82 41.05 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.423 1.106 . . . . 0.0 110.592 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.599 HG12 ' CG2' ' A' ' 135' ' ' VAL . 6.9 m -117.97 153.32 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.431 ' O ' ' OE1' ' A' ' 133' ' ' GLU . 68.7 m-85 -121.65 144.42 48.77 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.56 139.17 16.06 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -87.98 153.21 7.12 Favored 'Trans proline' 0 N--CA 1.513 2.618 0 C-N-CA 123.944 3.096 . . . . 0.0 114.88 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.5 mt -118.22 132.64 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 43.1 m-85 -103.24 148.91 25.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.947 -1.096 . . . . 0.0 113.532 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 156' ' ' ASN . 52.2 t0 -72.47 51.15 0.25 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 153' ' ' TYR . 31.1 tt0 42.98 17.28 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.231 -0.918 . . . . 0.0 111.033 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 158' ' ' LYS . 36.2 m120 -132.99 30.77 3.95 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.885 -1.135 . . . . 0.0 109.073 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 61.82 3.64 0.94 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.8 mptt -86.19 133.76 33.83 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.724 ' H ' HE21 ' A' ' 159' ' ' GLN . 0.0 OUTLIER -85.72 129.09 34.92 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -175.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.13 8.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.813 0 O-C-N 118.841 -2.412 . . . . 0.0 117.305 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.28 -179.9 44.26 Favored Glycine 0 N--CA 1.515 3.915 0 C-N-CA 115.918 -3.039 . . . . 0.0 112.077 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 101' ' ' THR . 70.8 t -141.95 138.85 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.892 -1.358 . . . . 0.0 111.668 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.94 126.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.547 ' O ' HG22 ' A' ' 99' ' ' VAL . . . -114.27 158.8 20.92 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 147' ' ' ARG . 35.4 mt -151.43 101.04 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.225 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.98 131.03 10.46 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.264 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.817 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -93.14 110.35 21.85 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.46 ' CD ' ' N ' ' A' ' 169' ' ' LEU . 14.8 tm-20 -57.61 163.74 2.34 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 143' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.976 0 O-C-N 120.517 -1.365 . . . . 0.0 110.644 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 48' ' ' THR . 48.9 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.418 0.628 . . . . 0.0 109.366 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 49' ' ' ARG . 27.3 m-20 -69.59 -56.74 6.47 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.832 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -51.73 -45.98 63.83 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.219 -1.551 . . . . 0.0 109.466 -173.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 45' ' ' SER . 6.0 t -60.3 -32.3 71.08 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' THR . 69.2 ttt180 -42.48 -61.3 1.25 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.244 -1.535 . . . . 0.0 110.481 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.95 -59.93 2.51 Favored 'General case' 0 N--CA 1.507 2.391 0 C-N-CA 125.686 1.594 . . . . 0.0 114.496 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 52' ' ' LEU . . . -79.13 -49.34 6.38 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.97 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -48.95 -44.65 40.83 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 121.273 2.537 . . . . 0.0 107.17 176.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 57' ' ' LEU . . . -48.94 -70.58 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.937 -1.102 . . . . 0.0 109.09 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -61.56 -55.72 27.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.825 0.822 . . . . 0.0 111.843 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -63.32 -61.25 2.48 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' HB3' HD12 ' A' ' 52' ' ' LEU . . . -65.7 -27.48 68.37 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 121.947 2.158 . . . . 0.0 111.75 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.8 tt -66.02 -31.36 72.21 Favored 'General case' 0 C--N 1.283 -2.325 0 O-C-N 119.662 -1.899 . . . . 0.0 108.359 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.91 -46.36 14.17 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.63 -33.96 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 118.597 -2.564 . . . . 0.0 106.224 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 98' ' ' ILE . . . -59.43 -37.47 78.15 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 117.871 -1.531 . . . . 0.0 107.281 174.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.559 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 2.6 ptt180 -64.49 -15.03 60.09 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.741 -1.184 . . . . 0.0 108.397 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.683 HG22 HD12 ' A' ' 63' ' ' LEU . 6.7 m -67.49 -49.06 65.18 Favored 'General case' 0 CA--C 1.485 -1.526 0 C-N-CA 114.666 -2.814 . . . . 0.0 104.848 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 62' ' ' THR . 5.7 mp -84.02 -45.1 13.45 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.533 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -50.59 -19.27 0.86 Allowed 'General case' 0 N--CA 1.524 3.269 0 CA-C-O 123.637 1.685 . . . . 0.0 106.544 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.535 ' N ' ' C ' ' A' ' 63' ' ' LEU . 17.7 t0 -88.03 -9.17 54.22 Favored 'General case' 0 N--CA 1.521 3.099 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.897 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.529 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -71.18 -154.2 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 120.46 -1.4 . . . . 0.0 110.523 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.567 ' C ' ' H ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -107.05 -32.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 123.626 2.884 . . . . 0.0 115.054 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.511 ' C ' HD12 ' A' ' 69' ' ' ILE . 12.6 pt-20 -77.88 33.51 0.18 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.658 HG22 ' N ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -110.34 -84.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 175.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.658 ' N ' HG22 ' A' ' 69' ' ' ILE . 78.8 ttt180 -45.19 -32.55 1.91 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.043 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 9.5 tt0 -85.56 -16.4 39.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.928 -1.107 . . . . 0.0 111.524 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -100.17 -10.46 45.32 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 104.77 -3.332 . . . . 0.0 104.77 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -85.17 -38.56 18.87 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 102.681 -3.081 . . . . 0.0 102.681 174.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.77 -6.6 1.82 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.832 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.748 ' O ' ' O ' ' A' ' 76' ' ' LYS . 18.8 mmtt -125.89 64.19 1.21 Allowed 'General case' 0 N--CA 1.526 3.355 0 CA-C-N 120.233 1.378 . . . . 0.0 112.228 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.748 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 25.4 153.38 0.0 OUTLIER Pre-proline 0 N--CA 1.524 3.253 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -31.93 -61.77 0.15 Allowed 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 123.027 2.485 . . . . 0.0 113.851 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.664 ' CB ' ' HZ2' ' A' ' 76' ' ' LYS . 7.8 tt0 -52.47 137.44 29.82 Favored 'General case' 0 C--N 1.287 -2.109 0 C-N-CA 117.81 -1.556 . . . . 0.0 108.617 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' A' ' 78' ' ' GLN . 24.1 tt0 77.23 -29.31 0.17 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.304 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.773 ' O ' ' N ' ' A' ' 82' ' ' ILE . 8.6 t -46.1 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.334 -1.479 . . . . 0.0 112.674 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -54.44 48.22 0.01 OUTLIER Glycine 0 CA--C 1.562 3.008 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.258 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.773 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.2 tp -56.78 3.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -1.207 . . . . 0.0 109.995 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.63 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 35.0 tp60 -57.74 -22.22 45.44 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.498 -1.376 . . . . 0.0 110.969 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.647 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -77.8 -72.51 0.36 Allowed 'General case' 0 N--CA 1.506 2.375 0 O-C-N 119.85 -1.781 . . . . 0.0 111.353 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -39.76 -55.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 120.518 1.508 . . . . 0.0 110.159 171.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.1 -35.7 48.68 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 119.907 -1.746 . . . . 0.0 108.807 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 69.9 tt0 -65.7 -56.09 13.92 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 114.075 -1.421 . . . . 0.0 112.03 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -61.71 -65.02 0.76 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 123.819 3.009 . . . . 0.0 109.412 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -45.78 -65.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 C-N-CA 115.021 -2.671 . . . . 0.0 110.769 -175.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.594 ' N ' ' HB2' ' A' ' 94' ' ' ASP . 48.4 ttp180 -34.52 -44.58 0.2 Allowed 'General case' 0 N--CA 1.516 2.853 0 O-C-N 121.012 -1.055 . . . . 0.0 109.622 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 90' ' ' ARG . 40.8 tptt -43.92 -60.11 1.98 Allowed 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 117.395 -1.722 . . . . 0.0 107.197 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 89' ' ' VAL . 38.7 mtm180 -61.99 -65.75 0.64 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.691 -1.204 . . . . 0.0 107.996 174.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 173.2 103.88 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.751 ' C ' ' H ' ' A' ' 96' ' ' LEU . 27.3 t70 -136.71 54.11 1.88 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.037 0.922 . . . . 0.0 109.2 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.3 mt -72.96 40.21 0.09 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 124.237 1.97 . . . . 0.0 106.609 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.965 HD11 HD12 ' A' ' 167' ' ' LEU 0.326 0.6 OUTLIER -107.17 175.43 5.5 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-N 111.312 -2.676 . . . . 0.0 109.65 -178.834 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -107.12 100.64 10.1 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 101.759 -3.423 . . . . 0.0 101.759 171.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.409 ' CD1' ' HB2' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -88.64 131.1 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.624 HG22 ' H ' ' A' ' 164' ' ' ALA . 0.9 OUTLIER -133.32 157.91 42.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 124.79 2.233 . . . . 0.0 113.525 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.15 125.23 38.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 1 N-CA-C 99.043 -4.428 . . . . 0.0 99.043 173.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.554 HG23 HG23 ' A' ' 99' ' ' VAL . 26.9 p -125.06 157.83 35.28 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 120.673 -1.267 . . . . 0.0 109.976 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -83.58 -175.17 5.69 Favored 'General case' 0 C--N 1.297 -1.707 1 N-CA-C 97.512 -4.995 . . . . 0.0 97.512 170.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -76.5 85.06 3.21 Favored 'General case' 0 C--N 1.267 -3.009 0 C-N-CA 114.877 -2.729 . . . . 0.0 105.312 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.524 ' O ' ' CB ' ' A' ' 105' ' ' SER . 3.0 tm0? -153.02 -42.25 0.1 Allowed 'General case' 0 CA--C 1.549 0.928 0 O-C-N 120.751 -1.218 . . . . 0.0 109.444 -176.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.625 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.1 t 83.23 138.32 0.06 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.724 ' H ' HH21 ' A' ' 107' ' ' ARG . 0.8 OUTLIER 154.15 134.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 177.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.724 HH21 ' H ' ' A' ' 106' ' ' LEU . 2.6 mmp_? -71.62 94.42 1.33 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 116.842 -1.943 . . . . 0.0 106.717 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.601 ' C ' HG21 ' A' ' 82' ' ' ILE . 2.6 m-85 -50.83 -37.08 40.84 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -118.12 167.55 11.38 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.024 -1.443 . . . . 0.0 112.441 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 1.004 ' CD2' HD11 ' A' ' 116' ' ' ILE . 11.9 p80 178.51 151.19 0.45 Allowed Pre-proline 0 N--CA 1.496 1.854 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.204 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.64 -28.3 1.8 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 N-CA-C 107.397 -1.809 . . . . 0.0 107.397 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -119.91 138.27 53.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.42 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.52 -50.38 38.34 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.022 -1.049 . . . . 0.0 113.555 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.15 -38.64 71.13 Favored 'General case' 0 CA--C 1.571 1.775 0 O-C-N 120.152 -1.593 . . . . 0.0 114.936 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.61 ' NH1' ' ND2' ' A' ' 138' ' ' ASN . 0.5 OUTLIER -57.87 -45.25 86.61 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.042 -2.286 . . . . 0.0 109.201 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 1.004 HD11 ' CD2' ' A' ' 110' ' ' HIS . 89.6 mt -29.95 -91.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.745 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -45.31 -16.78 0.1 Allowed Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.455 -0.778 . . . . 0.0 114.452 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -59.47 -65.7 1.89 Allowed Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 120.601 2.2 . . . . 0.0 112.439 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 116' ' ' ILE . 1.1 Cg_endo -39.41 103.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 123.487 2.791 . . . . 0.0 113.597 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 122' ' ' GLY . 35.4 t80 -162.43 141.51 9.18 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt 47.7 11.34 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.195 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 120' ' ' PHE . . . -60.45 -15.01 37.24 Favored Glycine 0 N--CA 1.505 3.282 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 122' ' ' GLY . 11.9 t70 71.99 -2.27 2.59 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.11 -1.229 . . . . 0.0 111.49 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.599 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 10.5 p-10 -92.56 -45.88 7.89 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.1 -15.84 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.548 -1.345 . . . . 0.0 110.095 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -55.24 -29.66 58.48 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.355 -1.466 . . . . 0.0 108.148 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 130' ' ' ASN . 68.5 mttm -79.91 -24.99 40.73 Favored 'General case' 0 C--O 1.194 -1.818 0 O-C-N 121.964 -0.46 . . . . 0.0 110.343 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.684 ' O ' ' ND2' ' A' ' 130' ' ' ASN . . . -90.09 -33.21 16.37 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 119.792 -1.818 . . . . 0.0 110.012 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 mt -48.98 -29.53 4.93 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.064 0.935 . . . . 0.0 109.009 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 1.081 ' ND2' ' H ' ' A' ' 131' ' ' GLY . 0.0 OUTLIER -56.9 -78.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 109.768 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 1.081 ' H ' ' ND2' ' A' ' 130' ' ' ASN . . . 167.34 35.05 0.02 OUTLIER Glycine 0 CA--C 1.539 1.578 0 C-N-CA 128.808 3.099 . . . . 0.0 107.586 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.613 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 93.6 mt-10 -141.03 162.69 34.9 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 119.605 1.702 . . . . 0.0 109.767 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -76.08 165.68 24.58 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.621 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -168.98 153.33 5.59 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -133.45 136.44 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.016 -1.052 . . . . 0.0 110.556 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.57 172.16 13.37 Favored 'General case' 0 N--CA 1.518 2.96 0 O-C-N 120.528 -1.357 . . . . 0.0 109.682 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.6 136.0 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 120.641 -1.287 . . . . 0.0 110.349 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.61 ' ND2' ' NH1' ' A' ' 115' ' ' ARG . 3.8 t30 -103.98 133.61 48.65 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.462 -0.774 . . . . 0.0 109.005 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -132.75 100.91 5.08 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.676 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -116.47 164.13 12.35 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -44.35 -13.89 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.34 -1.094 . . . . 0.0 110.494 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -75.53 -72.37 0.31 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.984 -1.073 . . . . 0.0 108.7 -179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 144' ' ' GLN . . . 176.43 149.61 0.13 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.428 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' ALA . 97.2 mt-30 -35.06 152.55 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.481 0.658 . . . . 0.0 110.139 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.974 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -157.2 152.4 26.17 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 117.357 -1.306 . . . . 0.0 107.855 -176.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.8 tp -116.37 144.23 44.54 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 123.149 2.704 . . . . 0.0 109.684 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -129.44 147.62 51.27 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.338 1.066 . . . . 0.0 110.97 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.52 HG12 ' CG2' ' A' ' 135' ' ' VAL . 7.3 m -114.05 158.35 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -132.88 138.96 47.18 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.67 138.76 29.03 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -86.45 155.31 9.24 Favored 'Trans proline' 0 C--N 1.295 -2.247 0 C-N-CA 122.555 2.17 . . . . 0.0 113.758 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 62.6 mt -118.2 135.44 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . 0.304 65.2 m-85 -106.24 151.77 24.36 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 155' ' ' GLU . 63.0 t0 -78.46 164.35 24.83 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.573 ' N ' ' OD1' ' A' ' 154' ' ' ASP . 18.5 tt0 -47.95 -9.31 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.241 -1.383 . . . . 0.0 112.976 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 154' ' ' ASP . 16.7 m120 -121.83 49.62 1.53 Allowed 'General case' 0 N--CA 1.518 2.971 0 O-C-N 120.348 -1.47 . . . . 0.0 114.268 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 57.39 9.32 0.73 Allowed 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.998 -1.064 . . . . 0.0 110.443 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -83.69 128.79 34.79 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.763 ' N ' HE21 ' A' ' 159' ' ' GLN . 0.0 OUTLIER -74.96 126.72 31.61 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.182 -0.949 . . . . 0.0 112.662 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.419 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.7 pp -141.73 12.43 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.601 0 O-C-N 119.028 -2.295 . . . . 0.0 116.231 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.11 174.51 46.83 Favored Glycine 0 N--CA 1.501 3.025 0 C-N-CA 115.774 -3.108 . . . . 0.0 112.002 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.9 t -137.55 143.51 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.576 1.179 . . . . 0.0 113.215 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 40.6 t -109.6 129.2 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.624 ' H ' HG22 ' A' ' 99' ' ' VAL . . . -127.01 157.53 39.35 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.231 -0.918 . . . . 0.0 108.845 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 147' ' ' ARG . 16.3 mt -151.12 99.99 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 96' ' ' LEU . . . -108.03 118.14 5.34 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.918 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.974 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.8 tp -72.38 120.23 17.71 Favored 'General case' 0 C--O 1.193 -1.914 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.07 -30.11 63.45 Favored 'General case' 1 N--CA 1.542 4.163 0 CA-C-O 123.11 1.433 . . . . 0.0 110.37 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.814 0 CA-C-N 113.67 -1.604 . . . . 0.0 114.399 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 46' ' ' ASP . 74.4 p . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.751 0.786 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 47' ' ' MET . 69.5 m-20 -74.75 -65.39 0.87 Allowed 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.529 1.157 . . . . 0.0 109.967 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 46' ' ' ASP . 26.4 ttt -41.76 -54.76 3.23 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 122.267 1.032 . . . . 0.0 111.146 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.539 ' OG1' ' HB3' ' A' ' 52' ' ' LEU . 13.5 t -58.77 -35.94 73.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.273 1.035 . . . . 0.0 110.158 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.447 ' N ' HG23 ' A' ' 48' ' ' THR . 67.1 ttp85 -39.04 -52.66 1.83 Allowed 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 122.253 1.025 . . . . 0.0 111.855 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -86.06 -55.44 3.94 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -78.2 -45.76 9.81 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.787 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.539 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -56.64 -41.82 77.82 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 120.894 2.347 . . . . 0.0 105.068 176.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 49' ' ' ARG . . . -51.05 -59.39 4.22 Favored 'General case' 0 C--O 1.206 -1.184 0 C-N-CA 117.613 -1.635 . . . . 0.0 107.86 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -74.85 -68.36 0.55 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.457 -1.402 . . . . 0.0 112.457 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 51' ' ' GLY . 25.7 mtpp -47.75 -41.56 23.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 112.703 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.593 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -86.62 -27.28 23.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 119.103 -2.248 . . . . 0.0 110.246 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 28.7 tp -62.93 -46.4 87.97 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 120.187 -1.571 . . . . 0.0 107.711 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.02 77.3 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 t -76.44 -30.72 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 119.378 -2.076 . . . . 0.0 107.261 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.973 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -64.44 -28.55 69.75 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 176.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -78.85 -16.89 56.49 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.398 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.0 m -72.29 -43.61 63.97 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 115.499 -2.48 . . . . 0.0 107.149 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.808 HD12 ' HB1' ' A' ' 84' ' ' ALA . 3.8 mm? -85.71 -36.18 20.37 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.313 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.846 ' O ' HG21 ' A' ' 69' ' ' ILE . . . -62.21 -13.66 30.01 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.492 ' N ' ' C ' ' A' ' 63' ' ' LEU . 16.3 t0 -94.52 -11.35 29.77 Favored 'General case' 0 N--CA 1.518 2.975 0 CA-C-N 112.652 -2.067 . . . . 0.0 112.07 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.522 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -66.38 -152.83 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.97 0 O-C-N 120.054 -1.653 . . . . 0.0 109.695 -179.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.5 OUTLIER -104.11 -38.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.478 2.119 . . . . 0.0 113.582 178.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 7.1 pt-20 -48.32 -29.65 4.12 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.763 1.268 . . . . 0.0 108.104 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.846 HG21 ' O ' ' A' ' 64' ' ' ALA . 42.9 mm -56.44 -78.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.028 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' ILE . 45.2 ttt85 -46.19 -31.23 2.32 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -79.16 -14.24 59.22 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.683 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.703 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -83.69 -43.82 7.11 Favored Glycine 0 N--CA 1.487 2.085 1 N-CA-C 101.966 -4.454 . . . . 0.0 101.966 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 152' ' ' ILE . 7.5 mp -49.31 -39.9 32.96 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.35 -2.87 4.95 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 72' ' ' GLY . 20.5 tptt -122.73 -158.15 0.77 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.238 -1.539 . . . . 0.0 108.306 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.458 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -133.69 168.78 16.18 Favored Pre-proline 0 CA--C 1.569 1.684 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -38.59 -73.53 0.04 OUTLIER 'Trans proline' 0 N--CA 1.521 3.12 0 C-N-CA 124.927 3.751 . . . . 0.0 117.996 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.523 ' H ' ' CD ' ' A' ' 78' ' ' GLN . 2.2 mp0 -56.08 -14.25 2.52 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -174.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.458 ' OE1' ' NZ ' ' A' ' 76' ' ' LYS . 44.3 tt0 -121.74 2.76 10.07 Favored 'General case' 0 N--CA 1.514 2.757 0 O-C-N 120.61 -1.306 . . . . 0.0 110.78 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 40.4 t -66.97 -154.78 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.889 -1.132 . . . . 0.0 109.218 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.492 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . -149.58 64.95 0.39 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.532 ' CD1' ' H ' ' A' ' 100' ' ' VAL . 3.7 tp -76.22 7.41 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.737 -0.86 . . . . 0.0 110.455 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.701 ' O ' ' HB3' ' A' ' 86' ' ' ALA . 13.5 pt20 -63.48 -26.78 68.88 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 120.329 -1.482 . . . . 0.0 112.837 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.893 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -83.12 -60.63 2.09 Favored 'General case' 0 C--O 1.202 -1.442 0 O-C-N 118.861 -2.399 . . . . 0.0 108.622 -176.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.994 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -41.51 -43.88 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.249 0 CA-C-N 123.517 2.871 . . . . 0.0 105.756 172.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 83' ' ' GLN . . . -44.25 -25.07 0.2 Allowed 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 121.498 1.954 . . . . 0.0 108.143 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.893 ' N ' ' O ' ' A' ' 84' ' ' ALA . 53.6 mt-10 -52.21 -33.89 43.1 Favored 'General case' 0 N--CA 1.536 3.849 0 N-CA-C 102.352 -3.203 . . . . 0.0 102.352 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.876 ' N ' ' O ' ' A' ' 85' ' ' ILE . . . -68.82 -29.81 68.22 Favored 'General case' 0 N--CA 1.52 3.028 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.609 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.678 ' N ' ' O ' ' A' ' 86' ' ' ALA . 1.8 t -55.0 -55.8 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 O-C-N 120.525 -1.359 . . . . 0.0 107.656 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -56.22 -59.9 4.27 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.66 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -54.89 -49.98 69.87 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.024 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -57.8 -81.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.949 -1.094 . . . . 0.0 110.475 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.33 27.4 0.93 Allowed 'General case' 0 N--CA 1.513 2.676 0 CA-C-N 122.258 2.299 . . . . 0.0 113.029 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.9 t70 70.74 -1.34 2.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.973 -1.079 . . . . 0.0 108.742 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 1.3 pp -146.06 162.36 38.07 Favored 'General case' 0 N--CA 1.519 2.996 0 C-N-CA 118.289 -1.364 . . . . 0.0 111.7 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.501 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER 152.91 170.69 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.361 0 CA-C-O 117.513 -1.232 . . . . 0.0 108.245 -179.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.664 ' CD1' ' CD2' ' A' ' 110' ' ' HIS . 0.0 OUTLIER -119.75 82.8 1.94 Allowed 'General case' 0 C--O 1.215 -0.752 1 N-CA-C 96.318 -5.438 . . . . 0.0 96.318 166.605 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.973 HD11 ' HB2' ' A' ' 60' ' ' ALA . 1.5 tt -87.94 110.46 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.64 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 5.1 p -120.56 137.69 53.51 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.975 0 CA-C-N 112.173 -2.285 . . . . 0.0 113.424 -172.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.532 ' H ' ' CD1' ' A' ' 82' ' ' ILE . 38.9 t -113.98 140.18 35.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 1 N-CA-C 97.953 -4.832 . . . . 0.0 97.953 171.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 102' ' ' ASP . 38.0 p -122.06 145.28 48.3 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 120.767 1.621 . . . . 0.0 111.192 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 104' ' ' GLN . 66.3 t0 -74.18 -168.07 0.59 Allowed 'General case' 0 C--N 1.319 -0.746 1 N-CA-C 99.914 -4.106 . . . . 0.0 99.914 168.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.587 ' O ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -78.64 66.1 4.07 Favored 'General case' 0 C--N 1.274 -2.694 0 C-N-CA 115.207 -2.597 . . . . 0.0 104.985 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 102' ' ' ASP . 5.1 tm0? -170.89 107.93 0.29 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 101.179 -3.638 . . . . 0.0 101.179 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.738 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 29.1 t -61.67 161.17 10.33 Favored 'General case' 0 CA--C 1.462 -2.408 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.693 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.738 ' HB2' ' O ' ' A' ' 105' ' ' SER . 12.1 tp 153.5 142.27 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 116' ' ' ILE . 99.1 mtt180 -75.68 109.44 9.27 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 101' ' ' THR . 4.6 m-30 -70.94 -34.68 71.73 Favored 'General case' 0 C--N 1.262 -3.216 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 1.1 t -119.84 157.75 28.03 Favored 'General case' 0 C--O 1.196 -1.746 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.657 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.664 ' CD2' ' CD1' ' A' ' 97' ' ' PHE . 47.1 t-80 169.86 140.12 0.07 OUTLIER Pre-proline 0 N--CA 1.524 3.228 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.37 -55.86 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 CA-C-N 120.561 1.236 . . . . 0.0 109.136 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.529 ' OE1' ' NH2' ' A' ' 115' ' ' ARG . 34.0 mt-10 -79.75 142.48 35.36 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.46 -42.91 24.3 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.548 -0.72 . . . . 0.0 112.638 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -60.87 -35.64 77.13 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.529 ' NH2' ' OE1' ' A' ' 112' ' ' GLU . 3.8 tpp180 -61.96 -31.72 72.08 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 119.39 -2.069 . . . . 0.0 108.151 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.657 ' O ' ' N ' ' A' ' 118' ' ' GLN . 55.6 mt -51.69 -82.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 117.955 -1.498 . . . . 0.0 111.242 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.595 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -33.96 -11.69 0.0 OUTLIER Glycine 0 N--CA 1.498 2.793 0 CA-C-O 119.156 -0.802 . . . . 0.0 113.97 -175.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 116' ' ' ILE . 6.2 mm-40 -80.79 -70.5 0.16 Allowed Pre-proline 0 N--CA 1.503 2.223 0 CA-C-N 121.383 2.591 . . . . 0.0 113.369 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 17.4 Cg_exo -29.91 117.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 124.196 3.264 . . . . 0.0 114.651 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 122' ' ' GLY . 85.3 t80 -175.37 149.86 1.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 123' ' ' ASP . 27.3 ttpt 48.95 11.32 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.327 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 120' ' ' PHE . . . -46.28 -12.54 0.06 OUTLIER Glycine 0 N--CA 1.501 2.967 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 121' ' ' LYS . 4.2 m-20 62.71 -11.88 0.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.585 -0.95 . . . . 0.0 111.232 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 122' ' ' GLY . 49.8 m-20 -75.34 -29.4 59.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' LEU . 16.3 pt -78.03 -34.24 19.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.654 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -38.5 -32.62 0.08 Allowed 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.536 -0.727 . . . . 0.0 110.289 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -90.55 -40.23 12.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.157 -0.965 . . . . 0.0 109.571 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -78.74 -48.15 15.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.971 -1.08 . . . . 0.0 109.192 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.622 ' C ' HD22 ' A' ' 130' ' ' ASN . 1.5 mt -36.44 -42.03 0.32 Allowed 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 123.171 1.463 . . . . 0.0 108.053 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.622 HD22 ' C ' ' A' ' 129' ' ' LEU . 3.8 m120 -102.44 22.04 14.14 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.078 -1.419 . . . . 0.0 113.388 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 132' ' ' GLU . . . 87.16 100.87 0.84 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 131' ' ' GLY . 4.1 tp10 167.75 140.47 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.069 0 CA-C-N 113.551 -1.325 . . . . 0.0 113.394 175.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -81.77 142.29 32.74 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.923 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 4.0 t-20 -162.55 144.9 10.84 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.248 -1.533 . . . . 0.0 110.592 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 147' ' ' ARG . 8.6 p -135.58 151.86 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 O-C-N 119.774 -1.829 . . . . 0.0 108.29 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -159.48 162.7 35.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.82 -1.175 . . . . 0.0 109.372 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.59 141.71 16.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-O 122.214 1.007 . . . . 0.0 112.49 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -106.9 159.63 16.11 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -147.97 103.04 3.45 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.082 -1.636 . . . . 0.0 110.376 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.511 ' CA ' ' HB3' ' A' ' 143' ' ' ALA . . . -143.15 161.52 27.59 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.311 -2.316 . . . . 0.0 107.311 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.582 ' C ' ' H ' ' A' ' 143' ' ' ALA . 84.0 m-85 -44.13 118.77 1.58 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.216 -1.167 . . . . 0.0 109.675 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER 62.7 -11.17 0.08 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.423 -0.798 . . . . 0.0 109.024 -179.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.582 ' H ' ' C ' ' A' ' 141' ' ' PHE . . . -81.31 -10.9 59.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.771 -1.206 . . . . 0.0 112.772 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 143' ' ' ALA . 93.0 mt-30 -40.9 114.44 0.48 Allowed 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.92 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -158.85 160.15 35.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.111 -1.618 . . . . 0.0 111.238 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 tp -105.19 160.81 14.79 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.79 -1.194 . . . . 0.0 108.285 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.781 ' O ' HG23 ' A' ' 135' ' ' VAL . 12.4 ptt180 -150.01 146.21 26.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.766 -1.209 . . . . 0.0 109.294 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.1 m -105.53 167.65 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 CA-C-O 122.008 0.908 . . . . 0.0 109.152 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 32.6 m-85 -134.98 138.63 44.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 p -144.48 157.56 55.67 Favored Pre-proline 0 C--N 1.308 -1.238 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -102.33 152.6 0.29 Allowed 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.369 2.713 . . . . 0.0 114.983 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.544 HG21 HD21 ' A' ' 73' ' ' LEU . 83.2 mt -113.48 134.94 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.461 ' C ' ' H ' ' A' ' 155' ' ' GLU . 66.6 m-85 -102.04 142.45 33.3 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.455 -0.778 . . . . 0.0 111.884 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 26.7 t70 -58.87 -2.41 0.23 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.586 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 154' ' ' ASP . 56.1 tt0 98.25 21.52 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -140.78 19.13 2.33 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 15.3 t60 69.35 11.47 8.11 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -96.1 116.76 29.47 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.668 ' NE2' ' N ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -65.08 122.58 17.37 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.445 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.5 pp -137.62 1.89 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 O-C-N 120.841 -1.162 . . . . 0.0 113.541 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.419 ' N ' HD12 ' A' ' 160' ' ' ILE . . . -166.75 176.08 41.91 Favored Glycine 0 N--CA 1.507 3.4 0 C-N-CA 119.243 -1.456 . . . . 0.0 110.587 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.18 145.92 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 O-C-N 121.175 -1.191 . . . . 0.0 112.939 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.65 116.07 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.64 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -113.07 157.51 21.5 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.593 HG21 ' HB1' ' A' ' 56' ' ' ALA . 48.9 mt -146.4 107.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.44 ' HA3' ' CD2' ' A' ' 97' ' ' PHE . . . -108.84 122.64 6.65 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.587 -1.292 . . . . 0.0 112.54 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.92 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 27.1 tp -85.61 108.95 18.23 Favored 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 169' ' ' LEU . 10.8 tm-20 -53.94 -36.37 62.72 Favored 'General case' 0 N--CA 1.518 2.93 0 O-C-N 123.786 0.679 . . . . 0.0 110.239 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 170' ' ' SER . 4.4 tp 73.66 152.18 0.12 Allowed 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.794 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.738 ' O ' ' N ' ' A' ' 172' ' ' VAL . 2.1 t 151.3 -104.81 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.847 ' O ' HG13 ' A' ' 172' ' ' VAL . 89.9 mtt180 -53.04 79.34 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.847 HG13 ' O ' ' A' ' 171' ' ' ARG . 1.3 m -175.12 -25.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.455 ' C ' ' O ' ' A' ' 172' ' ' VAL . 0.2 OUTLIER -35.56 -61.24 0.47 Allowed 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.786 -1.196 . . . . 0.0 110.881 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -43.36 -64.29 0.67 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.633 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -55.73 -39.94 71.79 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.129 0.966 . . . . 0.0 110.666 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 172' ' ' VAL . 5.5 mt -65.16 -33.76 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 120.838 -1.164 . . . . 0.0 110.477 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -81.49 -46.27 14.76 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 119.523 -1.986 . . . . 0.0 112.723 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -75.23 -62.6 1.5 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.149 -1.594 . . . . 0.0 109.759 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 59.9 p -58.23 -53.56 56.85 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.054 -1.029 . . . . 0.0 112.917 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 . . . . . 0 N--CA 1.504 2.269 0 O-C-N 119.876 -1.765 . . . . 0.0 109.346 179.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.5 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' MET . 76.2 m-20 -75.61 -59.02 2.93 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.41 1.1 . . . . 0.0 108.648 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.499 ' C ' ' SD ' ' A' ' 47' ' ' MET . 0.9 OUTLIER -36.97 -62.27 0.5 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 123.066 1.412 . . . . 0.0 109.666 -177.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.502 ' O ' ' HB3' ' A' ' 52' ' ' LEU . 5.9 t -54.78 -41.37 70.46 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.092 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' THR . 50.7 ttp180 -35.57 -51.22 0.63 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.661 -1.274 . . . . 0.0 112.57 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -91.55 -53.77 4.18 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -71.96 -47.3 32.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -176.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' A' ' 167' ' ' LEU . 0.9 OUTLIER -56.99 -44.06 82.32 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 175.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 49' ' ' ARG . . . -50.09 -55.8 13.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 118.081 -1.447 . . . . 0.0 109.932 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -83.53 -62.92 1.46 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.399 -1.438 . . . . 0.0 112.989 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' GLY . 5.3 ptmt -52.55 -34.69 51.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.456 -0.778 . . . . 0.0 111.217 -176.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -84.89 -31.62 23.6 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 119.443 -2.036 . . . . 0.0 109.176 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.8 tt -47.24 -46.12 24.2 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.35 -1.469 . . . . 0.0 108.165 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 61' ' ' ARG . . . -67.86 -41.3 83.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.685 -1.884 . . . . 0.0 110.208 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.987 HG13 ' HB1' ' A' ' 88' ' ' ALA . 25.0 t -52.73 -45.89 49.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 O-C-N 120.065 -1.647 . . . . 0.0 107.504 177.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.843 ' HB2' HD11 ' A' ' 165' ' ' ILE . . . -51.77 -24.13 5.53 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -73.59 -37.15 65.56 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 115.799 -2.36 . . . . 0.0 111.647 -178.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 m -57.71 -29.21 64.52 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 119.58 -1.95 . . . . 0.0 107.595 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.767 ' HB3' HD12 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -74.56 -26.13 59.74 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 117.59 -1.644 . . . . 0.0 108.051 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.65 -12.28 59.51 Favored 'General case' 0 C--N 1.262 -3.217 0 CA-C-O 117.668 -1.158 . . . . 0.0 110.952 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.456 ' OD2' ' NH1' ' A' ' 61' ' ' ARG . 3.9 m-20 -103.96 -24.8 13.21 Favored 'General case' 0 N--CA 1.51 2.555 0 CA-C-N 123.367 2.803 . . . . 0.0 113.853 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.534 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -76.61 -161.1 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 119.793 -1.817 . . . . 0.0 111.91 -175.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 68' ' ' GLU . 6.6 Cg_endo -109.92 -38.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 124.049 3.166 . . . . 0.0 114.172 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.609 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 2.5 pt-20 -52.01 -33.16 37.14 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.401 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.631 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.3 mp -58.71 -73.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.909 0.861 . . . . 0.0 111.744 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -48.46 -37.0 16.16 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -75.68 -14.08 60.34 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -82.01 -39.27 11.8 Favored Glycine 0 CA--C 1.486 -1.761 0 N-CA-C 103.324 -3.91 . . . . 0.0 103.324 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.81 -29.62 62.93 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -64.18 -3.78 3.05 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' CG ' ' H ' ' A' ' 76' ' ' LYS . 26.5 tptt -134.97 -150.58 0.39 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 78' ' ' GLN . 2.1 pttt -122.41 157.95 57.41 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 123.943 0.897 . . . . 0.0 109.119 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.669 ' O ' ' CE2' ' A' ' 108' ' ' TYR . 7.3 Cg_exo -29.0 -16.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.516 2.821 1 C-N-CA 125.551 4.167 . . . . 0.0 118.281 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 76' ' ' LYS . 83.0 mt-30 -90.37 1.66 56.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.191 -2.193 . . . . 0.0 108.918 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -132.68 2.3 3.74 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.659 ' N ' ' OH ' ' A' ' 108' ' ' TYR . 2.5 m -68.57 -156.75 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.146 -2.221 . . . . 0.0 108.863 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 83' ' ' GLN . . . -150.11 58.11 0.45 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.552 HD11 HD11 ' A' ' 85' ' ' ILE . 2.2 tp -49.55 -7.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 C-N-CA 123.203 0.601 . . . . 0.0 110.766 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 81' ' ' GLY . 86.6 mt-30 -47.38 -43.67 23.58 Favored 'General case' 0 C--N 1.269 -2.908 0 O-C-N 120.046 -1.659 . . . . 0.0 114.397 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.823 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -87.88 -53.34 4.8 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 119.365 -2.085 . . . . 0.0 110.122 -173.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.892 ' O ' ' N ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -46.32 -51.64 3.98 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.707 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 172.007 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.785 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -44.41 -21.93 0.06 Allowed 'General case' 0 N--CA 1.507 2.399 0 O-C-N 119.237 -2.164 . . . . 0.0 107.225 174.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.823 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.5 tt0 -48.47 -28.83 3.56 Favored 'General case' 1 N--CA 1.544 4.245 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 171.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.987 ' HB1' HG13 ' A' ' 59' ' ' VAL . . . -71.28 -28.05 63.86 Favored 'General case' 0 N--CA 1.515 2.778 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.698 172.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.785 ' N ' ' O ' ' A' ' 86' ' ' ALA . 33.0 m -65.69 -43.95 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.255 0 C-N-CA 116.241 -2.184 . . . . 0.0 110.346 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.512 ' N ' HG23 ' A' ' 89' ' ' VAL . 19.6 mtp-105 -56.19 -52.08 65.71 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -58.19 -30.69 66.64 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.383 -1.327 . . . . 0.0 108.63 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.435 ' NH2' HD11 ' A' ' 167' ' ' LEU . 6.5 mmm180 -76.33 -93.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.193 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.679 ' ND2' ' N ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -144.44 31.12 1.21 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.679 -1.263 . . . . 0.0 111.724 -177.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 60.7 24.07 13.9 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.292 -1.505 . . . . 0.0 109.414 -175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 96' ' ' LEU . 2.7 pp -167.13 160.08 13.55 Favored 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 119.271 -0.972 . . . . 0.0 108.575 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.418 ' CD2' ' O ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER 164.62 176.77 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.934 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -177.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 109' ' ' SER . 58.5 m-85 -136.75 80.51 1.82 Allowed 'General case' 0 C--O 1.214 -0.774 1 N-CA-C 99.295 -4.335 . . . . 0.0 99.295 170.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.62 ' CD1' HG12 ' A' ' 59' ' ' VAL . 11.7 tt -100.06 118.36 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -177.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.819 ' CG1' ' H ' ' A' ' 164' ' ' ALA . 10.9 p -98.7 131.93 44.9 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 CA-C-O 124.587 2.137 . . . . 0.0 111.067 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.686 HG22 HD22 ' A' ' 63' ' ' LEU . 97.1 t -132.9 109.95 14.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 1 N-CA-C 98.02 -4.807 . . . . 0.0 98.02 175.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.554 ' HG1' ' H ' ' A' ' 104' ' ' GLN . 1.2 t -130.6 170.69 13.94 Favored 'General case' 0 CA--C 1.461 -2.445 0 CA-C-O 122.386 1.088 . . . . 0.0 108.319 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 104' ' ' GLN . 44.4 t0 -78.9 -174.7 4.12 Favored 'General case' 0 C--N 1.269 -2.906 1 N-CA-C 99.458 -4.275 . . . . 0.0 99.458 169.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.89 72.35 0.09 Allowed 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 113.471 -3.292 . . . . 0.0 104.78 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.684 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.5 tp-100 -140.7 -52.24 0.47 Allowed 'General case' 0 C--N 1.364 1.198 0 O-C-N 119.453 -2.029 . . . . 0.0 111.057 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 104' ' ' GLN . 2.1 t 97.38 137.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.372 1.069 . . . . 0.0 108.794 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.5 OUTLIER 157.44 95.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 178.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.591 ' NH2' HH11 ' A' ' 147' ' ' ARG . 1.4 mtt180 -39.43 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 CA-C-N 112.524 -2.125 . . . . 0.0 110.167 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.669 ' CE2' ' O ' ' A' ' 77' ' ' PRO . 1.1 t80 -57.22 -26.18 60.27 Favored 'General case' 0 C--N 1.284 -2.245 0 O-C-N 121.02 -1.05 . . . . 0.0 108.471 -177.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -113.61 148.44 36.21 Favored 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.961 ' ND1' HD11 ' A' ' 116' ' ' ILE 0.256 45.1 p-80 -174.44 149.68 1.39 Allowed Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 118.0 -1.48 . . . . 0.0 113.349 -176.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.505 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 32.9 Cg_endo -91.09 -22.35 0.59 Allowed 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.463 2.109 . . . . 0.0 106.801 171.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.505 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 38.8 tt0 -111.44 136.62 50.34 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.02 -42.35 48.18 Favored 'General case' 0 C--N 1.289 -2.054 0 O-C-N 119.965 -1.709 . . . . 0.0 111.985 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 118' ' ' GLN . 87.7 mt-30 -70.36 -24.28 62.94 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 119.768 -1.832 . . . . 0.0 115.871 -176.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.415 HH21 ' C ' ' A' ' 139' ' ' ARG . 0.1 OUTLIER -67.47 -28.13 67.61 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 119.839 -1.788 . . . . 0.0 106.916 -178.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.961 HD11 ' ND1' ' A' ' 110' ' ' HIS . 87.9 mt -56.0 -88.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 117.453 -1.699 . . . . 0.0 109.991 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.571 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -37.02 -12.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 O-C-N 121.545 -0.722 . . . . 0.0 113.604 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.7 OUTLIER -69.64 -72.42 0.24 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 119.457 -2.202 . . . . 0.0 114.579 -174.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.426 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 19.2 Cg_exo -24.95 120.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 123.923 3.082 . . . . 0.0 113.82 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.587 ' C ' ' H ' ' A' ' 122' ' ' GLY . 0.8 OUTLIER -178.11 138.12 0.19 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 123' ' ' ASP . 85.6 mttt 50.47 4.98 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 CA-C-O 121.456 0.646 . . . . 0.0 109.389 -176.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 120' ' ' PHE . . . -42.94 -18.75 0.05 OUTLIER Glycine 0 N--CA 1.505 3.239 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 121' ' ' LYS . 11.1 t70 71.04 -17.98 0.29 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.292 -1.122 . . . . 0.0 111.233 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.22 -14.89 61.0 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.402 ' HA ' ' HB3' ' A' ' 128' ' ' ALA . 20.2 mt -89.99 -28.48 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.637 -0.664 . . . . 0.0 111.629 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -40.04 -56.34 1.88 Allowed 'General case' 0 N--CA 1.515 2.802 0 O-C-N 120.842 -1.161 . . . . 0.0 110.137 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -74.11 -37.08 64.22 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.773 -1.205 . . . . 0.0 110.591 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -63.28 -47.31 82.88 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 128' ' ' ALA . 0.3 OUTLIER -28.85 -44.68 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 113.587 -1.642 . . . . 0.0 106.966 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 2.1 m120 -105.0 -99.94 0.32 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -128.63 120.35 3.3 Favored Glycine 0 N--CA 1.507 3.431 0 CA-C-O 122.985 1.325 . . . . 0.0 112.124 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 133' ' ' GLU . 5.9 tp10 178.49 169.47 0.83 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 113.379 -1.41 . . . . 0.0 111.728 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.511 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 22.9 mp0 -124.21 127.45 47.73 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 176.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 133' ' ' GLU . 32.1 m120 -150.71 138.51 19.88 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.245 1.021 . . . . 0.0 111.072 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 147' ' ' ARG . 8.5 p -134.44 126.3 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.473 -0.767 . . . . 0.0 109.011 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.51 169.06 18.3 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 121.724 0.773 . . . . 0.0 111.368 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.6 mt -101.17 141.91 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-O 121.716 0.77 . . . . 0.0 112.826 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -114.07 153.61 29.15 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.415 ' C ' HH21 ' A' ' 115' ' ' ARG . 68.5 mtt85 -147.73 108.11 4.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.494 -1.379 . . . . 0.0 109.901 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.487 ' H ' ' HB3' ' A' ' 143' ' ' ALA . . . -158.06 106.23 0.29 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.498 ' C ' ' H ' ' A' ' 143' ' ' ALA . 84.1 t80 38.42 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.845 -0.797 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.918 HD12 ' O ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER 70.77 -30.15 0.2 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.56 -0.713 . . . . 0.0 110.268 179.09 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 145' ' ' ALA . . . -53.49 -2.93 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.105 -1.038 . . . . 0.0 113.035 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 143' ' ' ALA . 5.3 pt20 -45.01 98.88 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 O-C-N 119.949 -1.72 . . . . 0.0 107.842 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.948 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -149.17 163.36 37.82 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.599 -1.313 . . . . 0.0 110.024 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tp -108.45 155.51 20.51 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 120.777 -1.202 . . . . 0.0 110.912 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.693 ' O ' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -136.47 155.42 50.01 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.605 -0.684 . . . . 0.0 110.174 178.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.49 151.76 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.298 0 CA-C-O 121.691 0.757 . . . . 0.0 109.924 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.425 ' N ' ' O ' ' A' ' 134' ' ' ASN . 27.7 m-85 -116.8 138.97 51.12 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.751 0.786 . . . . 0.0 110.356 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 160.33 31.25 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 130' ' ' ASN . 0.1 OUTLIER -104.44 162.74 0.2 Allowed 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 123.537 2.825 . . . . 0.0 116.224 -178.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 47.7 mt -123.59 136.9 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 0.0 OUTLIER -117.14 157.05 26.59 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.401 1.096 . . . . 0.0 112.339 -179.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 155' ' ' GLU . 9.3 p30 -53.98 -95.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.232 -0.917 . . . . 0.0 110.327 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.537 ' H ' ' CG ' ' A' ' 154' ' ' ASP . 9.6 pt-20 -160.11 28.71 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.534 HD22 ' C ' ' A' ' 155' ' ' GLU . 2.3 m-80 -143.49 23.01 1.82 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.0 m80 67.1 46.83 1.45 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.153 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.77 122.43 30.55 Favored 'General case' 0 N--CA 1.522 3.173 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.71 ' N ' HE21 ' A' ' 159' ' ' GLN . 0.0 OUTLIER -58.23 118.35 5.4 Favored 'General case' 0 N--CA 1.518 2.934 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -177.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 160' ' ' ILE . 1.7 pp -141.27 22.32 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 O-C-N 120.349 -1.469 . . . . 0.0 112.124 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.04 169.42 41.75 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 101' ' ' THR . 5.5 t -136.0 138.93 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.252 0 CA-C-N 119.614 1.707 . . . . 0.0 112.502 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.447 ' CG2' HD21 ' A' ' 63' ' ' LEU . 1.9 p -119.68 113.83 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.459 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.819 ' H ' ' CG1' ' A' ' 99' ' ' VAL . . . -116.85 165.77 12.93 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.843 HD11 ' HB2' ' A' ' 60' ' ' ALA . 3.3 mt -142.92 107.99 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 120.03 -1.669 . . . . 0.0 106.919 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.91 114.79 4.87 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.556 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.948 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 5.1 tt -88.47 110.77 21.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.999 ' O ' ' O ' ' A' ' 169' ' ' LEU . 8.2 tm-20 -74.48 127.23 32.54 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.828 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.999 ' O ' ' O ' ' A' ' 168' ' ' GLU . 0.6 OUTLIER 34.05 148.56 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.16 0 CA-C-O 121.959 0.885 . . . . 0.0 110.283 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 172' ' ' VAL . 19.9 m -113.83 76.43 0.98 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.242 -0.911 . . . . 0.0 112.111 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.412 ' N ' HD12 ' A' ' 169' ' ' LEU . 56.3 ttt-85 -63.26 30.8 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.893 -1.129 . . . . 0.0 109.786 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.563 ' H ' ' C ' ' A' ' 170' ' ' SER . 1.8 m -124.14 -9.92 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.401 -1.437 . . . . 0.0 111.662 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 177' ' ' ASN . 0.2 OUTLIER -35.42 -51.55 0.61 Allowed 'General case' 0 N--CA 1.512 2.662 0 O-C-N 121.017 -1.052 . . . . 0.0 110.284 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -41.8 -71.68 0.08 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.123 -0.985 . . . . 0.0 110.293 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -51.87 -37.56 52.63 Favored 'General case' 0 N--CA 1.509 2.516 0 CA-C-O 121.714 0.769 . . . . 0.0 112.448 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.3 mm -79.72 -14.93 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.406 0.682 . . . . 0.0 110.034 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 173' ' ' THR . 43.3 t30 -86.84 -40.13 15.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.136 -0.978 . . . . 0.0 109.033 -178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.24 -70.01 0.32 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 119.756 -1.84 . . . . 0.0 109.802 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 14.5 t -47.79 -55.4 9.76 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 120.402 -1.436 . . . . 0.0 113.455 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.877 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.657 0.742 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -68.99 -67.16 0.49 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 123.051 1.405 . . . . 0.0 111.256 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.2 mtt -50.96 -49.1 60.66 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.313 -173.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.458 ' O ' ' C ' ' A' ' 49' ' ' ARG . 12.1 t -55.25 -35.93 65.51 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 48' ' ' THR . 62.5 ttt180 -40.67 -52.7 2.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.014 -1.054 . . . . 0.0 110.996 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.47 -60.44 2.19 Favored 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -73.31 -45.8 29.13 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.481 HD12 ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -54.64 -44.69 73.42 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 120.422 2.111 . . . . 0.0 105.598 176.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.716 ' O ' HD12 ' A' ' 57' ' ' LEU . . . -53.24 -50.8 64.03 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 117.726 -1.59 . . . . 0.0 109.452 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -80.24 -55.87 4.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 119.73 -1.856 . . . . 0.0 111.656 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 51' ' ' GLY . 18.1 mtpp -63.96 -27.1 68.9 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB3' HD12 ' A' ' 52' ' ' LEU . . . -95.56 -37.59 10.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 119.787 -1.821 . . . . 0.0 108.871 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.716 HD12 ' O ' ' A' ' 53' ' ' ALA . 35.2 mt -53.93 -35.45 61.72 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.291 -1.364 . . . . 0.0 108.047 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 61' ' ' ARG . . . -80.97 -46.32 15.3 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -70.85 -26.6 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 118.665 -2.522 . . . . 0.0 106.197 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.443 ' CB ' HD11 ' A' ' 98' ' ' ILE . . . -63.07 -29.07 70.52 Favored 'General case' 0 C--N 1.27 -2.861 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.456 ' O ' ' CG ' ' A' ' 65' ' ' ASP . 4.3 ptt180 -72.65 -19.7 61.39 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 117.164 -1.814 . . . . 0.0 110.84 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 m -68.29 -47.62 67.15 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 124.116 3.144 . . . . 0.0 107.009 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.691 HD22 ' HB1' ' A' ' 84' ' ' ALA . 50.2 mt -87.53 -41.81 13.21 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.833 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -56.32 -19.04 12.63 Favored 'General case' 0 N--CA 1.508 2.475 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.456 ' CG ' ' O ' ' A' ' 61' ' ' ARG . 40.2 m-20 -85.14 -4.3 59.11 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.123 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.512 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -76.86 -158.05 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 119.983 -1.698 . . . . 0.0 110.239 -178.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.555 ' C ' ' H ' ' A' ' 69' ' ' ILE . 3.1 Cg_endo -104.07 -27.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 123.586 2.857 . . . . 0.0 113.399 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 16.8 pt-20 -75.43 25.09 0.11 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.555 ' H ' ' C ' ' A' ' 67' ' ' PRO . 44.0 mm -106.13 -80.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -46.3 -31.95 2.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.68 -14.37 51.93 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.506 -1.371 . . . . 0.0 110.244 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -102.69 -3.54 49.53 Favored Glycine 0 N--CA 1.504 3.186 0 N-CA-C 107.101 -2.399 . . . . 0.0 107.101 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.52 -52.76 7.25 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 100.406 -3.924 . . . . 0.0 100.406 173.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -8.83 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 113.238 -1.801 . . . . 0.0 112.619 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.71 ' O ' ' O ' ' A' ' 76' ' ' LYS . 4.0 tmtm? -124.07 40.56 3.7 Favored 'General case' 0 N--CA 1.523 3.177 0 CA-C-N 122.732 2.515 . . . . 0.0 111.036 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.791 ' HZ2' ' H ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER 35.24 157.23 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.915 0 C-N-CA 125.532 1.533 . . . . 0.0 112.516 177.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -33.29 -63.48 0.14 Allowed 'Trans proline' 0 N--CA 1.513 2.66 0 C-N-CA 123.943 3.095 . . . . 0.0 115.72 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.791 ' H ' ' HZ2' ' A' ' 76' ' ' LYS . 78.6 mt-30 -50.1 142.02 10.2 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.098 -1.441 . . . . 0.0 108.762 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 63.52 5.9 2.33 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.306 -0.861 . . . . 0.0 113.137 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 1.035 ' O ' ' N ' ' A' ' 82' ' ' ILE . 70.9 p -81.22 86.55 6.19 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 119.154 -2.217 . . . . 0.0 109.542 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.696 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -35.92 47.24 0.0 OUTLIER Glycine 1 N--CA 1.518 4.139 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.754 -177.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.035 ' N ' ' O ' ' A' ' 80' ' ' SER . 1.1 tp -68.04 28.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 122.516 1.151 . . . . 0.0 107.924 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.696 ' H ' ' C ' ' A' ' 81' ' ' GLY . 43.7 tp60 -82.91 -22.3 33.93 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.707 ' O ' ' C ' ' A' ' 85' ' ' ILE . . . -73.73 -94.25 0.02 OUTLIER 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.707 ' C ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -20.18 -55.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.157 0 CA-C-N 123.651 2.932 . . . . 0.0 111.554 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -51.9 -49.12 63.63 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 119.333 -2.104 . . . . 0.0 110.161 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.682 ' N ' ' O ' ' A' ' 84' ' ' ALA . 66.1 tt0 -55.96 -54.55 43.42 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 116.624 -1.655 . . . . 0.0 114.393 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -77.79 -42.75 32.84 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 124.699 3.409 . . . . 0.0 108.236 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 88' ' ' ALA . 64.7 t -51.65 -71.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 115.115 -2.634 . . . . 0.0 107.592 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.677 ' O ' ' N ' ' A' ' 93' ' ' ASN . 4.3 ppt_? -40.26 -34.13 0.3 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.959 -1.088 . . . . 0.0 110.608 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.549 ' C ' ' O ' ' A' ' 90' ' ' ARG . 29.0 ttmt -39.38 -28.97 0.04 OUTLIER 'General case' 0 N--CA 1.536 3.827 0 C-N-CA 116.758 -1.977 . . . . 0.0 106.092 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 90' ' ' ARG . 10.6 ttm105 -36.49 -59.56 0.65 Allowed 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 166.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.677 ' N ' ' O ' ' A' ' 90' ' ' ARG . 0.4 OUTLIER -153.33 -56.38 0.12 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.397 -1.439 . . . . 0.0 110.192 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 1.1 m-20 164.02 1.38 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.864 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -135.57 160.69 37.71 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 117.729 -1.588 . . . . 0.0 113.975 -175.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 96' ' ' LEU . 2.8 pp 151.43 175.92 0.0 OUTLIER 'General case' 0 N--CA 1.534 3.738 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.426 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -139.66 86.58 2.12 Favored 'General case' 0 C--O 1.218 -0.603 1 N-CA-C 98.87 -4.493 . . . . 0.0 98.87 169.245 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.758 HD12 HG23 ' A' ' 165' ' ' ILE . 19.7 tt -101.61 134.72 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 123.396 1.569 . . . . 0.0 108.212 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.792 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 1.1 p -136.41 149.53 27.18 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.995 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -173.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.473 ' H ' ' CD1' ' A' ' 82' ' ' ILE . 4.2 p -111.28 131.35 62.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 1 N-CA-C 98.444 -4.65 . . . . 0.0 98.444 169.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.672 ' CG2' ' H ' ' A' ' 105' ' ' SER . 1.5 m -124.46 152.27 43.54 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 120.564 -1.335 . . . . 0.0 111.442 -175.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.612 ' O ' HG22 ' A' ' 101' ' ' THR . 24.5 t70 -87.2 -176.85 5.83 Favored 'General case' 0 C--N 1.284 -2.278 1 N-CA-C 98.033 -4.802 . . . . 0.0 98.033 169.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 103' ' ' MET . 1.8 ttt -77.67 73.53 4.23 Favored 'General case' 0 C--N 1.269 -2.9 0 C-N-CA 114.483 -2.887 . . . . 0.0 107.069 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' A' ' 105' ' ' SER . 9.0 tm0? -141.75 -41.51 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 119.595 -1.941 . . . . 0.0 110.483 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.672 ' H ' ' CG2' ' A' ' 101' ' ' THR . 10.5 t 84.88 136.96 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.747 0.819 . . . . 0.0 109.48 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.8 OUTLIER 156.81 134.86 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.618 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 177.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.465 ' HE ' ' HB2' ' A' ' 97' ' ' PHE . 9.6 mmm180 -71.9 100.87 2.52 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.628 ' C ' HG21 ' A' ' 82' ' ' ILE . 2.5 m-85 -54.4 -30.24 51.55 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.44 ' C ' ' ND1' ' A' ' 110' ' ' HIS . 12.0 t -101.17 144.78 29.63 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.44 ' ND1' ' C ' ' A' ' 109' ' ' SER . 1.5 m-70 -124.89 107.83 28.41 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -174.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.659 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 65.2 Cg_endo -85.81 -35.63 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 N-CA-C 103.882 -3.161 . . . . 0.0 103.882 172.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.659 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 13.5 mp0 -140.37 138.31 34.72 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 174.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.81 -48.18 64.21 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 118.303 2.705 . . . . 0.0 118.303 -172.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.535 ' H ' ' CD ' ' A' ' 114' ' ' GLN . 1.4 mp0 -66.2 -32.52 74.01 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.78 HH21 ' H ' ' A' ' 139' ' ' ARG . 19.3 tpt85 -61.54 -33.68 74.25 Favored 'General case' 0 C--O 1.201 -1.457 0 CA-C-N 122.358 2.345 . . . . 0.0 106.633 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.701 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.2 OUTLIER -53.17 -86.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.61 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.135 177.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.603 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -33.04 -11.63 0.0 OUTLIER Glycine 0 N--CA 1.499 2.866 0 C-N-CA 123.462 0.553 . . . . 0.0 113.748 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.701 ' N ' ' O ' ' A' ' 116' ' ' ILE . 1.3 mt-30 -79.33 -72.75 0.12 Allowed Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 120.017 1.909 . . . . 0.0 113.728 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 115' ' ' ARG . 6.6 Cg_exo -26.55 108.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 123.969 3.113 . . . . 0.0 114.939 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.555 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 48.5 t80 174.86 28.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -174.93 -12.64 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.091 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.76 -21.51 2.29 Favored Glycine 0 N--CA 1.502 3.058 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.6 t0 69.64 0.6 3.04 Favored 'General case' 0 N--CA 1.51 2.559 0 O-C-N 121.043 -1.269 . . . . 0.0 112.142 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.534 ' OD2' ' CE2' ' A' ' 149' ' ' PHE . 2.9 p-10 -82.45 -21.18 35.76 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.552 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 20.2 mt -79.42 -21.78 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.528 -0.733 . . . . 0.0 110.199 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -49.39 -37.09 23.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.577 -1.327 . . . . 0.0 108.418 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.631 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 59.0 mttp -74.32 -34.87 63.59 Favored 'General case' 0 C--O 1.194 -1.859 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.541 ' O ' ' ND2' ' A' ' 130' ' ' ASN . . . -89.43 -30.74 18.12 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 120.023 -1.673 . . . . 0.0 110.539 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.29 -26.35 1.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.858 -1.151 . . . . 0.0 109.705 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.861 ' ND2' ' N ' ' A' ' 131' ' ' GLY 0.278 0.0 OUTLIER -77.12 -92.49 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 108.904 179.408 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.861 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -164.66 42.8 0.3 Allowed Glycine 0 CA--C 1.565 3.166 0 C-N-CA 125.536 1.541 . . . . 0.0 110.106 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.517 ' H ' HD21 ' A' ' 130' ' ' ASN . 76.6 tt0 -145.06 164.72 30.35 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 120.316 2.058 . . . . 0.0 111.646 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -64.21 164.32 11.18 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 28.4 t-20 -170.97 138.16 1.27 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.298 -0.876 . . . . 0.0 109.267 176.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.638 HG22 HG12 ' A' ' 148' ' ' VAL . 1.3 t -130.83 138.43 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 120.315 -1.491 . . . . 0.0 108.776 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -151.51 167.6 27.54 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.644 -1.285 . . . . 0.0 110.213 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.7 mt -102.32 135.56 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.398 -0.814 . . . . 0.0 109.801 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.452 ' OD1' ' CZ ' ' A' ' 147' ' ' ARG . 0.9 OUTLIER -106.84 152.62 23.64 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.78 ' H ' HH21 ' A' ' 115' ' ' ARG . 3.5 ptm85 -159.68 97.94 1.34 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.734 ' H ' ' HB3' ' A' ' 143' ' ' ALA . . . -150.61 109.04 0.41 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.07 -1.538 . . . . 0.0 109.92 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 9.3 t80 59.1 -67.47 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 122.034 -0.686 . . . . 0.0 110.14 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 143' ' ' ALA . 0.7 OUTLIER -131.44 6.69 4.47 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.249 -0.907 . . . . 0.0 110.083 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.734 ' HB3' ' H ' ' A' ' 140' ' ' GLY . . . -81.13 5.36 17.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 113.775 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -48.78 91.24 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.217 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 1.029 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -169.03 173.06 7.11 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.301 -170.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 tp -115.01 159.19 21.08 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.461 -1.399 . . . . 0.0 110.89 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.452 ' CZ ' ' OD1' ' A' ' 138' ' ' ASN . 0.8 OUTLIER -143.89 152.33 40.99 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.142 0.972 . . . . 0.0 110.896 178.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.638 HG12 HG22 ' A' ' 135' ' ' VAL . 15.5 m -119.41 138.22 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.925 0 CA-C-O 122.119 0.961 . . . . 0.0 109.985 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.534 ' CE2' ' OD2' ' A' ' 124' ' ' ASP . 70.6 m-85 -111.63 145.73 38.68 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.646 0.736 . . . . 0.0 109.686 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.449 HG21 ' CD2' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -142.02 156.56 65.07 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -96.54 154.88 1.25 Allowed 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 123.996 3.131 . . . . 0.0 114.195 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 72.6 mt -117.97 136.33 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -107.73 149.16 28.49 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.827 ' O ' ' ND2' ' A' ' 156' ' ' ASN . 24.8 t0 -76.19 57.1 1.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 42.33 21.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 123.641 0.777 . . . . 0.0 112.463 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.827 ' ND2' ' O ' ' A' ' 154' ' ' ASP . 42.3 m-80 -140.28 35.42 1.89 Allowed 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.495 -1.378 . . . . 0.0 109.717 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 61.84 -2.92 0.25 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.571 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.8 mptt -80.45 122.05 26.5 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.924 ' O ' HG23 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -58.2 -154.65 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.058 0 O-C-N 120.861 -1.149 . . . . 0.0 111.136 -177.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.924 HG23 ' O ' ' A' ' 159' ' ' GLN . 2.7 pp 151.9 -6.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 CA-C-N 120.175 1.352 . . . . 0.0 112.883 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -172.24 179.86 43.57 Favored Glycine 0 N--CA 1.507 3.407 0 C-N-CA 115.981 -3.009 . . . . 0.0 111.583 -175.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -139.6 139.22 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -1.225 . . . . 0.0 112.042 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.4 t -108.09 127.31 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.792 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -115.99 144.23 44.37 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.758 HG23 HD12 ' A' ' 98' ' ' ILE . 6.2 mt -137.76 99.52 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.25 129.59 9.13 Favored Glycine 0 N--CA 1.485 1.947 0 CA-C-O 123.328 1.515 . . . . 0.0 112.762 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.029 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -88.62 115.31 26.05 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-N 113.475 -1.363 . . . . 0.0 107.925 177.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.883 ' O ' ' O ' ' A' ' 169' ' ' LEU . 0.7 OUTLIER -74.95 132.25 41.28 Favored 'General case' 0 N--CA 1.529 3.491 0 O-C-N 124.084 0.865 . . . . 0.0 110.237 -179.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.883 ' O ' ' O ' ' A' ' 168' ' ' GLU . 1.5 pp 30.1 166.46 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.017 0 O-C-N 120.566 -1.334 . . . . 0.0 113.487 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 172' ' ' VAL . 0.1 OUTLIER -171.55 61.0 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.596 0.713 . . . . 0.0 110.192 -179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.481 ' C ' ' O ' ' A' ' 170' ' ' SER . 80.2 mtm180 7.67 -37.0 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.062 0 C-N-CA 123.276 0.63 . . . . 0.0 112.606 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 1.157 ' N ' ' O ' ' A' ' 170' ' ' SER . 3.1 t -87.13 23.37 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.045 -1.66 . . . . 0.0 109.834 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.4 p -79.73 -39.34 31.34 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -74.75 -55.17 6.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.517 -1.365 . . . . 0.0 108.421 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.436 ' CG ' ' H ' ' A' ' 176' ' ' ILE . 4.7 pt20 -51.54 -68.66 0.15 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.883 HG23 ' H ' ' A' ' 177' ' ' ASN . 10.4 tp -41.84 -74.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.883 ' H ' HG23 ' A' ' 176' ' ' ILE . 21.7 m120 -46.17 -73.46 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.01 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 177' ' ' ASN . 50.1 m-20 -47.06 -59.4 3.15 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.821 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.476 ' OG ' ' N ' ' A' ' 180' ' ' ARG . 59.6 p -47.14 -70.62 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.722 -1.236 . . . . 0.0 109.639 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.476 ' N ' ' OG ' ' A' ' 179' ' ' SER . 97.8 mtt180 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 120.751 -1.218 . . . . 0.0 109.387 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.544 ' CG ' ' H ' ' A' ' 47' ' ' MET . 17.4 p-10 -66.29 -64.73 0.79 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.885 1.326 . . . . 0.0 110.786 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.544 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 16.3 mmm -43.54 -58.61 2.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.193 0.997 . . . . 0.0 111.443 -173.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' ARG . 6.4 t -53.18 -35.97 60.42 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 36.8 ttp180 -42.02 -51.05 4.59 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.805 -1.184 . . . . 0.0 111.841 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -80.77 -58.06 3.27 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -79.59 -45.3 8.7 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.541 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -54.96 -46.3 75.01 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 120.533 2.167 . . . . 0.0 105.525 176.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 49' ' ' ARG . . . -46.9 -57.98 4.4 Favored 'General case' 0 C--O 1.205 -1.275 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.345 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -81.87 -68.42 0.7 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.64 -1.288 . . . . 0.0 113.989 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 51' ' ' GLY . 57.4 mtpt -47.46 -27.53 1.77 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.094 -1.004 . . . . 0.0 111.647 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 52' ' ' LEU . . . -93.46 -32.3 14.25 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.053 -1.654 . . . . 0.0 108.782 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.3 tp -55.22 -40.21 70.56 Favored 'General case' 0 C--N 1.284 -2.239 0 O-C-N 121.035 -1.041 . . . . 0.0 109.309 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.617 ' O ' ' CG ' ' A' ' 61' ' ' ARG . . . -80.42 -47.49 14.3 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -177.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.664 ' HB ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -66.89 -32.95 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 117.616 -3.177 . . . . 0.0 104.618 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.599 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -58.84 -26.53 64.28 Favored 'General case' 0 C--N 1.265 -3.104 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.617 ' CG ' ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -49.79 -24.45 2.39 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 116.665 -2.014 . . . . 0.0 105.882 174.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.519 HG22 HG22 ' A' ' 85' ' ' ILE . 96.9 m -74.03 -39.76 63.34 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.826 ' O ' HD12 ' A' ' 85' ' ' ILE 0.276 0.3 OUTLIER -48.2 -42.19 29.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 124.761 2.22 . . . . 0.0 107.921 175.58 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.66 -4.7 59.21 Favored 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 112.553 -2.112 . . . . 0.0 113.081 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 66' ' ' SER . 34.5 t0 -99.02 -27.46 13.84 Favored 'General case' 0 N--CA 1.517 2.921 0 CA-C-N 123.713 2.961 . . . . 0.0 115.618 -172.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.577 ' HB2' HD13 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -60.12 -161.47 0.0 OUTLIER Pre-proline 0 C--N 1.278 -2.525 0 O-C-N 119.668 -1.895 . . . . 0.0 109.928 -178.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.725 ' HD2' ' H ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -114.52 -25.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 124.399 3.399 . . . . 0.0 113.584 176.032 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.725 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 16.4 pt-20 -56.75 -30.45 63.59 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 117.829 -1.548 . . . . 0.0 107.52 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.5 mt -45.25 -83.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.062 -178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -47.33 -39.03 13.95 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.978 0.894 . . . . 0.0 109.914 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -78.04 -13.0 60.03 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.931 -1.105 . . . . 0.0 111.08 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . -97.52 -1.38 59.06 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 105.046 -3.222 . . . . 0.0 105.046 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.571 ' O ' ' OD2' ' A' ' 102' ' ' ASP . 1.4 mp -89.61 -23.22 21.99 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 173.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -62.83 -0.72 0.71 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.642 ' CG ' ' H ' ' A' ' 76' ' ' LYS . 3.5 tptm -136.37 -140.81 0.16 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.204 -1.56 . . . . 0.0 107.175 174.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.642 ' H ' ' CG ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -129.12 156.14 78.69 Favored Pre-proline 0 CA--C 1.578 2.041 0 O-C-N 121.481 -0.762 . . . . 0.0 109.625 179.381 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' O ' ' CE2' ' A' ' 108' ' ' TYR . 0.9 OUTLIER -31.56 -10.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.528 3.546 1 C-N-CA 126.236 4.624 . . . . 0.0 118.946 -179.082 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' LYS . 44.0 tp60 -96.33 -14.08 22.83 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 119.798 -1.814 . . . . 0.0 109.622 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -116.11 0.74 13.05 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.232 -0.918 . . . . 0.0 112.472 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.694 ' N ' ' OH ' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -76.36 -155.4 0.06 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 119.234 -2.166 . . . . 0.0 107.703 178.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.97 17.25 0.22 Allowed Glycine 0 N--CA 1.496 2.676 0 O-C-N 120.523 -1.36 . . . . 0.0 109.727 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.624 HD12 ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -48.39 -24.37 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-O 121.898 0.856 . . . . 0.0 110.385 -179.12 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 7.3 tt0 -53.34 -7.74 0.1 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 82' ' ' ILE . . . -94.49 -52.81 4.15 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.002 -1.061 . . . . 0.0 112.689 -176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.826 HD12 ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -74.82 -34.2 32.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 177.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -57.97 -46.27 85.41 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 1.2 tt0 -49.67 -21.54 1.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.053 -1.43 . . . . 0.0 107.948 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.94 66.76 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 114.831 -2.748 . . . . 0.0 104.093 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.664 HG22 ' HB ' ' A' ' 59' ' ' VAL . 37.7 t -54.62 -72.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 C-N-CA 116.776 -1.97 . . . . 0.0 110.185 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 93' ' ' ASN . 1.5 ttt-85 -48.13 -69.61 0.12 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 124.499 1.119 . . . . 0.0 113.118 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 90' ' ' ARG . 37.9 pttt -35.61 -36.87 0.08 Allowed 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.953 -1.092 . . . . 0.0 109.187 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 90' ' ' ARG . 62.3 mtm-85 -86.51 -21.88 26.71 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.723 -1.236 . . . . 0.0 111.585 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.644 ' N ' ' O ' ' A' ' 90' ' ' ARG . 54.7 t-20 -97.9 -16.42 19.75 Favored 'General case' 0 N--CA 1.511 2.582 0 CA-C-N 120.979 1.718 . . . . 0.0 108.374 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.0 t70 73.28 24.7 2.34 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.886 0.875 . . . . 0.0 110.835 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LEU . 0.4 OUTLIER 173.27 153.71 0.09 Allowed 'General case' 0 N--CA 1.514 2.755 0 CA-C-N 121.726 2.057 . . . . 0.0 107.796 176.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.636 HD13 HG12 ' A' ' 89' ' ' VAL . 0.3 OUTLIER 156.17 164.69 0.01 OUTLIER 'General case' 1 N--CA 1.542 4.133 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.2 179.828 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.566 ' CD1' ' NE ' ' A' ' 107' ' ' ARG . 0.9 OUTLIER -143.52 89.21 2.06 Favored 'General case' 0 C--O 1.214 -0.816 1 N-CA-C 99.119 -4.4 . . . . 0.0 99.119 168.552 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.629 ' N ' ' OG ' ' A' ' 109' ' ' SER . 0.4 OUTLIER -93.19 129.09 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -175.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 164' ' ' ALA . 1.1 m -119.08 130.54 73.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -173.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.624 ' HB ' HD12 ' A' ' 82' ' ' ILE . 0.9 OUTLIER -123.64 124.47 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 1 N-CA-C 97.166 -5.124 . . . . 0.0 97.166 169.217 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.649 HG21 ' HA ' ' A' ' 105' ' ' SER . 11.5 p -136.09 164.2 28.57 Favored 'General case' 0 C--N 1.281 -2.372 0 O-C-N 120.61 -1.306 . . . . 0.0 108.416 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.707 ' O ' ' N ' ' A' ' 104' ' ' GLN . 1.7 m-20 -78.86 -175.13 4.32 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 100.873 -3.751 . . . . 0.0 100.873 170.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.514 ' CG ' ' O ' ' A' ' 103' ' ' MET . 1.6 ttt -68.28 69.82 0.15 Allowed 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 114.843 -2.743 . . . . 0.0 103.963 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.707 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -137.16 -50.37 0.64 Allowed 'General case' 0 C--N 1.358 0.965 0 O-C-N 120.488 -1.382 . . . . 0.0 108.408 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.649 ' HA ' HG21 ' A' ' 101' ' ' THR . 1.5 t 92.74 138.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.9 OUTLIER 157.04 139.34 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 102.092 -3.299 . . . . 0.0 102.092 178.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.74 ' NH2' HH11 ' A' ' 147' ' ' ARG . 39.4 mtt180 -86.19 96.65 9.99 Favored 'General case' 0 C--N 1.272 -2.795 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.791 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.694 ' OH ' ' N ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -55.95 -19.94 14.26 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 123.81 1.767 . . . . 0.0 107.282 -176.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.629 ' OG ' ' N ' ' A' ' 98' ' ' ILE . 25.6 p -113.36 146.02 40.15 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.534 -175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.552 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 13.3 p80 -155.53 137.25 9.64 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -174.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.622 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 40.5 Cg_endo -88.57 -32.25 0.15 Allowed 'Trans proline' 0 N--CA 1.482 0.815 0 N-CA-C 104.666 -2.859 . . . . 0.0 104.666 171.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.622 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 34.9 tp10 -127.35 124.83 39.57 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.24 81.83 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -68.28 -28.97 67.65 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 119.882 -1.762 . . . . 0.0 115.629 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.548 ' CD ' ' CE2' ' A' ' 97' ' ' PHE . 11.7 ttt85 -55.26 -29.04 57.33 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 119.103 -2.248 . . . . 0.0 105.544 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.751 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.2 OUTLIER -63.92 -87.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.214 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.437 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -32.55 -13.41 0.0 OUTLIER Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.419 -0.801 . . . . 0.0 112.949 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.751 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.9 mt-30 -71.5 -72.64 0.21 Allowed Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 119.632 -2.099 . . . . 0.0 110.892 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.512 ' O ' ' CB ' ' A' ' 120' ' ' PHE . 96.0 Cg_exo -19.04 142.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 124.309 3.339 . . . . 0.0 113.878 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.592 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 67.1 t80 140.89 21.64 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.441 ' C ' ' N ' ' A' ' 123' ' ' ASP . 23.7 ttmt -177.29 -2.8 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 O-C-N 121.434 -0.792 . . . . 0.0 110.196 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.6 -20.59 2.75 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.441 ' N ' ' C ' ' A' ' 121' ' ' LYS . 10.0 t70 72.6 -5.27 1.88 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -75.97 -21.1 57.33 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 119.756 -1.84 . . . . 0.0 108.861 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.469 ' HB ' HG21 ' A' ' 162' ' ' VAL . 14.7 pt -74.39 -23.67 18.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.02 -1.05 . . . . 0.0 109.947 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.76 -25.92 8.51 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -86.52 -39.14 16.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.671 -0.643 . . . . 0.0 111.594 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 150' ' ' THR . . . -79.73 -46.85 16.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 119.898 -1.752 . . . . 0.0 107.246 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.683 ' C ' HD22 ' A' ' 130' ' ' ASN . 0.1 OUTLIER -38.41 -41.93 0.69 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.683 HD22 ' C ' ' A' ' 129' ' ' LEU . 2.3 m120 -100.46 12.81 36.43 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.315 -1.311 . . . . 0.0 114.203 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.36 98.41 0.56 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 170.85 157.76 0.07 Allowed 'General case' 0 N--CA 1.514 2.746 0 CA-C-O 122.596 1.189 . . . . 0.0 111.399 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -101.53 144.74 29.92 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.303 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -159.75 144.34 15.01 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.824 -1.172 . . . . 0.0 109.693 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 147' ' ' ARG . 5.0 p -138.43 132.91 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 120.701 -1.249 . . . . 0.0 109.974 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -148.88 169.17 21.15 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.433 0.635 . . . . 0.0 110.452 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.444 HG22 ' OE1' ' A' ' 144' ' ' GLN . 0.8 OUTLIER -97.42 139.22 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-O 121.361 0.6 . . . . 0.0 111.5 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.536 ' CG ' HH22 ' A' ' 107' ' ' ARG . 28.1 t-20 -117.23 150.3 38.99 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.249 -0.907 . . . . 0.0 110.745 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -153.5 113.61 3.94 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 141' ' ' PHE . . . -150.28 112.61 0.55 Allowed Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.249 -1.453 . . . . 0.0 110.305 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 141' ' ' PHE . 54.5 t80 39.01 32.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.904 -0.762 . . . . 0.0 110.122 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.451 HD23 HH11 ' A' ' 115' ' ' ARG . 32.0 tp -152.98 -94.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.89 . . . . 0.0 110.736 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.486 ' CB ' ' HG ' ' A' ' 170' ' ' SER . . . -172.55 154.27 3.06 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.535 -1.353 . . . . 0.0 112.029 -178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.444 ' OE1' HG22 ' A' ' 137' ' ' ILE . 36.0 mm-40 -52.49 144.59 13.12 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.673 1.225 . . . . 0.0 111.747 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.922 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -162.1 158.03 24.2 Favored 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -177.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 tp -108.97 159.52 16.76 Favored 'General case' 0 N--CA 1.509 2.507 0 CA-C-N 121.351 1.887 . . . . 0.0 109.683 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.759 ' O ' HG23 ' A' ' 135' ' ' VAL . 11.3 ptt180 -152.3 149.04 28.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.725 -1.234 . . . . 0.0 110.768 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.25 157.47 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-O 122.291 1.043 . . . . 0.0 109.673 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 164' ' ' ALA . 26.1 m-85 -124.92 135.96 53.32 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.844 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.557 ' O ' ' HB1' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -142.63 161.16 50.93 Favored Pre-proline 0 C--N 1.31 -1.127 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -108.16 163.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 123.459 2.773 . . . . 0.0 116.027 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.519 ' CG1' HG23 ' A' ' 163' ' ' VAL . 48.9 mt -118.62 125.86 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -104.75 155.44 18.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 123.195 1.474 . . . . 0.0 110.666 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -53.08 -85.54 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -170.35 35.59 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -148.18 20.3 1.09 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 64.85 42.54 4.39 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 153' ' ' TYR . 0.6 OUTLIER -122.68 118.46 28.15 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.723 ' N ' HE21 ' A' ' 159' ' ' GLN . 0.0 OUTLIER -63.83 121.41 13.96 Favored 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -176.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.1 pp -140.31 13.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 O-C-N 120.536 -1.353 . . . . 0.0 113.749 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.48 178.93 40.73 Favored Glycine 1 N--CA 1.522 4.379 0 C-N-CA 118.816 -1.659 . . . . 0.0 112.361 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.544 HG23 HD22 ' A' ' 129' ' ' LEU . 16.8 t -123.3 134.02 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.26 0 CA-C-N 119.013 1.406 . . . . 0.0 112.593 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 152' ' ' ILE . 2.7 t -123.9 107.19 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.614 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.687 ' HB3' HG22 ' A' ' 99' ' ' VAL . . . -112.44 158.21 20.14 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.6 HG23 ' CG1' ' A' ' 98' ' ' ILE . 4.2 mt -143.33 101.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 97' ' ' PHE . . . -115.05 127.56 7.71 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.403 -1.38 . . . . 0.0 113.11 -175.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.922 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 13.4 tp -93.71 124.82 37.97 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.662 -1.269 . . . . 0.0 109.306 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.416 ' OE1' ' NH1' ' A' ' 115' ' ' ARG . 12.7 tp10 -73.79 134.38 43.39 Favored 'General case' 0 N--CA 1.521 3.086 0 C-N-CA 122.949 0.5 . . . . 0.0 109.942 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.489 ' H ' ' HB2' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -154.99 -167.47 2.59 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 119.327 -2.108 . . . . 0.0 109.167 178.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 1.354 ' O ' HG22 ' A' ' 172' ' ' VAL . 19.8 m -166.45 -126.21 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 110.089 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.597 ' O ' HG13 ' A' ' 172' ' ' VAL . 56.6 ttt85 -17.9 71.95 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.226 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 1.354 HG22 ' O ' ' A' ' 170' ' ' SER . 0.3 OUTLIER -165.88 -16.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.649 0 O-C-N 121.381 -0.824 . . . . 0.0 110.569 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.528 HG23 ' N ' ' A' ' 174' ' ' GLN . 9.6 t -69.61 -45.3 68.88 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.477 -1.389 . . . . 0.0 113.859 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . 0.528 ' N ' HG23 ' A' ' 173' ' ' THR . 67.4 tp60 -73.95 -53.7 9.52 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.268 -1.52 . . . . 0.0 110.566 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -52.12 -70.65 0.08 Allowed 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.471 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.616 HG22 ' N ' ' A' ' 177' ' ' ASN . 1.3 mp -42.5 -78.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.896 0.855 . . . . 0.0 111.438 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.616 ' N ' HG22 ' A' ' 176' ' ' ILE . 53.1 t30 -38.23 -78.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.868 -177.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -47.16 -60.85 2.2 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.593 -1.317 . . . . 0.0 110.645 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 9.7 m -55.53 -68.28 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.39 -1.443 . . . . 0.0 108.858 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 176' ' ' ILE . 63.5 ttp85 . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.331 -0.855 . . . . 0.0 109.818 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.421 ' O ' HG22 ' A' ' 48' ' ' THR . 50.6 p . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 49' ' ' ARG . 40.7 t0 -63.76 -64.56 0.86 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 123.871 1.796 . . . . 0.0 108.817 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.416 ' C ' ' O ' ' A' ' 46' ' ' ASP . 6.6 tmm? -32.12 -60.08 0.28 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 123.331 1.538 . . . . 0.0 111.116 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 52' ' ' LEU . 13.9 t -59.56 -32.62 70.51 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.448 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 46' ' ' ASP . 32.3 ttp85 -37.86 -51.98 1.31 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.699 -1.251 . . . . 0.0 111.81 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -84.49 -56.44 3.62 Favored 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -77.43 -43.36 15.9 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -176.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.635 HD11 HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -54.63 -45.82 73.81 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 120.352 2.076 . . . . 0.0 106.344 176.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.426 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . -48.32 -57.23 6.31 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.625 -1.23 . . . . 0.0 108.999 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -78.35 -55.77 4.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.435 -1.416 . . . . 0.0 113.402 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -67.86 -21.95 65.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.862 . . . . 0.0 111.874 -175.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.676 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -97.68 -35.35 10.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 120.784 1.629 . . . . 0.0 110.572 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.4 tt -65.03 -35.8 82.35 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.291 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.63 -45.38 21.66 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -72.64 -34.41 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 118.649 -2.532 . . . . 0.0 105.882 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.447 ' N ' HG13 ' A' ' 89' ' ' VAL . . . -60.84 -31.81 71.22 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.631 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 2.0 ptt180 -70.02 -16.64 63.19 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.614 -1.234 . . . . 0.0 110.318 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 m -63.58 -46.03 87.74 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 123.056 2.662 . . . . 0.0 105.734 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.724 HD22 ' HB1' ' A' ' 84' ' ' ALA . 54.1 mt -88.79 -37.6 15.3 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.897 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.631 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -58.86 -19.95 46.44 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 119.152 -2.218 . . . . 0.0 105.715 176.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 31.5 t70 -84.39 -4.33 58.84 Favored 'General case' 0 C--N 1.274 -2.717 0 O-C-N 121.367 -0.833 . . . . 0.0 110.517 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.516 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -74.84 -155.9 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 120.36 -1.462 . . . . 0.0 111.178 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -108.04 -20.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.316 2.677 . . . . 0.0 114.336 178.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.9 pt-20 -62.1 -36.34 81.44 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.621 -1.631 . . . . 0.0 106.938 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.762 ' CG2' HG21 ' A' ' 100' ' ' VAL . 7.9 mm -47.06 -88.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.828 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' H ' ' HB ' ' A' ' 69' ' ' ILE . 73.8 ttt180 -45.35 -31.25 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -78.51 -17.81 55.69 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.732 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.772 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -83.26 -40.84 8.86 Favored Glycine 0 N--CA 1.507 3.375 1 N-CA-C 102.453 -4.259 . . . . 0.0 102.453 178.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.466 HD11 HG22 ' A' ' 100' ' ' VAL . 5.7 mp -48.13 -35.64 11.9 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -78.59 5.57 10.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.779 ' O ' ' O ' ' A' ' 76' ' ' LYS . 31.4 mmtm -139.22 34.82 2.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.835 -1.165 . . . . 0.0 111.66 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.779 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 24.96 153.83 0.0 OUTLIER Pre-proline 0 N--CA 1.527 3.412 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 76' ' ' LYS . 5.7 Cg_exo -22.42 -62.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 124.411 3.407 . . . . 0.0 114.683 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -55.22 139.37 42.46 Favored 'General case' 0 C--N 1.283 -2.303 0 C-N-CA 117.326 -1.75 . . . . 0.0 107.777 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 61.58 13.89 5.54 Favored 'General case' 0 C--N 1.282 -2.341 0 C-N-CA 119.353 -0.939 . . . . 0.0 113.336 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.641 ' O ' ' N ' ' A' ' 82' ' ' ILE . 22.4 m -88.88 82.09 6.81 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 120.247 -1.533 . . . . 0.0 109.636 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 83' ' ' GLN . . . -43.98 10.42 0.0 OUTLIER Glycine 0 CA--C 1.577 3.918 0 CA-C-O 117.594 -1.67 . . . . 0.0 115.768 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.403 HG21 ' CG1' ' A' ' 100' ' ' VAL . 0.3 OUTLIER -49.06 -12.18 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 123.983 3.892 . . . . 0.0 110.849 -178.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.831 ' N ' HD12 ' A' ' 82' ' ' ILE . 1.1 tm0? -36.78 -19.47 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.724 ' HB1' HD22 ' A' ' 63' ' ' LEU . . . -63.87 -86.72 0.01 OUTLIER 'General case' 0 C--O 1.191 -1.995 1 N-CA-C 98.675 -4.565 . . . . 0.0 98.675 171.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.719 HD13 HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -16.96 -56.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.531 3.597 0 CA-C-N 124.009 3.095 . . . . 0.0 109.336 177.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -53.1 -58.36 7.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.008 -1.682 . . . . 0.0 109.611 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 84' ' ' ALA . 56.0 tt0 -43.67 -56.65 3.62 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 117.156 -1.402 . . . . 0.0 111.563 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -65.15 -59.26 4.29 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 124.318 3.235 . . . . 0.0 109.182 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -48.26 -59.57 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 C-N-CA 114.686 -2.805 . . . . 0.0 111.313 -175.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.829 ' O ' ' N ' ' A' ' 93' ' ' ASN . 24.6 ptt180 -52.14 -39.19 59.6 Favored 'General case' 0 C--O 1.193 -1.887 0 CA-C-N 120.567 1.53 . . . . 0.0 111.045 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.599 ' C ' ' O ' ' A' ' 90' ' ' ARG . 16.3 tttm -34.11 -44.75 0.19 Allowed 'General case' 0 N--CA 1.536 3.839 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 91' ' ' LYS . 16.0 mmm180 -35.63 -53.32 0.7 Allowed 'General case' 0 N--CA 1.516 2.873 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.829 ' N ' ' O ' ' A' ' 90' ' ' ARG . 74.6 m-80 -140.37 -66.65 0.44 Allowed 'General case' 0 N--CA 1.514 2.745 0 CA-C-N 121.737 2.062 . . . . 0.0 111.261 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 2.1 m-20 159.71 -7.85 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.054 0 CA-C-O 121.572 0.701 . . . . 0.0 109.732 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.76 155.82 22.91 Favored 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.919 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER 157.49 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.53 3.559 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.669 -178.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.86 83.14 1.94 Allowed 'General case' 0 C--O 1.215 -0.75 1 N-CA-C 98.532 -4.618 . . . . 0.0 98.532 169.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.58 HD12 HG23 ' A' ' 165' ' ' ILE . 16.6 tt -104.69 155.66 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 123.633 1.683 . . . . 0.0 109.461 -175.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.647 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -151.15 139.28 14.3 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 CA-C-N 112.399 -2.182 . . . . 0.0 113.149 -171.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 1.403 ' CG1' HG21 ' A' ' 82' ' ' ILE . 7.3 p -105.53 130.95 56.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 1 N-CA-C 94.246 -6.205 . . . . 0.0 94.246 169.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 102' ' ' ASP . 1.6 m -121.6 151.91 39.86 Favored 'General case' 0 N--CA 1.508 2.471 0 CA-C-N 121.573 1.988 . . . . 0.0 111.607 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.677 ' O ' HG22 ' A' ' 101' ' ' THR . 37.4 t70 -96.16 -163.07 1.01 Allowed 'General case' 0 C--N 1.29 -1.989 1 N-CA-C 98.507 -4.627 . . . . 0.0 98.507 167.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.674 ' SD ' HD21 ' A' ' 129' ' ' LEU . 4.2 tpt -89.41 77.72 7.29 Favored 'General case' 0 C--N 1.268 -2.975 0 C-N-CA 116.074 -2.25 . . . . 0.0 109.852 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 105' ' ' SER . 64.3 tp60 -150.97 -30.4 0.18 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 119.193 -2.192 . . . . 0.0 109.046 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.634 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 26.7 t 60.95 138.13 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 105' ' ' SER . 1.1 tp 153.51 140.43 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 139.69 58.8 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.477 ' HB3' HG13 ' A' ' 82' ' ' ILE . 3.4 m-30 -97.68 -1.18 44.13 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 t -129.03 146.84 50.9 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.606 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.527 ' H ' ' CD2' ' A' ' 110' ' ' HIS . 0.4 OUTLIER -142.3 105.0 5.55 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -172.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.556 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 27.7 Cg_endo -93.11 -46.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 N-CA-C 106.11 -2.304 . . . . 0.0 106.11 172.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.556 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 2.5 tm-20 -108.54 130.01 55.29 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 175.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.67 -58.59 7.89 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.409 ' N ' ' OE2' ' A' ' 112' ' ' GLU . 99.0 mm-40 -71.62 -29.64 64.89 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -174.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -58.92 -31.02 68.27 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 123.632 2.924 . . . . 0.0 106.437 -178.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.818 ' O ' ' N ' ' A' ' 118' ' ' GLN . 0.7 OUTLIER -54.04 -89.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.219 178.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.688 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -27.58 -8.61 0.0 OUTLIER Glycine 0 N--CA 1.493 2.436 0 C-N-CA 123.961 0.791 . . . . 0.0 114.647 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.818 ' N ' ' O ' ' A' ' 116' ' ' ILE . 3.6 mt-30 -76.56 -70.59 0.21 Allowed Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 118.954 -2.497 . . . . 0.0 114.034 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.432 ' C ' ' O ' ' A' ' 118' ' ' GLN . 51.9 Cg_exo -19.12 95.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 124.289 3.326 . . . . 0.0 115.536 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.492 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 0.0 OUTLIER 175.0 11.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 123' ' ' ASP . 74.4 tttt -164.56 -27.44 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.1 -1.0 . . . . 0.0 109.471 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -41.6 -13.75 0.01 OUTLIER Glycine 1 N--CA 1.516 4.009 0 O-C-N 121.303 -0.873 . . . . 0.0 111.908 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 121' ' ' LYS . 39.1 m-20 65.01 43.65 3.7 Favored 'General case' 0 N--CA 1.523 3.198 0 CA-C-N 118.712 1.256 . . . . 0.0 112.382 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -128.42 -26.98 2.7 Favored 'General case' 0 N--CA 1.518 2.931 0 C-N-CA 117.456 -1.697 . . . . 0.0 109.832 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.59 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 12.1 mt -80.02 -16.04 12.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 O-C-N 120.729 -1.232 . . . . 0.0 110.556 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -53.47 -44.21 68.77 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.432 -1.417 . . . . 0.0 110.276 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.543 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 59.3 mttm -73.54 -31.4 63.64 Favored 'General case' 0 C--O 1.193 -1.915 0 O-C-N 121.284 -0.885 . . . . 0.0 109.569 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.554 ' O ' ' ND2' ' A' ' 130' ' ' ASN . . . -83.07 -20.6 34.63 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.37 -1.456 . . . . 0.0 109.189 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.674 HD21 ' SD ' ' A' ' 103' ' ' MET . 0.6 OUTLIER -55.03 -18.7 5.58 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.565 -0.709 . . . . 0.0 109.291 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.753 ' ND2' ' N ' ' A' ' 131' ' ' GLY 0.348 0.0 OUTLIER -79.28 -105.87 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.341 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.753 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -156.22 41.85 0.56 Allowed Glycine 0 CA--C 1.563 3.067 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.635 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 68.5 tt0 -146.47 161.17 41.0 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 119.409 -2.23 . . . . 0.0 110.891 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 133' ' ' GLU . 6.8 mp0 -73.8 165.15 25.63 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 122.091 0.948 . . . . 0.0 112.706 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 53.7 t30 -166.03 150.93 8.33 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.658 ' CG2' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -134.38 131.18 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 O-C-N 119.661 -1.9 . . . . 0.0 110.473 -177.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.28 160.85 39.73 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.159 -0.963 . . . . 0.0 111.5 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.2 mt -102.39 142.45 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-O 121.835 0.826 . . . . 0.0 112.118 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.439 ' CG ' ' N ' ' A' ' 139' ' ' ARG . 4.1 t-20 -119.11 161.62 19.99 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 138' ' ' ASN . 2.6 ptm180 -164.27 109.05 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.405 -0.918 . . . . 0.0 108.57 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -162.76 114.61 0.61 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.722 -1.704 . . . . 0.0 110.56 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 3.4 t80 60.01 -73.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.572 -0.958 . . . . 0.0 109.444 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.134 HD13 ' OE2' ' A' ' 168' ' ' GLU . 33.7 mt -47.91 -79.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 142' ' ' LEU . . . 161.81 159.95 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.335 0.588 . . . . 0.0 110.606 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 143' ' ' ALA . 39.5 mt-30 -42.37 134.96 2.82 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.951 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -156.44 155.29 31.83 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.14 152.88 25.48 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 121.117 1.781 . . . . 0.0 111.192 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 155.34 49.87 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.658 HG12 ' CG2' ' A' ' 135' ' ' VAL . 3.6 m -118.15 155.79 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 47.3 m-85 -125.51 137.66 53.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.586 0.707 . . . . 0.0 109.375 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.09 146.54 43.72 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -92.42 154.82 3.03 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 123.812 3.008 . . . . 0.0 114.981 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.2 mt -117.29 133.45 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.773 -0.579 . . . . 0.0 109.934 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 155' ' ' GLU . 77.4 m-85 -103.13 144.12 31.72 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.4 51.11 0.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 153' ' ' TYR . 9.2 tt0 41.1 25.06 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.187 -0.946 . . . . 0.0 111.657 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -138.77 30.6 2.29 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 62.46 2.67 0.93 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -92.23 124.87 36.63 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.754 ' N ' HE21 ' A' ' 159' ' ' GLN . 0.0 OUTLIER -73.1 129.99 39.3 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -175.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.422 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.7 pp -138.94 14.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.24 -1.537 . . . . 0.0 114.404 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.23 176.09 45.98 Favored Glycine 0 N--CA 1.505 3.298 0 C-N-CA 116.042 -2.98 . . . . 0.0 112.798 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.5 ' O ' ' OG1' ' A' ' 101' ' ' THR . 55.5 t -136.61 133.73 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 121.771 0.796 . . . . 0.0 110.387 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 79.7 t -106.03 122.63 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.647 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -119.35 141.93 48.59 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.676 HG21 ' HB1' ' A' ' 56' ' ' ALA . 22.3 mt -131.67 110.91 17.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.25 119.21 6.31 Favored Glycine 0 N--CA 1.487 2.039 0 C-N-CA 119.095 -1.526 . . . . 0.0 111.528 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.951 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -94.5 114.89 26.96 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 1.134 ' OE2' HD13 ' A' ' 142' ' ' LEU . 13.5 tp10 -74.86 134.88 41.6 Favored 'General case' 0 N--CA 1.518 2.951 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 170' ' ' SER . 11.0 tp 25.44 -109.58 0.02 OUTLIER 'General case' 0 N--CA 1.534 3.725 0 CA-C-N 119.04 0.836 . . . . 0.0 111.315 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 172' ' ' VAL . 22.7 t 108.61 76.01 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 CA-C-O 122.657 1.218 . . . . 0.0 109.677 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 49.6 mmt-85 1.54 -53.69 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 112.8 -2.0 . . . . 0.0 114.41 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 170' ' ' SER . 2.2 t -81.56 23.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 O-C-N 119.819 -1.801 . . . . 0.0 112.883 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.2 p -82.04 -35.84 28.35 Favored 'General case' 0 C--N 1.274 -2.688 0 O-C-N 121.912 -0.493 . . . . 0.0 111.271 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 7.6 tm0? -73.74 -58.97 2.94 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 117.487 -1.685 . . . . 0.0 108.758 -176.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.439 ' CG ' ' H ' ' A' ' 176' ' ' ILE . 4.8 pt20 -51.16 -70.04 0.1 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.289 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.751 HG23 ' N ' ' A' ' 177' ' ' ASN . 9.1 tp -41.01 -70.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.751 ' N ' HG23 ' A' ' 176' ' ' ILE . 26.3 t-20 -41.4 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.964 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 179' ' ' SER . 60.6 t0 -51.51 -63.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.999 -1.063 . . . . 0.0 111.992 -177.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.496 ' O ' ' C ' ' A' ' 180' ' ' ARG . 1.7 t -48.05 -73.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.224 -1.39 . . . . 0.0 107.834 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 179' ' ' SER . 2.8 tmm_? . . . . . 0 N--CA 1.514 2.749 0 O-C-N 121.08 -1.013 . . . . 0.0 109.716 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.66 0.743 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -71.41 -65.6 0.73 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.336 -0.852 . . . . 0.0 108.957 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 24.6 ttt -41.42 -55.92 2.65 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.888 -1.132 . . . . 0.0 110.838 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.46 ' OG1' ' CD2' ' A' ' 52' ' ' LEU . 5.8 t -60.33 -32.61 71.4 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 122.181 0.991 . . . . 0.0 108.881 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' THR . 53.8 ttp180 -41.61 -60.86 1.21 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.25 -1.531 . . . . 0.0 112.538 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -76.57 -60.98 2.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.85 -49.55 22.58 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.915 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.545 HD11 HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -51.81 -43.45 63.1 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 120.747 2.273 . . . . 0.0 108.194 178.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.82 -49.09 71.87 Favored 'General case' 0 C--O 1.204 -1.322 0 C-N-CA 117.407 -1.717 . . . . 0.0 109.481 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -78.72 -69.51 0.56 Allowed 'General case' 0 C--N 1.308 -1.214 0 O-C-N 120.099 -1.626 . . . . 0.0 111.434 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -47.31 -59.45 3.18 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.274 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -66.32 -36.34 82.69 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 123.389 2.813 . . . . 0.0 111.609 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.25 -42.41 73.45 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.062 -1.648 . . . . 0.0 108.678 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.433 ' O ' ' HG3' ' A' ' 61' ' ' ARG . . . -75.85 -51.2 13.05 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' A' ' 88' ' ' ALA . 39.0 t -63.37 -43.8 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 119.428 -2.045 . . . . 0.0 106.678 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.02 -28.62 39.42 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -76.81 -20.78 56.0 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.429 -0.909 . . . . 0.0 111.971 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.3 m -67.36 -45.7 75.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 118.893 -2.379 . . . . 0.0 106.843 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.535 ' CD2' ' HB1' ' A' ' 84' ' ' ALA . 2.2 mt -90.2 -31.91 16.83 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 113.714 -1.585 . . . . 0.0 111.13 -177.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.653 ' O ' HG21 ' A' ' 69' ' ' ILE . . . -68.02 -15.87 63.79 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 119.84 -1.788 . . . . 0.0 106.246 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.446 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 28.4 t70 -90.22 -9.17 49.03 Favored 'General case' 0 N--CA 1.528 3.427 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.861 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.492 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -70.18 -152.23 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.27 0 O-C-N 120.075 -1.641 . . . . 0.0 110.695 -178.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.712 ' C ' ' H ' ' A' ' 69' ' ' ILE . 2.0 Cg_endo -104.82 -30.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.079 2.519 . . . . 0.0 114.683 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.474 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 13.2 pt-20 -72.27 26.81 0.05 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.712 ' H ' ' C ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -100.72 -83.0 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 176.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -47.23 -31.2 3.51 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.364 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -80.15 -18.76 48.87 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.329 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -86.91 -38.0 8.2 Favored Glycine 0 CA--C 1.479 -2.21 1 N-CA-C 101.633 -4.587 . . . . 0.0 101.633 178.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.422 HD11 ' O ' ' A' ' 101' ' ' THR . 1.9 tp -56.58 -34.21 66.93 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -77.74 0.51 23.3 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.829 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.799 ' O ' ' O ' ' A' ' 76' ' ' LYS . 4.7 tmtp? -131.95 45.9 2.72 Favored 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 120.319 1.418 . . . . 0.0 112.785 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.799 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 17.37 157.05 0.0 OUTLIER Pre-proline 0 N--CA 1.535 3.819 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -29.92 -60.58 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.364 2.709 . . . . 0.0 113.984 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -52.57 130.29 31.61 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 118.617 -1.233 . . . . 0.0 109.834 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.519 ' CD ' ' HZ1' ' A' ' 75' ' ' LYS . 31.5 tt0 65.49 13.8 9.08 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.877 176.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.831 ' O ' ' N ' ' A' ' 82' ' ' ILE . 15.3 t -79.56 97.9 6.65 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.499 -1.375 . . . . 0.0 110.094 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -43.76 66.73 0.0 OUTLIER Glycine 1 CA--C 1.578 4.018 0 C-N-CA 118.503 -1.808 . . . . 0.0 111.652 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.831 ' N ' ' O ' ' A' ' 80' ' ' SER . 7.7 tp -73.52 1.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.218 -1.754 . . . . 0.0 111.2 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -52.8 -29.06 25.44 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.7 -1.25 . . . . 0.0 113.161 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.847 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -81.26 -86.65 0.09 Allowed 'General case' 0 C--O 1.193 -1.911 0 N-CA-C 100.653 -3.832 . . . . 0.0 100.653 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.866 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -19.52 -63.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 121.548 1.977 . . . . 0.0 106.075 -178.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 1.002 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -42.56 -52.08 4.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.301 -1.5 . . . . 0.0 110.144 174.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.847 ' N ' ' O ' ' A' ' 84' ' ' ALA . 36.2 tp10 -36.86 -46.57 0.63 Allowed 'General case' 0 N--CA 1.536 3.828 0 C-N-CA 116.515 -2.074 . . . . 0.0 106.699 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.447 ' CB ' HG12 ' A' ' 59' ' ' VAL . . . -49.64 -17.34 0.31 Allowed 'General case' 0 N--CA 1.512 2.667 0 O-C-N 119.446 -2.034 . . . . 0.0 108.796 171.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 1.002 ' N ' ' O ' ' A' ' 86' ' ' ALA . 22.7 m -60.8 -33.97 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 C-N-CA 115.879 -2.328 . . . . 0.0 109.101 174.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 89' ' ' VAL . 33.1 ttm180 -85.51 -49.19 8.26 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 114.328 -1.305 . . . . 0.0 113.812 -174.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -60.58 -36.79 79.37 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.444 -1.303 . . . . 0.0 108.452 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.765 ' NH2' ' H ' ' A' ' 95' ' ' LEU . 36.1 ttp85 -60.94 -71.2 0.15 Allowed 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 94' ' ' ASP . 35.6 m120 -161.53 -27.69 0.05 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.673 -1.267 . . . . 0.0 112.007 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 18.9 t70 139.8 -28.54 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.836 0 CA-C-N 120.167 1.349 . . . . 0.0 110.141 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.765 ' H ' ' NH2' ' A' ' 92' ' ' ARG . 0.3 OUTLIER -122.54 151.57 41.25 Favored 'General case' 0 N--CA 1.521 3.075 0 CA-C-N 113.701 -1.59 . . . . 0.0 114.601 -177.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.668 ' CD1' HG22 ' A' ' 165' ' ' ILE . 0.2 OUTLIER 150.36 162.31 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.0 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 178.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -107.92 95.39 5.65 Favored 'General case' 0 C--O 1.207 -1.132 1 CA-C-N 126.509 4.231 . . . . 0.0 100.247 170.335 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.567 HG13 HG23 ' A' ' 165' ' ' ILE . 1.6 mt -90.36 117.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 164' ' ' ALA . 1.1 p -136.06 139.98 44.79 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.639 0 CA-C-N 111.402 -2.635 . . . . 0.0 112.568 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.64 141.2 22.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 1 N-CA-C 99.451 -4.277 . . . . 0.0 99.451 174.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.441 ' CG2' ' H ' ' A' ' 105' ' ' SER . 0.7 OUTLIER -131.49 153.38 49.84 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 120.534 -1.354 . . . . 0.0 110.664 -176.185 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -86.65 -172.52 4.05 Favored 'General case' 0 C--N 1.281 -2.376 1 N-CA-C 99.488 -4.264 . . . . 0.0 99.488 170.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.594 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -81.2 77.03 8.13 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 114.25 -2.98 . . . . 0.0 109.577 -177.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.473 ' O ' ' CB ' ' A' ' 105' ' ' SER . 8.2 tp-100 -147.85 -40.67 0.17 Allowed 'General case' 0 C--O 1.209 -1.026 0 O-C-N 119.375 -2.078 . . . . 0.0 111.14 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.568 ' OG ' ' CD1' ' A' ' 125' ' ' ILE . 7.6 t 89.56 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.337 1.055 . . . . 0.0 109.03 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.4 OUTLIER 157.81 121.87 0.0 OUTLIER 'General case' 0 C--O 1.191 -1.982 0 N-CA-C 103.884 -2.636 . . . . 0.0 103.884 177.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.613 ' HE ' ' N ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -64.41 103.95 0.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.523 ' CD1' HG23 ' A' ' 99' ' ' VAL . 3.1 m-85 -57.84 -27.47 63.23 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -122.86 165.79 16.07 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.018 -178.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.953 ' CD2' HD11 ' A' ' 116' ' ' ILE . 14.5 p80 179.01 161.97 0.71 Allowed Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.343 -0.848 . . . . 0.0 110.907 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -87.82 -44.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.483 0.885 0 N-CA-C 106.637 -2.101 . . . . 0.0 106.637 173.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.494 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -108.02 135.44 49.39 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 174.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.3 -25.17 64.1 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 119.007 -1.077 . . . . 0.0 112.171 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -65.19 -37.49 87.5 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 119.971 -1.705 . . . . 0.0 114.841 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.432 ' HE ' ' NE2' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -65.03 -30.21 71.17 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 119.434 -2.041 . . . . 0.0 107.818 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.953 HD11 ' CD2' ' A' ' 110' ' ' HIS . 55.0 mt -40.42 -85.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.589 0 CA-C-O 122.601 1.191 . . . . 0.0 111.639 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.67 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -45.53 -10.83 0.02 OUTLIER Glycine 0 N--CA 1.494 2.513 0 CA-C-N 115.144 -0.934 . . . . 0.0 113.691 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.432 ' NE2' ' HE ' ' A' ' 115' ' ' ARG . 3.2 mt-30 -64.2 -68.58 0.76 Allowed Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 120.394 2.097 . . . . 0.0 112.047 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 118' ' ' GLN . 2.7 Cg_exo -35.96 107.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 123.933 3.088 . . . . 0.0 115.274 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.586 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 45.8 t80 173.1 28.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -176.28 -8.66 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.65 -19.3 1.25 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.5 t70 68.56 3.92 4.07 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.144 -1.21 . . . . 0.0 109.731 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.457 ' CG ' ' CB ' ' A' ' 136' ' ' ALA . 27.9 m-20 -90.66 -24.63 20.42 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.486 -0.886 . . . . 0.0 108.75 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.568 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 31.0 mt -86.49 -26.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.207 -0.933 . . . . 0.0 112.806 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 125' ' ' ILE . 3.7 mm? -37.57 -50.9 1.16 Allowed 'General case' 0 N--CA 1.517 2.884 0 O-C-N 121.01 -1.056 . . . . 0.0 109.918 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.663 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 54.6 mttm -70.53 -29.7 66.25 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.848 -1.157 . . . . 0.0 109.29 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.611 ' C ' ' ND2' ' A' ' 130' ' ' ASN . . . -90.54 -33.99 15.7 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 120.976 -1.077 . . . . 0.0 109.481 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.4 OUTLIER -36.82 -38.13 0.17 Allowed 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.829 ' ND2' ' N ' ' A' ' 131' ' ' GLY . 0.1 OUTLIER -74.31 -91.91 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 177.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.829 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -168.5 57.12 0.21 Allowed Glycine 0 CA--C 1.558 2.753 0 O-C-N 120.068 -1.645 . . . . 0.0 110.347 176.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -140.23 157.05 46.19 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.715 -1.462 . . . . 0.0 109.048 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.457 ' O ' ' CG ' ' A' ' 134' ' ' ASN . 28.3 mp0 -68.66 159.22 32.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.651 -0.655 . . . . 0.0 111.797 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' A' ' 133' ' ' GLU . 22.6 m120 -166.28 142.06 4.74 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.656 ' CG2' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -132.74 131.38 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 O-C-N 119.646 -1.909 . . . . 0.0 110.419 -178.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.457 ' CB ' ' CG ' ' A' ' 124' ' ' ASP . . . -152.49 163.19 40.06 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.418 -0.801 . . . . 0.0 110.884 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.2 mt -97.02 128.63 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.648 0 O-C-N 121.146 -0.971 . . . . 0.0 111.353 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -97.21 153.15 18.18 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -133.44 156.99 46.7 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -166.18 161.94 35.54 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -44.34 -23.99 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -1.177 . . . . 0.0 110.186 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -73.3 -80.66 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.833 -1.167 . . . . 0.0 108.679 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -173.38 159.14 3.67 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.0 111.993 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.662 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 25.2 mp0 -45.31 143.39 1.75 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.699 0.761 . . . . 0.0 109.555 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.872 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -146.56 150.64 35.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 tp -108.43 152.51 24.59 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 122.006 2.185 . . . . 0.0 109.788 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -142.92 134.97 27.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.996 -1.065 . . . . 0.0 110.705 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.656 HG12 ' CG2' ' A' ' 135' ' ' VAL . 16.2 m -104.87 136.37 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 CA-C-O 122.232 1.015 . . . . 0.0 109.91 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 89.8 m-85 -108.42 140.87 41.1 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.506 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.88 150.89 67.05 Favored Pre-proline 0 C--O 1.204 -1.294 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.4 ' HB3' ' C ' ' A' ' 131' ' ' GLY . 0.8 OUTLIER -92.66 149.99 2.81 Favored 'Trans proline' 0 N--CA 1.515 2.769 0 C-N-CA 123.65 2.9 . . . . 0.0 116.757 -178.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 61.3 mt -116.25 125.83 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.528 ' C ' ' H ' ' A' ' 155' ' ' GLU . 97.3 m-85 -95.28 142.73 27.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.17 -0.956 . . . . 0.0 110.846 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 47.3 t0 -55.09 -3.36 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.548 -1.345 . . . . 0.0 109.23 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 154' ' ' ASP . 53.2 tt0 99.39 4.69 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 158' ' ' LYS . 32.6 m120 -129.07 36.7 4.16 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.099 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 60.98 -2.39 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.5 mptt -81.27 126.3 31.39 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.632 ' O ' ' CD ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -73.88 125.71 28.8 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -175.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.7 pp -143.07 7.31 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 118.799 -2.438 . . . . 0.0 116.971 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.64 173.12 44.44 Favored Glycine 0 N--CA 1.513 3.801 0 C-N-CA 116.619 -2.705 . . . . 0.0 111.853 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 101' ' ' THR . 58.3 t -137.25 139.96 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 120.965 -1.314 . . . . 0.0 111.118 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 56.1 t -103.91 127.79 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.561 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -114.99 155.64 26.56 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.668 HG22 ' CD1' ' A' ' 96' ' ' LEU . 12.8 mt -151.29 95.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.615 ' C ' HD13 ' A' ' 96' ' ' LEU . . . -105.06 135.37 12.52 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.888 -1.625 . . . . 0.0 113.354 -175.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.872 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 0.7 OUTLIER -100.74 112.09 24.43 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 113.897 -1.151 . . . . 0.0 108.633 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -48.64 77.15 Favored 'General case' 0 N--CA 1.524 3.227 0 CA-C-O 123.025 1.393 . . . . 0.0 109.565 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -163.68 179.02 7.45 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.811 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.745 ' O ' ' N ' ' A' ' 172' ' ' VAL . 1.2 m -162.96 60.14 0.19 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.545 ' C ' ' H ' ' A' ' 173' ' ' THR . 65.1 mtm180 15.08 -63.53 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.932 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.874 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.745 ' N ' ' O ' ' A' ' 170' ' ' SER . 3.1 t -68.69 32.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.519 -1.363 . . . . 0.0 109.645 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 171' ' ' ARG . 10.9 p -83.05 -31.18 27.5 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.818 -0.551 . . . . 0.0 110.586 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . 0.435 ' O ' ' OD1' ' A' ' 178' ' ' ASP . 0.9 OUTLIER -77.9 -57.52 3.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.441 -1.412 . . . . 0.0 108.432 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.664 ' H ' ' CD ' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -50.3 -68.71 0.15 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.782 HG23 ' N ' ' A' ' 177' ' ' ASN . 2.9 tp -45.41 -71.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.782 ' N ' HG23 ' A' ' 176' ' ' ILE . 12.0 t-20 -36.17 -78.61 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.211 -0.931 . . . . 0.0 112.448 -176.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 179' ' ' SER . 23.5 p-10 -50.02 -59.67 3.67 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.38 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 178' ' ' ASP . 28.8 p -53.73 -67.62 0.24 Allowed 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.362 -1.462 . . . . 0.0 109.135 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.443 ' N ' ' OG ' ' A' ' 179' ' ' SER . 16.4 tpt180 . . . . . 0 C--N 1.3 -1.547 0 O-C-N 121.078 -1.014 . . . . 0.0 109.615 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.73 0.776 . . . . 0.0 109.095 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.457 ' OD2' HG22 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -60.82 -51.43 69.36 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 124.269 1.985 . . . . 0.0 108.9 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -28.99 66.53 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.513 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.726 HG23 HD23 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -61.17 -36.94 81.19 Favored 'General case' 0 C--O 1.203 -1.367 0 O-C-N 118.106 -2.871 . . . . 0.0 104.478 175.274 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -54.87 -52.15 63.75 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 116.508 -2.077 . . . . 0.0 109.465 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.77 -65.67 0.65 Allowed 'General case' 0 N--CA 1.517 2.905 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 52' ' ' LEU . . . -65.38 -51.83 45.41 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.726 HD23 HG23 ' A' ' 48' ' ' THR . 0.2 OUTLIER -52.44 -37.9 57.98 Favored 'General case' 0 C--O 1.206 -1.234 0 O-C-N 120.34 -1.683 . . . . 0.0 106.9 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 57' ' ' LEU . . . -56.83 -65.08 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.228 -1.789 . . . . 0.0 108.045 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -55.34 -63.86 1.03 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.052 -1.655 . . . . 0.0 112.596 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -67.63 -20.0 65.28 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.868 -1.145 . . . . 0.0 112.352 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 52' ' ' LEU . . . -97.09 -35.7 10.72 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 121.226 1.83 . . . . 0.0 109.012 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 1.2 tt -64.76 -33.32 75.69 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 121.009 -1.057 . . . . 0.0 108.56 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.87 -43.58 44.82 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.334 -0.854 . . . . 0.0 112.865 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.41 -32.61 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 118.175 -2.828 . . . . 0.0 107.512 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.924 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -58.43 -25.11 61.83 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.423 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -72.03 -21.98 61.46 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 117.008 -1.877 . . . . 0.0 109.526 179.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 98.6 m -69.61 -53.96 16.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 118.111 -2.868 . . . . 0.0 108.616 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.587 ' N ' HD22 ' A' ' 63' ' ' LEU . 4.1 mm? -79.16 -44.03 22.77 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.048 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.78 -18.0 4.19 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 119.932 -1.73 . . . . 0.0 106.744 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.488 ' N ' ' C ' ' A' ' 63' ' ' LEU . 18.5 t0 -87.56 -10.91 50.24 Favored 'General case' 0 N--CA 1.52 3.047 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.909 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.527 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -73.05 -157.96 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.938 0 O-C-N 120.484 -1.385 . . . . 0.0 109.04 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.527 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -109.21 -15.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.619 2.879 . . . . 0.0 113.837 176.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -74.87 -41.11 60.45 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.462 -0.774 . . . . 0.0 109.825 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 70' ' ' ARG . 1.7 mp -57.33 -75.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.318 -1.489 . . . . 0.0 109.896 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.607 ' N ' HG22 ' A' ' 69' ' ' ILE . 62.4 ttt-85 -45.42 -35.79 3.91 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.399 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -77.88 -14.66 59.48 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 111.899 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.508 ' C ' ' N ' ' A' ' 74' ' ' GLN . . . -94.84 -47.97 2.58 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 103.538 -3.825 . . . . 0.0 103.538 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -49.23 -23.64 1.43 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.092 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.508 ' N ' ' C ' ' A' ' 72' ' ' GLY . 55.7 tp60 -50.76 -9.16 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.801 -1.545 . . . . 0.0 109.588 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.844 ' O ' ' O ' ' A' ' 76' ' ' LYS . 5.1 mmtp -150.51 85.46 1.38 Allowed 'General case' 0 N--CA 1.523 3.175 0 O-C-N 120.847 -1.158 . . . . 0.0 113.016 -177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.844 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 23.91 164.13 0.0 OUTLIER Pre-proline 1 N--CA 1.539 4.008 0 CA-C-N 121.986 2.175 . . . . 0.0 116.19 179.668 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 78' ' ' GLN . 6.2 Cg_exo -32.36 -68.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.509 2.41 0 C-N-CA 124.255 3.304 . . . . 0.0 115.293 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 77' ' ' PRO . 91.8 mt-30 -35.98 133.1 0.47 Allowed 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.784 1.278 . . . . 0.0 111.024 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 63.04 19.28 11.55 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.716 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.9 ' O ' ' N ' ' A' ' 82' ' ' ILE . 33.8 m -90.0 83.66 6.12 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.347 -1.471 . . . . 0.0 109.341 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -38.88 52.31 0.0 OUTLIER Glycine 0 N--CA 1.508 3.464 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.569 -177.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.9 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.4 tp -63.86 -1.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 120.514 -1.58 . . . . 0.0 108.038 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.44 ' H ' ' C ' ' A' ' 81' ' ' GLY . 17.7 mp0 -58.4 -21.92 52.14 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 120.974 -1.079 . . . . 0.0 112.199 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -85.84 -63.64 1.29 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 121.951 2.159 . . . . 0.0 112.061 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.568 HD11 HD12 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -48.27 -34.09 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 122.718 2.508 . . . . 0.0 107.067 172.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 90' ' ' ARG . . . -65.43 -48.36 73.02 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' ALA . 36.8 tt0 -48.22 -56.6 7.55 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 117.443 -1.265 . . . . 0.0 112.425 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.95 -44.16 23.06 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 123.553 2.888 . . . . 0.0 108.306 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 85' ' ' ILE . 98.8 t -55.97 -76.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 116.071 -2.251 . . . . 0.0 108.977 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.623 ' O ' ' C ' ' A' ' 91' ' ' LYS . 45.8 ttm-85 -34.7 -58.53 0.5 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.55 0.74 . . . . 0.0 110.038 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.623 ' C ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -32.32 -49.04 0.19 Allowed 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 117.35 -1.74 . . . . 0.0 107.582 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -55.35 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 117.064 -1.446 . . . . 0.0 111.107 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.926 ' O ' ' ND2' ' A' ' 93' ' ' ASN . 0.3 OUTLIER -71.27 -3.61 21.33 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 113.864 -3.134 . . . . 0.0 108.903 -172.097 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.539 ' O ' HD23 ' A' ' 95' ' ' LEU . 7.6 t70 62.01 40.87 11.77 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -174.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 94' ' ' ASP . 0.6 OUTLIER 158.94 165.23 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.605 HD22 HG22 ' A' ' 165' ' ' ILE . 4.1 mt 150.07 163.34 0.0 OUTLIER 'General case' 1 N--CA 1.557 4.924 0 CA-C-N 121.194 1.815 . . . . 0.0 108.505 178.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -113.82 85.87 2.29 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 171.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.924 HD11 ' HB2' ' A' ' 60' ' ' ALA . 0.9 OUTLIER -91.62 113.1 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 104.708 -2.331 . . . . 0.0 104.708 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.662 ' CG2' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -122.13 135.75 61.22 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.379 0 CA-C-N 112.808 -1.996 . . . . 0.0 112.454 -174.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.489 HG11 HG23 ' A' ' 69' ' ' ILE . 7.1 p -111.19 128.78 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 1 N-CA-C 98.679 -4.563 . . . . 0.0 98.679 171.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.662 HG23 ' CG2' ' A' ' 99' ' ' VAL . 3.3 p -117.89 155.05 30.84 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 120.343 -1.473 . . . . 0.0 109.842 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.61 ' O ' ' N ' ' A' ' 104' ' ' GLN . 1.5 t70 -82.3 -175.85 5.89 Favored 'General case' 0 C--N 1.285 -2.201 1 N-CA-C 97.592 -4.966 . . . . 0.0 97.592 170.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.532 ' C ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -70.47 75.64 0.56 Allowed 'General case' 0 C--N 1.268 -2.951 0 C-N-CA 113.89 -3.124 . . . . 0.0 105.499 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.61 ' N ' ' O ' ' A' ' 102' ' ' ASP . 6.6 mm-40 -136.78 -51.54 0.68 Allowed 'General case' 0 C--O 1.214 -0.798 0 O-C-N 119.365 -2.085 . . . . 0.0 108.189 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.766 ' OG ' HD13 ' A' ' 125' ' ' ILE . 0.5 OUTLIER 84.6 134.51 0.05 Allowed 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -178.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.647 ' H ' ' NH2' ' A' ' 107' ' ' ARG . 1.5 pp 148.41 147.4 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.647 ' NH2' ' H ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -69.07 139.87 54.85 Favored 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 178.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.512 ' CD2' HD13 ' A' ' 82' ' ' ILE . 1.6 m-85 -96.73 -35.8 10.87 Favored 'General case' 0 C--N 1.258 -3.387 0 N-CA-C 103.498 -2.778 . . . . 0.0 103.498 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.22 167.48 10.65 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 112.197 -2.274 . . . . 0.0 112.222 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.512 ' CD2' HD11 ' A' ' 116' ' ' ILE . 17.3 p80 -175.16 153.77 1.6 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 120.813 -1.179 . . . . 0.0 112.482 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.578 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 41.1 Cg_endo -90.75 -37.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 N-CA-C 106.191 -2.273 . . . . 0.0 106.191 172.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.578 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 57.0 tt0 -102.17 115.18 30.0 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.404 ' HA ' ' ND1' ' A' ' 110' ' ' HIS . . . -48.47 -47.43 38.5 Favored 'General case' 0 C--N 1.29 -1.99 0 O-C-N 121.011 -1.055 . . . . 0.0 112.084 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -64.39 -31.06 72.12 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.271 -1.518 . . . . 0.0 115.034 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.678 ' NE ' ' OE1' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -66.83 -22.21 66.01 Favored 'General case' 0 C--O 1.197 -1.687 0 O-C-N 119.35 -2.094 . . . . 0.0 107.969 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.84 HG22 ' N ' ' A' ' 117' ' ' GLY . 54.8 mt -35.11 -91.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.84 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -85.81 -9.72 77.33 Favored Glycine 0 N--CA 1.502 3.078 0 O-C-N 121.025 -1.047 . . . . 0.0 114.034 -173.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.688 ' N ' ' HD2' ' A' ' 119' ' ' PRO . 3.2 pt20 -60.5 -40.66 77.97 Favored Pre-proline 0 C--N 1.294 -1.807 0 C-N-CA 116.442 -2.103 . . . . 0.0 110.14 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 118' ' ' GLN . 8.3 Cg_endo -48.15 113.87 0.95 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.662 2.241 . . . . 0.0 112.894 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.445 ' CD2' ' O ' ' A' ' 120' ' ' PHE . 69.7 t80 -178.89 29.06 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -132.45 42.74 3.07 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.665 -0.647 . . . . 0.0 112.518 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.35 -46.94 0.1 Allowed Glycine 0 N--CA 1.51 3.59 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 75.32 20.03 2.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.917 -0.754 . . . . 0.0 111.421 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.468 ' OD2' ' CE2' ' A' ' 149' ' ' PHE . 19.7 p-10 -84.1 -2.68 57.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.213 -1.554 . . . . 0.0 108.563 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.766 HD13 ' OG ' ' A' ' 105' ' ' SER . 12.3 pt -84.51 -23.73 7.52 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 O-C-N 120.941 -1.1 . . . . 0.0 110.684 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' A' ' 125' ' ' ILE . 71.6 mt -35.65 -46.09 0.4 Allowed 'General case' 0 N--CA 1.52 3.044 0 O-C-N 121.198 -0.938 . . . . 0.0 110.061 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -79.48 -40.95 28.54 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.351 -0.843 . . . . 0.0 110.81 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -83.1 -30.73 27.72 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.218 -1.551 . . . . 0.0 108.317 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.584 ' N ' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -38.85 -34.18 0.14 Allowed 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 128' ' ' ALA . 1.6 m120 -99.42 -104.32 0.22 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -132.11 54.12 0.79 Allowed Glycine 0 N--CA 1.506 3.32 0 C-N-CA 119.801 -1.19 . . . . 0.0 115.27 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -144.55 142.84 30.49 Favored 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 120.515 2.157 . . . . 0.0 108.776 178.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.595 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 89.2 mt-10 -69.66 157.1 37.9 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 119.888 -1.758 . . . . 0.0 109.987 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 133' ' ' GLU . 20.3 m-80 -160.11 142.55 13.27 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.532 HG22 HG12 ' A' ' 148' ' ' VAL . 2.3 t -131.29 145.3 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.556 -1.34 . . . . 0.0 108.909 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.62 164.18 29.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 109.066 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.2 mt -99.6 139.88 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 O-C-N 120.717 -1.239 . . . . 0.0 111.029 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.446 HD21 ' CZ ' ' A' ' 115' ' ' ARG . 8.3 t-20 -106.36 138.95 41.62 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.701 0.762 . . . . 0.0 109.709 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.594 ' N ' HH12 ' A' ' 115' ' ' ARG . 14.6 ptm180 -166.95 115.89 0.85 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.38 -1.328 . . . . 0.0 109.43 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.51 ' C ' ' N ' ' A' ' 142' ' ' LEU . . . -162.27 109.21 0.38 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 107.729 -2.149 . . . . 0.0 107.729 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 50.4 13.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.997 -1.296 . . . . 0.0 108.405 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.51 ' N ' ' C ' ' A' ' 140' ' ' GLY . 13.0 tp -134.34 172.5 12.8 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.52 -142.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.233 -1.542 . . . . 0.0 112.465 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -110.79 146.58 36.14 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 176.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.762 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -150.62 142.61 23.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.957 -1.714 . . . . 0.0 107.191 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.423 ' HA ' HD12 ' A' ' 146' ' ' LEU . 9.7 tp -101.79 149.41 24.2 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 122.781 2.537 . . . . 0.0 106.89 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.593 ' NH2' ' CZ ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -144.81 150.55 37.36 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.409 1.099 . . . . 0.0 111.207 -178.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 53' ' ' ALA . 23.9 m -113.14 143.23 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.717 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.49 ' CD1' HG22 ' A' ' 125' ' ' ILE . 28.2 m-85 -110.69 135.02 51.93 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.657 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -136.24 166.4 28.23 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -111.61 154.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.5 1.912 0 C-N-CA 124.306 3.338 . . . . 0.0 114.803 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 54.2 mt -118.89 127.68 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.544 ' C ' ' H ' ' A' ' 155' ' ' GLU . 83.4 m-85 -101.76 144.18 30.77 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.927 -1.108 . . . . 0.0 112.201 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 55.7 t0 -65.66 12.79 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.547 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER 86.81 15.65 0.1 Allowed 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.98 -1.075 . . . . 0.0 108.455 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 158' ' ' LYS . 77.7 m-20 -139.27 36.16 2.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.84 -1.162 . . . . 0.0 108.303 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 59.56 3.36 0.41 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.512 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.6 mptt -85.91 130.81 34.44 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.745 ' O ' ' NE2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -85.01 125.62 32.87 Favored 'General case' 0 N--CA 1.512 2.655 0 CA-C-N 119.848 1.204 . . . . 0.0 113.571 -177.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.08 5.49 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 O-C-N 119.926 -1.734 . . . . 0.0 113.88 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -171.26 173.6 44.81 Favored Glycine 0 N--CA 1.501 3.01 0 C-N-CA 118.18 -1.962 . . . . 0.0 112.033 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.569 ' O ' ' OG1' ' A' ' 101' ' ' THR . 1.5 t -133.21 141.99 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 O-C-N 121.799 -0.824 . . . . 0.0 110.708 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.443 ' O ' ' OG1' ' A' ' 150' ' ' THR . 9.2 t -113.25 119.64 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 120.961 -1.087 . . . . 0.0 108.179 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.64 ' HB3' ' CG1' ' A' ' 99' ' ' VAL . . . -112.93 156.61 22.7 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.605 HG22 HD22 ' A' ' 96' ' ' LEU . 23.6 mt -152.14 109.64 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.596 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -115.8 137.09 13.49 Favored Glycine 0 N--CA 1.489 2.178 0 CA-C-O 122.805 1.225 . . . . 0.0 113.636 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.762 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 3.5 tp -95.45 103.27 15.13 Favored 'General case' 0 N--CA 1.514 2.763 0 CA-C-N 113.809 -1.196 . . . . 0.0 108.124 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.582 ' O ' ' CB ' ' A' ' 169' ' ' LEU . 7.1 tt0 -47.47 -60.27 2.64 Favored 'General case' 0 N--CA 1.523 3.208 0 O-C-N 124.384 1.053 . . . . 0.0 109.684 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 1.062 HD22 ' H ' ' A' ' 170' ' ' SER . 0.2 OUTLIER 150.44 156.05 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.359 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.767 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 1.062 ' H ' HD22 ' A' ' 169' ' ' LEU . 49.9 m -163.56 -37.57 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.821 -0.549 . . . . 0.0 110.233 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.525 ' O ' ' HB ' ' A' ' 172' ' ' VAL . 48.7 ttp85 149.15 146.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 171' ' ' ARG . 82.1 t 102.03 -2.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 44.7 p -74.79 -48.51 25.03 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.339 0.59 . . . . 0.0 111.422 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -75.94 -47.11 26.46 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.113 -0.992 . . . . 0.0 109.452 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.49 ' NE2' ' H ' ' A' ' 175' ' ' GLN . 4.5 mp0 -50.52 -75.44 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.66 HG22 ' N ' ' A' ' 177' ' ' ASN . 3.7 mm -41.81 -77.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-O 121.317 0.58 . . . . 0.0 112.456 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.66 ' N ' HG22 ' A' ' 176' ' ' ILE . 57.0 t-20 -40.51 -77.74 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 177' ' ' ASN . 3.8 m-20 -45.55 -61.08 1.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.72 -1.238 . . . . 0.0 110.724 -176.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 180' ' ' ARG . 59.9 p -50.91 -69.24 0.12 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.83 -1.169 . . . . 0.0 109.385 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.523 ' N ' ' OG ' ' A' ' 179' ' ' SER . 59.2 ttt-85 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.48 -0.763 . . . . 0.0 109.552 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.634 0.73 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.593 ' H ' HD13 ' A' ' 176' ' ' ILE . 55.1 t0 -65.28 -56.34 13.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 124.068 1.889 . . . . 0.0 107.303 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 46' ' ' ASP . 11.1 ttt -36.78 -56.92 0.83 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.896 -174.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.542 ' OG1' HD13 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -59.01 -36.44 74.94 Favored 'General case' 0 C--O 1.202 -1.405 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.089 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.484 ' C ' ' O ' ' A' ' 48' ' ' THR . 55.9 ttt-85 -35.79 -64.31 0.31 Allowed 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.044 0.926 . . . . 0.0 111.397 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -70.42 -57.73 4.49 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.96 -35.56 21.15 Favored Glycine 0 N--CA 1.497 2.759 0 C-N-CA 119.572 -1.299 . . . . 0.0 111.397 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.785 HD11 HD21 ' A' ' 96' ' ' LEU . 11.3 tp -53.36 -47.66 69.24 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 120.783 2.291 . . . . 0.0 107.145 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.565 ' HB2' HG11 ' A' ' 148' ' ' VAL . . . -50.7 -61.76 2.01 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.767 -1.173 . . . . 0.0 109.51 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.529 ' C ' HD22 ' A' ' 54' ' ' ASN . 0.4 OUTLIER -69.3 -56.37 7.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.268 -1.52 . . . . 0.0 113.359 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -69.58 -41.34 75.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -0.884 . . . . 0.0 112.335 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.63 ' HB1' HG21 ' A' ' 165' ' ' ILE . . . -72.86 -35.23 67.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 119.715 -1.866 . . . . 0.0 110.11 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 57' ' ' LEU . 7.2 tt -65.22 -41.31 94.54 Favored 'General case' 0 C--N 1.288 -2.106 0 O-C-N 121.057 -1.027 . . . . 0.0 111.492 177.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.88 -44.42 49.01 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.297 -1.502 . . . . 0.0 114.885 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.38 -43.63 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 118.836 -2.415 . . . . 0.0 106.607 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.875 ' CB ' HD13 ' A' ' 98' ' ' ILE . . . -57.9 -26.42 62.14 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.641 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -71.08 -15.84 62.55 Favored 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 118.474 -1.29 . . . . 0.0 109.009 179.005 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -64.85 -42.47 94.87 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 115.105 -2.638 . . . . 0.0 104.143 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.613 HD22 ' HB1' ' A' ' 84' ' ' ALA . 49.0 mt -87.45 -42.02 13.12 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.801 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.641 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -55.77 -18.47 8.47 Favored 'General case' 0 N--CA 1.522 3.17 0 O-C-N 119.989 -1.694 . . . . 0.0 107.166 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 12.2 t0 -85.49 -22.72 28.08 Favored 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.959 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.51 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -58.38 -156.69 0.0 OUTLIER Pre-proline 0 C--N 1.281 -2.397 0 O-C-N 120.699 -1.251 . . . . 0.0 111.742 -177.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -107.4 -35.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.513 2.62 0 C-N-CA 124.476 3.451 . . . . 0.0 115.396 178.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 72' ' ' GLY . 7.4 pt-20 -55.74 -30.98 62.12 Favored 'General case' 0 N--CA 1.508 2.448 0 C-N-CA 118.735 -1.186 . . . . 0.0 109.166 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -53.08 -76.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 122.267 1.032 . . . . 0.0 111.034 -179.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.486 ' N ' HG22 ' A' ' 69' ' ' ILE . 72.5 ttt180 -49.94 -33.85 18.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -83.02 -18.75 38.66 Favored 'General case' 0 C--N 1.276 -2.617 0 C-N-CA 118.817 -1.153 . . . . 0.0 112.763 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.783 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -86.31 -46.11 5.37 Favored Glycine 0 N--CA 1.498 2.816 1 N-CA-C 101.931 -4.468 . . . . 0.0 101.931 179.098 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.421 HD11 ' HA ' ' A' ' 102' ' ' ASP . 15.2 tp -46.6 -39.2 10.71 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 175.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -68.88 6.2 0.94 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 113.999 -1.455 . . . . 0.0 109.091 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.783 ' N ' ' O ' ' A' ' 72' ' ' GLY . 4.3 tmtt? -143.56 52.84 1.33 Allowed 'General case' 0 N--CA 1.512 2.668 0 O-C-N 120.265 -1.522 . . . . 0.0 114.526 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.658 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 32.95 149.55 0.0 OUTLIER Pre-proline 0 N--CA 1.524 3.24 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 178.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -30.79 -70.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.513 2.644 0 C-N-CA 124.875 3.717 . . . . 0.0 118.232 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' HB2' ' HZ2' ' A' ' 76' ' ' LYS . 26.5 mt-30 -44.27 -43.45 7.34 Favored 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -101.97 9.36 40.56 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.483 -1.386 . . . . 0.0 110.15 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.5 m -88.32 125.82 34.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.42 71.97 0.96 Allowed Glycine 0 N--CA 1.489 2.182 0 O-C-N 118.699 -2.501 . . . . 0.0 109.981 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.523 HD11 ' H ' ' A' ' 100' ' ' VAL . 3.1 tp -63.89 -4.64 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 C-N-CA 125.078 1.351 . . . . 0.0 109.585 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.649 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 55.3 tt0 -50.09 -32.7 16.44 Favored 'General case' 0 C--N 1.279 -2.468 0 O-C-N 120.851 -1.155 . . . . 0.0 110.038 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -71.64 -98.5 0.01 OUTLIER 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.787 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -16.08 -44.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.952 0 CA-C-N 121.788 2.085 . . . . 0.0 111.904 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -73.2 -48.08 38.13 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 119.678 -1.889 . . . . 0.0 109.601 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.649 ' HG2' ' O ' ' A' ' 83' ' ' GLN . 50.9 mm-40 -49.86 -49.8 47.95 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.718 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -66.33 -56.39 11.35 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 125.529 3.786 . . . . 0.0 108.564 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.755 HG13 HD13 ' A' ' 96' ' ' LEU . 1.2 t -52.96 -65.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 115.638 -2.425 . . . . 0.0 108.945 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 1.027 ' HD3' ' H ' ' A' ' 96' ' ' LEU . 1.9 tpp85 -37.97 -46.05 0.94 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.467 -1.395 . . . . 0.0 109.218 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.605 ' C ' ' O ' ' A' ' 90' ' ' ARG . 14.4 ttmm -34.48 -43.45 0.17 Allowed 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 117.592 -1.643 . . . . 0.0 106.705 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.753 ' HD3' ' O ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -39.78 -39.53 0.81 Allowed 'General case' 0 N--CA 1.509 2.484 0 CA-C-O 117.369 -1.3 . . . . 0.0 109.06 172.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 90' ' ' ARG . 1.5 m120 -156.58 -62.93 0.1 Allowed 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 124.783 3.447 . . . . 0.0 111.106 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 93' ' ' ASN . 1.1 m-20 166.11 -13.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.085 -1.009 . . . . 0.0 111.365 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.44 60.98 1.49 Allowed 'General case' 0 N--CA 1.533 3.696 0 C-N-CA 118.422 -1.311 . . . . 0.0 113.972 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.027 ' H ' ' HD3' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -120.14 142.23 49.12 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 116.793 -1.575 . . . . 0.0 110.773 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -119.95 100.22 7.09 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 124.752 3.433 . . . . 0.0 109.409 176.241 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.875 HD13 ' CB ' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -95.22 111.76 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 174.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.675 ' CG2' ' HB3' ' A' ' 164' ' ' ALA . 4.5 m -112.37 124.21 68.83 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.594 0 CA-C-N 112.097 -2.319 . . . . 0.0 110.199 -173.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.523 ' H ' HD11 ' A' ' 82' ' ' ILE . 9.5 p -96.68 128.08 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 1 N-CA-C 98.754 -4.536 . . . . 0.0 98.754 176.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 104' ' ' GLN . 81.0 p -119.99 151.49 38.88 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.464 -175.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 104' ' ' GLN . 38.8 t0 -81.91 -174.77 5.24 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 100.498 -3.89 . . . . 0.0 100.498 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 43.1 ttm -74.81 71.22 1.97 Allowed 'General case' 0 C--N 1.268 -2.976 0 C-N-CA 114.889 -2.724 . . . . 0.0 107.837 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.625 ' O ' ' HB ' ' A' ' 101' ' ' THR . 3.5 pp0? -171.82 136.07 0.89 Allowed 'General case' 0 N--CA 1.436 -1.132 1 N-CA-C 96.844 -5.243 . . . . 0.0 96.844 176.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.698 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 16.3 t -107.72 -179.95 4.05 Favored 'General case' 0 CA--C 1.47 -2.117 0 C-N-CA 116.741 -1.983 . . . . 0.0 106.581 -176.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.698 ' HB2' ' O ' ' A' ' 105' ' ' SER . 3.3 tp 154.04 144.84 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.673 ' HA ' HG11 ' A' ' 99' ' ' VAL . 1.8 mmp_? -77.02 91.51 3.64 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.416 -1.713 . . . . 0.0 108.413 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 107' ' ' ARG . 3.2 m-85 -46.25 -31.14 2.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.416 ' N ' ' C ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -124.42 171.51 9.89 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 113.811 -1.54 . . . . 0.0 113.715 -178.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.421 ' CE1' ' HG3' ' A' ' 107' ' ' ARG . 0.1 OUTLIER 172.09 166.6 0.24 Allowed Pre-proline 0 N--CA 1.51 2.531 0 O-C-N 121.511 -0.743 . . . . 0.0 109.576 -179.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.447 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 46.5 Cg_endo -88.48 -40.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 122.768 2.312 . . . . 0.0 107.31 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 111' ' ' PRO . 18.4 tp10 -107.96 93.98 4.83 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.97 1.367 . . . . 0.0 107.663 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' GLU . . . -31.11 -45.78 0.08 Allowed 'General case' 0 N--CA 1.503 2.195 0 CA-C-N 113.27 -1.786 . . . . 0.0 113.007 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -60.01 -33.35 71.88 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 120.395 -1.441 . . . . 0.0 113.772 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -60.9 -36.82 80.23 Favored 'General case' 0 C--O 1.203 -1.387 0 O-C-N 120.114 -1.616 . . . . 0.0 108.151 -178.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.734 ' O ' ' N ' ' A' ' 118' ' ' GLN . 79.7 mt -41.88 -84.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.075 177.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.466 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -27.64 -17.1 0.0 OUTLIER Glycine 0 N--CA 1.497 2.713 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.81 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.734 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.4 mp0 -77.61 -73.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.836 0 CA-C-N 120.946 2.373 . . . . 0.0 114.205 -175.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -30.86 115.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 123.325 2.683 . . . . 0.0 115.224 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.518 ' O ' ' CG ' ' A' ' 120' ' ' PHE . 72.2 t80 171.73 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 123' ' ' ASP . 42.3 mttm -157.1 -26.13 0.09 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.41 -176.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 121' ' ' LYS . . . -41.06 -25.35 0.12 Allowed Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.041 -1.037 . . . . 0.0 110.549 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 121' ' ' LYS . 57.6 m-20 60.17 10.83 2.47 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.757 -0.849 . . . . 0.0 110.897 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -88.57 -23.64 23.07 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.493 ' O ' ' N ' ' A' ' 128' ' ' ALA . 3.9 mt -80.68 -17.16 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.77 -1.206 . . . . 0.0 112.034 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 125' ' ' ILE . 54.4 mt -49.36 -32.97 12.46 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.556 -1.34 . . . . 0.0 107.481 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.608 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 94.8 mttt -79.65 -30.31 41.21 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.534 ' C ' ' ND2' ' A' ' 130' ' ' ASN . . . -92.44 -36.32 13.17 Favored 'General case' 0 N--CA 1.51 2.534 0 CA-C-N 120.417 1.462 . . . . 0.0 109.262 -176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.4 mt -41.15 -30.49 0.16 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.265 -0.897 . . . . 0.0 108.686 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.809 ' ND2' ' N ' ' A' ' 131' ' ' GLY . 0.0 OUTLIER -77.97 -95.56 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.809 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -160.88 33.22 0.39 Allowed Glycine 0 CA--C 1.562 2.978 0 O-C-N 120.594 -1.316 . . . . 0.0 111.131 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.454 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 63.6 tt0 -122.98 161.97 23.21 Favored 'General case' 0 N--CA 1.52 3.061 0 O-C-N 119.012 -2.463 . . . . 0.0 109.463 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -77.45 170.66 16.16 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.424 -0.798 . . . . 0.0 112.625 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.855 HD22 ' H ' ' A' ' 135' ' ' VAL . 0.2 OUTLIER -171.67 149.97 2.65 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.855 ' H ' HD22 ' A' ' 134' ' ' ASN . 0.9 OUTLIER -133.67 131.88 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 119.877 -1.764 . . . . 0.0 108.93 -178.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.01 177.17 9.81 Favored 'General case' 0 N--CA 1.514 2.756 0 O-C-N 121.068 -1.02 . . . . 0.0 110.969 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.78 134.61 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.895 -1.128 . . . . 0.0 111.297 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -98.77 120.19 38.78 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.197 -0.939 . . . . 0.0 110.479 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.611 ' NE ' HE22 ' A' ' 144' ' ' GLN . 6.8 ptp180 -141.41 110.02 6.04 Favored 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 117.871 -1.532 . . . . 0.0 112.062 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -156.81 105.91 0.28 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 58.44 -39.84 0.06 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.343 -0.504 . . . . 0.0 111.586 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 140' ' ' GLY . 71.8 mt -72.81 -85.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.908 -1.12 . . . . 0.0 110.769 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.405 ' CB ' HD23 ' A' ' 169' ' ' LEU . . . -179.05 154.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.964 -1.094 . . . . 0.0 110.25 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.611 HE22 ' NE ' ' A' ' 139' ' ' ARG . 5.0 mm100 -46.46 136.14 7.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.092 -1.005 . . . . 0.0 108.496 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.88 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -148.04 156.6 42.82 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tp -114.93 150.76 35.19 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-N 122.5 2.409 . . . . 0.0 109.621 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.61 ' NH2' ' NH1' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -150.41 129.32 12.53 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.849 1.309 . . . . 0.0 112.449 -179.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 53' ' ' ALA . 10.0 m -91.91 150.15 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.317 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 46.3 m-85 -116.03 138.79 50.91 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.481 ' O ' ' N ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -138.3 138.75 23.39 Favored Pre-proline 0 C--O 1.208 -1.126 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -89.68 155.29 5.17 Favored 'Trans proline' 0 N--CA 1.515 2.782 0 C-N-CA 123.881 3.054 . . . . 0.0 115.136 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.8 mt -121.35 131.4 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.865 -0.522 . . . . 0.0 109.65 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.522 ' C ' ' H ' ' A' ' 155' ' ' GLU . 86.9 m-85 -101.29 144.15 30.48 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.022 -1.049 . . . . 0.0 111.283 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 155' ' ' GLU . 57.0 t0 -58.86 2.49 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.57 -1.252 . . . . 0.0 109.768 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 153' ' ' TYR . 17.9 tt0 86.24 29.62 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.825 -1.172 . . . . 0.0 108.629 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -149.36 18.6 0.94 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 71.63 9.78 6.36 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -88.55 116.79 27.04 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.707 ' NE2' ' N ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -68.69 117.54 10.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.087 -1.008 . . . . 0.0 113.332 -177.134 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.421 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.8 pp -134.19 11.13 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -174.21 179.19 45.71 Favored Glycine 0 N--CA 1.504 3.208 0 C-N-CA 115.163 -3.399 . . . . 0.0 114.146 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 96.7 t -143.32 140.62 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 CA-C-O 122.484 1.135 . . . . 0.0 111.779 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 150' ' ' THR . 63.6 t -111.36 127.39 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.675 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . . . -115.72 153.13 31.91 Favored 'General case' 0 N--CA 1.51 2.563 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.63 HG21 ' HB1' ' A' ' 56' ' ' ALA . 24.5 mt -148.6 103.5 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.181 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -114.25 140.97 16.72 Favored Glycine 0 N--CA 1.485 1.946 0 CA-C-O 123.399 1.555 . . . . 0.0 112.115 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.88 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 50.6 tp -97.12 106.23 18.52 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 169' ' ' LEU . 0.5 OUTLIER -72.87 142.59 47.94 Favored 'General case' 0 N--CA 1.524 3.269 0 O-C-N 124.002 0.813 . . . . 0.0 109.414 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 168' ' ' GLU . 3.1 mt 38.9 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.777 0 O-C-N 120.039 -1.663 . . . . 0.0 113.935 175.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 171' ' ' ARG . 1.9 t 166.72 -86.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.28 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 170' ' ' SER . 0.3 OUTLIER 151.53 -28.31 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.222 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.746 178.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.467 ' O ' HD12 ' A' ' 176' ' ' ILE . 1.8 t -95.11 30.95 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.375 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 67.5 p -77.16 -46.57 22.95 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.189 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -69.89 -52.08 27.74 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -52.79 -69.13 0.12 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.593 HD13 ' H ' ' A' ' 46' ' ' ASP . 68.6 mt -44.59 -80.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 121.552 -0.717 . . . . 0.0 112.179 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.521 ' N ' HG22 ' A' ' 176' ' ' ILE . 87.2 m-20 -36.45 -80.0 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -176.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -44.27 -52.53 7.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.961 -1.087 . . . . 0.0 110.76 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 180' ' ' ARG . 28.7 p -57.69 -65.5 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.894 -1.128 . . . . 0.0 109.715 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.512 ' N ' ' OG ' ' A' ' 179' ' ' SER . 48.6 ttt85 . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.083 -1.011 . . . . 0.0 109.306 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 48' ' ' THR . 62.0 p . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 121.988 0.899 . . . . 0.0 108.907 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 49' ' ' ARG . 35.0 t70 -60.92 -57.59 12.01 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.128 0.966 . . . . 0.0 110.97 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 15.5 mmm -39.4 -59.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.819 -1.175 . . . . 0.0 111.575 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.45 ' OG1' ' CD2' ' A' ' 52' ' ' LEU . 11.6 t -57.91 -31.73 67.07 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 62.3 ttt180 -42.32 -56.43 2.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.779 -1.201 . . . . 0.0 110.761 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -69.98 -63.39 1.09 Allowed 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 126.18 1.792 . . . . 0.0 114.511 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . -83.14 -41.01 8.8 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 119.204 -1.474 . . . . 0.0 111.243 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.572 HD11 HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -50.69 -45.61 58.35 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.596 2.698 . . . . 0.0 106.309 176.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.435 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . -48.98 -65.94 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.995 -1.066 . . . . 0.0 110.004 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -67.14 -55.79 12.69 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.585 -1.322 . . . . 0.0 112.64 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' GLY . 55.0 mtpt -68.55 -49.6 58.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -174.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.66 -33.14 70.64 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 118.965 -2.334 . . . . 0.0 111.267 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.881 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.8 tt -65.64 -37.89 87.84 Favored 'General case' 0 C--N 1.285 -2.211 0 O-C-N 120.505 -1.372 . . . . 0.0 110.921 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 61' ' ' ARG . . . -74.42 -47.46 33.69 Favored 'General case' 0 N--CA 1.511 2.592 0 O-C-N 119.201 -2.187 . . . . 0.0 115.703 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.68 -35.95 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 118.617 -2.552 . . . . 0.0 106.395 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.528 ' HB2' HD12 ' A' ' 98' ' ' ILE . . . -55.96 -32.42 63.84 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.606 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -67.83 -22.58 65.15 Favored 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 117.726 -1.131 . . . . 0.0 111.093 178.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 m -59.77 -47.89 83.88 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 123.701 2.955 . . . . 0.0 106.429 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.684 HD22 ' HB1' ' A' ' 84' ' ' ALA . 26.1 mt -85.77 -36.49 20.09 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.314 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -64.73 -22.0 66.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 119.81 -1.807 . . . . 0.0 106.194 176.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 61' ' ' ARG . 15.5 t0 -78.58 -11.08 59.95 Favored 'General case' 0 N--CA 1.53 3.529 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.732 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.513 ' CB ' ' CD ' ' A' ' 67' ' ' PRO 0.265 0.9 OUTLIER -71.62 -152.54 0.0 OUTLIER Pre-proline 0 C--N 1.277 -2.586 0 O-C-N 120.662 -1.274 . . . . 0.0 108.426 179.206 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 0.3 OUTLIER -103.27 -20.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 123.252 2.635 . . . . 0.0 111.542 176.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.504 ' H ' ' CD ' ' A' ' 67' ' ' PRO . 9.6 pt-20 -58.06 -37.23 74.03 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.368 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.799 HG22 ' H ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -49.5 -78.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.771 0 O-C-N 120.228 -1.545 . . . . 0.0 111.403 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.799 ' H ' HG22 ' A' ' 69' ' ' ILE . 61.2 ttt180 -52.11 -31.3 30.13 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -174.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 19.5 tt0 -84.83 -12.07 54.35 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.102 -1.439 . . . . 0.0 112.386 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 75' ' ' LYS . . . -91.09 -51.35 2.62 Favored Glycine 0 N--CA 1.503 3.148 1 N-CA-C 101.72 -4.552 . . . . 0.0 101.72 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.448 HD13 HG12 ' A' ' 100' ' ' VAL . 6.2 tp -43.71 -38.87 3.35 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 112.837 -1.682 . . . . 0.0 107.403 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 23.4 tt0 -64.97 -0.83 1.7 Allowed 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.384 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.894 ' O ' ' O ' ' A' ' 76' ' ' LYS . 21.1 tptp -135.44 68.59 1.45 Allowed 'General case' 0 N--CA 1.517 2.894 0 O-C-N 119.985 -1.697 . . . . 0.0 113.698 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.894 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 11.61 154.55 0.0 OUTLIER Pre-proline 0 N--CA 1.536 3.853 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -29.33 -56.05 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.4 2.733 . . . . 0.0 115.315 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -53.0 131.96 36.95 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 118.158 -1.417 . . . . 0.0 109.766 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 68.78 9.43 7.36 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.864 ' O ' ' N ' ' A' ' 82' ' ' ILE . 30.1 m -78.85 84.24 4.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.746 -1.846 . . . . 0.0 110.043 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -41.98 64.44 0.0 OUTLIER Glycine 0 N--CA 1.504 3.199 0 C-N-CA 119.721 -1.228 . . . . 0.0 111.248 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.864 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.8 tp -71.68 4.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.606 -1.526 . . . . 0.0 107.699 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.579 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 34.5 tp60 -53.99 -32.13 53.08 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.346 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.75 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -79.31 -99.75 0.03 OUTLIER 'General case' 0 C--O 1.189 -2.105 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.682 ' C ' ' O ' ' A' ' 84' ' ' ALA . 2.0 mp -9.58 -54.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.597 0 CA-C-N 122.592 2.451 . . . . 0.0 111.651 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 84' ' ' ALA . . . -59.76 -53.64 55.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 119.977 -1.702 . . . . 0.0 109.477 176.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.75 ' N ' ' O ' ' A' ' 84' ' ' ALA . 87.6 tt0 -40.06 -55.02 2.17 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.319 -1.309 . . . . 0.0 112.074 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -66.11 -63.86 0.99 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 114.2 -3.0 . . . . 0.0 108.159 -177.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 90' ' ' ARG . 2.1 t -45.09 -72.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 115.162 -2.615 . . . . 0.0 110.303 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 1.213 ' CG ' HD11 ' A' ' 96' ' ' LEU . 78.1 mtp180 -32.5 -49.76 0.22 Allowed 'General case' 0 N--CA 1.51 2.53 0 O-C-N 121.08 -1.012 . . . . 0.0 110.308 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.576 ' C ' ' O ' ' A' ' 90' ' ' ARG . 15.6 tptm -33.96 -36.45 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 118.291 -1.364 . . . . 0.0 108.037 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.561 ' N ' ' O ' ' A' ' 90' ' ' ARG . 60.5 mtm180 -56.01 -65.63 0.57 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 117.392 -1.29 . . . . 0.0 108.471 171.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.618 ' O ' ' CG ' ' A' ' 94' ' ' ASP . 2.1 p30 -115.9 -69.9 0.83 Allowed 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 113.869 -3.132 . . . . 0.0 109.673 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.618 ' CG ' ' O ' ' A' ' 93' ' ' ASN . 34.4 m-20 155.35 -9.49 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.71 0 CA-C-O 121.972 0.892 . . . . 0.0 109.988 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.692 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -120.45 152.51 37.89 Favored 'General case' 0 C--O 1.182 -2.476 0 CA-C-N 114.344 -1.298 . . . . 0.0 108.89 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.213 HD11 ' CG ' ' A' ' 90' ' ' ARG . 0.5 OUTLIER 142.2 152.37 0.0 OUTLIER 'General case' 1 N--CA 1.549 4.494 0 CA-C-O 115.971 -1.966 . . . . 0.0 109.379 -178.211 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 110' ' ' HIS . 0.1 OUTLIER -116.1 96.84 5.76 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 125.239 3.654 . . . . 0.0 103.754 171.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -90.31 107.03 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 178.558 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 164' ' ' ALA . 22.0 m -131.44 143.89 39.19 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-O 124.2 1.953 . . . . 0.0 115.644 -171.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.753 HG21 HD11 ' A' ' 69' ' ' ILE . 38.3 t -109.62 138.34 37.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 101.901 -3.37 . . . . 0.0 101.901 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.436 ' HA ' ' CE1' ' A' ' 108' ' ' TYR . 11.3 p -118.91 148.56 42.8 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 104' ' ' GLN . 32.8 t70 -80.21 -173.71 4.14 Favored 'General case' 0 C--N 1.288 -2.1 1 N-CA-C 98.992 -4.447 . . . . 0.0 98.992 171.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 ttp -74.55 71.02 1.83 Allowed 'General case' 0 C--N 1.27 -2.849 0 C-N-CA 113.978 -3.089 . . . . 0.0 105.084 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.2 tp-100 -145.14 -47.81 0.23 Allowed 'General case' 0 C--O 1.211 -0.965 0 O-C-N 120.31 -1.494 . . . . 0.0 110.116 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.566 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.7 t 86.9 138.0 0.05 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 105' ' ' SER . 0.4 OUTLIER 156.35 138.7 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 102.537 -3.135 . . . . 0.0 102.537 176.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.529 HH22 ' CG ' ' A' ' 138' ' ' ASN . 2.6 mpt_? -74.47 97.79 3.18 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.436 ' CE1' ' HA ' ' A' ' 101' ' ' THR . 2.9 m-85 -49.21 -22.53 1.04 Allowed 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.504 ' N ' ' C ' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -131.58 163.44 28.04 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -175.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 97' ' ' PHE . 0.1 OUTLIER 170.96 143.99 0.11 Allowed Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 120.959 -1.088 . . . . 0.0 110.943 178.249 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.44 -44.32 6.68 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 N-CA-C 105.479 -2.546 . . . . 0.0 105.479 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -108.3 109.17 20.44 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.75 67.7 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.561 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.51 -36.94 74.58 Favored 'General case' 0 C--N 1.282 -2.369 0 O-C-N 119.153 -2.217 . . . . 0.0 113.179 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.488 ' NH1' ' N ' ' A' ' 140' ' ' GLY . 0.5 OUTLIER -56.5 -41.6 76.93 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.466 -2.021 . . . . 0.0 107.35 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.741 ' O ' ' N ' ' A' ' 118' ' ' GLN . 85.6 mt -40.66 -80.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.102 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 116' ' ' ILE . . . -27.58 -18.72 0.0 OUTLIER Glycine 0 N--CA 1.497 2.742 0 CA-C-O 119.451 -0.638 . . . . 0.0 113.431 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.741 ' N ' ' O ' ' A' ' 116' ' ' ILE . 5.5 mm-40 -73.43 -70.96 0.24 Allowed Pre-proline 0 N--CA 1.501 2.125 0 CA-C-N 120.942 2.371 . . . . 0.0 112.885 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.666 ' O ' ' O ' ' A' ' 118' ' ' GLN . 75.7 Cg_exo -20.11 156.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 124.05 3.166 . . . . 0.0 114.155 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.496 ' CB ' ' O ' ' A' ' 119' ' ' PRO . 28.4 t80 89.16 145.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.76 72.89 0.5 Allowed 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 117.375 -1.73 . . . . 0.0 111.358 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.665 ' O ' ' OD2' ' A' ' 123' ' ' ASP . . . -152.36 -58.23 0.01 OUTLIER Glycine 0 N--CA 1.507 3.393 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 176.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.665 ' OD2' ' O ' ' A' ' 122' ' ' GLY . 14.3 m-20 131.78 1.88 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.546 0 CA-C-N 117.653 0.727 . . . . 0.0 110.567 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -95.31 -26.7 15.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.572 -1.33 . . . . 0.0 108.683 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.486 ' CD1' ' OG ' ' A' ' 105' ' ' SER . 0.3 OUTLIER -84.44 -18.11 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 120.272 -1.518 . . . . 0.0 109.928 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -50.42 -36.08 31.41 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.654 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 58.5 mttp -80.24 -33.76 37.73 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.27 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.497 ' C ' ' ND2' ' A' ' 130' ' ' ASN . . . -86.74 -28.68 22.9 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 119.788 -1.82 . . . . 0.0 110.321 -176.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.4 mt -50.11 -25.75 3.81 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.648 0.737 . . . . 0.0 109.127 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.831 ' ND2' ' N ' ' A' ' 131' ' ' GLY 0.269 0.0 OUTLIER -78.28 -97.05 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.61 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.831 ' N ' ' ND2' ' A' ' 130' ' ' ASN . . . -161.75 49.15 0.35 Allowed Glycine 0 CA--C 1.549 2.218 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.478 ' H ' HD21 ' A' ' 130' ' ' ASN . 93.2 mt-10 -142.31 163.46 32.79 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.178 -1.778 . . . . 0.0 109.632 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 149' ' ' PHE . 56.2 mm-40 -71.82 165.3 24.37 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.345 0.593 . . . . 0.0 112.054 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 149' ' ' PHE . 5.2 t30 -168.69 144.62 3.55 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.599 ' CG2' HG12 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -132.49 131.12 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 120.24 -1.538 . . . . 0.0 109.848 -178.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.28 168.18 24.02 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.327 -0.858 . . . . 0.0 109.911 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.83 139.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.85 0.833 . . . . 0.0 111.635 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.529 ' CG ' HH22 ' A' ' 107' ' ' ARG . 6.7 t-20 -101.93 130.14 48.37 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 122.231 1.015 . . . . 0.0 111.973 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -127.96 119.65 25.97 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.583 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.488 ' N ' ' NH1' ' A' ' 115' ' ' ARG . . . -156.0 167.66 33.32 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.455 ' C ' ' O ' ' A' ' 140' ' ' GLY . 73.2 m-85 -34.48 -36.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.915 -0.756 . . . . 0.0 110.973 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.71 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 47.5 mt -60.87 -67.92 0.36 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.896 -1.128 . . . . 0.0 110.076 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 142' ' ' LEU . . . 158.36 158.43 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.842 0.829 . . . . 0.0 110.718 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -44.77 137.25 4.06 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.085 0.945 . . . . 0.0 111.341 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.817 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -151.48 150.88 30.91 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 tp -104.67 157.09 17.43 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-N 122.032 2.196 . . . . 0.0 108.896 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.456 ' HD2' HH21 ' A' ' 107' ' ' ARG . 12.4 ptt180 -146.21 153.82 41.05 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.423 1.106 . . . . 0.0 110.592 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.599 HG12 ' CG2' ' A' ' 135' ' ' VAL . 6.9 m -117.97 153.32 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.867 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.431 ' O ' ' OE1' ' A' ' 133' ' ' GLU . 68.7 m-85 -121.65 144.42 48.77 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.56 139.17 16.06 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -87.98 153.21 7.12 Favored 'Trans proline' 0 N--CA 1.513 2.618 0 C-N-CA 123.944 3.096 . . . . 0.0 114.88 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.5 mt -118.22 132.64 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 43.1 m-85 -103.24 148.91 25.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.947 -1.096 . . . . 0.0 113.532 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 156' ' ' ASN . 52.2 t0 -72.47 51.15 0.25 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 153' ' ' TYR . 31.1 tt0 42.98 17.28 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.231 -0.918 . . . . 0.0 111.033 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 158' ' ' LYS . 36.2 m120 -132.99 30.77 3.95 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.885 -1.135 . . . . 0.0 109.073 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 61.82 3.64 0.94 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 156' ' ' ASN . 14.8 mptt -86.19 133.76 33.83 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.724 ' H ' HE21 ' A' ' 159' ' ' GLN . 0.0 OUTLIER -85.72 129.09 34.92 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -175.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.13 8.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.813 0 O-C-N 118.841 -2.412 . . . . 0.0 117.305 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -173.28 -179.9 44.26 Favored Glycine 0 N--CA 1.515 3.915 0 C-N-CA 115.918 -3.039 . . . . 0.0 112.077 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 101' ' ' THR . 70.8 t -141.95 138.85 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.892 -1.358 . . . . 0.0 111.668 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.94 126.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.547 ' O ' HG22 ' A' ' 99' ' ' VAL . . . -114.27 158.8 20.92 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 147' ' ' ARG . 35.4 mt -151.43 101.04 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.225 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.98 131.03 10.46 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.264 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.817 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -93.14 110.35 21.85 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.46 ' CD ' ' N ' ' A' ' 169' ' ' LEU . 14.8 tm-20 -57.61 163.74 2.34 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 143' ' ' ALA . 0.8 OUTLIER -43.95 144.02 0.99 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.517 -1.365 . . . . 0.0 110.644 -179.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 171' ' ' ARG . 1.5 t -109.36 -59.16 1.94 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 120.817 -1.177 . . . . 0.0 110.718 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 170' ' ' SER . 22.9 ttm180 148.99 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.6 0 CA-C-N 113.138 -1.846 . . . . 0.0 109.305 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 176' ' ' ILE . 2.6 t -87.72 24.41 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 O-C-N 120.336 -1.478 . . . . 0.0 108.939 -177.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 65.7 p -80.09 -39.16 30.18 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -75.47 -57.87 3.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.501 -1.374 . . . . 0.0 108.542 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.512 ' CG ' ' H ' ' A' ' 176' ' ' ILE . 7.8 pt20 -50.09 -69.93 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.747 HG23 ' N ' ' A' ' 177' ' ' ASN . 7.7 tp -42.7 -73.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.747 ' N ' HG23 ' A' ' 176' ' ' ILE . 26.2 t30 -43.28 -73.17 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.919 -0.488 . . . . 0.0 110.682 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 179' ' ' SER . 65.0 t0 -46.95 -60.53 2.38 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.155 -0.966 . . . . 0.0 109.82 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 178' ' ' ASP . 81.1 p -43.78 -71.68 0.07 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.114 -0.991 . . . . 0.0 109.741 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.541 178.496 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.506 ' O ' HG22 ' A' ' 48' ' ' THR . 48.9 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.418 0.628 . . . . 0.0 109.366 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 49' ' ' ARG . 27.3 m-20 -69.59 -56.74 6.47 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.832 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -51.73 -45.98 63.83 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.219 -1.551 . . . . 0.0 109.466 -173.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 45' ' ' SER . 6.0 t -60.3 -32.3 71.08 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' THR . 69.2 ttt180 -42.48 -61.3 1.25 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.244 -1.535 . . . . 0.0 110.481 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.95 -59.93 2.51 Favored 'General case' 0 N--CA 1.507 2.391 0 C-N-CA 125.686 1.594 . . . . 0.0 114.496 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 52' ' ' LEU . . . -79.13 -49.34 6.38 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.97 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER -48.95 -44.65 40.83 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 121.273 2.537 . . . . 0.0 107.17 176.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 57' ' ' LEU . . . -48.94 -70.58 0.09 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.937 -1.102 . . . . 0.0 109.09 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -61.56 -55.72 27.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.825 0.822 . . . . 0.0 111.843 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -63.32 -61.25 2.48 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' HB3' HD12 ' A' ' 52' ' ' LEU . . . -65.7 -27.48 68.37 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 121.947 2.158 . . . . 0.0 111.75 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 57' ' ' LEU . 4.8 tt -66.02 -31.36 72.21 Favored 'General case' 0 C--N 1.283 -2.325 0 O-C-N 119.662 -1.899 . . . . 0.0 108.359 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.91 -46.36 14.17 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.63 -33.96 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 118.597 -2.564 . . . . 0.0 106.224 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 98' ' ' ILE . . . -59.43 -37.47 78.15 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 117.871 -1.531 . . . . 0.0 107.281 174.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.559 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 2.6 ptt180 -64.49 -15.03 60.09 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.741 -1.184 . . . . 0.0 108.397 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.683 HG22 HD12 ' A' ' 63' ' ' LEU . 6.7 m -67.49 -49.06 65.18 Favored 'General case' 0 CA--C 1.485 -1.526 0 C-N-CA 114.666 -2.814 . . . . 0.0 104.848 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 62' ' ' THR . 5.7 mp -84.02 -45.1 13.45 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.533 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' A' ' 61' ' ' ARG . . . -50.59 -19.27 0.86 Allowed 'General case' 0 N--CA 1.524 3.269 0 CA-C-O 123.637 1.685 . . . . 0.0 106.544 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.535 ' N ' ' C ' ' A' ' 63' ' ' LEU . 17.7 t0 -88.03 -9.17 54.22 Favored 'General case' 0 N--CA 1.521 3.099 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.897 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.529 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -71.18 -154.2 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 120.46 -1.4 . . . . 0.0 110.523 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.567 ' C ' ' H ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -107.05 -32.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 123.626 2.884 . . . . 0.0 115.054 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.511 ' C ' HD12 ' A' ' 69' ' ' ILE . 12.6 pt-20 -77.88 33.51 0.18 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.658 HG22 ' N ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -110.34 -84.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 175.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.658 ' N ' HG22 ' A' ' 69' ' ' ILE . 78.8 ttt180 -45.19 -32.55 1.91 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.043 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' A' ' 71' ' ' GLN . 9.5 tt0 -85.56 -16.4 39.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.928 -1.107 . . . . 0.0 111.524 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -100.17 -10.46 45.32 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 104.77 -3.332 . . . . 0.0 104.77 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -85.17 -38.56 18.87 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 102.681 -3.081 . . . . 0.0 102.681 174.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.77 -6.6 1.82 Allowed 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.832 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.748 ' O ' ' O ' ' A' ' 76' ' ' LYS . 18.8 mmtt -125.89 64.19 1.21 Allowed 'General case' 0 N--CA 1.526 3.355 0 CA-C-N 120.233 1.378 . . . . 0.0 112.228 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.748 ' O ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 25.4 153.38 0.0 OUTLIER Pre-proline 0 N--CA 1.524 3.253 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -31.93 -61.77 0.15 Allowed 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 123.027 2.485 . . . . 0.0 113.851 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.664 ' CB ' ' HZ2' ' A' ' 76' ' ' LYS . 7.8 tt0 -52.47 137.44 29.82 Favored 'General case' 0 C--N 1.287 -2.109 0 C-N-CA 117.81 -1.556 . . . . 0.0 108.617 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' A' ' 78' ' ' GLN . 24.1 tt0 77.23 -29.31 0.17 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.304 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.773 ' O ' ' N ' ' A' ' 82' ' ' ILE . 8.6 t -46.1 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.334 -1.479 . . . . 0.0 112.674 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' A' ' 83' ' ' GLN . . . -54.44 48.22 0.01 OUTLIER Glycine 0 CA--C 1.562 3.008 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.258 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.773 ' N ' ' O ' ' A' ' 80' ' ' SER . 2.2 tp -56.78 3.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -1.207 . . . . 0.0 109.995 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.63 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 35.0 tp60 -57.74 -22.22 45.44 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.498 -1.376 . . . . 0.0 110.969 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.647 ' C ' HD23 ' A' ' 63' ' ' LEU . . . -77.8 -72.51 0.36 Allowed 'General case' 0 N--CA 1.506 2.375 0 O-C-N 119.85 -1.781 . . . . 0.0 111.353 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -39.76 -55.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 120.518 1.508 . . . . 0.0 110.159 171.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.1 -35.7 48.68 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 119.907 -1.746 . . . . 0.0 108.807 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 83' ' ' GLN . 69.9 tt0 -65.7 -56.09 13.92 Favored 'General case' 0 N--CA 1.513 2.698 0 CA-C-N 114.075 -1.421 . . . . 0.0 112.03 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.496 ' O ' ' C ' ' A' ' 89' ' ' VAL . . . -61.71 -65.02 0.76 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 123.819 3.009 . . . . 0.0 109.412 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -45.78 -65.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 C-N-CA 115.021 -2.671 . . . . 0.0 110.769 -175.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.594 ' N ' ' HB2' ' A' ' 94' ' ' ASP . 48.4 ttp180 -34.52 -44.58 0.2 Allowed 'General case' 0 N--CA 1.516 2.853 0 O-C-N 121.012 -1.055 . . . . 0.0 109.622 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 90' ' ' ARG . 40.8 tptt -43.92 -60.11 1.98 Allowed 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 117.395 -1.722 . . . . 0.0 107.197 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 89' ' ' VAL . 38.7 mtm180 -61.99 -65.75 0.64 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.691 -1.204 . . . . 0.0 107.996 174.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 173.2 103.88 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.751 ' C ' ' H ' ' A' ' 96' ' ' LEU . 27.3 t70 -136.71 54.11 1.88 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.037 0.922 . . . . 0.0 109.2 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.3 mt -72.96 40.21 0.09 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 124.237 1.97 . . . . 0.0 106.609 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.965 HD11 HD12 ' A' ' 167' ' ' LEU 0.326 0.6 OUTLIER -107.17 175.43 5.5 Favored 'General case' 0 N--CA 1.512 2.665 0 CA-C-N 111.312 -2.676 . . . . 0.0 109.65 -178.834 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -107.12 100.64 10.1 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 101.759 -3.423 . . . . 0.0 101.759 171.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.409 ' CD1' ' HB2' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -88.64 131.1 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.624 HG22 ' H ' ' A' ' 164' ' ' ALA . 0.9 OUTLIER -133.32 157.91 42.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 124.79 2.233 . . . . 0.0 113.525 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.15 125.23 38.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.363 1 N-CA-C 99.043 -4.428 . . . . 0.0 99.043 173.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.554 HG23 HG23 ' A' ' 99' ' ' VAL . 26.9 p -125.06 157.83 35.28 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 120.673 -1.267 . . . . 0.0 109.976 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -83.58 -175.17 5.69 Favored 'General case' 0 C--N 1.297 -1.707 1 N-CA-C 97.512 -4.995 . . . . 0.0 97.512 170.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -76.5 85.06 3.21 Favored 'General case' 0 C--N 1.267 -3.009 0 C-N-CA 114.877 -2.729 . . . . 0.0 105.312 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.524 ' O ' ' CB ' ' A' ' 105' ' ' SER . 3.0 tm0? -153.02 -42.25 0.1 Allowed 'General case' 0 CA--C 1.549 0.928 0 O-C-N 120.751 -1.218 . . . . 0.0 109.444 -176.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.625 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.1 t 83.23 138.32 0.06 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.724 ' H ' HH21 ' A' ' 107' ' ' ARG . 0.8 OUTLIER 154.15 134.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 177.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.724 HH21 ' H ' ' A' ' 106' ' ' LEU . 2.6 mmp_? -71.62 94.42 1.33 Allowed 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 116.842 -1.943 . . . . 0.0 106.717 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.601 ' C ' HG21 ' A' ' 82' ' ' ILE . 2.6 m-85 -50.83 -37.08 40.84 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -118.12 167.55 11.38 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.024 -1.443 . . . . 0.0 112.441 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 1.004 ' CD2' HD11 ' A' ' 116' ' ' ILE . 11.9 p80 178.51 151.19 0.45 Allowed Pre-proline 0 N--CA 1.496 1.854 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.204 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.64 -28.3 1.8 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 N-CA-C 107.397 -1.809 . . . . 0.0 107.397 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -119.91 138.27 53.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.42 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.52 -50.38 38.34 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.022 -1.049 . . . . 0.0 113.555 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.15 -38.64 71.13 Favored 'General case' 0 CA--C 1.571 1.775 0 O-C-N 120.152 -1.593 . . . . 0.0 114.936 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.61 ' NH1' ' ND2' ' A' ' 138' ' ' ASN . 0.5 OUTLIER -57.87 -45.25 86.61 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 119.042 -2.286 . . . . 0.0 109.201 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 1.004 HD11 ' CD2' ' A' ' 110' ' ' HIS . 89.6 mt -29.95 -91.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.745 ' N ' HG22 ' A' ' 116' ' ' ILE . . . -45.31 -16.78 0.1 Allowed Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.455 -0.778 . . . . 0.0 114.452 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -59.47 -65.7 1.89 Allowed Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 120.601 2.2 . . . . 0.0 112.439 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 116' ' ' ILE . 1.1 Cg_endo -39.41 103.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 123.487 2.791 . . . . 0.0 113.597 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 122' ' ' GLY . 35.4 t80 -162.43 141.51 9.18 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt 47.7 11.34 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.195 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 120' ' ' PHE . . . -60.45 -15.01 37.24 Favored Glycine 0 N--CA 1.505 3.282 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 122' ' ' GLY . 11.9 t70 71.99 -2.27 2.59 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.11 -1.229 . . . . 0.0 111.49 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.599 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 10.5 p-10 -92.56 -45.88 7.89 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.1 -15.84 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.548 -1.345 . . . . 0.0 110.095 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -55.24 -29.66 58.48 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.355 -1.466 . . . . 0.0 108.148 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 130' ' ' ASN . 68.5 mttm -79.91 -24.99 40.73 Favored 'General case' 0 C--O 1.194 -1.818 0 O-C-N 121.964 -0.46 . . . . 0.0 110.343 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.684 ' O ' ' ND2' ' A' ' 130' ' ' ASN . . . -90.09 -33.21 16.37 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 119.792 -1.818 . . . . 0.0 110.012 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 mt -48.98 -29.53 4.93 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.064 0.935 . . . . 0.0 109.009 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 1.081 ' ND2' ' H ' ' A' ' 131' ' ' GLY . 0.0 OUTLIER -56.9 -78.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 109.768 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 1.081 ' H ' ' ND2' ' A' ' 130' ' ' ASN . . . 167.34 35.05 0.02 OUTLIER Glycine 0 CA--C 1.539 1.578 0 C-N-CA 128.808 3.099 . . . . 0.0 107.586 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.613 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 93.6 mt-10 -141.03 162.69 34.9 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 119.605 1.702 . . . . 0.0 109.767 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -76.08 165.68 24.58 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.621 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -168.98 153.33 5.59 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -133.45 136.44 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.016 -1.052 . . . . 0.0 110.556 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.57 172.16 13.37 Favored 'General case' 0 N--CA 1.518 2.96 0 O-C-N 120.528 -1.357 . . . . 0.0 109.682 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.6 136.0 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 120.641 -1.287 . . . . 0.0 110.349 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.61 ' ND2' ' NH1' ' A' ' 115' ' ' ARG . 3.8 t30 -103.98 133.61 48.65 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.462 -0.774 . . . . 0.0 109.005 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -132.75 100.91 5.08 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.676 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -116.47 164.13 12.35 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -44.35 -13.89 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.34 -1.094 . . . . 0.0 110.494 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -75.53 -72.37 0.31 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.984 -1.073 . . . . 0.0 108.7 -179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 144' ' ' GLN . . . 176.43 149.61 0.13 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.428 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' ALA . 97.2 mt-30 -35.06 152.55 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 CA-C-O 121.481 0.658 . . . . 0.0 110.139 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.974 ' HB1' ' O ' ' A' ' 167' ' ' LEU . . . -157.2 152.4 26.17 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 117.357 -1.306 . . . . 0.0 107.855 -176.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.8 tp -116.37 144.23 44.54 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 123.149 2.704 . . . . 0.0 109.684 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -129.44 147.62 51.27 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.338 1.066 . . . . 0.0 110.97 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.52 HG12 ' CG2' ' A' ' 135' ' ' VAL . 7.3 m -114.05 158.35 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -132.88 138.96 47.18 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.67 138.76 29.03 Favored Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -86.45 155.31 9.24 Favored 'Trans proline' 0 C--N 1.295 -2.247 0 C-N-CA 122.555 2.17 . . . . 0.0 113.758 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 62.6 mt -118.2 135.44 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . 0.304 65.2 m-85 -106.24 151.77 24.36 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 155' ' ' GLU . 63.0 t0 -78.46 164.35 24.83 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.573 ' N ' ' OD1' ' A' ' 154' ' ' ASP . 18.5 tt0 -47.95 -9.31 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.241 -1.383 . . . . 0.0 112.976 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 154' ' ' ASP . 16.7 m120 -121.83 49.62 1.53 Allowed 'General case' 0 N--CA 1.518 2.971 0 O-C-N 120.348 -1.47 . . . . 0.0 114.268 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 57.39 9.32 0.73 Allowed 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.998 -1.064 . . . . 0.0 110.443 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -83.69 128.79 34.79 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.763 ' N ' HE21 ' A' ' 159' ' ' GLN . 0.0 OUTLIER -74.96 126.72 31.61 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.182 -0.949 . . . . 0.0 112.662 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.419 ' C ' HD12 ' A' ' 160' ' ' ILE . 2.7 pp -141.73 12.43 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.601 0 O-C-N 119.028 -2.295 . . . . 0.0 116.231 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.11 174.51 46.83 Favored Glycine 0 N--CA 1.501 3.025 0 C-N-CA 115.774 -3.108 . . . . 0.0 112.002 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.9 t -137.55 143.51 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.576 1.179 . . . . 0.0 113.215 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 40.6 t -109.6 129.2 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.624 ' H ' HG22 ' A' ' 99' ' ' VAL . . . -127.01 157.53 39.35 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.231 -0.918 . . . . 0.0 108.845 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 147' ' ' ARG . 16.3 mt -151.12 99.99 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 96' ' ' LEU . . . -108.03 118.14 5.34 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.918 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.974 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.8 tp -72.38 120.23 17.71 Favored 'General case' 0 C--O 1.193 -1.914 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.07 -30.11 63.45 Favored 'General case' 1 N--CA 1.542 4.163 0 CA-C-O 123.11 1.433 . . . . 0.0 110.37 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -170.78 176.95 4.01 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 113.67 -1.604 . . . . 0.0 114.399 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 1.004 ' O ' ' N ' ' A' ' 172' ' ' VAL . 2.9 t -179.76 64.05 0.01 OUTLIER 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.115 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 14.55 -32.3 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 125.2 1.4 . . . . 0.0 114.624 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 1.004 ' N ' ' O ' ' A' ' 170' ' ' SER . 3.0 t -93.18 36.49 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.197 -1.564 . . . . 0.0 108.24 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 82.2 p -84.85 -35.36 22.29 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -77.42 -51.56 10.59 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -54.43 -69.1 0.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.047 0.927 . . . . 0.0 110.058 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.843 HG23 ' H ' ' A' ' 177' ' ' ASN . 9.8 tp -41.57 -72.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 O-C-N 121.071 -1.018 . . . . 0.0 112.042 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.843 ' H ' HG23 ' A' ' 176' ' ' ILE . 29.8 m120 -44.16 -77.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.403 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -48.38 -58.4 4.66 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.454 -1.404 . . . . 0.0 112.091 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.471 ' OG ' ' N ' ' A' ' 180' ' ' ARG . 56.1 p -44.75 -66.35 0.41 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.747 -1.22 . . . . 0.0 111.191 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.471 ' N ' ' OG ' ' A' ' 179' ' ' SER . 67.0 ttt180 . . . . . 0 C--N 1.302 -1.477 0 O-C-N 121.025 -1.047 . . . . 0.0 109.874 -178.939 . . . . . . . . 1 1 . 1 stop_ save_